Processing 00000000.tx.1: He was transferred to the Valtawnprinceel Community Memorial Hospital for endoscopy and esophagoscopy on the 16th of November which showed a 2 cm linear tear of the esophagus at 30 to 32 cm . 

Phrase: He

Phrase: was

Phrase: transferred to the Valtawnprinceel Community Memorial Hospital
Meta Mapping (701):
   748   transferred (Surgical transfer - action) [Functional Concept]
   774   hospital community (Hospitals, Community) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   Transferred (Transfer Technique) [Functional Concept]
   774   hospital community (Hospitals, Community) [Health Care Related Organization,Manufactured Object]

Phrase: for endoscopy
Meta Mapping (1000):
  1000   ENDOSCOPY (Endoscopy (procedure)) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Endoscopy (Clinic / Center - Endoscopy) [Health Care Related Organization,Manufactured Object]

Phrase: and

Phrase: esophagoscopy on the 16th of November
Meta Mapping (672):
   753   Oesophagoscopy, NOS (Esophagoscopy) [Diagnostic Procedure]
   586   November [Temporal Concept]

Phrase: which

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a 2 cm linear tear of the esophagus
Meta Mapping (677):
   578   +2 [Quantitative Concept]
   578   Linear [Spatial Concept]
   767   ESOPHAGUS TEAR (Mallory-Weiss Syndrome) [Disease or Syndrome]
Meta Mapping (677):
   578   2+ (2+ Score) [Quantitative Concept]
   578   Linear [Spatial Concept]
   767   ESOPHAGUS TEAR (Mallory-Weiss Syndrome) [Disease or Syndrome]
Meta Mapping (677):
   578   2+ (2+ Score, WHO) [Classification]
   578   Linear [Spatial Concept]
   767   ESOPHAGUS TEAR (Mallory-Weiss Syndrome) [Disease or Syndrome]
Meta Mapping (677):
   578   2+ [Finding]
   578   Linear [Spatial Concept]
   767   ESOPHAGUS TEAR (Mallory-Weiss Syndrome) [Disease or Syndrome]

Phrase: at 30 to 32 cm .
Meta Mapping (760):
   760   30% [Finding]
Processing 00000000.tx.2: An electrocardiogram showed ST depressions in V2 through V4 which improved with sublingual and intravenous nitroglycerin . 

Phrase: An electrocardiogram
Meta Mapping (1000):
  1000   Electrocardiogram [Finding]
Meta Mapping (1000):
  1000   Electro-Cardiogram [Spatial Concept]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: ST depressions in V2
Meta Mapping (783):
   819   depressions st (ST segment depression (finding)) [Finding]
   604   V2 (V2 stage) [Finding]
Meta Mapping (783):
   819   depressions st (ST segment depression (finding)) [Finding]
   604   V2 (Posterior segmental vein) [Body Part, Organ, or Organ Component]
Meta Mapping (783):
   819   depressions st (ST segment depression (finding)) [Finding]
   604   V2 (TRGV9 gene) [Gene or Genome]

Phrase: through V4
Meta Mapping (1000):
  1000   V4+ [Element, Ion, or Isotope]

Phrase: which

Phrase: improved with sublingual
Meta Mapping (746):
   790   Improved [Qualitative Concept]
   790   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
Meta Mapping (746):
   790   Improved [Qualitative Concept]
   790   Sublingual (Sublingual location) [Body Location or Region]
Meta Mapping (746):
   790   Improved (Better) [Qualitative Concept]
   790   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
Meta Mapping (746):
   790   Improved (Better) [Qualitative Concept]
   790   Sublingual (Sublingual location) [Body Location or Region]
Meta Mapping (746):
   790   Improved (Admission Level of Care Code - Improved) [Intellectual Product]
   790   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
Meta Mapping (746):
   790   Improved (Admission Level of Care Code - Improved) [Intellectual Product]
   790   Sublingual (Sublingual location) [Body Location or Region]

Phrase: and

Phrase: intravenous nitroglycerin .
Meta Mapping (888):
   694   Intravenous [Spatial Concept]
   861   nitroglycerine (Nitroglycerin) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   Intravenous [Spatial Concept]
   861   nitroglycerine (Glonoine, nitroglycerine, Homeopathic preparation) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.3: The patient &apos;s social history is remarkable for greater than 80 pack years of smoking , which he discontinued 15 years prior to admission . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s social history
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   Social history (Social and personal history) [Finding]
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   Social History [Finding]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   Social history (Social and personal history) [Finding]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   Social History [Finding]

Phrase: is

Phrase: remarkable for greater
Meta Mapping (623):
   623   Greater [Quantitative Concept]

Phrase: than 80 pack years of smoking ,
Meta Mapping (725):
   586   80% [Finding]
   790   Pack years [Intellectual Product]
   586   SMOKING (Smoking) [Individual Behavior]
Meta Mapping (725):
   586   80% [Finding]
   790   Pack years [Intellectual Product]
   586   Smoking (Tobacco smoking behavior) [Individual Behavior]
Meta Mapping (725):
   586   80% [Finding]
   790   Pack years [Intellectual Product]
   586   Smoking (Medical Device Emits Smoke) [Phenomenon or Process]

Phrase: which

Phrase: he

Phrase: discontinued
Meta Mapping (1000):
  1000   Discontinued [Finding]

Phrase: 15 years prior to admission .
Meta Mapping (787):
   760   YEARS (year) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (787):
   760   YEARS (year) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Admission activity) [Health Care Activity]
Processing 00000000.tx.4: His abdomen was benign . 

Phrase: His abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: benign .
Meta Mapping (1000):
  1000   BENIGN (Benign) [Qualitative Concept]
Processing 00000000.tx.5: He thought he was in &quot; Em Nysonken Medical Center &quot; . 

Phrase: He

Phrase: thought
Meta Mapping (1000):
  1000   Thought (Thinking, function) [Mental Process]

Phrase: he

Phrase: was in &quot

Phrase: ; Em Nysonken Medical Center &quot
Meta Mapping (673):
   673   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (673):
   673   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: ; .
Processing 00000000.tx.6: He was taken for esophagogastroduodenoscopy by the Surgical Service after elective intubation for airway control . 

Phrase: He

Phrase: was

Phrase: taken for esophagogastroduodenoscopy
Meta Mapping (746):
   790   Taken [Conceptual Entity]
   790   Oesophagogastroduodenoscopy (Esophagogastroduodenoscopy) [Diagnostic Procedure]

Phrase: by the Surgical Service after elective intubation
Meta Mapping (696):
   778   Surgical Service (Surgical service) [Health Care Activity]
   581   ELECTIVE (Elective Surgical Procedures) [Therapeutic or Preventive Procedure]
   581   INTUBATION (Intubation) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   778   Surgical Service (Surgical service) [Health Care Activity]
   581   Elective (elective) [Temporal Concept]
   581   INTUBATION (Intubation) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   748   Service (Services) [Occupational Activity]
   607   Elective Surgical (Elective Surgical Procedures) [Therapeutic or Preventive Procedure]
   581   INTUBATION (Intubation) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   748   Service (Software Service) [Manufactured Object]
   607   Elective Surgical (Elective Surgical Procedures) [Therapeutic or Preventive Procedure]
   581   INTUBATION (Intubation) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   748   service (ActInformationPrivacyReason <service>) [Idea or Concept]
   607   Elective Surgical (Elective Surgical Procedures) [Therapeutic or Preventive Procedure]
   581   INTUBATION (Intubation) [Therapeutic or Preventive Procedure]

Phrase: for airway control .
Meta Mapping (1000):
  1000   Control, Airway (Airway Management) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: The patient died on the 31st . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: died on the 31st .
Meta Mapping (770):
   770   Died (Cessation of life) [Organism Function]
Meta Mapping (770):
   770   Died (Death (finding)) [Finding]
Meta Mapping (770):
   770   Died (Patient Outcome - Died) [Finding]
Processing 00000000.tx.8: 11/05/95 TD : ARF32 FA He was edentulous . 

Phrase: 11/05/95 TD
Meta Mapping (812):
   812   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (812):
   812   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :

Phrase: ARF32 FA

Phrase: He

Phrase: was

Phrase: edentulous .
Meta Mapping (1000):
  1000   EDENTULOUS (Mouth, Edentulous) [Finding]
Processing 00000000.tx.9: Liver edge , thickened abdominal wall was palpable . 

Phrase: Liver edge ,
Meta Mapping (1000):
  1000   Liver edge [Finding]

Phrase: thickened
Meta Mapping (1000):
  1000   Thickened [Finding]

Phrase: abdominal wall
Meta Mapping (1000):
  1000   ABDOMINAL WALL (Abdominal wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Abdominal wall (Entire abdominal wall) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: palpable .
Meta Mapping (1000):
  1000   Palpable [Qualitative Concept]
Processing 00000000.tx.10: On mental status exam , he was somnolent but arousable . 

Phrase: On mental status exam ,
Meta Mapping (901):
   734   Mental status (Mental state (observable entity)) [Finding]
   827   Exam (Medical Examination) [Health Care Activity]

Phrase: he

Phrase: was

Phrase: somnolent
Meta Mapping (1000):
  1000   SOMNOLENT (Drowsiness) [Finding]
Meta Mapping (1000):
  1000   Somnolent (Somnolence) [Finding]

Phrase: but

Phrase: arousable .
Processing 00000000.tx.11: Oriented to name , year , and hospital . 

Phrase: Oriented
Meta Mapping (1000):
  1000   Oriented (Orientation (spatial)) [Spatial Concept]
Meta Mapping (1000):
  1000   Oriented (Oriented to place) [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: name
Meta Mapping (1000):
  1000   Name [Intellectual Product]
Meta Mapping (1000):
  1000   Name (Person Name) [Intellectual Product]

Phrase: ,

Phrase: year ,
Meta Mapping (1000):
  1000   YEAR (year) [Temporal Concept]
Meta Mapping (1000):
  1000   /Year (per year) [Temporal Concept]

Phrase: and

Phrase: hospital .
Meta Mapping (1000):
  1000   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (1000):
  1000   Hospital (Hospital environment) [Qualitative Concept]
Processing 00000000.tx.12: <TEXT> CMC Report Status : 11/03/2002 ACUTE MYELOGENOUS LEUKEMIA . 

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > CMC Report Status
Meta Mapping (901):
   660   CMC (MCC protocol) [Therapeutic or Preventive Procedure]
   901   Report status [Finding]
Meta Mapping (901):
   660   CMC (Capillary malformation (disorder)) [Congenital Abnormality]
   901   Report status [Finding]
Meta Mapping (901):
   660   CMC (Circulating Melanoma Cell) [Cell]
   901   Report status [Finding]

Phrase: :

Phrase: 11/03/2002 ACUTE MYELOGENOUS LEUKEMIA .
Meta Mapping (861):
   861   Acute myelogenous leukaemia (Leukemia, Myelocytic, Acute) [Neoplastic Process]
Processing 00000000.tx.13: HOSPITAL COURSE : Clotrimazole by mouth one troche four times per day , Colace 100 mg p.o. b.i.d. 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: Clotrimazole by mouth one troche four times
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   MOUTH (Oral cavity) [Body Space or Junction]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosing Unit) [Quantitative Concept]
   581   Four [Quantitative Concept]
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   MOUTH (Oral cavity) [Body Space or Junction]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosage Form) [Biomedical or Dental Material]
   581   Four [Quantitative Concept]
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   Mouth (Oral region) [Body Location or Region]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosing Unit) [Quantitative Concept]
   581   Four [Quantitative Concept]
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   Mouth (Oral region) [Body Location or Region]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosage Form) [Biomedical or Dental Material]
   581   Four [Quantitative Concept]
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   Mouth, NOS (Entire mouth region) [Body Location or Region]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosing Unit) [Quantitative Concept]
   581   Four [Quantitative Concept]
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   Mouth, NOS (Entire mouth region) [Body Location or Region]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosage Form) [Biomedical or Dental Material]
   581   Four [Quantitative Concept]
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   Mouth (Entire oral cavity) [Body Location or Region]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosing Unit) [Quantitative Concept]
   581   Four [Quantitative Concept]
Meta Mapping (745):
   748   Klotrimazole (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
   581   Mouth (Entire oral cavity) [Body Location or Region]
   591   one time [Intellectual Product]
   581   TROCHE (Troche Dosage Form) [Biomedical or Dental Material]
   581   Four [Quantitative Concept]

Phrase: per day ,
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]

Phrase: Colace 100 mg p.o. b.i.d.
Meta Mapping (816):
   816   Docusate Sodium 100 MG [Clinical Drug]
Processing 00000000.tx.14: , multivitamin 1 tab p.o. q d , Trazodone 50 mg q h.s. 

Phrase: , multivitamin 1 tab p.o. q d ,
Meta Mapping (552):
   629   Multivitamin (Multivitamin preparation) [Organic Chemical,Pharmacologic Substance,Vitamin]
   629   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
Meta Mapping (552):
   629   Multivitamin (Multivitamin preparation) [Organic Chemical,Pharmacologic Substance,Vitamin]
   629   Tab (Tablet Dosing Unit) [Quantitative Concept]

Phrase: Trazodone 50 mg q h.s.
Meta Mapping (864):
   861   trazodone 50 mg [Clinical Drug]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (864):
   861   trazodone 50 mg [Clinical Drug]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (864):
   861   trazodone 50 mg [Clinical Drug]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (864):
   861   trazodone 50 mg [Clinical Drug]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.15: , Nexium 20 mg p.o. q d , Tylenol p.r.n. 

Phrase: , Nexium 20 mg p.o. q d ,
Meta Mapping (772):
   629   Nexium [Organic Chemical,Pharmacologic Substance]
   629   20% [Finding]
   861   mg/d (milligram/day) [Quantitative Concept]

Phrase: Tylenol
Meta Mapping (1000):
  1000   Tylenol [Organic Chemical,Pharmacologic Substance]

Phrase: p.r.n.
Meta Mapping (901):
   827   P NOS (P Blood group antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Meta Mapping (901):
   827   P' (P prime) [Clinical Attribute]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Processing 00000000.tx.16: Eucerin p.r.n. 

Phrase: Eucerin
Meta Mapping (1000):
  1000   EUCERIN (eucerin) [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: p.r.n.
Meta Mapping (901):
   827   P NOS (P Blood group antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Meta Mapping (901):
   827   P' (P prime) [Clinical Attribute]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Processing 00000000.tx.17: Batch : 04/08/1998 The patient was in her usual state of health , carrying the diagnosis of right lung chorio carcinoma , when she began to develop dyspnea and on 03/24/98 an echocardiogram revealed a pericardial effusion and possible tamponade clinically . 

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: 04/08/1998

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was in her usual state of health ,
Meta Mapping (770):
   748   Usual [Qualitative Concept]
   814   state of health (personal health) [Finding]

Phrase: carrying
Meta Mapping (1000):
  1000   Carrying [Activity]

Phrase: the diagnosis of right lung chorio carcinoma ,
Meta Mapping (812):
   748   DIAGNOSIS (Diagnosis) [Finding]
   581   RIGHT (Right) [Spatial Concept]
   659   Carcinoma of the Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (812):
   748   DIAGNOSIS (Diagnosis) [Finding]
   581   Right (Right sided) [Spatial Concept]
   659   Carcinoma of the Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (812):
   748   diagnosis (diagnosis aspect) [Qualitative Concept]
   581   RIGHT (Right) [Spatial Concept]
   659   Carcinoma of the Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (812):
   748   diagnosis (diagnosis aspect) [Qualitative Concept]
   581   Right (Right sided) [Spatial Concept]
   659   Carcinoma of the Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (812):
   748   DIAGNOSIS (Diagnosis Study) [Research Activity]
   581   RIGHT (Right) [Spatial Concept]
   659   Carcinoma of the Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (812):
   748   DIAGNOSIS (Diagnosis Study) [Research Activity]
   581   Right (Right sided) [Spatial Concept]
   659   Carcinoma of the Lung (Carcinoma of lung) [Neoplastic Process]

Phrase: when

Phrase: she

Phrase: began
Meta Mapping (966):
   966   Begin (Beginning) [Temporal Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: develop

Phrase: dyspnea
Meta Mapping (1000):
  1000   DYSPNOEA (Dyspnea) [Sign or Symptom]

Phrase: and on 03/24/98

Phrase: an echocardiogram
Meta Mapping (1000):
  1000   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Echocardiogram (Echocardiogram (image)) [Intellectual Product]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a pericardial effusion
Meta Mapping (1000):
  1000   Effusion, Pericardial (Pericardial effusion) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Pericardial effusion (Pericardial effusion body substance) [Body Substance]

Phrase: and

Phrase: possible tamponade clinically .
Meta Mapping (790):
   660   Possible [Qualitative Concept]
   827   Tamponade (Compressed structure) [Functional Concept]
Meta Mapping (790):
   660   Possible [Qualitative Concept]
   827   Tamponade (Tamponade - action) [Therapeutic or Preventive Procedure]
Meta Mapping (790):
   660   Possible (Possibly Related to Intervention) [Qualitative Concept]
   827   Tamponade (Compressed structure) [Functional Concept]
Meta Mapping (790):
   660   Possible (Possibly Related to Intervention) [Qualitative Concept]
   827   Tamponade (Tamponade - action) [Therapeutic or Preventive Procedure]
Meta Mapping (790):
   660   Possible (Possible diagnosis) [Qualitative Concept]
   827   Tamponade (Compressed structure) [Functional Concept]
Meta Mapping (790):
   660   Possible (Possible diagnosis) [Qualitative Concept]
   827   Tamponade (Tamponade - action) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: The patient lives in Jer by herself . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: lives in Jer
Meta Mapping (790):
   790   lives (Household composition) [Finding]
Meta Mapping (790):
   790   Live (Live - Specimen Condition) [Qualitative Concept]
Meta Mapping (790):
   790   % live [Qualitative Concept]
Meta Mapping (790):
   790   Live (Reside) [Activity]

Phrase: by herself .
Processing 00000000.tx.19: HABITS : VITAL SIGNS : Temperature 97.5 , heart rate 90 , blood pressure 104/80 , respiratory rate 18 . 

Phrase: HABITS
Meta Mapping (1000):
  1000   Habits (Behaviorial Habits) [Individual Behavior]

Phrase: :

Phrase: VITAL SIGNS
Meta Mapping (1000):
  1000   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (1000):
  1000   Signs, Vital (Vital signs) [Clinical Attribute]

Phrase: :

Phrase: Temperature 97.5 ,
Meta Mapping (790):
   827   temperature (Body Temperature) [Organism Attribute]
   827   97 [Intellectual Product]
Meta Mapping (790):
   827   temperature (Body Temperature) [Organism Attribute]
   827   >97 [Quantitative Concept]
Meta Mapping (790):
   827   *Temperature (Temperature) [Quantitative Concept]
   827   97 [Intellectual Product]
Meta Mapping (790):
   827   *Temperature (Temperature) [Quantitative Concept]
   827   >97 [Quantitative Concept]

Phrase: heart rate 90 ,
Meta Mapping (901):
   901   Heart Rate (heart rate) [Clinical Attribute]
   827   >90 [Quantitative Concept]
Meta Mapping (901):
   901   Heart Rate (heart rate) [Clinical Attribute]
   827   <90 [Quantitative Concept]
Meta Mapping (901):
   901   Heart Rate (heart rate) [Clinical Attribute]
   827   90% [Finding]

Phrase: blood pressure 104/80 ,
Meta Mapping (824):
   861   BLOOD PRESSURE (Blood Pressure) [Organism Function]
   812   80% [Finding]
Meta Mapping (824):
   861   Blood Pressure (Blood pressure finding) [Finding]
   812   80% [Finding]
Meta Mapping (824):
   861   Blood pressure (Systemic arterial pressure) [Finding]
   812   80% [Finding]

Phrase: respiratory rate 18 .
Meta Mapping (901):
   901   Respiratory Rate (Respiratory rate) [Clinical Attribute]
Meta Mapping (901):
   901   Respiratory rate (Breaths:Number = Count/Time:Point in time:Respiratory system:Quantitative) [Clinical Attribute]
Processing 00000000.tx.20: During that time , on 03/26/98 a pericardial centesis was performed and 550 cc of bloody fluid were removed . 

Phrase: During

Phrase: that time ,
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: on 03/26/98

Phrase: a pericardial centesis
Meta Mapping (888):
   694   Pericardial (Pericardial sac structure) [Body Part, Organ, or Organ Component]
   861   Centesis (Paracentesis) [Health Care Activity]
Meta Mapping (888):
   694   Pericardial (Pericardial body location) [Body Location or Region]
   861   Centesis (Paracentesis) [Health Care Activity]

Phrase: was

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: and

Phrase: 550 cc of bloody fluid
Meta Mapping (696):
   760   CC (C-Circle) [Cell Component]
   593   Bloody (Hemorrhagic) [Qualitative Concept]
   593   FLUID (Body Fluids) [Body Substance]
Meta Mapping (696):
   760   CC (C-Circle) [Cell Component]
   593   Bloody (Hemorrhagic) [Qualitative Concept]
   593   fluid (Liquid substance) [Substance]
Meta Mapping (696):
   760   CC (C-Circle) [Cell Component]
   593   Bloody (Hemorrhagic) [Qualitative Concept]
   593   Fluid (Fluid behavior) [Qualitative Concept]
Meta Mapping (696):
   760   CC (C-Circle) [Cell Component]
   593   Bloody (Hemorrhagic) [Qualitative Concept]
   593   Fluid (fluid - substance) [Substance]

Phrase: were

Phrase: removed .
Meta Mapping (1000):
  1000   Removed [Qualitative Concept]
Processing 00000000.tx.21: Apulmonary embolus was suspected . 

Phrase: Apulmonary embolus
Meta Mapping (861):
   861   EMBOLUS (Embolus) [Finding]

Phrase: was

Phrase: suspected .
Meta Mapping (1000):
  1000   Suspected (Suspected diagnosis) [Qualitative Concept]
Meta Mapping (1000):
  1000   Suspected (Suspected qualifier) [Idea or Concept]
Processing 00000000.tx.22: 7. 

Phrase: 7.
Processing 00000000.tx.23: Trazodone 150 mg p.o. q h.s. 

Phrase: Trazodone 150 mg p.o. q h.s.
Meta Mapping (781):
   793   TRAZODONE (Trazodone) [Organic Chemical,Pharmacologic Substance]
   850   mg/h [Quantitative Concept]
Processing 00000000.tx.24: Dictated By : Attending : </RECORD> 70344737 02/04/2001 6U-489 Full code Food / Drug Interaction Instruction No Restrictions Activity - As tolerated Immediately HTN NIDDM-DIET TL TONSILECT ATYPICAL CP OPERATIONS AND PROCEDURES : DISCHARGE CONDITION : TO DO / PLAN : SKILUCRE , CINEJEANALF NALDDEDE CARLT , M.D. 

Phrase: Dictated By
Meta Mapping (833):
   833   dictated (dictated - ParticipationMode) [Functional Concept]
Meta Mapping (833):
   833   Dictated (dictated - DocumentCompletion) [Idea or Concept]

Phrase: :

Phrase: Attending
Meta Mapping (1000):
  1000   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   attending (Attending (action)) [Functional Concept]

Phrase: :

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 70344737 02/04/2001 6U-489 Full code Food / Drug Interaction Instruction
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   code (Coding) [Occupational Activity]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   Instruction (Educational process of instructing) [Educational Activity]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   code (Coding) [Occupational Activity]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   Instruction (Instruction [Publication Type]) [Intellectual Product]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   code (Coding) [Occupational Activity]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   instruction (Instructions) [Idea or Concept]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   CODE (Code) [Intellectual Product]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   Instruction (Educational process of instructing) [Educational Activity]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   CODE (Code) [Intellectual Product]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   Instruction (Instruction [Publication Type]) [Intellectual Product]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   CODE (Code) [Intellectual Product]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   instruction (Instructions) [Idea or Concept]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   Code (eTMF Content Model Code) [Intellectual Product]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   Instruction (Educational process of instructing) [Educational Activity]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   Code (eTMF Content Model Code) [Intellectual Product]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   Instruction (Instruction [Publication Type]) [Intellectual Product]
Meta Mapping (712):
   621   Full [Qualitative Concept]
   621   Code (eTMF Content Model Code) [Intellectual Product]
   645   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   787   instruction (Instructions) [Idea or Concept]

Phrase: No Restrictions Activity -
Meta Mapping (872):
   661   Restriction (Restricted) [Functional Concept]
   861   Activity (Active) [Functional Concept]
Meta Mapping (872):
   661   Restriction (Restricted) [Functional Concept]
   861   % Activity (Percent Activity) [Quantitative Concept]
Meta Mapping (872):
   661   Restriction (Restricted) [Functional Concept]
   861   ACTIVITY (Activities) [Activity]
Meta Mapping (872):
   661   Restriction (Restricted) [Functional Concept]
   861   *Activity (*Activity (kind of quantity)) [Idea or Concept]
Meta Mapping (872):
   661   Restriction (Restricted) [Functional Concept]
   861 N Activity (Activity (animal life circumstance)) [Finding]
Meta Mapping (872):
   661   Restriction (Restricted) [Functional Concept]
   861   ACTIVITY (Physical Activity Measurement) [Laboratory Procedure]
Meta Mapping (872):
   661   Restriction (Restricted) [Functional Concept]
   861   ACTIVITY (FDA Establishment Activity Terminology) [Intellectual Product]

Phrase: As

Phrase: tolerated

Phrase: Immediately HTN NIDDM-DIET TL TONSILECT ATYPICAL CP OPERATIONS
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624 N NIDDM (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet therapy) [Health Care Activity]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   DIET (Basal Diet) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical [Qualitative Concept]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (Surgical aspects) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (741):
   624   Immediately (Stat (do immediately)) [Temporal Concept]
   624 N HTN (Hypertensive disease) [Disease or Syndrome]
   624   NIDDM (NEUROD1 wt Allele) [Gene or Genome]
   624   Diet (Diet (animal life circumstance)) [Food]
   624   TL (Tokelau) [Geographic Area]
   624   Atypical (atypia morphology) [Finding]
   624   CP (Clipperton Island) [Geographic Area]
   791   operations (HL7PublishingSubSection <operations>) [Intellectual Product]

Phrase: AND

Phrase: PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: DISCHARGE CONDITION
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]

Phrase: :

Phrase: TO DO / PLAN
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Planned) [Functional Concept]

Phrase: :

Phrase: SKILUCRE ,

Phrase: CINEJEANALF NALDDEDE CARLT ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.25: , PH.D. 

Phrase: , PH.D.
Meta Mapping (1000):
  1000   Ph.D. (Doctor of Philosophy) [Intellectual Product]
Processing 00000000.tx.26: ( BW48 ) 02/05/01 12:50 PM Failed left total hip replacement . 

Phrase: ( BW48

Phrase: )

Phrase: 02/05/01 12

Phrase: :

Phrase: 50 PM Failed left total hip replacement .
Meta Mapping (836):
   629   50% [Finding]
   629   PM (Panama) [Geographic Area]
   629   Failed (failed) [Functional Concept]
   629   LEFT (Left) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   50% [Finding]
   629   PM (Panama) [Geographic Area]
   629   Failed (failed) [Functional Concept]
   629   Left (Left sided) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   50% [Finding]
   629   PM (Panama) [Geographic Area]
   629   Failed (failed) [Functional Concept]
   629   left (Table Cell Horizontal Align - left) [Functional Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   50% [Finding]
   629   PM (Infusion pump Alert priority PM) [Finding]
   629   Failed (failed) [Functional Concept]
   629   LEFT (Left) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   50% [Finding]
   629   PM (Infusion pump Alert priority PM) [Finding]
   629   Failed (failed) [Functional Concept]
   629   Left (Left sided) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   50% [Finding]
   629   PM (Infusion pump Alert priority PM) [Finding]
   629   Failed (failed) [Functional Concept]
   629   left (Table Cell Horizontal Align - left) [Functional Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   <50 [Finding]
   629   PM (Panama) [Geographic Area]
   629   Failed (failed) [Functional Concept]
   629   LEFT (Left) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   <50 [Finding]
   629   PM (Panama) [Geographic Area]
   629   Failed (failed) [Functional Concept]
   629   Left (Left sided) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   <50 [Finding]
   629   PM (Panama) [Geographic Area]
   629   Failed (failed) [Functional Concept]
   629   left (Table Cell Horizontal Align - left) [Functional Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   <50 [Finding]
   629   PM (Infusion pump Alert priority PM) [Finding]
   629   Failed (failed) [Functional Concept]
   629   LEFT (Left) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   <50 [Finding]
   629   PM (Infusion pump Alert priority PM) [Finding]
   629   Failed (failed) [Functional Concept]
   629   Left (Left sided) [Spatial Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (836):
   629   <50 [Finding]
   629   PM (Infusion pump Alert priority PM) [Finding]
   629   Failed (failed) [Functional Concept]
   629   left (Table Cell Horizontal Align - left) [Functional Concept]
   845   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.27: The left total hip replacement now needs revision due to the multiple dislocations . 

Phrase: The left total hip replacement
Meta Mapping (916):
   645   LEFT (Left) [Spatial Concept]
   923   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (916):
   645   Left (Left sided) [Spatial Concept]
   923   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (916):
   645   left (Table Cell Horizontal Align - left) [Functional Concept]
   923   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]

Phrase: now
Meta Mapping (1000):
  1000   Now (Now (temporal qualifier)) [Temporal Concept]

Phrase: needs
Meta Mapping (1000):
  1000   Needs [Qualitative Concept]
Meta Mapping (1000):
  1000   needs (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: revision due to the multiple dislocations .
Meta Mapping (759):
   753   Revision [Temporal Concept]
   623   Due To (Due to) [Functional Concept]
   623   MULTIPLE DISLOCATIONS (Dislocation, multiple) [Injury or Poisoning]
Meta Mapping (759):
   753   Revision (Surgical revision) [Therapeutic or Preventive Procedure]
   623   Due To (Due to) [Functional Concept]
   623   MULTIPLE DISLOCATIONS (Dislocation, multiple) [Injury or Poisoning]
Meta Mapping (759):
   753   Revision (Revision procedure) [Therapeutic or Preventive Procedure]
   623   Due To (Due to) [Functional Concept]
   623   MULTIPLE DISLOCATIONS (Dislocation, multiple) [Injury or Poisoning]
Processing 00000000.tx.28: Nystatin powder to groin and lobular area b.i.d. prn . 

Phrase: Nystatin powder to groin
Meta Mapping (733):
   604   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   770   POWDER (Powder dose form) [Biomedical or Dental Material]
   604   Groin (Inguinal region) [Body Location or Region]
Meta Mapping (733):
   604   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   770   POWDER (Powder dose form) [Biomedical or Dental Material]
   604   Groin (Inguinal part of abdomen) [Body Location or Region]
Meta Mapping (733):
   604   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   770   Powder (powder physical state) [Substance]
   604   Groin (Inguinal region) [Body Location or Region]
Meta Mapping (733):
   604   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   770   Powder (powder physical state) [Substance]
   604   Groin (Inguinal part of abdomen) [Body Location or Region]

Phrase: and

Phrase: lobular area b.i.d. prn .
Meta Mapping (589):
   632   Lobular [Qualitative Concept]
   632   Area (Geographic Locations) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (589):
   632   Lobular [Qualitative Concept]
   632   AREA (Area) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.29: Multivitamin 1 tablet PO q.day . 

Phrase: Multivitamin 1 tablet PO q.day .
Meta Mapping (768):
   672   Multivitamin tablet [Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   799   /day (Daily) [Temporal Concept]
Meta Mapping (768):
   672   Multivitamin tablet [Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   799   DAY (day) [Temporal Concept]
Meta Mapping (768):
   672   Multivitamin tablet [Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   799   /day (per day) [Temporal Concept]
Meta Mapping (768):
   672   Multivitamin tablet [Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   799   /day (Daily) [Temporal Concept]
Meta Mapping (768):
   672   Multivitamin tablet [Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   799   DAY (day) [Temporal Concept]
Meta Mapping (768):
   672   Multivitamin tablet [Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   799   /day (per day) [Temporal Concept]
Processing 00000000.tx.30: The decision was made to give her two units of packed red blood cells due to a borderline hypotension . 

Phrase: The decision
Meta Mapping (1000):
  1000   Decision [Mental Process]

Phrase: was

Phrase: made
Meta Mapping (966):
   966   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: give
Meta Mapping (1000):
  1000   Give (Give - dosing instruction imperative) [Functional Concept]

Phrase: her two units of packed red blood cells
Meta Mapping (820):
   578   Two [Quantitative Concept]
   855   Packed red blood cells units (Packed erythrocytes units) [Quantitative Concept]

Phrase: due to a borderline hypotension .
Meta Mapping (888):
   694   BORDERLINE (Borderline) [Qualitative Concept]
   861   HYPOTENSION (Hypotension) [Finding]
Meta Mapping (888):
   694   BORDERLINE (Borderline) [Qualitative Concept]
   861   Hypotension (Hypotension Adverse Event) [Finding]
Processing 00000000.tx.31: She was seen by both Diabetes and Pulmonary Services who recommended appropriate adjustment of her insulin doses as well as her pulmonary issues ; primarily she was treated with nebulizers and inhalers as well as chest physical therapy and had no pulmonary complications . 

Phrase: She

Phrase: was

Phrase: seen by both Diabetes
Meta Mapping (708):
   770   Seen (seen) [Qualitative Concept]
   770   Diabetes [Disease or Syndrome]
Meta Mapping (708):
   770   Seen (seen) [Qualitative Concept]
   770   Diabetes (Diabetes Mellitus) [Disease or Syndrome]

Phrase: and

Phrase: Pulmonary Services
Meta Mapping (983):
   983   Pulmonary Service (Pulmonary service) [Health Care Related Organization]

Phrase: who

Phrase: recommended
Meta Mapping (1000):
  1000   Recommended (Recommendation) [Idea or Concept]

Phrase: appropriate adjustment of her insulin doses
Meta Mapping (710):
   586   Appropriate [Qualitative Concept]
   753   Adjustment (Individual Adjustment) [Individual Behavior]
   606   Insulin Dose (Insulin regular:Mass:Pt:Dose:Qn) [Clinical Attribute]
Meta Mapping (710):
   586   Appropriate [Qualitative Concept]
   753   Adjustment (Adjustment Action) [Functional Concept]
   606   Insulin Dose (Insulin regular:Mass:Pt:Dose:Qn) [Clinical Attribute]
Meta Mapping (710):
   586   Appropriate [Qualitative Concept]
   753   adjustment (Psychological adjustment) [Individual Behavior]
   606   Insulin Dose (Insulin regular:Mass:Pt:Dose:Qn) [Clinical Attribute]
Meta Mapping (710):
   586   Appropriate [Qualitative Concept]
   586   INSULIN (Insulin) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   767   Dose Adjustment [Health Care Activity]
Meta Mapping (710):
   586   Appropriate [Qualitative Concept]
   586   INSULIN (Recombinant Insulin) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   767   Dose Adjustment [Health Care Activity]
Meta Mapping (710):
   586   Appropriate [Qualitative Concept]
   586   Insulin (Insulin [EPC]) [Pharmacologic Substance]
   767   Dose Adjustment [Health Care Activity]
Meta Mapping (710):
   586   Appropriate [Qualitative Concept]
   586   INSULIN (Insulin Drug Class) [Hormone,Pharmacologic Substance]
   767   Dose Adjustment [Health Care Activity]

Phrase: as well as

Phrase: her pulmonary issues
Meta Mapping (872):
   694   pulmonary (Lung) [Body Part, Organ, or Organ Component]
   827   Issue (Problem) [Finding]
Meta Mapping (872):
   694   pulmonary (Lung) [Body Part, Organ, or Organ Component]
   827   Issue (Issue (document)) [Intellectual Product]
Meta Mapping (872):
   694   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
   827   Issue (Problem) [Finding]
Meta Mapping (872):
   694   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
   827   Issue (Issue (document)) [Intellectual Product]
Meta Mapping (872):
   694   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
   827   Issue (Problem) [Finding]
Meta Mapping (872):
   694   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
   827   Issue (Issue (document)) [Intellectual Product]

Phrase: ; primarily

Phrase: she

Phrase: was

Phrase: treated with nebulizers
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Nebulizers [Medical Device]

Phrase: and

Phrase: inhalers
Meta Mapping (1000):
  1000   Inhalers (Inhaler) [Medical Device]

Phrase: as well as

Phrase: chest physical therapy
Meta Mapping (1000):
  1000   Chest Physical Therapy [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: had

Phrase: no pulmonary complications .
Meta Mapping (1000):
  1000 N pulmonary complications [Pathologic Function]
Processing 00000000.tx.32: Well butrin slow release 150 mg. 

Phrase: Well butrin slow release 150 mg.
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well (Good) [Qualitative Concept]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Patient Discharge) [Health Care Activity]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Released (action)) [Functional Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   % release (% release (qualifier value)) [Quantitative Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   release (Discharge (release)) [Health Care Activity]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release - action (qualifier value)) [Functional Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   MG (Mongolia) [Geographic Area]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (763):
   632   Well [Manufactured Object]
   632   butrin [Organic Chemical,Pharmacologic Substance]
   632   Slow [Qualitative Concept]
   632   Release (Release (procedure)) [Therapeutic or Preventive Procedure]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.33: PO b.i.d. 

Phrase: PO b.i.d.
Meta Mapping (824):
   812   PO (Portugal) [Geographic Area]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (824):
   812   PO (Oral) [Spatial Concept]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.34: Goal INR should be between 1.5 and 2.0 and she will continue on Coumadin for three more weeks .

Phrase: Goal INR
Meta Mapping (888):
   694   Goal (objective (goal)) [Intellectual Product]
   861   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (888):
   694   Goal (objective (goal)) [Intellectual Product]
   861   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Goal (Act Mood - Goal) [Idea or Concept]
   861   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (888):
   694   Goal (Act Mood - Goal) [Idea or Concept]
   861   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]

Phrase: should

Phrase: be between 1.5
Meta Mapping (833):
   833   1/5 [Quantitative Concept]

Phrase: and

Phrase: 2.0
Meta Mapping (888):
   861   +2 [Quantitative Concept]
   861   0% [Finding]
Meta Mapping (888):
   861   2+ (2+ Score) [Quantitative Concept]
   861   0% [Finding]
Meta Mapping (888):
   861   2+ (2+ Score, WHO) [Classification]
   861   0% [Finding]
Meta Mapping (888):
   861   2+ [Finding]
   861   0% [Finding]

Phrase: and

Phrase: she

Phrase: will

Phrase: continue on Coumadin
Meta Mapping (746):
   790   Continue (Continuous) [Idea or Concept]
   790   Coumadin [Organic Chemical,Pharmacologic Substance]

Phrase: for three more weeks .
Meta Mapping (913):
   913   Three weeks [Temporal Concept]
Processing 00000000.tx.1: HLGMC Discharge Summary Signed Report Status : 10/04/2001 MS Contin has been increased since she has been out of the hospital and she has started to complain of problems of constipation . 

Phrase: HLGMC Discharge Summary Signed Report Status
Meta Mapping (805):
   876   Discharge status [Finding]
   672   Summary Report [Intellectual Product]
   632   Signed (Signature) [Intellectual Product]
Meta Mapping (805):
   876   Discharge status [Finding]
   672   Summary Report [Intellectual Product]
   632   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (805):
   876   Discharge Status (Discharge Status:-:Point in time:^Patient:-) [Clinical Attribute]
   672   Summary Report [Intellectual Product]
   632   Signed (Signature) [Intellectual Product]
Meta Mapping (805):
   876   Discharge Status (Discharge Status:-:Point in time:^Patient:-) [Clinical Attribute]
   672   Summary Report [Intellectual Product]
   632   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (805):
   660   Discharge summary [Intellectual Product]
   632   Signed (Signature) [Intellectual Product]
   827   Report status [Finding]
Meta Mapping (805):
   660   Discharge summary [Intellectual Product]
   632   signed (signed - ParticipationSignature) [Intellectual Product]
   827   Report status [Finding]
Meta Mapping (805):
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   632   Signed (Signature) [Intellectual Product]
   827   Report status [Finding]
Meta Mapping (805):
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   632   signed (signed - ParticipationSignature) [Intellectual Product]
   827   Report status [Finding]

Phrase: :

Phrase: 10/04/2001 MS Contin
Meta Mapping (812):
   637   10% [Finding]
   840   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]

Phrase: has

Phrase: been

Phrase: increased
Meta Mapping (1000):
  1000   Increased [Quantitative Concept]
Meta Mapping (1000):
  1000   Increased (Increase) [Functional Concept]

Phrase: since

Phrase: she

Phrase: has

Phrase: been out of the hospital
Meta Mapping (844):
   844   Out-of-Hospital [Finding]

Phrase: and

Phrase: she

Phrase: has

Phrase: started
Meta Mapping (1000):
  1000   Started [Qualitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: complain of problems of constipation .
Meta Mapping (686):
   760   Problems (Problems - What subject filter) [Idea or Concept]
   760   CONSTIPATION (Constipation) [Sign or Symptom]
Meta Mapping (686):
   760   Problems (Problems - What subject filter) [Idea or Concept]
   760   Constipation (Constipation Adverse Event) [Finding]
Processing 00000000.tx.2: On 9/27 , she experienced another episode of constipation and impaction , came to Liccam Community Medical Center Emergency Room where she was manually disimpacted and received enema and she was discharged . 

Phrase: On 9/27 ,
Meta Mapping (1000):
  1000   9-27 (IFITM1 protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Meta Mapping (1000):
  1000   9-27 (IFITM1 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   9-27 (IFITM1 wt Allele) [Gene or Genome]

Phrase: she

Phrase: experienced
Meta Mapping (966):
   966   experience (Practice Experience) [Mental Process]
Meta Mapping (966):
   966   Experience [Mental Process]

Phrase: another episode of constipation
Meta Mapping (810):
   833   Episode of [Temporal Concept]
   604   CONSTIPATION (Constipation) [Sign or Symptom]
Meta Mapping (810):
   833   Episode of [Temporal Concept]
   604   Constipation (Constipation Adverse Event) [Finding]

Phrase: and

Phrase: impaction ,
Meta Mapping (1000):
  1000   Impaction (Impacted tooth) [Anatomical Abnormality]
Meta Mapping (1000):
  1000   Impaction [Pathologic Function]

Phrase: came to Liccam Community Medical Center Emergency Room where
Meta Mapping (742):
   790   Community medical centre (Community medical center) [Health Care Related Organization,Manufactured Object]
   764   EMERGENCY ROOM (Accident and Emergency department) [Health Care Related Organization]

Phrase: she

Phrase: was

Phrase: manually
Meta Mapping (1000):
  1000   Manually [Finding]

Phrase: disimpacted

Phrase: and

Phrase: received enema
Meta Mapping (888):
   694   RECEIVED (Receive) [Qualitative Concept]
   861   Enema (Administration of enema) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   RECEIVED (Receive) [Qualitative Concept]
   861   ENEMA (Enema) [Biomedical or Dental Material]
Meta Mapping (888):
   694   RECEIVED (Receive) [Qualitative Concept]
   861   Enema (Enema (eukaryote)) [Eukaryote]

Phrase: and

Phrase: she

Phrase: was

Phrase: discharged .
Meta Mapping (1000):
  1000   Discharged (Patient Discharge) [Health Care Activity]
Processing 00000000.tx.3: 7. 

Phrase: 7.
Processing 00000000.tx.4: Hypothyroidism PAST SURGICAL HISTORY : 3. 

Phrase: Hypothyroidism PAST SURGICAL HISTORY
Meta Mapping (916):
   645   HYPOTHYROIDISM (Hypothyroidism) [Disease or Syndrome]
   923   Past surgical history (H/O: surgery) [Finding]

Phrase: :

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.5: 90 mg. q.day DISCHARGE MEDICATIONS : 11. 

Phrase: 90 mg. q.day DISCHARGE MEDICATIONS
Meta Mapping (786):
   632   >90 [Quantitative Concept]
   672   mg day (milligram/day) [Quantitative Concept]
   827   Discharge medications (Medication.discharge) [Finding]
Meta Mapping (786):
   632   <90 [Quantitative Concept]
   672   mg day (milligram/day) [Quantitative Concept]
   827   Discharge medications (Medication.discharge) [Finding]
Meta Mapping (786):
   632   90% [Finding]
   672   mg day (milligram/day) [Quantitative Concept]
   827   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: 11.
Processing 00000000.tx.6: Lactulose 15 mg. 

Phrase: Lactulose 15 mg.
Meta Mapping (802):
   660   LACTULOSE (Lactulose) [Organic Chemical,Pharmacologic Substance]
   827   MG (Mongolia) [Geographic Area]
Meta Mapping (802):
   660   LACTULOSE (Lactulose) [Organic Chemical,Pharmacologic Substance]
   827   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (802):
   660   LACTULOSE (Lactulose) [Organic Chemical,Pharmacologic Substance]
   827   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (802):
   660   LACTULOSE (Lactulose) [Organic Chemical,Pharmacologic Substance]
   827   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.7: PO b.i.d. 

Phrase: PO b.i.d.
Meta Mapping (824):
   812   PO (Portugal) [Geographic Area]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (824):
   812   PO (Oral) [Spatial Concept]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.8: HLGMC 5151891 </TEXT>

Phrase: HLGMC 5151891

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >
Processing 00000000.tx.1: CMC 3/25/2002 12:00:00 AM DULCOLAX ( BISACODYL ) 10 MG PR QD RETURN TO WORK : Please check fingerstick once a day , and record , call MD if greater than 200 . 

Phrase: CMC 3/25/2002 12
Meta Mapping (804):
   804   CMC (MCC protocol) [Therapeutic or Preventive Procedure]
Meta Mapping (804):
   804   CMC (Capillary malformation (disorder)) [Congenital Abnormality]
Meta Mapping (804):
   804   CMC (Circulating Melanoma Cell) [Cell]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: DULCOLAX
Meta Mapping (1000):
  1000   Dulcolax [Organic Chemical,Pharmacologic Substance]

Phrase: ( BISACODYL
Meta Mapping (1000):
  1000   BISACODYL (Bisacodyl) [Organic Chemical,Pharmacologic Substance]

Phrase: )

Phrase: 10 MG PR QD
Meta Mapping (833):
   645   10% [Finding]
   645   MG (Mongolia) [Geographic Area]
   645   PR+ (progesterone receptor positive) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   MG (Mongolia) [Geographic Area]
   645   PR- (progesterone receptor negative) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   MG (Mongolia) [Geographic Area]
   645   PR@ (PR@ gene cluster) [Gene or Genome]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   MG (Mongolia) [Geographic Area]
   645   PR (STANDARDS Pain Relief Questionnaire) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   MG (Mongolia) [Geographic Area]
   645   PR (Procedure Domain) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   MG (Mongolia) [Geographic Area]
   645   PR (Progesterone Receptor Measurement) [Laboratory Procedure]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   MG (Mongolia) [Geographic Area]
   645   PR (Per rectum) [Functional Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   645   PR+ (progesterone receptor positive) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   645   PR- (progesterone receptor negative) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   645   PR@ (PR@ gene cluster) [Gene or Genome]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   645   PR (STANDARDS Pain Relief Questionnaire) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   645   PR (Procedure Domain) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   645   PR (Progesterone Receptor Measurement) [Laboratory Procedure]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   645   PR (Per rectum) [Functional Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   645   PR+ (progesterone receptor positive) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   645   PR- (progesterone receptor negative) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   645   PR@ (PR@ gene cluster) [Gene or Genome]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   645   PR (STANDARDS Pain Relief Questionnaire) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   645   PR (Procedure Domain) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   645   PR (Progesterone Receptor Measurement) [Laboratory Procedure]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   645   PR (Per rectum) [Functional Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   PR+ (progesterone receptor positive) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   PR- (progesterone receptor negative) [Laboratory or Test Result]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   PR@ (PR@ gene cluster) [Gene or Genome]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   PR (STANDARDS Pain Relief Questionnaire) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   PR (Procedure Domain) [Intellectual Product]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   PR (Progesterone Receptor Measurement) [Laboratory Procedure]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   10% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   PR (Per rectum) [Functional Concept]
   812   QD (Daily) [Temporal Concept]

Phrase: RETURN
Meta Mapping (1000):
  1000   Return (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]

Phrase: TO
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: WORK
Meta Mapping (1000):
  1000   Work [Occupational Activity]

Phrase: :

Phrase: Please

Phrase: check fingerstick once
Meta Mapping (802):
   660   Check (Checking (action)) [Activity]
   827   Finger Stick (Finger-prick sampling (procedure)) [Diagnostic Procedure]
Meta Mapping (802):
   660   Cheque [Manufactured Object]
   827   Finger Stick (Finger-prick sampling (procedure)) [Diagnostic Procedure]

Phrase: a day ,
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]

Phrase: and

Phrase: record ,
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: call MD
Meta Mapping (694):
   694   Call (Decision) [Mental Process]
Meta Mapping (694):
   694   c all (Precursor B-cell lymphoblastic leukemia) [Neoplastic Process]
Meta Mapping (694):
   694   Call (Call (Instruction)) [Functional Concept]

Phrase: if

Phrase: greater than 200 .
Meta Mapping (882):
   882   Greater Than [Quantitative Concept]
Processing 00000000.tx.2: 3/31/02 . 

Phrase: 3/31/02 .
Meta Mapping (790):
   827   <3 (<3 (qualifier value)) [Quantitative Concept]
   827   31 [Intellectual Product]
Meta Mapping (790):
   827   3+ (3+ Score) [Quantitative Concept]
   827   31 [Intellectual Product]
Meta Mapping (790):
   827   3+ (3+ Score, WHO) [Classification]
   827   31 [Intellectual Product]
Meta Mapping (790):
   827   3+ (3+ Answer to Question) [Finding]
   827   31 [Intellectual Product]
Processing 00000000.tx.3: 03/29/02 03:43 PM 9/18/2001 12:00:00 AM The patient presented with a chief complaint of WHEEZES . 

Phrase: 03/29/02 03
Meta Mapping (812):
   812   29+ [Finding]

Phrase: :

Phrase: 43 PM 9/18/2001 12
Meta Mapping (762):
   799   PM (Panama) [Geographic Area]
   827   9-18 [Finding]
Meta Mapping (762):
   799   PM (Infusion pump Alert priority PM) [Finding]
   827   9-18 [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: presented with a chief complaint of WHEEZES .
Meta Mapping (692):
   748   Presented (Presentation) [Idea or Concept]
   778   Chief Complaint (Chief complaint (finding)) [Finding]
   748   Wheezes (Wheezing) [Sign or Symptom]
Processing 00000000.tx.4: 158011729 Signed His cardiology workup revealed significant three vessel coronary artery disease and the patient was referred to the Camweissallcoa Medical Center for myocardial revascularization . 

Phrase: 158011729 Signed
Meta Mapping (861):
   861   Signed (Signature) [Intellectual Product]
Meta Mapping (861):
   861   signed (signed - ParticipationSignature) [Intellectual Product]

Phrase: His cardiology workup
Meta Mapping (901):
   694   Cardiology (Cardiology discipline) [Biomedical Occupation or Discipline]
   861   Work-up (work up) [Diagnostic Procedure]
Meta Mapping (901):
   694   Cardiology (Cardiology service) [Health Care Related Organization]
   861   Work-up (work up) [Diagnostic Procedure]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: significant three vessel coronary artery disease
Meta Mapping (938):
   632   significant (Statistical Significance) [Quantitative Concept]
   947   Three Vessel Coronary Artery Disease (Three Vessel Coronary Disease) [Disease or Syndrome]
Meta Mapping (938):
   632   Significant [Idea or Concept]
   947   Three Vessel Coronary Artery Disease (Three Vessel Coronary Disease) [Disease or Syndrome]
Meta Mapping (938):
   632   Significant (Event Seriousness - Significant) [Qualitative Concept]
   947   Three Vessel Coronary Artery Disease (Three Vessel Coronary Disease) [Disease or Syndrome]

Phrase: and

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: referred to the Camweissallcoa Medical Center
Meta Mapping (722):
   753   referred (Referring) [Functional Concept]
   790   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (722):
   753   referred (Referring) [Functional Concept]
   790   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (722):
   753   Referred (Referral placed) [Functional Concept]
   790   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (722):
   753   Referred (Referral placed) [Functional Concept]
   790   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: for myocardial revascularization .
Meta Mapping (1000):
  1000   Myocardial revascularisation (Myocardial Revascularization) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.5: Clear . 

Phrase: Clear .
Meta Mapping (1000):
  1000   Clear (Negative Surgical Margin) [Finding]
Meta Mapping (1000):
  1000   Clear [Qualitative Concept]
Processing 00000000.tx.6: Mr. 

Phrase: Mr.
Meta Mapping (1000):
  1000   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   MR (Minor Response) [Finding]
Processing 00000000.tx.7: Tlandpiernshi underwent coronary artery bypass grafting x2 with saphenous vein graft to the obtuse marginal , and saphenous vein graft to the left anterior descending artery on 7/20/98 . 

Phrase: Tlandpiernshi

Phrase: underwent

Phrase: coronary artery bypass grafting x2 with saphenous vein graft
Meta Mapping (612):
   575   coronary (Heart) [Body Part, Organ, or Organ Component]
   642   Arterial bypass graft with vein (Arterial bypass using vein graft) [Therapeutic or Preventive Procedure]

Phrase: to the obtuse marginal ,
Meta Mapping (964):
   964   Obtuse margin (Entire left margin of heart) [Body Location or Region]

Phrase: and

Phrase: saphenous vein graft to the left anterior descending artery
Meta Mapping (777):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   651   Left anterior descending artery (Anterior descending branch of left coronary artery) [Body Part, Organ, or Organ Component]

Phrase: on 7/20/98 .
Meta Mapping (827):
   827   20% [Finding]
Processing 00000000.tx.8: The patient showed no signs of ischemia . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: no signs of ischemia .
Meta Mapping (708):
   770   signs (Aspects of signs) [Functional Concept]
   604 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (708):
   770   signs (Manufactured sign) [Manufactured Object]
   604 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (708):
   770   SIGNS (Physical findings) [Finding]
   604 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Processing 00000000.tx.9: He achieved good rate control and intermittent periods of sinus rhythm as well . 

Phrase: He

Phrase: achieved

Phrase: good rate control
Meta Mapping (901):
   660   Good [Qualitative Concept]
   901   Rate control (rate control) [Functional Concept]

Phrase: and

Phrase: intermittent periods of sinus rhythm
Meta Mapping (741):
   593   INTERMITTENT (Intermittent) [Temporal Concept]
   726   /period (per period (qualifier value)) [Temporal Concept]
   640   SINUS RHYTHM (Sinus rhythm) [Finding]
Meta Mapping (741):
   593   INTERMITTENT (Intermittent) [Temporal Concept]
   726   Period (Period (temporal qualifier)) [Temporal Concept]
   640   SINUS RHYTHM (Sinus rhythm) [Finding]

Phrase: as well .
Meta Mapping (1000):
  1000   Well (Good) [Qualitative Concept]
Meta Mapping (1000):
  1000   Well [Manufactured Object]
Processing 00000000.tx.10: CONDITION ON DISCHARGE : 0571009 PRELIMINARY REPORT 205025 KOTE , CIHA L DISCHARGE DATE : PRINCIPAL DIAGNOSIS : Enlarging liver metastases were seen and in April 2001 , the patient underwent implantation of a hepatic arterial infusion pump . 

Phrase: CONDITION ON DISCHARGE
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Discharge, body substance) [Body Substance]

Phrase: :

Phrase: 0571009 PRELIMINARY REPORT 205025 KOTE ,
Meta Mapping (562):
   637   Preliminary [Temporal Concept]
   637   Report (Report (document)) [Intellectual Product]
Meta Mapping (562):
   637   Preliminary [Temporal Concept]
   637   Report (Reporting) [Health Care Activity]
Meta Mapping (562):
   637   Preliminary [Temporal Concept]
   637   Report (Regulatory Report) [Intellectual Product]

Phrase: CIHA L DISCHARGE DATE
Meta Mapping (861):
   861   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (861):
   861   Discharge date [Temporal Concept]

Phrase: :

Phrase: PRINCIPAL DIAGNOSIS
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal diagnosis) [Qualitative Concept]
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal Diagnosis:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: Enlarging liver metastases
Meta Mapping (901):
   660   enlarging (Enlarged) [Qualitative Concept]
   901   Liver Metastases (Secondary malignant neoplasm of liver) [Neoplastic Process]

Phrase: were

Phrase: seen
Meta Mapping (1000):
  1000   Seen (seen) [Qualitative Concept]

Phrase: and in April 2001 ,
Meta Mapping (770):
   770   April [Temporal Concept]
Meta Mapping (770):
   770   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (770):
   770   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: underwent

Phrase: implantation of a hepatic arterial infusion pump .
Meta Mapping (755):
   748   Implantation (Implantation procedure) [Therapeutic or Preventive Procedure]
   647   Hepatic Arterial Infusion (hepatic arterial infusion) [Therapeutic or Preventive Procedure]
   581   Pump (pump (device)) [Medical Device]
Meta Mapping (755):
   748   Implantation (Implantation procedure) [Therapeutic or Preventive Procedure]
   647   Hepatic Arterial Infusion (hepatic arterial infusion) [Therapeutic or Preventive Procedure]
   581   Pump (Pump Device Component) [Manufactured Object]
Meta Mapping (755):
   748   Implantation (Blastocyst Implantation, natural) [Organism Function]
   647   Hepatic Arterial Infusion (hepatic arterial infusion) [Therapeutic or Preventive Procedure]
   581   Pump (pump (device)) [Medical Device]
Meta Mapping (755):
   748   Implantation (Blastocyst Implantation, natural) [Organism Function]
   647   Hepatic Arterial Infusion (hepatic arterial infusion) [Therapeutic or Preventive Procedure]
   581   Pump (Pump Device Component) [Manufactured Object]
Processing 00000000.tx.11: On exam , he was well-developed , well-nourished with good range of motion of his head and neck without masses . 

Phrase: On exam ,
Meta Mapping (1000):
  1000   Exam (Medical Examination) [Health Care Activity]

Phrase: he

Phrase: was

Phrase: well-developed , well-nourished with good range of motion of his head
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   570   HEAD (Head) [Body Location or Region]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   570   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   570   Head (Head - Component of Device) [Manufactured Object]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   570   HEAD (Head) [Body Location or Region]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   570   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   570   Head (Head - Component of Device) [Manufactured Object]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   Range of motion [Clinical Attribute]
   570   HEAD (Head) [Body Location or Region]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   Range of motion [Clinical Attribute]
   570   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (679):
   751   Well nourished (Actual Positive Nutritional Status) [Finding]
   570   Good [Qualitative Concept]
   604   Range of motion [Clinical Attribute]
   570   Head (Head - Component of Device) [Manufactured Object]

Phrase: and

Phrase: neck without masses .
Meta Mapping (841):
   841   NECK MASS (Mass of neck) [Finding]
Processing 00000000.tx.12: The patient tolerated the procedure well and was taken to the recovery room in stable condition . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: tolerated

Phrase: the procedure well
Meta Mapping (888):
   861   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (Procedure (set of actions)) [Activity]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Procedure (set of actions)) [Activity]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (Procedure Domain) [Intellectual Product]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Procedure Domain) [Intellectual Product]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
   694   Well [Manufactured Object]

Phrase: and

Phrase: was

Phrase: taken to the recovery room
Meta Mapping (745):
   760   Taken [Conceptual Entity]
   806   Recovery room (Postoperative anesthesia care unit (PACU)) [Health Care Related Organization,Manufactured Object]

Phrase: in stable condition .
Meta Mapping (1000):
  1000   Stable condition (Stable Disease) [Finding]
Meta Mapping (1000):
  1000   Stable condition (Stable chronic Graft vs Host Disease) [Finding]
Processing 00000000.tx.13: His fever work-up was negative for infection . 

Phrase: His fever work-up
Meta Mapping (901):
   660 N FEVER (Fever) [Finding]
   901   Work-up (work up) [Diagnostic Procedure]
Meta Mapping (901):
   660 N Fever (Fever symptoms (finding)) [Finding]
   901   Work-up (work up) [Diagnostic Procedure]

Phrase: was

Phrase: negative for infection .
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623 N INFECTION (Infection) [Pathologic Function]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623 N INFECTION (Infection) [Pathologic Function]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623 N INFECTION (Infection) [Pathologic Function]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623 N INFECTION (Infection) [Pathologic Function]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623 N INFECTION (Infection) [Pathologic Function]
Processing 00000000.tx.14: He was afebrile with stable vital signs . 

Phrase: He

Phrase: was

Phrase: afebrile with stable vital signs .
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   STABLE (Stable status) [Qualitative Concept]
   640   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   STABLE (Stable status) [Qualitative Concept]
   640   Signs, Vital (Vital signs) [Clinical Attribute]
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   Stable (Patient Condition Code - Stable) [Intellectual Product]
   640   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   Stable (Patient Condition Code - Stable) [Intellectual Product]
   640   Signs, Vital (Vital signs) [Clinical Attribute]
Processing 00000000.tx.15: TR : WILL D / C ORDER BE USED AS THE D / C SUMMARY : YES OTHER DIAGNOSIS ; none OTHER TREATMENTS / PROCEDURES ( NOT IN O.R. ) hemodyalysis Patient was DNR / DNI on admission . 

Phrase: TR
Meta Mapping (1000):
  1000   TR (TXNRD1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (TXNRD2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (Tumor Results Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   TR (Thioredoxin Reductase 1, Cytoplasmic) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :

Phrase: WILL

Phrase: D / C ORDER
Meta Mapping (901):
   734   D & C (Dilatation and Curettage) [Therapeutic or Preventive Procedure]
   827   Order (Order (document)) [Intellectual Product]
Meta Mapping (901):
   734   D & C (Dilatation and Curettage) [Therapeutic or Preventive Procedure]
   827   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (901):
   734   D & C (Dilatation and Curettage) [Therapeutic or Preventive Procedure]
   827   Order (Order (taxonomic)) [Classification]
Meta Mapping (901):
   734   D & C (Dilatation and Curettage) [Therapeutic or Preventive Procedure]
   827   Order (Order (action)) [Activity]
Meta Mapping (901):
   734   D & C (Dilatation and Curettage) [Therapeutic or Preventive Procedure]
   827   Order (Permutation) [Qualitative Concept]
Meta Mapping (901):
   734   D & C (Dilatation and Curettage) [Therapeutic or Preventive Procedure]
   827   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]
Meta Mapping (901):
   734   D.C. (District of Columbia) [Geographic Area]
   827   Order (Order (document)) [Intellectual Product]
Meta Mapping (901):
   734   D.C. (District of Columbia) [Geographic Area]
   827   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (901):
   734   D.C. (District of Columbia) [Geographic Area]
   827   Order (Order (taxonomic)) [Classification]
Meta Mapping (901):
   734   D.C. (District of Columbia) [Geographic Area]
   827   Order (Order (action)) [Activity]
Meta Mapping (901):
   734   D.C. (District of Columbia) [Geographic Area]
   827   Order (Permutation) [Qualitative Concept]
Meta Mapping (901):
   734   D.C. (District of Columbia) [Geographic Area]
   827   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]
Meta Mapping (901):
   734   D/C (Discontinued) [Finding]
   827   Order (Order (document)) [Intellectual Product]
Meta Mapping (901):
   734   D/C (Discontinued) [Finding]
   827   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (901):
   734   D/C (Discontinued) [Finding]
   827   Order (Order (taxonomic)) [Classification]
Meta Mapping (901):
   734   D/C (Discontinued) [Finding]
   827   Order (Order (action)) [Activity]
Meta Mapping (901):
   734   D/C (Discontinued) [Finding]
   827   Order (Permutation) [Qualitative Concept]
Meta Mapping (901):
   734   D/C (Discontinued) [Finding]
   827   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]
Meta Mapping (901):
   734   D.C. (Doctor of Chiropractic) [Intellectual Product]
   827   Order (Order (document)) [Intellectual Product]
Meta Mapping (901):
   734   D.C. (Doctor of Chiropractic) [Intellectual Product]
   827   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (901):
   734   D.C. (Doctor of Chiropractic) [Intellectual Product]
   827   Order (Order (taxonomic)) [Classification]
Meta Mapping (901):
   734   D.C. (Doctor of Chiropractic) [Intellectual Product]
   827   Order (Order (action)) [Activity]
Meta Mapping (901):
   734   D.C. (Doctor of Chiropractic) [Intellectual Product]
   827   Order (Permutation) [Qualitative Concept]
Meta Mapping (901):
   734   D.C. (Doctor of Chiropractic) [Intellectual Product]
   827   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]

Phrase: BE

Phrase: USED AS THE D / C SUMMARY
Meta Mapping (672):
   753   used (Used by) [Finding]
   753   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (672):
   753   used (Used by) [Finding]
   753   Summary (Summary (document)) [Intellectual Product]

Phrase: :

Phrase: YES
Meta Mapping (1000):
  1000   Yes (Yes - Yes/no indicator) [Idea or Concept]
Meta Mapping (1000):
  1000   YES (Yes (indicator)) [Conceptual Entity]

Phrase: OTHER DIAGNOSIS
Meta Mapping (1000):
  1000   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (1000):
  1000   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (1000):
  1000   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: ;

Phrase: none OTHER TREATMENTS / PROCEDURES
Meta Mapping (1000):
  1000   treatments procedures (treatments and procedures) [Therapeutic or Preventive Procedure]

Phrase: (

Phrase: NOT IN O.R.
Meta Mapping (708):
   770   Not (Negation) [Functional Concept]
   770   R- (Right) [Spatial Concept]
Meta Mapping (708):
   770   Not (Negation) [Functional Concept]
   770   R. (Rabbi) [Professional or Occupational Group]
Meta Mapping (708):
   770   Not (Negation) [Functional Concept]
   770   R' (R prime) [Clinical Attribute]

Phrase: )

Phrase: hemodyalysis Patient
Meta Mapping (861):
   861   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (861):
   861   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (861):
   861   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (861):
   861   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: DNR / DNI
Meta Mapping (694):
   694   DNR (Daunorubicin) [Antibiotic,Organic Chemical]
Meta Mapping (694):
   694 N DNR (DNR - Do not resuscitate) [Finding]

Phrase: on admission .
Meta Mapping (1000):
  1000   On admission [Temporal Concept]
Processing 00000000.tx.16: Labs for CBC , DIC panels , HIT antibodies and electrolytes are still Pending . 

Phrase: Labs for CBC ,
Meta Mapping (746):
   790   Labs (Laboratory test finding) [Finding]
   623   CBC (Complete Blood Count) [Laboratory Procedure]
Meta Mapping (746):
   790   Labs (Laboratory test finding) [Finding]
   623   CBC (Nuclear cap binding complex location) [Cell Component]

Phrase: DIC panels ,
Meta Mapping (861):
   861   Panel (Groups) [Idea or Concept]
Meta Mapping (861):
   861   Panel (Laboratory Order Panels) [Intellectual Product]
Meta Mapping (861):
   861   Panel (Panel Device Component) [Manufactured Object]

Phrase: HIT antibodies
Meta Mapping (888):
   861   HIT (Heparin-induced thrombocytopenia) [Disease or Syndrome]
   861   Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (888):
   861   hit (Struck by) [Functional Concept]
   861   Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (888):
   861   HIT (Hit - database search return) [Functional Concept]
   861   Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: and

Phrase: electrolytes
Meta Mapping (1000):
  1000   ELECTROLYTES (Electrolytes) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Electrolytes (Electrolyte [EPC]) [Pharmacologic Substance]

Phrase: are

Phrase: still

Phrase: Pending .
Processing 00000000.tx.17: She was severely anemicon admission to Neriereten , and subsequently bled of unknown cause after dialysis . 

Phrase: She

Phrase: was

Phrase: severely anemicon admission to Neriereten ,
Meta Mapping (686):
   593   Severely (Severe (severity modifier)) [Qualitative Concept]
   760   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (686):
   593   Severely (Severe (severity modifier)) [Qualitative Concept]
   760   Admission (Admission activity) [Health Care Activity]

Phrase: and

Phrase: subsequently

Phrase: bled of unknown cause
Meta Mapping (772):
   737   bleed (Hemorrhage) [Pathologic Function]
   833   unknown cause (etiology unknown) [Finding]

Phrase: after dialysis .
Meta Mapping (1000):
  1000   Dialysis (Physical Dialysis) [Natural Phenomenon or Process]
Meta Mapping (1000):
  1000   Dialysis (Dialysis procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Dialysis (Genus Dialysis) [Eukaryote]
Processing 00000000.tx.18: It was unclear which even happened first . 

Phrase: It

Phrase: was

Phrase: unclear

Phrase: which

Phrase: even

Phrase: happened
Meta Mapping (1000):
  1000   Happened (Occur (action)) [Activity]

Phrase: first .
Meta Mapping (1000):
  1000   First (First (number)) [Quantitative Concept]
Meta Mapping (1000):
  1000   First (Firstly) [Qualitative Concept]
Processing 00000000.tx.19: Patient was DNR / DNI on admission . 

Phrase: Patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: DNR / DNI
Meta Mapping (694):
   694   DNR (Daunorubicin) [Antibiotic,Organic Chemical]
Meta Mapping (694):
   694   DNR (DNR - Do not resuscitate) [Finding]

Phrase: on admission .
Meta Mapping (1000):
  1000   On admission [Temporal Concept]
Processing 00000000.tx.20: Addended by : HLGMC 414-44-84 In the emergency department , he was afebrile with a temperature of 97.5 , blood pressure 153/55 , breathing 15 respirations a minute , oxygen saturations 97% on room air . 

Phrase: Addended by

Phrase: :

Phrase: HLGMC 414-44-84 In the emergency department ,
Meta Mapping (770):
   770   Emergency Department (Accident and Emergency department) [Health Care Related Organization]

Phrase: he

Phrase: was

Phrase: afebrile with a temperature of 97.5 ,
Meta Mapping (652):
   748   Afebrile (Apyrexial) [Finding]
   581   temperature (Body Temperature) [Organism Attribute]
   581   97 [Intellectual Product]
Meta Mapping (652):
   748   Afebrile (Apyrexial) [Finding]
   581   temperature (Body Temperature) [Organism Attribute]
   581   >97 [Quantitative Concept]
Meta Mapping (652):
   748   Afebrile (Apyrexial) [Finding]
   581   *Temperature (Temperature) [Quantitative Concept]
   581   97 [Intellectual Product]
Meta Mapping (652):
   748   Afebrile (Apyrexial) [Finding]
   581   *Temperature (Temperature) [Quantitative Concept]
   581   >97 [Quantitative Concept]

Phrase: blood pressure 153/55 ,
Meta Mapping (824):
   861   BLOOD PRESSURE (Blood Pressure) [Organism Function]
   812   55 [Intellectual Product]
Meta Mapping (824):
   861   Blood Pressure (Blood pressure finding) [Finding]
   812   55 [Intellectual Product]
Meta Mapping (824):
   861   Blood pressure (Systemic arterial pressure) [Finding]
   812   55 [Intellectual Product]

Phrase: breathing
Meta Mapping (1000):
  1000   breathing (Inspiration function) [Organism Function]
Meta Mapping (1000):
  1000   Breathing (Respiration) [Physiologic Function]
Meta Mapping (1000):
  1000   breathing (respiratory gaseous exchange in organisms) [Biologic Function]

Phrase: 15 respirations
Meta Mapping (861):
   861   respirations (Respiration) [Physiologic Function]

Phrase: a minute ,
Meta Mapping (1000):
  1000   MINUTE (Minute of time) [Temporal Concept]
Meta Mapping (1000):
  1000   minute (Small) [Quantitative Concept]
Meta Mapping (1000):
  1000   /minute (Per Minute) [Temporal Concept]
Meta Mapping (1000):
  1000   Minute (Minute (diminutive)) [Quantitative Concept]
Meta Mapping (1000):
  1000   Minute (Minute Unit of Plane Angle) [Quantitative Concept]

Phrase: oxygen saturations 97% on room air .
Meta Mapping (759):
   790   oxygen saturations (Oxygen saturation test result) [Organism Attribute]
   753   97 [Intellectual Product]
   790   Room air [Finding]
Meta Mapping (759):
   790   oxygen saturations (Oxygen saturation test result) [Organism Attribute]
   753   >97 [Quantitative Concept]
   790   Room air [Finding]
Processing 00000000.tx.21: Lived at nursing home for the past ten months . 

Phrase: Lived at nursing home
Meta Mapping (766):
   737   Live (Live - Specimen Condition) [Qualitative Concept]
   833   NURSING HOME (Nursing Homes) [Health Care Related Organization,Manufactured Object]
Meta Mapping (766):
   737   % live [Qualitative Concept]
   833   NURSING HOME (Nursing Homes) [Health Care Related Organization,Manufactured Object]
Meta Mapping (766):
   737   Live (Reside) [Activity]
   833   NURSING HOME (Nursing Homes) [Health Care Related Organization,Manufactured Object]

Phrase: for the past ten months .
Meta Mapping (851):
   660   Past [Temporal Concept]
   660   TEN (Toxic Epidermal Necrolysis) [Disease or Syndrome]
   827   MONTHS (month) [Temporal Concept]
Meta Mapping (851):
   660   Past [Temporal Concept]
   660   Ten [Quantitative Concept]
   827   MONTHS (month) [Temporal Concept]
Processing 00000000.tx.22: Extremities : He intermittently fell asleep on examination ; he was lethargic but arousable to voice . 

Phrase: Extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: He

Phrase: intermittently

Phrase: fell
Meta Mapping (966):
   966   FALL (Falls) [Finding]
Meta Mapping (966):
   966   Fall (Autumn) [Temporal Concept]

Phrase: asleep on examination
Meta Mapping (790):
   790   Asleep [Finding]

Phrase: ;

Phrase: he

Phrase: was

Phrase: lethargic
Meta Mapping (1000):
  1000   Lethargic (Lethargy) [Sign or Symptom]

Phrase: but

Phrase: arousable

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: voice .
Meta Mapping (1000):
  1000   VOICE (Voice) [Organism Function]
Meta Mapping (1000):
  1000   voice (TelecommunicationCapabilities <voice>) [Qualitative Concept]
Processing 00000000.tx.23: Direct bilirubin was 2.9 , total bilirubin 3.5 , alkaline phosphatase 1598 , serum glutamic pyruvic transaminase 307 , amylase 180 , lipase 54 , serum glutamic oxaloacetic transaminase 169 . 

Phrase: Direct bilirubin
Meta Mapping (1000):
  1000   Direct bilirubin (Direct reacting bilirubin) [Biologically Active Substance,Organic Chemical]

Phrase: was

Phrase: 2.9 ,
Meta Mapping (861):
   861   +2 [Quantitative Concept]
Meta Mapping (861):
   861   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (861):
   861   2+ (2+ Score, WHO) [Classification]
Meta Mapping (861):
   861   2+ [Finding]

Phrase: total bilirubin 3.5 ,
Meta Mapping (861):
   861   Bilirubin, total (Bilirubin) [Biologically Active Substance,Organic Chemical]
Meta Mapping (861):
   861   total bilirubin (Total bilirubin level) [Laboratory or Test Result]

Phrase: alkaline phosphatase 1598 ,
Meta Mapping (901):
   901   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (901):
   901   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: serum glutamic pyruvic transaminase 307 ,
Meta Mapping (937):
   937   serum Glutamic Pyruvic Transaminase (SGPT - Glutamate pyruvate transaminase) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: amylase 180 ,
Meta Mapping (861):
   861   AMYLASE (Amylases) [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: lipase 54 ,
Meta Mapping (861):
   861   LIPASE (Lipase) [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: serum glutamic oxaloacetic transaminase 169 .
Meta Mapping (937):
   937   Transaminase, Serum Glutamic-Oxaloacetic (SGOT - Glutamate oxaloacetate transaminase) [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.24: His urinalysis showed positive nitrites , 0-2 white blood cells , negative for bacteria . 

Phrase: His urinalysis
Meta Mapping (1000):
  1000   Urinalysis [Laboratory Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: positive nitrites ,
Meta Mapping (888):
   694   % Positive (percent positive cells) [Quantitative Concept]
   861   Nitrites [Chemical Viewed Structurally]
Meta Mapping (888):
   694   Positive [Qualitative Concept]
   861   Nitrites [Chemical Viewed Structurally]
Meta Mapping (888):
   694   POSITIVE (Positive Finding) [Finding]
   861   Nitrites [Chemical Viewed Structurally]
Meta Mapping (888):
   694   Positive (Positive Charge) [Qualitative Concept]
   861   Nitrites [Chemical Viewed Structurally]
Meta Mapping (888):
   694   Positive (Positive Number) [Conceptual Entity]
   861   Nitrites [Chemical Viewed Structurally]

Phrase: 0-2 white blood cells ,
Meta Mapping (850):
   637   0% [Finding]
   884   White Blood Cells (White Blood Cell Count procedure) [Laboratory Procedure]
Meta Mapping (850):
   637   0% [Finding]
   884   White Blood Cells (Leukocytes) [Cell]

Phrase: negative for bacteria .
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623   Bacterium (Bacteria) [Bacterium]
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623   bacteria (bacteria aspects) [Functional Concept]
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623   % Bacteria (Percent of Bacteria) [Quantitative Concept]
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623   Bacteria (Bacteria <stick insect genus>) [Eukaryote]
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623 N Bacterium (Bacteria present) [Finding]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623   Bacterium (Bacteria) [Bacterium]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623   bacteria (bacteria aspects) [Functional Concept]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623   % Bacteria (Percent of Bacteria) [Quantitative Concept]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623   Bacteria (Bacteria <stick insect genus>) [Eukaryote]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623 N Bacterium (Bacteria present) [Finding]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623   Bacterium (Bacteria) [Bacterium]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623   bacteria (bacteria aspects) [Functional Concept]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623   % Bacteria (Percent of Bacteria) [Quantitative Concept]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623   Bacteria (Bacteria <stick insect genus>) [Eukaryote]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623 N Bacterium (Bacteria present) [Finding]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623   Bacterium (Bacteria) [Bacterium]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623   bacteria (bacteria aspects) [Functional Concept]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623   % Bacteria (Percent of Bacteria) [Quantitative Concept]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623   Bacteria (Bacteria <stick insect genus>) [Eukaryote]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623 N Bacterium (Bacteria present) [Finding]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623   Bacterium (Bacteria) [Bacterium]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623   bacteria (bacteria aspects) [Functional Concept]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623   % Bacteria (Percent of Bacteria) [Quantitative Concept]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623   Bacteria (Bacteria <stick insect genus>) [Eukaryote]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623 N Bacterium (Bacteria present) [Finding]
Processing 00000000.tx.25: At this point , Oncology consultation was obtained . 

Phrase: At this point ,
Meta Mapping (1000):
  1000   POINT (point - UnitsOfMeasure) [Quantitative Concept]
Meta Mapping (1000):
  1000   point (Point Name) [Quantitative Concept]
Meta Mapping (1000):
  1000   Point [Spatial Concept]

Phrase: Oncology consultation
Meta Mapping (888):
   694   Oncology (Neoplasms) [Neoplastic Process]
   861   Consultation [Health Care Activity]
Meta Mapping (888):
   694   Oncology (oncology field) [Biomedical Occupation or Discipline]
   861   Consultation [Health Care Activity]

Phrase: was

Phrase: obtained .
Meta Mapping (1000):
  1000   Obtained (Obtain) [Functional Concept]
Processing 00000000.tx.26: During this meeting , he was made do not resuscitate / do not intubate and he is to be discharged to the Hend Geadcoastcar Hospital where the emphasis should be entirely on this patient &apos;s comfort ; that is antiemetics as he needs , pain control as needed and nutrition for his comfort . 

Phrase: During this meeting ,
Meta Mapping (1000):
  1000   Meeting (Meetings) [Activity]

Phrase: he

Phrase: was

Phrase: made
Meta Mapping (966):
   966   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: do not resuscitate /
Meta Mapping (1000):
  1000   Do not resuscitate (DNR - Do not resuscitate) [Finding]

Phrase: do

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: intubate

Phrase: and

Phrase: he

Phrase: is

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: discharged to the Hend Geadcoastcar Hospital where
Meta Mapping (793):
   793   Discharge to hospital (Discharge to hospital (procedure)) [Health Care Activity]

Phrase: the emphasis

Phrase: should

Phrase: be

Phrase: entirely on this patient &apos
Meta Mapping (760):
   760   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (760):
   760   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (760):
   760   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (760):
   760   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s comfort
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Comfort [Mental Process]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Comfort [Mental Process]

Phrase: ;

Phrase: that

Phrase: is

Phrase: antiemetics
Meta Mapping (1000):
  1000   ANTIEMETICS (Antiemetics) [Pharmacologic Substance]

Phrase: as

Phrase: he needs ,
Meta Mapping (1000):
  1000   Needs [Qualitative Concept]
Meta Mapping (1000):
  1000   needs (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: pain control
Meta Mapping (1000):
  1000   Pain Control (Pain management) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Pain control [Therapeutic or Preventive Procedure]

Phrase: as needed
Meta Mapping (1000):
  1000   As needed (PRN (schedule frequency)) [Temporal Concept]
Meta Mapping (1000):
  1000   As Needed [Qualitative Concept]

Phrase: and

Phrase: nutrition for his comfort .
Meta Mapping (708):
   770   Nutrition (Science of nutrition) [Biomedical Occupation or Discipline]
   604   Comfort [Mental Process]
Meta Mapping (708):
   770   nutrition (Nutritional status) [Finding]
   604   Comfort [Mental Process]
Meta Mapping (708):
   770   Nutrition (Nutrition outcomes) [Intellectual Product]
   604   Comfort [Mental Process]
Meta Mapping (708):
   770   Nutrition (Nutrition function) [Organism Function]
   604   Comfort [Mental Process]
Processing 00000000.tx.27: They will be added to this discharge summary . 

Phrase: They

Phrase: will

Phrase: be

Phrase: added to this discharge summary .
Meta Mapping (745):
   760   Added (Additional) [Functional Concept]
   806   Discharge summary [Intellectual Product]
Meta Mapping (745):
   760   Added (Additional) [Functional Concept]
   806   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Processing 00000000.tx.28: TD : 01/23/2000 Intravenous chemotherapy with Taxol on 01/30/2000 . 

Phrase: TD
Meta Mapping (1000):
  1000   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (1000):
  1000   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :

Phrase: 01/23/2000 Intravenous chemotherapy with Taxol
Meta Mapping (713):
   581   23 [Quantitative Concept]
   548   2000s [Temporal Concept]
   778   Intravenous chemotherapy [Therapeutic or Preventive Procedure]
   581   Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: on 01/30/2000 .
Meta Mapping (773):
   827   30% [Finding]
   793   2000s [Temporal Concept]
Processing 00000000.tx.29: Colace 100 mg PO t.i.d. 

Phrase: Colace 100 mg PO t.i.d.
Meta Mapping (797):
   660   Docusate Sodium 100 MG [Clinical Drug]
   795   PO (Portugal) [Geographic Area]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (797):
   660   Docusate Sodium 100 MG [Clinical Drug]
   795   PO (Oral) [Spatial Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.30: Senna tablets two tablets PO b.i.d. 

Phrase: Senna tablets two tablets PO b.i.d.
Meta Mapping (743):
   618   Senokot Tablets [Clinical Drug]
   626   Two [Quantitative Concept]
   793   PO (Portugal) [Geographic Area]
   645   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (743):
   618   Senokot Tablets [Clinical Drug]
   626   Two [Quantitative Concept]
   793   PO (Oral) [Spatial Concept]
   645   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.31: Arimidex 1 mg PO q.d. 

Phrase: Arimidex 1 mg PO q.d.
Meta Mapping (768):
   632   Arimidex [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (768):
   632   Arimidex [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
Processing 00000000.tx.32: Fentanyl patch 50 mcg per hour replace every 72 hours Dulcolax suppository 10 mg q.d. p.r.n. constipation Fragmin 8000 units subcutaneously b.i.d. 

Phrase: Fentanyl patch 50 mcg per hour
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   50% [Finding]
   753   mcg (microgram) [Quantitative Concept]
   586   HOUR (Hour) [Temporal Concept]
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   50% [Finding]
   753   mcg (microgram) [Quantitative Concept]
   586   /hour [Quantitative Concept]
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   50% [Finding]
   753   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   586   HOUR (Hour) [Temporal Concept]
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   50% [Finding]
   753   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   586   /hour [Quantitative Concept]
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   <50 [Finding]
   753   mcg (microgram) [Quantitative Concept]
   586   HOUR (Hour) [Temporal Concept]
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   <50 [Finding]
   753   mcg (microgram) [Quantitative Concept]
   586   /hour [Quantitative Concept]
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   <50 [Finding]
   753   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   586   HOUR (Hour) [Temporal Concept]
Meta Mapping (753):
   623   Fentanyl Patch (Fentanyl Transdermal Patch) [Clinical Drug]
   586   <50 [Finding]
   753   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   586   /hour [Quantitative Concept]

Phrase: replace
Meta Mapping (1000):
  1000   Replace (Replacement) [Functional Concept]
Meta Mapping (1000):
  1000   Replace (Replace - HL7UpdateMode) [Idea or Concept]

Phrase: every 72 hours Dulcolax suppository 10 mg q.d. p.r.n. constipation Fragmin 8000 units subcutaneously b.i.d.
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   795   mg/d (milligram/day) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   MG (Mongolia) [Geographic Area]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg% (mg/dL) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   mg % (Milligram percent) [Quantitative Concept]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   CONSTIPATION (Constipation) [Sign or Symptom]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   UNITS (Unit) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit of Measure) [Quantitative Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I- (Iodides) [Inorganic Chemical]
Meta Mapping (705):
   790   72 Hours [Temporal Concept]
   790   dulcolax suppository (dulcolax suppositories) [Clinical Drug]
   783   10% [Finding]
   783   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   790   R.N. (Registered nurse) [Professional or Occupational Group]
   783   Constipation (Constipation Adverse Event) [Finding]
   783   Fragmin [Organic Chemical,Pharmacologic Substance]
   783   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   783   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.33: Hydromorphone 2-4 mg PO q3-4h p.r.n. pain Warfarin 5 mg PO q.d. 

Phrase: Hydromorphone 2-4 mg PO q3-4h p.r.n. pain Warfarin 5 mg PO q.d.
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   651   PO N [Clinical Attribute]
   618   4H (4 Hours) [Temporal Concept]
   618   R- (Right) [Spatial Concept]
   618   PAIN (Pain) [Sign or Symptom]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   651   PO N [Clinical Attribute]
   618   4H (4 Hours) [Temporal Concept]
   618   R- (Right) [Spatial Concept]
   618   Pain NOS (Pain NOS Adverse Event) [Finding]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   651   PO N [Clinical Attribute]
   618   4H (4 Hours) [Temporal Concept]
   618   R. (Rabbi) [Professional or Occupational Group]
   618   PAIN (Pain) [Sign or Symptom]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   651   PO N [Clinical Attribute]
   618   4H (4 Hours) [Temporal Concept]
   618   R. (Rabbi) [Professional or Occupational Group]
   618   Pain NOS (Pain NOS Adverse Event) [Finding]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   651   PO N [Clinical Attribute]
   618   4H (4 Hours) [Temporal Concept]
   618   R' (R prime) [Clinical Attribute]
   618   PAIN (Pain) [Sign or Symptom]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   651   PO N [Clinical Attribute]
   618   4H (4 Hours) [Temporal Concept]
   618   R' (R prime) [Clinical Attribute]
   618   Pain NOS (Pain NOS Adverse Event) [Finding]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   618   PO (Portugal) [Geographic Area]
   618   4H (4 Hours) [Temporal Concept]
   625   R.N. (Registered nurse) [Professional or Occupational Group]
   618   PAIN (Pain) [Sign or Symptom]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   618   PO (Portugal) [Geographic Area]
   618   4H (4 Hours) [Temporal Concept]
   625   R.N. (Registered nurse) [Professional or Occupational Group]
   618   Pain NOS (Pain NOS Adverse Event) [Finding]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   618   PO (Oral) [Spatial Concept]
   618   4H (4 Hours) [Temporal Concept]
   625   R.N. (Registered nurse) [Professional or Occupational Group]
   618   PAIN (Pain) [Sign or Symptom]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (715):
   618   HYDROMORPHONE (Hydromorphone) [Organic Chemical,Pharmacologic Substance]
   870   mg/mg/d (Gram per Gram per Day) [Quantitative Concept]
   618   PO (Oral) [Spatial Concept]
   618   4H (4 Hours) [Temporal Concept]
   625   R.N. (Registered nurse) [Professional or Occupational Group]
   618   Pain NOS (Pain NOS Adverse Event) [Finding]
   618   WARFARIN (Warfarin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.34: Admission Date : Discharge Date : The patient was in her usual state of health until about three weeks prior to admission when she began to notice increased weakness and bruising . 

Phrase: Admission Date
Meta Mapping (1000):
  1000   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (1000):
  1000   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: Discharge Date
Meta Mapping (1000):
  1000   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Discharge date [Temporal Concept]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was in her usual state of health
Meta Mapping (770):
   748   Usual [Qualitative Concept]
   814   state of health (personal health) [Finding]

Phrase: until

Phrase: about three weeks prior to admission
Meta Mapping (839):
   586   About (Approximate) [Qualitative Concept]
   790   Three weeks [Temporal Concept]
   623   Prior to (Before) [Temporal Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (839):
   586   About (Approximate) [Qualitative Concept]
   790   Three weeks [Temporal Concept]
   623   Prior to (Before) [Temporal Concept]
   586   Admission (Admission activity) [Health Care Activity]

Phrase: when

Phrase: she

Phrase: began
Meta Mapping (966):
   966   Begin (Beginning) [Temporal Concept]

Phrase: to notice increased weakness
Meta Mapping (775):
   645   TO (Togo) [Geographic Area]
   645   Increased [Quantitative Concept]
   812   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (775):
   645   TO (Togo) [Geographic Area]
   645   Increased (Increase) [Functional Concept]
   812   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (775):
   645   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   645   Increased [Quantitative Concept]
   812   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (775):
   645   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   645   Increased (Increase) [Functional Concept]
   812   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (775):
   645   To [Qualitative Concept]
   645   Increased [Quantitative Concept]
   812   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (775):
   645   To [Qualitative Concept]
   645   Increased (Increase) [Functional Concept]
   812   WEAKNESS (Weakness) [Sign or Symptom]

Phrase: and

Phrase: bruising .
Meta Mapping (1000):
  1000   Bruising (Contusions) [Injury or Poisoning]
Processing 00000000.tx.35: The patient had been doing aerobics three times a week until a couple of weeks before admission . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: been

Phrase: doing

Phrase: aerobics three times
Meta Mapping (851):
   660   aerobics (Exercise, Aerobic) [Therapeutic or Preventive Procedure]
   660   Three [Quantitative Concept]
   827   times (Time) [Temporal Concept]
Meta Mapping (851):
   660   aerobics (Exercise, Aerobic) [Therapeutic or Preventive Procedure]
   660   Three [Quantitative Concept]
   827   Times [Quantitative Concept]

Phrase: a week until a couple of weeks
Meta Mapping (652):
   748   /week (Weekly) [Temporal Concept]
   581   couple (Couples (persons)) [Family Group]
   581   WEEKS (week) [Temporal Concept]
Meta Mapping (652):
   748   /week (Weekly) [Temporal Concept]
   581   Couple (Couple (action)) [Functional Concept]
   581   WEEKS (week) [Temporal Concept]
Meta Mapping (652):
   748   WEEK (week) [Temporal Concept]
   581   couple (Couples (persons)) [Family Group]
   581   WEEKS (week) [Temporal Concept]
Meta Mapping (652):
   748   WEEK (week) [Temporal Concept]
   581   Couple (Couple (action)) [Functional Concept]
   581   WEEKS (week) [Temporal Concept]

Phrase: before admission .
Meta Mapping (1000):
  1000   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admission (Admission activity) [Health Care Activity]
Processing 00000000.tx.36: The patient &apos;s physical examination revealed a well-developed , well-nourished white female in no apparent distress . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s physical examination
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a well-developed , well-nourished white female in no apparent distress .
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasoid Race) [Population Group]
   738   FEMALE (Female) [Organism Attribute]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasoid Race) [Population Group]
   738   female (Woman) [Population Group]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasoid Race) [Population Group]
   738   female (Females) [Population Group]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasoid Race) [Population Group]
   738   Female (Female, Self-Report) [Qualitative Concept]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasoid Race) [Population Group]
   738   Female (Female Phenotype) [Qualitative Concept]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasians) [Population Group]
   738   FEMALE (Female) [Organism Attribute]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasians) [Population Group]
   738   female (Woman) [Population Group]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasians) [Population Group]
   738   female (Females) [Population Group]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasians) [Population Group]
   738   Female (Female, Self-Report) [Qualitative Concept]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (Caucasians) [Population Group]
   738   Female (Female Phenotype) [Qualitative Concept]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (White color) [Qualitative Concept]
   738   FEMALE (Female) [Organism Attribute]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (White color) [Qualitative Concept]
   738   female (Woman) [Population Group]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (White color) [Qualitative Concept]
   738   female (Females) [Population Group]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (White color) [Qualitative Concept]
   738   Female (Female, Self-Report) [Qualitative Concept]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Meta Mapping (653):
   587 N Well nourished (Actual Positive Nutritional Status) [Finding]
   738   WHITE (White color) [Qualitative Concept]
   738   Female (Female Phenotype) [Qualitative Concept]
   571   apparent [Idea or Concept]
   571 N Distress [Mental Process]
Processing 00000000.tx.37: AST 29 , ALK 151 , total bilirubin 0.2 , total protein 7.2 , albumin 4.3 , globulins 2.9 , calcium 8.9 . 

Phrase: AST 29 ,
Meta Mapping (888):
   861   AST (Atlantic Standard Time) [Temporal Concept]
   861   29+ [Finding]

Phrase: ALK 151 ,
Meta Mapping (861):
   861   ALK (ALK protein, human) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: total bilirubin 0.2 ,
Meta Mapping (824):
   861   Bilirubin, total (Bilirubin) [Biologically Active Substance,Organic Chemical]
   812   0% [Finding]
Meta Mapping (824):
   861   total bilirubin (Total bilirubin level) [Laboratory or Test Result]
   812   0% [Finding]

Phrase: total protein 7.2 ,
Meta Mapping (861):
   861   Total protein (Total protein measurement) [Laboratory Procedure]
Meta Mapping (861):
   861   total protein (Total protein result) [Laboratory or Test Result]

Phrase: albumin 4.3 ,
Meta Mapping (827):
   827   ALBUMIN (Albumins) [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: globulins 2.9 ,
Meta Mapping (827):
   827   Globulins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: calcium 8.9 .
Meta Mapping (827):
   827   CALCIUM (Calcium) [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (827):
   827   Calcium (Calcium, Dietary) [Inorganic Chemical]
Meta Mapping (827):
   827   Calcium (Calcium [EPC]) [Pharmacologic Substance]
Meta Mapping (827):
   827   CALCIUM (CALCIUM SUPPLEMENTS) [Pharmacologic Substance,Vitamin]
Meta Mapping (827):
   827   CALCIUM (Calcium Drug Class) [Pharmacologic Substance]
Processing 00000000.tx.38: The regimen included cyclophosphamide , daunorubicin , prednisone , Vincristine and PEG-asparaginase . 

Phrase: The regimen
Meta Mapping (1000):
  1000   Regimen (Treatment Protocols) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   regimen (Regimen - CHV concept) [Intellectual Product]

Phrase: included
Meta Mapping (1000):
  1000   included (Including (qualifier)) [Functional Concept]

Phrase: cyclophosphamide ,
Meta Mapping (1000):
  1000   CYCLOPHOSPHAMIDE (Cyclophosphamide) [Organic Chemical,Pharmacologic Substance]

Phrase: daunorubicin ,
Meta Mapping (1000):
  1000   DAUNORUBICIN (Daunorubicin) [Antibiotic,Organic Chemical]

Phrase: prednisone ,
Meta Mapping (1000):
  1000   PREDNISONE (Prednisone) [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: Vincristine
Meta Mapping (1000):
  1000   VINCRISTINE (Vincristine) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: PEG-asparaginase .
Meta Mapping (1000):
  1000   PEG-Asparaginase (pegaspargase) [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.39: The patient tolerated the chemotherapy regimen well . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: tolerated

Phrase: the chemotherapy regimen well .
Meta Mapping (901):
   901   Chemotherapy Regimen [Therapeutic or Preventive Procedure]
   660   Well (Good) [Qualitative Concept]
Meta Mapping (901):
   901   Chemotherapy Regimen [Therapeutic or Preventive Procedure]
   660   Well [Manufactured Object]
Processing 00000000.tx.40: 11) Simethicone 80 mg p.o. q.i.d. p.r.n. gas pain . 

Phrase: 11

Phrase: )

Phrase: Simethicone 80 mg p.o. q.i.d. p.r.n. gas pain .
Meta Mapping (790):
   642   Simethicone 80 MG [Clinical Drug]
   797   GAS PAIN (Abdominal wind pain) [Sign or Symptom]
Processing 00000000.tx.41: 15) Peridex 30 cc p.o. b.i.d. x 14 days . 

Phrase: 15

Phrase: )

Phrase: Peridex 30 cc p.o. b.i.d. x 14 days .
Meta Mapping (741):
   622   Peridex [Organic Chemical,Pharmacologic Substance]
   880   30 days [Temporal Concept]
   622   CC (C-Circle) [Cell Component]
   634   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.42: Dictated By : Attending : TELSHEY K. 

Phrase: Dictated By
Meta Mapping (833):
   833   dictated (dictated - ParticipationMode) [Functional Concept]
Meta Mapping (833):
   833   Dictated (dictated - DocumentCompletion) [Idea or Concept]

Phrase: :

Phrase: Attending
Meta Mapping (1000):
  1000   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   attending (Attending (action)) [Functional Concept]

Phrase: :

Phrase: TELSHEY K.
Meta Mapping (861):
   861   K+ (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (861):
   861   K' (K Prime) [Quantitative Concept]
Processing 00000000.tx.43: SWATLLEEBTIK , M.D. 

Phrase: SWATLLEEBTIK ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.44: NJ38 ME089/6922

Phrase: NJ38 ME089/6922
Processing 00000000.tx.1: CONGESTIVE HEART FAILURE . 

Phrase: CONGESTIVE HEART FAILURE .
Meta Mapping (1000):
  1000   CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Processing 00000000.tx.2: No other history is available . 

Phrase: No

Phrase: other history
Meta Mapping (1000):
  1000   History [Occupation or Discipline]
Meta Mapping (1000):
  1000   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (1000):
  1000   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (1000):
  1000 N History (Medical History) [Finding]
Meta Mapping (1000):
  1000   History (Concept History) [Conceptual Entity]
Meta Mapping (1000):
  1000 N History (History of previous events) [Finding]

Phrase: is

Phrase: available .
Meta Mapping (1000):
  1000   Available (Availability of) [Functional Concept]
Processing 00000000.tx.3: 5. 

Phrase: 5.
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]
Processing 00000000.tx.4: peripheral vascular disease . 

Phrase: peripheral vascular disease .
Meta Mapping (1000):
  1000   PERIPHERAL VASCULAR DISEASE (Peripheral Vascular Diseases) [Disease or Syndrome]
Processing 00000000.tx.5: 6. 

Phrase: 6.
Processing 00000000.tx.6: schizotypal personality disorder . 

Phrase: schizotypal personality disorder .
Meta Mapping (1000):
  1000   Disorder, Schizotypal Personality (Schizotypal Personality Disorder) [Mental or Behavioral Dysfunction]
Processing 00000000.tx.7: LABORATORY DATA : A repeat chest X-ray on April 9 showed markedly improved congestive heart failure with mild residual redistribution of the vasculature , and very small pleural effusions . 

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: A repeat chest X-ray on April 9
Meta Mapping (731):
   578   Repeat [Functional Concept]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   April [Temporal Concept]
Meta Mapping (731):
   578   Repeat [Functional Concept]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (731):
   578   Repeat [Functional Concept]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]
Meta Mapping (731):
   578   Repeat [Functional Concept]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   April [Temporal Concept]
Meta Mapping (731):
   578   Repeat [Functional Concept]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (731):
   578   Repeat [Functional Concept]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]
Meta Mapping (731):
   578   Repeat (Repeat Pattern) [Temporal Concept]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   April [Temporal Concept]
Meta Mapping (731):
   578   Repeat (Repeat Pattern) [Temporal Concept]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (731):
   578   Repeat (Repeat Pattern) [Temporal Concept]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]
Meta Mapping (731):
   578   Repeat (Repeat Pattern) [Temporal Concept]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   April [Temporal Concept]
Meta Mapping (731):
   578   Repeat (Repeat Pattern) [Temporal Concept]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (731):
   578   Repeat (Repeat Pattern) [Temporal Concept]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]
Meta Mapping (731):
   578   Repeat (Repeat Object) [Conceptual Entity]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   April [Temporal Concept]
Meta Mapping (731):
   578   Repeat (Repeat Object) [Conceptual Entity]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (731):
   578   Repeat (Repeat Object) [Conceptual Entity]
   800   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   578   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]
Meta Mapping (731):
   578   Repeat (Repeat Object) [Conceptual Entity]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   April [Temporal Concept]
Meta Mapping (731):
   578   Repeat (Repeat Object) [Conceptual Entity]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (731):
   578   Repeat (Repeat Object) [Conceptual Entity]
   800   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   578   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: markedly
Meta Mapping (1000):
  1000   Markedly (Massive) [Qualitative Concept]

Phrase: improved
Meta Mapping (1000):
  1000   Improved [Qualitative Concept]
Meta Mapping (1000):
  1000   Improved (Better) [Qualitative Concept]
Meta Mapping (1000):
  1000   Improved (Admission Level of Care Code - Improved) [Intellectual Product]

Phrase: congestive heart failure with mild residual redistribution of the vasculature ,
Meta Mapping (710):
   739   Congestive (congestive) [Qualitative Concept]
   739   FAILURE (Failure (biologic function)) [Functional Concept]
   573   MILD (Mild (qualifier value)) [Qualitative Concept]
   573   Residual [Qualitative Concept]
   573   Redistribution [Functional Concept]
   775   Vasculature of heart [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   739   Congestive (congestive) [Qualitative Concept]
   739   failure (Personal failure) [Individual Behavior]
   573   MILD (Mild (qualifier value)) [Qualitative Concept]
   573   Residual [Qualitative Concept]
   573   Redistribution [Functional Concept]
   775   Vasculature of heart [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: very small pleural effusions .
Meta Mapping (888):
   694   Very Small (Can Do Very Little) [Intellectual Product]
   861   Pleural Effusions (Pleural effusion disorder) [Disease or Syndrome]
Processing 00000000.tx.8: The remainder of the patient &apos;s medical issues were stable during this hospitalization . 

Phrase: The remainder of the patient &apos
Meta Mapping (586):
   586   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (586):
   586   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (586):
   586   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (586):
   586   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s medical issues
Meta Mapping (890):
   660   /s (per second) [Quantitative Concept]
   884   Medical Issue (Patient Problem) [Finding]
Meta Mapping (890):
   660   /s (per second) [Quantitative Concept]
   884   Medical Issue (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (890):
   660   S' (S prime) [Clinical Attribute]
   884   Medical Issue (Patient Problem) [Finding]
Meta Mapping (890):
   660   S' (S prime) [Clinical Attribute]
   884   Medical Issue (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: were

Phrase: stable during this hospitalization .
Meta Mapping (708):
   770   STABLE (Stable status) [Qualitative Concept]
   604   hospitalisation (Hospitalization) [Health Care Activity]
Meta Mapping (708):
   770   Stable (Patient Condition Code - Stable) [Intellectual Product]
   604   hospitalisation (Hospitalization) [Health Care Activity]
Processing 00000000.tx.9: She did allow daily weights and chest X-rays on occasion . 

Phrase: She

Phrase: did

Phrase: allow
Meta Mapping (1000):
  1000   allow (allowing) [Social Behavior]

Phrase: daily weights
Meta Mapping (888):
   861   Daily [Temporal Concept]
   861   WEIGHTS (Weight) [Quantitative Concept]
Meta Mapping (888):
   861   Daily [Temporal Concept]
   861   Weights (Weights - exercise activity) [Finding]

Phrase: and

Phrase: chest X-rays on occasion .
Meta Mapping (780):
   862   chest x rays (Plain chest X-ray) [Diagnostic Procedure]
   521   Occasional (Infrequent) [Temporal Concept]
Processing 00000000.tx.10: She was also compliant with her daily Accu checks for blood glucose monitoring . 

Phrase: She

Phrase: was

Phrase: also compliant with her daily Accu checks
Meta Mapping (641):
   748   Compliant (Compliant (qualifier value)) [Qualitative Concept]
   581   Daily [Temporal Concept]
   548   Check (Checking (action)) [Activity]
Meta Mapping (641):
   748   Compliant (Compliance behavior) [Individual Behavior]
   581   Daily [Temporal Concept]
   548   Check (Checking (action)) [Activity]

Phrase: for blood glucose monitoring .
Meta Mapping (1000):
  1000   blood glucose monitoring (Monitors blood glucose) [Finding]
Meta Mapping (1000):
  1000   Blood glucose monitoring (Blood glucose monitoring (regime/therapy)) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: The patient was discharged in stable condition to Den Health . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: discharged in stable condition
Meta Mapping (783):
   770   Discharged (Patient Discharge) [Health Care Activity]
   833   Stable condition (Stable Disease) [Finding]
Meta Mapping (783):
   770   Discharged (Patient Discharge) [Health Care Activity]
   833   Stable condition (Stable chronic Graft vs Host Disease) [Finding]

Phrase: to Den Health .
Meta Mapping (888):
   694   DEN (density) [Quantitative Concept]
   861   Health [Idea or Concept]
Processing 00000000.tx.12: She will continue to receive intravenous medications and close monitoring of her multiple medical problems there . 

Phrase: She

Phrase: will

Phrase: continue
Meta Mapping (1000):
  1000   Continue (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: receive
Meta Mapping (1000):
  1000   Receive [Qualitative Concept]

Phrase: intravenous medications
Meta Mapping (888):
   694   Intravenous [Spatial Concept]
   861   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (888):
   694   Intravenous [Spatial Concept]
   861   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (888):
   694   Intravenous [Spatial Concept]
   861   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: and

Phrase: close monitoring of her multiple medical problems there .
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   750   Monitoring problem [Finding]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   578   Medical (Medical service) [Health Care Activity]
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   750   Monitoring problem [Finding]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   578   Medical [Functional Concept]
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   744   Monitoring (Preventive monitoring) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical Problem (Patient Problem) [Finding]
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   744   Monitoring (Preventive monitoring) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical problem (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   744   Monitoring (Monitoring - action) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical Problem (Patient Problem) [Finding]
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   744   Monitoring (Monitoring - action) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical problem (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   744   monitoring (Clinical Trials, Monitoring) [Research Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical Problem (Patient Problem) [Finding]
Meta Mapping (682):
   578   Close (Closed) [Functional Concept]
   744   monitoring (Clinical Trials, Monitoring) [Research Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical problem (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (682):
   578   Close [Finding]
   750   Monitoring problem [Finding]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   578   Medical (Medical service) [Health Care Activity]
Meta Mapping (682):
   578   Close [Finding]
   750   Monitoring problem [Finding]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   578   Medical [Functional Concept]
Meta Mapping (682):
   578   Close [Finding]
   744   Monitoring (Preventive monitoring) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical Problem (Patient Problem) [Finding]
Meta Mapping (682):
   578   Close [Finding]
   744   Monitoring (Preventive monitoring) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical problem (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (682):
   578   Close [Finding]
   744   Monitoring (Monitoring - action) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical Problem (Patient Problem) [Finding]
Meta Mapping (682):
   578   Close [Finding]
   744   Monitoring (Monitoring - action) [Health Care Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical problem (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (682):
   578   Close [Finding]
   744   monitoring (Clinical Trials, Monitoring) [Research Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical Problem (Patient Problem) [Finding]
Meta Mapping (682):
   578   Close [Finding]
   744   monitoring (Clinical Trials, Monitoring) [Research Activity]
   578   MULTIPLE (Numerous) [Quantitative Concept]
   587   Medical problem (Medical problem:Finding:Point in time:^Patient:Nominal) [Clinical Attribute]
Processing 00000000.tx.13: TD :

Phrase: TD
Meta Mapping (1000):
  1000   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (1000):
  1000   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :
Processing 00000000.tx.1: 289724916 0051811 Unsigned Report Status : Unsigned carcinoma of the kidney , hypovolemia , metastatic liver disease and intrathoracic lymphadenopathy . 

Phrase: 289724916 0051811 Unsigned Report Status
Meta Mapping (840):
   840   Report status [Finding]

Phrase: :

Phrase: Unsigned carcinoma of the kidney ,
Meta Mapping (844):
   844   carcinoma of kidney (Renal Cell Carcinoma) [Neoplastic Process]
Meta Mapping (844):
   844   CARCINOMA OF KIDNEY (Renal carcinoma) [Neoplastic Process]

Phrase: hypovolemia ,
Meta Mapping (1000):
  1000   HYPOVOLEMIA (Hypovolemia) [Finding]

Phrase: metastatic liver disease
Meta Mapping (901):
   913   metastatic disease (Neoplasm Metastasis) [Neoplastic Process]
   827   LIVER (Liver) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   metastatic disease (Neoplasm Metastasis) [Neoplastic Process]
   827   LIVER (Liver parenchyma) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   metastatic disease (Neoplasm Metastasis) [Neoplastic Process]
   827   Liver (Entire liver) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   metastatic disease (Neoplasm Metastasis) [Neoplastic Process]
   827   LIVER (Liver Flavor) [Food]
Meta Mapping (901):
   913   Metastatic disease (Secondary Neoplasm) [Neoplastic Process]
   827   LIVER (Liver) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   Metastatic disease (Secondary Neoplasm) [Neoplastic Process]
   827   LIVER (Liver parenchyma) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   Metastatic disease (Secondary Neoplasm) [Neoplastic Process]
   827   Liver (Entire liver) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   Metastatic disease (Secondary Neoplasm) [Neoplastic Process]
   827   LIVER (Liver Flavor) [Food]
Meta Mapping (901):
   913   Metastatic Disease (Metastatic Neoplasm) [Neoplastic Process]
   827   LIVER (Liver) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   Metastatic Disease (Metastatic Neoplasm) [Neoplastic Process]
   827   LIVER (Liver parenchyma) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   Metastatic Disease (Metastatic Neoplasm) [Neoplastic Process]
   827   Liver (Entire liver) [Body Part, Organ, or Organ Component]
Meta Mapping (901):
   913   Metastatic Disease (Metastatic Neoplasm) [Neoplastic Process]
   827   LIVER (Liver Flavor) [Food]
Meta Mapping (901):
   660   Metastatic (Metastatic to) [Functional Concept]
   901   LIVER DISEASE (Liver diseases) [Disease or Syndrome]
Meta Mapping (901):
   660   metastatic (metastatic qualifier) [Quantitative Concept]
   901   LIVER DISEASE (Liver diseases) [Disease or Syndrome]

Phrase: and

Phrase: intrathoracic lymphadenopathy .
Meta Mapping (1000):
  1000   Intrathoracic lymphadenopathy (Thoracic lymphadenopathy) [Disease or Syndrome]
Processing 00000000.tx.2: HISTORY OF PRESENT ILLNESS : ( at time of admission ) the blood pressure 100/65 ; The lungs were clear , heart normal .

Phrase: HISTORY OF PRESENT ILLNESS
Meta Mapping (1000):
  1000   HISTORY OF PRESENT ILLNESS (History of present illness) [Organism Attribute]
Meta Mapping (1000):
  1000   History of present illness (History of present illness:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]

Phrase: :

Phrase: (

Phrase: at time of admission
Meta Mapping (819):
   819   Admission time (Admission time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]
Meta Mapping (819):
   819   Admission time [Temporal Concept]

Phrase: )

Phrase: the blood pressure 100/65
Meta Mapping (861):
   861   BLOOD PRESSURE (Blood Pressure) [Organism Function]
   812   100% [Quantitative Concept]
   812   65 [Intellectual Product]
Meta Mapping (861):
   861   BLOOD PRESSURE (Blood Pressure) [Organism Function]
   812   100% [Quantitative Concept]
   812   65+ [Finding]
Meta Mapping (861):
   861   Blood Pressure (Blood pressure finding) [Finding]
   812   100% [Quantitative Concept]
   812   65 [Intellectual Product]
Meta Mapping (861):
   861   Blood Pressure (Blood pressure finding) [Finding]
   812   100% [Quantitative Concept]
   812   65+ [Finding]
Meta Mapping (861):
   861   Blood pressure (Systemic arterial pressure) [Finding]
   812   100% [Quantitative Concept]
   812   65 [Intellectual Product]
Meta Mapping (861):
   861   Blood pressure (Systemic arterial pressure) [Finding]
   812   100% [Quantitative Concept]
   812   65+ [Finding]

Phrase: ;

Phrase: The lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: clear , heart
Meta Mapping (888):
   694   Clear (Negative Surgical Margin) [Finding]
   861   HEART (Heart) [Body Part, Organ, or Organ Component]
Meta Mapping (888):
   694   Clear (Negative Surgical Margin) [Finding]
   861   Heart (Entire heart) [Body Part, Organ, or Organ Component]
Meta Mapping (888):
   694   Clear [Qualitative Concept]
   861   HEART (Heart) [Body Part, Organ, or Organ Component]
Meta Mapping (888):
   694   Clear [Qualitative Concept]
   861   Heart (Entire heart) [Body Part, Organ, or Organ Component]

Phrase: normal .
Meta Mapping (1000):
  1000   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (1000):
  1000   Normal (Gait normal) [Finding]
Meta Mapping (1000):
  1000   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (1000):
  1000   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.1: PRINCIPAL DIAGNOSIS : 3. 

Phrase: PRINCIPAL DIAGNOSIS
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal diagnosis) [Qualitative Concept]
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal Diagnosis:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.2: Ecotrin , 325 mg. 

Phrase: Ecotrin ,
Meta Mapping (1000):
  1000   Ecotrin [Organic Chemical,Pharmacologic Substance]

Phrase: 325 mg.
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.3: , po , qD. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: qD.
Meta Mapping (1000):
  1000   QD (Daily) [Temporal Concept]
Processing 00000000.tx.4: He was treated with intravenous Streptokinase , intravenous heparin , intravenous nitroglycerin . 

Phrase: He

Phrase: was

Phrase: treated with intravenous Streptokinase ,
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   Intravenous [Spatial Concept]
   770   STREPTOKINASE (Streptokinase) [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: intravenous heparin ,
Meta Mapping (1000):
  1000   Intravenous heparin [Organic Chemical,Pharmacologic Substance]

Phrase: intravenous nitroglycerin .
Meta Mapping (888):
   694   Intravenous [Spatial Concept]
   861   nitroglycerine (Nitroglycerin) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   Intravenous [Spatial Concept]
   861   nitroglycerine (Glonoine, nitroglycerine, Homeopathic preparation) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.5: The carotids were normal . 

Phrase: The carotids
Meta Mapping (1000):
  1000   carotids (carotid) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: normal .
Meta Mapping (1000):
  1000   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (1000):
  1000   Normal (Gait normal) [Finding]
Meta Mapping (1000):
  1000   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (1000):
  1000   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.6: 9/12/94 09/13/94 CC : 7213645 Discharge Summary He is a heavy smoker and drinks 2-3 shots per day at times . 

Phrase: 9/12/94 09/13/94 CC
Meta Mapping (795):
   795   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: 7213645 Discharge Summary
Meta Mapping (901):
   901   Discharge summary [Intellectual Product]
Meta Mapping (901):
   901   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: He

Phrase: is

Phrase: a heavy smoker
Meta Mapping (888):
   861   Heavy (Heavy sensation quality) [Qualitative Concept]
   861   Smoker [Finding]

Phrase: and

Phrase: drinks
Meta Mapping (1000):
  1000   Drinks (Drink (dietary substance)) [Food]

Phrase: 2-3 shots per day
Meta Mapping (761):
   640   2-3 (Phase II/III Trial) [Research Activity]
   760   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   593   /day (Daily) [Temporal Concept]
Meta Mapping (761):
   640   2-3 (Phase II/III Trial) [Research Activity]
   760   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   593   DAY (day) [Temporal Concept]
Meta Mapping (761):
   640   2-3 (Phase II/III Trial) [Research Activity]
   760   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   593   /day (per day) [Temporal Concept]
Meta Mapping (761):
   593   +2 [Quantitative Concept]
   760   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   631   Day 3 [Finding]
Meta Mapping (761):
   593   2+ (2+ Score) [Quantitative Concept]
   760   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   631   Day 3 [Finding]
Meta Mapping (761):
   593   2+ (2+ Score, WHO) [Classification]
   760   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   631   Day 3 [Finding]
Meta Mapping (761):
   593   2+ [Finding]
   760   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   631   Day 3 [Finding]

Phrase: at times .
Meta Mapping (1000):
  1000   times (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Times [Quantitative Concept]
Processing 00000000.tx.7: PAST MEDICAL HISTORY : On sensory examination , had decreased pin prick , temperature , vibration in the left side of the body . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: On sensory examination ,
Meta Mapping (694):
   694   Sensory (Sensory (qualifier value)) [Qualitative Concept]

Phrase: had

Phrase: decreased pin prick ,
Meta Mapping (851):
   660   Decreased [Quantitative Concept]
   827   Pin (Medical pins) [Medical Device]
   827   Prick (Puncture wound) [Injury or Poisoning]
Meta Mapping (851):
   660   Decreased [Quantitative Concept]
   827   Pin (Medical pins) [Medical Device]
   827   Prick (Pricking sensation quality) [Finding]
Meta Mapping (851):
   660   Decreased [Quantitative Concept]
   827   Pin (Pin Device Component) [Manufactured Object]
   827   Prick (Puncture wound) [Injury or Poisoning]
Meta Mapping (851):
   660   Decreased [Quantitative Concept]
   827   Pin (Pin Device Component) [Manufactured Object]
   827   Prick (Pricking sensation quality) [Finding]
Meta Mapping (851):
   660   Decreased (Reduced) [Qualitative Concept]
   827   Pin (Medical pins) [Medical Device]
   827   Prick (Puncture wound) [Injury or Poisoning]
Meta Mapping (851):
   660   Decreased (Reduced) [Qualitative Concept]
   827   Pin (Medical pins) [Medical Device]
   827   Prick (Pricking sensation quality) [Finding]
Meta Mapping (851):
   660   Decreased (Reduced) [Qualitative Concept]
   827   Pin (Pin Device Component) [Manufactured Object]
   827   Prick (Puncture wound) [Injury or Poisoning]
Meta Mapping (851):
   660   Decreased (Reduced) [Qualitative Concept]
   827   Pin (Pin Device Component) [Manufactured Object]
   827   Prick (Pricking sensation quality) [Finding]
Meta Mapping (851):
   660   decreased (Decreasing) [Qualitative Concept]
   827   Pin (Medical pins) [Medical Device]
   827   Prick (Puncture wound) [Injury or Poisoning]
Meta Mapping (851):
   660   decreased (Decreasing) [Qualitative Concept]
   827   Pin (Medical pins) [Medical Device]
   827   Prick (Pricking sensation quality) [Finding]
Meta Mapping (851):
   660   decreased (Decreasing) [Qualitative Concept]
   827   Pin (Pin Device Component) [Manufactured Object]
   827   Prick (Puncture wound) [Injury or Poisoning]
Meta Mapping (851):
   660   decreased (Decreasing) [Qualitative Concept]
   827   Pin (Pin Device Component) [Manufactured Object]
   827   Prick (Pricking sensation quality) [Finding]

Phrase: temperature ,
Meta Mapping (1000):
  1000   temperature (Body Temperature) [Organism Attribute]
Meta Mapping (1000):
  1000   *Temperature (Temperature) [Quantitative Concept]

Phrase: vibration in the left side of the body .
Meta Mapping (774):
   744   Vibration NOS (Vibration - treatment) [Therapeutic or Preventive Procedure]
   656   Left side of body (Structure of left half of body) [Body Part, Organ, or Organ Component]
Meta Mapping (774):
   744   Vibration (Vibration - physical agent) [Natural Phenomenon or Process]
   656   Left side of body (Structure of left half of body) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.8: The finger-to-nose was okay on the right . 

Phrase: The finger-to-nose
Meta Mapping (802):
   660   FINGER (Fingers) [Body Location or Region]
   827   NOSE (Nose) [Body Part, Organ, or Organ Component]
Meta Mapping (802):
   660   FINGER (Fingers) [Body Location or Region]
   827   Nose (Entire nose) [Body Part, Organ, or Organ Component]
Meta Mapping (802):
   660   Finger (Entire finger) [Body Part, Organ, or Organ Component]
   827   NOSE (Nose) [Body Part, Organ, or Organ Component]
Meta Mapping (802):
   660   Finger (Entire finger) [Body Part, Organ, or Organ Component]
   827   Nose (Entire nose) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: okay on the right .
Meta Mapping (770):
   770   RIGHT (Right) [Spatial Concept]
Meta Mapping (770):
   770   Right (Right sided) [Spatial Concept]
Processing 00000000.tx.9: Head computerized tomography scan showed 1.5 to 2 centimeter bleed in the right thalamus extending to the internal capsule with mild distortion only , no shift . 

Phrase: Head computerized tomography scan
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   Scan (Radionuclide Imaging) [Diagnostic Procedure]
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   Scan (Scanning) [Diagnostic Procedure]
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   SCAN (Related to Cancer) [Finding]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: 1.5 to 2 centimeter
Meta Mapping (745):
   806   1/5 [Quantitative Concept]
   760   centimetre (centimeter) [Quantitative Concept]
Meta Mapping (745):
   797   1/2 [Intellectual Product]
   760   centimetre (centimeter) [Quantitative Concept]
Meta Mapping (745):
   797   1-2 (Phase I/II Trial) [Research Activity]
   760   centimetre (centimeter) [Quantitative Concept]
Meta Mapping (745):
   797   1-2 [Finding]
   760   centimetre (centimeter) [Quantitative Concept]

Phrase: bleed in the right thalamus extending
Meta Mapping (725):
   753   bleed (Hemorrhage) [Pathologic Function]
   790   Right thalamus [Body Part, Organ, or Organ Component]
   753   Extending (Extent) [Spatial Concept]

Phrase: to the internal capsule with mild distortion only ,
Meta Mapping (688):
   770   Internal Capsule (Internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion (Abnormal shape) [Anatomical Abnormality]
   578   Only (Singular) [Quantitative Concept]
Meta Mapping (688):
   770   Internal Capsule (Internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion (Abnormal shape) [Anatomical Abnormality]
   578   Only (Only - dosing instruction fragment) [Intellectual Product]
Meta Mapping (688):
   770   Internal Capsule (Internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion [Qualitative Concept]
   578   Only (Singular) [Quantitative Concept]
Meta Mapping (688):
   770   Internal Capsule (Internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion [Qualitative Concept]
   578   Only (Only - dosing instruction fragment) [Intellectual Product]
Meta Mapping (688):
   770   Internal capsule (Entire internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion (Abnormal shape) [Anatomical Abnormality]
   578   Only (Singular) [Quantitative Concept]
Meta Mapping (688):
   770   Internal capsule (Entire internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion (Abnormal shape) [Anatomical Abnormality]
   578   Only (Only - dosing instruction fragment) [Intellectual Product]
Meta Mapping (688):
   770   Internal capsule (Entire internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion [Qualitative Concept]
   578   Only (Singular) [Quantitative Concept]
Meta Mapping (688):
   770   Internal capsule (Entire internal capsule of brain) [Body Part, Organ, or Organ Component]
   578   MILD (Mild (qualifier value)) [Qualitative Concept]
   578   Distortion [Qualitative Concept]
   578   Only (Only - dosing instruction fragment) [Intellectual Product]

Phrase: no shift .
Meta Mapping (1000):
  1000   Shift (shift displacement) [Functional Concept]
Meta Mapping (1000):
  1000   Shift (Physical Shift) [Phenomenon or Process]
Processing 00000000.tx.10: DISCHARGE DIAGNOSIS : HLGMC 3-26-93 4-3-93 The heart exam revealed a normal Sl and S2 was normally split . 

Phrase: DISCHARGE DIAGNOSIS
Meta Mapping (1000):
  1000   Discharge diagnosis (discharge diagnosis) [Finding]

Phrase: :

Phrase: HLGMC 3-26-93 4-3-93

Phrase: The heart exam
Meta Mapping (1000):
  1000   heart exam (Examination of heart) [Health Care Activity]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a normal Sl
Meta Mapping (694):
   694   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (694):
   694   Normal (Gait normal) [Finding]
Meta Mapping (694):
   694   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (694):
   694   % Normal (Mean Percent of Normal) [Quantitative Concept]

Phrase: and

Phrase: S2
Meta Mapping (1000):
  1000   S2 (S2 innervation) [Body Location or Region]
Meta Mapping (1000):
  1000   S2 (PSMD2 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   S2 (RPS2 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   S2 (Testicular Cancer Serum Markers Test Result S2) [Laboratory or Test Result]
Meta Mapping (1000):
  1000   S2 [Finding]

Phrase: was

Phrase: normally

Phrase: split .
Meta Mapping (1000):
  1000   Split (Splitting) [Functional Concept]
Meta Mapping (1000):
  1000   Split (Medical Device Material Split) [Phenomenon or Process]
Processing 00000000.tx.11: There was an S4 , no S3 , grade II/VI apical murmur in systole , no rubs . 

Phrase: There

Phrase: was

Phrase: an S4 ,
Meta Mapping (1000):
  1000   S4+ [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   S4 (S4 heart sound) [Finding]

Phrase: no S3 ,
Meta Mapping (1000):
  1000   S3 (S3 (sacral segmental innervation)) [Body Location or Region]
Meta Mapping (1000):
  1000   S3 (RPS3 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   S3 (PSMD3 gene) [Gene or Genome]
Meta Mapping (1000):
  1000 N S3 (Testicular Cancer Serum Markers Test Result S3) [Laboratory or Test Result]

Phrase: grade II/VI apical murmur in systole ,
Meta Mapping (851):
   842 N grade VI apical systolic murmur [Finding]

Phrase: no

Phrase: rubs .
Meta Mapping (1000):
  1000 N Rubs [Finding]
Processing 00000000.tx.12: In view of these findings , it was elected to discharge her on her present medical program . 

Phrase: In view of these findings ,
Meta Mapping (1000):
  1000   findings (findings aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Findings (Procedure findings:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   FINDINGS (CDISC Findings Class) [Intellectual Product]

Phrase: it

Phrase: was

Phrase: elected
Meta Mapping (1000):
  1000   Elected (Choose (action)) [Activity]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: discharge
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: her on her present medical program .
Meta Mapping (685):
   753   Present [Quantitative Concept]
   753   Medical (Medical service) [Health Care Activity]
   753   Program (Program - framework of goals) [Conceptual Entity]
Meta Mapping (685):
   753   Present [Quantitative Concept]
   753   Medical (Medical service) [Health Care Activity]
   753   Program [Pharmacologic Substance]
Meta Mapping (685):
   753   Present [Quantitative Concept]
   753   Medical (Medical service) [Health Care Activity]
   753   Program (Programs) [Functional Concept]
Meta Mapping (685):
   753   Present [Quantitative Concept]
   753   Medical [Functional Concept]
   753   Program (Program - framework of goals) [Conceptual Entity]
Meta Mapping (685):
   753   Present [Quantitative Concept]
   753   Medical [Functional Concept]
   753   Program [Pharmacologic Substance]
Meta Mapping (685):
   753   Present [Quantitative Concept]
   753   Medical [Functional Concept]
   753   Program (Programs) [Functional Concept]
Meta Mapping (685):
   753   Present (Presentation) [Idea or Concept]
   753   Medical (Medical service) [Health Care Activity]
   753   Program (Program - framework of goals) [Conceptual Entity]
Meta Mapping (685):
   753   Present (Presentation) [Idea or Concept]
   753   Medical (Medical service) [Health Care Activity]
   753   Program [Pharmacologic Substance]
Meta Mapping (685):
   753   Present (Presentation) [Idea or Concept]
   753   Medical (Medical service) [Health Care Activity]
   753   Program (Programs) [Functional Concept]
Meta Mapping (685):
   753   Present (Presentation) [Idea or Concept]
   753   Medical [Functional Concept]
   753   Program (Program - framework of goals) [Conceptual Entity]
Meta Mapping (685):
   753   Present (Presentation) [Idea or Concept]
   753   Medical [Functional Concept]
   753   Program [Pharmacologic Substance]
Meta Mapping (685):
   753   Present (Presentation) [Idea or Concept]
   753   Medical [Functional Concept]
   753   Program (Programs) [Functional Concept]
Processing 00000000.tx.13: CHPO E. 

Phrase: CHPO E.
Processing 00000000.tx.14: JESCOBEA , M.D. 

Phrase: JESCOBEA ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.15: Unsigned Lumbar puncture 3/5/94 . 

Phrase: Unsigned Lumbar puncture 3/5/94 .
Meta Mapping (827):
   827   Lumbar Puncture (Spinal Puncture) [Health Care Activity]
Meta Mapping (827):
   827   Lumbar puncture, NOS (Diagnostic lumbar puncture) [Diagnostic Procedure]
Meta Mapping (827):
   827   Lumbar Puncture (Consent Type - Lumbar Puncture) [Health Care Activity]
Processing 00000000.tx.16: Migraine headaches with visual changes , headache and photophobia had been present for many years . 

Phrase: Migraine headaches with visual changes ,
Meta Mapping (779):
   806   Migraine Headaches (Migraine Disorders) [Disease or Syndrome]
   640   Visual changes [Finding]

Phrase: headache
Meta Mapping (1000):
  1000   HEADACHE (Headache) [Sign or Symptom]

Phrase: and

Phrase: photophobia
Meta Mapping (1000):
  1000   PHOTOPHOBIA (Photophobia) [Sign or Symptom]

Phrase: had

Phrase: been

Phrase: present for many years .
Meta Mapping (708):
   770   Present [Quantitative Concept]
   604   YEARS (year) [Temporal Concept]
Meta Mapping (708):
   770   Present (Presentation) [Idea or Concept]
   604   YEARS (year) [Temporal Concept]
Processing 00000000.tx.17: Increased imbalance occurred in 1991 , at which time he was unable to walk tandem and swayed on the Romberg test . 

Phrase: Increased imbalance
Meta Mapping (888):
   694   Increased [Quantitative Concept]
   861   Imbalance [Sign or Symptom]
Meta Mapping (888):
   694   Increased (Increase) [Functional Concept]
   861   Imbalance [Sign or Symptom]

Phrase: occurred in 1991 ,
Meta Mapping (790):
   790   Occurred (Occur (action)) [Activity]

Phrase: at which time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: he

Phrase: was

Phrase: unable
Meta Mapping (1000):
  1000   Unable [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: walk
Meta Mapping (1000):
  1000   Walk (Walking (activity)) [Daily or Recreational Activity]

Phrase: tandem
Meta Mapping (1000):
  1000   TANDEM [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: swayed on the Romberg test .
Meta Mapping (806):
   806   Romberg test (Romberg sign finding) [Finding]
Meta Mapping (806):
   806   Romberg test (Romberg test procedure) [Diagnostic Procedure]
Processing 00000000.tx.18: There was no aphasia . 

Phrase: There

Phrase: was

Phrase: no aphasia .
Meta Mapping (1000):
  1000 N APHASIA (Aphasia) [Mental or Behavioral Dysfunction]
Processing 00000000.tx.19: 03/06/94 TD : Copy to Dr. 

Phrase: 03/06/94 TD
Meta Mapping (812):
   812   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (812):
   812   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :

Phrase: Copy to Dr.
Meta Mapping (746):
   790   Copy (Copy (object)) [Manufactured Object]
   623   DR (Dominican Republic) [Geographic Area]
Meta Mapping (746):
   790   Copy (Copy (object)) [Manufactured Object]
   623   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (746):
   790   Copy (Copy (object)) [Manufactured Object]
   623   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (746):
   790   Copy (Copy (object)) [Manufactured Object]
   623   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (746):
   790   Copy (Copy (object)) [Manufactured Object]
   623   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.20: Breutzoln . 

Phrase: Breutzoln .
Processing 00000000.tx.21: DISCHARGE DIAGNOSES : 1. 

Phrase: DISCHARGE DIAGNOSES
Meta Mapping (966):
   966   Discharge diagnosis (discharge diagnosis) [Finding]

Phrase: :

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.22: Carotid stenosis . 

Phrase: Carotid stenosis .
Meta Mapping (1000):
  1000   CAROTID STENOSIS (Carotid Stenosis) [Disease or Syndrome]
Processing 00000000.tx.23: The pain and light-headedness is now severely lifestyle limiting and the patient requested evaluation for possible aortic valve replacement . 

Phrase: The pain
Meta Mapping (1000):
  1000   PAIN (Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: and

Phrase: light-headedness
Meta Mapping (1000):
  1000   Lightheadedness (Dizziness) [Sign or Symptom]
Meta Mapping (1000):
  1000   LIGHTHEADEDNESS (Lightheadedness) [Sign or Symptom]

Phrase: is

Phrase: now severely lifestyle limiting
Meta Mapping (833):
   645   Now (Now (temporal qualifier)) [Temporal Concept]
   645   Severely (Severe (severity modifier)) [Qualitative Concept]
   645   Lifestyle (Life Style) [Social Behavior]
   812   limiting (Limited (extensiveness)) [Functional Concept]

Phrase: and

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: requested
Meta Mapping (1000):
  1000   Requested (Request - action) [Functional Concept]

Phrase: evaluation for possible aortic valve replacement .
Meta Mapping (789):
   753   Evaluation [Health Care Activity]
   586   Possible [Qualitative Concept]
   666   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   753   Evaluation [Health Care Activity]
   586   Possible (Possibly Related to Intervention) [Qualitative Concept]
   666   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   753   Evaluation [Health Care Activity]
   586   Possible (Possible diagnosis) [Qualitative Concept]
   666   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   753   Evaluation (Evaluation procedure) [Health Care Activity]
   586   Possible [Qualitative Concept]
   666   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   753   Evaluation (Evaluation procedure) [Health Care Activity]
   586   Possible (Possibly Related to Intervention) [Qualitative Concept]
   666   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   753   Evaluation (Evaluation procedure) [Health Care Activity]
   586   Possible (Possible diagnosis) [Qualitative Concept]
   666   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   586   Possible [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   Replacement (Surgical Replantation) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   586   Possible [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   REPLACEMENT (Replacement) [Functional Concept]
Meta Mapping (789):
   586   Possible [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   Replacement (Replacement - supply) [Health Care Activity]
Meta Mapping (789):
   586   Possible (Possibly Related to Intervention) [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   Replacement (Surgical Replantation) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   586   Possible (Possibly Related to Intervention) [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   REPLACEMENT (Replacement) [Functional Concept]
Meta Mapping (789):
   586   Possible (Possibly Related to Intervention) [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   Replacement (Replacement - supply) [Health Care Activity]
Meta Mapping (789):
   586   Possible (Possible diagnosis) [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   Replacement (Surgical Replantation) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   586   Possible (Possible diagnosis) [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   REPLACEMENT (Replacement) [Functional Concept]
Meta Mapping (789):
   586   Possible (Possible diagnosis) [Qualitative Concept]
   820   aortic valve Evaluation [Therapeutic or Preventive Procedure]
   586   Replacement (Replacement - supply) [Health Care Activity]
Processing 00000000.tx.24: Her abdomen was soft , nontender with good bowel sounds . 

Phrase: Her abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: soft , nontender with good bowel sounds .
Meta Mapping (741):
   586   Soft [Qualitative Concept]
   753   Nontender (Non-tender) [Qualitative Concept]
   586   Good [Qualitative Concept]
   623   Bowel sounds [Finding]
Meta Mapping (741):
   586   SOFT (SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME) [Disease or Syndrome]
   753   Nontender (Non-tender) [Qualitative Concept]
   586   Good [Qualitative Concept]
   623   Bowel sounds [Finding]
Processing 00000000.tx.25: She was admitted and evaluated by the cardiac surgery service after having undergone cardiac catheterization which revealed a 70% stenosis of her left circumflex artery , 50% stenosis of the left anterior descending and 10% stenosis of the right coronary artery . 

Phrase: She

Phrase: was

Phrase: admitted
Meta Mapping (1000):
  1000   admitted (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admitted (Admission activity) [Health Care Activity]

Phrase: and

Phrase: evaluated by the cardiac surgery service
Meta Mapping (780):
   753   Evaluated (Evaluation) [Health Care Activity]
   833   Cardiac surgery service [Health Care Related Organization]

Phrase: after

Phrase: having

Phrase: undergone cardiac catheterization
Meta Mapping (901):
   901   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]

Phrase: which

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a 70% stenosis of her left circumflex artery ,
Meta Mapping (730):
   578   70% [Finding]
   793   Stenosis of artery (Stricture of artery) [Pathologic Function]
   578   LEFT (Left) [Spatial Concept]
   578   Circumflex [Spatial Concept]
Meta Mapping (730):
   578   70% [Finding]
   793   Stenosis of artery (Stricture of artery) [Pathologic Function]
   578   Left (Left sided) [Spatial Concept]
   578   Circumflex [Spatial Concept]
Meta Mapping (730):
   578   70% [Finding]
   793   Stenosis of artery (Stricture of artery) [Pathologic Function]
   578   left (Table Cell Horizontal Align - left) [Functional Concept]
   578   Circumflex [Spatial Concept]

Phrase: 50% stenosis of the left anterior descending
Meta Mapping (710):
   581   50% [Finding]
   748   Stenosis (Stenosis Morphology) [Qualitative Concept]
   612   Left anterior [Spatial Concept]
   581   Descending [Qualitative Concept]
Meta Mapping (710):
   581   50% [Finding]
   748   Stenosis (Stenosis Morphology) [Qualitative Concept]
   612   Left anterior [Spatial Concept]
   581   Descending (Sequencing - Descending) [Functional Concept]
Meta Mapping (710):
   581   50% [Finding]
   748   Stenosis [Pathologic Function]
   612   Left anterior [Spatial Concept]
   581   Descending [Qualitative Concept]
Meta Mapping (710):
   581   50% [Finding]
   748   Stenosis [Pathologic Function]
   612   Left anterior [Spatial Concept]
   581   Descending (Sequencing - Descending) [Functional Concept]
Meta Mapping (710):
   581   50% [Finding]
   748   Stenosis (Stenosis (invertebrate)) [Eukaryote]
   612   Left anterior [Spatial Concept]
   581   Descending [Qualitative Concept]
Meta Mapping (710):
   581   50% [Finding]
   748   Stenosis (Stenosis (invertebrate)) [Eukaryote]
   612   Left anterior [Spatial Concept]
   581   Descending (Sequencing - Descending) [Functional Concept]
Meta Mapping (710):
   581   <50 [Finding]
   748   Stenosis (Stenosis Morphology) [Qualitative Concept]
   612   Left anterior [Spatial Concept]
   581   Descending [Qualitative Concept]
Meta Mapping (710):
   581   <50 [Finding]
   748   Stenosis (Stenosis Morphology) [Qualitative Concept]
   612   Left anterior [Spatial Concept]
   581   Descending (Sequencing - Descending) [Functional Concept]
Meta Mapping (710):
   581   <50 [Finding]
   748   Stenosis [Pathologic Function]
   612   Left anterior [Spatial Concept]
   581   Descending [Qualitative Concept]
Meta Mapping (710):
   581   <50 [Finding]
   748   Stenosis [Pathologic Function]
   612   Left anterior [Spatial Concept]
   581   Descending (Sequencing - Descending) [Functional Concept]
Meta Mapping (710):
   581   <50 [Finding]
   748   Stenosis (Stenosis (invertebrate)) [Eukaryote]
   612   Left anterior [Spatial Concept]
   581   Descending [Qualitative Concept]
Meta Mapping (710):
   581   <50 [Finding]
   748   Stenosis (Stenosis (invertebrate)) [Eukaryote]
   612   Left anterior [Spatial Concept]
   581   Descending (Sequencing - Descending) [Functional Concept]

Phrase: and

Phrase: 10% stenosis of the right coronary artery .
Meta Mapping (770):
   581   10% [Finding]
   804   Stenosis of artery (Stricture of artery) [Pathologic Function]
   612   Right coronary (Right side of heart) [Body Location or Region]
Processing 00000000.tx.26: She was extubated on postoperative day number one and otherwise had an unremarkable postoperative course with the exception of her left upper extremity weakness . 

Phrase: She

Phrase: was

Phrase: extubated on postoperative day number one
Meta Mapping (746):
   719   Extubate (Tracheal Extubation) [Therapeutic or Preventive Procedure]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   *Number (Numbers) [Quantitative Concept]
   783   One day [Finding]
Meta Mapping (746):
   719   Extubate (Tracheal Extubation) [Therapeutic or Preventive Procedure]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   Number (Count of entities) [Quantitative Concept]
   783   One day [Finding]

Phrase: and

Phrase: otherwise

Phrase: had

Phrase: an unremarkable postoperative course with the exception of her left upper extremity weakness .
Meta Mapping (689):
   569   Unremarkable (Normal) [Qualitative Concept]
   569   Postoperative (Postoperative Period) [Temporal Concept]
   735   Course [Temporal Concept]
   569   exception (exception - ResponseLevel) [Idea or Concept]
   617   Left upper extremity weakness (Left Upper Extremity Paresis) [Disease or Syndrome]
Meta Mapping (689):
   569   Unremarkable (Normal) [Qualitative Concept]
   569   Postoperative (Postoperative Period) [Temporal Concept]
   735   Course [Temporal Concept]
   569   exception (exception - ResponseLevel) [Idea or Concept]
   617   left upper extremity weakness (Weakness of left arm) [Sign or Symptom]
Meta Mapping (689):
   569   Unremarkable (Normal) [Qualitative Concept]
   569   Postoperative (Postoperative Period) [Temporal Concept]
   735   Course [Temporal Concept]
   569   Exception (Exception - Property or Attribute) [Conceptual Entity]
   617   Left upper extremity weakness (Left Upper Extremity Paresis) [Disease or Syndrome]
Meta Mapping (689):
   569   Unremarkable (Normal) [Qualitative Concept]
   569   Postoperative (Postoperative Period) [Temporal Concept]
   735   Course [Temporal Concept]
   569   Exception (Exception - Property or Attribute) [Conceptual Entity]
   617   left upper extremity weakness (Weakness of left arm) [Sign or Symptom]
Processing 00000000.tx.27: She was worked up aggressively with the physical therapy and occupational services , made good progress and began ambulating with assistance with a walker but with minimal assistance from an aid . 

Phrase: She

Phrase: was

Phrase: worked up aggressively
Meta Mapping (866):
   866   Work-up (work up) [Diagnostic Procedure]

Phrase: with the physical therapy
Meta Mapping (1000):
  1000   physical therapy (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Physical Therapy (Physical therapy) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: occupational services ,
Meta Mapping (888):
   694   Occupational [Functional Concept]
   861   Services [Occupational Activity]

Phrase: made
Meta Mapping (966):
   966   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: good progress
Meta Mapping (888):
   694   Good [Qualitative Concept]
   861   progress (status - In progress) [Functional Concept]
Meta Mapping (888):
   694   Good [Qualitative Concept]
   861   Progress [Functional Concept]

Phrase: and

Phrase: began
Meta Mapping (966):
   966   Begin (Beginning) [Temporal Concept]

Phrase: ambulating with assistance
Meta Mapping (730):
   756   Ambulate [Finding]
   623   Assistance (Helping Behavior) [Social Behavior]
Meta Mapping (730):
   756   Ambulate [Finding]
   623   Assistance (Assisted (qualifier value)) [Qualitative Concept]

Phrase: with a walker
Meta Mapping (1000):
  1000   Walker (Walkers) [Medical Device]

Phrase: but with minimal assistance
Meta Mapping (722):
   770   Minimal [Qualitative Concept]
   770   Assistance (Helping Behavior) [Social Behavior]
Meta Mapping (722):
   770   Minimal [Qualitative Concept]
   770   Assistance (Assisted (qualifier value)) [Qualitative Concept]
Meta Mapping (722):
   770   MINIMAL (Minimum) [Qualitative Concept]
   770   Assistance (Helping Behavior) [Social Behavior]
Meta Mapping (722):
   770   MINIMAL (Minimum) [Qualitative Concept]
   770   Assistance (Assisted (qualifier value)) [Qualitative Concept]
Meta Mapping (722):
   770   Minimal (Mild (qualifier value)) [Qualitative Concept]
   770   Assistance (Helping Behavior) [Social Behavior]
Meta Mapping (722):
   770   Minimal (Mild (qualifier value)) [Qualitative Concept]
   770   Assistance (Assisted (qualifier value)) [Qualitative Concept]

Phrase: from an aid .
Meta Mapping (1000):
  1000   Aid (Manufactured aid) [Manufactured Object]
Meta Mapping (1000):
  1000   Aid (Assisted (qualifier value)) [Qualitative Concept]
Meta Mapping (1000):
  1000   AID (AICDA wt Allele) [Gene or Genome]
Processing 00000000.tx.28: D :

Phrase: D
Meta Mapping (1000):
  1000   D NOS (Blood group antigen D) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (1000):
  1000   /d (Daily) [Temporal Concept]

Phrase: :
Processing 00000000.tx.1: Discharge Summary He was ambulating well . 

Phrase: Discharge Summary
Meta Mapping (1000):
  1000   Discharge summary [Intellectual Product]
Meta Mapping (1000):
  1000   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: He

Phrase: was

Phrase: ambulating
Meta Mapping (966):
   966   Ambulate [Finding]

Phrase: well .
Meta Mapping (1000):
  1000   Well (Good) [Qualitative Concept]
Meta Mapping (1000):
  1000   Well [Manufactured Object]
Processing 00000000.tx.2: MEDICATIONS : RASHANEMAR S. 

Phrase: MEDICATIONS
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: RASHANEMAR S.
Processing 00000000.tx.3: LANCEDUHE , M.D. 

Phrase: LANCEDUHE ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.4: HW8 VE160/3653 10/04/93 <RECORD ID="665"> Patient had a blood pressure of 128/72 , a pulse of 84 that was regular , and she was afebrile at 98.4 . 

Phrase: HW8 VE160/3653 10/04/93
Meta Mapping (799):
   799   10% [Finding]

Phrase: <RECORD ID="665"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > Patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: a blood pressure of 128/72 ,
Meta Mapping (790):
   790   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (790):
   790   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (790):
   790   Blood pressure (Systemic arterial pressure) [Finding]

Phrase: a pulse of 84
Meta Mapping (770):
   770   PULSE (Pulse Rate) [Clinical Attribute]
Meta Mapping (770):
   770   Pulse (Physiologic pulse) [Physiologic Function]
Meta Mapping (770):
   770   Pulse (Pulse phenomenon) [Phenomenon or Process]

Phrase: that

Phrase: was

Phrase: regular ,
Meta Mapping (1000):
  1000   Regular [Qualitative Concept]

Phrase: and

Phrase: she

Phrase: was

Phrase: afebrile at 98.4 .
Meta Mapping (770):
   770   Afebrile (Apyrexial) [Finding]
Processing 00000000.tx.5: LUNGS : Her CA-125 was 20 and she had a chest X-Ray that showed no infiltrates and a mammogram that showed a left upper quadrant large calcified fibroadenoma and right upper mid area of calcification . 

Phrase: LUNGS
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: Her CA-125
Meta Mapping (1000):
  1000   CA-125 (CA-125 Antigen) [Immunologic Factor,Organic Chemical]
Meta Mapping (1000):
  1000   CA-125 (Mucin-16) [Amino Acid, Peptide, or Protein]

Phrase: was

Phrase: 20
Meta Mapping (1000):
  1000   20% [Finding]

Phrase: and

Phrase: she

Phrase: had

Phrase: a chest X-Ray
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: that

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: no infiltrates
Meta Mapping (1000):
  1000 N Infiltrates (Infiltration) [Pathologic Function]

Phrase: and

Phrase: a mammogram
Meta Mapping (1000):
  1000   Mammogram (Mammography) [Diagnostic Procedure]

Phrase: that

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a left upper quadrant large calcified fibroadenoma
Meta Mapping (851):
   694   Left upper quadrant [Spatial Concept]
   632   LARGE (Large) [Quantitative Concept]
   632   Calcified (Calcified (qualifier)) [Qualitative Concept]
   799 N Fibroadenoma (Fibroadenoma of breast) [Neoplastic Process]
Meta Mapping (851):
   694   Left upper quadrant [Spatial Concept]
   632   LARGE (Large) [Quantitative Concept]
   632   Calcified (Calcified (qualifier)) [Qualitative Concept]
   799 N Fibroadenoma [Neoplastic Process]
Meta Mapping (851):
   694   Left upper quadrant [Spatial Concept]
   632   LARGE (Large) [Quantitative Concept]
   632   Calcified (Calcified Medical Device Material) [Phenomenon or Process]
   799 N Fibroadenoma (Fibroadenoma of breast) [Neoplastic Process]
Meta Mapping (851):
   694   Left upper quadrant [Spatial Concept]
   632   LARGE (Large) [Quantitative Concept]
   632   Calcified (Calcified Medical Device Material) [Phenomenon or Process]
   799 N Fibroadenoma [Neoplastic Process]
Meta Mapping (851):
   694   Left upper quadrant [Spatial Concept]
   632   LARGE (Large) [Quantitative Concept]
   632   CALCIFIED (Calcified Specimen) [Qualitative Concept]
   799 N Fibroadenoma (Fibroadenoma of breast) [Neoplastic Process]
Meta Mapping (851):
   694   Left upper quadrant [Spatial Concept]
   632   LARGE (Large) [Quantitative Concept]
   632   CALCIFIED (Calcified Specimen) [Qualitative Concept]
   799 N Fibroadenoma [Neoplastic Process]

Phrase: and

Phrase: right upper mid area of calcification .
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   Area (Geographic Locations) [Geographic Area]
   586   Calcification (Physiologic calcification) [Organ or Tissue Function]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   Area (Geographic Locations) [Geographic Area]
   586 N Calcification (Calcinosis) [Pathologic Function]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   Area (Geographic Locations) [Geographic Area]
   586   Calcification (Calcified (qualifier)) [Qualitative Concept]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   Area (Geographic Locations) [Geographic Area]
   586   Calcification [Organ or Tissue Function]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   Area (Geographic Locations) [Geographic Area]
   586   Calcification (Calcified Medical Device Material) [Phenomenon or Process]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   Area (Geographic Locations) [Geographic Area]
   586 N Calcification, NOS (Pathologic calcification, calcified structure) [Finding]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   AREA (Area) [Spatial Concept]
   586   Calcification (Physiologic calcification) [Organ or Tissue Function]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   AREA (Area) [Spatial Concept]
   586 N Calcification (Calcinosis) [Pathologic Function]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   AREA (Area) [Spatial Concept]
   586   Calcification (Calcified (qualifier)) [Qualitative Concept]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   AREA (Area) [Spatial Concept]
   586   Calcification [Organ or Tissue Function]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   AREA (Area) [Spatial Concept]
   586   Calcification (Calcified Medical Device Material) [Phenomenon or Process]
Meta Mapping (712):
   623   Right Upper (Right superior) [Spatial Concept]
   753   AREA (Area) [Spatial Concept]
   586 N Calcification, NOS (Pathologic calcification, calcified structure) [Finding]
Processing 00000000.tx.6: Cardiology was consulted to evaluate this and felt that the changes seen on the EKG were not significant . 

Phrase: Cardiology
Meta Mapping (1000):
  1000   Cardiology (Cardiology discipline) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Cardiology (Cardiology service) [Health Care Related Organization]

Phrase: was

Phrase: consulted
Meta Mapping (1000):
  1000   consulted (Consultation) [Health Care Activity]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: evaluate
Meta Mapping (1000):
  1000   Evaluate (Evaluation) [Health Care Activity]

Phrase: this

Phrase: and

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: the changes
Meta Mapping (1000):
  1000   changes (Changing) [Functional Concept]
Meta Mapping (1000):
  1000   changes (Changed status) [Quantitative Concept]

Phrase: seen on the EKG
Meta Mapping (708):
   770   Seen (seen) [Qualitative Concept]
   770   EKG (Electrocardiogram) [Finding]
Meta Mapping (708):
   770   Seen (seen) [Qualitative Concept]
   770   EKG (Electrocardiography) [Diagnostic Procedure]

Phrase: were

Phrase: not significant .
Meta Mapping (1000):
  1000   Not significant [Finding]
Processing 00000000.tx.7: RIMARVNAA D. 

Phrase: RIMARVNAA D.
Processing 00000000.tx.8: KUSHDREPS , M.D. 

Phrase: KUSHDREPS ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.9: AV94 </TEXT> <TEXT> On 10/9/94 , she was taken back to the operating room . 

Phrase: AV94

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: On 10/9/94 ,
Meta Mapping (827):
   827   10% [Finding]

Phrase: she

Phrase: was

Phrase: taken
Meta Mapping (1000):
  1000   Taken [Conceptual Entity]

Phrase: back to the operating room .
Meta Mapping (745):
   760   BACK (Back) [Body Location or Region]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   BACK (Back) [Body Location or Region]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]
Meta Mapping (745):
   760   BACK (Dorsal) [Spatial Concept]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   BACK (Dorsal) [Spatial Concept]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]
Meta Mapping (745):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]
Meta Mapping (745):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]
Processing 00000000.tx.10: 763970014 DIS Index No. 

Phrase: 763970014 DIS Index
Meta Mapping (790):
   660   DIS (Diagnostic interview schedule) [Intellectual Product]
   827   Index [Intellectual Product]
Meta Mapping (790):
   660   DIS (Diagnostic interview schedule) [Intellectual Product]
   827   index (Html Link Type - index) [Idea or Concept]
Meta Mapping (790):
   660   DIS (Diagnostic interview schedule) [Intellectual Product]
   827   % index [Quantitative Concept]
Meta Mapping (790):
   660   DIS (Discontinued) [Finding]
   827   Index [Intellectual Product]
Meta Mapping (790):
   660   DIS (Discontinued) [Finding]
   827   index (Html Link Type - index) [Idea or Concept]
Meta Mapping (790):
   660   DIS (Discontinued) [Finding]
   827   % index [Quantitative Concept]

Phrase: No.
Processing 00000000.tx.11: WZGE1 XNHQ Four months prior to admission , she had occasional band like chest pain across her entire chest . 

Phrase: WZGE1 XNHQ Four months prior to admission ,
Meta Mapping (737):
   581   Four [Quantitative Concept]
   748   MONTHS (month) [Temporal Concept]
   612   Prior to (Before) [Temporal Concept]
   581   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (737):
   581   Four [Quantitative Concept]
   748   MONTHS (month) [Temporal Concept]
   612   Prior to (Before) [Temporal Concept]
   581   Admission (Admission activity) [Health Care Activity]

Phrase: she

Phrase: had

Phrase: occasional band like chest pain across her entire chest .
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Bands) [Medical Device]
   764   CHEST PAIN (Chest Pain) [Sign or Symptom]
   575   Entire [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Bands) [Medical Device]
   764   CHEST PAIN (Chest Pain) [Sign or Symptom]
   575   ENTIRE (Whole) [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Bands) [Medical Device]
   764   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   575   Entire [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Bands) [Medical Device]
   764   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   575   ENTIRE (Whole) [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Band form) [Spatial Concept]
   764   CHEST PAIN (Chest Pain) [Sign or Symptom]
   575   Entire [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Band form) [Spatial Concept]
   764   CHEST PAIN (Chest Pain) [Sign or Symptom]
   575   ENTIRE (Whole) [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Band form) [Spatial Concept]
   764   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   575   Entire [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   Band (Band form) [Spatial Concept]
   764   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   575   ENTIRE (Whole) [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   band (Chromosome band) [Cell Component]
   764   CHEST PAIN (Chest Pain) [Sign or Symptom]
   575   Entire [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   band (Chromosome band) [Cell Component]
   764   CHEST PAIN (Chest Pain) [Sign or Symptom]
   575   ENTIRE (Whole) [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   band (Chromosome band) [Cell Component]
   764   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   575   Entire [Quantitative Concept]
Meta Mapping (667):
   575   Occasional (Infrequent) [Temporal Concept]
   575   band (Chromosome band) [Cell Component]
   764   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   575   ENTIRE (Whole) [Quantitative Concept]
Processing 00000000.tx.12: (2) Status post a cholecystectomy , appendectomy , and hysterectomy . 

Phrase: (2
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]

Phrase: )

Phrase: Status post a cholecystectomy ,
Meta Mapping (1000):
  1000   CHOLECYSTECTOMY (Cholecystectomy procedure) [Therapeutic or Preventive Procedure]

Phrase: appendectomy ,
Meta Mapping (1000):
  1000   APPENDECTOMY (Appendectomy) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: hysterectomy .
Meta Mapping (1000):
  1000   Hysterectomy [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Hysterectomy (Consent Type - Hysterectomy) [Health Care Activity]
Processing 00000000.tx.13: The patient was started on Ecotrin and a beta blocker as well as Isordil and Diltiazem for the possibility of 5-FU induced vasal spasm . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: started on Ecotrin
Meta Mapping (746):
   790   Started [Qualitative Concept]
   790   Ecotrin [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: a beta blocker
Meta Mapping (901):
   901   Beta Blocker (Adrenergic beta-Antagonists) [Pharmacologic Substance]

Phrase: as well as

Phrase: Isordil
Meta Mapping (1000):
  1000   Isordil [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: Diltiazem for the possibility of 5-FU
Meta Mapping (628):
   748   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   510   Possible [Qualitative Concept]
   581   FU (Fluorouracil) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Meta Mapping (628):
   748   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   510   Possible [Qualitative Concept]
   581   FU (STK36 gene) [Gene or Genome]
Meta Mapping (628):
   748   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   510   Possible (Possibly Related to Intervention) [Qualitative Concept]
   581   FU (Fluorouracil) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Meta Mapping (628):
   748   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   510   Possible (Possibly Related to Intervention) [Qualitative Concept]
   581   FU (STK36 gene) [Gene or Genome]
Meta Mapping (628):
   748   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   510   Possible (Possible diagnosis) [Qualitative Concept]
   581   FU (Fluorouracil) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Meta Mapping (628):
   748   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   510   Possible (Possible diagnosis) [Qualitative Concept]
   581   FU (STK36 gene) [Gene or Genome]

Phrase: induced
Meta Mapping (1000):
  1000   Induced (Induce (action)) [Functional Concept]

Phrase: vasal spasm .
Meta Mapping (888):
   694   Vasal (vasal) [Organic Chemical,Pharmacologic Substance]
   861   Spasm (Muscle Cramp) [Sign or Symptom]
Meta Mapping (888):
   694   Vasal (vasal) [Organic Chemical,Pharmacologic Substance]
   861   Spasm [Sign or Symptom]
Meta Mapping (888):
   694   Vasal (vasal) [Organic Chemical,Pharmacologic Substance]
   861   Spasm (KANTR gene) [Gene or Genome]
Processing 00000000.tx.14: Include Pepcid 20 mg b.i.d. 

Phrase: Include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: Pepcid 20 mg b.i.d.
Meta Mapping (769):
   632   Pepcid [Organic Chemical,Pharmacologic Substance]
   632   20% [Finding]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (769):
   632   Pepcid [Organic Chemical,Pharmacologic Substance]
   632   20% [Finding]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (769):
   632   Pepcid [Organic Chemical,Pharmacologic Substance]
   632   20% [Finding]
   799   MG (Mongolia) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   Pepcid [Organic Chemical,Pharmacologic Substance]
   632   20% [Finding]
   799   mg% (mg/dL) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   Pepcid [Organic Chemical,Pharmacologic Substance]
   632   20% [Finding]
   799   mg % (Milligram percent) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   Pepcid [Organic Chemical,Pharmacologic Substance]
   632   20% [Finding]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.15: , Lopressor 25 mg b.i.d. 

Phrase: , Lopressor 25 mg b.i.d.
Meta Mapping (768):
   632   Lopressor [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (768):
   632   Lopressor [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (768):
   632   Lopressor [Organic Chemical,Pharmacologic Substance]
   799   MG (Mongolia) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   632   Lopressor [Organic Chemical,Pharmacologic Substance]
   799   mg% (mg/dL) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   632   Lopressor [Organic Chemical,Pharmacologic Substance]
   799   mg % (Milligram percent) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   632   Lopressor [Organic Chemical,Pharmacologic Substance]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.16: , Diltiazem 30 mg t.i.d. 

Phrase: , Diltiazem 30 mg t.i.d.
Meta Mapping (769):
   632   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   632   30% [Finding]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (769):
   632   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   632   30% [Finding]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (769):
   632   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   632   30% [Finding]
   799   MG (Mongolia) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   632   30% [Finding]
   799   mg% (mg/dL) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   632   30% [Finding]
   799   mg % (Milligram percent) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
   632   30% [Finding]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.17: , Isordil 10 mg t.i.d. 

Phrase: , Isordil 10 mg t.i.d.
Meta Mapping (819):
   842   Isosorbide Dinitrate 10 MG [Clinical Drug]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: , and Ecotrin one tablet p.o. q.d. 

Phrase: ,

Phrase: and

Phrase: Ecotrin one tablet p.o. q.d.
Meta Mapping (561):
   635   aspirin tablet (Aspirin Oral Tablet) [Clinical Drug]
   629   ONE (One) [Quantitative Concept]
Processing 00000000.tx.19: 19 days prior to admission , he was found to have a mass in the right upper lung on chest x-ray . 

Phrase: 19 days prior to admission ,
Meta Mapping (787):
   760   DAYS (day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (787):
   760   DAYS (day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Admission activity) [Health Care Activity]

Phrase: he

Phrase: was

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: a mass in the right upper lung
Meta Mapping (729):
   774   mass lung (Lung mass) [Finding]
   612   Right Upper (Right superior) [Spatial Concept]

Phrase: on chest x-ray .
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
Processing 00000000.tx.20: MEDICATIONS ON DISCHARGE : CMC MYOCARDIAL INFARCTION . 

Phrase: MEDICATIONS ON DISCHARGE
Meta Mapping (858):
   858   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: CMC MYOCARDIAL INFARCTION .
Meta Mapping (901):
   660   CMC (MCC protocol) [Therapeutic or Preventive Procedure]
   901   Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (901):
   660   CMC (MCC protocol) [Therapeutic or Preventive Procedure]
   901   MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (901):
   660   CMC (MCC protocol) [Therapeutic or Preventive Procedure]
   901   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (901):
   660   CMC (MCC protocol) [Therapeutic or Preventive Procedure]
   901   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (901):
   660   CMC (Capillary malformation (disorder)) [Congenital Abnormality]
   901   Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (901):
   660   CMC (Capillary malformation (disorder)) [Congenital Abnormality]
   901   MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (901):
   660   CMC (Capillary malformation (disorder)) [Congenital Abnormality]
   901   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (901):
   660   CMC (Capillary malformation (disorder)) [Congenital Abnormality]
   901   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (901):
   660   CMC (Circulating Melanoma Cell) [Cell]
   901   Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (901):
   660   CMC (Circulating Melanoma Cell) [Cell]
   901   MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (901):
   660   CMC (Circulating Melanoma Cell) [Cell]
   901   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (901):
   660   CMC (Circulating Melanoma Cell) [Cell]
   901   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Processing 00000000.tx.21: CORONARY ARTERY DISEASE . 

Phrase: CORONARY ARTERY DISEASE .
Meta Mapping (1000):
  1000   coronary artery disease (Coronary Arteriosclerosis) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Coronary (artery) disease (Coronary heart disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000   CORONARY ARTERY DISEASE (Coronary Artery Disease) [Disease or Syndrome]
Processing 00000000.tx.22: He was ruled in for a non-Q wave MI with peak CKs of 531 , positive for MB . 

Phrase: He

Phrase: was

Phrase: ruled in
Meta Mapping (833):
   833   ruled (Positive) [Qualitative Concept]

Phrase: for a non-Q wave MI with peak CKs of 531 ,
Meta Mapping (742):
   797   non-q wave mi [Disease or Syndrome]
   571   Peak (Peak level) [Quantitative Concept]

Phrase: positive for MB .
Meta Mapping (746):
   790   % Positive (percent positive cells) [Quantitative Concept]
   623   MB (Martinique) [Geographic Area]
Meta Mapping (746):
   790   Positive [Qualitative Concept]
   623   MB (Martinique) [Geographic Area]
Meta Mapping (746):
   790 N POSITIVE (Positive Finding) [Finding]
   623   MB (Martinique) [Geographic Area]
Meta Mapping (746):
   790   Positive (Positive Charge) [Qualitative Concept]
   623   MB (Martinique) [Geographic Area]
Meta Mapping (746):
   790   Positive (Positive Number) [Conceptual Entity]
   623   MB (Martinique) [Geographic Area]
Processing 00000000.tx.23: The episode on 12/21 was noteworthy for shortness of breath and ST depression in V4-6 which required IV TNG , which was used briefly that night . 

Phrase: The episode on 12/21
Meta Mapping (760):
   760   Episode (Episode of) [Temporal Concept]

Phrase: was

Phrase: noteworthy for shortness of breath
Meta Mapping (695):
   695   SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (695):
   695   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: and

Phrase: ST depression in V4-6
Meta Mapping (745):
   806   ST DEPRESSION (ST segment depression (finding)) [Finding]
   593   V4+ [Element, Ion, or Isotope]

Phrase: which

Phrase: required
Meta Mapping (1000):
  1000   Required (Requirement) [Functional Concept]

Phrase: IV TNG ,
Meta Mapping (694):
   694   IV (Ivory Coast) [Geographic Area]

Phrase: which

Phrase: was

Phrase: used
Meta Mapping (1000):
  1000   used (Used by) [Finding]

Phrase: briefly

Phrase: that night .
Meta Mapping (1000):
  1000   Night (Night time) [Temporal Concept]
Processing 00000000.tx.24: On 12/22 , he was transferred to Norri Hospital for evaluation of his post MI angina . 

Phrase: On 12/22 ,

Phrase: he

Phrase: was

Phrase: transferred to Norri Hospital
Meta Mapping (708):
   770   transferred (Surgical transfer - action) [Functional Concept]
   770   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (708):
   770   transferred (Surgical transfer - action) [Functional Concept]
   770   Hospital (Hospital environment) [Qualitative Concept]
Meta Mapping (708):
   770   Transferred (Transfer Technique) [Functional Concept]
   770   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (708):
   770   Transferred (Transfer Technique) [Functional Concept]
   770   Hospital (Hospital environment) [Qualitative Concept]

Phrase: for evaluation of his post MI angina .
Meta Mapping (701):
   748   Evaluation [Health Care Activity]
   612   post mi [Disease or Syndrome]
   581   ANGINA (Angina Pectoris) [Finding]
Meta Mapping (701):
   748   Evaluation (Evaluation procedure) [Health Care Activity]
   612   post mi [Disease or Syndrome]
   581   ANGINA (Angina Pectoris) [Finding]
Processing 00000000.tx.25: Rectal : On the above chest x-ray no evidence of dissection was noted . 

Phrase: Rectal
Meta Mapping (1000):
  1000   Rectal (rectal) [Spatial Concept]

Phrase: :

Phrase: On the above chest x-ray
Meta Mapping (916):
   645   Above (Upper) [Spatial Concept]
   923   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (916):
   645   Above (Upper) [Spatial Concept]
   923   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
Meta Mapping (916):
   645   above (Table Frame - above) [Idea or Concept]
   923   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (916):
   645   above (Table Frame - above) [Idea or Concept]
   923   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: no evidence of dissection
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604   Dissection (Tissue Dissection) [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604 N Dissection (Dissecting hemorrhage) [Pathologic Function]

Phrase: was

Phrase: noted .
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]
Processing 00000000.tx.26: The patient was intubated and prior to intubation his rhythm was noted to be in the low junctional vs. accelerated idioventricular pattern . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: intubated

Phrase: and prior to intubation
Meta Mapping (810):
   833   Prior to (Before) [Temporal Concept]
   770   INTUBATION (Intubation) [Therapeutic or Preventive Procedure]

Phrase: his rhythm
Meta Mapping (1000):
  1000   Rhythm [Finding]
Meta Mapping (1000):
  1000   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (1000):
  1000   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be in the low junctional
Meta Mapping (695):
   760   Low (low) [Qualitative Concept]
   760   Junctional [Spatial Concept]
Meta Mapping (695):
   760   low (low confidentiality) [Intellectual Product]
   760   Junctional [Spatial Concept]
Meta Mapping (695):
   760   Low (Low Mitosis-Karyorrhexis Index) [Quantitative Concept]
   760   Junctional [Spatial Concept]
Meta Mapping (695):
   760   low (low exposure) [Qualitative Concept]
   760   Junctional [Spatial Concept]

Phrase: vs. accelerated idioventricular pattern .
Meta Mapping (802):
   660   Accelerated [Functional Concept]
   827   Pattern (Patterns) [Spatial Concept]
Processing 00000000.tx.27: At this time the decision to cardiovert the patient was made and he was cardioverted at 40 joules without significant change . congestive heart failure . 

Phrase: At this time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: the decision
Meta Mapping (1000):
  1000   Decision [Mental Process]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: cardiovert

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: made
Meta Mapping (966):
   966   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: and

Phrase: he

Phrase: was

Phrase: cardioverted at 40 joules
Meta Mapping (722):
   770   /40 [Temporal Concept]
   770   Joules (Joule, Unit of energy) [Quantitative Concept]
Meta Mapping (722):
   770   40% [Quantitative Concept]
   770   Joules (Joule, Unit of energy) [Quantitative Concept]

Phrase: without significant change . congestive heart failure .
Meta Mapping (875):
   637   significant (Statistical Significance) [Quantitative Concept]
   637   Change (Changing) [Functional Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   significant (Statistical Significance) [Quantitative Concept]
   637   change (Changed status) [Quantitative Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   significant (Statistical Significance) [Quantitative Concept]
   637   Change (Delta (difference)) [Quantitative Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   Significant [Idea or Concept]
   637   Change (Changing) [Functional Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   Significant [Idea or Concept]
   637   change (Changed status) [Quantitative Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   Significant [Idea or Concept]
   637   Change (Delta (difference)) [Quantitative Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   Significant (Event Seriousness - Significant) [Qualitative Concept]
   637   Change (Changing) [Functional Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   Significant (Event Seriousness - Significant) [Qualitative Concept]
   637   change (Changed status) [Quantitative Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (875):
   637   Significant (Event Seriousness - Significant) [Qualitative Concept]
   637   Change (Delta (difference)) [Quantitative Concept]
   884 N CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Processing 00000000.tx.28: He had a very stormy course , dominated by post infarction angina pectoris , high grade atrial ventricular block , gastrointestinal bleeding , pneumonia , and no noliguric renal failure . 

Phrase: He

Phrase: had

Phrase: a very stormy course ,
Meta Mapping (828):
   660   Very [Qualitative Concept]
   589   Storm NOS [Injury or Poisoning]
   827   Course [Temporal Concept]
Meta Mapping (828):
   660   Very (Very Much) [Qualitative Concept]
   589   Storm NOS [Injury or Poisoning]
   827   Course [Temporal Concept]

Phrase: dominated by post infarction angina pectoris ,
Meta Mapping (799):
   799   Post infarct angina [Disease or Syndrome]

Phrase: high grade atrial ventricular block ,
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular (Heart Ventricle) [Body Part, Organ, or Organ Component]
   804   Block (Obstruction) [Pathologic Function]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular (Heart Ventricle) [Body Part, Organ, or Organ Component]
   804   Block (Blocking) [Functional Concept]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular (Heart Ventricle) [Body Part, Organ, or Organ Component]
   804   Block (Block Specimens) [Substance]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular (Heart Ventricle) [Body Part, Organ, or Organ Component]
   804   Block ((City) Block) [Geographic Area]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular (Heart Ventricle) [Body Part, Organ, or Organ Component]
   804   Block (Block (unit of measure)) [Quantitative Concept]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular [Spatial Concept]
   804   Block (Obstruction) [Pathologic Function]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular [Spatial Concept]
   804   Block (Blocking) [Functional Concept]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular [Spatial Concept]
   804   Block (Block Specimens) [Substance]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular [Spatial Concept]
   804   Block ((City) Block) [Geographic Area]
Meta Mapping (840):
   673   High Grade (Severe (severity modifier)) [Qualitative Concept]
   637   Atrial (Heart Atrium) [Body Part, Organ, or Organ Component]
   637   Ventricular [Spatial Concept]
   804   Block (Block (unit of measure)) [Quantitative Concept]

Phrase: gastrointestinal bleeding ,
Meta Mapping (1000):
  1000   gastro intestinal bleeding (Gastrointestinal Hemorrhage) [Pathologic Function]

Phrase: pneumonia ,
Meta Mapping (1000):
  1000   PNEUMONIA (Pneumonia) [Disease or Syndrome]

Phrase: and

Phrase: no noliguric renal failure .
Meta Mapping (901):
   901 N Failure, Renal (Kidney Failure) [Disease or Syndrome]
Meta Mapping (901):
   901 N Renal failure (Renal Failure Adverse Event) [Pathologic Function]
Processing 00000000.tx.29: An intra-aortic balloon pump was required for stabilization . 

Phrase: An intra-aortic balloon pump
Meta Mapping (1000):
  1000   intra-aortic balloon pump (Intra-Aortic Balloon Pumping) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   intraaortic balloon pump (Intra-aortic balloon pump device) [Medical Device]
Meta Mapping (1000):
  1000   Intra-aortic balloon pump (Collapsible balloon, device) [Medical Device]

Phrase: was

Phrase: required for stabilization .
Meta Mapping (746):
   790   Required (Requirement) [Functional Concept]
   790   Stabilization [Therapeutic or Preventive Procedure]
Processing 00000000.tx.30: PHYSICAL EXAMINATION : The liver was enlarged 2 finger breadths below the right costal margin , and there was 1-2+ peripheral edema . 

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: The liver
Meta Mapping (1000):
  1000   LIVER (Liver) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   LIVER (Liver parenchyma) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Liver (Entire liver) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   LIVER (Liver Flavor) [Food]

Phrase: was

Phrase: enlarged
Meta Mapping (1000):
  1000   Enlarged [Qualitative Concept]
Meta Mapping (1000):
  1000   Enlarged (Enlargement procedure) [Therapeutic or Preventive Procedure]

Phrase: 2 finger breadths below the right costal margin ,
Meta Mapping (742):
   767   Finger 2 (Index finger) [Body Part, Organ, or Organ Component]
   633   Right costal margin [Body Location or Region]

Phrase: and

Phrase: there

Phrase: was

Phrase: 1-2+ peripheral edema .
Meta Mapping (888):
   694   1/2 [Intellectual Product]
   861   Peripheral oedema (Peripheral edema) [Finding]
Meta Mapping (888):
   694   1-2 (Phase I/II Trial) [Research Activity]
   861   Peripheral oedema (Peripheral edema) [Finding]
Meta Mapping (888):
   694   1-2 [Finding]
   861   Peripheral oedema (Peripheral edema) [Finding]
Processing 00000000.tx.31: A Persantine Thallium scan on 3/31/93 , showed increased lung uptake , cavity dilatation and a large inferior , apical scar , without evidence of active ischemia . 

Phrase: A Persantine Thallium scan on 3/31/93 ,
Meta Mapping (684):
   578   Persantine [Organic Chemical,Pharmacologic Substance]
   770   Thallium scan [Diagnostic Procedure]
   578   31 [Intellectual Product]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: increased lung uptake ,
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   LUNG (Lung) [Body Part, Organ, or Organ Component]
   827   Uptake [Physiologic Function]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   LUNG (Lung) [Body Part, Organ, or Organ Component]
   827   % uptake (percent uptake) [Quantitative Concept]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   LUNG (Lung) [Body Part, Organ, or Organ Component]
   827   uptake (Import into cell) [Cell Function]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   LUNG (Structure of parenchyma of lung) [Tissue]
   827   Uptake [Physiologic Function]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   LUNG (Structure of parenchyma of lung) [Tissue]
   827   % uptake (percent uptake) [Quantitative Concept]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   LUNG (Structure of parenchyma of lung) [Tissue]
   827   uptake (Import into cell) [Cell Function]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   Lung (Entire lung) [Body Part, Organ, or Organ Component]
   827   Uptake [Physiologic Function]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   Lung (Entire lung) [Body Part, Organ, or Organ Component]
   827   % uptake (percent uptake) [Quantitative Concept]
Meta Mapping (851):
   660   Increased [Quantitative Concept]
   660   Lung (Entire lung) [Body Part, Organ, or Organ Component]
   827   uptake (Import into cell) [Cell Function]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   LUNG (Lung) [Body Part, Organ, or Organ Component]
   827   Uptake [Physiologic Function]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   LUNG (Lung) [Body Part, Organ, or Organ Component]
   827   % uptake (percent uptake) [Quantitative Concept]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   LUNG (Lung) [Body Part, Organ, or Organ Component]
   827   uptake (Import into cell) [Cell Function]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   LUNG (Structure of parenchyma of lung) [Tissue]
   827   Uptake [Physiologic Function]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   LUNG (Structure of parenchyma of lung) [Tissue]
   827   % uptake (percent uptake) [Quantitative Concept]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   LUNG (Structure of parenchyma of lung) [Tissue]
   827   uptake (Import into cell) [Cell Function]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   Lung (Entire lung) [Body Part, Organ, or Organ Component]
   827   Uptake [Physiologic Function]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   Lung (Entire lung) [Body Part, Organ, or Organ Component]
   827   % uptake (percent uptake) [Quantitative Concept]
Meta Mapping (851):
   660   Increased (Increase) [Functional Concept]
   660   Lung (Entire lung) [Body Part, Organ, or Organ Component]
   827   uptake (Import into cell) [Cell Function]

Phrase: cavity dilatation
Meta Mapping (888):
   694   cavity (Dental caries) [Disease or Syndrome]
   861   Dilatation (Pathological Dilatation) [Pathologic Function]
Meta Mapping (888):
   694   cavity (Dental caries) [Disease or Syndrome]
   861   DILATATION (Dilated) [Finding]
Meta Mapping (888):
   694   cavity (Dental caries) [Disease or Syndrome]
   861   Dilatation (Dilate procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Cavity (Body cavities) [Body Space or Junction]
   861   Dilatation (Pathological Dilatation) [Pathologic Function]
Meta Mapping (888):
   694   Cavity (Body cavities) [Body Space or Junction]
   861   DILATATION (Dilated) [Finding]
Meta Mapping (888):
   694   Cavity (Body cavities) [Body Space or Junction]
   861   Dilatation (Dilate procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Cavity (Cavitation) [Anatomical Abnormality]
   861   Dilatation (Pathological Dilatation) [Pathologic Function]
Meta Mapping (888):
   694   Cavity (Cavitation) [Anatomical Abnormality]
   861   DILATATION (Dilated) [Finding]
Meta Mapping (888):
   694   Cavity (Cavitation) [Anatomical Abnormality]
   861   Dilatation (Dilate procedure) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: a large inferior , apical scar ,
Meta Mapping (833):
   645   LARGE (Large) [Quantitative Concept]
   645   INFERIOR (Inferior) [Spatial Concept]
   645   APICAL (Apical) [Spatial Concept]
   812   scar (Scar Tissue) [Finding]
Meta Mapping (833):
   645   LARGE (Large) [Quantitative Concept]
   645   INFERIOR (Inferior) [Spatial Concept]
   645   APICAL (Apical) [Spatial Concept]
   812   Scar NOS (Cicatrix) [Pathologic Function]
Meta Mapping (833):
   645   LARGE (Large) [Quantitative Concept]
   645   inferior (inferiority) [Social Behavior]
   645   APICAL (Apical) [Spatial Concept]
   812   scar (Scar Tissue) [Finding]
Meta Mapping (833):
   645   LARGE (Large) [Quantitative Concept]
   645   inferior (inferiority) [Social Behavior]
   645   APICAL (Apical) [Spatial Concept]
   812   Scar NOS (Cicatrix) [Pathologic Function]

Phrase: without evidence of active ischemia .
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Active [Functional Concept]
   593 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   active (active (HL7 RoleLink)) [Idea or Concept]
   593 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Active (Active License) [Qualitative Concept]
   593 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Processing 00000000.tx.32: The saphenous vein graft to three distal marginal branches was patent with good flow . 

Phrase: The saphenous vein graft to three distal marginal branches
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal [Spatial Concept]
   542   Branch (Branch of) [Body Part, Organ, or Organ Component]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal [Spatial Concept]
   542   Branch (Macromolecular Branch) [Chemical Viewed Structurally]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal [Spatial Concept]
   542   Branch (Branch of plant) [Plant]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal [Spatial Concept]
   542   BRANCH (Clinical Trial Branch) [Intellectual Product]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   marginal (Target Awareness - marginal) [Finding]
   542   Branch (Branch of) [Body Part, Organ, or Organ Component]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   marginal (Target Awareness - marginal) [Finding]
   542   Branch (Macromolecular Branch) [Chemical Viewed Structurally]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   marginal (Target Awareness - marginal) [Finding]
   542   Branch (Branch of plant) [Plant]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   marginal (Target Awareness - marginal) [Finding]
   542   BRANCH (Clinical Trial Branch) [Intellectual Product]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal (Marginal (quality)) [Qualitative Concept]
   542   Branch (Branch of) [Body Part, Organ, or Organ Component]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal (Marginal (quality)) [Qualitative Concept]
   542   Branch (Macromolecular Branch) [Chemical Viewed Structurally]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal (Marginal (quality)) [Qualitative Concept]
   542   Branch (Branch of plant) [Plant]
Meta Mapping (716):
   790   SAPHENOUS VEIN GRAFT (Saphenous vein graft) [Body Part, Organ, or Organ Component]
   575   Three [Quantitative Concept]
   575   DISTAL (Distal) [Spatial Concept]
   575   Marginal (Marginal (quality)) [Qualitative Concept]
   542   BRANCH (Clinical Trial Branch) [Intellectual Product]

Phrase: was

Phrase: patent with good flow .
Meta Mapping (733):
   770   patent (Legal patent) [Intellectual Product]
   604   Good [Qualitative Concept]
   604   Flow (flow) [Natural Phenomenon or Process]
Meta Mapping (733):
   770   Patent (Open) [Spatial Concept]
   604   Good [Qualitative Concept]
   604   Flow (flow) [Natural Phenomenon or Process]
Processing 00000000.tx.33: ETHELAN KOTEFYFECHIRD , M.D. go / bmot 23293/6v1c He had no known drug allergies . 

Phrase: ETHELAN KOTEFYFECHIRD ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]

Phrase: go
Meta Mapping (1000):
  1000   GO (GORAB gene) [Gene or Genome]

Phrase: / bmot 23293/6v1c

Phrase: He

Phrase: had

Phrase: no known drug allergies .
Meta Mapping (901):
   660   Known [Qualitative Concept]
   901 N Drug Allergies (Drug Allergy) [Disease or Syndrome]
Processing 00000000.tx.34: There was a right facial droop which was mild . 

Phrase: There

Phrase: was

Phrase: a right facial droop
Meta Mapping (901):
   660   RIGHT (Right) [Spatial Concept]
   901   FACIAL DROOP (Facial Paresis) [Sign or Symptom]
Meta Mapping (901):
   660   Right (Right sided) [Spatial Concept]
   901   FACIAL DROOP (Facial Paresis) [Sign or Symptom]

Phrase: which

Phrase: was

Phrase: mild .
Meta Mapping (1000):
  1000   MILD (Mild (qualifier value)) [Qualitative Concept]
Processing 00000000.tx.35: Motor - right flaccid arm and he moved his left purposefully , but did not squeeze his hands . 

Phrase: Motor - right flaccid arm
Meta Mapping (861):
   902   Motor arm [Finding]
   645   RIGHT (Right) [Spatial Concept]
   645   Flaccid [Qualitative Concept]
Meta Mapping (861):
   902   Motor arm [Finding]
   645   Right (Right sided) [Spatial Concept]
   645   Flaccid [Qualitative Concept]
Meta Mapping (861):
   645   Motor (motor movement) [Functional Concept]
   875   Right arm (Right upper arm structure) [Body Part, Organ, or Organ Component]
   645   Flaccid [Qualitative Concept]
Meta Mapping (861):
   645   Motor (motor movement) [Functional Concept]
   875   Right arm (Entire right upper arm) [Body Part, Organ, or Organ Component]
   645   Flaccid [Qualitative Concept]
Meta Mapping (861):
   645   Motor (motor movement) [Functional Concept]
   875   Right Arm (Right arm) [Body Part, Organ, or Organ Component]
   645   Flaccid [Qualitative Concept]
Meta Mapping (861):
   645   Motor (Device Motor) [Manufactured Object]
   875   Right arm (Right upper arm structure) [Body Part, Organ, or Organ Component]
   645   Flaccid [Qualitative Concept]
Meta Mapping (861):
   645   Motor (Device Motor) [Manufactured Object]
   875   Right arm (Entire right upper arm) [Body Part, Organ, or Organ Component]
   645   Flaccid [Qualitative Concept]
Meta Mapping (861):
   645   Motor (Device Motor) [Manufactured Object]
   875   Right Arm (Right arm) [Body Part, Organ, or Organ Component]
   645   Flaccid [Qualitative Concept]

Phrase: and

Phrase: he

Phrase: moved
Meta Mapping (1000):
  1000   moved (Moved from) [Functional Concept]
Meta Mapping (1000):
  1000   moved (Moved to) [Functional Concept]
Meta Mapping (1000):
  1000   Moved (Relocation of home or business) [Activity]

Phrase: his left purposefully ,
Meta Mapping (861):
   861   LEFT (Left) [Spatial Concept]
Meta Mapping (861):
   861   Left (Left sided) [Spatial Concept]
Meta Mapping (861):
   861   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: but

Phrase: did

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: squeeze
Meta Mapping (1000):
  1000 N Squeeze (Barotrauma of descent) [Injury or Poisoning]

Phrase: his hands .
Meta Mapping (1000):
  1000   Hands (Hand) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.36: He had clonus bilaterally with up going toe on the right , but not the left . 

Phrase: He

Phrase: had

Phrase: clonus bilaterally with up going toe
Meta Mapping (672):
   753   CLONUS (Clonus) [Sign or Symptom]
   586   TOE (Toes) [Body Part, Organ, or Organ Component]
Meta Mapping (672):
   753   CLONUS (Clonus) [Sign or Symptom]
   586   Toe (Entire toe) [Body Part, Organ, or Organ Component]

Phrase: on the right ,
Meta Mapping (1000):
  1000   RIGHT (Right) [Spatial Concept]
Meta Mapping (1000):
  1000   Right (Right sided) [Spatial Concept]

Phrase: but

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: the left .
Meta Mapping (1000):
  1000   LEFT (Left) [Spatial Concept]
Meta Mapping (1000):
  1000   Left (Left sided) [Spatial Concept]
Meta Mapping (1000):
  1000   left (Table Cell Horizontal Align - left) [Functional Concept]
Processing 00000000.tx.37: The medial region of the hematoma was felt to be suspicious for tumor versus arteriovenous malformation . 

Phrase: The medial region of the hematoma
Meta Mapping (672):
   586   MEDIAL (Medial) [Spatial Concept]
   753   Region (Geographic Locations) [Geographic Area]
   586   HEMATOMA (Hematoma) [Pathologic Function]
Meta Mapping (672):
   586   MEDIAL (Medial) [Spatial Concept]
   753   Region (Geographic Locations) [Geographic Area]
   586   Hematoma (Hematoma Adverse Event) [Finding]
Meta Mapping (672):
   586   MEDIAL (Medial) [Spatial Concept]
   753   Region (regional) [Spatial Concept]
   586   HEMATOMA (Hematoma) [Pathologic Function]
Meta Mapping (672):
   586   MEDIAL (Medial) [Spatial Concept]
   753   Region (regional) [Spatial Concept]
   586   Hematoma (Hematoma Adverse Event) [Finding]

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: suspicious for tumor
Meta Mapping (746):
   790   Suspicious [Idea or Concept]
   623   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (746):
   790   Suspicious [Idea or Concept]
   623   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (746):
   790   Suspicious [Idea or Concept]
   623   Tumor (Tumor Mass) [Finding]
Meta Mapping (746):
   790   Suspicious (Suspicious for Malignancy) [Finding]
   623   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (746):
   790   Suspicious (Suspicious for Malignancy) [Finding]
   623   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (746):
   790   Suspicious (Suspicious for Malignancy) [Finding]
   623   Tumor (Tumor Mass) [Finding]

Phrase: versus

Phrase: arteriovenous malformation .
Meta Mapping (1000):
  1000   Arteriovenous Malformation (Congenital arteriovenous malformation) [Congenital Abnormality,Disease or Syndrome]
Meta Mapping (1000):
  1000   Arteriovenous Malformation (Arteriovenous hemangioma) [Neoplastic Process]
Processing 00000000.tx.38: The GI Service was consulted on this mass and suggested an magnetic resonance imaging study of the liver . 

Phrase: The GI Service
Meta Mapping (888):
   694   Gi (GNAI1 wt Allele) [Gene or Genome]
   861   Service (Services) [Occupational Activity]
Meta Mapping (888):
   694   Gi (GNAI1 wt Allele) [Gene or Genome]
   861   Service (Software Service) [Manufactured Object]
Meta Mapping (888):
   694   Gi (GNAI1 wt Allele) [Gene or Genome]
   861   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (888):
   694   GI (Digestive System Findings Domain) [Intellectual Product]
   861   Service (Services) [Occupational Activity]
Meta Mapping (888):
   694   GI (Digestive System Findings Domain) [Intellectual Product]
   861   Service (Software Service) [Manufactured Object]
Meta Mapping (888):
   694   GI (Digestive System Findings Domain) [Intellectual Product]
   861   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (888):
   694   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   861   Service (Services) [Occupational Activity]
Meta Mapping (888):
   694   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   861   Service (Software Service) [Manufactured Object]
Meta Mapping (888):
   694   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   861   service (ActInformationPrivacyReason <service>) [Idea or Concept]

Phrase: was

Phrase: consulted on this mass
Meta Mapping (708):
   770   consulted (Consultation) [Health Care Activity]
   770   MASS (Mass of body structure) [Finding]
Meta Mapping (708):
   770   consulted (Consultation) [Health Care Activity]
   770   Mass (Mass of body region) [Sign or Symptom]
Meta Mapping (708):
   770   consulted (Consultation) [Health Care Activity]
   770   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
Meta Mapping (708):
   770   consulted (Consultation) [Health Care Activity]
   770   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
Meta Mapping (708):
   770   consulted (Consultation) [Health Care Activity]
   770   Mass (Molecular Mass) [Quantitative Concept]
Meta Mapping (708):
   770   consulted (Consultation) [Health Care Activity]
   770   mAs (Milliampere second) [Quantitative Concept]

Phrase: and

Phrase: suggested
Meta Mapping (966):
   966   Suggest (suggestion) [Idea or Concept]

Phrase: an magnetic resonance imaging study of the liver .
Meta Mapping (830):
   845   Magnetic resonance imaging of liver (Magnetic Resonance Imaging (MRI) of Liver) [Diagnostic Procedure]
   744   Study (Room of building - Study) [Manufactured Object]
Meta Mapping (830):
   845   Magnetic resonance imaging of liver (Magnetic Resonance Imaging (MRI) of Liver) [Diagnostic Procedure]
   744   Study [Research Activity]
Processing 00000000.tx.39: This confirmed an 8 mm. mass which was bright on T2 and homogeneous in the right lateral segment and medial lobe of the liver , which was consistent with a benign hemangioma or cyst . 

Phrase: This confirmed
Meta Mapping (1000):
  1000   confirmed (Confirmed by) [Qualitative Concept]
Meta Mapping (1000):
  1000   Confirmed (Confirmation) [Idea or Concept]

Phrase: an 8 mm. mass
Meta Mapping (827):
   827   MASS (Mass of body structure) [Finding]
Meta Mapping (827):
   827   Mass (Mass of body region) [Sign or Symptom]
Meta Mapping (827):
   827   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
Meta Mapping (827):
   827   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
Meta Mapping (827):
   827   Mass (Molecular Mass) [Quantitative Concept]
Meta Mapping (827):
   827   mAs (Milliampere second) [Quantitative Concept]

Phrase: which

Phrase: was

Phrase: bright on T2
Meta Mapping (790):
   790   Bright (Above average intellect) [Finding]
Meta Mapping (790):
   790   BRIGHT (ARID1B wt Allele) [Gene or Genome]

Phrase: and

Phrase: homogeneous in the right lateral segment
Meta Mapping (725):
   753   Homogeneous (Homogeneity) [Qualitative Concept]
   623   Right lateral (Lateral to the right) [Spatial Concept]
   586   SEGMENT (Anatomical segmentation) [Spatial Concept]
Meta Mapping (725):
   753   Homogeneous (Homogeneity) [Qualitative Concept]
   586   RIGHT (Right) [Spatial Concept]
   623   Lateral segment [Spatial Concept]
Meta Mapping (725):
   753   Homogeneous (Homogeneity) [Qualitative Concept]
   586   Right (Right sided) [Spatial Concept]
   623   Lateral segment [Spatial Concept]

Phrase: and

Phrase: medial lobe of the liver ,
Meta Mapping (816):
   593   MEDIAL (Medial) [Spatial Concept]
   844   Lobe of liver [Body Part, Organ, or Organ Component]

Phrase: which

Phrase: was

Phrase: consistent with a benign hemangioma
Meta Mapping (779):
   806   Consistent with [Idea or Concept]
   640   Benign haemangioma (Hemangioma) [Neoplastic Process]

Phrase: or

Phrase: cyst .
Meta Mapping (1000):
  1000   CYST (Cyst) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Cyst (Cyst form of protozoa) [Eukaryote]
Processing 00000000.tx.40: He still spends a lot of time in bed , although easily arousable . 

Phrase: He

Phrase: still

Phrase: spends
Meta Mapping (1000):
  1000   spends (spending) [Quantitative Concept]

Phrase: a lot of time
Meta Mapping (708):
   770   LOT (Lot Number) [Intellectual Product]
   604   TIME (Time) [Temporal Concept]
Meta Mapping (708):
   770   LOT (Lot Number) [Intellectual Product]
   604   Time (Time (foundation metadata concept)) [Temporal Concept]
Meta Mapping (708):
   770   Lot (Lot (entire collection)) [Qualitative Concept]
   604   TIME (Time) [Temporal Concept]
Meta Mapping (708):
   770   Lot (Lot (entire collection)) [Qualitative Concept]
   604   Time (Time (foundation metadata concept)) [Temporal Concept]
Meta Mapping (708):
   770   Lot (Stock (in-store merchandise)) [Idea or Concept]
   604   TIME (Time) [Temporal Concept]
Meta Mapping (708):
   770   Lot (Stock (in-store merchandise)) [Idea or Concept]
   604   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: in bed ,
Meta Mapping (1000):
  1000   Bed (Beds) [Manufactured Object]

Phrase: although

Phrase: easily arousable .
Meta Mapping (694):
   694   Easily (Easy) [Qualitative Concept]
Processing 00000000.tx.41: He had limited vertical up gaze . 

Phrase: He

Phrase: had

Phrase: limited vertical up gaze .
Meta Mapping (775):
   645   Limited (Limited (extensiveness)) [Functional Concept]
   645   Vertical [Spatial Concept]
   812   Gaze [Finding]
Meta Mapping (775):
   645   Limited (Limited Walking Ability) [Finding]
   645   Vertical [Spatial Concept]
   812   Gaze [Finding]
Meta Mapping (775):
   645   Limited (Limited component (foundation metadata concept)) [Intellectual Product]
   645   Vertical [Spatial Concept]
   812   Gaze [Finding]
Meta Mapping (775):
   645   Limited (Limited Lifting Ability) [Intellectual Product]
   645   Vertical [Spatial Concept]
   812   Gaze [Finding]
Processing 00000000.tx.42: A head computerized tomography scan was repeated on 08/08/92 which revealed some resolution of blood . 

Phrase: A head computerized tomography scan
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   Scan (Radionuclide Imaging) [Diagnostic Procedure]
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   Scan (Scanning) [Diagnostic Procedure]
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   SCAN (Related to Cancer) [Finding]

Phrase: was

Phrase: repeated on 08/08/92
Meta Mapping (760):
   760   Repeated (Repeat) [Functional Concept]

Phrase: which

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: some resolution of blood .
Meta Mapping (708):
   770   Resolution (physiologic resolution) [Pathologic Function]
   604   Blood [Tissue]
Meta Mapping (708):
   770   Resolution (physiologic resolution) [Pathologic Function]
   604   BLOOD (In Blood) [Body Substance]
Meta Mapping (708):
   770   Resolution (physiologic resolution) [Pathologic Function]
   604   BLOOD (peripheral blood) [Body Substance]
Meta Mapping (708):
   770   Resolution (Resolution Property) [Quantitative Concept]
   604   Blood [Tissue]
Meta Mapping (708):
   770   Resolution (Resolution Property) [Quantitative Concept]
   604   BLOOD (In Blood) [Body Substance]
Meta Mapping (708):
   770   Resolution (Resolution Property) [Quantitative Concept]
   604   BLOOD (peripheral blood) [Body Substance]
Meta Mapping (708):
   770   Resolution [Conceptual Entity]
   604   Blood [Tissue]
Meta Mapping (708):
   770   Resolution [Conceptual Entity]
   604   BLOOD (In Blood) [Body Substance]
Meta Mapping (708):
   770   Resolution [Conceptual Entity]
   604   BLOOD (peripheral blood) [Body Substance]
Processing 00000000.tx.43: Depending upon his head computerized tomography scan , he will proceed to a brain biopsy if needed . 

Phrase: Depending upon his head computerized tomography scan ,
Meta Mapping (747):
   714   depend [Medical Device]
   814   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   748   Scan (Radionuclide Imaging) [Diagnostic Procedure]
Meta Mapping (747):
   714   depend [Medical Device]
   814   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   748   Scan (Scanning) [Diagnostic Procedure]
Meta Mapping (747):
   714   depend [Medical Device]
   814   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   748   SCAN (Related to Cancer) [Finding]

Phrase: he

Phrase: will

Phrase: proceed to a brain biopsy
Meta Mapping (806):
   806   Brain Biopsy (brain biopsy) [Diagnostic Procedure]

Phrase: if

Phrase: needed .
Meta Mapping (1000):
  1000   Needed (Needs) [Qualitative Concept]
Meta Mapping (1000):
  1000   needed (Patient need for (contextual qualifier)) [Functional Concept]
Processing 00000000.tx.44: The patient will be discharged to Limestrict T Pio Medical Center and will be followed by Dr. 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: will

Phrase: be

Phrase: discharged to Limestrict T Pio Medical Center
Meta Mapping (701):
   748   Discharged (Patient Discharge) [Health Care Activity]
   748   PIO (Pemoline) [Organic Chemical,Pharmacologic Substance]
   778   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   Discharged (Patient Discharge) [Health Care Activity]
   748   PIO (Pemoline) [Organic Chemical,Pharmacologic Substance]
   778   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   Discharged (Patient Discharge) [Health Care Activity]
   748   PIO (Protocol Information Office) [Health Care Related Organization]
   778   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   Discharged (Patient Discharge) [Health Care Activity]
   748   PIO (Protocol Information Office) [Health Care Related Organization]
   778   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: and

Phrase: will

Phrase: be

Phrase: followed by Dr.
Meta Mapping (901):
   882   Followed by [Temporal Concept]
   790   DR (Dominican Republic) [Geographic Area]
Meta Mapping (901):
   882   Followed by [Temporal Concept]
   790   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (901):
   882   Followed by [Temporal Concept]
   790   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (901):
   882   Followed by [Temporal Concept]
   790   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (901):
   882   Followed by [Temporal Concept]
   790   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.45: Mo Muell in one month in the Neurologic Clinic . 

Phrase: Mo Muell in one month
Meta Mapping (579):
   593   MO (Morocco) [Geographic Area]
   640   One month [Temporal Concept]
Meta Mapping (579):
   593   /mo (Monthly (qualifier value)) [Temporal Concept]
   640   One month [Temporal Concept]
Meta Mapping (579):
   593   MO (Morphology Findings Domain) [Intellectual Product]
   640   One month [Temporal Concept]

Phrase: in the Neurologic Clinic .
Meta Mapping (964):
   964   Neurology clinic [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.46: MEDICATIONS ON DISCHARGE : DD : </RECORD> 04/25/1992 12:00:00 AM Lytic lesion , left femoral neck . 

Phrase: MEDICATIONS ON DISCHARGE
Meta Mapping (858):
   858   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: DD
Meta Mapping (1000):
  1000   DD (AKR1C2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   DD (ATP2A2 wt Allele) [Gene or Genome]

Phrase: :

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 04/25/1992 12

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: Lytic lesion ,
Meta Mapping (1000):
  1000   LYTIC LESION (Lytic lesion) [Pathologic Function]

Phrase: left
Meta Mapping (1000):
  1000   LEFT (Left) [Spatial Concept]
Meta Mapping (1000):
  1000   Left (Left sided) [Spatial Concept]
Meta Mapping (1000):
  1000   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: femoral neck .
Meta Mapping (1000):
  1000   Femoral Neck (Structure of neck of femur) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.47: Incisional biopsy , left hip ; bipolar hemiarthroplasty insertion . 

Phrase: Incisional biopsy ,
Meta Mapping (1000):
  1000   Incisional Biopsy (Incisional biopsy - action) [Diagnostic Procedure]

Phrase: left hip
Meta Mapping (1000):
  1000   Left hip (Structure of left hip) [Body Location or Region]
Meta Mapping (1000):
  1000   Left hip (Entire left hip region) [Body Location or Region]

Phrase: ; bipolar hemiarthroplasty insertion .
Meta Mapping (851):
   660   Bipolar [Spatial Concept]
   660   Hemiarthroplasty [Therapeutic or Preventive Procedure]
   827   Insertion (Implantation procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (851):
   660   Bipolar [Spatial Concept]
   660   Hemiarthroplasty [Therapeutic or Preventive Procedure]
   827   Insertion (Clinical act of insertion) [Health Care Activity]
Meta Mapping (851):
   660   Bipolar [Spatial Concept]
   660   Hemiarthroplasty [Therapeutic or Preventive Procedure]
   827   Insertion (Insertion Mutation) [Genetic Function]
Meta Mapping (851):
   660   Bipolar [Spatial Concept]
   660   Hemiarthroplasty [Therapeutic or Preventive Procedure]
   827   Insertion (Insert (object)) [Functional Concept]
Processing 00000000.tx.48: ALLERGIES : Positive for her mother with breast cancer , father leukemia , an aunt with bone cancer . 

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: Positive for her mother
Meta Mapping (708):
   770   % Positive (percent positive cells) [Quantitative Concept]
   604   Mother (Mother (person)) [Family Group]
Meta Mapping (708):
   770   Positive [Qualitative Concept]
   604   Mother (Mother (person)) [Family Group]
Meta Mapping (708):
   770   POSITIVE (Positive Finding) [Finding]
   604   Mother (Mother (person)) [Family Group]
Meta Mapping (708):
   770   Positive (Positive Charge) [Qualitative Concept]
   604   Mother (Mother (person)) [Family Group]
Meta Mapping (708):
   770   Positive (Positive Number) [Conceptual Entity]
   604   Mother (Mother (person)) [Family Group]

Phrase: with breast cancer ,
Meta Mapping (1000):
  1000   -- Breast Cancer (Malignant neoplasm of breast) [Neoplastic Process]
Meta Mapping (1000):
  1000   Breast Cancer (Breast Carcinoma) [Neoplastic Process]

Phrase: father leukemia ,
Meta Mapping (888):
   694   Father (Father (person)) [Family Group]
   861   LEUKAEMIA (leukemia) [Neoplastic Process]

Phrase: an aunt with bone cancer .
Meta Mapping (745):
   760   Aunt [Family Group]
   640   -- Bone Cancer (Malignant Bone Neoplasm) [Neoplastic Process]
Meta Mapping (745):
   760   Aunt [Family Group]
   640   bone cancer (Osteosarcoma of bone) [Neoplastic Process]
Processing 00000000.tx.49: Clear to auscultation . 

Phrase: Clear to auscultation .
Meta Mapping (746):
   790   Clear (Negative Surgical Margin) [Finding]
   790   AUSCULTATION (Auscultation) [Diagnostic Procedure]
Meta Mapping (746):
   790   Clear [Qualitative Concept]
   790   AUSCULTATION (Auscultation) [Diagnostic Procedure]
Processing 00000000.tx.50: Benign without mass or organomegaly . 

Phrase: Benign without mass
Meta Mapping (746):
   790   BENIGN (Benign) [Qualitative Concept]
   623 N MASS (Mass of body structure) [Finding]
Meta Mapping (746):
   790   BENIGN (Benign) [Qualitative Concept]
   623 N Mass (Mass of body region) [Sign or Symptom]
Meta Mapping (746):
   790   BENIGN (Benign) [Qualitative Concept]
   623 N MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
Meta Mapping (746):
   790   BENIGN (Benign) [Qualitative Concept]
   623   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
Meta Mapping (746):
   790   BENIGN (Benign) [Qualitative Concept]
   623   Mass (Molecular Mass) [Quantitative Concept]
Meta Mapping (746):
   790   BENIGN (Benign) [Qualitative Concept]
   623   mAs (Milliampere second) [Quantitative Concept]

Phrase: or

Phrase: organomegaly .
Meta Mapping (1000):
  1000 N Organomegaly [Finding]
Processing 00000000.tx.51: She needs to have a mammogram in Usyork and followup with her local doctor there . 

Phrase: She

Phrase: needs
Meta Mapping (1000):
  1000   Needs [Qualitative Concept]
Meta Mapping (1000):
  1000   needs (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: a mammogram in Usyork
Meta Mapping (770):
   770   Mammogram (Mammography) [Diagnostic Procedure]

Phrase: and

Phrase: followup with her local doctor there .
Meta Mapping (682):
   753   Follow-up (Follow-up status) [Finding]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (682):
   753   Follow-up (Follow-up status) [Finding]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (682):
   753   Followup (follow-up) [Health Care Activity]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (682):
   753   Followup (follow-up) [Health Care Activity]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (682):
   753   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (682):
   753   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (682):
   753   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (682):
   753   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   LOCAL (Local) [Spatial Concept]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Processing 00000000.tx.52: 07-26-93 OTHER PROCEDURES : Further evaluation at Heaonboburg Linpack Grant Medical Center , demonstrated that the patient had mitral valve endocarditis with mitral regurgitation that was initially managed medically . 

Phrase: 07-26-93

Phrase: OTHER PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: Further evaluation at Heaonboburg Linpack Grant Medical Center ,
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation [Health Care Activity]
   578   Grant (funding grant) [Quantitative Concept]
   604   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation [Health Care Activity]
   578   Grant (funding grant) [Quantitative Concept]
   604   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation [Health Care Activity]
   578   Grant (Charge type - Grant) [Idea or Concept]
   604   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation [Health Care Activity]
   578   Grant (Charge type - Grant) [Idea or Concept]
   604   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation (Evaluation procedure) [Health Care Activity]
   578   Grant (funding grant) [Quantitative Concept]
   604   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation (Evaluation procedure) [Health Care Activity]
   578   Grant (funding grant) [Quantitative Concept]
   604   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation (Evaluation procedure) [Health Care Activity]
   578   Grant (Charge type - Grant) [Idea or Concept]
   604   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   744   Evaluation (Evaluation procedure) [Health Care Activity]
   578   Grant (Charge type - Grant) [Idea or Concept]
   604   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (688):
   578   Further [Spatial Concept]
   578   Grant (funding grant) [Quantitative Concept]
   767   Medical Evaluation (Medical Examination) [Health Care Activity]
   578   Centre (Central) [Spatial Concept]
Meta Mapping (688):
   578   Further [Spatial Concept]
   578   Grant (funding grant) [Quantitative Concept]
   767   Medical Evaluation (Medical Examination) [Health Care Activity]
   578   Center (Center of town) [Finding]
Meta Mapping (688):
   578   Further [Spatial Concept]
   578   Grant (Charge type - Grant) [Idea or Concept]
   767   Medical Evaluation (Medical Examination) [Health Care Activity]
   578   Centre (Central) [Spatial Concept]
Meta Mapping (688):
   578   Further [Spatial Concept]
   578   Grant (Charge type - Grant) [Idea or Concept]
   767   Medical Evaluation (Medical Examination) [Health Care Activity]
   578   Center (Center of town) [Finding]

Phrase: demonstrated

Phrase: that

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: mitral valve endocarditis with mitral regurgitation
Meta Mapping (780):
   833   Mitral valve endocarditis (Endocarditis of mitral valve) [Disease or Syndrome]
   586   Regurgitation (Regurgitates after swallowing) [Finding]
Meta Mapping (780):
   833   Mitral valve endocarditis (Endocarditis of mitral valve) [Disease or Syndrome]
   586   Regurgitation (Regurgitation - mechanism) [Functional Concept]
Meta Mapping (780):
   833   Mitral valve endocarditis (Endocarditis of mitral valve) [Disease or Syndrome]
   586   REGURGITATION (Regurgitation) [Sign or Symptom]
Meta Mapping (780):
   654   MITRAL VALVE REGURGITATION (Mitral Valve Insufficiency) [Pathologic Function]
   753   ENDOCARDITIS (Endocarditis) [Disease or Syndrome]

Phrase: that

Phrase: was

Phrase: initially
Meta Mapping (1000):
  1000   Initially [Temporal Concept]

Phrase: managed
Meta Mapping (1000):
  1000   Managed (Management procedure) [Occupational Activity]

Phrase: medically .
Processing 00000000.tx.53: She was placed on intravenous antibiotics with gradual decrease in her temperature , although some low grade temperatures initially persisted . 

Phrase: She

Phrase: was

Phrase: placed on intravenous antibiotics
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, Antitubercular) [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics for systemic use) [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antifungal Antibiotics, Topical) [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotic throat preparations) [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE) [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, Gynecological) [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (antibiotics, intestinal) [Antibiotic]
Meta Mapping (722):
   737   Place [Spatial Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, ophthalmologic) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, Antitubercular) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics for systemic use) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antifungal Antibiotics, Topical) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotic throat preparations) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, Gynecological) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (antibiotics, intestinal) [Antibiotic]
Meta Mapping (722):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, ophthalmologic) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, Antitubercular) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics for systemic use) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antifungal Antibiotics, Topical) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotic throat preparations) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, Gynecological) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (antibiotics, intestinal) [Antibiotic]
Meta Mapping (722):
   737   Place (put - instruction imperative) [Activity]
   770   Intravenous [Spatial Concept]
   770   Antibiotics (Antibiotics, ophthalmologic) [Antibiotic]

Phrase: with gradual decrease in her temperature ,
Meta Mapping (722):
   586   Gradual [Qualitative Concept]
   783   TEMPERATURE DECREASE [Finding]

Phrase: although

Phrase: some low grade temperatures
Meta Mapping (901):
   913   low temperatures (Cold Temperature) [Natural Phenomenon or Process]
   660   Grade [Classification]
Meta Mapping (901):
   913   low temperatures (Cold Temperature) [Natural Phenomenon or Process]
   660   Grade (Histopathologic Grade) [Classification]
Meta Mapping (901):
   913   low temperatures (Cold Temperature) [Natural Phenomenon or Process]
   660   grade (School Grade) [Finding]
Meta Mapping (901):
   734   Low Grade (low grade) [Qualitative Concept]
   827   Temperatures (Temperature) [Quantitative Concept]

Phrase: initially
Meta Mapping (1000):
  1000   Initially [Temporal Concept]

Phrase: persisted .
Processing 00000000.tx.54: In addition , she was evaluated by the Sileyer Medical Center and there was no evidence of active dental infection . 

Phrase: In addition ,
Meta Mapping (861):
   861   Addition (In addition to) [Functional Concept]
Meta Mapping (861):
   861   Addition (Add - instruction imperative) [Functional Concept]

Phrase: she

Phrase: was

Phrase: evaluated by the Sileyer Medical Center
Meta Mapping (722):
   753   Evaluated (Evaluation) [Health Care Activity]
   790   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (722):
   753   Evaluated (Evaluation) [Health Care Activity]
   790   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: and

Phrase: there

Phrase: was

Phrase: no evidence of active dental infection .
Meta Mapping (725):
   753   Evidence [Idea or Concept]
   586   Active [Functional Concept]
   623 N Dental Infection (Infection of tooth) [Disease or Syndrome]
Meta Mapping (725):
   753   Evidence [Idea or Concept]
   586   active (active (HL7 RoleLink)) [Idea or Concept]
   623 N Dental Infection (Infection of tooth) [Disease or Syndrome]
Meta Mapping (725):
   753   Evidence [Idea or Concept]
   586   Active (Active License) [Qualitative Concept]
   623 N Dental Infection (Infection of tooth) [Disease or Syndrome]
Processing 00000000.tx.55: She was moved to the Intensive Care Unit and underwent subsequent cardiac catheterization in preparation for possible surgery . 

Phrase: She

Phrase: was

Phrase: moved to the Intensive Care Unit
Meta Mapping (794):
   790   Moved to [Functional Concept]
   833   INTENSIVE CARE UNIT (intensive care unit) [Health Care Related Organization,Manufactured Object]
Meta Mapping (794):
   790   Moved to [Functional Concept]
   833   Intensive care unit (Room type - Intensive care unit) [Idea or Concept]

Phrase: and

Phrase: underwent

Phrase: subsequent cardiac catheterization in preparation
Meta Mapping (761):
   593   Subsequent (Following) [Temporal Concept]
   806   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
   593   Preparation [Activity]
Meta Mapping (761):
   593   Subsequent (Following) [Temporal Concept]
   806   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
   593   Preparation (Prepared Material) [Quantitative Concept]

Phrase: for possible surgery .
Meta Mapping (888):
   694   Possible [Qualitative Concept]
   861   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (888):
   694   Possible [Qualitative Concept]
   861   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (888):
   694   Possible [Qualitative Concept]
   861   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (888):
   694   Possible [Qualitative Concept]
   861   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (888):
   694   Possible [Qualitative Concept]
   861   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Meta Mapping (888):
   694   Possible (Possibly Related to Intervention) [Qualitative Concept]
   861   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (888):
   694   Possible (Possibly Related to Intervention) [Qualitative Concept]
   861   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (888):
   694   Possible (Possibly Related to Intervention) [Qualitative Concept]
   861   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (888):
   694   Possible (Possibly Related to Intervention) [Qualitative Concept]
   861   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (888):
   694   Possible (Possibly Related to Intervention) [Qualitative Concept]
   861   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Meta Mapping (888):
   694   Possible (Possible diagnosis) [Qualitative Concept]
   861   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (888):
   694   Possible (Possible diagnosis) [Qualitative Concept]
   861   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (888):
   694   Possible (Possible diagnosis) [Qualitative Concept]
   861   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (888):
   694   Possible (Possible diagnosis) [Qualitative Concept]
   861   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (888):
   694   Possible (Possible diagnosis) [Qualitative Concept]
   861   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Processing 00000000.tx.56: She remained on full support in the Intensive Care Unit , on dialysis , with ongoing evidence of acidosis . 

Phrase: She

Phrase: remained on full support
Meta Mapping (722):
   770   Full [Qualitative Concept]
   770   Support, NOS (Support, device) [Medical Device]
Meta Mapping (722):
   770   Full [Qualitative Concept]
   770   Support (Supportive assistance) [Conceptual Entity]

Phrase: in the Intensive Care Unit ,
Meta Mapping (1000):
  1000   INTENSIVE CARE UNIT (intensive care unit) [Health Care Related Organization,Manufactured Object]
Meta Mapping (1000):
  1000   Intensive care unit (Room type - Intensive care unit) [Idea or Concept]

Phrase: on dialysis ,
Meta Mapping (1000):
  1000   Dialysis (Physical Dialysis) [Natural Phenomenon or Process]
Meta Mapping (1000):
  1000   Dialysis (Dialysis procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Dialysis (Genus Dialysis) [Eukaryote]

Phrase: with ongoing evidence of acidosis .
Meta Mapping (696):
   593   ONGOING (Continuous) [Idea or Concept]
   760   Evidence [Idea or Concept]
   593   ACIDOSIS (Acidosis) [Pathologic Function]
Meta Mapping (696):
   593   ONGOING (Continuous) [Idea or Concept]
   760   Evidence [Idea or Concept]
   593   Acidosis (Metabolic acidosis) [Pathologic Function]
Processing 00000000.tx.57: Report Status : 1. 

Phrase: Report Status
Meta Mapping (1000):
  1000   Report status [Finding]

Phrase: :

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.58: Coronary artery disease , 2. 

Phrase: Coronary artery disease ,
Meta Mapping (1000):
  1000   coronary artery disease (Coronary Arteriosclerosis) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Coronary (artery) disease (Coronary heart disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000   CORONARY ARTERY DISEASE (Coronary Artery Disease) [Disease or Syndrome]

Phrase: 2.
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]
Processing 00000000.tx.59: unstable angina ( postmyocardial infarction angina ) , 1. 

Phrase: unstable angina
Meta Mapping (1000):
  1000   Angina, Unstable [Disease or Syndrome]

Phrase: ( postmyocardial infarction angina
Meta Mapping (916):
   734   Post Myocardial Infarction (Postmyocardial infarction syndrome) [Disease or Syndrome]
   827   ANGINA (Angina Pectoris) [Finding]

Phrase: )

Phrase: ,

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.60: Percutaneous transluminal coronary angioplasty and coronary atherectomy of the left anterior descending , 8-17-93 , HISTORY OF PRESENT ILLNESS : The patient was transferred to the Gemenadentoolpai Medical Center and was admitted . 

Phrase: Percutaneous transluminal coronary angioplasty
Meta Mapping (1000):
  1000   Percutaneous Transluminal Coronary Angioplasty [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: coronary atherectomy of the left anterior descending ,
Meta Mapping (728):
   778   Atherectomy, Coronary (Coronary Atherectomy) [Therapeutic or Preventive Procedure]
   612   Left anterior [Spatial Concept]
   581   Descending [Qualitative Concept]
Meta Mapping (728):
   778   Atherectomy, Coronary (Coronary Atherectomy) [Therapeutic or Preventive Procedure]
   612   Left anterior [Spatial Concept]
   581   Descending (Sequencing - Descending) [Functional Concept]

Phrase: 8-17-93 ,

Phrase: HISTORY OF PRESENT ILLNESS
Meta Mapping (1000):
  1000   HISTORY OF PRESENT ILLNESS (History of present illness) [Organism Attribute]
Meta Mapping (1000):
  1000   History of present illness (History of present illness:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: transferred to the Gemenadentoolpai Medical Center
Meta Mapping (722):
   753   transferred (Surgical transfer - action) [Functional Concept]
   790   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (722):
   753   transferred (Surgical transfer - action) [Functional Concept]
   790   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (722):
   753   Transferred (Transfer Technique) [Functional Concept]
   790   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (722):
   753   Transferred (Transfer Technique) [Functional Concept]
   790   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: and

Phrase: was

Phrase: admitted .
Meta Mapping (1000):
  1000   admitted (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admitted (Admission activity) [Health Care Activity]
Processing 00000000.tx.61: PAST MEDICAL HISTORY : The cardiac examination revealed anapical impulse in the fifth left intercostal space , left to mid clavicular line . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: The cardiac examination
Meta Mapping (1000):
  1000   Cardiac examination (Examination of heart) [Health Care Activity]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: anapical impulse in the fifth left intercostal space ,
Meta Mapping (731):
   744   Impulse (Impulse technique) [Therapeutic or Preventive Procedure]
   626   Fifth intercostal space (Structure of fifth intercostal space) [Body Space or Junction]
   578   LEFT (Left) [Spatial Concept]
Meta Mapping (731):
   744   Impulse (Impulse technique) [Therapeutic or Preventive Procedure]
   626   Fifth intercostal space (Structure of fifth intercostal space) [Body Space or Junction]
   578   Left (Left sided) [Spatial Concept]
Meta Mapping (731):
   744   Impulse (Impulse technique) [Therapeutic or Preventive Procedure]
   626   Fifth intercostal space (Structure of fifth intercostal space) [Body Space or Junction]
   578   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (731):
   744   Impulse (Impulse technique) [Therapeutic or Preventive Procedure]
   626   Fifth intercostal space (Entire fifth intercostal space) [Body Space or Junction]
   578   LEFT (Left) [Spatial Concept]
Meta Mapping (731):
   744   Impulse (Impulse technique) [Therapeutic or Preventive Procedure]
   626   Fifth intercostal space (Entire fifth intercostal space) [Body Space or Junction]
   578   Left (Left sided) [Spatial Concept]
Meta Mapping (731):
   744   Impulse (Impulse technique) [Therapeutic or Preventive Procedure]
   626   Fifth intercostal space (Entire fifth intercostal space) [Body Space or Junction]
   578   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: left to mid clavicular line .
Meta Mapping (721):
   762   Left clavicle [Body Part, Organ, or Organ Component]
   760   Line (Linear) [Spatial Concept]
Meta Mapping (721):
   762   Left clavicle [Body Part, Organ, or Organ Component]
   760   Line (Intravascular line) [Medical Device]
Meta Mapping (721):
   762   Left clavicle [Body Part, Organ, or Organ Component]
   760   Line (Line Specimen) [Substance]
Meta Mapping (721):
   762   Left clavicle [Body Part, Organ, or Organ Component]
   760   Line (Line Unit of Length) [Quantitative Concept]
Processing 00000000.tx.62: She had no murmurs and no gallops . 

Phrase: She

Phrase: had

Phrase: no murmurs
Meta Mapping (1000):
  1000 N murmurs (Heart murmur) [Finding]

Phrase: and

Phrase: no gallops .
Processing 00000000.tx.63: The patient was admitted to the Medical Service . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted to the Medical Service .
Meta Mapping (745):
   760   admitted (Hospital admission) [Health Care Activity]
   806   Medical service [Health Care Activity]
Meta Mapping (745):
   760   admitted (Hospital admission) [Health Care Activity]
   806   medical service (Physician service) [Health Care Activity]
Meta Mapping (745):
   760   admitted (Hospital admission) [Health Care Activity]
   806   Medical Service (Hospital Service - Medical Service) [Health Care Related Organization]
Meta Mapping (745):
   760   Admitted (Admission activity) [Health Care Activity]
   806   Medical service [Health Care Activity]
Meta Mapping (745):
   760   Admitted (Admission activity) [Health Care Activity]
   806   medical service (Physician service) [Health Care Activity]
Meta Mapping (745):
   760   Admitted (Admission activity) [Health Care Activity]
   806   Medical Service (Hospital Service - Medical Service) [Health Care Related Organization]
Processing 00000000.tx.64: Dr. 

Phrase: Dr.
Meta Mapping (1000):
  1000   DR (Dominican Republic) [Geographic Area]
Meta Mapping (1000):
  1000   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.65: Aalv Lorjes Salv Manual Pasi Admission Date : 01/19/2002 ****** DISCHARGE ORDERS GLOMOBESAP , BAMJET ELLDAN , M.D. 

Phrase: Aalv Lorjes Salv Manual Pasi Admission Date
Meta Mapping (753):
   629   Manual (Manuals as Topic) [Intellectual Product,Manufactured Object]
   818   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (753):
   629   Manual (Manuals as Topic) [Intellectual Product,Manufactured Object]
   818   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (753):
   629   Manual [Functional Concept]
   818   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (753):
   629   Manual [Functional Concept]
   818   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (753):
   629   Manual (Laboratory Sample Manual) [Intellectual Product]
   818   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (753):
   629   Manual (Laboratory Sample Manual) [Intellectual Product]
   818   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: 01/19/2002

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: * DISCHARGE
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: ORDERS
Meta Mapping (1000):
  1000   Order (Order (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Order (Order (taxonomic)) [Classification]
Meta Mapping (1000):
  1000   Order (Order (action)) [Activity]
Meta Mapping (1000):
  1000   Order (Permutation) [Qualitative Concept]
Meta Mapping (1000):
  1000   orders (orders - HL7PublishingDomain) [Intellectual Product]
Meta Mapping (1000):
  1000   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]

Phrase: GLOMOBESAP ,

Phrase: BAMJET ELLDAN ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.66: Expired <RECORD ID="677"> <TEXT> 057593846 6364933 <TEXT> His course was then complicated by fevers and neutropenia which were treated with antibiotics and a diffuse erythroderm felt to be a drug reaction . 

Phrase: Expired
Meta Mapping (1000):
  1000   EXPIRED (Cessation of life) [Organism Function]
Meta Mapping (1000):
  1000   Expired (Expiration, function) [Organ or Tissue Function]
Meta Mapping (1000):
  1000   Expired (Expiration) [Idea or Concept]

Phrase: <RECORD ID="677"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: >

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 057593846 6364933

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: His course
Meta Mapping (1000):
  1000   Course [Temporal Concept]

Phrase: was

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: complicated by fevers
Meta Mapping (746):
   790   Complicated [Functional Concept]
   790   Fevers (Fever) [Finding]

Phrase: and

Phrase: neutropenia
Meta Mapping (1000):
  1000   NEUTROPENIA (Leukopenia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   NEUTROPENIA (Neutropenia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Neutropenia (Neutrophil count decreased) [Finding]

Phrase: which

Phrase: were

Phrase: treated with antibiotics
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (Antibiotics, Antitubercular) [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (Antibiotics for systemic use) [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (Antifungal Antibiotics, Topical) [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (Antibiotic throat preparations) [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE) [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (Antibiotics, Gynecological) [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (antibiotics, intestinal) [Antibiotic]
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   Antibiotics (Antibiotics, ophthalmologic) [Antibiotic]

Phrase: and

Phrase: a diffuse erythroderm
Meta Mapping (888):
   694   DIFFUSE (Diffuse) [Qualitative Concept]
   861   Erythroderm (Exfoliative dermatitis) [Disease or Syndrome]

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: a drug reaction .
Meta Mapping (1000):
  1000   DRUG REACTION (Adverse reaction to drug) [Injury or Poisoning]
Processing 00000000.tx.67: On 06/24/00 the patient was found to have pulmonary infiltrates and some hemoptysis . 

Phrase: On 06/24/00

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: pulmonary infiltrates
Meta Mapping (1000):
  1000   Pulmonary infiltrates (Infiltrate of lung) [Finding]

Phrase: and

Phrase: some hemoptysis .
Meta Mapping (1000):
  1000   HEMOPTYSIS (Hemoptysis) [Sign or Symptom]
Processing 00000000.tx.68: It was felt at that time that the changing mental status and respiratory distress might be due to a combination of medication and worsening mucositis . 

Phrase: It

Phrase: was

Phrase: felt at
Meta Mapping (799):
   799   feel (Emotions) [Mental Process]

Phrase: that time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: that

Phrase: the changing mental status
Meta Mapping (901):
   913   Changing status (modify status) [Functional Concept]
   660   mental (Psyche structure) [Mental Process]
Meta Mapping (901):
   660   Changing [Functional Concept]
   901   Mental status (Mental state (observable entity)) [Finding]
Meta Mapping (901):
   660   changing (Changed status) [Quantitative Concept]
   901   Mental status (Mental state (observable entity)) [Finding]

Phrase: and

Phrase: respiratory distress
Meta Mapping (1000):
  1000   Distress, Respiratory (Respiratory distress) [Sign or Symptom]

Phrase: might

Phrase: be due to a combination of medication
Meta Mapping (719):
   778   Due To (Due to) [Functional Concept]
   774   Combination Medication [Pharmacologic Substance]

Phrase: and

Phrase: worsening mucositis .
Meta Mapping (888):
   694   Worsening (Worsening pattern) [Qualitative Concept]
   861   MUCOSITIS NOS (Inflammatory disease of mucous membrane) [Pathologic Function]
Meta Mapping (888):
   694   Worsening (Worsening pattern) [Qualitative Concept]
   861   Mucositis (Gastrointestinal mucositis) [Disease or Syndrome]
Meta Mapping (888):
   694   Worsening (Worse) [Finding]
   861   MUCOSITIS NOS (Inflammatory disease of mucous membrane) [Pathologic Function]
Meta Mapping (888):
   694   Worsening (Worse) [Finding]
   861   Mucositis (Gastrointestinal mucositis) [Disease or Syndrome]
Meta Mapping (888):
   694   Worsening (Patient Outcome - Worsening) [Idea or Concept]
   861   MUCOSITIS NOS (Inflammatory disease of mucous membrane) [Pathologic Function]
Meta Mapping (888):
   694   Worsening (Patient Outcome - Worsening) [Idea or Concept]
   861   Mucositis (Gastrointestinal mucositis) [Disease or Syndrome]
Processing 00000000.tx.69: Because of this continued agitation , a head CT was performed on 07/01/00 and it revealed an intraparenchymal hemorrhage . 

Phrase: Because of this continued agitation ,
Meta Mapping (888):
   694   Continued (Continuous) [Idea or Concept]
   861   AGITATION (Agitation) [Sign or Symptom]

Phrase: a head CT
Meta Mapping (1000):
  1000   Head CT (CAT scan of head) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Head CT (Multisection:Finding:Point in time:Head:Narrative:COMPUTERIZED TOMOGRAPHY) [Clinical Attribute]

Phrase: was

Phrase: performed on 07/01/00
Meta Mapping (760):
   760   Performed [Functional Concept]

Phrase: and

Phrase: it

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: an intraparenchymal hemorrhage .
Meta Mapping (888):
   861   INTRAPARENCHYMAL (Intraparenchymal Route of Administration) [Functional Concept]
   861   HEMORRHAGE (Hemorrhage) [Pathologic Function]
Processing 00000000.tx.70: D : 923091 JEM , ON 2513486 </RECORD> 2/1/2001 12:00:00 AM UNSIGNED DIS DISCHARGE SUMMARY NAME : HE HAD SEVERE AORTIC INSUFFICIENCY AND A SMALL EMBOLIC EVENT . 

Phrase: D
Meta Mapping (1000):
  1000   D NOS (Blood group antigen D) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (1000):
  1000   /d (Daily) [Temporal Concept]

Phrase: :

Phrase: 923091 JEM ,

Phrase: ON 2513486

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 2/1/2001 12
Meta Mapping (861):
   861   2-1 (SPRR2A protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: UNSIGNED DIS DISCHARGE SUMMARY NAME
Meta Mapping (798):
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   673   Discharge summary [Intellectual Product]
   804   Name [Intellectual Product]
Meta Mapping (798):
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   673   Discharge summary [Intellectual Product]
   804   Name (Person Name) [Intellectual Product]
Meta Mapping (798):
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   804   Name [Intellectual Product]
Meta Mapping (798):
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   804   Name (Person Name) [Intellectual Product]
Meta Mapping (798):
   637   DIS (Discontinued) [Finding]
   673   Discharge summary [Intellectual Product]
   804   Name [Intellectual Product]
Meta Mapping (798):
   637   DIS (Discontinued) [Finding]
   673   Discharge summary [Intellectual Product]
   804   Name (Person Name) [Intellectual Product]
Meta Mapping (798):
   637   DIS (Discontinued) [Finding]
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   804   Name [Intellectual Product]
Meta Mapping (798):
   637   DIS (Discontinued) [Finding]
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   804   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: HE

Phrase: HAD

Phrase: SEVERE AORTIC INSUFFICIENCY
Meta Mapping (901):
   660   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   901   AORTIC INSUFFICIENCY (Aortic Valve Insufficiency) [Disease or Syndrome]
Meta Mapping (901):
   660   Severe (Severe Extremity Pain) [Intellectual Product]
   901   AORTIC INSUFFICIENCY (Aortic Valve Insufficiency) [Disease or Syndrome]
Meta Mapping (901):
   660   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   901   AORTIC INSUFFICIENCY (Aortic Valve Insufficiency) [Disease or Syndrome]

Phrase: AND

Phrase: A SMALL EMBOLIC EVENT .
Meta Mapping (851):
   660   SMALL (Small) [Quantitative Concept]
   660   Embolic (Embolism) [Pathologic Function]
   827   Event [Event]
Meta Mapping (851):
   660   SMALL (Small) [Quantitative Concept]
   660   Embolic (Embolism) [Pathologic Function]
   827   Event (National reporting jurisdiction:Loc:Pt:^Event:Nom) [Clinical Attribute]
Processing 00000000.tx.71: BLOOD CULTURES WERE POSITIVE FOR S. 

Phrase: BLOOD CULTURES
Meta Mapping (966):
   966   Blood culture [Laboratory Procedure]

Phrase: WERE

Phrase: POSITIVE FOR S.
Meta Mapping (790):
   790   % Positive (percent positive cells) [Quantitative Concept]
Meta Mapping (790):
   790   Positive [Qualitative Concept]
Meta Mapping (790):
   790   POSITIVE (Positive Finding) [Finding]
Meta Mapping (790):
   790   Positive (Positive Charge) [Qualitative Concept]
Meta Mapping (790):
   790   Positive (Positive Number) [Conceptual Entity]
Processing 00000000.tx.72: VERIDANS . 

Phrase: VERIDANS .
Processing 00000000.tx.73: A TRANSESOPHAGEAL ECHO DONE AT THIS TIME SHOWED AN AORTIC PERIVALVULAR LEAK . 

Phrase: A TRANSESOPHAGEAL ECHO
Meta Mapping (888):
   861   Transesophageal (Transesophageal approach) [Spatial Concept]
   861   ECHO (ECHO protocol) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   861   Transesophageal (Transesophageal approach) [Spatial Concept]
   861   Echo (Echo (insect)) [Eukaryote]

Phrase: DONE AT THIS TIME
Meta Mapping (708):
   770   Done (Done (qualifier value)) [Qualitative Concept]
   770   TIME (Time) [Temporal Concept]
Meta Mapping (708):
   770   Done (Done (qualifier value)) [Qualitative Concept]
   770   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: SHOWED
Meta Mapping (966):
   966   Show [Animal]

Phrase: AN AORTIC PERIVALVULAR LEAK .
Meta Mapping (901):
   660   Aortic (Aorta) [Body Part, Organ, or Organ Component]
   901   Perivalvular Leak [Finding]
Meta Mapping (901):
   660   Aortic (Aorta) [Body Part, Organ, or Organ Component]
   901   Perivalvular Leak (Perivalvular Leak Medical Device Problem) [Phenomenon or Process]
Processing 00000000.tx.74: AMPICILLIN 2 GM IV AS DIRECTED GENTAMICIN 70 MG IV Q8HR COUMADIN 5.0/7.5 MG PO AS DIRECTED XANAX 1 MG PO BID PROTONIX 40 MG PO QD ALBUTEROL MDI QID ATROVENT MDI QID 31.1 , 45 , UAS-WBC : ADMISSION CHEST XRAY : SOCIAL HISTORY : HAS BEEN SMOKING APPROXIMATELY 10 CIGARETTES A DAY . 

Phrase: AMPICILLIN 2 GM IV
Meta Mapping (775):
   645   AMPICILLIN (Ampicillin) [Antibiotic,Organic Chemical]
   645   GM (Germany) [Geographic Area]
   812   IV (Ivory Coast) [Geographic Area]
Meta Mapping (775):
   645   AMPICILLIN (Ampicillin) [Antibiotic,Organic Chemical]
   645   GM (Gentamicin Sulfate (USP)) [Antibiotic,Organic Chemical]
   812   IV (Ivory Coast) [Geographic Area]

Phrase: AS DIRECTED GENTAMICIN 70 MG IV Q8HR COUMADIN 5.0/7.5 MG PO
Meta Mapping (709):
   548   Directions [Spatial Concept]
   620   Gentamycin (Gentamicin Sulfate (USP)) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Portugal) [Geographic Area]
Meta Mapping (709):
   548   Directions [Spatial Concept]
   620   Gentamycin (Gentamicin Sulfate (USP)) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Oral) [Spatial Concept]
Meta Mapping (709):
   548   Directions [Spatial Concept]
   620   Gentamycin (Gentamicin) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Portugal) [Geographic Area]
Meta Mapping (709):
   548   Directions [Spatial Concept]
   620   Gentamycin (Gentamicin) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Oral) [Spatial Concept]
Meta Mapping (709):
   548   Direction [Spatial Concept]
   620   Gentamycin (Gentamicin Sulfate (USP)) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Portugal) [Geographic Area]
Meta Mapping (709):
   548   Direction [Spatial Concept]
   620   Gentamycin (Gentamicin Sulfate (USP)) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Oral) [Spatial Concept]
Meta Mapping (709):
   548   Direction [Spatial Concept]
   620   Gentamycin (Gentamicin) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Portugal) [Geographic Area]
Meta Mapping (709):
   548   Direction [Spatial Concept]
   620   Gentamycin (Gentamicin) [Antibiotic,Organic Chemical]
   620   70% [Finding]
   689   mg/mg [Quantitative Concept]
   620   IV (Ivory Coast) [Geographic Area]
   620   Coumadin [Organic Chemical,Pharmacologic Substance]
   620   0% [Finding]
   786   PO (Oral) [Spatial Concept]

Phrase: AS DIRECTED XANAX 1 MG PO BID PROTONIX 40 MG PO QD ALBUTEROL MDI QID ATROVENT MDI QID 31.1 ,
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Directions [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Portugal) [Geographic Area]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   /40 [Temporal Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Metered Dose Inhaler) [Medical Device]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (MAJOR AFFECTIVE DISORDER 2) [Mental or Behavioral Dysfunction]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]
Meta Mapping (688):
   712   Direction [Spatial Concept]
   783   Xanax [Organic Chemical,Pharmacologic Substance]
   813   mg/mg [Quantitative Concept]
   783   PO (Oral) [Spatial Concept]
   783   Protonix [Organic Chemical,Pharmacologic Substance]
   783   40% [Quantitative Concept]
   783   QD (Daily) [Temporal Concept]
   783   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   783   MDI (Myositis Damage Index) [Intellectual Product]
   783   QID (Four times daily) [Temporal Concept]
   783   Atrovent [Organic Chemical,Pharmacologic Substance]
   783   31 [Intellectual Product]

Phrase: 45 ,

Phrase: UAS-WBC
Meta Mapping (861):
   861   WBC (Leukocytes) [Cell]
Meta Mapping (861):
   861   % WBC (Percent in White Blood Count Differential) [Quantitative Concept]

Phrase: :

Phrase: ADMISSION CHEST XRAY
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray (roentgenographic) [Functional Concept]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray, NOS (Diagnostic radiologic examination) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   Xray (Roentgen Rays) [Natural Phenomenon or Process]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray (Plain x-ray) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-RAY (Radiographic imaging procedure) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray (Radiography Study File) [Intellectual Product]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray (roentgenographic) [Functional Concept]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray, NOS (Diagnostic radiologic examination) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   Xray (Roentgen Rays) [Natural Phenomenon or Process]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray (Plain x-ray) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-RAY (Radiographic imaging procedure) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Hospital admission) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray (Radiography Study File) [Intellectual Product]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray (roentgenographic) [Functional Concept]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray, NOS (Diagnostic radiologic examination) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   Xray (Roentgen Rays) [Natural Phenomenon or Process]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray (Plain x-ray) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-RAY (Radiographic imaging procedure) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   CHEST (Chest) [Body Location or Region]
   827   X-ray (Radiography Study File) [Intellectual Product]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray (roentgenographic) [Functional Concept]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray, NOS (Diagnostic radiologic examination) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   Xray (Roentgen Rays) [Natural Phenomenon or Process]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray (Plain x-ray) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-RAY (Radiographic imaging procedure) [Diagnostic Procedure]
Meta Mapping (861):
   660   Admission (Admission activity) [Health Care Activity]
   660   Chest (Anterior thoracic region) [Body Location or Region]
   827   X-ray (Radiography Study File) [Intellectual Product]

Phrase: :

Phrase: SOCIAL HISTORY
Meta Mapping (1000):
  1000   Social history (Social and personal history) [Finding]
Meta Mapping (1000):
  1000   Social History [Finding]

Phrase: :

Phrase: HAS

Phrase: BEEN

Phrase: SMOKING
Meta Mapping (1000):
  1000   SMOKING (Smoking) [Individual Behavior]
Meta Mapping (1000):
  1000   Smoking (Tobacco smoking behavior) [Individual Behavior]
Meta Mapping (1000):
  1000   Smoking (Medical Device Emits Smoke) [Phenomenon or Process]

Phrase: APPROXIMATELY 10 CIGARETTES
Meta Mapping (851):
   660   Approximately (Approximate) [Qualitative Concept]
   660   10% [Finding]
   827   Cigarettes (Cigarette) [Manufactured Object]

Phrase: A DAY .
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]
Processing 00000000.tx.75: NON-HYPEREMIC PHARYNX . 

Phrase: NON-HYPEREMIC PHARYNX .
Meta Mapping (828):
   660   Non (Negation) [Functional Concept]
   589 N Hyperemias (Hyperemia) [Disease or Syndrome]
   827   PHARYNX (Pharyngeal structure) [Body Part, Organ, or Organ Component]
Meta Mapping (828):
   660   Non (Negation) [Functional Concept]
   589 N Hyperemias (Hyperemia) [Disease or Syndrome]
   827   Pharynx (Entire pharynx) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.76: ULNAR : POSTERIOR TIBIALIS : 2+ 2+ PULSES ( LEFT ) RADIAL : HE WILL CONTINUE INTRAVENOUS VANCOMYCIN UNTIL January 3 , 2001 TO A TOTAL OF THREE WEEKS . 

Phrase: ULNAR
Meta Mapping (1000):
  1000   Ulnar [Body Location or Region]

Phrase: :

Phrase: POSTERIOR TIBIALIS
Meta Mapping (1000):
  1000   posterior tibialis (Tibialis posterior muscle structure) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: 2+ 2+ PULSES
Meta Mapping (802):
   660   +2 [Quantitative Concept]
   827   Pulses (Pulse taking) [Health Care Activity]
Meta Mapping (802):
   660   +2 [Quantitative Concept]
   827   PULSES (Physiologic pulse) [Physiologic Function]
Meta Mapping (802):
   660   2+ (2+ Score) [Quantitative Concept]
   827   Pulses (Pulse taking) [Health Care Activity]
Meta Mapping (802):
   660   2+ (2+ Score) [Quantitative Concept]
   827   PULSES (Physiologic pulse) [Physiologic Function]
Meta Mapping (802):
   660   2+ (2+ Score, WHO) [Classification]
   827   Pulses (Pulse taking) [Health Care Activity]
Meta Mapping (802):
   660   2+ (2+ Score, WHO) [Classification]
   827   PULSES (Physiologic pulse) [Physiologic Function]
Meta Mapping (802):
   660   2+ [Finding]
   827   Pulses (Pulse taking) [Health Care Activity]
Meta Mapping (802):
   660   2+ [Finding]
   827   PULSES (Physiologic pulse) [Physiologic Function]

Phrase: ( LEFT
Meta Mapping (1000):
  1000   LEFT (Left) [Spatial Concept]
Meta Mapping (1000):
  1000   Left (Left sided) [Spatial Concept]
Meta Mapping (1000):
  1000   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: )

Phrase: RADIAL
Meta Mapping (1000):
  1000   Radial [Conceptual Entity]
Meta Mapping (1000):
  1000   Radial (Circumpennate) [Conceptual Entity]

Phrase: :

Phrase: HE

Phrase: WILL

Phrase: CONTINUE
Meta Mapping (1000):
  1000   Continue (Continuous) [Idea or Concept]

Phrase: INTRAVENOUS VANCOMYCIN UNTIL January 3 ,
Meta Mapping (696):
   593   Intravenous [Spatial Concept]
   760   VANCOMYCIN (Vancomycin) [Amino Acid, Peptide, or Protein,Antibiotic]
   593   January [Qualitative Concept]

Phrase: 2001 TO A TOTAL OF THREE WEEKS .
Meta Mapping (706):
   748   % total (% of total) [Quantitative Concept]
   778   Three weeks [Temporal Concept]
Meta Mapping (706):
   748   Total [Qualitative Concept]
   778   Three weeks [Temporal Concept]
Processing 00000000.tx.77: TREATMENTS : MONITOR COUMADIN MONDAY , WEDNESDAY , AND FRIDAY . khu

Phrase: TREATMENTS
Meta Mapping (1000):
  1000   Treatments (Therapeutic procedure) [Therapeutic or Preventive Procedure]

Phrase: :

Phrase: MONITOR COUMADIN MONDAY ,
Meta Mapping (851):
   660   monitor (Patient Monitoring) [Health Care Activity]
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   Monday [Temporal Concept]
Meta Mapping (851):
   660   monitor (Preventive monitoring) [Health Care Activity]
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   Monday [Temporal Concept]
Meta Mapping (851):
   660   Monitor (Biomedical Monitors) [Medical Device]
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   Monday [Temporal Concept]
Meta Mapping (851):
   660   Monitor (Monitoring Device) [Medical Device]
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   Monday [Temporal Concept]
Meta Mapping (851):
   660   Monitor (Monitor, occupation) [Professional or Occupational Group]
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   Monday [Temporal Concept]
Meta Mapping (851):
   660   Monitor (Monitor Device Component) [Manufactured Object]
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   Monday [Temporal Concept]

Phrase: WEDNESDAY ,
Meta Mapping (1000):
  1000   Wednesday [Temporal Concept]

Phrase: AND

Phrase: FRIDAY . khu
Meta Mapping (694):
   694   Friday [Temporal Concept]
Processing 00000000.tx.1: </RECORD> 466217945 158979 Discharge Summary Signed DISCHARGE SUMMARY NAME : DISCHARGE DATE : PRINCIPAL PROCEDURES : Incision and drainage of wound infection on 3/7/02 . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 466217945 158979 Discharge Summary Signed DISCHARGE SUMMARY NAME
Meta Mapping (739):
   645   Discharge summary [Intellectual Product]
   626   Signed (Signature) [Intellectual Product]
   793   Name [Intellectual Product]
Meta Mapping (739):
   645   Discharge summary [Intellectual Product]
   626   Signed (Signature) [Intellectual Product]
   793   Name (Person Name) [Intellectual Product]
Meta Mapping (739):
   645   Discharge summary [Intellectual Product]
   626   signed (signed - ParticipationSignature) [Intellectual Product]
   793   Name [Intellectual Product]
Meta Mapping (739):
   645   Discharge summary [Intellectual Product]
   626   signed (signed - ParticipationSignature) [Intellectual Product]
   793   Name (Person Name) [Intellectual Product]
Meta Mapping (739):
   645   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   626   Signed (Signature) [Intellectual Product]
   793   Name [Intellectual Product]
Meta Mapping (739):
   645   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   626   Signed (Signature) [Intellectual Product]
   793   Name (Person Name) [Intellectual Product]
Meta Mapping (739):
   645   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   626   signed (signed - ParticipationSignature) [Intellectual Product]
   793   Name [Intellectual Product]
Meta Mapping (739):
   645   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   626   signed (signed - ParticipationSignature) [Intellectual Product]
   793   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: DISCHARGE DATE
Meta Mapping (1000):
  1000   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Discharge date [Temporal Concept]

Phrase: :

Phrase: PRINCIPAL PROCEDURES
Meta Mapping (983):
   983   Principal procedure (Primary procedure) [Functional Concept]

Phrase: :

Phrase: Incision
Meta Mapping (1000):
  1000   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (1000):
  1000   Incision (Cranial incision point) [Body Location or Region]

Phrase: and

Phrase: drainage of wound infection
Meta Mapping (783):
   819   Wound Drainage (Wound discharge finding) [Finding]
   604   Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (783):
   819   Wound Drainage (Wound discharge finding) [Finding]
   604   INFECTION (Infection) [Pathologic Function]
Meta Mapping (783):
   819   drainage wound (Wound drainage specimen) [Body Substance]
   604   Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (783):
   819   drainage wound (Wound drainage specimen) [Body Substance]
   604   INFECTION (Infection) [Pathologic Function]
Meta Mapping (783):
   819   wound drainage (Wound drainage procedure) [Therapeutic or Preventive Procedure]
   604   Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (783):
   819   wound drainage (Wound drainage procedure) [Therapeutic or Preventive Procedure]
   604   INFECTION (Infection) [Pathologic Function]
Meta Mapping (783):
   770   Drainage, NOS (Body Fluid Discharge) [Body Substance]
   666   Wound Infection [Pathologic Function]
Meta Mapping (783):
   770   Drainage (Drainage procedure) [Therapeutic or Preventive Procedure]
   666   Wound Infection [Pathologic Function]
Meta Mapping (783):
   770   Drainage (Discharge, body substance) [Body Substance]
   666   Wound Infection [Pathologic Function]

Phrase: on 3/7/02 .
Meta Mapping (827):
   827   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (827):
   827   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (827):
   827   3+ (3+ Score, WHO) [Classification]
Meta Mapping (827):
   827   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.2: PHYSICAL EXAMINATION ON ADMISSION : Wound cultures remained negative at that time . 

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: ON ADMISSION
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: :

Phrase: Wound cultures remained negative at
Meta Mapping (734):
   593   WOUND (Injury wounds) [Injury or Poisoning]
   781   culture negative [Laboratory or Test Result]
Meta Mapping (734):
   593   Wound (Traumatic injury) [Injury or Poisoning]
   781   culture negative [Laboratory or Test Result]

Phrase: that time .
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]
Processing 00000000.tx.3: We contacted the patient &apos;s primary care physician , Dr. 

Phrase: We

Phrase: contacted
Meta Mapping (966):
   966   contact (Contact with) [Functional Concept]
Meta Mapping (966):
   966   Contact (contact person) [Population Group]
Meta Mapping (966):
   966   Contact (Communication Contact) [Idea or Concept]
Meta Mapping (966):
   966   Contact (Personal Contact) [Activity]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s primary care physician ,
Meta Mapping (916):
   645   /s (per second) [Quantitative Concept]
   923   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (916):
   645   S' (S prime) [Clinical Attribute]
   923   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]

Phrase: Dr.
Meta Mapping (1000):
  1000   DR (Dominican Republic) [Geographic Area]
Meta Mapping (1000):
  1000   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.4: Aslinke ______ , regarding his cardiac medication management . 

Phrase: Aslinke ______ ,

Phrase: regarding

Phrase: his cardiac medication management .
Meta Mapping (901):
   734   cardiac Medication (Cardiac agent) [Pharmacologic Substance]
   827   Management (Administration occupational activities) [Occupational Activity]
Meta Mapping (901):
   734   cardiac Medication (Cardiac agent) [Pharmacologic Substance]
   827   management (Disease Management) [Health Care Activity]
Meta Mapping (901):
   734   cardiac Medication (Cardiac agent) [Pharmacologic Substance]
   827   Management (Management procedure) [Occupational Activity]
Meta Mapping (901):
   734   cardiac Medication (Cardiac agent) [Pharmacologic Substance]
   827   Management (Management Occupations) [Occupation or Discipline]
Meta Mapping (901):
   660   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   901   Medication Management [Health Care Activity]
Meta Mapping (901):
   660   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   901   medication management (Administration of medication) [Health Care Activity]
Meta Mapping (901):
   660   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   901   Medication Management [Health Care Activity]
Meta Mapping (901):
   660   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   901   medication management (Administration of medication) [Health Care Activity]
Processing 00000000.tx.5: We agreed that he should resume his atenolol . 

Phrase: We

Phrase: agreed
Meta Mapping (966):
   966   Agree [Intellectual Product]

Phrase: that

Phrase: he

Phrase: should

Phrase: resume
Meta Mapping (1000):
  1000   Resume (Resume - Remote control command) [Idea or Concept]
Meta Mapping (1000):
  1000   Resume (Curriculum Vitae) [Intellectual Product]
Meta Mapping (1000):
  1000   resume (resume - DataOperation) [Functional Concept]

Phrase: his atenolol .
Meta Mapping (1000):
  1000   ATENOLOL (Atenolol) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.6: He was started on 2.5 mg PO qd . 

Phrase: He

Phrase: was

Phrase: started on 2.5 mg PO qd .
Meta Mapping (706):
   748   Started [Qualitative Concept]
   774   Mg+2 (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   748   PO (Portugal) [Geographic Area]
   748   QD (Daily) [Temporal Concept]
Meta Mapping (706):
   748   Started [Qualitative Concept]
   774   Mg+2 (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   748   PO (Oral) [Spatial Concept]
   748   QD (Daily) [Temporal Concept]
Meta Mapping (706):
   748   Started [Qualitative Concept]
   748   MG (Mongolia) [Geographic Area]
   774   PO-2 [Organic Chemical]
   748   QD (Daily) [Temporal Concept]
Meta Mapping (706):
   748   Started [Qualitative Concept]
   748   mg% (mg/dL) [Quantitative Concept]
   774   PO-2 [Organic Chemical]
   748   QD (Daily) [Temporal Concept]
Meta Mapping (706):
   748   Started [Qualitative Concept]
   748   mg % (Milligram percent) [Quantitative Concept]
   774   PO-2 [Organic Chemical]
   748   QD (Daily) [Temporal Concept]
Meta Mapping (706):
   748   Started [Qualitative Concept]
   748   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   774   PO-2 [Organic Chemical]
   748   QD (Daily) [Temporal Concept]
Processing 00000000.tx.7: In consultation with Infectious Disease , it was agreed to discharge the patient on Augmentin for coverage . 

Phrase: In consultation with Infectious Disease ,
Meta Mapping (745):
   760   Consultation [Health Care Activity]
   640   Infectious Disease (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (745):
   760   Consultation [Health Care Activity]
   640   Infectious Disease (Infectious Disease Pathway) [Functional Concept]

Phrase: it

Phrase: was

Phrase: agreed
Meta Mapping (966):
   966   Agree [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: discharge
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: the patient on Augmentin
Meta Mapping (708):
   770   *^patient (Patients) [Patient or Disabled Group]
   604   Augmentin [Antibiotic,Organic Chemical]
Meta Mapping (708):
   770   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   604   Augmentin [Antibiotic,Organic Chemical]
Meta Mapping (708):
   770   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   604   Augmentin [Antibiotic,Organic Chemical]
Meta Mapping (708):
   770   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   604   Augmentin [Antibiotic,Organic Chemical]

Phrase: for coverage .
Meta Mapping (1000):
  1000   coverage (coverage - financial contract) [Idea or Concept]
Meta Mapping (1000):
  1000   Coverage (Cover - action) [Functional Concept]
Meta Mapping (1000):
  1000   coverage (coverage - HL7PublishingDomain) [Intellectual Product]
Processing 00000000.tx.8: LAKO C SCARVTWI , M.D. 

Phrase: LAKO C SCARVTWI ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.9: 03/13/2002 Signed Initial blood pressure on presentation was recorded at 83/47 . 

Phrase: 03/13/2002 Signed Initial blood pressure on presentation
Meta Mapping (695):
   575   Signed (Signature) [Intellectual Product]
   595   Initial presentation [Functional Concept]
   764   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (695):
   575   Signed (Signature) [Intellectual Product]
   595   Initial presentation [Functional Concept]
   764   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (695):
   575   Signed (Signature) [Intellectual Product]
   595   Initial presentation [Functional Concept]
   764   Blood pressure (Systemic arterial pressure) [Finding]
Meta Mapping (695):
   575   signed (signed - ParticipationSignature) [Intellectual Product]
   595   Initial presentation [Functional Concept]
   764   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (695):
   575   signed (signed - ParticipationSignature) [Intellectual Product]
   595   Initial presentation [Functional Concept]
   764   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (695):
   575   signed (signed - ParticipationSignature) [Intellectual Product]
   595   Initial presentation [Functional Concept]
   764   Blood pressure (Systemic arterial pressure) [Finding]

Phrase: was

Phrase: recorded at 83/47 .
Meta Mapping (737):
   737   Record (Records) [Intellectual Product]
Meta Mapping (737):
   737   record (Record - QueryRequestLimit) [Quantitative Concept]
Processing 00000000.tx.10: On initial exam the patient was noted to have full left sided strength . 

Phrase: On initial exam
Meta Mapping (888):
   694   Initial (Initially) [Temporal Concept]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   Initial (Firstly) [Qualitative Concept]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   Initial (Initial (abbreviation)) [Idea or Concept]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   INITIAL (Initial Usage) [Functional Concept]
   861   Exam (Medical Examination) [Health Care Activity]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: full left sided strength .
Meta Mapping (861):
   645   Full [Qualitative Concept]
   694   left sided (Left) [Spatial Concept]
   812   Strength (Physical Strength) [Quantitative Concept]
Meta Mapping (861):
   645   Full [Qualitative Concept]
   694   left sided (Left) [Spatial Concept]
   812   Strength (STRENGTH (attribute)) [Idea or Concept]
Meta Mapping (861):
   645   Full [Qualitative Concept]
   694   left sided (Left) [Spatial Concept]
   812   Strength (Pharmaceutical Strength) [Quantitative Concept]
Meta Mapping (861):
   645   Full [Qualitative Concept]
   694   Left sided [Spatial Concept]
   812   Strength (Physical Strength) [Quantitative Concept]
Meta Mapping (861):
   645   Full [Qualitative Concept]
   694   Left sided [Spatial Concept]
   812   Strength (STRENGTH (attribute)) [Idea or Concept]
Meta Mapping (861):
   645   Full [Qualitative Concept]
   694   Left sided [Spatial Concept]
   812   Strength (Pharmaceutical Strength) [Quantitative Concept]
Processing 00000000.tx.11: The patient quit tobacco 45 years ago . 

Phrase: The patient quit tobacco 45 years ago .
Meta Mapping (734):
   632   *^patient (Patients) [Patient or Disabled Group]
   632   QUIT [Idea or Concept]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   *^patient (Patients) [Patient or Disabled Group]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   *^patient (Patients) [Patient or Disabled Group]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   *^patient (Patients) [Patient or Disabled Group]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   *^patient (Patients) [Patient or Disabled Group]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   *^patient (Patients) [Patient or Disabled Group]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   QUIT [Idea or Concept]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana) [Plant]
   799   YEARS (year) [Temporal Concept]
Meta Mapping (734):
   632   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   632   Quit (Stop (Instruction Imperative)) [Activity]
   632   Tobacco (Nicotiana tabacum) [Plant]
   799   YEARS (year) [Temporal Concept]
Processing 00000000.tx.12: On motor examination he had a slight right pronator drift with trace weakness in the right proximal upper extremity . 

Phrase: On motor examination
Meta Mapping (694):
   694   Motor (motor movement) [Functional Concept]
Meta Mapping (694):
   694   Motor (Device Motor) [Manufactured Object]

Phrase: he

Phrase: had

Phrase: a slight right pronator drift with trace weakness
Meta Mapping (709):
   578   Slight (Slight (qualifier value)) [Qualitative Concept]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (trace amount) [Quantitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Slight (qualifier value)) [Qualitative Concept]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Minimum) [Qualitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Slight (qualifier value)) [Qualitative Concept]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Sequence Chromatogram) [Functional Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Slight (qualifier value)) [Qualitative Concept]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (trace amount) [Quantitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Slight (qualifier value)) [Qualitative Concept]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Minimum) [Qualitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Slight (qualifier value)) [Qualitative Concept]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Sequence Chromatogram) [Functional Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Mild (qualifier value)) [Qualitative Concept]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (trace amount) [Quantitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Mild (qualifier value)) [Qualitative Concept]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Minimum) [Qualitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Mild (qualifier value)) [Qualitative Concept]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Sequence Chromatogram) [Functional Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Mild (qualifier value)) [Qualitative Concept]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (trace amount) [Quantitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Mild (qualifier value)) [Qualitative Concept]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Minimum) [Qualitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Mild (qualifier value)) [Qualitative Concept]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Sequence Chromatogram) [Functional Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Borg Category-Ratio 10 Perceived Exertion Score 2) [Intellectual Product]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (trace amount) [Quantitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Borg Category-Ratio 10 Perceived Exertion Score 2) [Intellectual Product]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Minimum) [Qualitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Borg Category-Ratio 10 Perceived Exertion Score 2) [Intellectual Product]
   578   RIGHT (Right) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Sequence Chromatogram) [Functional Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Borg Category-Ratio 10 Perceived Exertion Score 2) [Intellectual Product]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (trace amount) [Quantitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Borg Category-Ratio 10 Perceived Exertion Score 2) [Intellectual Product]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Minimum) [Qualitative Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]
Meta Mapping (709):
   578   Slight (Borg Category-Ratio 10 Perceived Exertion Score 2) [Intellectual Product]
   578   Right (Right sided) [Spatial Concept]
   770   Pronator drift [Pathologic Function]
   578   Trace (Sequence Chromatogram) [Functional Concept]
   578   WEAKNESS (Weakness) [Sign or Symptom]

Phrase: in the right proximal upper extremity .
Meta Mapping (916):
   923   Right upper extremity [Body Part, Organ, or Organ Component]
   645   PROXIMAL (Proximal) [Spatial Concept]
Processing 00000000.tx.13: In the right leg he was initially 0 out of 5 in the iliopsoas and distally . 

Phrase: In the right leg
Meta Mapping (1000):
  1000   Right leg (Right lower extremity) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Right leg (Structure of right lower leg) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Right leg (Entire right lower leg) [Body Part, Organ, or Organ Component]

Phrase: he

Phrase: was

Phrase: initially 0 out of 5
Meta Mapping (761):
   760   Initially [Temporal Concept]
   797   0/5 [Quantitative Concept]
   760   Out (Out (direction)) [Spatial Concept]
Meta Mapping (761):
   760   Initially [Temporal Concept]
   797   0/5 [Quantitative Concept]
   760   Out (Removed) [Qualitative Concept]

Phrase: in the iliopsoas
Meta Mapping (1000):
  1000   Iliopsoas (Structure of iliopsoas muscle) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Iliopsoas (Entire iliopsoas muscle) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: distally .
Processing 00000000.tx.14: It was thought by NeuroRadiology that this lesion given its proximity to the petrous portion in bone would not be amenable to stenting . 

Phrase: It

Phrase: was

Phrase: thought by NeuroRadiology
Meta Mapping (746):
   790   Thought (Thinking, function) [Mental Process]
   790   Neuroradiology (Neuroradiologist) [Professional or Occupational Group]

Phrase: that

Phrase: this lesion
Meta Mapping (1000):
  1000   Lesion [Finding]
Meta Mapping (1000):
  1000   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]

Phrase: given
Meta Mapping (1000):
  1000   GIVEN [Conceptual Entity]
Meta Mapping (1000):
  1000   given (Entity Name Part Type - given) [Idea or Concept]
Meta Mapping (1000):
  1000   Given (Give - dosing instruction imperative) [Functional Concept]
Meta Mapping (1000):
  1000   given (Given name) [Intellectual Product]

Phrase: its proximity to the petrous portion
Meta Mapping (672):
   753   Proximity [Spatial Concept]
   586   Petrous [Qualitative Concept]
   586   Portion (Part) [Spatial Concept]

Phrase: in bone
Meta Mapping (1000):
  1000   BONE (Skeletal bone) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   BONE (Bone Tissue) [Tissue]
Meta Mapping (1000):
  1000   Bone, NOS (Entire bone (organ)) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Bone (Entire bony skeleton) [Body System]

Phrase: would

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: be

Phrase: amenable to stenting .
Meta Mapping (746):
   790   Amenable [Qualitative Concept]
   623   stenting (Stent, device) [Medical Device]
Meta Mapping (746):
   790   Amenable [Qualitative Concept]
   623   Stenting [Therapeutic or Preventive Procedure]
Processing 00000000.tx.15: 2. 

Phrase: 2.
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]
Processing 00000000.tx.16: Renal : He was started on Nexium in addition to Zantac for further GI prophylaxis . 

Phrase: Renal
Meta Mapping (1000):
  1000   Renal (Kidney) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: He

Phrase: was

Phrase: started on Nexium
Meta Mapping (746):
   790   Started [Qualitative Concept]
   790   Nexium [Organic Chemical,Pharmacologic Substance]

Phrase: in addition to Zantac for further GI prophylaxis .
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   Gi (GNAI1 wt Allele) [Gene or Genome]
   578   prophylaxis (prevention & control) [Intellectual Product]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   Gi (GNAI1 wt Allele) [Gene or Genome]
   578   Prophylaxis (Prophylactic treatment) [Therapeutic or Preventive Procedure]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   Gi (GNAI1 wt Allele) [Gene or Genome]
   578   prophylaxis (prophylaxis - ActNonObservationIndicationCode) [Therapeutic or Preventive Procedure]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   GI (Digestive System Findings Domain) [Intellectual Product]
   578   prophylaxis (prevention & control) [Intellectual Product]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   GI (Digestive System Findings Domain) [Intellectual Product]
   578   Prophylaxis (Prophylactic treatment) [Therapeutic or Preventive Procedure]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   GI (Digestive System Findings Domain) [Intellectual Product]
   578   prophylaxis (prophylaxis - ActNonObservationIndicationCode) [Therapeutic or Preventive Procedure]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   578   prophylaxis (prevention & control) [Intellectual Product]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   578   Prophylaxis (Prophylactic treatment) [Therapeutic or Preventive Procedure]
Meta Mapping (748):
   633   In addition to [Functional Concept]
   744   Zantac [Organic Chemical,Pharmacologic Substance]
   578   Further [Spatial Concept]
   578   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   578   prophylaxis (prophylaxis - ActNonObservationIndicationCode) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.17: YUGEORG GINMAV , M.D. 

Phrase: YUGEORG GINMAV ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.18: CA SCGACH , M.D. 

Phrase: CA SCGACH ,
Meta Mapping (694):
   694   CA (Hippocampus Proper) [Body Part, Organ, or Organ Component]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.19: STAT

Phrase: STAT
Meta Mapping (1000):
  1000   STAT (Stat (do immediately)) [Temporal Concept]
Processing 00000000.tx.1: <RECORD ID="685"> She has an associated dry cough but no fevers , chills , or leg pain . 

Phrase: <RECORD ID="685"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: >

Phrase: She

Phrase: has

Phrase: an associated dry cough
Meta Mapping (901):
   660   Associated (Associated with) [Qualitative Concept]
   901   COUGH, DRY (Dry cough) [Sign or Symptom]

Phrase: but

Phrase: no fevers ,
Meta Mapping (1000):
  1000 N Fevers (Fever) [Finding]

Phrase: chills ,
Meta Mapping (1000):
  1000 N CHILLS (Chills) [Sign or Symptom]

Phrase: or

Phrase: leg pain .
Meta Mapping (1000):
  1000 N LEG PAIN (Pain in lower limb) [Sign or Symptom]
Processing 00000000.tx.2: She becomes short of breath just by getting up from her chair and can only walk 2-3 steps on a flat surface . 

Phrase: She

Phrase: becomes short of breath just
Meta Mapping (686):
   760   short (Shortened) [Qualitative Concept]
   760   Breath [Body Substance]
Meta Mapping (686):
   760   Short [Quantitative Concept]
   760   Breath [Body Substance]
Meta Mapping (686):
   760   Short (Short Value) [Quantitative Concept]
   760   Breath [Body Substance]

Phrase: by getting up

Phrase: from her chair
Meta Mapping (1000):
  1000   Chair (Chairs) [Manufactured Object]
Meta Mapping (1000):
  1000   Chair (Chairperson) [Professional or Occupational Group]

Phrase: and

Phrase: can

Phrase: only
Meta Mapping (1000):
  1000   Only (Singular) [Quantitative Concept]
Meta Mapping (1000):
  1000   Only (Only - dosing instruction fragment) [Intellectual Product]

Phrase: walk
Meta Mapping (1000):
  1000   Walk (Walking (activity)) [Daily or Recreational Activity]

Phrase: 2-3 steps on a flat surface .
Meta Mapping (710):
   612   2-3 (Phase II/III Trial) [Research Activity]
   748   steps (Step (specific stage)) [Conceptual Entity]
   581   Flat (Flat shape) [Spatial Concept]
   581   SURFACE (Surface) [Spatial Concept]
Meta Mapping (710):
   612   2-3 (Phase II/III Trial) [Research Activity]
   748   steps (Step (specific stage)) [Conceptual Entity]
   581   Flat (Residential flat) [Manufactured Object]
   581   SURFACE (Surface) [Spatial Concept]
Meta Mapping (710):
   612   2-3 (Phase II/III Trial) [Research Activity]
   748   STEPS (Step Unit of Distance) [Quantitative Concept]
   581   Flat (Flat shape) [Spatial Concept]
   581   SURFACE (Surface) [Spatial Concept]
Meta Mapping (710):
   612   2-3 (Phase II/III Trial) [Research Activity]
   748   STEPS (Step Unit of Distance) [Quantitative Concept]
   581   Flat (Residential flat) [Manufactured Object]
   581   SURFACE (Surface) [Spatial Concept]
Processing 00000000.tx.3: She sleeps in a chair up right for the last 2 1/2 years secondary to osteoarthritis . 

Phrase: She

Phrase: sleeps in a chair
Meta Mapping (708):
   770   sleeps (Sleep) [Organism Function]
   770   Chair (Chairs) [Manufactured Object]
Meta Mapping (708):
   770   sleeps (Sleep) [Organism Function]
   770   Chair (Chairperson) [Professional or Occupational Group]

Phrase: up right for the last 2 1/2 years
Meta Mapping (636):
   742   UP (Ukraine) [Geographic Area]
   742   RIGHT (Right) [Spatial Concept]
   575   YEARS (year) [Temporal Concept]
Meta Mapping (636):
   742   UP (Ukraine) [Geographic Area]
   742   Right (Right sided) [Spatial Concept]
   575   YEARS (year) [Temporal Concept]
Meta Mapping (636):
   742   Up [Spatial Concept]
   742   RIGHT (Right) [Spatial Concept]
   575   YEARS (year) [Temporal Concept]
Meta Mapping (636):
   742   Up [Spatial Concept]
   742   Right (Right sided) [Spatial Concept]
   575   YEARS (year) [Temporal Concept]
Meta Mapping (636):
   742   Up (Upward) [Spatial Concept]
   742   RIGHT (Right) [Spatial Concept]
   575   YEARS (year) [Temporal Concept]
Meta Mapping (636):
   742   Up (Upward) [Spatial Concept]
   742   Right (Right sided) [Spatial Concept]
   575   YEARS (year) [Temporal Concept]

Phrase: secondary to osteoarthritis .
Meta Mapping (901):
   882   Secondary to [Temporal Concept]
   623   OSTEOARTHRITIS (Degenerative polyarthritis) [Disease or Syndrome]
Processing 00000000.tx.4: Anicteric . 

Phrase: Anicteric .
Meta Mapping (1000):
  1000   Anicteric [Finding]
Processing 00000000.tx.5: No delayed upstroke . 

Phrase: No delayed upstroke .
Meta Mapping (694):
   694   Delayed (Deferred) [Temporal Concept]
Meta Mapping (694):
   694   Delayed (Delayed Testing) [Qualitative Concept]
Processing 00000000.tx.6: 3 plus pitting edema to the knee bilaterally with areas of darkened erythema which is crusted , indented . 

Phrase: 3 plus pitting edema to the knee bilaterally
Meta Mapping (731):
   578   Plus (In addition to) [Functional Concept]
   793   Pitting oedema +3 (3+ pitting edema) [Finding]
   578   Knee [Body Part, Organ, or Organ Component]
Meta Mapping (731):
   578   Plus (In addition to) [Functional Concept]
   793   Pitting oedema +3 (3+ pitting edema) [Finding]
   578   Knee (Knee joint) [Body Space or Junction]
Meta Mapping (731):
   578   Plus (In addition to) [Functional Concept]
   793   Pitting oedema +3 (3+ pitting edema) [Finding]
   578   Knee (Entire knee region) [Body Location or Region]
Meta Mapping (731):
   578   Plus (In addition to) [Functional Concept]
   793   Pitting oedema +3 (3+ pitting edema) [Finding]
   578   Knee, NOS (Knee region structure) [Body Location or Region]

Phrase: with areas of darkened erythema
Meta Mapping (686):
   760   areas (Area) [Spatial Concept]
   593   ERYTHEMA (Erythema) [Disease or Syndrome]

Phrase: which

Phrase: is

Phrase: crusted
Meta Mapping (1000):
  1000   Crusted [Qualitative Concept]

Phrase: ,

Phrase: indented .
Meta Mapping (1000):
  1000   Indented (Indentation) [Spatial Concept]
Processing 00000000.tx.7: Sodium 134 , potassium 4.0 , chloride 91 , bicarbonate 33 , BUN 21 , creatinine 1.1 , glucose 99 , CK 22 , troponin 0 . 

Phrase: Sodium 134 ,
Meta Mapping (861):
   861   SODIUM (Sodium) [Biologically Active Substance,Element, Ion, or Isotope]
Meta Mapping (861):
   861   Sodium+ (Sodium Cation) [Element, Ion, or Isotope]
Meta Mapping (861):
   861   Sodium (Sodium supplements) [Pharmacologic Substance]
Meta Mapping (861):
   861   SODIUM (Sodium Drug Class) [Pharmacologic Substance]

Phrase: potassium 4.0 ,
Meta Mapping (802):
   827   POTASSIUM (Potassium) [Element, Ion, or Isotope]
   827   0% [Finding]
Meta Mapping (802):
   827   Potassium+ (Potassium measurement) [Laboratory Procedure]
   827   0% [Finding]
Meta Mapping (802):
   827   POTASSIUM (Potassium supplement) [Inorganic Chemical,Pharmacologic Substance]
   827   0% [Finding]
Meta Mapping (802):
   827   Potassium (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
   827   0% [Finding]
Meta Mapping (802):
   827   POTASSIUM (Potassium Drug Class) [Pharmacologic Substance]
   827   0% [Finding]

Phrase: chloride 91 ,
Meta Mapping (861):
   861   Chloride, NOS (Chlorides) [Inorganic Chemical]
Meta Mapping (861):
   861   CHLORIDE (Chloride Ion) [Element, Ion, or Isotope]

Phrase: bicarbonate 33 ,
Meta Mapping (861):
   861   Bicarbonate (Bicarbonates) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (861):
   861   Bicarbonate (bicarbonate ion) [Inorganic Chemical]
Meta Mapping (861):
   861   BICARBONATE (Bicarbonate preparation) [Organic Chemical,Pharmacologic Substance]

Phrase: BUN 21 ,

Phrase: creatinine 1.1 ,
Meta Mapping (827):
   827   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (827):
   827   Creatinine (Creatinine finding) [Finding]

Phrase: glucose 99 ,
Meta Mapping (861):
   861   GLUCOSE (Glucose) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: CK 22 ,
Meta Mapping (861):
   861   CK (Cocos (Keeling) Islands) [Geographic Area]
Meta Mapping (861):
   861   CK (Creatine Kinase) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: troponin 0 .
Meta Mapping (888):
   861   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   0% [Finding]
Processing 00000000.tx.8: INR 1.1 , PTT 30.3.Chest x-ray shows cardiomegaly . 

Phrase: INR 1.1 ,
Meta Mapping (827):
   827   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (827):
   827   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]

Phrase: PTT 30.3.Chest x-ray
Meta Mapping (804):
   632   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
   632   30% [Finding]
   861   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (804):
   632   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
   632   30% [Finding]
   861   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: shows
Meta Mapping (1000):
  1000   Show [Animal]

Phrase: cardiomegaly .
Meta Mapping (1000):
  1000   CARDIOMEGALY (Cardiomegaly) [Finding]
Processing 00000000.tx.9: Electrocardiogram shows normal sinus rhythm at 50 . 

Phrase: Electrocardiogram
Meta Mapping (1000):
  1000   Electrocardiogram [Finding]
Meta Mapping (1000):
  1000   Electro-Cardiogram [Spatial Concept]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]

Phrase: shows
Meta Mapping (1000):
  1000   Show [Animal]

Phrase: normal sinus rhythm at 50 .
Meta Mapping (816):
   862   NORMAL SINUS RHYTHM (Normal sinus rhythm) [Finding]
   593   50% [Finding]
Meta Mapping (816):
   862   NORMAL SINUS RHYTHM (Normal sinus rhythm) [Finding]
   593   <50 [Finding]
Processing 00000000.tx.10: She has severe sleep apnea and falls asleep midsentence . 

Phrase: She

Phrase: has

Phrase: severe sleep apnea
Meta Mapping (901):
   660   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   901   Sleep apnoea (Sleep Apnea Syndromes) [Disease or Syndrome]
Meta Mapping (901):
   660   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   901   SLEEP APNEA (SLEEP APNEA (device)) [Medical Device]
Meta Mapping (901):
   660   Severe (Severe Extremity Pain) [Intellectual Product]
   901   Sleep apnoea (Sleep Apnea Syndromes) [Disease or Syndrome]
Meta Mapping (901):
   660   Severe (Severe Extremity Pain) [Intellectual Product]
   901   SLEEP APNEA (SLEEP APNEA (device)) [Medical Device]
Meta Mapping (901):
   660   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   901   Sleep apnoea (Sleep Apnea Syndromes) [Disease or Syndrome]
Meta Mapping (901):
   660   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   901   SLEEP APNEA (SLEEP APNEA (device)) [Medical Device]

Phrase: and

Phrase: falls
Meta Mapping (1000):
  1000   Falls (Accidental Falls) [Injury or Poisoning]
Meta Mapping (1000):
  1000   FALLS (Falls) [Finding]
Meta Mapping (1000):
  1000   Fall (Autumn) [Temporal Concept]

Phrase: asleep midsentence .
Meta Mapping (694):
   694   Asleep [Finding]
Processing 00000000.tx.11: D-dimer in the emergency room was greater than 1000 and a right common femoral clot was seen . 

Phrase: D-dimer in the emergency room
Meta Mapping (746):
   790   D-dimer (Fibrin fragment D) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   623   EMERGENCY ROOM (Accident and Emergency department) [Health Care Related Organization]

Phrase: was

Phrase: greater than 1000
Meta Mapping (882):
   882   Greater Than [Quantitative Concept]

Phrase: and

Phrase: a right common femoral clot
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   Common (Common (qualifier value)) [Quantitative Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   CLOT (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   Common (Common (qualifier value)) [Quantitative Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   Clot (Blood Clot) [Body Substance]
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   Common (shared attribute) [Functional Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   CLOT (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   Common (shared attribute) [Functional Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   Clot (Blood Clot) [Body Substance]
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   common (Common Specifications in HL7 V3 Publishing) [Intellectual Product]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   CLOT (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   common (Common Specifications in HL7 V3 Publishing) [Intellectual Product]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   Clot (Blood Clot) [Body Substance]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   Common (Common (qualifier value)) [Quantitative Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   CLOT (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   Common (Common (qualifier value)) [Quantitative Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   Clot (Blood Clot) [Body Substance]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   Common (shared attribute) [Functional Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   CLOT (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   Common (shared attribute) [Functional Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   Clot (Blood Clot) [Body Substance]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   common (Common Specifications in HL7 V3 Publishing) [Intellectual Product]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   CLOT (Clotrimazole) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   common (Common Specifications in HL7 V3 Publishing) [Intellectual Product]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   812   Clot (Blood Clot) [Body Substance]

Phrase: was

Phrase: seen .
Meta Mapping (1000):
  1000   Seen (seen) [Qualitative Concept]
Processing 00000000.tx.12: It was a poor study . 

Phrase: It

Phrase: was

Phrase: a poor study .
Meta Mapping (888):
   694   Poor (Poverty) [Group Attribute]
   861   Study (Room of building - Study) [Manufactured Object]
Meta Mapping (888):
   694   Poor (Poverty) [Group Attribute]
   861   Study [Research Activity]
Meta Mapping (888):
   694   Poor (Poor - grade value) [Qualitative Concept]
   861   Study (Room of building - Study) [Manufactured Object]
Meta Mapping (888):
   694   Poor (Poor - grade value) [Qualitative Concept]
   861   Study [Research Activity]
Meta Mapping (888):
   694   Poor (Poor - qualifier) [Qualitative Concept]
   861   Study (Room of building - Study) [Manufactured Object]
Meta Mapping (888):
   694   Poor (Poor - qualifier) [Qualitative Concept]
   861   Study [Research Activity]
Processing 00000000.tx.13: Discharge INR 1.8 . 

Phrase: Discharge INR 1.8 .
Meta Mapping (750):
   812   Discharge (Body Fluid Discharge) [Body Substance]
   812   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (750):
   812   Discharge (Body Fluid Discharge) [Body Substance]
   812   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]
Meta Mapping (750):
   812   Discharge (Patient Discharge) [Health Care Activity]
   812   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (750):
   812   Discharge (Patient Discharge) [Health Care Activity]
   812   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]
Meta Mapping (750):
   812   Discharge (Discharge, body substance) [Body Substance]
   812   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (750):
   812   Discharge (Discharge, body substance) [Body Substance]
   812   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.14: DISCHARGE INSTRUCTIONS : Low cholesterol . 

Phrase: DISCHARGE INSTRUCTIONS
Meta Mapping (1000):
  1000   Discharge instructions (hospital discharge instructions (treatment)) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge instructions (Discharge instructions:Find:Pt:{Setting}:Doc:{Provider}) [Clinical Attribute]

Phrase: :

Phrase: Low cholesterol .
Meta Mapping (1000):
  1000   Low cholesterol [Finding]
Processing 00000000.tx.15: Needs anticoagulation for 6 months for right common femoral artery deep venous thrombosis . 

Phrase: Needs
Meta Mapping (1000):
  1000   Needs [Qualitative Concept]
Meta Mapping (1000):
  1000   needs (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: anticoagulation for 6 months
Meta Mapping (708):
   770   anticoagulation (Anticoagulation Therapy) [Therapeutic or Preventive Procedure]
   604   MONTHS (month) [Temporal Concept]
Meta Mapping (708):
   770   Anticoagulation (Negative Regulation of Coagulation) [Physiologic Function]
   604   MONTHS (month) [Temporal Concept]
Meta Mapping (708):
   770   ANTICOAGULATION (ANTICOAGULATION (finding)) [Finding]
   604   MONTHS (month) [Temporal Concept]
Meta Mapping (708):
   770   Anticoagulation (Decreased Coagulation Activity [PE]) [Physiologic Function]
   604   MONTHS (month) [Temporal Concept]

Phrase: for right common femoral artery deep venous thrombosis .
Meta Mapping (863):
   685   Right femoral artery (Structure of right femoral artery) [Body Part, Organ, or Organ Component]
   629   Common (Common (qualifier value)) [Quantitative Concept]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (863):
   685   Right femoral artery (Structure of right femoral artery) [Body Part, Organ, or Organ Component]
   629   Common (shared attribute) [Functional Concept]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (863):
   685   Right femoral artery (Structure of right femoral artery) [Body Part, Organ, or Organ Component]
   629   common (Common Specifications in HL7 V3 Publishing) [Intellectual Product]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (863):
   685   Right femoral artery (Entire right femoral artery) [Body Part, Organ, or Organ Component]
   629   Common (Common (qualifier value)) [Quantitative Concept]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (863):
   685   Right femoral artery (Entire right femoral artery) [Body Part, Organ, or Organ Component]
   629   Common (shared attribute) [Functional Concept]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (863):
   685   Right femoral artery (Entire right femoral artery) [Body Part, Organ, or Organ Component]
   629   common (Common Specifications in HL7 V3 Publishing) [Intellectual Product]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (863):
   629   RIGHT (Right) [Spatial Concept]
   895   Common femoral artery thrombosis [Disease or Syndrome]
   795   DEEP (Depth) [Spatial Concept]
   795   Venous (Veins) [Body Part, Organ, or Organ Component]
Meta Mapping (863):
   629   RIGHT (Right) [Spatial Concept]
   895   Common femoral artery thrombosis [Disease or Syndrome]
   795   DEEP (Depth) [Spatial Concept]
   795   Venous [Spatial Concept]
Meta Mapping (863):
   629   RIGHT (Right) [Spatial Concept]
   679   COMMON FEMORAL ARTERY (Common femoral artery) [Body Part, Organ, or Organ Component]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (863):
   629   Right (Right sided) [Spatial Concept]
   895   Common femoral artery thrombosis [Disease or Syndrome]
   795   DEEP (Depth) [Spatial Concept]
   795   Venous (Veins) [Body Part, Organ, or Organ Component]
Meta Mapping (863):
   629   Right (Right sided) [Spatial Concept]
   895   Common femoral artery thrombosis [Disease or Syndrome]
   795   DEEP (Depth) [Spatial Concept]
   795   Venous [Spatial Concept]
Meta Mapping (863):
   629   Right (Right sided) [Spatial Concept]
   679   COMMON FEMORAL ARTERY (Common femoral artery) [Body Part, Organ, or Organ Component]
   845   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]
Processing 00000000.tx.16: Attending : </RECORD> 7/22/23 Plavix 75 mg PO QD . 

Phrase: Attending
Meta Mapping (1000):
  1000   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   attending (Attending (action)) [Functional Concept]

Phrase: :

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 7/22/23 Plavix 75 mg PO QD .
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Portugal) [Geographic Area]
   793   QD (Daily) [Temporal Concept]
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Oral) [Spatial Concept]
   793   QD (Daily) [Temporal Concept]
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   793   QD (Daily) [Temporal Concept]
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   793   QD (Daily) [Temporal Concept]
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   793   QD (Daily) [Temporal Concept]
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   793   QD (Daily) [Temporal Concept]
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Portugal) [Geographic Area]
   793   QD (Daily) [Temporal Concept]
Meta Mapping (705):
   626   23 [Quantitative Concept]
   626   Plavix [Organic Chemical,Pharmacologic Substance]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Oral) [Spatial Concept]
   793   QD (Daily) [Temporal Concept]
Processing 00000000.tx.17: NPH Insulin 15 units q. morning and q. afternoon before dinner . 

Phrase: NPH Insulin 15 units q. morning
Meta Mapping (768):
   660   Insulin, NPH (insulin, isophane) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   632   UNITS (Unit) [Quantitative Concept]
   799   Morning [Temporal Concept]
Meta Mapping (768):
   660   Insulin, NPH (insulin, isophane) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   632   Units (Unit of Measure) [Quantitative Concept]
   799   Morning [Temporal Concept]
Meta Mapping (768):
   660   Insulin, NPH (insulin, isophane) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   632   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   799   Morning [Temporal Concept]

Phrase: and

Phrase: q. afternoon before dinner .
Meta Mapping (708):
   770   Afternoon [Temporal Concept]
   604   Dinner (Supper) [Daily or Recreational Activity]
Meta Mapping (708):
   770   Afternoon [Temporal Concept]
   604   Dinner [Daily or Recreational Activity]
Processing 00000000.tx.18: O2 hemostasis of 97% , neurological awake , alert and oriented x three but poor short term memory and mild confusion . 

Phrase: O2 hemostasis of 97% ,
Meta Mapping (733):
   604   O2 (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]
   770   Hemostasis (Hemostatic function) [Organ or Tissue Function]
   604   97 [Intellectual Product]
Meta Mapping (733):
   604   O2 (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]
   770   Hemostasis (Hemostatic function) [Organ or Tissue Function]
   604   >97 [Quantitative Concept]
Meta Mapping (733):
   604   O2 (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]
   770   Hemostasis (Hemostasis procedure) [Therapeutic or Preventive Procedure]
   604   97 [Intellectual Product]
Meta Mapping (733):
   604   O2 (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]
   770   Hemostasis (Hemostasis procedure) [Therapeutic or Preventive Procedure]
   604   >97 [Quantitative Concept]

Phrase: neurological awake , alert
Meta Mapping (851):
   660   NEUROLOGICAL (Neurologic (qualifier value)) [Qualitative Concept]
   660   Awake [Finding]
   827   ALERT (Consciousness clear) [Finding]
Meta Mapping (851):
   660   NEUROLOGICAL (Neurologic (qualifier value)) [Qualitative Concept]
   660   Awake [Finding]
   827   Alert [Functional Concept]
Meta Mapping (851):
   660   NEUROLOGICAL (Neurologic (qualifier value)) [Qualitative Concept]
   660   Awake [Finding]
   827   Alert (Alert:Type:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (851):
   660   Neurological (Neurological:-:Point in time:^Patient:-) [Clinical Attribute]
   660   Awake [Finding]
   827   ALERT (Consciousness clear) [Finding]
Meta Mapping (851):
   660   Neurological (Neurological:-:Point in time:^Patient:-) [Clinical Attribute]
   660   Awake [Finding]
   827   Alert [Functional Concept]
Meta Mapping (851):
   660   Neurological (Neurological:-:Point in time:^Patient:-) [Clinical Attribute]
   660   Awake [Finding]
   827   Alert (Alert:Type:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: and

Phrase: oriented x three
Meta Mapping (802):
   827   Oriented (Orientation (spatial)) [Spatial Concept]
   827   Three [Quantitative Concept]
Meta Mapping (802):
   827   Oriented (Oriented to place) [Finding]
   827   Three [Quantitative Concept]

Phrase: but

Phrase: poor short term memory
Meta Mapping (1000):
  1000   Poor short-term memory [Mental or Behavioral Dysfunction]

Phrase: and

Phrase: mild confusion .
Meta Mapping (888):
   694   MILD (Mild (qualifier value)) [Qualitative Concept]
   861   CONFUSION (Confusion) [Mental or Behavioral Dysfunction]
Meta Mapping (888):
   694   MILD (Mild (qualifier value)) [Qualitative Concept]
   861   Confusion (Clouded consciousness) [Sign or Symptom]
Meta Mapping (888):
   694   MILD (Mild (qualifier value)) [Qualitative Concept]
   861   Confusion (Confusion Adverse Event) [Finding]
Processing 00000000.tx.19: MRI was recommended , and on 11/12 she underwent an MRI which revealed an acute infarct in the left posterior corona radiata and narrowing at the P2 segment of the right PCA . 

Phrase: MRI
Meta Mapping (1000):
  1000   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]

Phrase: was

Phrase: recommended
Meta Mapping (1000):
  1000   Recommended (Recommendation) [Idea or Concept]

Phrase: ,

Phrase: and on 11/12
Meta Mapping (833):
   833   11-12 [Finding]

Phrase: she

Phrase: underwent

Phrase: an MRI
Meta Mapping (1000):
  1000   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]

Phrase: which

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: an acute infarct in the left posterior corona radiata
Meta Mapping (712):
   764   Acute infarct [Pathologic Function]
   598   Left posterior [Spatial Concept]
   598   Corona radiata [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: narrowing at the P2 segment of the right PCA .
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   P2 (Blood group antigen P2) [Immunologic Factor]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   P2 (Blood group antigen P2) [Immunologic Factor]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   P2 (RPLP2 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   P2 (RPLP2 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   p2 (EXOSC10 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   p2 (EXOSC10 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   P2 (Bone structure of middle phalanx) [Body Part, Organ, or Organ Component]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing (Narrowed structure) [Spatial Concept]
   575   P2 (Bone structure of middle phalanx) [Body Part, Organ, or Organ Component]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   P2 (Blood group antigen P2) [Immunologic Factor]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   P2 (Blood group antigen P2) [Immunologic Factor]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   P2 (RPLP2 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   P2 (RPLP2 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   p2 (EXOSC10 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   p2 (EXOSC10 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   P2 (Bone structure of middle phalanx) [Body Part, Organ, or Organ Component]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   narrowing (Narrow) [Quantitative Concept]
   575   P2 (Bone structure of middle phalanx) [Body Part, Organ, or Organ Component]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   P2 (Blood group antigen P2) [Immunologic Factor]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   P2 (Blood group antigen P2) [Immunologic Factor]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   P2 (RPLP2 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   P2 (RPLP2 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   p2 (EXOSC10 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   p2 (EXOSC10 gene) [Gene or Genome]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   P2 (Bone structure of middle phalanx) [Body Part, Organ, or Organ Component]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   RIGHT (Right) [Spatial Concept]
Meta Mapping (637):
   742   Narrowing [Anatomical Abnormality]
   575   P2 (Bone structure of middle phalanx) [Body Part, Organ, or Organ Component]
   575   SEGMENT (Anatomical segmentation) [Spatial Concept]
   575   Right (Right sided) [Spatial Concept]
Processing 00000000.tx.20: Throughout the hospitalization she remained fatigued and lethargic , resisting mobilization . 

Phrase: Throughout the hospitalization
Meta Mapping (1000):
  1000   hospitalisation (Hospitalization) [Health Care Activity]

Phrase: she

Phrase: remained

Phrase: fatigued
Meta Mapping (1000):
  1000   Fatigued (Fatigue) [Sign or Symptom]

Phrase: and

Phrase: lethargic ,
Meta Mapping (1000):
  1000   Lethargic (Lethargy) [Sign or Symptom]

Phrase: resisting

Phrase: mobilization .
Meta Mapping (1000):
  1000   Mobilization (Therapeutic Mobilization) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   mobilization [Functional Concept]
Processing 00000000.tx.21: She underwent abdominal CT which was negative for retroperitoneal bleed . 

Phrase: She

Phrase: underwent

Phrase: abdominal CT
Meta Mapping (888):
   694   Abdominal (Abdomen) [Body Location or Region]
   861   CT (Central African Republic) [Geographic Area]
Meta Mapping (888):
   694   Abdominal (Abdomen) [Body Location or Region]
   861   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (888):
   694   Abdominal (Abdomen) [Body Location or Region]
   861   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (888):
   694   Abdominal (Abdomen) [Body Location or Region]
   861   CT (Computed Tomography Study File) [Intellectual Product]

Phrase: which

Phrase: was

Phrase: negative for retroperitoneal bleed .
Meta Mapping (783):
   770   Negative [Qualitative Concept]
   666 N retroperitoneal bleed (Retroperitoneal hemorrhage) [Finding]
Meta Mapping (783):
   770   NEGATIVE (Negative Finding) [Finding]
   666 N retroperitoneal bleed (Retroperitoneal hemorrhage) [Finding]
Meta Mapping (783):
   770   Negative (Negative Number) [Conceptual Entity]
   666 N retroperitoneal bleed (Retroperitoneal hemorrhage) [Finding]
Meta Mapping (783):
   770   Negative (Negative Charge) [Qualitative Concept]
   666 N retroperitoneal bleed (Retroperitoneal hemorrhage) [Finding]
Meta Mapping (783):
   770   Negative (Negative - answer) [Qualitative Concept]
   666 N retroperitoneal bleed (Retroperitoneal hemorrhage) [Finding]
Processing 00000000.tx.22: TR : <TEXT> 938547318 NEU CONTINGENT UPON Not Applicable SUMMARY : DISCHARGE MEDICATIONS : TYLENOL ( ACETAMINOPHEN ) 650 MG PO Q4H PRN headache COLACE ( DOCUSATE SODIUM ) 100 MG PO BID FOLATE ( FOLIC ACID ) 1 MG PO QD THIAMINE HCL 100 MG PO QD MVI THERAPEUTIC ( THERAPEUTIC MULTIVITAMINS ) 1 TAB PO QD ZYPREXA ( OLANZAPINE ) 5 MG PO QHS Starting Today ( 07/04 ) 5 No Restrictions Follow up with Dr. 

Phrase: TR
Meta Mapping (1000):
  1000   TR (TXNRD1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (TXNRD2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (Tumor Results Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   TR (Thioredoxin Reductase 1, Cytoplasmic) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 938547318 NEU CONTINGENT UPON
Meta Mapping (722):
   604   NEU (ERBB2 protein, human) [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   Contingent (Conditional) [Qualitative Concept]

Phrase: Not Applicable SUMMARY
Meta Mapping (901):
   734   NOT APPLICABLE (Not Applicable) [Qualitative Concept]
   827   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (901):
   734   NOT APPLICABLE (Not Applicable) [Qualitative Concept]
   827   Summary (Summary (document)) [Intellectual Product]
Meta Mapping (901):
   734   Not Applicable (Package Type Not Applicable) [Functional Concept]
   827   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (901):
   734   Not Applicable (Package Type Not Applicable) [Functional Concept]
   827   Summary (Summary (document)) [Intellectual Product]

Phrase: :

Phrase: DISCHARGE MEDICATIONS
Meta Mapping (1000):
  1000 N Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: TYLENOL
Meta Mapping (1000):
  1000   Tylenol [Organic Chemical,Pharmacologic Substance]

Phrase: ( ACETAMINOPHEN
Meta Mapping (1000):
  1000   ACETAMINOPHEN (Acetaminophen) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Acetaminophen (Acetaminophen [EPC]) [Pharmacologic Substance]

Phrase: )

Phrase: 650 MG PO Q4H PRN headache COLACE
Meta Mapping (724):
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]
Meta Mapping (724):
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]
Meta Mapping (724):
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]
Meta Mapping (724):
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]
Meta Mapping (724):
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]
Meta Mapping (724):
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]
Meta Mapping (724):
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]
Meta Mapping (724):
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   Q4H (Every four hours) [Temporal Concept]
   629   HEADACHE (Headache) [Sign or Symptom]
   795   Colace [Organic Chemical,Pharmacologic Substance]

Phrase: ( DOCUSATE SODIUM
Meta Mapping (1000):
  1000   DOCUSATE SODIUM (Docusate Sodium) [Organic Chemical,Pharmacologic Substance]

Phrase: )

Phrase: 100 MG PO BID FOLATE
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   MG (Mongolia) [Geographic Area]
   637   PO (Portugal) [Geographic Area]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   MG (Mongolia) [Geographic Area]
   637   PO (Oral) [Spatial Concept]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   mg% (mg/dL) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   mg% (mg/dL) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   mg % (Milligram percent) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   mg % (Milligram percent) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   637   PO (Portugal) [Geographic Area]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (766):
   637   100% [Quantitative Concept]
   637   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   637   PO (Oral) [Spatial Concept]
   804   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ( FOLIC ACID
Meta Mapping (1000):
  1000   FOLIC ACID (Folic Acid) [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: )

Phrase: 1 MG PO QD THIAMINE HCL 100 MG PO QD MVI
Meta Mapping (570):
   622   1+ (1+ Score) [Quantitative Concept]
   683   mg/mg [Quantitative Concept]
   622   PO (Portugal) [Geographic Area]
   622   QD (Daily) [Temporal Concept]
   634   thiamine hcl (Thiamine hydrochloride) [Organic Chemical,Pharmacologic Substance,Vitamin]
   622   100% [Quantitative Concept]
Meta Mapping (570):
   622   1+ (1+ Score) [Quantitative Concept]
   683   mg/mg [Quantitative Concept]
   622   PO (Oral) [Spatial Concept]
   622   QD (Daily) [Temporal Concept]
   634   thiamine hcl (Thiamine hydrochloride) [Organic Chemical,Pharmacologic Substance,Vitamin]
   622   100% [Quantitative Concept]
Meta Mapping (570):
   622   1+ (1+ Score, WHO) [Classification]
   683   mg/mg [Quantitative Concept]
   622   PO (Portugal) [Geographic Area]
   622   QD (Daily) [Temporal Concept]
   634   thiamine hcl (Thiamine hydrochloride) [Organic Chemical,Pharmacologic Substance,Vitamin]
   622   100% [Quantitative Concept]
Meta Mapping (570):
   622   1+ (1+ Score, WHO) [Classification]
   683   mg/mg [Quantitative Concept]
   622   PO (Oral) [Spatial Concept]
   622   QD (Daily) [Temporal Concept]
   634   thiamine hcl (Thiamine hydrochloride) [Organic Chemical,Pharmacologic Substance,Vitamin]
   622   100% [Quantitative Concept]
Meta Mapping (570):
   622   1+ [Finding]
   683   mg/mg [Quantitative Concept]
   622   PO (Portugal) [Geographic Area]
   622   QD (Daily) [Temporal Concept]
   634   thiamine hcl (Thiamine hydrochloride) [Organic Chemical,Pharmacologic Substance,Vitamin]
   622   100% [Quantitative Concept]
Meta Mapping (570):
   622   1+ [Finding]
   683   mg/mg [Quantitative Concept]
   622   PO (Oral) [Spatial Concept]
   622   QD (Daily) [Temporal Concept]
   634   thiamine hcl (Thiamine hydrochloride) [Organic Chemical,Pharmacologic Substance,Vitamin]
   622   100% [Quantitative Concept]

Phrase: THERAPEUTIC
Meta Mapping (1000):
  1000   Therapeutic (Therapeutic procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Therapeutic [Functional Concept]

Phrase: ( THERAPEUTIC MULTIVITAMINS
Meta Mapping (1000):
  1000   therapeutic multivitamins [Pharmacologic Substance,Vitamin]

Phrase: )

Phrase: 1 TAB PO QD ZYPREXA
Meta Mapping (822):
   637   1+ (1+ Score) [Quantitative Concept]
   637   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   637   PO (Portugal) [Geographic Area]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ (1+ Score) [Quantitative Concept]
   637   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   637   PO (Oral) [Spatial Concept]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ (1+ Score) [Quantitative Concept]
   637   Tab (Tablet Dosing Unit) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ (1+ Score) [Quantitative Concept]
   637   Tab (Tablet Dosing Unit) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ (1+ Score, WHO) [Classification]
   637   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   637   PO (Portugal) [Geographic Area]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ (1+ Score, WHO) [Classification]
   637   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   637   PO (Oral) [Spatial Concept]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ (1+ Score, WHO) [Classification]
   637   Tab (Tablet Dosing Unit) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ (1+ Score, WHO) [Classification]
   637   Tab (Tablet Dosing Unit) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ [Finding]
   637   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   637   PO (Portugal) [Geographic Area]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ [Finding]
   637   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   637   PO (Oral) [Spatial Concept]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ [Finding]
   637   Tab (Tablet Dosing Unit) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   1+ [Finding]
   637   Tab (Tablet Dosing Unit) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   637   QD (Daily) [Temporal Concept]
   804   ZyPREXA (Zyprexa) [Organic Chemical,Pharmacologic Substance]

Phrase: ( OLANZAPINE
Meta Mapping (1000):
  1000   OLANZAPINE (olanzapine) [Organic Chemical,Pharmacologic Substance]

Phrase: )

Phrase: 5 MG PO QHS Starting Today
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   >5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (809):
   632   +5 [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   qHS (Once a day, at bedtime) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]

Phrase: ( 07/04

Phrase: )

Phrase: 5
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]

Phrase: No Restrictions
Meta Mapping (966):
   966   Restriction (Restricted) [Functional Concept]

Phrase: Follow up with Dr.
Meta Mapping (783):
   833 N Follow-up (Follow-up status) [Finding]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833 N Follow-up (Follow-up status) [Finding]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833 N Follow-up (Follow-up status) [Finding]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833 N Follow-up (Follow-up status) [Finding]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833 N Follow-up (Follow-up status) [Finding]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.23: Briz within 4 weeks , No Known Allergies OTHER TREATMENTS / PROCEDURES ( NOT IN O.R. ) ADDITIONAL COMMENTS : DISCHARGE CONDITION : </RECORD> BH 3515997 909544 PANDEPROB , ORINNEREEN HISTORY OF PRESENT ILLNESS : There was a reported examination of her peritoneal fluid when fluid was being drawn for culture . 

Phrase: Briz within 4 weeks ,
Meta Mapping (604):
   604   WEEKS (week) [Temporal Concept]

Phrase: No Known Allergies
Meta Mapping (983):
   983 N Known allergy [Finding]

Phrase: OTHER TREATMENTS / PROCEDURES
Meta Mapping (1000):
  1000   treatments procedures (treatments and procedures) [Therapeutic or Preventive Procedure]

Phrase: (

Phrase: NOT IN O.R.
Meta Mapping (708):
   770   Not (Negation) [Functional Concept]
   770   R- (Right) [Spatial Concept]
Meta Mapping (708):
   770   Not (Negation) [Functional Concept]
   770   R. (Rabbi) [Professional or Occupational Group]
Meta Mapping (708):
   770   Not (Negation) [Functional Concept]
   770   R' (R prime) [Clinical Attribute]

Phrase: )

Phrase: ADDITIONAL COMMENTS
Meta Mapping (1000):
  1000 N Additional comments [Finding]

Phrase: :

Phrase: DISCHARGE CONDITION
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861 N condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861 N condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861 N condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]

Phrase: :

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > BH 3515997 909544 PANDEPROB ,
Meta Mapping (645):
   645   BH (Bahrain) [Geographic Area]
Meta Mapping (645):
   645   BH (Belize) [Geographic Area]
Meta Mapping (645):
   645   BH (BLMH gene) [Gene or Genome]
Meta Mapping (645):
   645   BH (Behavioral Domain) [Intellectual Product]

Phrase: ORINNEREEN HISTORY OF PRESENT ILLNESS
Meta Mapping (926):
   926   HISTORY OF PRESENT ILLNESS (History of present illness) [Organism Attribute]
Meta Mapping (926):
   926   History of present illness (History of present illness:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]

Phrase: :

Phrase: There

Phrase: was

Phrase: a reported examination of her peritoneal fluid
Meta Mapping (752):
   581   Reported (Report (document)) [Intellectual Product]
   804   Peritoneal Fluid examination (Ascitic fluid examination) [Laboratory Procedure]
Meta Mapping (752):
   581   Reported (Reporting) [Health Care Activity]
   804   Peritoneal Fluid examination (Ascitic fluid examination) [Laboratory Procedure]

Phrase: when

Phrase: fluid
Meta Mapping (1000):
  1000   FLUID (Body Fluids) [Body Substance]
Meta Mapping (1000):
  1000   fluid (Liquid substance) [Substance]
Meta Mapping (1000):
  1000   Fluid (Fluid behavior) [Qualitative Concept]
Meta Mapping (1000):
  1000   Fluid (fluid - substance) [Substance]

Phrase: was

Phrase: being

Phrase: drawn for culture .
Meta Mapping (730):
   756   Draw (Drawings (art)) [Intellectual Product]
   790   Culture (Anthropological Culture) [Idea or Concept]
Meta Mapping (730):
   756   Draw (Drawings (art)) [Intellectual Product]
   790   culture (Cultural aspects) [Functional Concept]
Meta Mapping (730):
   756   Draw (Drawings (art)) [Intellectual Product]
   790   Culture (Laboratory culture) [Laboratory Procedure]
Meta Mapping (730):
   756   Draw (Drawings (art)) [Intellectual Product]
   790   Culture (Microbial culture (procedure)) [Laboratory Procedure]
Processing 00000000.tx.24: A catheter was subsequently placed for treatment of __________ for three days of ceftazidime . 

Phrase: A catheter
Meta Mapping (1000):
  1000   CATHETER (catheter device) [Medical Device]
Meta Mapping (1000):
  1000   Catheter (Catheter Device Component) [Medical Device]

Phrase: was

Phrase: subsequently

Phrase: placed for treatment of __________
Meta Mapping (691):
   737   Place [Spatial Concept]
   770   treatment (therapeutic aspects) [Functional Concept]
Meta Mapping (691):
   737   Place [Spatial Concept]
   770   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (691):
   737   Place [Spatial Concept]
   770   Treatment (Treating) [Functional Concept]
Meta Mapping (691):
   737   Place [Spatial Concept]
   770   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (691):
   737   Place [Spatial Concept]
   770   Treatment (Biomaterial Treatment) [Conceptual Entity]
Meta Mapping (691):
   737   Place [Spatial Concept]
   770   TREATMENT (Treatment Epoch) [Research Activity]
Meta Mapping (691):
   737   Place [Spatial Concept]
   770   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
Meta Mapping (691):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   treatment (therapeutic aspects) [Functional Concept]
Meta Mapping (691):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (691):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Treatment (Treating) [Functional Concept]
Meta Mapping (691):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (691):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   Treatment (Biomaterial Treatment) [Conceptual Entity]
Meta Mapping (691):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   TREATMENT (Treatment Epoch) [Research Activity]
Meta Mapping (691):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   770   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
Meta Mapping (691):
   737   Place (put - instruction imperative) [Activity]
   770   treatment (therapeutic aspects) [Functional Concept]
Meta Mapping (691):
   737   Place (put - instruction imperative) [Activity]
   770   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (691):
   737   Place (put - instruction imperative) [Activity]
   770   Treatment (Treating) [Functional Concept]
Meta Mapping (691):
   737   Place (put - instruction imperative) [Activity]
   770   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (691):
   737   Place (put - instruction imperative) [Activity]
   770   Treatment (Biomaterial Treatment) [Conceptual Entity]
Meta Mapping (691):
   737   Place (put - instruction imperative) [Activity]
   770   TREATMENT (Treatment Epoch) [Research Activity]
Meta Mapping (691):
   737   Place (put - instruction imperative) [Activity]
   770   treatment (treatment - ActInformationManagementReason) [Health Care Activity]

Phrase: for three days of ceftazidime .
Meta Mapping (696):
   593   Three [Quantitative Concept]
   760   DAYS (day) [Temporal Concept]
   593   CEFTAZIDIME (Ceftazidime) [Antibiotic,Organic Chemical]
Processing 00000000.tx.25: Alumbar puncture of on 07/31/2002 was significant for an opening pressure reported as 12 cm of water . 

Phrase: Alumbar puncture of
Meta Mapping (790):
   790   Puncture (Puncture wound) [Injury or Poisoning]
Meta Mapping (790):
   790   Puncture (Puncture procedure) [Health Care Activity]
Meta Mapping (790):
   790   Puncture (Medical Device Material Puncture) [Phenomenon or Process]

Phrase: on 07/31/2002
Meta Mapping (827):
   827   31 [Intellectual Product]

Phrase: was

Phrase: significant for an opening pressure
Meta Mapping (696):
   760   significant (Statistical Significance) [Quantitative Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (696):
   760   significant (Statistical Significance) [Quantitative Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure (finding)) [Finding]
Meta Mapping (696):
   760   significant (Statistical Significance) [Quantitative Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure - action) [Functional Concept]
Meta Mapping (696):
   760   significant (Statistical Significance) [Quantitative Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (696):
   760   significant (Statistical Significance) [Quantitative Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure (finding)) [Finding]
Meta Mapping (696):
   760   significant (Statistical Significance) [Quantitative Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure - action) [Functional Concept]
Meta Mapping (696):
   760   Significant [Idea or Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (696):
   760   Significant [Idea or Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure (finding)) [Finding]
Meta Mapping (696):
   760   Significant [Idea or Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure - action) [Functional Concept]
Meta Mapping (696):
   760   Significant [Idea or Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (696):
   760   Significant [Idea or Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure (finding)) [Finding]
Meta Mapping (696):
   760   Significant [Idea or Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure - action) [Functional Concept]
Meta Mapping (696):
   760   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (696):
   760   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure (finding)) [Finding]
Meta Mapping (696):
   760   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   Opening (Open) [Spatial Concept]
   593   Pressure (Pressure - action) [Functional Concept]
Meta Mapping (696):
   760   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (696):
   760   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure (finding)) [Finding]
Meta Mapping (696):
   760   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   Opening [Spatial Concept]
   593   Pressure (Pressure - action) [Functional Concept]

Phrase: reported as 12 cm of water .
Meta Mapping (672):
   753   Reported (Report (document)) [Intellectual Product]
   753   WATER (Water) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (672):
   753   Reported (Report (document)) [Intellectual Product]
   753   WATER (Drinking Water) [Substance]
Meta Mapping (672):
   753   Reported (Report (document)) [Intellectual Product]
   753   Water (Water Specimen) [Inorganic Chemical]
Meta Mapping (672):
   753   Reported (Reporting) [Health Care Activity]
   753   WATER (Water) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (672):
   753   Reported (Reporting) [Health Care Activity]
   753   WATER (Drinking Water) [Substance]
Meta Mapping (672):
   753   Reported (Reporting) [Health Care Activity]
   753   Water (Water Specimen) [Inorganic Chemical]
Processing 00000000.tx.26: There was no erythema around the catheter site . 

Phrase: There

Phrase: was

Phrase: no erythema around the catheter site .
Meta Mapping (722):
   753 N ERYTHEMA (Erythema) [Disease or Syndrome]
   623   Catheter Site (Site of catheter) [Spatial Concept]
Processing 00000000.tx.27: She moved all extremities . 

Phrase: She

Phrase: moved
Meta Mapping (1000):
  1000   moved (Moved from) [Functional Concept]
Meta Mapping (1000):
  1000   moved (Moved to) [Functional Concept]
Meta Mapping (1000):
  1000   Moved (Relocation of home or business) [Activity]

Phrase: all extremities .
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.28: She missed her nose with both hands when asked to touch her nose . 

Phrase: She

Phrase: missed
Meta Mapping (1000):
  1000   Missed (Missing) [Qualitative Concept]

Phrase: her nose with both hands
Meta Mapping (686):
   760   NOSE (Nose) [Body Part, Organ, or Organ Component]
   593   Hands (Hand) [Body Part, Organ, or Organ Component]
Meta Mapping (686):
   760   Nose (Entire nose) [Body Part, Organ, or Organ Component]
   593   Hands (Hand) [Body Part, Organ, or Organ Component]

Phrase: when

Phrase: asked

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: touch
Meta Mapping (1000):
  1000   Touch (Therapeutic tactile stimulation) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Touch (Tactile) [Qualitative Concept]
Meta Mapping (1000):
  1000   Touch (Touch sensation) [Organ or Tissue Function]

Phrase: her nose .
Meta Mapping (1000):
  1000   NOSE (Nose) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Nose (Entire nose) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.29: She answered appropriately to yes-no questions , but _____________ She appeared to understand questions , but then could not come up with the answers , or where she was , and she could not give her name , but did respond when her name was used . 

Phrase: She

Phrase: answered
Meta Mapping (966):
   966   Answer (Response (statement)) [Intellectual Product]

Phrase: appropriately to yes-no questions ,
Meta Mapping (752):
   806   yes/no (Yes or No Response) [Classification]
   726   Question (Question (inquiry)) [Intellectual Product]

Phrase: but ____________

Phrase: _

Phrase: She

Phrase: appeared
Meta Mapping (966):
   966   APPEAR (Appearance) [Qualitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: understand
Meta Mapping (1000):
  1000   Understand (Comprehension) [Mental Process]

Phrase: questions ,
Meta Mapping (966):
   966   Question (Question (inquiry)) [Intellectual Product]

Phrase: but

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: could

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: come up

Phrase: with the answers ,
Meta Mapping (966):
   966   Answer (Response (statement)) [Intellectual Product]

Phrase: or

Phrase: where

Phrase: she

Phrase: was

Phrase: ,

Phrase: and

Phrase: she

Phrase: could

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: give
Meta Mapping (1000):
  1000   Give (Give - dosing instruction imperative) [Functional Concept]

Phrase: her name ,
Meta Mapping (1000):
  1000   Name [Intellectual Product]
Meta Mapping (1000):
  1000   Name (Person Name) [Intellectual Product]

Phrase: but

Phrase: did

Phrase: respond

Phrase: when

Phrase: her name
Meta Mapping (1000):
  1000   Name [Intellectual Product]
Meta Mapping (1000):
  1000   Name (Person Name) [Intellectual Product]

Phrase: was

Phrase: used .
Meta Mapping (1000):
  1000   used (Used by) [Finding]
Processing 00000000.tx.30: Her liver function tests were all within normal limits . 

Phrase: Her liver function tests
Meta Mapping (1000):
  1000   Liver Function Tests [Laboratory Procedure]

Phrase: were

Phrase: all within normal limits .
Meta Mapping (833):
   833   Normal limits [Quantitative Concept]
Processing 00000000.tx.31: The differential was 85% polymorphonuclearleukocytes . 

Phrase: The differential
Meta Mapping (1000):
  1000   Differential (Differential quality) [Qualitative Concept]
Meta Mapping (1000):
  1000   Differential (Different) [Qualitative Concept]

Phrase: was

Phrase: 85% polymorphonuclearleukocytes .
Processing 00000000.tx.32: Work up included from a neurologic perspective brain MRI , brain EEG , lumbar puncture . 

Phrase: Work up
Meta Mapping (1000):
  1000   Work-up (work up) [Diagnostic Procedure]

Phrase: included from a neurologic perspective brain MRI ,
Meta Mapping (692):
   748   included (Including (qualifier)) [Functional Concept]
   748   NEUROLOGIC (Neurologic (qualifier value)) [Qualitative Concept]
   778   brain MRI (MRI brain procedure) [Diagnostic Procedure]
Meta Mapping (692):
   748   included (Including (qualifier)) [Functional Concept]
   748   NEUROLOGIC (Neurologic (qualifier value)) [Qualitative Concept]
   778   Brain MRI (Multisection:Finding:Point in time:Brain:Narrative:MRI) [Clinical Attribute]
Meta Mapping (692):
   748   included (Including (qualifier)) [Functional Concept]
   746   Nervous System, Brain (Brain) [Body Part, Organ, or Organ Component]
   748   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (692):
   748   included (Including (qualifier)) [Functional Concept]
   746   Nervous System, Brain (Brain) [Body Part, Organ, or Organ Component]
   748   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (692):
   748   included (Including (qualifier)) [Functional Concept]
   746   Nervous System, Brain (Brain) [Body Part, Organ, or Organ Component]
   748   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]

Phrase: brain EEG ,
Meta Mapping (888):
   694   BRAIN (Brain) [Body Part, Organ, or Organ Component]
   861   EEG, NOS (Electroencephalography) [Diagnostic Procedure]
Meta Mapping (888):
   694   BRAIN (Brain) [Body Part, Organ, or Organ Component]
   861   EEG (Technician - EEG) [Professional or Occupational Group]
Meta Mapping (888):
   694   Brain (Entire brain) [Body Part, Organ, or Organ Component]
   861   EEG, NOS (Electroencephalography) [Diagnostic Procedure]
Meta Mapping (888):
   694   Brain (Entire brain) [Body Part, Organ, or Organ Component]
   861   EEG (Technician - EEG) [Professional or Occupational Group]

Phrase: lumbar puncture .
Meta Mapping (1000):
  1000   Lumbar Puncture (Spinal Puncture) [Health Care Activity]
Meta Mapping (1000):
  1000   Lumbar puncture, NOS (Diagnostic lumbar puncture) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Lumbar Puncture (Consent Type - Lumbar Puncture) [Health Care Activity]
Processing 00000000.tx.33: No obvious source of infection was found , with negative cultures from blood , urine , sputum , the peritoneal fluid , and cerebrospinal fluid . 

Phrase: No obvious source of infection
Meta Mapping (862):
   862 N Source of infection [Finding]

Phrase: was

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: ,

Phrase: with negative cultures from blood ,
Meta Mapping (833):
   824   negative blood culture (blood culture negative) [Laboratory or Test Result]

Phrase: urine ,
Meta Mapping (1000):
  1000   URINE (Urine) [Body Substance]
Meta Mapping (1000):
  1000   URINE (In Urine) [Functional Concept]
Meta Mapping (1000):
  1000   Urine (Portion of urine) [Body Substance]

Phrase: sputum ,
Meta Mapping (1000):
  1000   SPUTUM (Sputum) [Body Substance]

Phrase: the peritoneal fluid ,
Meta Mapping (1000):
  1000   FLUID, PERITONEAL (Peritoneal Fluid (body substance)) [Body Substance]

Phrase: and

Phrase: cerebrospinal fluid .
Meta Mapping (1000):
  1000   Spinal Fluid, Cerebro (Cerebrospinal Fluid) [Body Substance]
Meta Mapping (1000):
  1000   cerebrospinal fluid (In Cerebrospinal Fluid) [Functional Concept]
Processing 00000000.tx.34: We will discuss the case further with the Neurology Service , who will evaluate the case more carefully tomorrow with their attending . 

Phrase: We

Phrase: will

Phrase: discuss
Meta Mapping (1000):
  1000   Discuss (Discussion (communication)) [Social Behavior]

Phrase: the case further with the Neurology Service ,
Meta Mapping (696):
   748   Case (Case (situation)) [Functional Concept]
   581   Further [Spatial Concept]
   612   Neurology service (neurology services (treatment)) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   748   Case (Case (situation)) [Functional Concept]
   581   Further [Spatial Concept]
   612   Neurology service [Health Care Related Organization]
Meta Mapping (696):
   748   CASE (Packaging Case) [Medical Device]
   581   Further [Spatial Concept]
   612   Neurology service (neurology services (treatment)) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   748   CASE (Packaging Case) [Medical Device]
   581   Further [Spatial Concept]
   612   Neurology service [Health Care Related Organization]
Meta Mapping (696):
   748   Case (Clinical Study Case) [Conceptual Entity]
   581   Further [Spatial Concept]
   612   Neurology service (neurology services (treatment)) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   748   Case (Clinical Study Case) [Conceptual Entity]
   581   Further [Spatial Concept]
   612   Neurology service [Health Care Related Organization]

Phrase: who

Phrase: will

Phrase: evaluate
Meta Mapping (1000):
  1000   Evaluate (Evaluation) [Health Care Activity]

Phrase: the case more carefully tomorrow with their attending .
Meta Mapping (656):
   744   Case (Case (situation)) [Functional Concept]
   744   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (656):
   744   Case (Case (situation)) [Functional Concept]
   744   attending (Attending (action)) [Functional Concept]
Meta Mapping (656):
   744   CASE (Packaging Case) [Medical Device]
   744   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (656):
   744   CASE (Packaging Case) [Medical Device]
   744   attending (Attending (action)) [Functional Concept]
Meta Mapping (656):
   744   Case (Clinical Study Case) [Conceptual Entity]
   744   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (656):
   744   Case (Clinical Study Case) [Conceptual Entity]
   744   attending (Attending (action)) [Functional Concept]
Processing 00000000.tx.35: _____________________________ AVEJOH IRY SUCH , M.D. 

Phrase: _____________________________ AVEJOH IRY

Phrase: SUCH ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.36: TR : yy 08/14/2002 7:36 A 909544 </RECORD> DIS OSS 12/01/02 AT 12:00 PM DISCHARGE MEDICATIONS : Addended by : TO DO / PLAN : BH 8/12/2003 12:00:00 AM DISCHARGE SUMMARY NAME : SIAYUDE LARI AGACHJESCTLANDSTONGE HISTORY AND REASON FOR HOSPITALIZATION : The patient is a 76-year-old , female , who was transferred from a rehab hospital with worsening abdominal pain , with known chronic abdominal ischemia . 

Phrase: TR
Meta Mapping (1000):
  1000   TR (TXNRD1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (TXNRD2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (Tumor Results Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   TR (Thioredoxin Reductase 1, Cytoplasmic) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :

Phrase: yy 08/14/2002 7
Meta Mapping (853):
   853   14 7 (7+14+7) [Quantitative Concept]

Phrase: :

Phrase: 36

Phrase: A 909544

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > DIS OSS 12/01/02 AT 12
Meta Mapping (667):
   748   DIS (Diagnostic interview schedule) [Intellectual Product]
   748   OSS (OSS tumor staging notations) [Body Location or Region]
Meta Mapping (667):
   748   DIS (Discontinued) [Finding]
   748   OSS (OSS tumor staging notations) [Body Location or Region]

Phrase: :

Phrase: 00 PM DISCHARGE MEDICATIONS
Meta Mapping (824):
   645   PM (Panama) [Geographic Area]
   861   Discharge medications (Medication.discharge) [Finding]
Meta Mapping (824):
   645   PM (Infusion pump Alert priority PM) [Finding]
   861   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: Addended by

Phrase: :

Phrase: TO DO / PLAN
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Planned) [Functional Concept]

Phrase: :

Phrase: BH 8/12/2003 12
Meta Mapping (804):
   804   BH (Bahrain) [Geographic Area]
Meta Mapping (804):
   804   BH (Belize) [Geographic Area]
Meta Mapping (804):
   804   BH (BLMH gene) [Gene or Genome]
Meta Mapping (804):
   804   BH (Behavioral Domain) [Intellectual Product]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: DISCHARGE
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: SUMMARY NAME
Meta Mapping (888):
   694   summary (summary - ActRelationshipSubset) [Intellectual Product]
   861   Name [Intellectual Product]
Meta Mapping (888):
   694   summary (summary - ActRelationshipSubset) [Intellectual Product]
   861   Name (Person Name) [Intellectual Product]
Meta Mapping (888):
   694   Summary (Summary (document)) [Intellectual Product]
   861   Name [Intellectual Product]
Meta Mapping (888):
   694   Summary (Summary (document)) [Intellectual Product]
   861   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: SIAYUDE LARI AGACHJESCTLANDSTONGE HISTORY
Meta Mapping (812):
   812   History [Occupation or Discipline]
Meta Mapping (812):
   812   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (812):
   812   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (812):
   812   History (Medical History) [Finding]
Meta Mapping (812):
   812   History (Concept History) [Conceptual Entity]
Meta Mapping (812):
   812   History (History of previous events) [Finding]

Phrase: AND

Phrase: REASON FOR HOSPITALIZATION
Meta Mapping (1000):
  1000   Reason for hospitalization [Finding]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: a 76-year-old ,
Meta Mapping (790):
   660   YEAR (year) [Temporal Concept]
   827   Old [Temporal Concept]
Meta Mapping (790):
   660   /Year (per year) [Temporal Concept]
   827   Old [Temporal Concept]

Phrase: female ,
Meta Mapping (1000):
  1000   FEMALE (Female) [Organism Attribute]
Meta Mapping (1000):
  1000   female (Woman) [Population Group]
Meta Mapping (1000):
  1000   female (Females) [Population Group]
Meta Mapping (1000):
  1000   Female (Female, Self-Report) [Qualitative Concept]
Meta Mapping (1000):
  1000   Female (Female Phenotype) [Qualitative Concept]

Phrase: who

Phrase: was

Phrase: transferred from a rehab hospital
Meta Mapping (922):
   891   Transfer from a hospital [Idea or Concept]
   760   Rehab (Rehabilitation therapy) [Therapeutic or Preventive Procedure]

Phrase: with worsening abdominal pain ,
Meta Mapping (901):
   660   Worsening (Worsening pattern) [Qualitative Concept]
   901   ABDOMINAL PAIN (Abdominal Pain) [Sign or Symptom]
Meta Mapping (901):
   660   Worsening (Worse) [Finding]
   901   ABDOMINAL PAIN (Abdominal Pain) [Sign or Symptom]
Meta Mapping (901):
   660   Worsening (Patient Outcome - Worsening) [Idea or Concept]
   901   ABDOMINAL PAIN (Abdominal Pain) [Sign or Symptom]

Phrase: with known chronic abdominal ischemia .
Meta Mapping (833):
   645   Known [Qualitative Concept]
   645   CHRONIC (chronic) [Temporal Concept]
   645   Abdominal (Abdomen) [Body Location or Region]
   812   Ischaemia, NOS (Ischemia) [Pathologic Function]
Processing 00000000.tx.37: PAST SURGICAL HISTORY : Her pupils were equal . 

Phrase: PAST SURGICAL HISTORY
Meta Mapping (1000):
  1000   Past surgical history (H/O: surgery) [Finding]

Phrase: :

Phrase: Her pupils
Meta Mapping (1000):
  1000   Pupils (Pupil) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: equal .
Meta Mapping (1000):
  1000   Equal [Qualitative Concept]
Meta Mapping (1000):
  1000   Equal (Relational Operator - Equal) [Intellectual Product]
Processing 00000000.tx.38: Abdomen was distended with decreased bowel sounds . 

Phrase: Abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: distended with decreased bowel sounds .
Meta Mapping (816):
   760   Distended (Dilated) [Finding]
   862   Bowel sounds, decreased (Decreased bowel sounds) [Sign or Symptom]
Processing 00000000.tx.39: She was soft and slightly tender to palpation but no evidence of peritonitis . 

Phrase: She

Phrase: was

Phrase: soft
Meta Mapping (1000):
  1000   Soft [Qualitative Concept]
Meta Mapping (1000):
  1000   SOFT (SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME) [Disease or Syndrome]

Phrase: and

Phrase: slightly tender to palpation
Meta Mapping (733):
   604   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   770   Tender [Qualitative Concept]
   604   PALPATION (Palpation) [Diagnostic Procedure]
Meta Mapping (733):
   604   Slightly (Slight (qualifier value)) [Qualitative Concept]
   770   Tender [Qualitative Concept]
   604   PALPATION (Palpation) [Diagnostic Procedure]

Phrase: but

Phrase: no evidence of peritonitis .
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604 N PERITONITIS (Peritonitis) [Disease or Syndrome]
Processing 00000000.tx.40: Dead . 

Phrase: Dead .
Meta Mapping (1000):
  1000   Dead (Cessation of life) [Organism Function]
Processing 00000000.tx.41: </TEXT> MRN : The patient presented with a chief complaint of RT FACIAL DROOP . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > MRN

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: presented with a chief complaint of RT FACIAL DROOP .
Meta Mapping (692):
   742   Presented (Presentation) [Idea or Concept]
   764   Chief Complaint (Chief complaint (finding)) [Finding]
   742   RT (Structure of right thigh) [Body Part, Organ, or Organ Component]
   764   FACIAL DROOP (Facial Paresis) [Sign or Symptom]
Processing 00000000.tx.42: DIS PRELIMINARY REPORT This is to notify you that your patient , KAYSLANCE , ICEROYLN arrived in the Emergency Department at Bri Health on 03/17/2003 02:52 AM . 

Phrase: DIS
Meta Mapping (1000):
  1000   DIS (Diagnostic interview schedule) [Intellectual Product]
Meta Mapping (1000):
  1000   DIS (Discontinued) [Finding]

Phrase: PRELIMINARY
Meta Mapping (1000):
  1000   Preliminary [Temporal Concept]

Phrase: REPORT
Meta Mapping (1000):
  1000   Report (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Report (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]

Phrase: This

Phrase: is

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: notify
Meta Mapping (1000):
  1000   Notify (Notifications) [Health Care Activity]

Phrase: you

Phrase: that

Phrase: your patient ,
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: KAYSLANCE ,

Phrase: ICEROYLN

Phrase: arrived in the Emergency Department
Meta Mapping (745):
   760   Arrived (Arrival - action) [Activity]
   806   Emergency Department (Accident and Emergency department) [Health Care Related Organization]

Phrase: at Bri Health on 03/17/2003 02
Meta Mapping (659):
   578   BRI (ITM2B gene) [Gene or Genome]
   744   Health [Idea or Concept]

Phrase: :

Phrase: 52

Phrase: AM .
Processing 00000000.tx.43: Following evaluation and treatment , the patient &apos;s disposition at the end ofthe visit was ADMITTED AS AN INPATIENT TO BRI HEALTH . 

Phrase: Following
Meta Mapping (1000):
  1000   Following (Status post) [Temporal Concept]
Meta Mapping (1000):
  1000   Following [Temporal Concept]

Phrase: evaluation
Meta Mapping (1000):
  1000   Evaluation [Health Care Activity]
Meta Mapping (1000):
  1000   Evaluation (Evaluation procedure) [Health Care Activity]

Phrase: and

Phrase: treatment ,
Meta Mapping (1000):
  1000   treatment (therapeutic aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Treatment (Treating) [Functional Concept]
Meta Mapping (1000):
  1000   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Treatment (Biomaterial Treatment) [Conceptual Entity]
Meta Mapping (1000):
  1000   TREATMENT (Treatment Epoch) [Research Activity]
Meta Mapping (1000):
  1000   treatment (treatment - ActInformationManagementReason) [Health Care Activity]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s disposition at the end ofthe visit
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition [Idea or Concept]
   581   End [Spatial Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition [Idea or Concept]
   581   End [Spatial Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition [Idea or Concept]
   581   End [Spatial Concept]
   581   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition [Idea or Concept]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition [Idea or Concept]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition [Idea or Concept]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End [Spatial Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End [Spatial Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End [Spatial Concept]
   581   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition [Idea or Concept]
   581   End [Spatial Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition [Idea or Concept]
   581   End [Spatial Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition [Idea or Concept]
   581   End [Spatial Concept]
   581   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition [Idea or Concept]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition [Idea or Concept]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition [Idea or Concept]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End [Spatial Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End [Spatial Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End [Spatial Concept]
   581   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   Visit [Behavior]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   visit (Patient Visit) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Disposition (Disposition Domain) [Intellectual Product]
   581   End (Stop (qualifier value)) [Temporal Concept]
   581   VISIT (Visit Name) [Intellectual Product]

Phrase: was

Phrase: ADMITTED AS AN INPATIENT
Meta Mapping (708):
   770   admitted (Hospital admission) [Health Care Activity]
   770   Inpatient (inpatient) [Patient or Disabled Group]
Meta Mapping (708):
   770   admitted (Hospital admission) [Health Care Activity]
   770   Inpatient (Referral category - Inpatient) [Idea or Concept]
Meta Mapping (708):
   770   admitted (Hospital admission) [Health Care Activity]
   770   Inpatient (Patient Class - Inpatient) [Idea or Concept]
Meta Mapping (708):
   770   Admitted (Admission activity) [Health Care Activity]
   770   Inpatient (inpatient) [Patient or Disabled Group]
Meta Mapping (708):
   770   Admitted (Admission activity) [Health Care Activity]
   770   Inpatient (Referral category - Inpatient) [Idea or Concept]
Meta Mapping (708):
   770   Admitted (Admission activity) [Health Care Activity]
   770   Inpatient (Patient Class - Inpatient) [Idea or Concept]

Phrase: TO BRI HEALTH .
Meta Mapping (888):
   694   BRI (ITM2B gene) [Gene or Genome]
   861   Health [Idea or Concept]
Processing 00000000.tx.44: The patient &apos;s preliminary admitting physician is HEAGLEINCHIRD , JEANSIA S and the preliminary diagnosis is HIP FRACTURE . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s preliminary admitting physician
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Preliminary [Temporal Concept]
   861   Admitting Physician (Admitting physician) [Professional or Occupational Group]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Preliminary [Temporal Concept]
   861   Admitting Physician (Admitting physician) [Professional or Occupational Group]

Phrase: is

Phrase: HEAGLEINCHIRD ,

Phrase: JEANSIA S

Phrase: and

Phrase: the preliminary diagnosis
Meta Mapping (1000):
  1000   Preliminary diagnosis (Preliminary diagnosis qualifier value) [Qualitative Concept]
Meta Mapping (1000):
  1000   Preliminary diagnosis (Diagnosis.preliminary:Impression/interpretation of study:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: is

Phrase: HIP FRACTURE .
Meta Mapping (1000):
  1000   HIP FRACTURE (Hip Fractures) [Injury or Poisoning]
Meta Mapping (1000):
  1000   Hip Fracture (Fracture of pelvis) [Injury or Poisoning]
Processing 00000000.tx.45: PRINCIPAL DIAGNOSIS : An MRI was done on 08/27/03 that showed an 8 cm left lower quadrant mass with both cystic and solid components . 

Phrase: PRINCIPAL DIAGNOSIS
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal diagnosis) [Qualitative Concept]
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal Diagnosis:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: An MRI
Meta Mapping (1000):
  1000   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]

Phrase: was

Phrase: done on 08/27/03
Meta Mapping (760):
   760   Done (Done (qualifier value)) [Qualitative Concept]

Phrase: that

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: an 8 cm left lower quadrant mass with both cystic
Meta Mapping (717):
   615   Left lower quadrant [Spatial Concept]
   757   mass cystic [Disease or Syndrome]

Phrase: and

Phrase: solid components .
Meta Mapping (888):
   694   Solid [Qualitative Concept]
   861   Components (Component object) [Manufactured Object]
Meta Mapping (888):
   694   Solid, NOS (solid substance) [Substance]
   861   Components (Component object) [Manufactured Object]
Meta Mapping (888):
   694   Solid (Solid Dose Form) [Biomedical or Dental Material]
   861   Components (Component object) [Manufactured Object]
Processing 00000000.tx.46: The patient was started on Lupron on 10/18/03 , but pain was not affected . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: started on Lupron
Meta Mapping (746):
   790   Started [Qualitative Concept]
   790   Lupron [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: on 10/18/03 ,
Meta Mapping (827):
   827   10% [Finding]

Phrase: but

Phrase: pain
Meta Mapping (1000):
  1000   PAIN (Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: was

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: affected .
Meta Mapping (1000):
  1000   Affected (Affecting) [Functional Concept]
Meta Mapping (1000):
  1000   Affected (Involvement with) [Functional Concept]
Processing 00000000.tx.47: A TAH-BSO in 1980 and an exploratory laparotomy with resection of a pelvic mass in 06/22 . 

Phrase: A TAH-BSO in 1980
Meta Mapping (729):
   806   tah bso (Total abdominal hysterectomy with bilateral salpingo-oophorectomy) [Therapeutic or Preventive Procedure]
   560   1980s [Temporal Concept]

Phrase: and

Phrase: an exploratory laparotomy with resection of a pelvic mass
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   595   pelvic resection (Excision of pelvis) [Therapeutic or Preventive Procedure]
   575   MASS (Mass of body structure) [Finding]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   595   pelvic resection (Excision of pelvis) [Therapeutic or Preventive Procedure]
   575   Mass (Mass of body region) [Sign or Symptom]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   595   pelvic resection (Excision of pelvis) [Therapeutic or Preventive Procedure]
   575   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   595   pelvic resection (Excision of pelvis) [Therapeutic or Preventive Procedure]
   575   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   595   pelvic resection (Excision of pelvis) [Therapeutic or Preventive Procedure]
   575   Mass (Molecular Mass) [Quantitative Concept]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   595   pelvic resection (Excision of pelvis) [Therapeutic or Preventive Procedure]
   575   mAs (Milliampere second) [Quantitative Concept]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   575   resection (removal technique) [Therapeutic or Preventive Procedure]
   598   pelvic mass (Pelvic swelling) [Finding]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   575   resection (removal technique) [Therapeutic or Preventive Procedure]
   598   PELVIC MASS (Pelvic mass) [Finding]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   575   Pelvic (Pelvis) [Body Part, Organ, or Organ Component]
   595   mass resection (mass removal) [Therapeutic or Preventive Procedure]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   575   Pelvic (Pelvis) [Body Part, Organ, or Organ Component]
   595   resection mass (mass excision) [Therapeutic or Preventive Procedure]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   575   Resection (Excision) [Therapeutic or Preventive Procedure]
   598   pelvic mass (Pelvic swelling) [Finding]
Meta Mapping (684):
   764   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]
   575   Resection (Excision) [Therapeutic or Preventive Procedure]
   598   PELVIC MASS (Pelvic mass) [Finding]

Phrase: in 06/22 .
Processing 00000000.tx.48: MEDICATIONS AT HOME : 1. 

Phrase: MEDICATIONS
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: AT HOME
Meta Mapping (888):
   861   At [Spatial Concept]
   861   HOME (Home environment) [Conceptual Entity]
Meta Mapping (888):
   861   AT (GATM wt Allele) [Gene or Genome]
   861   HOME (Home environment) [Conceptual Entity]

Phrase: :

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.49: Vicodin 75/750 p.r.n. 

Phrase: Vicodin 75/750 p.r.n.
Meta Mapping (805):
   632   Vicodin [Organic Chemical,Pharmacologic Substance]
   827   R.N. (Registered nurse) [Professional or Occupational Group]
Processing 00000000.tx.50: 6. 

Phrase: 6.
Processing 00000000.tx.51: Arthrotec 0.2 mg b.i.d. 

Phrase: Arthrotec 0.2 mg b.i.d.
Meta Mapping (796):
   629   Arthrotec [Organic Chemical,Pharmacologic Substance]
   845   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.52: No tobacco , alcohol or drug use . 

Phrase: No tobacco ,
Meta Mapping (1000):
  1000   TOBACCO (Tobacco) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Tobacco (Nicotiana) [Plant]
Meta Mapping (1000):
  1000   Tobacco (Nicotiana tabacum) [Plant]

Phrase: alcohol
Meta Mapping (1000):
  1000   ALCOHOL (Ethanol) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Alcohol (Alcohols) [Organic Chemical,Pharmacologic Substance]

Phrase: or

Phrase: drug use .
Meta Mapping (1000):
  1000 N Drug use (Drug usage) [Mental or Behavioral Dysfunction]
Processing 00000000.tx.53: On 11/20/03 , a PE protocol CT was negative for both DVT and PE . 

Phrase: On 11/20/03 ,
Meta Mapping (827):
   827   20% [Finding]

Phrase: a PE protocol CT
Meta Mapping (901):
   734   PE protocol [Therapeutic or Preventive Procedure]
   827   CT (Central African Republic) [Geographic Area]
Meta Mapping (901):
   734   PE protocol [Therapeutic or Preventive Procedure]
   827   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (901):
   734   PE protocol [Therapeutic or Preventive Procedure]
   827   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (901):
   734   PE protocol [Therapeutic or Preventive Procedure]
   827   CT (Computed Tomography Study File) [Intellectual Product]

Phrase: was

Phrase: negative for both DVT
Meta Mapping (708):
   770   Negative [Qualitative Concept]
   604 N DVT NOS (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (708):
   770   Negative [Qualitative Concept]
   604   DVT (Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (708):
   770   Negative [Qualitative Concept]
   604   DVT (Data Validation Test Document) [Intellectual Product]
Meta Mapping (708):
   770   NEGATIVE (Negative Finding) [Finding]
   604 N DVT NOS (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (708):
   770   NEGATIVE (Negative Finding) [Finding]
   604   DVT (Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (708):
   770   NEGATIVE (Negative Finding) [Finding]
   604   DVT (Data Validation Test Document) [Intellectual Product]
Meta Mapping (708):
   770   Negative (Negative Number) [Conceptual Entity]
   604 N DVT NOS (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (708):
   770   Negative (Negative Number) [Conceptual Entity]
   604   DVT (Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (708):
   770   Negative (Negative Number) [Conceptual Entity]
   604   DVT (Data Validation Test Document) [Intellectual Product]
Meta Mapping (708):
   770   Negative (Negative Charge) [Qualitative Concept]
   604 N DVT NOS (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (708):
   770   Negative (Negative Charge) [Qualitative Concept]
   604   DVT (Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (708):
   770   Negative (Negative Charge) [Qualitative Concept]
   604   DVT (Data Validation Test Document) [Intellectual Product]
Meta Mapping (708):
   770   Negative (Negative - answer) [Qualitative Concept]
   604 N DVT NOS (Deep Vein Thrombosis) [Disease or Syndrome]
Meta Mapping (708):
   770   Negative (Negative - answer) [Qualitative Concept]
   604   DVT (Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (708):
   770   Negative (Negative - answer) [Qualitative Concept]
   604   DVT (Data Validation Test Document) [Intellectual Product]

Phrase: and

Phrase: PE .
Meta Mapping (1000):
  1000   PE (phosphoethanolamine) [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.54: Postoperative course by systems is as follows : The patient was seen by Onc Psychiatry consult , who recommended imipramine 75 mg ; that was subsequently increased to 150 mg p.o. q.h.s. 

Phrase: Postoperative course by systems
Meta Mapping (722):
   604   Postoperative (Postoperative Period) [Temporal Concept]
   770   Course [Temporal Concept]
   570   System [Functional Concept]
Meta Mapping (722):
   604   Postoperative (Postoperative Period) [Temporal Concept]
   770   Course [Temporal Concept]
   570   System (System - kit) [Manufactured Object]
Meta Mapping (722):
   604   Postoperative (Postoperative Period) [Temporal Concept]
   770   Course [Temporal Concept]
   570   System (Device Component System) [Manufactured Object]

Phrase: is

Phrase: as

Phrase: follows
Meta Mapping (1000):
  1000   follows (Followed by) [Temporal Concept]
Meta Mapping (1000):
  1000   Follow [Intellectual Product]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: seen by Onc Psychiatry
Meta Mapping (708):
   770   Seen (seen) [Qualitative Concept]
   770   Psychiatry (Psychiatry Specialty) [Biomedical Occupation or Discipline]

Phrase: consult
Meta Mapping (1000):
  1000   Consult (Consultation) [Health Care Activity]

Phrase: ,

Phrase: who

Phrase: recommended
Meta Mapping (1000):
  1000   Recommended (Recommendation) [Idea or Concept]

Phrase: imipramine 75 mg
Meta Mapping (802):
   660   IMIPRAMINE (Imipramine) [Organic Chemical,Pharmacologic Substance]
   827   MG (Mongolia) [Geographic Area]
Meta Mapping (802):
   660   IMIPRAMINE (Imipramine) [Organic Chemical,Pharmacologic Substance]
   827   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (802):
   660   IMIPRAMINE (Imipramine) [Organic Chemical,Pharmacologic Substance]
   827   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (802):
   660   IMIPRAMINE (Imipramine) [Organic Chemical,Pharmacologic Substance]
   827   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ;

Phrase: that

Phrase: was

Phrase: subsequently

Phrase: increased to 150 mg p.o. q.h.s.
Meta Mapping (720):
   762   mg++ increased [Finding]
   784   h s p (Hermanski-Pudlak Syndrome) [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.55: , trazadone 100 mg q.h.s. and Ambien 10 mg q.h.s. 

Phrase: , trazadone 100 mg q.h.s.
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (787):
   632   100% [Quantitative Concept]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]

Phrase: and

Phrase: Ambien 10 mg q.h.s.
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   MG (Mongolia) [Geographic Area]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg% (mg/dL) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   mg % (Milligram percent) [Quantitative Concept]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   H+ (Hepatic Involvement) [Classification]
Meta Mapping (827):
   632   Ambien [Organic Chemical,Pharmacologic Substance]
   632   10% [Finding]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   672   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   632   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.56: At the time of transfer to the ________ Onc Service , blood pressure was within the normal range . 

Phrase: At the time of transfer
Meta Mapping (686):
   760   TIME (Time) [Temporal Concept]
   593   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (686):
   760   TIME (Time) [Temporal Concept]
   593   Transfer (Transfer Technique) [Functional Concept]
Meta Mapping (686):
   760   Time (Time (foundation metadata concept)) [Temporal Concept]
   593   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (686):
   760   Time (Time (foundation metadata concept)) [Temporal Concept]
   593   Transfer (Transfer Technique) [Functional Concept]

Phrase: to the ________ Onc Service ,
Meta Mapping (861):
   861   Service (Services) [Occupational Activity]
Meta Mapping (861):
   861   Service (Software Service) [Manufactured Object]
Meta Mapping (861):
   861   service (ActInformationPrivacyReason <service>) [Idea or Concept]

Phrase: blood pressure
Meta Mapping (1000):
  1000   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (1000):
  1000   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (1000):
  1000   Blood pressure (Systemic arterial pressure) [Finding]

Phrase: was within the normal range .
Meta Mapping (806):
   806   Normal Range [Quantitative Concept]
Processing 00000000.tx.57: The patient was extubated on 11/22/03 . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: extubated on 11/22/03 .
Meta Mapping (726):
   726   Extubate (Tracheal Extubation) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.58: The patient was restarted on Advair and by 12/15/03 , was weaned to room air likely an effective Advair and control of anxiety and psychiatric issues . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: restarted on Advair
Meta Mapping (730):
   756   Restart [Qualitative Concept]
   790   Advair [Organic Chemical,Pharmacologic Substance]

Phrase: and by 12/15/03 ,

Phrase: was

Phrase: weaned to room air likely
Meta Mapping (761):
   760   Weaned (Weaning) [Finding]
   806   Room air [Finding]
   760   Likely (Probable diagnosis) [Qualitative Concept]
Meta Mapping (761):
   760   Weaned (Weaning) [Finding]
   806   Room air [Finding]
   760   Likely (Probably) [Idea or Concept]

Phrase: an effective Advair
Meta Mapping (888):
   694   effective (Effectiveness) [Qualitative Concept]
   861   Advair [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   Effective [Qualitative Concept]
   861   Advair [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: control of anxiety
Meta Mapping (746):
   790   control (control aspects) [Qualitative Concept]
   623   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   control (control aspects) [Qualitative Concept]
   623   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   control (control aspects) [Qualitative Concept]
   623   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (746):
   790   Control (control substance) [Substance]
   623   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (control substance) [Substance]
   623   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (control substance) [Substance]
   623   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (746):
   790   Control (Scientific Control) [Conceptual Entity]
   623   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (Scientific Control) [Conceptual Entity]
   623   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (Scientific Control) [Conceptual Entity]
   623   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (746):
   790   Control (Control function) [Functional Concept]
   623   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (Control function) [Functional Concept]
   623   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (Control function) [Functional Concept]
   623   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (746):
   790   Control (True Control Status) [Qualitative Concept]
   623   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (True Control Status) [Qualitative Concept]
   623   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (746):
   790   Control (True Control Status) [Qualitative Concept]
   623   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]

Phrase: and

Phrase: psychiatric issues .
Meta Mapping (983):
   983   psychiatric issue [Mental or Behavioral Dysfunction]
Processing 00000000.tx.59: The patient was taken to the OR on postop day 5 for emergent exploratory laparotomy that disclosed a small bowel enterotomy with 2 liters of bilious fluid within the peritoneum . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: taken to the
Meta Mapping (790):
   790   Taken [Conceptual Entity]

Phrase: OR on postop day 5
Meta Mapping (763):
   760   Postop (Postoperative Period) [Temporal Concept]
   806   Day 5 [Finding]

Phrase: for emergent exploratory laparotomy
Meta Mapping (901):
   660   emergent [Idea or Concept]
   901   EXPLORATORY LAPAROTOMY (Exploratory laparotomy) [Diagnostic Procedure]

Phrase: that

Phrase: disclosed

Phrase: a small bowel enterotomy with 2 liters of bilious fluid
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   FLUID (Body Fluids) [Body Substance]
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   fluid (Liquid substance) [Substance]
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (Fluid behavior) [Qualitative Concept]
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (fluid - substance) [Substance]
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   FLUID (Body Fluids) [Body Substance]
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   fluid (Liquid substance) [Substance]
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (Fluid behavior) [Qualitative Concept]
Meta Mapping (649):
   593   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (fluid - substance) [Substance]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   FLUID (Body Fluids) [Body Substance]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   fluid (Liquid substance) [Substance]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (Fluid behavior) [Qualitative Concept]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (fluid - substance) [Substance]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   FLUID (Body Fluids) [Body Substance]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   fluid (Liquid substance) [Substance]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (Fluid behavior) [Qualitative Concept]
Meta Mapping (649):
   593   Small Bowel (Small Intestinal Wall Tissue) [Tissue]
   739   Enterotomy (Incision of small intestine) [Therapeutic or Preventive Procedure]
   540   LITER (liter) [Quantitative Concept]
   573   Fluid (fluid - substance) [Substance]

Phrase: within the peritoneum .
Meta Mapping (1000):
  1000   PERITONEUM (Peritoneum) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.60: The patient , at the time of transfer , was tolerating clears with low stoma output , likely to tolerate slow advancement . 

Phrase: The patient ,
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: at the time of transfer ,
Meta Mapping (686):
   760   TIME (Time) [Temporal Concept]
   593   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (686):
   760   TIME (Time) [Temporal Concept]
   593   Transfer (Transfer Technique) [Functional Concept]
Meta Mapping (686):
   760   Time (Time (foundation metadata concept)) [Temporal Concept]
   593   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (686):
   760   Time (Time (foundation metadata concept)) [Temporal Concept]
   593   Transfer (Transfer Technique) [Functional Concept]

Phrase: was

Phrase: tolerating

Phrase: clears with low stoma output ,
Meta Mapping (733):
   760   Clear (Negative Surgical Margin) [Finding]
   760   Low (low) [Qualitative Concept]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]
Meta Mapping (733):
   760   Clear (Negative Surgical Margin) [Finding]
   760   low (low confidentiality) [Intellectual Product]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]
Meta Mapping (733):
   760   Clear (Negative Surgical Margin) [Finding]
   760   Low (Low Mitosis-Karyorrhexis Index) [Quantitative Concept]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]
Meta Mapping (733):
   760   Clear (Negative Surgical Margin) [Finding]
   760   low (low exposure) [Qualitative Concept]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]
Meta Mapping (733):
   760   Clear [Qualitative Concept]
   760   Low (low) [Qualitative Concept]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]
Meta Mapping (733):
   760   Clear [Qualitative Concept]
   760   low (low confidentiality) [Intellectual Product]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]
Meta Mapping (733):
   760   Clear [Qualitative Concept]
   760   Low (Low Mitosis-Karyorrhexis Index) [Quantitative Concept]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]
Meta Mapping (733):
   760   Clear [Qualitative Concept]
   760   low (low exposure) [Qualitative Concept]
   760   Stoma (Surgical Stoma) [Anatomical Structure]
   760   Output (system output) [Conceptual Entity]

Phrase: likely
Meta Mapping (1000):
  1000   Likely (Probable diagnosis) [Qualitative Concept]
Meta Mapping (1000):
  1000   Likely (Probably) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: tolerate

Phrase: slow advancement .
Meta Mapping (888):
   694   Slow [Qualitative Concept]
   861   Advancement (Surgical advancement - action) [Functional Concept]
Processing 00000000.tx.61: 7. 

Phrase: 7.
Processing 00000000.tx.62: Heme : D : 62y This is to notify you that your patient , CARD , I arrived in the Emergency Department at Bri Health on 08/24/2004 03:43 AM . 

Phrase: Heme
Meta Mapping (1000):
  1000   Haem (Heme) [Biologically Active Substance,Organic Chemical]

Phrase: :

Phrase: D
Meta Mapping (1000):
  1000   D NOS (Blood group antigen D) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (1000):
  1000   /d (Daily) [Temporal Concept]

Phrase: :

Phrase: 62y

Phrase: This

Phrase: is

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: notify
Meta Mapping (1000):
  1000   Notify (Notifications) [Health Care Activity]

Phrase: you

Phrase: that

Phrase: your patient ,
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: CARD ,
Meta Mapping (1000):
  1000   Card (Card (document)) [Intellectual Product]

Phrase: I
Meta Mapping (1000):
  1000   I- (Iodides) [Inorganic Chemical]
Meta Mapping (1000):
  1000   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: arrived in the Emergency Department
Meta Mapping (745):
   760   Arrived (Arrival - action) [Activity]
   806   Emergency Department (Accident and Emergency department) [Health Care Related Organization]

Phrase: at Bri Health on 08/24/2004 03
Meta Mapping (659):
   578   BRI (ITM2B gene) [Gene or Genome]
   744   Health [Idea or Concept]

Phrase: :

Phrase: 43

Phrase: AM .
Processing 00000000.tx.63: 601883 84y The patient presented with a chief complaint of HEAD BLEED . 

Phrase: 601883 84y

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: presented with a chief complaint of HEAD BLEED .
Meta Mapping (682):
   744   Presented (Presentation) [Idea or Concept]
   770   Chief Complaint (Chief complaint (finding)) [Finding]
   744   HEAD (Head) [Body Location or Region]
   744   bleed (Hemorrhage) [Pathologic Function]
Meta Mapping (682):
   744   Presented (Presentation) [Idea or Concept]
   770   Chief Complaint (Chief complaint (finding)) [Finding]
   744   Head (Entire head) [Body Part, Organ, or Organ Component]
   744   bleed (Hemorrhage) [Pathologic Function]
Meta Mapping (682):
   744   Presented (Presentation) [Idea or Concept]
   770   Chief Complaint (Chief complaint (finding)) [Finding]
   744   Head (Head - Component of Device) [Manufactured Object]
   744   bleed (Hemorrhage) [Pathologic Function]
Processing 00000000.tx.64: </TEXT> <RECORD ID="700"> SIGNED DIS BH Signed Hypertension , asthma , obesity , history of heart murmur , hemorrhoids , whooping cough as a child . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: <RECORD ID="700"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > SIGNED DIS BH Signed Hypertension ,
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Bahrain) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Bahrain) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Belize) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Belize) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (BLMH gene) [Gene or Genome]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (BLMH gene) [Gene or Genome]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Bahrain) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Bahrain) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Belize) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Belize) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (BLMH gene) [Gene or Genome]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (BLMH gene) [Gene or Genome]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   Signed (Signature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Bahrain) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Bahrain) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Belize) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Belize) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (BLMH gene) [Gene or Genome]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (BLMH gene) [Gene or Genome]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Bahrain) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Bahrain) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Belize) [Geographic Area]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Belize) [Geographic Area]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (BLMH gene) [Gene or Genome]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (BLMH gene) [Gene or Genome]
   804   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (766):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   637   DIS (Discontinued) [Finding]
   637   BH (Behavioral Domain) [Intellectual Product]
   804   Hypertension (Hypertension Adverse Event) [Finding]

Phrase: asthma ,
Meta Mapping (1000):
  1000   -- Asthma (Asthma) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Asthma (Asthma Pathway) [Functional Concept]

Phrase: obesity ,
Meta Mapping (1000):
  1000   OBESITY (Obesity) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Obesity (Obesity Adverse Event) [Finding]

Phrase: history of heart murmur ,
Meta Mapping (783):
   770   History [Occupation or Discipline]
   666   HEART MURMUR (Heart murmur) [Finding]
Meta Mapping (783):
   770   history (Historical aspects qualifier) [Functional Concept]
   666   HEART MURMUR (Heart murmur) [Finding]
Meta Mapping (783):
   770   History, NOS (History of present illness) [Organism Attribute]
   666   HEART MURMUR (Heart murmur) [Finding]
Meta Mapping (783):
   770   History (Medical History) [Finding]
   666   HEART MURMUR (Heart murmur) [Finding]
Meta Mapping (783):
   770   History (Concept History) [Conceptual Entity]
   666   HEART MURMUR (Heart murmur) [Finding]
Meta Mapping (783):
   770   History (History of previous events) [Finding]
   666   HEART MURMUR (Heart murmur) [Finding]

Phrase: hemorrhoids ,
Meta Mapping (1000):
  1000   HEMORRHOIDS (Hemorrhoids) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Hemorrhoids (Hemorrhoids Adverse Event) [Finding]

Phrase: whooping cough as a child .
Meta Mapping (745):
   806   Whooping Cough (Pertussis) [Disease or Syndrome]
   593   CHILD (Child) [Age Group]
Meta Mapping (745):
   806   Whooping Cough (Pertussis) [Disease or Syndrome]
   593   CHILD (Offspring) [Family Group]
Meta Mapping (745):
   806   WHOOPING COUGH (Whooping cough due to unspecified organism) [Disease or Syndrome]
   593   CHILD (Child) [Age Group]
Meta Mapping (745):
   806   WHOOPING COUGH (Whooping cough due to unspecified organism) [Disease or Syndrome]
   593   CHILD (Offspring) [Family Group]
Processing 00000000.tx.65: Tonsillectomy in 1947 , removal of a renal calculus in 1979 , cholecystectomy in 1986 . 

Phrase: Tonsillectomy in 1947 ,
Meta Mapping (790):
   790   TONSILLECTOMY (Tonsillectomy) [Therapeutic or Preventive Procedure]

Phrase: removal of a renal calculus
Meta Mapping (745):
   760   Removal (removal technique) [Therapeutic or Preventive Procedure]
   640   RENAL CALCULUS (Kidney Calculi) [Disease or Syndrome]
Meta Mapping (745):
   760   REMOVAL (Extraction) [Therapeutic or Preventive Procedure]
   640   RENAL CALCULUS (Kidney Calculi) [Disease or Syndrome]
Meta Mapping (745):
   760   Removal (Excision) [Therapeutic or Preventive Procedure]
   640   RENAL CALCULUS (Kidney Calculi) [Disease or Syndrome]
Meta Mapping (745):
   593   Renal (Kidney) [Body Part, Organ, or Organ Component]
   797   Calculus removal (stone removal) [Therapeutic or Preventive Procedure]

Phrase: in 1979 ,

Phrase: cholecystectomy in 1986 .
Meta Mapping (790):
   790   CHOLECYSTECTOMY (Cholecystectomy procedure) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.66: G5 , P5 normal Pap smears , sexual active without dyspareunia . 

Phrase: G5 ,
Meta Mapping (1000):
  1000   G5 (GPANK1 gene) [Gene or Genome]

Phrase: P5 normal Pap smears ,
Meta Mapping (861):
   645   P5 (PDIA6 gene) [Gene or Genome]
   645   NORMAL (Normal) [Qualitative Concept]
   861   pap smears (Pap smear) [Diagnostic Procedure]
Meta Mapping (861):
   645   P5 (PDIA6 gene) [Gene or Genome]
   645   Normal (Gait normal) [Finding]
   861   pap smears (Pap smear) [Diagnostic Procedure]
Meta Mapping (861):
   645   P5 (PDIA6 gene) [Gene or Genome]
   645   % normal (Percent normal) [Quantitative Concept]
   861   pap smears (Pap smear) [Diagnostic Procedure]
Meta Mapping (861):
   645   P5 (PDIA6 gene) [Gene or Genome]
   645   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   pap smears (Pap smear) [Diagnostic Procedure]
Meta Mapping (861):
   645   p5 (EXOSC9 gene) [Gene or Genome]
   645   NORMAL (Normal) [Qualitative Concept]
   861   pap smears (Pap smear) [Diagnostic Procedure]
Meta Mapping (861):
   645   p5 (EXOSC9 gene) [Gene or Genome]
   645   Normal (Gait normal) [Finding]
   861   pap smears (Pap smear) [Diagnostic Procedure]
Meta Mapping (861):
   645   p5 (EXOSC9 gene) [Gene or Genome]
   645   % normal (Percent normal) [Quantitative Concept]
   861   pap smears (Pap smear) [Diagnostic Procedure]
Meta Mapping (861):
   645   p5 (EXOSC9 gene) [Gene or Genome]
   645   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   pap smears (Pap smear) [Diagnostic Procedure]

Phrase: sexual active without dyspareunia .
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   Active [Functional Concept]
   604 N DYSPAREUNIA (Dyspareunia (female)) [Disease or Syndrome]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   Active [Functional Concept]
   604 N Dyspareunia (Painful intercourse female) [Finding]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   Active [Functional Concept]
   604 N DYSPAREUNIA (Dyspareunia) [Finding]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   active (active (HL7 RoleLink)) [Idea or Concept]
   604 N DYSPAREUNIA (Dyspareunia (female)) [Disease or Syndrome]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   active (active (HL7 RoleLink)) [Idea or Concept]
   604 N Dyspareunia (Painful intercourse female) [Finding]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   active (active (HL7 RoleLink)) [Idea or Concept]
   604 N DYSPAREUNIA (Dyspareunia) [Finding]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   Active (Active License) [Qualitative Concept]
   604 N DYSPAREUNIA (Dyspareunia (female)) [Disease or Syndrome]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   Active (Active License) [Qualitative Concept]
   604 N Dyspareunia (Painful intercourse female) [Finding]
Meta Mapping (733):
   604   Sexual (Sex Behavior) [Behavior]
   770   Active (Active License) [Qualitative Concept]
   604 N DYSPAREUNIA (Dyspareunia) [Finding]
Processing 00000000.tx.67: Demerol . 

Phrase: Demerol .
Meta Mapping (1000):
  1000   Demerol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.68: The patient developed ulceration after IM injection . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: developed

Phrase: ulceration after IM injection .
Meta Mapping (783):
   770   Ulceration (Ulcer) [Disease or Syndrome]
   666   IM injection (Intramuscular injection) [Functional Concept]
Meta Mapping (783):
   770   Ulceration (Ulceration Adverse Event) [Finding]
   666   IM injection (Intramuscular injection) [Functional Concept]
Meta Mapping (783):
   770   Ulceration [Pathologic Function]
   666   IM injection (Intramuscular injection) [Functional Concept]
Processing 00000000.tx.69: On postoperative day one , the patient &apos;s urine culture came back with moderate E. coli . 

Phrase: On postoperative day one ,
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   /day (Daily) [Temporal Concept]
   827   ONE (One) [Quantitative Concept]
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   DAY (day) [Temporal Concept]
   827   ONE (One) [Quantitative Concept]
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   /day (per day) [Temporal Concept]
   827   ONE (One) [Quantitative Concept]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s urine culture
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   Urine culture (Urine for culture) [Laboratory Procedure]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   Urine culture (Urine for culture) [Laboratory Procedure]

Phrase: came

Phrase: back with moderate E. coli .
Meta Mapping (761):
   760   BACK (Back) [Body Location or Region]
   593   Moderate (Moderate (severity modifier)) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   BACK (Back) [Body Location or Region]
   593   MODERATE (Moderation) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   BACK (Back) [Body Location or Region]
   593   Moderate (Moderate Extremity Pain) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   BACK (Back) [Body Location or Region]
   593   Moderate (Borg Category-Ratio 10 Perceived Exertion Score 3) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   BACK (Dorsal) [Spatial Concept]
   593   Moderate (Moderate (severity modifier)) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   BACK (Dorsal) [Spatial Concept]
   593   MODERATE (Moderation) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   BACK (Dorsal) [Spatial Concept]
   593   Moderate (Moderate Extremity Pain) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   BACK (Dorsal) [Spatial Concept]
   593   Moderate (Borg Category-Ratio 10 Perceived Exertion Score 3) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   593   Moderate (Moderate (severity modifier)) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   593   MODERATE (Moderation) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   593   Moderate (Moderate Extremity Pain) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   593   Moderate (Borg Category-Ratio 10 Perceived Exertion Score 3) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   593   Moderate (Moderate (severity modifier)) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   593   MODERATE (Moderation) [Qualitative Concept]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   593   Moderate (Moderate Extremity Pain) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Meta Mapping (761):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   593   Moderate (Borg Category-Ratio 10 Perceived Exertion Score 3) [Intellectual Product]
   640   E coli (Escherichia coli) [Bacterium]
Processing 00000000.tx.70: The patient was also started on a clear diet . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: also

Phrase: started on a clear diet .
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear (Negative Surgical Margin) [Finding]
   760   Diet [Food]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear (Negative Surgical Margin) [Finding]
   760   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear (Negative Surgical Margin) [Finding]
   760   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear (Negative Surgical Margin) [Finding]
   760   DIET (Basal Diet) [Food]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear (Negative Surgical Margin) [Finding]
   760   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear [Qualitative Concept]
   760   Diet [Food]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear [Qualitative Concept]
   760   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear [Qualitative Concept]
   760   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear [Qualitative Concept]
   760   DIET (Basal Diet) [Food]
Meta Mapping (696):
   760   Started [Qualitative Concept]
   760   Clear [Qualitative Concept]
   760   Diet (Diet (animal life circumstance)) [Food]
Processing 00000000.tx.71: On postoperative day two , her Foley was discontinued . 

Phrase: On postoperative day two ,
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   /day (Daily) [Temporal Concept]
   827   Two [Quantitative Concept]
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   DAY (day) [Temporal Concept]
   827   Two [Quantitative Concept]
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   /day (per day) [Temporal Concept]
   827   Two [Quantitative Concept]

Phrase: her Foley

Phrase: was

Phrase: discontinued .
Meta Mapping (1000):
  1000   Discontinued [Finding]
Processing 00000000.tx.72: The patient was out of bed . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was out of bed .
Meta Mapping (708):
   770   Out (Out (direction)) [Spatial Concept]
   770   Bed (Beds) [Manufactured Object]
Meta Mapping (708):
   770   Out (Removed) [Qualitative Concept]
   770   Bed (Beds) [Manufactured Object]
Processing 00000000.tx.73: The patient was afebrile , her vital signs were stable and she maintained a good urine output . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: afebrile ,
Meta Mapping (1000):
  1000   Afebrile (Apyrexial) [Finding]

Phrase: her vital signs
Meta Mapping (1000):
  1000   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (1000):
  1000   Signs, Vital (Vital signs) [Clinical Attribute]

Phrase: were

Phrase: stable
Meta Mapping (1000):
  1000   STABLE (Stable status) [Qualitative Concept]
Meta Mapping (1000):
  1000   Stable (Patient Condition Code - Stable) [Intellectual Product]

Phrase: and

Phrase: she

Phrase: maintained
Meta Mapping (1000):
  1000   Maintained (Maintaining (action)) [Functional Concept]

Phrase: a good urine output .
Meta Mapping (901):
   660   Good [Qualitative Concept]
   901   urine output (Urine volume function) [Clinical Attribute]
Meta Mapping (901):
   660   Good [Qualitative Concept]
   901   Urine output (Urine volume finding) [Finding]
Processing 00000000.tx.74: 05/26/2004 <TEXT> 803896937 130275 DIS DISCHARGE SUMMARY NAME : 06/04/2005 Electronically Signed OLE STREET , M.D. 

Phrase: 05/26/2004

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 803896937 130275 DIS DISCHARGE SUMMARY NAME
Meta Mapping (762):
   632   DIS (Diagnostic interview schedule) [Intellectual Product]
   660   Discharge summary [Intellectual Product]
   799   Name [Intellectual Product]
Meta Mapping (762):
   632   DIS (Diagnostic interview schedule) [Intellectual Product]
   660   Discharge summary [Intellectual Product]
   799   Name (Person Name) [Intellectual Product]
Meta Mapping (762):
   632   DIS (Diagnostic interview schedule) [Intellectual Product]
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   799   Name [Intellectual Product]
Meta Mapping (762):
   632   DIS (Diagnostic interview schedule) [Intellectual Product]
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   799   Name (Person Name) [Intellectual Product]
Meta Mapping (762):
   632   DIS (Discontinued) [Finding]
   660   Discharge summary [Intellectual Product]
   799   Name [Intellectual Product]
Meta Mapping (762):
   632   DIS (Discontinued) [Finding]
   660   Discharge summary [Intellectual Product]
   799   Name (Person Name) [Intellectual Product]
Meta Mapping (762):
   632   DIS (Discontinued) [Finding]
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   799   Name [Intellectual Product]
Meta Mapping (762):
   632   DIS (Discontinued) [Finding]
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   799   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: 06/04/2005 Electronically Signed OLE STREET ,
Meta Mapping (718):
   629   Signed (Signature) [Intellectual Product]
   795   Street (Street (environment)) [Manufactured Object]
Meta Mapping (718):
   629   Signed (Signature) [Intellectual Product]
   795   STREET (Street address) [Finding]
Meta Mapping (718):
   629   signed (signed - ParticipationSignature) [Intellectual Product]
   795   Street (Street (environment)) [Manufactured Object]
Meta Mapping (718):
   629   signed (signed - ParticipationSignature) [Intellectual Product]
   795   STREET (Street address) [Finding]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.75: 06/13/2005 9:42 A 130275 7432347 ED DISCHARGE NOTIFICATION FREIREKOTE , SONYLA <TEXT> NVH In the intervening period , he has had atrial fibrillation as his baseline rhythm which has been treated with Procainamide . 

Phrase: 06/13/2005 9

Phrase: :

Phrase: 42

Phrase: A 130275 7432347 ED DISCHARGE NOTIFICATION FREIREKOTE ,
Meta Mapping (546):
   632   ED (Endocrine System Findings Domain) [Idea or Concept]
   632   Discharge (Body Fluid Discharge) [Body Substance]
   632   NOTIFICATION (Notifications) [Health Care Activity]
Meta Mapping (546):
   632   ED (Endocrine System Findings Domain) [Idea or Concept]
   632   Discharge (Patient Discharge) [Health Care Activity]
   632   NOTIFICATION (Notifications) [Health Care Activity]
Meta Mapping (546):
   632   ED (Endocrine System Findings Domain) [Idea or Concept]
   632   Discharge (Discharge, body substance) [Body Substance]
   632   NOTIFICATION (Notifications) [Health Care Activity]

Phrase: SONYLA

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > NVH In the intervening period ,
Meta Mapping (593):
   593   /period (per period (qualifier value)) [Temporal Concept]
Meta Mapping (593):
   593   Period (Period (temporal qualifier)) [Temporal Concept]

Phrase: he

Phrase: has

Phrase: had

Phrase: atrial fibrillation as his baseline rhythm
Meta Mapping (719):
   790   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   Rhythm [Finding]
Meta Mapping (719):
   790   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (719):
   790   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
Meta Mapping (719):
   790   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   586   Baseline [Quantitative Concept]
   586   Rhythm [Finding]
Meta Mapping (719):
   790   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   586   Baseline [Quantitative Concept]
   586   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (719):
   790   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   586   Baseline [Quantitative Concept]
   586   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
Meta Mapping (719):
   790   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   Rhythm [Finding]
Meta Mapping (719):
   790   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (719):
   790   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
Meta Mapping (719):
   790   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   586   Baseline [Quantitative Concept]
   586   Rhythm [Finding]
Meta Mapping (719):
   790   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   586   Baseline [Quantitative Concept]
   586   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (719):
   790   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   586   Baseline [Quantitative Concept]
   586   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
Meta Mapping (719):
   790   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   Rhythm [Finding]
Meta Mapping (719):
   790   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (719):
   790   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   586   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
Meta Mapping (719):
   790   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   586   Baseline [Quantitative Concept]
   586   Rhythm [Finding]
Meta Mapping (719):
   790   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   586   Baseline [Quantitative Concept]
   586   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (719):
   790   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   586   Baseline [Quantitative Concept]
   586   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
Meta Mapping (719):
   783   Atrial rhythm [Finding]
   753   FIBRILLATION (Fibrillation) [Disease or Syndrome]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (719):
   783   Atrial rhythm [Finding]
   753   FIBRILLATION (Fibrillation) [Disease or Syndrome]
   586   Baseline [Quantitative Concept]

Phrase: which

Phrase: has

Phrase: been

Phrase: treated with Procainamide .
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   PROCAINAMIDE (Procainamide) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.76: He has had three-pillow orthopnea , paroxysmal nocturnal dyspnea , and nocturia three to four times per night but no swelling and no weight gain ( although he has had four-inch increase in his abdominal girth in the past year ) . 

Phrase: He

Phrase: has

Phrase: had

Phrase: three-pillow orthopnea ,
Meta Mapping (851):
   660   Three [Quantitative Concept]
   660   Pillow [Manufactured Object]
   827   Orthopnoea (Orthopnea) [Sign or Symptom]

Phrase: paroxysmal nocturnal dyspnea ,
Meta Mapping (1000):
  1000   Paroxysmal nocturnal dyspnoea (Paroxysmal nocturnal dyspnea) [Disease or Syndrome]

Phrase: and

Phrase: nocturia three to four times
Meta Mapping (724):
   760   NOCTURIA (Nocturia) [Disease or Syndrome]
   760   Three [Quantitative Concept]
   760   Four [Quantitative Concept]
   760   times (Time) [Temporal Concept]
Meta Mapping (724):
   760   NOCTURIA (Nocturia) [Disease or Syndrome]
   760   Three [Quantitative Concept]
   760   Four [Quantitative Concept]
   760   Times [Quantitative Concept]

Phrase: per night
Meta Mapping (1000):
  1000   Night (Night time) [Temporal Concept]

Phrase: but

Phrase: no swelling
Meta Mapping (1000):
  1000 N SWELLING (Edema) [Finding]
Meta Mapping (1000):
  1000 N SWELLING (Swelling) [Finding]

Phrase: and

Phrase: no weight gain
Meta Mapping (1000):
  1000 N Gain, Weight (Weight Gain) [Finding]
Meta Mapping (1000):
  1000 N Weight gain (Weight Gain Adverse Event) [Finding]

Phrase: (

Phrase: although

Phrase: he

Phrase: has

Phrase: had

Phrase: four-inch
Meta Mapping (888):
   694   Four [Quantitative Concept]
   861   INCH (Inch Unit of Length) [Quantitative Concept]
Meta Mapping (888):
   694   Four [Quantitative Concept]
   861   inch (Inch British) [Quantitative Concept]
Meta Mapping (888):
   694   Four [Quantitative Concept]
   861   inch (Survey Inch) [Quantitative Concept]

Phrase: increase in his abdominal girth
Meta Mapping (686):
   760   Increase [Functional Concept]
   760   Abdominal (Abdomen) [Body Location or Region]

Phrase: in the past year
Meta Mapping (888):
   694   Past [Temporal Concept]
   861   YEAR (year) [Temporal Concept]
Meta Mapping (888):
   694   Past [Temporal Concept]
   861   /Year (per year) [Temporal Concept]

Phrase: ) .
Processing 00000000.tx.77: The morning of admission , he had another episode with waves of nausea , dizziness , light-headedness , and pallor . 

Phrase: The morning of admission ,
Meta Mapping (708):
   770   Morning [Temporal Concept]
   604   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (708):
   770   Morning [Temporal Concept]
   604   Admission (Admission activity) [Health Care Activity]

Phrase: he

Phrase: had

Phrase: another episode with waves of nausea ,
Meta Mapping (725):
   783   Episode of [Temporal Concept]
   586   waves (wave - physical agent) [Natural Phenomenon or Process]
   586   NAUSEA (Nausea) [Sign or Symptom]
Meta Mapping (725):
   783   Episode of [Temporal Concept]
   586   waves (wave - physical agent) [Natural Phenomenon or Process]
   586   Nausea (Nausea Adverse Event) [Pathologic Function]

Phrase: dizziness ,
Meta Mapping (1000):
  1000   Dizzyness (Dizziness) [Sign or Symptom]
Meta Mapping (1000):
  1000   dizziness (Vertigo) [Sign or Symptom]
Meta Mapping (1000):
  1000   Dizziness (Dizziness Adverse Event) [Finding]

Phrase: light-headedness ,
Meta Mapping (1000):
  1000   Lightheadedness (Dizziness) [Sign or Symptom]
Meta Mapping (1000):
  1000   LIGHTHEADEDNESS (Lightheadedness) [Sign or Symptom]

Phrase: and

Phrase: pallor .
Meta Mapping (1000):
  1000   PALLOR (Pallor) [Finding]
Processing 00000000.tx.78: Shellfish , which causes nausea and vomiting . 

Phrase: Shellfish ,
Meta Mapping (1000):
  1000   Shellfish (Shellfish - dietary) [Food]
Meta Mapping (1000):
  1000   SHELLFISH (Shellfish) [Eukaryote]

Phrase: which

Phrase: causes
Meta Mapping (1000):
  1000   causes (Etiology aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Causes (Etiology) [Functional Concept]
Meta Mapping (1000):
  1000   Cause (Science of Etiology) [Conceptual Entity]

Phrase: nausea
Meta Mapping (1000):
  1000   NAUSEA (Nausea) [Sign or Symptom]
Meta Mapping (1000):
  1000   Nausea (Nausea Adverse Event) [Pathologic Function]

Phrase: and

Phrase: vomiting .
Meta Mapping (1000):
  1000   VOMITING (Vomiting) [Sign or Symptom]
Meta Mapping (1000):
  1000   Vomiting (Vomiting Adverse Event) [Pathologic Function]
Processing 00000000.tx.79: There were no murmurs . 

Phrase: There

Phrase: were

Phrase: no murmurs .
Meta Mapping (1000):
  1000 N murmurs (Heart murmur) [Finding]
Processing 00000000.tx.80: Finger-to-nose and heel-to-shin were normal . 

Phrase: Finger-to-nose
Meta Mapping (802):
   660   FINGER (Fingers) [Body Location or Region]
   827   NOSE (Nose) [Body Part, Organ, or Organ Component]
Meta Mapping (802):
   660   FINGER (Fingers) [Body Location or Region]
   827   Nose (Entire nose) [Body Part, Organ, or Organ Component]
Meta Mapping (802):
   660   Finger (Entire finger) [Body Part, Organ, or Organ Component]
   827   NOSE (Nose) [Body Part, Organ, or Organ Component]
Meta Mapping (802):
   660   Finger (Entire finger) [Body Part, Organ, or Organ Component]
   827   Nose (Entire nose) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: heel-to-shin
Meta Mapping (802):
   660   Heel [Body Location or Region]
   827   Shin [Body Location or Region]
Meta Mapping (802):
   660   Heel (Entire heel) [Body Location or Region]
   827   Shin [Body Location or Region]

Phrase: were

Phrase: normal .
Meta Mapping (1000):
  1000   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (1000):
  1000   Normal (Gait normal) [Finding]
Meta Mapping (1000):
  1000   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (1000):
  1000   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.81: ELECTROCARDIOGRAM : A right heart catheterization was performed , and a left heart catheterization was performed , which revealed a right atrial pressure of 10 , a right ventricular pressure of 60/10 , a pulmonary arterial pressure of 40 , a pulmonary capillary wedge pressure of 34 , a left ventricular pressure of 115/24 . 

Phrase: ELECTROCARDIOGRAM
Meta Mapping (1000):
  1000   Electrocardiogram [Finding]
Meta Mapping (1000):
  1000   Electro-Cardiogram [Spatial Concept]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]

Phrase: :

Phrase: A right heart catheterization
Meta Mapping (1000):
  1000   Right heart catheterisation (Catheterization of right heart) [Diagnostic Procedure]

Phrase: was

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: ,

Phrase: and

Phrase: a left heart catheterization
Meta Mapping (1000):
  1000   Left Heart Catheterization (Catheterization of left heart) [Diagnostic Procedure]

Phrase: was

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: ,

Phrase: which

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a right atrial pressure of 10 ,
Meta Mapping (780):
   833   Right atrial pressure [Clinical Attribute]
   586   10% [Finding]
Meta Mapping (780):
   833   Right atrial pressure (Intrachamber:Pres:Pt:Heart.atrium.right:Qn) [Clinical Attribute]
   586   10% [Finding]

Phrase: a right ventricular pressure of 60/10 ,
Meta Mapping (746):
   814   Right ventricular pressure [Laboratory or Test Result]
   581   60% [Finding]
   581   10% [Finding]

Phrase: a pulmonary arterial pressure of 40 ,
Meta Mapping (780):
   833   pulmonary arterial pressure [Diagnostic Procedure]
   586   /40 [Temporal Concept]
Meta Mapping (780):
   833   pulmonary arterial pressure [Diagnostic Procedure]
   586   40% [Quantitative Concept]

Phrase: a pulmonary capillary wedge pressure of 34 ,
Meta Mapping (853):
   853   Pulmonary Capillary Wedge Pressure [Clinical Attribute]

Phrase: a left ventricular pressure of 115/24 .
Meta Mapping (814):
   814   Left ventricular pressure [Laboratory or Test Result]
Processing 00000000.tx.82: Captopril 25 mg. p.o. q.i.d. 

Phrase: Captopril 25 mg. p.o. q.i.d.
Meta Mapping (835):
   835   Captopril 25 MG [Clinical Drug]
Processing 00000000.tx.83: Digoxin 0.125 mg. p.o. q.d. 

Phrase: Digoxin 0.125 mg. p.o. q.d.
Meta Mapping (795):
   626   DIGOXIN (Digoxin) [Organic Chemical,Pharmacologic Substance]
   850   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.84: Lasix 80 mg. p.o. q.d. 

Phrase: Lasix 80 mg. p.o. q.d.
Meta Mapping (772):
   629   Lasix [Organic Chemical,Pharmacologic Substance]
   629   80% [Finding]
   861   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.85: Isordil 20 mg. p.o. at 8:00 a.m. and 1:00 p.m. 

Phrase: Isordil 20 mg. p.o.
Meta Mapping (699):
   699   Isosorbide Dinitrate 20 MG [Clinical Drug]

Phrase: at 8

Phrase: :

Phrase: 00 a.m.
Meta Mapping (827):
   827   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (827):
   827   M+ (M+ (tumor staging)) [Intellectual Product]

Phrase: and

Phrase: 1
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]

Phrase: :

Phrase: 00 p.m.
Meta Mapping (827):
   827   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (827):
   827   M+ (M+ (tumor staging)) [Intellectual Product]
Processing 00000000.tx.86: Metoprolol 12.5 mg. p.o. t.i.d. 

Phrase: Metoprolol 12.5 mg. p.o. t.i.d.
Meta Mapping (794):
   791   METOPROLOL (Metoprolol) [Organic Chemical,Pharmacologic Substance]
   854   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.87: Nitroglycerin sublingual p.r.n. chest pain . 

Phrase: Nitroglycerin sublingual p.r.n. chest pain .
Meta Mapping (773):
   629   nitroglycerine (Nitroglycerin) [Organic Chemical,Pharmacologic Substance]
   629   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   CHEST PAIN (Chest Pain) [Sign or Symptom]
Meta Mapping (773):
   629   nitroglycerine (Nitroglycerin) [Organic Chemical,Pharmacologic Substance]
   629   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (773):
   629   nitroglycerine (Nitroglycerin) [Organic Chemical,Pharmacologic Substance]
   629   Sublingual (Sublingual location) [Body Location or Region]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   CHEST PAIN (Chest Pain) [Sign or Symptom]
Meta Mapping (773):
   629   nitroglycerine (Nitroglycerin) [Organic Chemical,Pharmacologic Substance]
   629   Sublingual (Sublingual location) [Body Location or Region]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (773):
   629   nitroglycerine (Glonoine, nitroglycerine, Homeopathic preparation) [Organic Chemical,Pharmacologic Substance]
   629   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   CHEST PAIN (Chest Pain) [Sign or Symptom]
Meta Mapping (773):
   629   nitroglycerine (Glonoine, nitroglycerine, Homeopathic preparation) [Organic Chemical,Pharmacologic Substance]
   629   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (773):
   629   nitroglycerine (Glonoine, nitroglycerine, Homeopathic preparation) [Organic Chemical,Pharmacologic Substance]
   629   Sublingual (Sublingual location) [Body Location or Region]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   CHEST PAIN (Chest Pain) [Sign or Symptom]
Meta Mapping (773):
   629   nitroglycerine (Glonoine, nitroglycerine, Homeopathic preparation) [Organic Chemical,Pharmacologic Substance]
   629   Sublingual (Sublingual location) [Body Location or Region]
   651   R.N. (Registered nurse) [Professional or Occupational Group]
   818   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Processing 00000000.tx.88: Index No. 

Phrase: Index
Meta Mapping (1000):
  1000   Index [Intellectual Product]
Meta Mapping (1000):
  1000   index (Html Link Type - index) [Idea or Concept]
Meta Mapping (1000):
  1000   % index [Quantitative Concept]

Phrase: No.
Processing 00000000.tx.89: <TEXT> 488202469 She , on one occasion , had sinus rhythm very briefly . 

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 488202469

Phrase: She ,

Phrase: on one occasion ,
Meta Mapping (853):
   694   ONE (One) [Quantitative Concept]
   789   Occasional (Infrequent) [Temporal Concept]

Phrase: had

Phrase: sinus rhythm very briefly .
Meta Mapping (824):
   861   SINUS RHYTHM (Sinus rhythm) [Finding]
   812   Very [Qualitative Concept]
Meta Mapping (824):
   861   SINUS RHYTHM (Sinus rhythm) [Finding]
   812   Very (Very Much) [Qualitative Concept]
Processing 00000000.tx.90: Nevertheless , because of recurrent failure , it was felt that she should be transferred up to the Bri Health for further evaluation . 

Phrase: Nevertheless ,

Phrase: because of recurrent failure ,
Meta Mapping (888):
   694   RECURRENT (Recurrent) [Temporal Concept]
   861   FAILURE (Failure (biologic function)) [Functional Concept]
Meta Mapping (888):
   694   RECURRENT (Recurrent) [Temporal Concept]
   861   failure (Personal failure) [Individual Behavior]

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: she

Phrase: should

Phrase: be

Phrase: transferred up to the Bri Health
Meta Mapping (672):
   753   transferred (Surgical transfer - action) [Functional Concept]
   753   BRI (ITM2B gene) [Gene or Genome]
   753   Health [Idea or Concept]
Meta Mapping (672):
   753   Transferred (Transfer Technique) [Functional Concept]
   753   BRI (ITM2B gene) [Gene or Genome]
   753   Health [Idea or Concept]

Phrase: for further evaluation .
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Evaluation [Health Care Activity]
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Evaluation (Evaluation procedure) [Health Care Activity]
Processing 00000000.tx.91: The observation in the hospital showed that she had recurrent runs of rapid atrial fibrillation as well as rapid supraventricular tachycardia going around 130 . 

Phrase: The observation in the hospital
Meta Mapping (686):
   760   Observation (Observation in research) [Research Activity]
   593   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (686):
   760   Observation (Observation in research) [Research Activity]
   593   Hospital (Hospital environment) [Qualitative Concept]
Meta Mapping (686):
   760   Observation (Patient observation) [Health Care Activity]
   593   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (686):
   760   Observation (Patient observation) [Health Care Activity]
   593   Hospital (Hospital environment) [Qualitative Concept]
Meta Mapping (686):
   760   OBSERVATION (Observation - diagnostic procedure) [Diagnostic Procedure]
   593   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (686):
   760   OBSERVATION (Observation - diagnostic procedure) [Diagnostic Procedure]
   593   Hospital (Hospital environment) [Qualitative Concept]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: that

Phrase: she

Phrase: had

Phrase: recurrent runs of rapid atrial fibrillation
Meta Mapping (776):
   654   recurrent atrial fibrillation (atrial fibrillation recurrent) [Disease or Syndrome]
   753   Runs (Does run (finding)) [Finding]
   586   Rapid [Qualitative Concept]
Meta Mapping (776):
   586   RECURRENT (Recurrent) [Temporal Concept]
   753   Runs (Does run (finding)) [Finding]
   666   Rapid atrial fibrillation [Disease or Syndrome]

Phrase: as well as

Phrase: rapid supraventricular tachycardia
Meta Mapping (901):
   660   Rapid [Qualitative Concept]
   901   SUPRAVENTRICULAR TACHYCARDIA (Supraventricular tachycardia) [Disease or Syndrome]
Meta Mapping (901):
   660   Rapid [Qualitative Concept]
   901   Supraventricular tachycardia (Supraventricular Tachycardia Adverse Event) [Pathologic Function]
Meta Mapping (901):
   660   Rapid [Qualitative Concept]
   901   Supraventricular Tachycardia (Supraventricular Tachycardia by ECG Finding) [Finding]

Phrase: going around 130 .
Processing 00000000.tx.92: We will ambulate her over the next couple of days . 

Phrase: We

Phrase: will

Phrase: ambulate
Meta Mapping (1000):
  1000   Ambulate [Finding]

Phrase: her over the next couple of days .
Meta Mapping (656):
   748   next (Adjacent) [Spatial Concept]
   748   couple (Couples (persons)) [Family Group]
   748   DAYS (day) [Temporal Concept]
Meta Mapping (656):
   748   next (Adjacent) [Spatial Concept]
   748   Couple (Couple (action)) [Functional Concept]
   748   DAYS (day) [Temporal Concept]
Meta Mapping (656):
   748   Next (Following) [Temporal Concept]
   748   couple (Couples (persons)) [Family Group]
   748   DAYS (day) [Temporal Concept]
Meta Mapping (656):
   748   Next (Following) [Temporal Concept]
   748   Couple (Couple (action)) [Functional Concept]
   748   DAYS (day) [Temporal Concept]
Meta Mapping (656):
   748   Next (Then) [Temporal Concept]
   748   couple (Couples (persons)) [Family Group]
   748   DAYS (day) [Temporal Concept]
Meta Mapping (656):
   748   Next (Then) [Temporal Concept]
   748   Couple (Couple (action)) [Functional Concept]
   748   DAYS (day) [Temporal Concept]
Processing 00000000.tx.93: 05/12/92 </TEXT> DIS January 2 CT scan of the chest showed a type III descending thoracic aortic aneurysm beginning distal to the left subclavian artery and ending above the renal artery . 

Phrase: 05/12/92

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > DIS January 2 CT scan of the chest
Meta Mapping (760):
   578   DIS (Diagnostic interview schedule) [Intellectual Product]
   578   January [Qualitative Concept]
   822   CT scan of chest (Chest CT) [Diagnostic Procedure]
Meta Mapping (760):
   578   DIS (Diagnostic interview schedule) [Intellectual Product]
   578   January [Qualitative Concept]
   822   CT scan of chest [Diagnostic Procedure]
Meta Mapping (760):
   578   DIS (Discontinued) [Finding]
   578   January [Qualitative Concept]
   822   CT scan of chest (Chest CT) [Diagnostic Procedure]
Meta Mapping (760):
   578   DIS (Discontinued) [Finding]
   578   January [Qualitative Concept]
   822   CT scan of chest [Diagnostic Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a type III
Meta Mapping (1000):
  1000   Type III (Type 3) [Classification]

Phrase: descending
Meta Mapping (1000):
  1000   Descending [Qualitative Concept]
Meta Mapping (1000):
  1000   Descending (Sequencing - Descending) [Functional Concept]

Phrase: thoracic aortic aneurysm
Meta Mapping (1000):
  1000   ANEURYSM, THORACIC AORTIC (Aortic Aneurysm, Thoracic) [Disease or Syndrome]

Phrase: beginning
Meta Mapping (1000):
  1000   Beginning [Temporal Concept]

Phrase: distal to the left subclavian artery
Meta Mapping (901):
   901   Distal to left subclavian artery [Spatial Concept]

Phrase: and

Phrase: ending above the renal artery .
Meta Mapping (745):
   760   ending (End) [Spatial Concept]
   640   RENAL ARTERY (Structure of renal artery) [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   ending (End) [Spatial Concept]
   640   Renal artery (Entire renal artery) [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   Ending (Stop (qualifier value)) [Temporal Concept]
   640   RENAL ARTERY (Structure of renal artery) [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   Ending (Stop (qualifier value)) [Temporal Concept]
   640   Renal artery (Entire renal artery) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.94: The patient reports having been hospitalized for approximately one month , at which time she was discharged to a nursing home after refusing surgery . 

Phrase: The patient reports
Meta Mapping (983):
   983   patient report [Finding]

Phrase: having

Phrase: been

Phrase: hospitalized for approximately one month ,
Meta Mapping (761):
   760   HOSPITALIZED (Patient in hospital) [Finding]
   760   Approximately (Approximate) [Qualitative Concept]
   806   One month [Temporal Concept]

Phrase: at which time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: she

Phrase: was

Phrase: discharged to a nursing home
Meta Mapping (879):
   879   Discharge to nursing home [Health Care Activity]

Phrase: after refusing surgery .
Meta Mapping (872):
   661   Refuse (Garbage) [Environmental Effect of Humans]
   861   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (872):
   661   Refuse (Garbage) [Environmental Effect of Humans]
   861   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (872):
   661   Refuse (Garbage) [Environmental Effect of Humans]
   861   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (872):
   661   Refuse (Garbage) [Environmental Effect of Humans]
   861   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (872):
   661   Refuse (Garbage) [Environmental Effect of Humans]
   861   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Meta Mapping (872):
   661   REFUSE (Refused) [Activity]
   861   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (872):
   661   REFUSE (Refused) [Activity]
   861   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (872):
   661   REFUSE (Refused) [Activity]
   861   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (872):
   661   REFUSE (Refused) [Activity]
   861   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (872):
   661   REFUSE (Refused) [Activity]
   861   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Processing 00000000.tx.95: Status post total abdominal hysterectomy . 

Phrase: Status post total abdominal hysterectomy .
Meta Mapping (1000):
  1000   Total Abdominal Hysterectomy (Total abdominal hysterectomy) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.96: MEDICATIONS : She is afebrile with irregular heart rate at 96 . 

Phrase: MEDICATIONS
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: She

Phrase: is

Phrase: afebrile with irregular heart rate
Meta Mapping (816):
   760   Afebrile (Apyrexial) [Finding]
   695   Irregular heart rate (Irregular heart beat) [Finding]

Phrase: at 96 .
Processing 00000000.tx.97: Postoperatively the patient did require epinephrine and Levophed as well as resuscitation , multiple blood products . 

Phrase: Postoperatively

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: did

Phrase: require

Phrase: epinephrine
Meta Mapping (1000):
  1000   EPINEPHRINE (Epinephrine) [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: Levophed
Meta Mapping (1000):
  1000   Levophed [Organic Chemical,Pharmacologic Substance]

Phrase: as well as

Phrase: resuscitation ,
Meta Mapping (1000):
  1000   Resuscitation (Resuscitation procedure) [Therapeutic or Preventive Procedure]

Phrase: multiple blood products .
Meta Mapping (901):
   660   MULTIPLE (Numerous) [Quantitative Concept]
   901   Blood products (Blood product) [Pharmacologic Substance]
Processing 00000000.tx.98: Her chest x-ray prior to discharge demonstrated bilateral small effusions , right greater than left . 

Phrase: Her chest x-ray prior to discharge
Meta Mapping (810):
   814   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   612   Prior to (Before) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (810):
   814   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   612   Prior to (Before) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (810):
   814   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   612   Prior to (Before) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (810):
   814   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   612   Prior to (Before) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (810):
   814   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   612   Prior to (Before) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (810):
   814   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   612   Prior to (Before) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]

Phrase: demonstrated

Phrase: bilateral small effusions ,
Meta Mapping (851):
   660   BILATERAL (Bilateral) [Spatial Concept]
   660   SMALL (Small) [Quantitative Concept]
   827   EFFUSIONS (effusion) [Pathologic Function]

Phrase: right
Meta Mapping (1000):
  1000   RIGHT (Right) [Spatial Concept]
Meta Mapping (1000):
  1000   Right (Right sided) [Spatial Concept]

Phrase: greater than left .
Meta Mapping (901):
   882   Greater Than [Quantitative Concept]
   623   LEFT (Left) [Spatial Concept]
Meta Mapping (901):
   882   Greater Than [Quantitative Concept]
   623   Left (Left sided) [Spatial Concept]
Meta Mapping (901):
   882   Greater Than [Quantitative Concept]
   623   left (Table Cell Horizontal Align - left) [Functional Concept]
Processing 00000000.tx.99: DISPOSITION : Albuterol nebulizer 2.5 milligrams q.4h. 

Phrase: DISPOSITION
Meta Mapping (1000):
  1000   Disposition [Idea or Concept]
Meta Mapping (1000):
  1000   Disposition (Disposition Domain) [Intellectual Product]

Phrase: :

Phrase: Albuterol nebulizer 2.5 milligrams q.4h.
Meta Mapping (735):
   629   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   629   Nebuliser (Nebulizers) [Medical Device]
   629   milligrams (milligram) [Quantitative Concept]
   795   4H (4 Hours) [Temporal Concept]
Meta Mapping (735):
   629   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   629   Nebulizer (Nebulizer Device Component) [Manufactured Object]
   629   milligrams (milligram) [Quantitative Concept]
   795   4H (4 Hours) [Temporal Concept]
Processing 00000000.tx.100: alternating with Atrovent nebulizer 0.5 milligrams inhaler q.4h. 

Phrase: alternating with Atrovent nebulizer 0.5 milligrams inhaler q.4h.
Meta Mapping (710):
   739   Alternating [Functional Concept]
   573   Atrovent [Organic Chemical,Pharmacologic Substance]
   573   Nebuliser (Nebulizers) [Medical Device]
   593   0/5 [Quantitative Concept]
   573   milligrams (milligram) [Quantitative Concept]
   573   INHALER (Inhaler) [Medical Device]
   573   4H (4 Hours) [Temporal Concept]
Meta Mapping (710):
   739   Alternating [Functional Concept]
   573   Atrovent [Organic Chemical,Pharmacologic Substance]
   573   Nebuliser (Nebulizers) [Medical Device]
   593   0/5 [Quantitative Concept]
   573   milligrams (milligram) [Quantitative Concept]
   573   INHALER (Inhaler Dosing Unit) [Quantitative Concept]
   573   4H (4 Hours) [Temporal Concept]
Meta Mapping (710):
   739   Alternating [Functional Concept]
   573   Atrovent [Organic Chemical,Pharmacologic Substance]
   573   Nebulizer (Nebulizer Device Component) [Manufactured Object]
   593   0/5 [Quantitative Concept]
   573   milligrams (milligram) [Quantitative Concept]
   573   INHALER (Inhaler) [Medical Device]
   573   4H (4 Hours) [Temporal Concept]
Meta Mapping (710):
   739   Alternating [Functional Concept]
   573   Atrovent [Organic Chemical,Pharmacologic Substance]
   573   Nebulizer (Nebulizer Device Component) [Manufactured Object]
   593   0/5 [Quantitative Concept]
   573   milligrams (milligram) [Quantitative Concept]
   573   INHALER (Inhaler Dosing Unit) [Quantitative Concept]
   573   4H (4 Hours) [Temporal Concept]
Processing 00000000.tx.101: ; digoxin 0.25 milligrams p.o. q.d. 

Phrase: ; digoxin 0.25 milligrams p.o. q.d.
Meta Mapping (559):
   626   DIGOXIN (Digoxin) [Organic Chemical,Pharmacologic Substance]
   626   milligrams (milligram) [Quantitative Concept]
Processing 00000000.tx.102: ; Lasix 60 milligrams p.o. b.i.d. times ten days , continuation or discontinuation of this medication per Cardiology ; K-Dur 40 mEqp .o. q.d. times ten days ; Glyburide 2.5 milligrams p.o. b.i.d. 

Phrase: ; Lasix 60 milligrams p.o. b.i.d. times ten days ,
Meta Mapping (735):
   622   Lasix [Organic Chemical,Pharmacologic Substance]
   622   60% [Finding]
   622   milligrams (milligram) [Quantitative Concept]
   634   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
   793   times day (times/day) [Quantitative Concept]
   622   TEN (Toxic Epidermal Necrolysis) [Disease or Syndrome]
Meta Mapping (735):
   622   Lasix [Organic Chemical,Pharmacologic Substance]
   622   60% [Finding]
   622   milligrams (milligram) [Quantitative Concept]
   634   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
   793   times day (times/day) [Quantitative Concept]
   622   Ten [Quantitative Concept]
Meta Mapping (735):
   622   Lasix [Organic Chemical,Pharmacologic Substance]
   622   60% [Finding]
   622   milligrams (milligram) [Quantitative Concept]
   634   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
   622   times (Time) [Temporal Concept]
   784   TEN-DAY (Ten-Day Report) [Intellectual Product]
Meta Mapping (735):
   622   Lasix [Organic Chemical,Pharmacologic Substance]
   622   60% [Finding]
   622   milligrams (milligram) [Quantitative Concept]
   634   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
   622   Times [Quantitative Concept]
   784   TEN-DAY (Ten-Day Report) [Intellectual Product]

Phrase: continuation

Phrase: or

Phrase: discontinuation of this medication
Meta Mapping (708):
   770   Discontinuation (Discontinuation (procedure)) [Health Care Activity]
   604   Medication (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (708):
   770   Discontinuation (Discontinuation (procedure)) [Health Care Activity]
   604   medication (medication - HL7 publishing domain) [Functional Concept]
Meta Mapping (708):
   770   Discontinuation (Discontinued) [Finding]
   604   Medication (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (708):
   770   Discontinuation (Discontinued) [Finding]
   604   medication (medication - HL7 publishing domain) [Functional Concept]

Phrase: per Cardiology
Meta Mapping (1000):
  1000   Cardiology (Cardiology discipline) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Cardiology (Cardiology service) [Health Care Related Organization]

Phrase: ; K-Dur 40 mEqp .o. q.d. times ten days
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   /40 [Temporal Concept]
   796   times day (times/day) [Quantitative Concept]
   623   TEN (Toxic Epidermal Necrolysis) [Disease or Syndrome]
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   /40 [Temporal Concept]
   796   times day (times/day) [Quantitative Concept]
   623   Ten [Quantitative Concept]
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   /40 [Temporal Concept]
   623   times (Time) [Temporal Concept]
   787   TEN-DAY (Ten-Day Report) [Intellectual Product]
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   /40 [Temporal Concept]
   623   Times [Quantitative Concept]
   787   TEN-DAY (Ten-Day Report) [Intellectual Product]
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   40% [Quantitative Concept]
   796   times day (times/day) [Quantitative Concept]
   623   TEN (Toxic Epidermal Necrolysis) [Disease or Syndrome]
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   40% [Quantitative Concept]
   796   times day (times/day) [Quantitative Concept]
   623   Ten [Quantitative Concept]
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   40% [Quantitative Concept]
   623   times (Time) [Temporal Concept]
   787   TEN-DAY (Ten-Day Report) [Intellectual Product]
Meta Mapping (742):
   637   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   623   40% [Quantitative Concept]
   623   Times [Quantitative Concept]
   787   TEN-DAY (Ten-Day Report) [Intellectual Product]

Phrase: ; Glyburide 2.5 milligrams p.o. b.i.d.
Meta Mapping (718):
   791   GLYBURIDE (Glyburide) [Organic Chemical,Pharmacologic Substance]
   791   milligrams (milligram) [Quantitative Concept]
Processing 00000000.tx.103: ; sliding scale regular insulin q.a.c and h.s. 

Phrase: ; sliding scale regular insulin q.a.c
Meta Mapping (599):
   651   sliding scale [Therapeutic or Preventive Procedure]
   651   Insulin, Regular (Insulin) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: and

Phrase: h.s.
Meta Mapping (861):
   861   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (861):
   861   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (861):
   861   H+ (Hepatic Involvement) [Classification]
Meta Mapping (861):
   861   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.104: ; Percocet one to two tablets p.o. q.4h. 

Phrase: ; Percocet one to two tablets p.o. q.4h.
Meta Mapping (667):
   595   Percocet Tablets [Clinical Drug]
   742   ONE (One) [Quantitative Concept]
   575   Two [Quantitative Concept]
   575   4H (4 Hours) [Temporal Concept]
Processing 00000000.tx.105: p.r.n. pain ; Lopressor 75 milligrams p.o.b.i.d.; Premarin 0.625 milligrams p.o. q.d. 

Phrase: p.r.n. pain
Meta Mapping (861):
   645   P NOS (P Blood group antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   694   R.N. (Registered nurse) [Professional or Occupational Group]
   812   PAIN (Pain) [Sign or Symptom]
Meta Mapping (861):
   645   P NOS (P Blood group antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   694   R.N. (Registered nurse) [Professional or Occupational Group]
   812   Pain NOS (Pain NOS Adverse Event) [Finding]
Meta Mapping (861):
   645   P' (P prime) [Clinical Attribute]
   694   R.N. (Registered nurse) [Professional or Occupational Group]
   812   PAIN (Pain) [Sign or Symptom]
Meta Mapping (861):
   645   P' (P prime) [Clinical Attribute]
   694   R.N. (Registered nurse) [Professional or Occupational Group]
   812   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: ; Lopressor 75 milligrams p.o.b.i.d.
Meta Mapping (545):
   626   Lopressor [Organic Chemical,Pharmacologic Substance]
   626   milligrams (milligram) [Quantitative Concept]

Phrase: ; Premarin 0.625 milligrams p.o. q.d.
Meta Mapping (559):
   626   Premarin [Hormone,Organic Chemical,Pharmacologic Substance]
   626   milligrams (milligram) [Quantitative Concept]
Processing 00000000.tx.106: ; Colace 100 milligramsp .o. t.i.d. 

Phrase: ; Colace 100 milligramsp .o. t.i.d.
Meta Mapping (707):
   795   Colace [Organic Chemical,Pharmacologic Substance]
   795   100% [Quantitative Concept]
Processing 00000000.tx.107: ; Captopril 37.5 milligrams p.o. t.i.d. 

Phrase: ; Captopril 37.5 milligrams p.o. t.i.d.
Meta Mapping (718):
   791   CAPTOPRIL (Captopril) [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   791   milligrams (milligram) [Quantitative Concept]
Processing 00000000.tx.108: ; enteric coated aspirin 325 milligrams p.o. q.d. 

Phrase: ; enteric coated aspirin 325 milligrams p.o. q.d.
Meta Mapping (603):
   660   enteric coated aspirin (aspirin enteric coated) [Organic Chemical,Pharmacologic Substance]
   624   milligrams (milligram) [Quantitative Concept]
Processing 00000000.tx.109: Dictated By : 1/2/2004 12:00:00 AM DISCHARGE PATIENT ON : YES Override added on 01/02/04 by KOTESLENT , ANT ODEWYJU , M.D. on order for AMIODARONE IV 1 ( ref # 45803793 ) SERIOUS INTERACTION : will follow B-3 and SIMVASTATIN B-3 and SIMVASTATIN 5 PLAVIX ( CLOPIDOGREL ) 75 MG PO QD Starting Today ( 01/06 ) KEFLEX ( CEPHALEXIN ) 500 MG PO QID X 40 doses AMIODARONE 400 MG PO QD House / Low chol / low sat. fat ALLERGY : in USOH until this am when felt LH and then ICD discharge . 

Phrase: Dictated By
Meta Mapping (833):
   833   dictated (dictated - ParticipationMode) [Functional Concept]
Meta Mapping (833):
   833   Dictated (dictated - DocumentCompletion) [Idea or Concept]

Phrase: :

Phrase: 1/2/2004 12
Meta Mapping (861):
   861   1/2 [Intellectual Product]
Meta Mapping (861):
   861   1-2 (Phase I/II Trial) [Research Activity]
Meta Mapping (861):
   861   1-2 [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: DISCHARGE
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: PATIENT ON
Meta Mapping (833):
   833   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (833):
   833   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (833):
   833   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (833):
   833   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: :

Phrase: YES
Meta Mapping (1000):
  1000   Yes (Yes - Yes/no indicator) [Idea or Concept]
Meta Mapping (1000):
  1000   YES (Yes (indicator)) [Conceptual Entity]

Phrase: Override
Meta Mapping (1000):
  1000   Override [Activity]

Phrase: added on 01/02/04
Meta Mapping (760):
   760   Added (Additional) [Functional Concept]

Phrase: by KOTESLENT ,

Phrase: ANT ODEWYJU ,
Meta Mapping (694):
   694   Ant (Ants) [Eukaryote]
Meta Mapping (694):
   694   ANT (Adenine Nucleotide Translocase) [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]

Phrase: on order for AMIODARONE IV 1
Meta Mapping (672):
   753   Order (Order (document)) [Intellectual Product]
   586   AMIODARONE (Amiodarone) [Organic Chemical,Pharmacologic Substance]
   586   IV (Ivory Coast) [Geographic Area]
Meta Mapping (672):
   753   Order (Order (arrangement)) [Qualitative Concept]
   586   AMIODARONE (Amiodarone) [Organic Chemical,Pharmacologic Substance]
   586   IV (Ivory Coast) [Geographic Area]
Meta Mapping (672):
   753   Order (Order (taxonomic)) [Classification]
   586   AMIODARONE (Amiodarone) [Organic Chemical,Pharmacologic Substance]
   586   IV (Ivory Coast) [Geographic Area]
Meta Mapping (672):
   753   Order (Order (action)) [Activity]
   586   AMIODARONE (Amiodarone) [Organic Chemical,Pharmacologic Substance]
   586   IV (Ivory Coast) [Geographic Area]
Meta Mapping (672):
   753   Order (Permutation) [Qualitative Concept]
   586   AMIODARONE (Amiodarone) [Organic Chemical,Pharmacologic Substance]
   586   IV (Ivory Coast) [Geographic Area]
Meta Mapping (672):
   753   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]
   586   AMIODARONE (Amiodarone) [Organic Chemical,Pharmacologic Substance]
   586   IV (Ivory Coast) [Geographic Area]

Phrase: ( ref # 45803793
Meta Mapping (861):
   861   REF (ALYREF gene) [Gene or Genome]

Phrase: )

Phrase: SERIOUS INTERACTION
Meta Mapping (888):
   694   Serious [Qualitative Concept]
   861   Interaction [Functional Concept]

Phrase: :

Phrase: will

Phrase: follow
Meta Mapping (1000):
  1000   follow (Followed by) [Temporal Concept]
Meta Mapping (1000):
  1000   Follow [Intellectual Product]

Phrase: B-3
Meta Mapping (1000):
  1000   b-3 (((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: SIMVASTATIN B-3
Meta Mapping (827):
   827   SIMVASTATIN (Simvastatin) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: SIMVASTATIN 5 PLAVIX
Meta Mapping (802):
   660   SIMVASTATIN (Simvastatin) [Organic Chemical,Pharmacologic Substance]
   827   Plavix [Organic Chemical,Pharmacologic Substance]

Phrase: ( CLOPIDOGREL
Meta Mapping (1000):
  1000   CLOPIDOGREL (clopidogrel) [Organic Chemical,Pharmacologic Substance]

Phrase: )

Phrase: 75 MG PO QD Starting Today
Meta Mapping (763):
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (763):
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (763):
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (763):
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (763):
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (763):
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (763):
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]
Meta Mapping (763):
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today [Antibiotic,Organic Chemical]
Meta Mapping (763):
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   QD (Daily) [Temporal Concept]
   599   Start (Beginning) [Temporal Concept]
   799   Today (Today (temporal qualifier)) [Temporal Concept]

Phrase: ( 01/06

Phrase: )

Phrase: KEFLEX
Meta Mapping (1000):
  1000   Keflex [Antibiotic,Organic Chemical]

Phrase: ( CEPHALEXIN
Meta Mapping (1000):
  1000   Cefalexin (Cephalexin) [Antibiotic,Organic Chemical]

Phrase: )

Phrase: 500 MG PO QID X 40 doses AMIODARONE 400 MG PO QD House / Low chol / low sat. fat ALLERGY
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   MG (Mongolia) [Geographic Area]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg% (mg/dL) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   mg % (Milligram percent) [Quantitative Concept]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Portugal) [Geographic Area]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   /40 [Temporal Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   house (Home environment) [Conceptual Entity]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 wt Allele) [Gene or Genome]
Meta Mapping (696):
   617   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   617   PO (Oral) [Spatial Concept]
   617   QID (Four times daily) [Temporal Concept]
   617   40% [Quantitative Concept]
   617   Doses (Dosage) [Quantitative Concept]
   848   Amiodarone allergy [Disease or Syndrome]
   617   QD (Daily) [Temporal Concept]
   617   House (House (environment)) [Manufactured Object]
   640   low fat (Fat-Restricted Diet) [Therapeutic or Preventive Procedure]
   617   CHOL (Cholesterol measurement test) [Laboratory Procedure]
   617   SAT (SAT1 protein, human) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :

Phrase: in USOH until this

Phrase: am

Phrase: when

Phrase: felt LH
Meta Mapping (872):
   661   feel (Emotions) [Mental Process]
   861   LH (Lithuania) [Geographic Area]

Phrase: and

Phrase: then ICD discharge .
Meta Mapping (851):
   660   Then [Temporal Concept]
   660   ICD (Disruptive, Impulse Control, and Conduct Disorders) [Mental or Behavioral Dysfunction]
   827   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (851):
   660   Then [Temporal Concept]
   660   ICD (Disruptive, Impulse Control, and Conduct Disorders) [Mental or Behavioral Dysfunction]
   827   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (851):
   660   Then [Temporal Concept]
   660   ICD (Disruptive, Impulse Control, and Conduct Disorders) [Mental or Behavioral Dysfunction]
   827   Discharge (Discharge, body substance) [Body Substance]
Processing 00000000.tx.110: 39.1 , ECG is AV paced but prior shower R on T VPB c monomorphic VT then overdrive paced . 

Phrase: 39.1 ,

Phrase: ECG
Meta Mapping (1000):
  1000   ECG NOS (Electrocardiography) [Diagnostic Procedure]

Phrase: is

Phrase: AV paced
Meta Mapping (827):
   827   PACE (paired basic amino acid cleaving enzyme) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (827):
   827   Pace (pace - unit of measure) [Quantitative Concept]
Meta Mapping (827):
   827   PACE (cisplatin/cyclophosphamide/doxorubicin/etoposide) [Pharmacologic Substance]

Phrase: but

Phrase: prior shower R on T VPB c monomorphic VT
Meta Mapping (679):
   575   Prior (Before) [Temporal Concept]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R T (Total airway resistance) [Clinical Attribute]
   575   VPB (Premature ventricular contractions) [Pathologic Function]
   575   VT (Vatican City) [Geographic Area]
Meta Mapping (679):
   575   Prior (Before) [Temporal Concept]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R T (Total airway resistance) [Clinical Attribute]
   575   VPB (bleomycin/procarbazine/vinblastine) [Therapeutic or Preventive Procedure]
   575   VT (Vatican City) [Geographic Area]
Meta Mapping (679):
   575   Prior (Before) [Temporal Concept]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R & C [Organic Chemical,Pharmacologic Substance]
   575   VPB (Premature ventricular contractions) [Pathologic Function]
   575   VT (Vatican City) [Geographic Area]
Meta Mapping (679):
   575   Prior (Before) [Temporal Concept]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R & C [Organic Chemical,Pharmacologic Substance]
   575   VPB (bleomycin/procarbazine/vinblastine) [Therapeutic or Preventive Procedure]
   575   VT (Vatican City) [Geographic Area]
Meta Mapping (679):
   575   PRIOR (Prior Medication Usage) [Event]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R T (Total airway resistance) [Clinical Attribute]
   575   VPB (Premature ventricular contractions) [Pathologic Function]
   575   VT (Vatican City) [Geographic Area]
Meta Mapping (679):
   575   PRIOR (Prior Medication Usage) [Event]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R T (Total airway resistance) [Clinical Attribute]
   575   VPB (bleomycin/procarbazine/vinblastine) [Therapeutic or Preventive Procedure]
   575   VT (Vatican City) [Geographic Area]
Meta Mapping (679):
   575   PRIOR (Prior Medication Usage) [Event]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R & C [Organic Chemical,Pharmacologic Substance]
   575   VPB (Premature ventricular contractions) [Pathologic Function]
   575   VT (Vatican City) [Geographic Area]
Meta Mapping (679):
   575   PRIOR (Prior Medication Usage) [Event]
   575   Shower (Shower (physical object)) [Manufactured Object]
   762   R & C [Organic Chemical,Pharmacologic Substance]
   575   VPB (bleomycin/procarbazine/vinblastine) [Therapeutic or Preventive Procedure]
   575   VT (Vatican City) [Geographic Area]

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: overdrive

Phrase: paced .
Meta Mapping (966):
   966   PACE (paired basic amino acid cleaving enzyme) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (966):
   966   Pace (pace - unit of measure) [Quantitative Concept]
Meta Mapping (966):
   966   PACE (cisplatin/cyclophosphamide/doxorubicin/etoposide) [Pharmacologic Substance]
Processing 00000000.tx.111: **** Course baseline PFTs as staring amio

Phrase: *

Phrase: *

Phrase: *

Phrase: * Course baseline PFTs as staring amio
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   719   PFT (Pulmonary function tests) [Diagnostic Procedure]
   586   Staring [Disease or Syndrome]
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   719   PFT (Pulmonary function tests) [Diagnostic Procedure]
   586   STARING (RNF40 gene) [Gene or Genome]
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   719   PFT (fluorouracil/melphalan/tamoxifen) [Therapeutic or Preventive Procedure]
   586   Staring [Disease or Syndrome]
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   719   PFT (fluorouracil/melphalan/tamoxifen) [Therapeutic or Preventive Procedure]
   586   STARING (RNF40 gene) [Gene or Genome]
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   Baseline [Quantitative Concept]
   719   PFT (Pulmonary function tests) [Diagnostic Procedure]
   586   Staring [Disease or Syndrome]
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   Baseline [Quantitative Concept]
   719   PFT (Pulmonary function tests) [Diagnostic Procedure]
   586   STARING (RNF40 gene) [Gene or Genome]
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   Baseline [Quantitative Concept]
   719   PFT (fluorouracil/melphalan/tamoxifen) [Therapeutic or Preventive Procedure]
   586   Staring [Disease or Syndrome]
Meta Mapping (689):
   586   Course [Temporal Concept]
   586   Baseline [Quantitative Concept]
   719   PFT (fluorouracil/melphalan/tamoxifen) [Therapeutic or Preventive Procedure]
   586   STARING (RNF40 gene) [Gene or Genome]
Processing 00000000.tx.1: 270045381 6676757 JUNK , KACHOLERA DISCHARGE DATE : Adult-onset diabetes mellitus x 40 years , history of silent myocardial infarction , coronary artery bypass graft ( three vessels in 1987 ) , history of chronic , stable angina pectoris , Fournier &apos;s gangrene versus necrotizing fasciitis , congestive heart failure in 03/97 while in the hospital for a rib fracture , glaucoma , diabetic retinopathy with blindness in the right eye , history of gastric stapling , left rib fracture , right femur surgery . 

Phrase: 270045381 6676757 JUNK ,
Meta Mapping (827):
   827   Junk (Heroin) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: KACHOLERA DISCHARGE DATE
Meta Mapping (901):
   901   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (901):
   901   Discharge date [Temporal Concept]

Phrase: :

Phrase: Adult-onset diabetes mellitus x 40 years ,
Meta Mapping (823):
   710   ADULT ONSET DIABETES MELLITUS (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   629   /40 [Temporal Concept]
   795   YEARS (year) [Temporal Concept]
Meta Mapping (823):
   710   ADULT ONSET DIABETES MELLITUS (Diabetes Mellitus, Non-Insulin-Dependent) [Disease or Syndrome]
   629   40% [Quantitative Concept]
   795   YEARS (year) [Temporal Concept]

Phrase: history of silent myocardial infarction ,
Meta Mapping (928):
   891   History of Myocardial Infarction (Old myocardial infarction) [Disease or Syndrome]
   593   Silent [Qualitative Concept]
Meta Mapping (928):
   891   History of Myocardial Infarction (Old myocardial infarction) [Disease or Syndrome]
   593   Silent (Absence of Signs or Symptoms) [Finding]
Meta Mapping (928):
   891   History of - myocardial infarction (History of myocardial infarction) [Finding]
   593   Silent [Qualitative Concept]
Meta Mapping (928):
   891   History of - myocardial infarction (History of myocardial infarction) [Finding]
   593   Silent (Absence of Signs or Symptoms) [Finding]

Phrase: coronary artery bypass graft
Meta Mapping (1000):
  1000   Coronary Artery Bypass Graft (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   coronary artery bypass graft (coronary artery graft device) [Medical Device]

Phrase: ( three vessels in 1987
Meta Mapping (833):
   833   Three vessels [Body Part, Organ, or Organ Component]

Phrase: )

Phrase: ,

Phrase: history of chronic , stable angina pectoris ,
Meta Mapping (888):
   858   History of - angina pectoris (H/O: angina pectoris) [Finding]
   586   CHRONIC (chronic) [Temporal Concept]
   586   STABLE (Stable status) [Qualitative Concept]
Meta Mapping (888):
   858   History of - angina pectoris (H/O: angina pectoris) [Finding]
   586   CHRONIC (chronic) [Temporal Concept]
   586   Stable (Patient Condition Code - Stable) [Intellectual Product]

Phrase: Fournier &apos

Phrase: ;s gangrene
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   GANGRENE (Gangrene) [Disease or Syndrome]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   GANGRENE (Gangrene) [Disease or Syndrome]

Phrase: versus

Phrase: necrotizing fasciitis ,
Meta Mapping (1000):
  1000   Necrotising fasciitis (Necrotizing fasciitis) [Disease or Syndrome]

Phrase: congestive heart failure in 03/97
Meta Mapping (780):
   833   CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
   586   97 [Intellectual Product]
Meta Mapping (780):
   833   CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
   586   >97 [Quantitative Concept]

Phrase: while in the hospital
Meta Mapping (770):
   770   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (770):
   770   Hospital (Hospital environment) [Qualitative Concept]

Phrase: for a rib fracture ,
Meta Mapping (1000):
  1000   RIB FRACTURE (Rib Fractures) [Injury or Poisoning]

Phrase: glaucoma ,
Meta Mapping (1000):
  1000   GLAUCOMA (Glaucoma) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Glaucoma (Glaucoma (eukaryote)) [Eukaryote]
Meta Mapping (1000):
  1000   Glaucoma (Glaucoma Adverse Event) [Finding]

Phrase: diabetic retinopathy with blindness
Meta Mapping (783):
   833   DIABETIC RETINOPATHY (Diabetic Retinopathy) [Disease or Syndrome]
   604   BLINDNESS (Blind Vision) [Finding]

Phrase: in the right eye ,
Meta Mapping (1000):
  1000   Right Eye (Right eye) [Body Location or Region]

Phrase: history of gastric stapling ,
Meta Mapping (783):
   770   History [Occupation or Discipline]
   666   GASTRIC STAPLING (Stomach Stapling) [Therapeutic or Preventive Procedure]
Meta Mapping (783):
   770   history (Historical aspects qualifier) [Functional Concept]
   666   GASTRIC STAPLING (Stomach Stapling) [Therapeutic or Preventive Procedure]
Meta Mapping (783):
   770   History, NOS (History of present illness) [Organism Attribute]
   666   GASTRIC STAPLING (Stomach Stapling) [Therapeutic or Preventive Procedure]
Meta Mapping (783):
   770   History (Medical History) [Finding]
   666   GASTRIC STAPLING (Stomach Stapling) [Therapeutic or Preventive Procedure]
Meta Mapping (783):
   770   History (Concept History) [Conceptual Entity]
   666   GASTRIC STAPLING (Stomach Stapling) [Therapeutic or Preventive Procedure]
Meta Mapping (783):
   770   History (History of previous events) [Finding]
   666   GASTRIC STAPLING (Stomach Stapling) [Therapeutic or Preventive Procedure]

Phrase: left rib fracture ,
Meta Mapping (901):
   660   LEFT (Left) [Spatial Concept]
   901   RIB FRACTURE (Rib Fractures) [Injury or Poisoning]
Meta Mapping (901):
   660   Left (Left sided) [Spatial Concept]
   901   RIB FRACTURE (Rib Fractures) [Injury or Poisoning]
Meta Mapping (901):
   660   left (Table Cell Horizontal Align - left) [Functional Concept]
   901   RIB FRACTURE (Rib Fractures) [Injury or Poisoning]

Phrase: right femur surgery .
Meta Mapping (901):
   734   Right femur [Body Part, Organ, or Organ Component]
   827   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (901):
   734   Right femur [Body Part, Organ, or Organ Component]
   827   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (901):
   734   Right femur [Body Part, Organ, or Organ Component]
   827   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (901):
   734   Right femur [Body Part, Organ, or Organ Component]
   827   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (901):
   734   Right femur [Body Part, Organ, or Organ Component]
   827   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Processing 00000000.tx.2: Upper endoscopy x 2 . 

Phrase: Upper endoscopy x 2 .
Meta Mapping (861):
   861   upper endoscopy (Endoscopy of stomach) [Diagnostic Procedure]
Processing 00000000.tx.3: The fracture was seen by Orthopedics and was reduced . 

Phrase: The fracture
Meta Mapping (1000):
  1000   FRACTURE (Fracture) [Injury or Poisoning]

Phrase: was

Phrase: seen by Orthopedics
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   Orthopedics [Biomedical Occupation or Discipline]
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   orthopedics (Orthopedic Surgical Procedures) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: was

Phrase: reduced .
Meta Mapping (1000):
  1000   Reduced [Qualitative Concept]
Processing 00000000.tx.4: He was reported to have had a myocardial infarction in the past ( EKG positive for ischemia , exercise tolerance test positive , cardiac catheterization positive , the patient is now status posta three-vessel coronary artery bypass graft in 1987 ) . 

Phrase: He

Phrase: was

Phrase: reported
Meta Mapping (1000):
  1000   Reported (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Reported (Reporting) [Health Care Activity]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: had

Phrase: a myocardial infarction in the past
Meta Mapping (820):
   820   PAST MYOCARDIAL INFARCTION (Old myocardial infarction) [Disease or Syndrome]

Phrase: ( EKG positive for ischemia ,
Meta Mapping (733):
   604   EKG (Electrocardiogram) [Finding]
   770   % Positive (percent positive cells) [Quantitative Concept]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiogram) [Finding]
   770   Positive [Qualitative Concept]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiogram) [Finding]
   770   POSITIVE (Positive Finding) [Finding]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiogram) [Finding]
   770   Positive (Positive Charge) [Qualitative Concept]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiogram) [Finding]
   770   Positive (Positive Number) [Conceptual Entity]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiography) [Diagnostic Procedure]
   770   % Positive (percent positive cells) [Quantitative Concept]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiography) [Diagnostic Procedure]
   770   Positive [Qualitative Concept]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiography) [Diagnostic Procedure]
   770   POSITIVE (Positive Finding) [Finding]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiography) [Diagnostic Procedure]
   770   Positive (Positive Charge) [Qualitative Concept]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   604   EKG (Electrocardiography) [Diagnostic Procedure]
   770   Positive (Positive Number) [Conceptual Entity]
   604   Ischaemia, NOS (Ischemia) [Pathologic Function]

Phrase: exercise tolerance test positive ,
Meta Mapping (916):
   756   Exercise tolerance test NOS (Exercise stress test) [Diagnostic Procedure]
   812   % Positive (percent positive cells) [Quantitative Concept]
Meta Mapping (916):
   756   Exercise tolerance test NOS (Exercise stress test) [Diagnostic Procedure]
   812   Positive [Qualitative Concept]
Meta Mapping (916):
   756   Exercise tolerance test NOS (Exercise stress test) [Diagnostic Procedure]
   812   POSITIVE (Positive Finding) [Finding]
Meta Mapping (916):
   756   Exercise tolerance test NOS (Exercise stress test) [Diagnostic Procedure]
   812   Positive (Positive Charge) [Qualitative Concept]
Meta Mapping (916):
   756   Exercise tolerance test NOS (Exercise stress test) [Diagnostic Procedure]
   812   Positive (Positive Number) [Conceptual Entity]
Meta Mapping (916):
   756   Exercise tolerance test (Exercise stress ECG test) [Diagnostic Procedure]
   812   % Positive (percent positive cells) [Quantitative Concept]
Meta Mapping (916):
   756   Exercise tolerance test (Exercise stress ECG test) [Diagnostic Procedure]
   812   Positive [Qualitative Concept]
Meta Mapping (916):
   756   Exercise tolerance test (Exercise stress ECG test) [Diagnostic Procedure]
   812   POSITIVE (Positive Finding) [Finding]
Meta Mapping (916):
   756   Exercise tolerance test (Exercise stress ECG test) [Diagnostic Procedure]
   812   Positive (Positive Charge) [Qualitative Concept]
Meta Mapping (916):
   756   Exercise tolerance test (Exercise stress ECG test) [Diagnostic Procedure]
   812   Positive (Positive Number) [Conceptual Entity]

Phrase: cardiac catheterization positive ,
Meta Mapping (901):
   734   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
   827   % Positive (percent positive cells) [Quantitative Concept]
Meta Mapping (901):
   734   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
   827   Positive [Qualitative Concept]
Meta Mapping (901):
   734   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
   827   POSITIVE (Positive Finding) [Finding]
Meta Mapping (901):
   734   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
   827   Positive (Positive Charge) [Qualitative Concept]
Meta Mapping (901):
   734   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
   827   Positive (Positive Number) [Conceptual Entity]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: now status posta three-vessel coronary artery bypass graft in 1987
Meta Mapping (727):
   571   Now (Now (temporal qualifier)) [Temporal Concept]
   571   Status [Qualitative Concept]
   571   Three [Quantitative Concept]
   571   Vessel (Blood Vessel) [Body Part, Organ, or Organ Component]
   797   Coronary Artery Bypass Graft (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]
Meta Mapping (727):
   571   Now (Now (temporal qualifier)) [Temporal Concept]
   571   Status [Qualitative Concept]
   571   Three [Quantitative Concept]
   571   Vessel (Blood Vessel) [Body Part, Organ, or Organ Component]
   797   coronary artery bypass graft (coronary artery graft device) [Medical Device]
Meta Mapping (727):
   571   Now (Now (temporal qualifier)) [Temporal Concept]
   571   Status [Qualitative Concept]
   571   Three [Quantitative Concept]
   571   Vessel (Blood Vessel Tissue) [Tissue]
   797   Coronary Artery Bypass Graft (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]
Meta Mapping (727):
   571   Now (Now (temporal qualifier)) [Temporal Concept]
   571   Status [Qualitative Concept]
   571   Three [Quantitative Concept]
   571   Vessel (Blood Vessel Tissue) [Tissue]
   797   coronary artery bypass graft (coronary artery graft device) [Medical Device]

Phrase: ) .
Processing 00000000.tx.5: No hemoptysis , hematemesis , abdominal pain , black or tarry stools , dysuria / frequency/urgency . 

Phrase: No hemoptysis ,
Meta Mapping (1000):
  1000 N HEMOPTYSIS (Hemoptysis) [Sign or Symptom]

Phrase: hematemesis ,
Meta Mapping (1000):
  1000 N HEMATEMESIS (Hematemesis) [Sign or Symptom]

Phrase: abdominal pain ,
Meta Mapping (1000):
  1000 N ABDOMINAL PAIN (Abdominal Pain) [Sign or Symptom]

Phrase: black
Meta Mapping (1000):
  1000   Black (Black race) [Population Group]
Meta Mapping (1000):
  1000   Black (African race) [Population Group]
Meta Mapping (1000):
  1000   Black (African American) [Population Group]
Meta Mapping (1000):
  1000   Black (Black color) [Qualitative Concept]

Phrase: or

Phrase: tarry
Meta Mapping (1000):
  1000 N Tarry [Finding]

Phrase: stools ,
Meta Mapping (1000):
  1000   Stools (Feces) [Body Substance]
Meta Mapping (1000):
  1000   Stools (Stools:Appearance:Point in time:Lower GI tract:Nominal) [Clinical Attribute]

Phrase: dysuria / frequency/urgency .
Meta Mapping (851):
   660 N DYSURIA (Dysuria) [Sign or Symptom]
   660   Frequency (With frequency) [Quantitative Concept]
   827   Urgency (Urgent) [Temporal Concept]
Meta Mapping (851):
   660 N DYSURIA (Dysuria) [Sign or Symptom]
   660   Frequency (Frequencies (time pattern)) [Temporal Concept]
   827   Urgency (Urgent) [Temporal Concept]
Meta Mapping (851):
   660 N DYSURIA (Dysuria) [Sign or Symptom]
   660   Frequency (Spatial Frequency) [Quantitative Concept]
   827   Urgency (Urgent) [Temporal Concept]
Meta Mapping (851):
   660 N DYSURIA (Dysuria) [Sign or Symptom]
   660   Frequency (Kind of quantity - Frequency) [Qualitative Concept]
   827   Urgency (Urgent) [Temporal Concept]
Meta Mapping (851):
   660 N DYSURIA (Dysuria) [Sign or Symptom]
   660   Frequency (Statistical Frequency) [Quantitative Concept]
   827   Urgency (Urgent) [Temporal Concept]
Meta Mapping (851):
   660 N DYSURIA (Dysuria) [Sign or Symptom]
   660   Frequency (How Often) [Intellectual Product]
   827   Urgency (Urgent) [Temporal Concept]
Processing 00000000.tx.6: Righteye surgery for glaucoma in 05/97 . no known drug allergies . 

Phrase: Righteye surgery for glaucoma
Meta Mapping (819):
   819   surgery glaucoma (Glaucoma surgery) [Therapeutic or Preventive Procedure]
Meta Mapping (819):
   819   Glaucoma surgery (Glaucoma surgery speciality) [Biomedical Occupation or Discipline]

Phrase: in 05/97 .
Meta Mapping (861):
   861   97 [Intellectual Product]
Meta Mapping (861):
   861   >97 [Quantitative Concept]

Phrase: no known drug allergies .
Meta Mapping (901):
   660   Known [Qualitative Concept]
   901 N Drug Allergies (Drug Allergy) [Disease or Syndrome]
Processing 00000000.tx.7: Mild right facial droop . 

Phrase: Mild right facial droop .
Meta Mapping (916):
   923   Mild Facial droop (Facial weakness, mild) [Finding]
   645   RIGHT (Right) [Spatial Concept]
Meta Mapping (916):
   923   Mild Facial droop (Facial weakness, mild) [Finding]
   645   Right (Right sided) [Spatial Concept]
Processing 00000000.tx.8: Chest / lungs : The patient is diffusely wheezy upon presentation . 

Phrase: Chest / lungs
Meta Mapping (1000):
  1000   Chest+Lungs [Body Location or Region]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: diffusely wheezy upon presentation .
Meta Mapping (708):
   770   Wheezy (Wheezing) [Sign or Symptom]
   604   Presentation [Idea or Concept]
Processing 00000000.tx.9: Rectal : Neurological : RADIOLOGIC STUDIES : Two major fracture fragments were seen at the humeral head , articulating with the glenoid fossa . 

Phrase: Rectal
Meta Mapping (1000):
  1000   Rectal (rectal) [Spatial Concept]

Phrase: :

Phrase: Neurological
Meta Mapping (1000):
  1000   NEUROLOGICAL (Neurologic (qualifier value)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Neurological (Neurological:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: RADIOLOGIC STUDIES
Meta Mapping (964):
   964   Radiology studies [Diagnostic Procedure]

Phrase: :

Phrase: Two major fracture fragments
Meta Mapping (833):
   645   Two [Quantitative Concept]
   645   Major (Severe (severity modifier)) [Qualitative Concept]
   645   FRACTURE (Fracture) [Injury or Poisoning]
   812   fragments (Fragment of (qualifier value)) [Functional Concept]
Meta Mapping (833):
   645   Two [Quantitative Concept]
   645   Major (Severe (severity modifier)) [Qualitative Concept]
   645   FRACTURE (Fracture) [Injury or Poisoning]
   812   Fragments [Body Substance]
Meta Mapping (833):
   645   Two [Quantitative Concept]
   645   Major [Qualitative Concept]
   645   FRACTURE (Fracture) [Injury or Poisoning]
   812   fragments (Fragment of (qualifier value)) [Functional Concept]
Meta Mapping (833):
   645   Two [Quantitative Concept]
   645   Major [Qualitative Concept]
   645   FRACTURE (Fracture) [Injury or Poisoning]
   812   Fragments [Body Substance]

Phrase: were

Phrase: seen at the humeral head ,
Meta Mapping (745):
   760   Seen (seen) [Qualitative Concept]
   806   Humeral Head (Structure of head of humerus) [Body Part, Organ, or Organ Component]

Phrase: articulating with the glenoid fossa .
Meta Mapping (806):
   806   Glenoid Fossa (Glenoid structure) [Body Space or Junction]
Processing 00000000.tx.10: EKG : 3. 

Phrase: EKG
Meta Mapping (1000):
  1000   EKG (Electrocardiogram) [Finding]
Meta Mapping (1000):
  1000   EKG (Electrocardiography) [Diagnostic Procedure]

Phrase: :

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.11: CARDIOVASCULAR : Cardiology recommended that in addition to the medications already stated above , his hematocrit be kept greater than 30 . 

Phrase: CARDIOVASCULAR
Meta Mapping (1000):
  1000   Cardiovascular (Cardiovascular system) [Body System]
Meta Mapping (1000):
  1000   CARDIOVASCULAR (Cardiovascular) [Body Location or Region]

Phrase: :

Phrase: Cardiology
Meta Mapping (1000):
  1000   Cardiology (Cardiology discipline) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Cardiology (Cardiology service) [Health Care Related Organization]

Phrase: recommended
Meta Mapping (1000):
  1000   Recommended (Recommendation) [Idea or Concept]

Phrase: that in addition to the medications
Meta Mapping (780):
   833   In addition to [Functional Concept]
   753   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (780):
   833   In addition to [Functional Concept]
   753   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (780):
   833   In addition to [Functional Concept]
   753   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: already

Phrase: stated
Meta Mapping (1000):
  1000   stated (Geographic state) [Geographic Area]
Meta Mapping (1000):
  1000   Stated (State) [Functional Concept]

Phrase: above ,
Meta Mapping (1000):
  1000   Above (Upper) [Spatial Concept]
Meta Mapping (1000):
  1000   above (Table Frame - above) [Idea or Concept]

Phrase: his hematocrit
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit level) [Finding]

Phrase: be

Phrase: kept
Meta Mapping (966):
   966   Keep (Retained) [Functional Concept]

Phrase: greater than 30 .
Meta Mapping (901):
   882   Greater Than [Quantitative Concept]
   623   30% [Finding]
Processing 00000000.tx.12: A second endoscopy was also performed several days later , in order to rule out a gastric ulcer , and also because the patient had had another episode of melena . 

Phrase: A second endoscopy
Meta Mapping (888):
   694   Second (second (number)) [Quantitative Concept]
   861   ENDOSCOPY (Endoscopy (procedure)) [Diagnostic Procedure]
Meta Mapping (888):
   694   Second (second (number)) [Quantitative Concept]
   861   Endoscopy (Clinic / Center - Endoscopy) [Health Care Related Organization,Manufactured Object]
Meta Mapping (888):
   694   SECOND (seconds) [Temporal Concept]
   861   ENDOSCOPY (Endoscopy (procedure)) [Diagnostic Procedure]
Meta Mapping (888):
   694   SECOND (seconds) [Temporal Concept]
   861   Endoscopy (Clinic / Center - Endoscopy) [Health Care Related Organization,Manufactured Object]
Meta Mapping (888):
   694   /second (per second) [Quantitative Concept]
   861   ENDOSCOPY (Endoscopy (procedure)) [Diagnostic Procedure]
Meta Mapping (888):
   694   /second (per second) [Quantitative Concept]
   861   Endoscopy (Clinic / Center - Endoscopy) [Health Care Related Organization,Manufactured Object]
Meta Mapping (888):
   694   second (Precision - second) [Idea or Concept]
   861   ENDOSCOPY (Endoscopy (procedure)) [Diagnostic Procedure]
Meta Mapping (888):
   694   second (Precision - second) [Idea or Concept]
   861   Endoscopy (Clinic / Center - Endoscopy) [Health Care Related Organization,Manufactured Object]
Meta Mapping (888):
   694   Second (Second Suffix) [Qualitative Concept]
   861   ENDOSCOPY (Endoscopy (procedure)) [Diagnostic Procedure]
Meta Mapping (888):
   694   Second (Second Suffix) [Qualitative Concept]
   861   Endoscopy (Clinic / Center - Endoscopy) [Health Care Related Organization,Manufactured Object]

Phrase: was

Phrase: also

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: several days later ,
Meta Mapping (901):
   901   Several days [Finding]
   660   Later (Late) [Temporal Concept]

Phrase: in order
Meta Mapping (1000):
  1000   Order (Order (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Order (Order (taxonomic)) [Classification]
Meta Mapping (1000):
  1000   Order (Order (action)) [Activity]
Meta Mapping (1000):
  1000   Order (Permutation) [Qualitative Concept]
Meta Mapping (1000):
  1000   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: rule
Meta Mapping (1000):
  1000   Rule (derivation calculation) [Idea or Concept]
Meta Mapping (1000):
  1000   Rule (Rule (guideline)) [Intellectual Product]
Meta Mapping (1000):
  1000   rule (Positive) [Qualitative Concept]

Phrase: out
Meta Mapping (1000):
  1000   Out (Out (direction)) [Spatial Concept]
Meta Mapping (1000):
  1000   Out (Removed) [Qualitative Concept]

Phrase: a gastric ulcer ,
Meta Mapping (1000):
  1000 N GASTRIC ULCER (Gastric ulcer) [Disease or Syndrome]

Phrase: and

Phrase: also

Phrase: because

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: had

Phrase: another episode of melena .
Meta Mapping (810):
   833   Episode of [Temporal Concept]
   604 N MELENA (Melena) [Pathologic Function]
Processing 00000000.tx.13: The patient is to arrange follow up with a GI doctor in Jotar Boulevard , Cunahtampfordama , South Dakota 62848 through his primary-care physician . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is to

Phrase: arrange

Phrase: follow up with a GI doctor
Meta Mapping (719):
   790   Follow-up (Follow-up status) [Finding]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow-up (Follow-up status) [Finding]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow-up (Follow-up status) [Finding]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow-up (Follow-up status) [Finding]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow-up (Follow-up status) [Finding]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow-up (Follow-up status) [Finding]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow Up (follow-up) [Health Care Activity]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow Up (follow-up) [Health Care Activity]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow Up (follow-up) [Health Care Activity]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow Up (follow-up) [Health Care Activity]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow Up (follow-up) [Health Care Activity]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow Up (follow-up) [Health Care Activity]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   Gi (GNAI1 wt Allele) [Gene or Genome]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   GI (Digestive System Findings Domain) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]
Meta Mapping (719):
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (719):
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   586   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   586   Doctor (Doctor - Title) [Conceptual Entity]

Phrase: in Jotar Boulevard ,
Meta Mapping (861):
   861   boulevard [Manufactured Object]

Phrase: Cunahtampfordama ,

Phrase: South Dakota 62848 through his primary-care physician .
Meta Mapping (742):
   770   South Dakota [Geographic Area]
   800   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Processing 00000000.tx.14: The patient transfused 2 units on 10/15/97 for a hematocrit of 27.6 . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: transfused
Meta Mapping (1000):
  1000   Transfused [Idea or Concept]

Phrase: 2 units on 10/15/97
Meta Mapping (685):
   586   +2 [Quantitative Concept]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   +2 [Quantitative Concept]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   +2 [Quantitative Concept]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   +2 [Quantitative Concept]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   +2 [Quantitative Concept]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   +2 [Quantitative Concept]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ (2+ Score) [Quantitative Concept]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ (2+ Score) [Quantitative Concept]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ (2+ Score) [Quantitative Concept]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ (2+ Score) [Quantitative Concept]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ (2+ Score) [Quantitative Concept]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ (2+ Score) [Quantitative Concept]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ (2+ Score, WHO) [Classification]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ (2+ Score, WHO) [Classification]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ (2+ Score, WHO) [Classification]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ (2+ Score, WHO) [Classification]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ (2+ Score, WHO) [Classification]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ (2+ Score, WHO) [Classification]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ [Finding]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ [Finding]
   753   UNITS (Unit) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ [Finding]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ [Finding]
   753   Units (Unit of Measure) [Quantitative Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]
Meta Mapping (685):
   586   2+ [Finding]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   97 [Intellectual Product]
Meta Mapping (685):
   586   2+ [Finding]
   753   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   586   10% [Finding]
   586   >97 [Quantitative Concept]

Phrase: for a hematocrit of 27.6 .
Meta Mapping (753):
   753   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (753):
   753   Hematocrit (Hematocrit level) [Finding]
Processing 00000000.tx.15: Colace 100 mg. p.o. t.i.d. 

Phrase: Colace 100 mg. p.o. t.i.d.
Meta Mapping (816):
   816   Docusate Sodium 100 MG [Clinical Drug]
Processing 00000000.tx.16: Senokot 1 p.o. q. h.s. 

Phrase: Senokot 1 p.o. q. h.s.
Meta Mapping (893):
   893   SENOKOT-S [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.17: Nystatin powder to affected area t.i.d. 

Phrase: Nystatin powder to affected area t.i.d.
Meta Mapping (707):
   578   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   744   POWDER (Powder dose form) [Biomedical or Dental Material]
   604   Affected Area [Finding]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (707):
   578   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   744   Powder (powder physical state) [Substance]
   604   Affected Area [Finding]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: Lopressor 25 mg. p.o. b.i.d. 

Phrase: Lopressor 25 mg. p.o. b.i.d.
Meta Mapping (795):
   793   Lopressor [Organic Chemical,Pharmacologic Substance]
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.19: Atrovent 0.8/2.5 c.c. normal saline nebulizers q. 

Phrase: Atrovent 0.8/2.5 c.c. normal saline nebulizers q.
Meta Mapping (582):
   622   Atrovent [Organic Chemical,Pharmacologic Substance]
   634   Normal saline [Inorganic Chemical,Pharmacologic Substance]
   622   Nebulizers [Medical Device]
Processing 00000000.tx.20: 8 h. 

Phrase: 8 h.
Meta Mapping (861):
   861   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (861):
   861   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (861):
   861   H+ (Hepatic Involvement) [Classification]
Meta Mapping (861):
   861   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.21: Albuterol 2.5/5 c.c. normal saline nebulizers q. 

Phrase: Albuterol 2.5/5 c.c. normal saline nebulizers q.
Meta Mapping (583):
   623   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   637   Normal saline [Inorganic Chemical,Pharmacologic Substance]
   623   Nebulizers [Medical Device]
Processing 00000000.tx.22: 4 h. with q. 

Phrase: 4 h.
Meta Mapping (888):
   694   4+ (4+ Answer to question) [Finding]
   861   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (888):
   694   4+ (4+ Answer to question) [Finding]
   861   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (888):
   694   4+ (4+ Answer to question) [Finding]
   861   H+ (Hepatic Involvement) [Classification]
Meta Mapping (888):
   694   4+ (4+ Answer to question) [Finding]
   861   /h (/hour) [Quantitative Concept]

Phrase: with q.
Processing 00000000.tx.23: 2 h. p.r.n. 

Phrase: 2 h. p.r.n.
Meta Mapping (813):
   673   2 H (Deuterium) [Element, Ion, or Isotope]
   840   R.N. (Registered nurse) [Professional or Occupational Group]
Processing 00000000.tx.24: Percocet 1-2 p.o. q. 

Phrase: Percocet 1-2 p.o. q.
Meta Mapping (632):
   632   Percocet [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.25: 4 h. p.r.n. pain . 

Phrase: 4 h. p.r.n. pain .
Meta Mapping (799):
   799   PAIN (Pain) [Sign or Symptom]
Meta Mapping (799):
   799   Pain NOS (Pain NOS Adverse Event) [Finding]
Processing 00000000.tx.26: <TEXT> INTRAUTERINE PREGNANCY AT 23 WEEKS . 

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > INTRAUTERINE PREGNANCY AT 23 WEEKS .
Meta Mapping (752):
   806   Intrauterine pregnancy [Organism Function]
   593   23 [Quantitative Concept]
   593   WEEKS (week) [Temporal Concept]
Meta Mapping (752):
   760   Intrauterine [Body Space or Junction]
   593   23 [Quantitative Concept]
   797   weeks Pregnancy (Weeks pregnant) [Finding]
Processing 00000000.tx.27: There was no obvious GIor pancreatic tumor identified . 

Phrase: There

Phrase: was

Phrase: no obvious GIor pancreatic tumor
Meta Mapping (861):
   861 N Pancreatic Tumour (Pancreatic Neoplasm) [Neoplastic Process]

Phrase: identified .
Meta Mapping (1000):
  1000   Identified [Qualitative Concept]
Meta Mapping (1000):
  1000 N Identified (Container status - Identified) [Finding]
Processing 00000000.tx.28: On admission included Percocet for pain and multivitamins . 

Phrase: On admission
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: included
Meta Mapping (1000):
  1000   included (Including (qualifier)) [Functional Concept]

Phrase: Percocet for pain
Meta Mapping (746):
   790   Percocet [Organic Chemical,Pharmacologic Substance]
   623   PAIN (Pain) [Sign or Symptom]
Meta Mapping (746):
   790   Percocet [Organic Chemical,Pharmacologic Substance]
   623   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: and

Phrase: multivitamins .
Meta Mapping (1000):
  1000   MULTIVITAMINS (Multivitamin preparation) [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (1000):
  1000   MULTIVITAMINS (Multivitamin Drug Class) [Pharmacologic Substance,Vitamin]
Processing 00000000.tx.29: NO KNOWN DRUG ALLERGIES . 

Phrase: NO KNOWN DRUG ALLERGIES .
Meta Mapping (1000):
  1000   No known drug allergies [Finding]
Processing 00000000.tx.30: The abdomen was tympanitic and nontender . 

Phrase: The abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: tympanitic
Meta Mapping (928):
   928   Tympanitis (Myringitis) [Disease or Syndrome]
Meta Mapping (928):
   928   TYMPANITES (Abdominal bloating) [Sign or Symptom]

Phrase: and

Phrase: nontender .
Meta Mapping (1000):
  1000   Nontender (Non-tender) [Qualitative Concept]
Processing 00000000.tx.31: The liver was 11 cm by percussion . 

Phrase: The liver
Meta Mapping (1000):
  1000   LIVER (Liver) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   LIVER (Liver parenchyma) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Liver (Entire liver) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   LIVER (Liver Flavor) [Food]

Phrase: was

Phrase: 11 cm by percussion .
Meta Mapping (604):
   604   Percussion [Diagnostic Procedure]
Meta Mapping (604):
   604   PERCUSSION (Dental Percussion Procedure) [Diagnostic Procedure]
Processing 00000000.tx.32: HOSPITAL COURSE : A bone scan revealed increased uptake in the left chest wall , left anterior ribs four to six , and increased uptake in the left and right lateral skull in the area of the parotids . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: A bone scan
Meta Mapping (1000):
  1000   Bone Scan (Radioisotope scan of bone) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Bone Scan (Views^W radionuclide Intravenous:Finding:Point in time:Bone:Narrative:Radnuc) [Clinical Attribute]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: increased uptake in the left chest wall ,
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   Uptake [Physiologic Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   Uptake [Physiologic Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   Uptake [Physiologic Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   Uptake [Physiologic Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   Uptake [Physiologic Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   Uptake [Physiologic Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   LEFT (Left) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   LEFT (Left) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   Left (Left sided) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   Left (Left sided) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   uptake (Import into cell) [Cell Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   uptake (Import into cell) [Cell Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   uptake (Import into cell) [Cell Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   uptake (Import into cell) [Cell Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   uptake (Import into cell) [Cell Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased [Quantitative Concept]
   748   uptake (Import into cell) [Cell Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   Uptake [Physiologic Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   Uptake [Physiologic Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   Uptake [Physiologic Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   Uptake [Physiologic Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   Uptake [Physiologic Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   Uptake [Physiologic Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   LEFT (Left) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   LEFT (Left) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   Left (Left sided) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   Left (Left sided) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   % uptake (percent uptake) [Quantitative Concept]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   uptake (Import into cell) [Cell Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   uptake (Import into cell) [Cell Function]
   581   LEFT (Left) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   uptake (Import into cell) [Cell Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   uptake (Import into cell) [Cell Function]
   581   Left (Left sided) [Spatial Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   uptake (Import into cell) [Cell Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest Wall (Chest wall structure) [Body Part, Organ, or Organ Component]
Meta Mapping (710):
   581   Increased (Increase) [Functional Concept]
   748   uptake (Import into cell) [Cell Function]
   581   left (Table Cell Horizontal Align - left) [Functional Concept]
   612   Chest wall (Entire chest wall) [Body Part, Organ, or Organ Component]

Phrase: left
Meta Mapping (1000):
  1000   LEFT (Left) [Spatial Concept]
Meta Mapping (1000):
  1000   Left (Left sided) [Spatial Concept]
Meta Mapping (1000):
  1000   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: anterior ribs four to six ,
Meta Mapping (761):
   797   Ribs.anterior [Body Part, Organ, or Organ Component]
   760   Four [Quantitative Concept]
   760   Six [Quantitative Concept]

Phrase: and

Phrase: increased uptake in the left
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   Uptake [Physiologic Function]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   Uptake [Physiologic Function]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   Uptake [Physiologic Function]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   % uptake (percent uptake) [Quantitative Concept]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   % uptake (percent uptake) [Quantitative Concept]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   % uptake (percent uptake) [Quantitative Concept]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   uptake (Import into cell) [Cell Function]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   uptake (Import into cell) [Cell Function]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (696):
   593   Increased [Quantitative Concept]
   760   uptake (Import into cell) [Cell Function]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   Uptake [Physiologic Function]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   Uptake [Physiologic Function]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   Uptake [Physiologic Function]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   % uptake (percent uptake) [Quantitative Concept]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   % uptake (percent uptake) [Quantitative Concept]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   % uptake (percent uptake) [Quantitative Concept]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   uptake (Import into cell) [Cell Function]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   uptake (Import into cell) [Cell Function]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (696):
   593   Increased (Increase) [Functional Concept]
   760   uptake (Import into cell) [Cell Function]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: and

Phrase: right lateral skull in the area of the parotids .
Meta Mapping (669):
   598   Right lateral (Lateral to the right) [Spatial Concept]
   742   SKULL (Bone structure of cranium) [Body Part, Organ, or Organ Component]
   575   Area (Geographic Locations) [Geographic Area]
   575   parotids (Parotid Gland) [Body Part, Organ, or Organ Component]
Meta Mapping (669):
   598   Right lateral (Lateral to the right) [Spatial Concept]
   742   SKULL (Bone structure of cranium) [Body Part, Organ, or Organ Component]
   575   AREA (Area) [Spatial Concept]
   575   parotids (Parotid Gland) [Body Part, Organ, or Organ Component]
Meta Mapping (669):
   595   Right parotids (Structure of right parotid gland) [Body Part, Organ, or Organ Component]
   575   LATERAL (Lateral) [Spatial Concept]
   742   SKULL (Bone structure of cranium) [Body Part, Organ, or Organ Component]
   575   Area (Geographic Locations) [Geographic Area]
Meta Mapping (669):
   595   Right parotids (Structure of right parotid gland) [Body Part, Organ, or Organ Component]
   575   LATERAL (Lateral) [Spatial Concept]
   742   SKULL (Bone structure of cranium) [Body Part, Organ, or Organ Component]
   575   AREA (Area) [Spatial Concept]
Meta Mapping (669):
   595   Right parotids (Entire right parotid gland) [Body Part, Organ, or Organ Component]
   575   LATERAL (Lateral) [Spatial Concept]
   742   SKULL (Bone structure of cranium) [Body Part, Organ, or Organ Component]
   575   Area (Geographic Locations) [Geographic Area]
Meta Mapping (669):
   595   Right parotids (Entire right parotid gland) [Body Part, Organ, or Organ Component]
   575   LATERAL (Lateral) [Spatial Concept]
   742   SKULL (Bone structure of cranium) [Body Part, Organ, or Organ Component]
   575   AREA (Area) [Spatial Concept]
Processing 00000000.tx.33: Ahead CT scan revealed a metastatic lesion in the right vertex of the calvarium but no intracranial abnormalities . 

Phrase: Ahead CT scan
Meta Mapping (901):
   901   CT SCAN (X-Ray Computed Tomography) [Diagnostic Procedure]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a metastatic lesion in the right vertex of the calvarium
Meta Mapping (655):
   760   Metastatic Lesion [Finding]
   573   RIGHT (Right) [Spatial Concept]
   573   Vertex [Body Location or Region]
   573   Calvarium (Calvaria) [Body Part, Organ, or Organ Component]
Meta Mapping (655):
   760   Metastatic Lesion [Finding]
   573   RIGHT (Right) [Spatial Concept]
   573   Vertex (Graph Node) [Conceptual Entity]
   573   Calvarium (Calvaria) [Body Part, Organ, or Organ Component]
Meta Mapping (655):
   760   Metastatic Lesion [Finding]
   573   Right (Right sided) [Spatial Concept]
   573   Vertex [Body Location or Region]
   573   Calvarium (Calvaria) [Body Part, Organ, or Organ Component]
Meta Mapping (655):
   760   Metastatic Lesion [Finding]
   573   Right (Right sided) [Spatial Concept]
   573   Vertex (Graph Node) [Conceptual Entity]
   573   Calvarium (Calvaria) [Body Part, Organ, or Organ Component]

Phrase: but

Phrase: no intracranial abnormalities .
Meta Mapping (888):
   694   Intracranial [Body Location or Region]
   861 N Abnormalities (Congenital Abnormality) [Congenital Abnormality]
Meta Mapping (888):
   694   Intracranial [Body Location or Region]
   861   abnormalities (teratologic) [Functional Concept]
Processing 00000000.tx.34: Direct bilirubin was 1.4 . 

Phrase: Direct bilirubin
Meta Mapping (1000):
  1000   Direct bilirubin (Direct reacting bilirubin) [Biologically Active Substance,Organic Chemical]

Phrase: was

Phrase: 1.4 .
Meta Mapping (861):
   861   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (861):
   861   1+ (1+ Score, WHO) [Classification]
Meta Mapping (861):
   861   1+ [Finding]
Processing 00000000.tx.35: Report : </TEXT>

Phrase: Report
Meta Mapping (1000):
  1000   Report (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Report (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]

Phrase: :

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >
Processing 00000000.tx.1: <TEXT> Unsigned DISCHARGE DATE : 04/01/97 Senokot one q.h.s. 

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > Unsigned DISCHARGE DATE
Meta Mapping (901):
   901   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (901):
   901   Discharge date [Temporal Concept]

Phrase: :

Phrase: 04/01/97 Senokot one q.h.s.
Meta Mapping (750):
   626   97 [Intellectual Product]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (750):
   626   97 [Intellectual Product]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (750):
   626   97 [Intellectual Product]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   H+ (Hepatic Involvement) [Classification]
Meta Mapping (750):
   626   97 [Intellectual Product]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   /h (/hour) [Quantitative Concept]
Meta Mapping (750):
   626   >97 [Quantitative Concept]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (750):
   626   >97 [Quantitative Concept]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (750):
   626   >97 [Quantitative Concept]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   H+ (Hepatic Involvement) [Classification]
Meta Mapping (750):
   626   >97 [Quantitative Concept]
   626   Senokot [Organic Chemical,Pharmacologic Substance]
   793   ONE (One) [Quantitative Concept]
   656   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   626   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.2: The patient resides in the Pcaer,ter Medical Center , is nonambulatory , and her code status is do not resuscitate / do not intubate . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: resides in the Pcaer,
Meta Mapping (770):
   770   Reside [Activity]

Phrase: ter Medical Center ,
Meta Mapping (901):
   660   TER (TECR gene) [Gene or Genome]
   901   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (901):
   660   TER (TECR gene) [Gene or Genome]
   901   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (901):
   660   TER (DNA replication termination region) [Cell Component]
   901   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (901):
   660   TER (DNA replication termination region) [Cell Component]
   901   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: is

Phrase: nonambulatory ,
Meta Mapping (1000):
  1000   Non-ambulatory (Unable to walk) [Finding]

Phrase: and

Phrase: her code status
Meta Mapping (888):
   694   code (Coding) [Occupational Activity]
   861   Status [Qualitative Concept]
Meta Mapping (888):
   694   CODE (Code) [Intellectual Product]
   861   Status [Qualitative Concept]
Meta Mapping (888):
   694   Code (eTMF Content Model Code) [Intellectual Product]
   861   Status [Qualitative Concept]

Phrase: is

Phrase: do not resuscitate /
Meta Mapping (1000):
  1000   Do not resuscitate (DNR - Do not resuscitate) [Finding]

Phrase: do

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: intubate .
Processing 00000000.tx.3: PHYSICAL EXAMINATION : No respiratory distress . 

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: No respiratory distress .
Meta Mapping (1000):
  1000 N Distress, Respiratory (Respiratory distress) [Sign or Symptom]
Processing 00000000.tx.4: LABORATORY DATA : The patient was admitted for treatment of a presumed aspiration pneumonia and for rehydration . 

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted for treatment of a presumed aspiration pneumonia
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   treatment (therapeutic aspects) [Functional Concept]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   treatment (therapeutic aspects) [Functional Concept]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Treating) [Functional Concept]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Treating) [Functional Concept]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Biomaterial Treatment) [Conceptual Entity]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   Treatment (Biomaterial Treatment) [Conceptual Entity]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   TREATMENT (Treatment Epoch) [Research Activity]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   TREATMENT (Treatment Epoch) [Research Activity]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   admitted (Hospital admission) [Health Care Activity]
   744   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   treatment (therapeutic aspects) [Functional Concept]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   treatment (therapeutic aspects) [Functional Concept]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Treating) [Functional Concept]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Treating) [Functional Concept]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Biomaterial Treatment) [Conceptual Entity]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   Treatment (Biomaterial Treatment) [Conceptual Entity]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   TREATMENT (Treatment Epoch) [Research Activity]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   TREATMENT (Treatment Epoch) [Research Activity]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
   770   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (677):
   744   Admitted (Admission activity) [Health Care Activity]
   744   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
   770   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]

Phrase: and for rehydration .
Meta Mapping (790):
   790   Rehydration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.5: 05/11/97 MI CUCHSLI , M.D. 

Phrase: 05/11/97 MI CUCHSLI ,
Meta Mapping (562):
   637   97 [Intellectual Product]
   637   MI (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (562):
   637   >97 [Quantitative Concept]
   637   MI (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.6: 10% BODY BURNS Only significant for excessive alcohol use . 

Phrase: 10% BODY
Meta Mapping (888):
   694   10% [Finding]
   861   body (Human body) [Human]
Meta Mapping (888):
   694   10% [Finding]
   861   Body (Human body structure) [Anatomical Structure]
Meta Mapping (888):
   694   10% [Finding]
   861   Body (Body structure) [Anatomical Structure]

Phrase: BURNS
Meta Mapping (1000):
  1000   BURNS (Burn injury) [Injury or Poisoning]
Meta Mapping (1000):
  1000   Burn (Burn Specimen) [Body Substance]
Meta Mapping (1000):
  1000   Burns (Burn Adverse Event) [Injury or Poisoning]

Phrase: Only significant for excessive alcohol use .
Meta Mapping (776):
   586   Only (Singular) [Quantitative Concept]
   753   significant (Statistical Significance) [Quantitative Concept]
   666   Excessive alcohol use (Alcohol intake above recommended sensible limits) [Finding]
Meta Mapping (776):
   586   Only (Singular) [Quantitative Concept]
   753   Significant [Idea or Concept]
   666   Excessive alcohol use (Alcohol intake above recommended sensible limits) [Finding]
Meta Mapping (776):
   586   Only (Singular) [Quantitative Concept]
   753   Significant (Event Seriousness - Significant) [Qualitative Concept]
   666   Excessive alcohol use (Alcohol intake above recommended sensible limits) [Finding]
Meta Mapping (776):
   586   Only (Only - dosing instruction fragment) [Intellectual Product]
   753   significant (Statistical Significance) [Quantitative Concept]
   666   Excessive alcohol use (Alcohol intake above recommended sensible limits) [Finding]
Meta Mapping (776):
   586   Only (Only - dosing instruction fragment) [Intellectual Product]
   753   Significant [Idea or Concept]
   666   Excessive alcohol use (Alcohol intake above recommended sensible limits) [Finding]
Meta Mapping (776):
   586   Only (Only - dosing instruction fragment) [Intellectual Product]
   753   Significant (Event Seriousness - Significant) [Qualitative Concept]
   666   Excessive alcohol use (Alcohol intake above recommended sensible limits) [Finding]
Processing 00000000.tx.7: ALLERGIES : No known drug allergies . 

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: No known drug allergies .
Meta Mapping (901):
   660   Known [Qualitative Concept]
   901 N Drug Allergies (Drug Allergy) [Disease or Syndrome]
Processing 00000000.tx.8: 99% saturation on room air . 

Phrase: 99% saturation on room air .
Meta Mapping (745):
   760   Saturation (Saturated) [Phenomenon or Process]
   640   Room air [Finding]
Processing 00000000.tx.9: The patient was not anxious or ill-appearing . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: not anxious
Meta Mapping (888):
   694   Not (Negation) [Functional Concept]
   861 N Anxious (Anxiety) [Mental or Behavioral Dysfunction]

Phrase: or

Phrase: ill-appearing .
Meta Mapping (872):
   694 N Ill (Malaise) [Sign or Symptom]
   827   APPEAR (Appearance) [Qualitative Concept]
Processing 00000000.tx.10: HOSPITAL COURSE : The patient was taken from the emergency room and transferred to the Surgical Intensive Care Unit for airway observation . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: taken from the emergency room
Meta Mapping (745):
   760   Taken [Conceptual Entity]
   806   EMERGENCY ROOM (Accident and Emergency department) [Health Care Related Organization]

Phrase: and

Phrase: transferred to the Surgical Intensive Care Unit
Meta Mapping (808):
   748   transferred (Surgical transfer - action) [Functional Concept]
   853   Surgical intensive care unit [Health Care Related Organization,Manufactured Object]
Meta Mapping (808):
   748   Transferred (Transfer Technique) [Functional Concept]
   853   Surgical intensive care unit [Health Care Related Organization,Manufactured Object]

Phrase: for airway observation .
Meta Mapping (888):
   694   Airway, NOS (Artificial Airways) [Medical Device]
   861   Observation (Observation in research) [Research Activity]
Meta Mapping (888):
   694   Airway, NOS (Artificial Airways) [Medical Device]
   861   Observation (Patient observation) [Health Care Activity]
Meta Mapping (888):
   694   Airway, NOS (Artificial Airways) [Medical Device]
   861   OBSERVATION (Observation - diagnostic procedure) [Diagnostic Procedure]
Meta Mapping (888):
   694   Airway (Airway structure) [Body Part, Organ, or Organ Component]
   861   Observation (Observation in research) [Research Activity]
Meta Mapping (888):
   694   Airway (Airway structure) [Body Part, Organ, or Organ Component]
   861   Observation (Patient observation) [Health Care Activity]
Meta Mapping (888):
   694   Airway (Airway structure) [Body Part, Organ, or Organ Component]
   861   OBSERVATION (Observation - diagnostic procedure) [Diagnostic Procedure]
Processing 00000000.tx.11: He was given three liters of IV hydration with good urine output response . 

Phrase: He

Phrase: was

Phrase: given
Meta Mapping (1000):
  1000   GIVEN [Conceptual Entity]
Meta Mapping (1000):
  1000   given (Entity Name Part Type - given) [Idea or Concept]
Meta Mapping (1000):
  1000   Given (Give - dosing instruction imperative) [Functional Concept]
Meta Mapping (1000):
  1000   given (Given name) [Intellectual Product]

Phrase: three liters of IV hydration
Meta Mapping (716):
   593   Three [Quantitative Concept]
   726   LITER (liter) [Quantitative Concept]
   593   IV (Ivory Coast) [Geographic Area]
   593   Hydration (Hydration status) [Finding]

Phrase: with good urine output response .
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   urine output (Urine volume function) [Clinical Attribute]
   812   Response (Response process) [Organism Attribute]
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   urine output (Urine volume function) [Clinical Attribute]
   812   Response (Disease Response) [Finding]
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   urine output (Urine volume function) [Clinical Attribute]
   812   Response (Response (statement)) [Intellectual Product]
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   urine output (Urine volume function) [Clinical Attribute]
   812   Response (Response (communication)) [Mental Process]
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   Urine output (Urine volume finding) [Finding]
   812   Response (Response process) [Organism Attribute]
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   Urine output (Urine volume finding) [Finding]
   812   Response (Disease Response) [Finding]
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   Urine output (Urine volume finding) [Finding]
   812   Response (Response (statement)) [Intellectual Product]
Meta Mapping (861):
   645   Good [Qualitative Concept]
   694   Urine output (Urine volume finding) [Finding]
   812   Response (Response (communication)) [Mental Process]
Processing 00000000.tx.12: The patient was screened by the rehabilitation facility and felt to be an acceptable candidate . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: screened by the rehabilitation facility
Meta Mapping (734):
   726   screen (Screening procedure) [Health Care Activity]
   806   Rehabilitation facility [Finding]
Meta Mapping (734):
   726   screen (Screening - procedure intent) [Functional Concept]
   806   Rehabilitation facility [Finding]
Meta Mapping (734):
   726   Screen (Screen Device Component) [Manufactured Object]
   806   Rehabilitation facility [Finding]

Phrase: and

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: an acceptable candidate .
Meta Mapping (694):
   694   Acceptable [Qualitative Concept]
Meta Mapping (694):
   694   Acceptable (Acceptable (foundation metadata concept)) [Qualitative Concept]
Processing 00000000.tx.13: The patient is to undergo dry dressing changes and splint to his right arm q.d. 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: undergo

Phrase: dry dressing changes
Meta Mapping (901):
   734   Dry dressing (Dry dressing, device) [Medical Device]
   827   changes (Changing) [Functional Concept]
Meta Mapping (901):
   734   Dry dressing (Dry dressing, device) [Medical Device]
   827   changes (Changed status) [Quantitative Concept]

Phrase: and

Phrase: splint to his right arm q.d.
Meta Mapping (706):
   748   Splint (Splint Device) [Medical Device]
   612   Right arm (Right upper arm structure) [Body Part, Organ, or Organ Component]
Meta Mapping (706):
   748   Splint (Splint Device) [Medical Device]
   612   Right arm (Entire right upper arm) [Body Part, Organ, or Organ Component]
Meta Mapping (706):
   748   Splint (Splint Device) [Medical Device]
   612   Right Arm (Right arm) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.14: 1. 

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.15: ERFIBOULDNON VALLEY MEMORIAL HOSPITAL <TEXT> ASSOCIATED PROCEDURES : In addition , she noted palpitations but had a negative Holter monitor for tachy arrhythmias . 

Phrase: ERFIBOULDNON VALLEY MEMORIAL HOSPITAL
Meta Mapping (763):
   645   Valley [Spatial Concept]
   812   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (763):
   645   Valley [Spatial Concept]
   812   Hospital (Hospital environment) [Qualitative Concept]

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > ASSOCIATED PROCEDURES
Meta Mapping (983):
   983   Associated procedure [Classification]

Phrase: :

Phrase: In addition ,
Meta Mapping (861):
   861   Addition (In addition to) [Functional Concept]
Meta Mapping (861):
   861   Addition (Add - instruction imperative) [Functional Concept]

Phrase: she

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: palpitations
Meta Mapping (1000):
  1000   PALPITATIONS (Palpitations) [Finding]
Meta Mapping (1000):
  1000   Palpitations (Palpitations Adverse Event) [Finding]

Phrase: but

Phrase: had

Phrase: a negative Holter monitor for tachy arrhythmias .
Meta Mapping (701):
   581   Negative [Qualitative Concept]
   778   Holter Monitor (Holter Electrocardiography) [Diagnostic Procedure]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   Negative [Qualitative Concept]
   778   Holter monitor (Holter Monitors) [Medical Device]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   NEGATIVE (Negative Finding) [Finding]
   778   Holter Monitor (Holter Electrocardiography) [Diagnostic Procedure]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   NEGATIVE (Negative Finding) [Finding]
   778   Holter monitor (Holter Monitors) [Medical Device]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   Negative (Negative Number) [Conceptual Entity]
   778   Holter Monitor (Holter Electrocardiography) [Diagnostic Procedure]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   Negative (Negative Number) [Conceptual Entity]
   778   Holter monitor (Holter Monitors) [Medical Device]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   Negative (Negative Charge) [Qualitative Concept]
   778   Holter Monitor (Holter Electrocardiography) [Diagnostic Procedure]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   Negative (Negative Charge) [Qualitative Concept]
   778   Holter monitor (Holter Monitors) [Medical Device]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   Negative (Negative - answer) [Qualitative Concept]
   778   Holter Monitor (Holter Electrocardiography) [Diagnostic Procedure]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Meta Mapping (701):
   581   Negative (Negative - answer) [Qualitative Concept]
   778   Holter monitor (Holter Monitors) [Medical Device]
   581   Arrhythmias (Cardiac Arrhythmia) [Finding]
Processing 00000000.tx.16: There was evidence of left-to-right shunting consistent with a patent foramen ovale prior to the trans-septal procedure . 

Phrase: There

Phrase: was

Phrase: evidence of left-to-right shunting
Meta Mapping (789):
   753   Evidence [Idea or Concept]
   666   Left to right [Functional Concept]
   586   shunting (Creation of shunt) [Therapeutic or Preventive Procedure]

Phrase: consistent with a patent foramen ovale
Meta Mapping (794):
   790   Consistent with [Idea or Concept]
   666   FORAMEN OVALE, PATENT (Foramen Ovale, Patent) [Congenital Abnormality,Disease or Syndrome]
Meta Mapping (794):
   790   Consistent with [Idea or Concept]
   666   Patent foramen ovale (Ostium secundum atrial septal defect) [Congenital Abnormality]

Phrase: prior to the trans-septal procedure .
Meta Mapping (851):
   660   TRANS (Transition Rule) [Idea or Concept]
   660   Septal [Spatial Concept]
   827   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (851):
   660   TRANS (Transition Rule) [Idea or Concept]
   660   Septal [Spatial Concept]
   827   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
Meta Mapping (851):
   660   TRANS (Transition Rule) [Idea or Concept]
   660   Septal [Spatial Concept]
   827   Procedure (Procedure (set of actions)) [Activity]
Meta Mapping (851):
   660   TRANS (Transition Rule) [Idea or Concept]
   660   Septal [Spatial Concept]
   827   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
Meta Mapping (851):
   660   TRANS (Transition Rule) [Idea or Concept]
   660   Septal [Spatial Concept]
   827   Procedure (Procedure Domain) [Intellectual Product]
Meta Mapping (851):
   660   TRANS (Transition Rule) [Idea or Concept]
   660   Septal [Spatial Concept]
   827   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
Processing 00000000.tx.17: There was an opening snap followed by a long 2 out of 6 diastolic apical rumble . 

Phrase: There

Phrase: was

Phrase: an opening snap
Meta Mapping (1000):
  1000   OPENING SNAP (Opening snap) [Finding]

Phrase: followed by a long 2
Meta Mapping (745):
   806   Followed by [Temporal Concept]
   760   Long [Qualitative Concept]
Meta Mapping (745):
   806   Followed by [Temporal Concept]
   760   Long (Long Variable) [Qualitative Concept]

Phrase: out of 6 diastolic apical rumble .
Meta Mapping (824):
   875   Diastolic rumble [Sign or Symptom]
   645   APICAL (Apical) [Spatial Concept]
Processing 00000000.tx.18: 03/02/2001 12:24 51356028 Signed DIS Report Status : Cardiac risk factors include a positive family history of a postmenopausal patient but no cigarette use , diabetes or high cholesterol . 

Phrase: 03/02/2001 12

Phrase: :

Phrase: 24 51356028 Signed DIS Report Status
Meta Mapping (762):
   632   Signed (Signature) [Intellectual Product]
   632   DIS (Diagnostic interview schedule) [Intellectual Product]
   827   Report status [Finding]
Meta Mapping (762):
   632   Signed (Signature) [Intellectual Product]
   632   DIS (Discontinued) [Finding]
   827   Report status [Finding]
Meta Mapping (762):
   632   signed (signed - ParticipationSignature) [Intellectual Product]
   632   DIS (Diagnostic interview schedule) [Intellectual Product]
   827   Report status [Finding]
Meta Mapping (762):
   632   signed (signed - ParticipationSignature) [Intellectual Product]
   632   DIS (Discontinued) [Finding]
   827   Report status [Finding]

Phrase: :

Phrase: Cardiac risk factors
Meta Mapping (901):
   660   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   901   Risk Factors (risk factors) [Quantitative Concept]
Meta Mapping (901):
   660   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   901   risk factors (risk factors - observation list) [Intellectual Product]
Meta Mapping (901):
   660   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   901   Risk Factors (risk factors) [Quantitative Concept]
Meta Mapping (901):
   660   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   901   risk factors (risk factors - observation list) [Intellectual Product]

Phrase: include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: a positive family history of a postmenopausal patient
Meta Mapping (713):
   578   % Positive (percent positive cells) [Quantitative Concept]
   578   post Menopausal (Postmenopausal state) [Temporal Concept]
   793   patient family history [Finding]
Meta Mapping (713):
   578   Positive [Qualitative Concept]
   578   post Menopausal (Postmenopausal state) [Temporal Concept]
   793   patient family history [Finding]
Meta Mapping (713):
   578   POSITIVE (Positive Finding) [Finding]
   578   post Menopausal (Postmenopausal state) [Temporal Concept]
   793   patient family history [Finding]
Meta Mapping (713):
   578   Positive (Positive Charge) [Qualitative Concept]
   578   post Menopausal (Postmenopausal state) [Temporal Concept]
   793   patient family history [Finding]
Meta Mapping (713):
   578   Positive (Positive Number) [Conceptual Entity]
   578   post Menopausal (Postmenopausal state) [Temporal Concept]
   793   patient family history [Finding]

Phrase: but

Phrase: no cigarette use ,
Meta Mapping (1000):
  1000   cigarette use [Individual Behavior]

Phrase: diabetes
Meta Mapping (1000):
  1000 N Diabetes [Disease or Syndrome]
Meta Mapping (1000):
  1000 N Diabetes (Diabetes Mellitus) [Disease or Syndrome]

Phrase: or

Phrase: high cholesterol .
Meta Mapping (1000):
  1000 N High cholesterol (Hypercholesterolemia) [Disease or Syndrome]
Meta Mapping (1000):
  1000 N High Cholesterol (Hypercholesterolemia result) [Finding]
Processing 00000000.tx.19: Recently in good health with no dyspnea on exertion . 

Phrase: Recently in good health
Meta Mapping (783):
   770   Recently (Recent) [Temporal Concept]
   833   good health (Overall Well Being) [Intellectual Product]

Phrase: with no dyspnea on exertion .
Meta Mapping (862):
   862 N Dyspnoea on exertion (Dyspnea on exertion) [Sign or Symptom]
Processing 00000000.tx.20: No clubbing , cyanosis or edema . 

Phrase: No clubbing ,
Meta Mapping (1000):
  1000 N Clubbing (Clubbed Fingers) [Anatomical Abnormality]
Meta Mapping (1000):
  1000 N CLUBBING (Clubbing) [Sign or Symptom]

Phrase: cyanosis
Meta Mapping (1000):
  1000 N CYANOSIS (Cyanosis) [Sign or Symptom]

Phrase: or

Phrase: edema .
Meta Mapping (1000):
  1000 N OEDEMA (Edema) [Finding]
Meta Mapping (1000):
  1000   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Processing 00000000.tx.21: Alert and oriented . 

Phrase: Alert
Meta Mapping (1000):
  1000   ALERT (Consciousness clear) [Finding]
Meta Mapping (1000):
  1000   Alert [Functional Concept]
Meta Mapping (1000):
  1000   Alert (Alert:Type:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: and

Phrase: oriented .
Meta Mapping (1000):
  1000   Oriented (Orientation (spatial)) [Spatial Concept]
Meta Mapping (1000):
  1000   Oriented (Oriented to place) [Finding]
Processing 00000000.tx.22: MCV 82 . 

Phrase: MCV 82 .
Meta Mapping (861):
   861   MCV (Molluscum contagiosum virus) [Virus]
Meta Mapping (861):
   861   MCV - NOS (Mean Corpuscular Volume (result)) [Laboratory or Test Result]
Processing 00000000.tx.23: The patient was discharged 09/09/94 in good condition . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: discharged
Meta Mapping (1000):
  1000   Discharged (Patient Discharge) [Health Care Activity]

Phrase: 09/09/94 in good condition .
Meta Mapping (679):
   753   Good [Qualitative Concept]
   753   condition (Disease) [Disease or Syndrome]
Meta Mapping (679):
   753   Good [Qualitative Concept]
   753   Condition [Qualitative Concept]
Meta Mapping (679):
   753   Good [Qualitative Concept]
   753   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (679):
   753   Good [Qualitative Concept]
   753   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Processing 00000000.tx.24: Attending : 10/15/94 596437842 At discharge after about two weeks post-extubation , he had an O2 saturation of approximately 95% on room air . 

Phrase: Attending
Meta Mapping (1000):
  1000   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   attending (Attending (action)) [Functional Concept]

Phrase: :

Phrase: 10/15/94 596437842 At discharge
Meta Mapping (672):
   753   10% [Finding]
   753   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (672):
   753   10% [Finding]
   753   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (672):
   753   10% [Finding]
   753   Discharge (Discharge, body substance) [Body Substance]

Phrase: after

Phrase: about two weeks
Meta Mapping (901):
   660   About (Approximate) [Qualitative Concept]
   901   Two weeks [Temporal Concept]

Phrase: post-extubation ,
Meta Mapping (888):
   861   Post [Temporal Concept]
   861   Extubation (Tracheal Extubation) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   861   Post (Post Device Component) [Manufactured Object]
   861   Extubation (Tracheal Extubation) [Therapeutic or Preventive Procedure]

Phrase: he

Phrase: had

Phrase: an O2 saturation of approximately 95%
Meta Mapping (722):
   790   O2 Saturation (Oxygen saturation measurement) [Laboratory Procedure]
   586   Approximately (Approximate) [Qualitative Concept]

Phrase: on room air .
Meta Mapping (1000):
  1000   Room air [Finding]
Processing 00000000.tx.25: ALT was 181 , AST was 156 , LDH was 336 , alkaline phosphatase was 214 , and bilirubin was 12.7 total . 

Phrase: ALT
Meta Mapping (1000):
  1000   ALT (Atypical Lipoma) [Neoplastic Process]

Phrase: was

Phrase: 181 ,

Phrase: AST
Meta Mapping (1000):
  1000   AST (Atlantic Standard Time) [Temporal Concept]

Phrase: was

Phrase: 156 ,

Phrase: LDH
Meta Mapping (1000):
  1000   LDH (Lactate Dehydrogenase) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: was

Phrase: 336 ,

Phrase: alkaline phosphatase
Meta Mapping (1000):
  1000   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: was

Phrase: 214 ,

Phrase: and

Phrase: bilirubin
Meta Mapping (1000):
  1000   BILIRUBIN (Bilirubin) [Biologically Active Substance,Organic Chemical]

Phrase: was

Phrase: 12.7 total .
Meta Mapping (827):
   827   % total (% of total) [Quantitative Concept]
Meta Mapping (827):
   827   Total [Qualitative Concept]
Processing 00000000.tx.26: The patient was admitted for work-up of his cholestatic jaundice picture along with work-up for his pulmonary process and treatment of both . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted for work-up of his cholestatic jaundice picture
Meta Mapping (692):
   742   admitted (Hospital admission) [Health Care Activity]
   764   Work-up (work up) [Diagnostic Procedure]
   764   CHOLESTATIC JAUNDICE (Jaundice, Obstructive) [Disease or Syndrome]
   742   picture (photograph) [Manufactured Object]
Meta Mapping (692):
   742   admitted (Hospital admission) [Health Care Activity]
   764   Work-up (work up) [Diagnostic Procedure]
   764   CHOLESTATIC JAUNDICE (Jaundice, Obstructive) [Disease or Syndrome]
   742   Picture [Manufactured Object]
Meta Mapping (692):
   742   Admitted (Admission activity) [Health Care Activity]
   764   Work-up (work up) [Diagnostic Procedure]
   764   CHOLESTATIC JAUNDICE (Jaundice, Obstructive) [Disease or Syndrome]
   742   picture (photograph) [Manufactured Object]
Meta Mapping (692):
   742   Admitted (Admission activity) [Health Care Activity]
   764   Work-up (work up) [Diagnostic Procedure]
   764   CHOLESTATIC JAUNDICE (Jaundice, Obstructive) [Disease or Syndrome]
   742   Picture [Manufactured Object]

Phrase: along with work-up for his pulmonary process
Meta Mapping (680):
   770   Work-up (work up) [Diagnostic Procedure]
   578   pulmonary (Lung) [Body Part, Organ, or Organ Component]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (680):
   770   Work-up (work up) [Diagnostic Procedure]
   578   pulmonary (Lung) [Body Part, Organ, or Organ Component]
   578   Process [Phenomenon or Process]
Meta Mapping (680):
   770   Work-up (work up) [Diagnostic Procedure]
   578   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (680):
   770   Work-up (work up) [Diagnostic Procedure]
   578   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
   578   Process [Phenomenon or Process]
Meta Mapping (680):
   770   Work-up (work up) [Diagnostic Procedure]
   578   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (680):
   770   Work-up (work up) [Diagnostic Procedure]
   578   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
   578   Process [Phenomenon or Process]

Phrase: and

Phrase: treatment of both .
Meta Mapping (790):
   790   treatment (therapeutic aspects) [Functional Concept]
Meta Mapping (790):
   790   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (790):
   790   Treatment (Treating) [Functional Concept]
Meta Mapping (790):
   790   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (790):
   790   Treatment (Biomaterial Treatment) [Conceptual Entity]
Meta Mapping (790):
   790   TREATMENT (Treatment Epoch) [Research Activity]
Meta Mapping (790):
   790   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
Processing 00000000.tx.27: No other cultures grew out and the patient &apos;s clinical status deteriorated . 

Phrase: No

Phrase: other cultures
Meta Mapping (1000):
  1000   Cultures (Anthropological Culture) [Idea or Concept]

Phrase: grew

Phrase: out
Meta Mapping (1000):
  1000   Out (Out (direction)) [Spatial Concept]
Meta Mapping (1000):
  1000   Out (Removed) [Qualitative Concept]

Phrase: and

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s clinical status
Meta Mapping (901):
   913   S status (Scleral tumor invasion status) [Classification]
   660   Clinical [Qualitative Concept]
Meta Mapping (901):
   913   S status (Scleral tumor invasion status) [Classification]
   660   Clinical (Psychologist - Clinical) [Professional or Occupational Group]
Meta Mapping (901):
   913   S status (Scleral tumor invasion status) [Classification]
   660   Clinical (Social Worker - Clinical) [Professional or Occupational Group]
Meta Mapping (901):
   913   S status (Scleral tumor invasion status) [Classification]
   660   Clinical (Neuropsychologist - Clinical) [Professional or Occupational Group]
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   Clinical status [Qualitative Concept]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   Clinical status [Qualitative Concept]

Phrase: deteriorated .
Meta Mapping (1000):
  1000 N Deteriorated (Worse) [Finding]
Processing 00000000.tx.28: He required elevated ventilatory pressures with PIPS often above 60 . 

Phrase: He

Phrase: required
Meta Mapping (1000):
  1000   Required (Requirement) [Functional Concept]

Phrase: elevated ventilatory pressures with PIPS often
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Often - answer to question) [Intellectual Product]
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Often - answer to question) [Intellectual Product]
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Often - answer to question) [Intellectual Product]
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated (High) [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Often - answer to question) [Intellectual Product]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Often - answer to question) [Intellectual Product]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   Pressures (Pressure- physical agent) [Phenomenon or Process]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Often - answer to question) [Intellectual Product]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (mercaptopurine/methotrexate/vincristine) [Therapeutic or Preventive Procedure]
   586   Often (Often - answer to question) [Intellectual Product]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Frequently) [Temporal Concept]
Meta Mapping (676):
   586   Elevated [Qualitative Concept]
   753   pressures (Pressure (finding)) [Finding]
   553   PIP (PIP gene) [Gene or Genome]
   586   Often (Often - answer to question) [Intellectual Product]

Phrase: above 60 .
Meta Mapping (1000):
  1000   60% [Finding]
Processing 00000000.tx.29: He had midline catheter that was still in place and was draining bile . 

Phrase: He

Phrase: had

Phrase: midline catheter
Meta Mapping (888):
   694   MIDLINE (Midline (qualifier value)) [Spatial Concept]
   861   CATHETER (catheter device) [Medical Device]
Meta Mapping (888):
   694   MIDLINE (Midline (qualifier value)) [Spatial Concept]
   861   Catheter (Catheter Device Component) [Medical Device]
Meta Mapping (888):
   694   midline (midline cell component) [Cell Component]
   861   CATHETER (catheter device) [Medical Device]
Meta Mapping (888):
   694   midline (midline cell component) [Cell Component]
   861   Catheter (Catheter Device Component) [Medical Device]
Meta Mapping (888):
   694   Midline (Median (qualifier value)) [Spatial Concept]
   861   CATHETER (catheter device) [Medical Device]
Meta Mapping (888):
   694   Midline (Median (qualifier value)) [Spatial Concept]
   861   Catheter (Catheter Device Component) [Medical Device]

Phrase: that

Phrase: was

Phrase: still in place
Meta Mapping (790):
   790   Place [Spatial Concept]
Meta Mapping (790):
   790   Place (Place - dosing instruction imperative) [Functional Concept]
Meta Mapping (790):
   790   Place (put - instruction imperative) [Activity]

Phrase: and

Phrase: was

Phrase: draining bile .
Meta Mapping (872):
   661   drain (Drainage procedure) [Therapeutic or Preventive Procedure]
   861   BILE (Bile fluid) [Body Substance]
Meta Mapping (872):
   661   DRAIN (Drain device) [Medical Device]
   861   BILE (Bile fluid) [Body Substance]
Processing 00000000.tx.30: He was tolerating p.o. and feeling back to his baseline . 

Phrase: He

Phrase: was

Phrase: tolerating p.o.

Phrase: and

Phrase: feeling
Meta Mapping (1000):
  1000   feeling (Emotions) [Mental Process]
Meta Mapping (1000):
  1000   Feeling (Feelings) [Mental Process]

Phrase: back to his baseline .
Meta Mapping (708):
   770   BACK (Back) [Body Location or Region]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   BACK (Back) [Body Location or Region]
   604   Baseline [Quantitative Concept]
Meta Mapping (708):
   770   BACK (Dorsal) [Spatial Concept]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   BACK (Dorsal) [Spatial Concept]
   604   Baseline [Quantitative Concept]
Meta Mapping (708):
   770   Back (Back structure, including back of neck) [Body Location or Region]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   Back (Back structure, including back of neck) [Body Location or Region]
   604   Baseline [Quantitative Concept]
Meta Mapping (708):
   770   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   604   Baseline [Quantitative Concept]
Processing 00000000.tx.31: LILLBI FYFEBREUN , M.D. 

Phrase: LILLBI FYFEBREUN ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.32: KE15 TB326/0625 </RECORD> Unsigned BEATHEMARES , KELAN Cerebral vascular accident . 

Phrase: KE15 TB326/0625

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > Unsigned BEATHEMARES ,

Phrase: KELAN Cerebral vascular accident .
Meta Mapping (923):
   923   CEREBRAL VASCULAR ACCIDENT (Cerebrovascular accident) [Disease or Syndrome]
Processing 00000000.tx.33: She also has a history of urinary tract infection . 

Phrase: She

Phrase: also

Phrase: has

Phrase: a history of urinary tract infection .
Meta Mapping (938):
   938   History of urinary tract infection [Finding]
Processing 00000000.tx.34: She has a history of diverticulosis with lower GI bleeds . 

Phrase: She

Phrase: has

Phrase: a history of diverticulosis
Meta Mapping (708):
   770   History [Occupation or Discipline]
   604   DIVERTICULOSIS (Diverticulosis) [Anatomical Abnormality,Disease or Syndrome]
Meta Mapping (708):
   770   history (Historical aspects qualifier) [Functional Concept]
   604   DIVERTICULOSIS (Diverticulosis) [Anatomical Abnormality,Disease or Syndrome]
Meta Mapping (708):
   770   History, NOS (History of present illness) [Organism Attribute]
   604   DIVERTICULOSIS (Diverticulosis) [Anatomical Abnormality,Disease or Syndrome]
Meta Mapping (708):
   770   History (Medical History) [Finding]
   604   DIVERTICULOSIS (Diverticulosis) [Anatomical Abnormality,Disease or Syndrome]
Meta Mapping (708):
   770   History (Concept History) [Conceptual Entity]
   604   DIVERTICULOSIS (Diverticulosis) [Anatomical Abnormality,Disease or Syndrome]
Meta Mapping (708):
   770   History (History of previous events) [Finding]
   604   DIVERTICULOSIS (Diverticulosis) [Anatomical Abnormality,Disease or Syndrome]

Phrase: with lower GI bleeds .
Meta Mapping (1000):
  1000   Lower GI bleeds (Lower gastrointestinal hemorrhage) [Pathologic Function]
Meta Mapping (1000):
  1000   Lower GI bleeds (Lower Gastrointestinal Hemorrhage Adverse Event NOS) [Finding]
Processing 00000000.tx.35: Her cardiac exam was irregular but her heart sounds were distant . 

Phrase: Her cardiac exam
Meta Mapping (1000):
  1000   Cardiac exam (Examination of heart) [Health Care Activity]

Phrase: was

Phrase: irregular
Meta Mapping (1000):
  1000   Irregular [Qualitative Concept]

Phrase: but

Phrase: her heart sounds
Meta Mapping (1000):
  1000   HEART SOUNDS (Heart Sounds) [Organ or Tissue Function]
Meta Mapping (1000):
  1000   Heart sounds (Heart sounds:Find:Pt:Heart:Nom) [Clinical Attribute]

Phrase: were

Phrase: distant .
Meta Mapping (1000):
  1000   DISTANT (Distant) [Spatial Concept]
Processing 00000000.tx.36: The recommendation from the rheumatology service was to attempt to decrease her Prednisone to 5 mg PO q.day with an eye on a change in the severity of her shoulder arthritis symptoms . 

Phrase: The recommendation from the rheumatology service
Meta Mapping (722):
   753   Recommendation [Idea or Concept]
   623   Rheumatology service [Health Care Activity]

Phrase: was

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: attempt
Meta Mapping (1000):
  1000   Attempt [Event]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: decrease
Meta Mapping (1000):
  1000   Decrease (Reduced) [Qualitative Concept]
Meta Mapping (1000):
  1000   Decrease [Quantitative Concept]

Phrase: her Prednisone to 5 mg PO q.day
Meta Mapping (721):
   793   Prednisone 5 MG [Clinical Drug]
   578   PO (Portugal) [Geographic Area]
   578   /day (Daily) [Temporal Concept]
Meta Mapping (721):
   793   Prednisone 5 MG [Clinical Drug]
   578   PO (Portugal) [Geographic Area]
   578   DAY (day) [Temporal Concept]
Meta Mapping (721):
   793   Prednisone 5 MG [Clinical Drug]
   578   PO (Portugal) [Geographic Area]
   578   /day (per day) [Temporal Concept]
Meta Mapping (721):
   793   Prednisone 5 MG [Clinical Drug]
   578   PO (Oral) [Spatial Concept]
   578   /day (Daily) [Temporal Concept]
Meta Mapping (721):
   793   Prednisone 5 MG [Clinical Drug]
   578   PO (Oral) [Spatial Concept]
   578   DAY (day) [Temporal Concept]
Meta Mapping (721):
   793   Prednisone 5 MG [Clinical Drug]
   578   PO (Oral) [Spatial Concept]
   578   /day (per day) [Temporal Concept]

Phrase: with an eye on a change
Meta Mapping (783):
   783   eye change [Disease or Syndrome]
Meta Mapping (783):
   783   Eye, Change (Medical and Surgical @ Eye @ Change) [Therapeutic or Preventive Procedure]

Phrase: in the severity of her shoulder arthritis symptoms .
Meta Mapping (742):
   793   Severity of symptoms (Symptom severity level) [Finding]
   604   Shoulder arthritis NOS (shoulder arthritis) [Disease or Syndrome]
Processing 00000000.tx.37: The patient was initially treated by increasing her aspirin from 81 mg to 325 mg . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: initially
Meta Mapping (1000):
  1000   Initially [Temporal Concept]

Phrase: treated by increasing
Meta Mapping (746):
   790   Treated (Treating) [Functional Concept]
   790   Increasing [Functional Concept]

Phrase: her aspirin from 81 mg
Meta Mapping (844):
   844   Aspirin 81 MG [Clinical Drug]

Phrase: to 325 mg .
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.38: After careful discussion with the neurology service , it was felt that the patient was at too great a risk to be started and maintained on anticoagulant therapy and therefore she was treated conservatively . 

Phrase: After careful discussion with the neurology service ,
Meta Mapping (678):
   510   Care (care activity) [Activity]
   748   Discussion (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   612   Neurology service (neurology services (treatment)) [Therapeutic or Preventive Procedure]
Meta Mapping (678):
   510   Care (care activity) [Activity]
   748   Discussion (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   612   Neurology service [Health Care Related Organization]
Meta Mapping (678):
   510   Care (care activity) [Activity]
   748   Discussion (Discussion (communication)) [Social Behavior]
   612   Neurology service (neurology services (treatment)) [Therapeutic or Preventive Procedure]
Meta Mapping (678):
   510   Care (care activity) [Activity]
   748   Discussion (Discussion (communication)) [Social Behavior]
   612   Neurology service [Health Care Related Organization]

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was at too great
Meta Mapping (770):
   770   Great (Large) [Quantitative Concept]
Meta Mapping (770):
   770   Great (Greater) [Quantitative Concept]

Phrase: a risk
Meta Mapping (1000):
  1000   Risk [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: started
Meta Mapping (1000):
  1000   Started [Qualitative Concept]

Phrase: and

Phrase: maintained on anticoagulant therapy
Meta Mapping (783):
   770   Maintained (Maintaining (action)) [Functional Concept]
   833   Anticoagulant therapy [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: therefore

Phrase: she

Phrase: was

Phrase: treated
Meta Mapping (1000):
  1000   Treated (Treating) [Functional Concept]

Phrase: conservatively .
Processing 00000000.tx.39: Major consideration toward the end of the patient &apos;s hospitalization was whether or not she would be able to take adequate PO intake to maintain her volume status . 

Phrase: Major consideration toward the end of the patient &apos
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major (Severe (severity modifier)) [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End [Spatial Concept]
   575   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (637):
   575   Major [Qualitative Concept]
   742   Consideration (consideration) [Finding]
   575   End (Stop (qualifier value)) [Temporal Concept]
   575   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s hospitalization
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   hospitalisation (Hospitalization) [Health Care Activity]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   hospitalisation (Hospitalization) [Health Care Activity]

Phrase: was

Phrase: whether

Phrase: or

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: she

Phrase: would

Phrase: be

Phrase: able
Meta Mapping (1000):
  1000   Able (Ability) [Organism Attribute]
Meta Mapping (1000):
  1000 N Able (Able (finding)) [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: take
Meta Mapping (1000):
  1000   Take [Health Care Activity]

Phrase: adequate PO intake
Meta Mapping (851):
   660   Adequate (Sufficient) [Qualitative Concept]
   660   PO (Portugal) [Geographic Area]
   827   Intake [Functional Concept]
Meta Mapping (851):
   660   Adequate (Sufficient) [Qualitative Concept]
   660   PO (Oral) [Spatial Concept]
   827   Intake [Functional Concept]
Meta Mapping (851):
   660   Adequate [Qualitative Concept]
   660   PO (Portugal) [Geographic Area]
   827   Intake [Functional Concept]
Meta Mapping (851):
   660   Adequate [Qualitative Concept]
   660   PO (Oral) [Spatial Concept]
   827   Intake [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: maintain
Meta Mapping (1000):
  1000   Maintain (Maintenance) [Activity]

Phrase: her volume status .
Meta Mapping (888):
   694   *Volume (Volume) [Quantitative Concept]
   861   Status [Qualitative Concept]
Meta Mapping (888):
   694   % volume (% volume (qualifier value)) [Qualitative Concept]
   861   Status [Qualitative Concept]
Meta Mapping (888):
   694   Volume (Volume (publication)) [Intellectual Product]
   861   Status [Qualitative Concept]
Meta Mapping (888):
   694   Volume (Volume Measurement) [Laboratory Procedure]
   861   Status [Qualitative Concept]
Processing 00000000.tx.40: Initially it was felt that the patient would require gastroscopy . 

Phrase: Initially
Meta Mapping (1000):
  1000   Initially [Temporal Concept]

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: would

Phrase: require

Phrase: gastroscopy .
Meta Mapping (1000):
  1000   Gastroscopy (Endoscopy of stomach) [Diagnostic Procedure]
Processing 00000000.tx.41: I discussed this with the granddaughter and told her that if her PO intake was inadequate , that gastrostomy tube would be reasonable in the future and that we would be available to assist in this as it became necessary . 

Phrase: I
Meta Mapping (1000):
  1000   I- (Iodides) [Inorganic Chemical]
Meta Mapping (1000):
  1000   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: discussed
Meta Mapping (966):
   966   Discuss (Discussion (communication)) [Social Behavior]

Phrase: this with the granddaughter
Meta Mapping (770):
   770   Granddaughter [Family Group]

Phrase: and

Phrase: told

Phrase: her

Phrase: that

Phrase: if

Phrase: her PO intake
Meta Mapping (888):
   694   PO (Portugal) [Geographic Area]
   861   Intake [Functional Concept]
Meta Mapping (888):
   694   PO (Oral) [Spatial Concept]
   861   Intake [Functional Concept]

Phrase: was

Phrase: inadequate ,
Meta Mapping (1000):
  1000   Inadequate (Inadequate (qualifier)) [Qualitative Concept]

Phrase: that gastrostomy tube
Meta Mapping (1000):
  1000   Gastrostomy tube [Medical Device]
Meta Mapping (1000):
  1000   Gastrostomy Tube (Gastrostomy Tube Route) [Functional Concept]
Meta Mapping (1000):
  1000   gastrostomy tube (Percutaneous endoscopic tube) [Medical Device]

Phrase: would

Phrase: be

Phrase: reasonable in the future
Meta Mapping (604):
   604   Future [Temporal Concept]

Phrase: and

Phrase: that

Phrase: we

Phrase: would

Phrase: be

Phrase: available
Meta Mapping (1000):
  1000   Available (Availability of) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: assist in this
Meta Mapping (790):
   790   assist (Helping Behavior) [Social Behavior]
Meta Mapping (790):
   790   assist (Assisting (procedure)) [Health Care Activity]
Meta Mapping (790):
   790   Assist (Assisted (qualifier value)) [Qualitative Concept]

Phrase: as

Phrase: it

Phrase: became

Phrase: necessary .
Processing 00000000.tx.42: My direct pager is 935-131-3314 . 

Phrase: My direct pager
Meta Mapping (888):
   694   Direct (Direct type of relationship) [Qualitative Concept]
   861   pager (Hospital Communication Systems, Paging) [Intellectual Product]
Meta Mapping (888):
   694   Direct (Direct type of relationship) [Qualitative Concept]
   861   Pager (Pagers) [Manufactured Object]
Meta Mapping (888):
   694   Direct (Direct (qualifier)) [Qualitative Concept]
   861   pager (Hospital Communication Systems, Paging) [Intellectual Product]
Meta Mapping (888):
   694   Direct (Direct (qualifier)) [Qualitative Concept]
   861   Pager (Pagers) [Manufactured Object]

Phrase: is

Phrase: 935-131-3314 .
Processing 00000000.tx.43: </TEXT> </RECORD> 7961198 UNIT NUMBER : ADMISSION DATE : She also had some black , tarry stool in her colostomy bag . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 7961198 UNIT NUMBER
Meta Mapping (790):
   660   Unit [Quantitative Concept]
   827   *Number (Numbers) [Quantitative Concept]
Meta Mapping (790):
   660   Unit [Quantitative Concept]
   827   Number (Count of entities) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Unit of Measure) [Quantitative Concept]
   827   *Number (Numbers) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Unit of Measure) [Quantitative Concept]
   827   Number (Count of entities) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Storage Unit) [Manufactured Object]
   827   *Number (Numbers) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Storage Unit) [Manufactured Object]
   827   Number (Count of entities) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Enzyme Unit) [Quantitative Concept]
   827   *Number (Numbers) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Enzyme Unit) [Quantitative Concept]
   827   Number (Count of entities) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
   827   *Number (Numbers) [Quantitative Concept]
Meta Mapping (790):
   660   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
   827   Number (Count of entities) [Quantitative Concept]

Phrase: :

Phrase: ADMISSION DATE
Meta Mapping (1000):
  1000   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (1000):
  1000   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: She

Phrase: also

Phrase: had

Phrase: some black ,
Meta Mapping (1000):
  1000   Black (Black race) [Population Group]
Meta Mapping (1000):
  1000   Black (African race) [Population Group]
Meta Mapping (1000):
  1000   Black (African American) [Population Group]
Meta Mapping (1000):
  1000   Black (Black color) [Qualitative Concept]

Phrase: tarry
Meta Mapping (1000):
  1000   Tarry [Finding]

Phrase: stool in her colostomy bag .
Meta Mapping (745):
   760   STOOL (Feces) [Body Substance]
   640   Colostomy bag [Medical Device]
Meta Mapping (745):
   760   Stool (Stool seat) [Medical Device]
   640   Colostomy bag [Medical Device]
Processing 00000000.tx.44: She was started on Pitressin , a Blakemore tube was inserted . 

Phrase: She

Phrase: was

Phrase: started on Pitressin ,
Meta Mapping (746):
   790   Started [Qualitative Concept]
   790   Pitressin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: a Blakemore tube
Meta Mapping (1000):
  1000   blakemore tube (tubes, esophageal, blakemore) [Medical Device]

Phrase: was

Phrase: inserted .
Meta Mapping (1000):
  1000   Inserted (Clinical act of insertion) [Health Care Activity]
Processing 00000000.tx.45: She was transferred to the Ph University Of Medical Center Intensive Care Unit where on January 25 in the morning her hematocrit was found to be 27.4 . 

Phrase: She

Phrase: was

Phrase: transferred to the Ph University Of Medical Center Intensive Care Unit where
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   ph+++ [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   pH [Quantitative Concept]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Intention - mental process) [Mental Process]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intense (With intensity) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   Intent (intent) [Qualitative Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit of Measure) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Storage Unit) [Manufactured Object]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Enzyme Unit) [Quantitative Concept]
Meta Mapping (705):
   755   Transfer of care [Health Care Activity]
   736   PH (Infusion pump Alert priority PH) [Finding]
   736   University (Universities) [Manufactured Object,Organization]
   753   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
   636   intent (Act Mood - intent) [Functional Concept]
   736   Unit (Unit - NCI Thesaurus Property) [Functional Concept]

Phrase: on January 25 in the morning
Meta Mapping (672):
   753   January [Qualitative Concept]
   753   Morning [Temporal Concept]

Phrase: her hematocrit
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit level) [Finding]

Phrase: was

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: 27.4 .
Processing 00000000.tx.46: No coronary disease , no diabetes and no hypertension . 

Phrase: No coronary disease ,
Meta Mapping (1000):
  1000 N CORONARY DISEASE (Coronary heart disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000 N Coronary Disease (Coronary Artery Disease) [Disease or Syndrome]

Phrase: no diabetes
Meta Mapping (1000):
  1000 N Diabetes [Disease or Syndrome]
Meta Mapping (1000):
  1000 N Diabetes (Diabetes Mellitus) [Disease or Syndrome]

Phrase: and

Phrase: no hypertension .
Meta Mapping (1000):
  1000 N HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000 N Hypertension (Hypertension Adverse Event) [Finding]
Processing 00000000.tx.47: She had medications on transfer which included Synthroid 0.15 mg QD , Zoloft 50 mg QD , Inderal 10 mg BID , Prilosec 20 mg QD , Neomycin 500 TID , Feosol 3 mg and Darvocet PRN . 

Phrase: She

Phrase: had

Phrase: medications on transfer
Meta Mapping (746):
   790   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
   623   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (746):
   790   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
   623   Transfer (Transfer Technique) [Functional Concept]
Meta Mapping (746):
   790   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
   623   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (746):
   790   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
   623   Transfer (Transfer Technique) [Functional Concept]
Meta Mapping (746):
   790   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]
   623   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (746):
   790   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]
   623   Transfer (Transfer Technique) [Functional Concept]

Phrase: which

Phrase: included
Meta Mapping (1000):
  1000   included (Including (qualifier)) [Functional Concept]

Phrase: Synthroid 0.15 mg QD ,
Meta Mapping (927):
   757   Levothyroxine Sodium 0.15 MG [Clinical Drug]
   804   QD (Daily) [Temporal Concept]

Phrase: Zoloft 50 mg QD ,
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   50% [Finding]
   645   MG (Mongolia) [Geographic Area]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   50% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   50% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   50% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   <50 [Finding]
   645   MG (Mongolia) [Geographic Area]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   <50 [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   <50 [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   Zoloft [Organic Chemical,Pharmacologic Substance]
   645   <50 [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   812   QD (Daily) [Temporal Concept]

Phrase: Inderal 10 mg BID ,
Meta Mapping (738):
   738   Propranolol Hydrochloride 10 MG [Clinical Drug]

Phrase: Prilosec 20 mg QD ,
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   MG (Mongolia) [Geographic Area]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   812   QD (Daily) [Temporal Concept]

Phrase: Neomycin 500 TID ,
Meta Mapping (802):
   660   NEOMYCIN (Neomycin) [Antibiotic,Organic Chemical]
   827   TID (Three times daily) [Temporal Concept]
Meta Mapping (802):
   660   NEOMYCIN (Neomycin) [Antibiotic,Organic Chemical]
   827   TID (three times a day at institution-specified times) [Temporal Concept]

Phrase: Feosol 3 mg
Meta Mapping (802):
   660   Feosol [Pharmacologic Substance]
   827   MG (Mongolia) [Geographic Area]
Meta Mapping (802):
   660   Feosol [Pharmacologic Substance]
   827   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (802):
   660   Feosol [Pharmacologic Substance]
   827   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (802):
   660   Feosol [Pharmacologic Substance]
   827   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: and

Phrase: Darvocet PRN .
Meta Mapping (694):
   694   Darvocet [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.48: Her husband died of lung cancer . 

Phrase: Her husband
Meta Mapping (1000):
  1000   Husband (husband) [Family Group]

Phrase: died of lung cancer .
Meta Mapping (916):
   770   Died (Cessation of life) [Organism Function]
   881   Cancer of Lung (Malignant neoplasm of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Cessation of life) [Organism Function]
   881   Cancer of Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Death (finding)) [Finding]
   881   Cancer of Lung (Malignant neoplasm of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Death (finding)) [Finding]
   881   Cancer of Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Patient Outcome - Died) [Finding]
   881   Cancer of Lung (Malignant neoplasm of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Patient Outcome - Died) [Finding]
   881   Cancer of Lung (Carcinoma of lung) [Neoplastic Process]
Processing 00000000.tx.49: She lives alone in Burg Chi Sternafre , Massachusetts . 

Phrase: She

Phrase: lives
Meta Mapping (1000):
  1000   lives (Household composition) [Finding]
Meta Mapping (1000):
  1000   Live (Live - Specimen Condition) [Qualitative Concept]
Meta Mapping (1000):
  1000   % live [Qualitative Concept]
Meta Mapping (1000):
  1000   Live (Reside) [Activity]

Phrase: alone in Burg Chi Sternafre ,
Meta Mapping (686):
   760   Alone (Singular) [Quantitative Concept]
   593   Chi [Intellectual Product]
Meta Mapping (686):
   760   Alone (Living Alone) [Finding]
   593   Chi [Intellectual Product]
Meta Mapping (686):
   760   alone (alone - group size) [Group Attribute]
   593   Chi [Intellectual Product]

Phrase: Massachusetts .
Meta Mapping (1000):
  1000   Massachusetts (Massachusetts (geographic location)) [Geographic Area]
Processing 00000000.tx.50: Her friends check up on her . 

Phrase: Her friends check up on her .
Meta Mapping (734):
   586   Friends (friend) [Population Group]
   790   check up (Encounter due to Unspecified general medical examination) [Finding]
Meta Mapping (734):
   586   Friends (friend) [Population Group]
   790   Checkup (checkup examination) [Health Care Activity]
Meta Mapping (734):
   586   Friends (Friends - (Religious Affiliation)) [Idea or Concept]
   790   check up (Encounter due to Unspecified general medical examination) [Finding]
Meta Mapping (734):
   586   Friends (Friends - (Religious Affiliation)) [Idea or Concept]
   790   Checkup (checkup examination) [Health Care Activity]
Processing 00000000.tx.51: She does not have a home health aide . vital signs : She had no evidence of asterixis . 

Phrase: She

Phrase: does

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: have

Phrase: a home health aide . vital signs
Meta Mapping (893):
   717   Home Health Aide (Home Health Aides) [Professional or Occupational Group]
   840   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (893):
   717   Home Health Aide (Home Health Aides) [Professional or Occupational Group]
   840   Signs, Vital (Vital signs) [Clinical Attribute]

Phrase: :

Phrase: She

Phrase: had

Phrase: no evidence of asterixis .
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604 N ASTERIXIS (Asterixis) [Sign or Symptom]
Processing 00000000.tx.52: Her PT was 13.1 , PTT 26.7 . 

Phrase: Her PT
Meta Mapping (1000):
  1000   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]

Phrase: was

Phrase: 13.1 ,

Phrase: PTT 26.7 .
Meta Mapping (827):
   827   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
Processing 00000000.tx.53: The rest of her labs were unremarkable . 

Phrase: The rest of her labs
Meta Mapping (686):
   760   Rest [Daily or Recreational Activity]
   593   Labs (Laboratory test finding) [Finding]
Meta Mapping (686):
   760   ResT (site-specific telomere resolvase activity) [Molecular Function]
   593   Labs (Laboratory test finding) [Finding]

Phrase: were

Phrase: unremarkable .
Meta Mapping (1000):
  1000   Unremarkable (Normal) [Qualitative Concept]
Processing 00000000.tx.54: She was watched very closely while on the floor . 

Phrase: She

Phrase: was

Phrase: watched

Phrase: very closely
Meta Mapping (861):
   861   Very [Qualitative Concept]
Meta Mapping (861):
   861   Very (Very Much) [Qualitative Concept]

Phrase: while on the floor .
Meta Mapping (770):
   770   Floor (floor (object)) [Manufactured Object]
Meta Mapping (770):
   770   Floor (Floor - story of building) [Geographic Area]
Meta Mapping (770):
   770   Floor (Floor (anatomic)) [Anatomical Structure]
Processing 00000000.tx.55: She therefore _________ criteria for a spontaneous bacterial peritonitis . 

Phrase: She therefore _________ criteria for a spontaneous bacterial peritonitis .
Meta Mapping (739):
   744   Criteria (criteria) [Intellectual Product]
   633   Spontaneous bacterial peritonitis (Primary bacterial peritonitis) [Disease or Syndrome]
Processing 00000000.tx.56: MEDICATIONS ON DISCHARGE : cc : <TEXT> She was reportedly incontinent of urine and diaphoretic . vitamin B12 shots monthly . 

Phrase: MEDICATIONS ON DISCHARGE
Meta Mapping (858):
   858   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: cc
Meta Mapping (1000):
  1000   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: She

Phrase: was

Phrase: reportedly incontinent of urine
Meta Mapping (885):
   885   Incontinence of urine (Urinary Incontinence) [Pathologic Function]

Phrase: and

Phrase: diaphoretic . vitamin B12 shots monthly .
Meta Mapping (840):
   637   Diaphoretic [Qualitative Concept]
   673   Vitamin B12 (Vitamin B 12) [Organic Chemical,Pharmacologic Substance,Vitamin]
   804   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   637   Monthly (Monthly (qualifier value)) [Temporal Concept]
Meta Mapping (840):
   637   Diaphoretic [Qualitative Concept]
   673   Vitamin B12 (Vitamin B12 [EPC]) [Pharmacologic Substance]
   804   Shots (Childhood Immunization) [Therapeutic or Preventive Procedure]
   637   Monthly (Monthly (qualifier value)) [Temporal Concept]
Processing 00000000.tx.57: They recommended that a cytology sample be obtained and sent and that the patient be treated with a 14 day course of Keflex . ves / bmot <RECORD ID="720"> 570594910 Signed Addition of diltiazem to the patient &apos;s aspirin and Dyazide medical treatment had no improvement in symptoms . 

Phrase: They

Phrase: recommended
Meta Mapping (1000):
  1000   Recommended (Recommendation) [Idea or Concept]

Phrase: that

Phrase: a cytology sample
Meta Mapping (1000):
  1000   Cytology sample (Cytologic material) [Body Substance]

Phrase: be

Phrase: obtained
Meta Mapping (1000):
  1000   Obtained (Obtain) [Functional Concept]

Phrase: and

Phrase: sent
Meta Mapping (1000):
  1000   Sent (Send (transmission)) [Functional Concept]

Phrase: and

Phrase: that

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: be

Phrase: treated with a 14 day course of Keflex . ves / bmot
Meta Mapping (662):
   760   Treated with [Therapeutic or Preventive Procedure]
   739   /day (Daily) [Temporal Concept]
   739   Course [Temporal Concept]
   739   Keflex [Antibiotic,Organic Chemical]
   739   VES (Vesicular Exanthema of Swine) [Disease or Syndrome]
Meta Mapping (662):
   760   Treated with [Therapeutic or Preventive Procedure]
   739   DAY (day) [Temporal Concept]
   739   Course [Temporal Concept]
   739   Keflex [Antibiotic,Organic Chemical]
   739   VES (Vesicular Exanthema of Swine) [Disease or Syndrome]
Meta Mapping (662):
   760   Treated with [Therapeutic or Preventive Procedure]
   739   /day (per day) [Temporal Concept]
   739   Course [Temporal Concept]
   739   Keflex [Antibiotic,Organic Chemical]
   739   VES (Vesicular Exanthema of Swine) [Disease or Syndrome]

Phrase: <RECORD ID="720"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 570594910 Signed Addition of diltiazem
Meta Mapping (696):
   593   Signed (Signature) [Intellectual Product]
   760   Addition (In addition to) [Functional Concept]
   593   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (696):
   593   Signed (Signature) [Intellectual Product]
   760   Addition (Add - instruction imperative) [Functional Concept]
   593   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (696):
   593   signed (signed - ParticipationSignature) [Intellectual Product]
   760   Addition (In addition to) [Functional Concept]
   593   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (696):
   593   signed (signed - ParticipationSignature) [Intellectual Product]
   760   Addition (Add - instruction imperative) [Functional Concept]
   593   DILTIAZEM (Diltiazem) [Organic Chemical,Pharmacologic Substance]

Phrase: to the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s aspirin
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   ASPIRIN (Aspirin) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   ASPIRIN (Aspirin) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: Dyazide medical treatment
Meta Mapping (901):
   660   Dyazide [Organic Chemical,Pharmacologic Substance]
   901   medical Treatment (medical treatment method) [Therapeutic or Preventive Procedure]

Phrase: had

Phrase: no improvement in symptoms .
Meta Mapping (708):
   770   Improvement [Conceptual Entity]
   604   symptoms (Symptoms aspect) [Functional Concept]
Meta Mapping (708):
   770   Improvement [Conceptual Entity]
   604 N SYMPTOMS (Symptoms) [Sign or Symptom]
Processing 00000000.tx.58: SVR 943 . 

Phrase: SVR 943 .
Meta Mapping (861):
   861   SVR (Total Peripheral Resistance) [Physiologic Function]
Meta Mapping (861):
   861   SVR (Sustained Virologic Response) [Finding]
Processing 00000000.tx.59: It was thought that the drop in hematocrit was secondary to his chemotherapy , some small dilutional effect and small blood loss from the PTCA , although there was no evidence of significant bleeding . 

Phrase: It

Phrase: was

Phrase: thought
Meta Mapping (1000):
  1000   Thought (Thinking, function) [Mental Process]

Phrase: that

Phrase: the drop in hematocrit
Meta Mapping (909):
   909   Drop in hematocrit (Hematocrit decreased) [Finding]

Phrase: was

Phrase: secondary to his chemotherapy ,
Meta Mapping (783):
   833   Secondary to [Temporal Concept]
   604   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (783):
   833   Secondary to [Temporal Concept]
   604   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (783):
   833   Secondary to [Temporal Concept]
   604   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (783):
   833   Secondary to [Temporal Concept]
   604   Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: some small dilutional effect
Meta Mapping (828):
   660   SMALL (Small) [Quantitative Concept]
   589   dilutions (Dilution technique) [Laboratory Procedure]
   827   Effect [Qualitative Concept]
Meta Mapping (828):
   660   SMALL (Small) [Quantitative Concept]
   589   dilutions (Dilution technique) [Laboratory Procedure]
   827   Effect (Effect, Appearance) [Qualitative Concept]
Meta Mapping (828):
   660   SMALL (Small) [Quantitative Concept]
   589   Dilution (Dilute (action)) [Functional Concept]
   827   Effect [Qualitative Concept]
Meta Mapping (828):
   660   SMALL (Small) [Quantitative Concept]
   589   Dilution (Dilute (action)) [Functional Concept]
   827   Effect (Effect, Appearance) [Qualitative Concept]

Phrase: and

Phrase: small blood loss from the PTCA ,
Meta Mapping (725):
   586   SMALL (Small) [Quantitative Concept]
   790   Blood loss (Hemorrhage) [Pathologic Function]
   586   PTCA (Percutaneous Transluminal Coronary Angioplasty) [Therapeutic or Preventive Procedure]
Meta Mapping (725):
   586   SMALL (Small) [Quantitative Concept]
   790   Blood loss (Actual blood loss) [Clinical Attribute]
   586   PTCA (Percutaneous Transluminal Coronary Angioplasty) [Therapeutic or Preventive Procedure]
Meta Mapping (725):
   586   SMALL (Small) [Quantitative Concept]
   790   Blood Loss [Finding]
   586   PTCA (Percutaneous Transluminal Coronary Angioplasty) [Therapeutic or Preventive Procedure]

Phrase: although

Phrase: there

Phrase: was

Phrase: no evidence of significant bleeding .
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   significant (Statistical Significance) [Quantitative Concept]
   593 N BLEEDING (Hemorrhage) [Pathologic Function]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Significant [Idea or Concept]
   593 N BLEEDING (Hemorrhage) [Pathologic Function]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593 N BLEEDING (Hemorrhage) [Pathologic Function]
Processing 00000000.tx.60: R4900W17 HOUGHTJESCSLEM , RIESHINJIN R 6. 

Phrase: R4900W17 HOUGHTJESCSLEM ,

Phrase: RIESHINJIN R 6.
Meta Mapping (827):
   827   R- (Right) [Spatial Concept]
Meta Mapping (827):
   827   R. (Rabbi) [Professional or Occupational Group]
Meta Mapping (827):
   827   R' (R prime) [Clinical Attribute]
Processing 00000000.tx.61: right cheek basal cell carcinoma , 9. 

Phrase: right cheek basal cell carcinoma ,
Meta Mapping (893):
   673   Right cheek [Body Part, Organ, or Organ Component]
   884   BASAL CELL CARCINOMA (Basal cell carcinoma) [Neoplastic Process]
Meta Mapping (893):
   673   Right cheek [Body Part, Organ, or Organ Component]
   884   Basal cell carcinoma (Tissue Type Code - Basal cell carcinoma) [Intellectual Product]
Meta Mapping (893):
   673   Right cheek [Body Part, Organ, or Organ Component]
   884   Basal cell carcinoma (Basal Cell Carcinoma Pathway) [Functional Concept]
Meta Mapping (893):
   673   Right cheek [Body Part, Organ, or Organ Component]
   884   Basal Cell Carcinoma (NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology) [Intellectual Product]
Meta Mapping (893):
   673   Right cheek [Body Part, Organ, or Organ Component]
   884   Basal Cell Carcinoma (Experimental Organism Basal Cell Carcinoma) [Neoplastic Process]

Phrase: 9.
Processing 00000000.tx.62: status post laparoscopic cholecystectomy , ALLERGIES : No known drug allergies . 

Phrase: status post laparoscopic cholecystectomy ,
Meta Mapping (1000):
  1000   Cholecystectomy, Laparoscopic [Therapeutic or Preventive Procedure]

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: No known drug allergies .
Meta Mapping (901):
   660   Known [Qualitative Concept]
   901 N Drug Allergies (Drug Allergy) [Disease or Syndrome]
Processing 00000000.tx.63: 6. 

Phrase: 6.
Processing 00000000.tx.64: Digoxin .25 mg PO q.day , LABORATORY DATA : Impression was that this was an 83-year-old female with cardiac history , dyspnea on exertion , increased calcium and hyperparathyroidism who presents for parathyroidectomy . 

Phrase: Digoxin .25 mg PO q.day ,
Meta Mapping (768):
   632   DIGOXIN (Digoxin) [Organic Chemical,Pharmacologic Substance]
   858   mg day (milligram/day) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (768):
   632   DIGOXIN (Digoxin) [Organic Chemical,Pharmacologic Substance]
   858   mg day (milligram/day) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: Impression
Meta Mapping (1000):
  1000   impression (impression (attitude)) [Individual Behavior]
Meta Mapping (1000):
  1000   Impression [Qualitative Concept]
Meta Mapping (1000):
  1000   Impression (Radiologic Impression) [Finding]

Phrase: was

Phrase: that

Phrase: this

Phrase: was

Phrase: an 83-year-old female with cardiac history ,
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   YEAR (year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   FEMALE (Female) [Organism Attribute]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Woman) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   female (Females) [Population Group]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female, Self-Report) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   578   History (History of previous events) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History [Occupation or Discipline]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Medical History) [Finding]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (Concept History) [Conceptual Entity]
Meta Mapping (671):
   578   /Year (per year) [Temporal Concept]
   578   Old [Temporal Concept]
   744   Female (Female Phenotype) [Qualitative Concept]
   578   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   578   History (History of previous events) [Finding]

Phrase: dyspnea on exertion ,
Meta Mapping (1000):
  1000   Dyspnoea on exertion (Dyspnea on exertion) [Sign or Symptom]

Phrase: increased calcium
Meta Mapping (1000):
  1000   increased calcium (ca increase) [Finding]

Phrase: and

Phrase: hyperparathyroidism
Meta Mapping (1000):
  1000   HYPERPARATHYROIDISM (Hyperparathyroidism) [Disease or Syndrome]

Phrase: who

Phrase: presents for parathyroidectomy .
Meta Mapping (746):
   790   Present [Quantitative Concept]
   790   Parathyroidectomy [Therapeutic or Preventive Procedure]
Meta Mapping (746):
   790   Present (Presentation) [Idea or Concept]
   790   Parathyroidectomy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.65: 3. 

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.66: K-Dur 20 mg PO q.day , In addition , she is to follow up with her primary care physician to check her prothrombin time / INR as well as calcium , albumin and phosphate levels . 

Phrase: K-Dur 20 mg PO q.day ,
Meta Mapping (787):
   651   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   629   20% [Finding]
   845   mg day (milligram/day) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
Meta Mapping (787):
   651   K-Dur [Inorganic Chemical,Pharmacologic Substance]
   629   20% [Finding]
   845   mg day (milligram/day) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]

Phrase: In addition ,
Meta Mapping (861):
   861   Addition (In addition to) [Functional Concept]
Meta Mapping (861):
   861   Addition (Add - instruction imperative) [Functional Concept]

Phrase: she

Phrase: is

Phrase: to follow up with her primary care physician
Meta Mapping (742):
   600   To Physician (To doctor) [Finding]
   793   Follow-Up Care [Health Care Activity]
   578   Primary [Qualitative Concept]
Meta Mapping (742):
   600   To Physician (To doctor) [Finding]
   793   Follow-Up Care [Health Care Activity]
   578   Primary (True primary (qualifier value)) [Temporal Concept]
Meta Mapping (742):
   600   To Physician (To doctor) [Finding]
   793   Follow-Up Care [Health Care Activity]
   578   Primary (Primary operation) [Therapeutic or Preventive Procedure]
Meta Mapping (742):
   578   TO (Togo) [Geographic Area]
   770   Follow-up (Follow-up status) [Finding]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   TO (Togo) [Geographic Area]
   770   Follow Up (follow-up) [Health Care Activity]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   TO (Togo) [Geographic Area]
   770   Follow-Up (Follow-Up Report) [Intellectual Product]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   TO (Togo) [Geographic Area]
   770   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   770   Follow-up (Follow-up status) [Finding]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   770   Follow Up (follow-up) [Health Care Activity]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   770   Follow-Up (Follow-Up Report) [Intellectual Product]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   770   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   To [Qualitative Concept]
   770   Follow-up (Follow-up status) [Finding]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   To [Qualitative Concept]
   770   Follow Up (follow-up) [Health Care Activity]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   To [Qualitative Concept]
   770   Follow-Up (Follow-Up Report) [Intellectual Product]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]
Meta Mapping (742):
   578   To [Qualitative Concept]
   770   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   633   Primary Care Physician (Primary Care Physicians) [Professional or Occupational Group]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: check
Meta Mapping (1000):
  1000   Check (Checking (action)) [Activity]

Phrase: her prothrombin time / INR
Meta Mapping (901):
   734   Time, Prothrombin (Prothrombin time assay) [Laboratory Procedure]
   827   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (901):
   734   Time, Prothrombin (Prothrombin time assay) [Laboratory Procedure]
   827   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]
Meta Mapping (901):
   734   Prothrombin time (Coagulation tissue factor induced:Time:Pt:PPP:Qn:Coag) [Clinical Attribute]
   827   INR (International Normalized Ratio) [Laboratory Procedure]
Meta Mapping (901):
   734   Prothrombin time (Coagulation tissue factor induced:Time:Pt:PPP:Qn:Coag) [Clinical Attribute]
   827   INR (Integrated Neuromusculoskeletal Release) [Therapeutic or Preventive Procedure]

Phrase: as well as

Phrase: calcium ,
Meta Mapping (1000):
  1000   CALCIUM (Calcium) [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Calcium (Calcium, Dietary) [Inorganic Chemical]
Meta Mapping (1000):
  1000   Calcium (Calcium [EPC]) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   CALCIUM (CALCIUM SUPPLEMENTS) [Pharmacologic Substance,Vitamin]
Meta Mapping (1000):
  1000   CALCIUM (Calcium Drug Class) [Pharmacologic Substance]

Phrase: albumin
Meta Mapping (1000):
  1000   ALBUMIN (Albumins) [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: and

Phrase: phosphate levels .
Meta Mapping (966):
   966   phosphate level (Phosphate level result) [Laboratory or Test Result]
Processing 00000000.tx.67: She will be sent home with home Arnsperni Health . 

Phrase: She

Phrase: will

Phrase: be

Phrase: sent
Meta Mapping (1000):
  1000   Sent (Send (transmission)) [Functional Concept]

Phrase: home with home Arnsperni Health .
Meta Mapping (631):
   631   Home Health (Home Health Agencies) [Health Care Related Organization]
Meta Mapping (631):
   631   Home Health (Home health care specialty) [Biomedical Occupation or Discipline]
Processing 00000000.tx.68: TR : PRINCIPAL DIAGNOSIS : pq / bmot CC : <TEXT> PUOMC The patient &apos;s preliminary admitting physician is CHIRD , GRAJORD C and the preliminary diagnosis is PNA . 

Phrase: TR
Meta Mapping (1000):
  1000   TR (TXNRD1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (TXNRD2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (Tumor Results Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   TR (Thioredoxin Reductase 1, Cytoplasmic) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :

Phrase: PRINCIPAL DIAGNOSIS
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal diagnosis) [Qualitative Concept]
Meta Mapping (1000):
  1000   Principal Diagnosis (Principal Diagnosis:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: pq / bmot CC
Meta Mapping (802):
   660   PQ (Physical Quantity Data Type) [Qualitative Concept]
   827   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > PUOMC

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s preliminary admitting physician
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Preliminary [Temporal Concept]
   861   Admitting Physician (Admitting physician) [Professional or Occupational Group]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Preliminary [Temporal Concept]
   861   Admitting Physician (Admitting physician) [Professional or Occupational Group]

Phrase: is

Phrase: CHIRD ,

Phrase: GRAJORD C

Phrase: and

Phrase: the preliminary diagnosis
Meta Mapping (1000):
  1000   Preliminary diagnosis (Preliminary diagnosis qualifier value) [Qualitative Concept]
Meta Mapping (1000):
  1000   Preliminary diagnosis (Diagnosis.preliminary:Impression/interpretation of study:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: is

Phrase: PNA .
Meta Mapping (1000):
  1000   PNA (Peptide Nucleic Acids) [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.69: PCP Name : 9/15/2001 12:00:00 AM Signed 09/23/2001 ADMISSION MEDICATIONS : CTMC 48720920 Signed SOCIAL HISTORY : 8987576 HISTORY OF PRESENT ILLNESS : PHYSICAL EXAMINATION : ua Discharge Summary Unsigned The patient was a 63 year old female with long-standing history of polycythemia vera , managed medically , who on a routine follow-up examination complained of left side pain and had an ultrasound that demonstrated a complex left renal mass . 

Phrase: PCP Name
Meta Mapping (888):
   694   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]
   861   Name [Intellectual Product]
Meta Mapping (888):
   694   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]
   861   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: 9/15/2001 12

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: Signed
Meta Mapping (1000):
  1000   Signed (Signature) [Intellectual Product]
Meta Mapping (1000):
  1000   signed (signed - ParticipationSignature) [Intellectual Product]

Phrase: 09/23/2001 ADMISSION MEDICATIONS
Meta Mapping (740):
   637   23 [Quantitative Concept]
   637   Admission (Hospital admission) [Health Care Activity]
   804   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (740):
   637   23 [Quantitative Concept]
   637   Admission (Hospital admission) [Health Care Activity]
   804   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (740):
   637   23 [Quantitative Concept]
   637   Admission (Hospital admission) [Health Care Activity]
   804   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (740):
   637   23 [Quantitative Concept]
   637   Admission (Admission activity) [Health Care Activity]
   804   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (740):
   637   23 [Quantitative Concept]
   637   Admission (Admission activity) [Health Care Activity]
   804   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (740):
   637   23 [Quantitative Concept]
   637   Admission (Admission activity) [Health Care Activity]
   804   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: CTMC 48720920 Signed SOCIAL HISTORY
Meta Mapping (785):
   637   Signed (Signature) [Intellectual Product]
   840   Social history (Social and personal history) [Finding]
Meta Mapping (785):
   637   Signed (Signature) [Intellectual Product]
   840   Social History [Finding]
Meta Mapping (785):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   840   Social history (Social and personal history) [Finding]
Meta Mapping (785):
   637   signed (signed - ParticipationSignature) [Intellectual Product]
   840   Social History [Finding]

Phrase: :

Phrase: 8987576 HISTORY OF PRESENT ILLNESS
Meta Mapping (926):
   926   HISTORY OF PRESENT ILLNESS (History of present illness) [Organism Attribute]
Meta Mapping (926):
   926   History of present illness (History of present illness:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]

Phrase: :

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: ua Discharge Summary
Meta Mapping (901):
   660   UA (Ukraine) [Geographic Area]
   901   Discharge summary [Intellectual Product]
Meta Mapping (901):
   660   UA (Ukraine) [Geographic Area]
   901   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (901):
   660   UA (Urinalysis) [Laboratory Procedure]
   901   Discharge summary [Intellectual Product]
Meta Mapping (901):
   660   UA (Urinalysis) [Laboratory Procedure]
   901   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: Unsigned

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: a 63 year old female with long-standing history of polycythemia vera ,
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   FEMALE (Female) [Organism Attribute]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Woman) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   female (Females) [Population Group]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female, Self-Report) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History [Occupation or Discipline]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   history (Historical aspects qualifier) [Functional Concept]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History, NOS (History of present illness) [Organism Attribute]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Medical History) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (Concept History) [Conceptual Entity]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]
Meta Mapping (662):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Female (Female Phenotype) [Qualitative Concept]
   570   Long (Long Variable) [Qualitative Concept]
   570   STANDING (Standing position) [Physiologic Function]
   570   History (History of previous events) [Finding]
   586   Polycythaemia vera (Polycythemia Vera) [Neoplastic Process]

Phrase: managed
Meta Mapping (1000):
  1000   Managed (Management procedure) [Occupational Activity]

Phrase: medically ,

Phrase: who on a routine follow-up examination
Meta Mapping (770):
   748   Routine [Qualitative Concept]
   814   Follow-up examination (Unspecified follow-up examination) [Finding]

Phrase: complained of left side pain
Meta Mapping (763):
   806   Left side (Left) [Spatial Concept]
   760   PAIN (Pain) [Sign or Symptom]
Meta Mapping (763):
   806   Left side (Left) [Spatial Concept]
   760   Pain NOS (Pain NOS Adverse Event) [Finding]
Meta Mapping (763):
   760   LEFT (Left) [Spatial Concept]
   806   side pain [Sign or Symptom]
Meta Mapping (763):
   760   Left (Left sided) [Spatial Concept]
   806   side pain [Sign or Symptom]
Meta Mapping (763):
   760   left (Table Cell Horizontal Align - left) [Functional Concept]
   806   side pain [Sign or Symptom]

Phrase: and

Phrase: had

Phrase: an ultrasound
Meta Mapping (1000):
  1000   ULTRASOUND (Ultrasonography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   ultrasound (Ultrasonic Shockwave) [Natural Phenomenon or Process]
Meta Mapping (1000):
  1000   ultrasound (Ultrasonic) [Functional Concept]
Meta Mapping (1000):
  1000   Ultrasound (Ultrasonics (sound)) [Natural Phenomenon or Process]
Meta Mapping (1000):
  1000   ULTRASOUND (ultrasound device) [Medical Device]

Phrase: that

Phrase: demonstrated

Phrase: a complex left renal mass .
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   MASS (Mass of body structure) [Finding]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   Mass (Mass of body region) [Sign or Symptom]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   Mass (Molecular Mass) [Quantitative Concept]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   mAs (Milliampere second) [Quantitative Concept]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   645   LEFT (Left) [Spatial Concept]
   861   RENAL MASS (Renal mass) [Finding]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   645   Left (Left sided) [Spatial Concept]
   861   RENAL MASS (Renal mass) [Finding]
Meta Mapping (861):
   645   Complex [Qualitative Concept]
   645   left (Table Cell Horizontal Align - left) [Functional Concept]
   861   RENAL MASS (Renal mass) [Finding]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   MASS (Mass of body structure) [Finding]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   Mass (Mass of body region) [Sign or Symptom]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   Mass (Molecular Mass) [Quantitative Concept]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   694   Left Renal (Left kidney) [Body Part, Organ, or Organ Component]
   812   mAs (Milliampere second) [Quantitative Concept]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   645   LEFT (Left) [Spatial Concept]
   861   RENAL MASS (Renal mass) [Finding]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   645   Left (Left sided) [Spatial Concept]
   861   RENAL MASS (Renal mass) [Finding]
Meta Mapping (861):
   645   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   645   left (Table Cell Horizontal Align - left) [Functional Concept]
   861   RENAL MASS (Renal mass) [Finding]
Processing 00000000.tx.70: PHYSICAL EXAMINATION : Abdomen was benign . 

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: Abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: benign .
Meta Mapping (1000):
  1000   BENIGN (Benign) [Qualitative Concept]
Processing 00000000.tx.71: Extremities and neurological examinations were unremarkable . 

Phrase: Extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: neurological examinations
Meta Mapping (1000):
  1000   Neurological Examinations (Neurologic Examination) [Diagnostic Procedure]

Phrase: were

Phrase: unremarkable .
Meta Mapping (1000):
  1000   Unremarkable (Normal) [Qualitative Concept]
Processing 00000000.tx.72: HOSPITAL COURSE : At operation , there was no gross adenopathy or renal vein involvement , and it was felt that the tumor was completely excised . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: At operation ,
Meta Mapping (1000):
  1000   Operation (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (1000):
  1000   Operation (Operation Activity) [Activity]
Meta Mapping (1000):
  1000   Operation, Not Otherwise Specified [Activity]

Phrase: there

Phrase: was

Phrase: no gross adenopathy
Meta Mapping (888):
   694   Gross (Gross (qualifier value)) [Qualitative Concept]
   861 N ADENOPATHY (Lymphadenopathy) [Finding]

Phrase: or

Phrase: renal vein involvement ,
Meta Mapping (901):
   734   Renal Vein (Structure of renal vein) [Body Part, Organ, or Organ Component]
   827   Involvement (Involvement with) [Functional Concept]
Meta Mapping (901):
   734   Renal vein (Entire renal vein) [Body Part, Organ, or Organ Component]
   827   Involvement (Involvement with) [Functional Concept]

Phrase: and

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966 N feel (Emotions) [Mental Process]

Phrase: that

Phrase: the tumor
Meta Mapping (1000):
  1000 N Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (1000):
  1000   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (1000):
  1000 N Tumor (Tumor Mass) [Finding]

Phrase: was

Phrase: completely
Meta Mapping (1000):
  1000   Completely (Complete) [Qualitative Concept]

Phrase: excised .
Processing 00000000.tx.73: FOLLOW-UP will be with Dr. 

Phrase: FOLLOW-UP
Meta Mapping (1000):
  1000   Follow-up (Follow-up status) [Finding]
Meta Mapping (1000):
  1000   Follow Up (follow-up) [Health Care Activity]
Meta Mapping (1000):
  1000   Follow-Up (Follow-Up Report) [Intellectual Product]
Meta Mapping (1000):
  1000   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]

Phrase: will

Phrase: be with Dr.
Meta Mapping (790):
   790   DR (Dominican Republic) [Geographic Area]
Meta Mapping (790):
   790   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (790):
   790   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (790):
   790   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (790):
   790   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.74: Suot N. 

Phrase: Suot N.
Processing 00000000.tx.75: Dragtente and with her Venbonlea Health oncology fellows . 

Phrase: Dragtente

Phrase: and with her Venbonlea Health oncology fellows .
Meta Mapping (667):
   748   Health [Idea or Concept]
   748   Oncology (Neoplasms) [Neoplastic Process]
Meta Mapping (667):
   748   Health [Idea or Concept]
   748   Oncology (oncology field) [Biomedical Occupation or Discipline]
Processing 00000000.tx.76: PL926/1533 SUOT N. 

Phrase: PL926/1533 SUOT N.
Processing 00000000.tx.77: DRAGTENTE , M.D. 

Phrase: DRAGTENTE ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.78: GJ7 cc : 1. 

Phrase: GJ7 cc
Meta Mapping (861):
   861   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.79: VENBONLEA HEALTH PUOMC 9651828 DISCHARGE SUMMARY She had dropped her BUN and creatinine to normal and she was found to have may be metastatic disease to her skin on the right paraumbilical area . 

Phrase: VENBONLEA HEALTH PUOMC 9651828 DISCHARGE SUMMARY
Meta Mapping (787):
   632   Health [Idea or Concept]
   827   Discharge summary [Intellectual Product]
Meta Mapping (787):
   632   Health [Idea or Concept]
   827   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: She

Phrase: had

Phrase: dropped
Meta Mapping (1000):
  1000   Dropped (Dropping) [Activity]

Phrase: her BUN

Phrase: and

Phrase: creatinine to normal
Meta Mapping (858):
   858   normal creatinine (creatinine normal) [Finding]

Phrase: and

Phrase: she

Phrase: was

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: may

Phrase: be

Phrase: metastatic disease to her skin
Meta Mapping (825):
   825   Cutaneous metastatic disease (Secondary malignant neoplasm of skin) [Neoplastic Process]

Phrase: on the right paraumbilical area .
Meta Mapping (851):
   660   RIGHT (Right) [Spatial Concept]
   660   Paraumbilical [Spatial Concept]
   827   Area (Geographic Locations) [Geographic Area]
Meta Mapping (851):
   660   RIGHT (Right) [Spatial Concept]
   660   Paraumbilical [Spatial Concept]
   827   AREA (Area) [Spatial Concept]
Meta Mapping (851):
   660   Right (Right sided) [Spatial Concept]
   660   Paraumbilical [Spatial Concept]
   827   Area (Geographic Locations) [Geographic Area]
Meta Mapping (851):
   660   Right (Right sided) [Spatial Concept]
   660   Paraumbilical [Spatial Concept]
   827   AREA (Area) [Spatial Concept]
Processing 00000000.tx.80: </TEXT> 11/8/1993 12:00:00 AM Unsigned DIS Unsigned DISCHARGE DATE : craniopharyngioma of left petrous bone , cerebellar pontine angle and parasellar region . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 11/8/1993 12
Meta Mapping (902):
   902   11-12 [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: Unsigned DIS Unsigned DISCHARGE DATE
Meta Mapping (790):
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (790):
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   840   Discharge date [Temporal Concept]
Meta Mapping (790):
   637   DIS (Discontinued) [Finding]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (790):
   637   DIS (Discontinued) [Finding]
   840   Discharge date [Temporal Concept]

Phrase: :

Phrase: craniopharyngioma of left petrous bone ,
Meta Mapping (761):
   760   CRANIOPHARYNGIOMA (Craniopharyngioma) [Neoplastic Process]
   593   LEFT (Left) [Spatial Concept]
   640   Petrous Bone (Structure of petrous part of temporal bone) [Body Part, Organ, or Organ Component]
Meta Mapping (761):
   760   CRANIOPHARYNGIOMA (Craniopharyngioma) [Neoplastic Process]
   593   LEFT (Left) [Spatial Concept]
   640   Petrous bone (Entire petrous bone) [Body Part, Organ, or Organ Component]
Meta Mapping (761):
   760   CRANIOPHARYNGIOMA (Craniopharyngioma) [Neoplastic Process]
   593   Left (Left sided) [Spatial Concept]
   640   Petrous Bone (Structure of petrous part of temporal bone) [Body Part, Organ, or Organ Component]
Meta Mapping (761):
   760   CRANIOPHARYNGIOMA (Craniopharyngioma) [Neoplastic Process]
   593   Left (Left sided) [Spatial Concept]
   640   Petrous bone (Entire petrous bone) [Body Part, Organ, or Organ Component]
Meta Mapping (761):
   760   CRANIOPHARYNGIOMA (Craniopharyngioma) [Neoplastic Process]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
   640   Petrous Bone (Structure of petrous part of temporal bone) [Body Part, Organ, or Organ Component]
Meta Mapping (761):
   760   CRANIOPHARYNGIOMA (Craniopharyngioma) [Neoplastic Process]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
   640   Petrous bone (Entire petrous bone) [Body Part, Organ, or Organ Component]

Phrase: cerebellar pontine angle
Meta Mapping (851):
   660   Cerebellar (Cerebellum) [Body Part, Organ, or Organ Component]
   660   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   827   Angle (Angular) [Spatial Concept]
Meta Mapping (851):
   660   Cerebellar (Cortical Cell Layer of the Cerebellum) [Tissue]
   660   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   827   Angle (Angular) [Spatial Concept]

Phrase: and

Phrase: parasellar region .
Meta Mapping (861):
   861   Region (Geographic Locations) [Geographic Area]
Meta Mapping (861):
   861   Region (regional) [Spatial Concept]
Processing 00000000.tx.81: ALLERGIES : Her pupils equal , round , reactive to light and accommodation , 4 to 2 millimeters , direct and consensually . 

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: Her pupils equal , round , reactive to light
Meta Mapping (810):
   612   Pupils equal [Finding]
   581   ROUND (Round shape) [Spatial Concept]
   814   Reactive to light [Finding]

Phrase: and

Phrase: accommodation ,
Meta Mapping (1000):
  1000   Accommodation (Visual Accommodation) [Clinical Attribute]
Meta Mapping (1000):
  1000   Accommodation [Finding]

Phrase: 4 to 2 millimeters ,
Meta Mapping (708):
   770   4+ (4+ Answer to question) [Finding]
   770   millimeters (millimeter) [Quantitative Concept]

Phrase: direct
Meta Mapping (1000):
  1000   Direct (Direct type of relationship) [Qualitative Concept]
Meta Mapping (1000):
  1000   Direct (Direct (qualifier)) [Qualitative Concept]

Phrase: and

Phrase: consensually .
Processing 00000000.tx.82: The deep tendon reflexes revealed 3+ in the lower extremities , 2+ in the upper extremities , upgoing toe on the left and a question of an upgoing toe versus withdrawal on the right . 

Phrase: The deep tendon reflexes
Meta Mapping (1000):
  1000   Deep tendon reflexes (Deep Tendon Reflex) [Clinical Attribute]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: 3+
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]

Phrase: in the lower extremities ,
Meta Mapping (1000):
  1000   Extremities, Lower (Lower Extremity) [Body Location or Region]

Phrase: 2+
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]

Phrase: in the upper extremities ,
Meta Mapping (1000):
  1000   Extremities, Upper (Upper Extremity) [Body Part, Organ, or Organ Component]

Phrase: upgoing toe on the left
Meta Mapping (686):
   760   TOE (Toes) [Body Part, Organ, or Organ Component]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (686):
   760   TOE (Toes) [Body Part, Organ, or Organ Component]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (686):
   760   TOE (Toes) [Body Part, Organ, or Organ Component]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (686):
   760   Toe (Entire toe) [Body Part, Organ, or Organ Component]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (686):
   760   Toe (Entire toe) [Body Part, Organ, or Organ Component]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (686):
   760   Toe (Entire toe) [Body Part, Organ, or Organ Component]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: and

Phrase: a question of an upgoing toe
Meta Mapping (672):
   753   Question (Question (inquiry)) [Intellectual Product]
   586   TOE (Toes) [Body Part, Organ, or Organ Component]
Meta Mapping (672):
   753   Question (Question (inquiry)) [Intellectual Product]
   586   Toe (Entire toe) [Body Part, Organ, or Organ Component]

Phrase: versus

Phrase: withdrawal on the right .
Meta Mapping (708):
   770   Withdrawal (Withdraw (activity)) [Activity]
   604   RIGHT (Right) [Spatial Concept]
Meta Mapping (708):
   770   Withdrawal (Withdraw (activity)) [Activity]
   604   Right (Right sided) [Spatial Concept]
Meta Mapping (708):
   770   Withdrawal (Withdrawal (dysfunction)) [Mental or Behavioral Dysfunction]
   604   RIGHT (Right) [Spatial Concept]
Meta Mapping (708):
   770   Withdrawal (Withdrawal (dysfunction)) [Mental or Behavioral Dysfunction]
   604   Right (Right sided) [Spatial Concept]
Meta Mapping (708):
   770   Withdrawal (Withdrawal - birth control) [Finding]
   604   RIGHT (Right) [Spatial Concept]
Meta Mapping (708):
   770   Withdrawal (Withdrawal - birth control) [Finding]
   604   Right (Right sided) [Spatial Concept]
Meta Mapping (708):
   770   Withdrawal (Withdrawal Scale (BASC-2)) [Intellectual Product]
   604   RIGHT (Right) [Spatial Concept]
Meta Mapping (708):
   770   Withdrawal (Withdrawal Scale (BASC-2)) [Intellectual Product]
   604   Right (Right sided) [Spatial Concept]
Processing 00000000.tx.83: In addition , there was question of some upgaze nystagmus and diminished upgaze in the left eye , perhaps to 90%. 

Phrase: In addition ,
Meta Mapping (861):
   861   Addition (In addition to) [Functional Concept]
Meta Mapping (861):
   861   Addition (Add - instruction imperative) [Functional Concept]

Phrase: there

Phrase: was

Phrase: question of some upgaze nystagmus
Meta Mapping (686):
   760   Question (Question (inquiry)) [Intellectual Product]
   760   NYSTAGMUS (Nystagmus) [Disease or Syndrome]
Meta Mapping (686):
   760   Question (Question (inquiry)) [Intellectual Product]
   760   Nystagmus (Nystagmus Adverse Event) [Finding]

Phrase: and

Phrase: diminished upgaze in the left eye ,
Meta Mapping (719):
   586   Diminished (Decreased) [Quantitative Concept]
   783   Left upgaze (Gaze up and left) [Spatial Concept]
   586   EYE (Eye) [Body Part, Organ, or Organ Component]
Meta Mapping (719):
   586   Diminished (Decreased) [Quantitative Concept]
   783   Left upgaze (Gaze up and left) [Spatial Concept]
   586   ?Eye (Entire eye) [Body Part, Organ, or Organ Component]

Phrase: perhaps to 90%.
Meta Mapping (790):
   790   >90 [Quantitative Concept]
Meta Mapping (790):
   790   <90 [Quantitative Concept]
Meta Mapping (790):
   790   90% [Finding]
Processing 00000000.tx.84: . 

Phrase: .
Processing 00000000.tx.85: LABORATORY DATA : TD : 671277518 A gallium scan was positive at the right hilum . 

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: TD
Meta Mapping (1000):
  1000   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (1000):
  1000   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :

Phrase: 671277518

Phrase: A gallium scan
Meta Mapping (1000):
  1000   Gallium Scan (Gallium scan) [Diagnostic Procedure]

Phrase: was

Phrase: positive at the right hilum .
Meta Mapping (745):
   760   % Positive (percent positive cells) [Quantitative Concept]
   640   Right hilum [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   Positive [Qualitative Concept]
   640   Right hilum [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   POSITIVE (Positive Finding) [Finding]
   640   Right hilum [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   Positive (Positive Charge) [Qualitative Concept]
   640   Right hilum [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   Positive (Positive Number) [Conceptual Entity]
   640   Right hilum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.86: The patient was subsequently admitted to the Retelk County Medical Center with a temperature of 103.2 . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: subsequently

Phrase: admitted to the Retelk County Medical Center
Meta Mapping (701):
   748   admitted (Hospital admission) [Health Care Activity]
   748   County (county) [Geographic Area]
   778   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   admitted (Hospital admission) [Health Care Activity]
   748   County (county) [Geographic Area]
   778   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   admitted (Hospital admission) [Health Care Activity]
   748   Medical (Medical service) [Health Care Activity]
   774   Centre County (Centre County, PA) [Geographic Area]
Meta Mapping (701):
   748   admitted (Hospital admission) [Health Care Activity]
   748   Medical [Functional Concept]
   774   Centre County (Centre County, PA) [Geographic Area]
Meta Mapping (701):
   748   Admitted (Admission activity) [Health Care Activity]
   748   County (county) [Geographic Area]
   778   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   Admitted (Admission activity) [Health Care Activity]
   748   County (county) [Geographic Area]
   778   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (701):
   748   Admitted (Admission activity) [Health Care Activity]
   748   Medical (Medical service) [Health Care Activity]
   774   Centre County (Centre County, PA) [Geographic Area]
Meta Mapping (701):
   748   Admitted (Admission activity) [Health Care Activity]
   748   Medical [Functional Concept]
   774   Centre County (Centre County, PA) [Geographic Area]

Phrase: with a temperature of 103.2 .
Meta Mapping (753):
   753   temperature (Body Temperature) [Organism Attribute]
Meta Mapping (753):
   753   *Temperature (Temperature) [Quantitative Concept]
Processing 00000000.tx.87: The patient was discharged on AZT and Dapsone , and a CD4 count at that time was 40 . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: discharged on AZT
Meta Mapping (746):
   790   Discharged (Patient Discharge) [Health Care Activity]
   790   AZT (Zidovudine) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: and

Phrase: Dapsone ,
Meta Mapping (1000):
  1000   DAPSONE (Dapsone) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: a CD4 count at
Meta Mapping (833):
   833   CD4 Count (CD4 Count determination procedure) [Laboratory Procedure]
Meta Mapping (833):
   833   CD4 count (CTCAE CD4 count) [Finding]

Phrase: that time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: was

Phrase: 40 .
Meta Mapping (1000):
  1000   /40 [Temporal Concept]
Meta Mapping (1000):
  1000   40% [Quantitative Concept]
Processing 00000000.tx.88: The patient was otherwise doing well on AZT until November 30 , 1991 , at which time the patient developed a temperature of 103 accompanied by frontal headache , nonproductive cough , and rhinorrhea . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: otherwise

Phrase: doing

Phrase: well on AZT
Meta Mapping (746):
   790   Well (Good) [Qualitative Concept]
   790   AZT (Zidovudine) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Meta Mapping (746):
   790   Well [Manufactured Object]
   790   AZT (Zidovudine) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: until November 30 ,
Meta Mapping (888):
   861   November [Temporal Concept]
   861   30% [Finding]

Phrase: 1991 ,

Phrase: at which time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: developed

Phrase: a temperature of 103
Meta Mapping (770):
   770   temperature (Body Temperature) [Organism Attribute]
Meta Mapping (770):
   770   *Temperature (Temperature) [Quantitative Concept]

Phrase: accompanied by frontal headache ,
Meta Mapping (833):
   833   Frontal headache [Sign or Symptom]

Phrase: nonproductive cough ,
Meta Mapping (1000):
  1000   Non-productive cough (Dry cough) [Sign or Symptom]

Phrase: and

Phrase: rhinorrhea .
Meta Mapping (1000):
  1000   Rhinorrhoea (Rhinorrhea) [Sign or Symptom]
Processing 00000000.tx.89: The patient complained of intermittent shortness of breath , but no rigors , chest pain , or GI symptoms . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: complained of intermittent shortness of breath ,
Meta Mapping (864):
   851   intermittent shortness of breath (shortness of breath intermittent) [Finding]

Phrase: but

Phrase: no rigors ,
Meta Mapping (1000):
  1000 N RIGORS (Rigor - Temperature-associated observation) [Sign or Symptom]

Phrase: chest pain ,
Meta Mapping (1000):
  1000 N CHEST PAIN (Chest Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]

Phrase: or

Phrase: GI symptoms .
Meta Mapping (888):
   694   Gi (GNAI1 wt Allele) [Gene or Genome]
   861   symptoms (Symptoms aspect) [Functional Concept]
Meta Mapping (888):
   694   Gi (GNAI1 wt Allele) [Gene or Genome]
   861 N SYMPTOMS (Symptoms) [Sign or Symptom]
Meta Mapping (888):
   694   GI (Digestive System Findings Domain) [Intellectual Product]
   861   symptoms (Symptoms aspect) [Functional Concept]
Meta Mapping (888):
   694   GI (Digestive System Findings Domain) [Intellectual Product]
   861 N SYMPTOMS (Symptoms) [Sign or Symptom]
Meta Mapping (888):
   694   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   861   symptoms (Symptoms aspect) [Functional Concept]
Meta Mapping (888):
   694   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   861 N SYMPTOMS (Symptoms) [Sign or Symptom]
Processing 00000000.tx.90: The following day , the patient &apos;s ABG was noted to be a pH of 7.32 , p02 50 , pCO2 43 , 82% on 100% high flow face masks . 

Phrase: The following day ,
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   /day (Daily) [Temporal Concept]
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   DAY (day) [Temporal Concept]
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   /day (per day) [Temporal Concept]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   /day (Daily) [Temporal Concept]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   DAY (day) [Temporal Concept]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   /day (per day) [Temporal Concept]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s ABG
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   ABG (Analysis of arterial blood gases and pH) [Laboratory Procedure]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   ABG (A1BG gene) [Gene or Genome]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   ABG (Analysis of arterial blood gases and pH) [Laboratory Procedure]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   ABG (A1BG gene) [Gene or Genome]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: a pH of 7.32 ,
Meta Mapping (797):
   797   pH 7 (Neutral pH) [Qualitative Concept]

Phrase: p02 50 ,
Meta Mapping (888):
   861   P02 (P02 (message structure)) [Intellectual Product]
   861   50% [Finding]
Meta Mapping (888):
   861   P02 (P02 (message structure)) [Intellectual Product]
   861   <50 [Finding]
Meta Mapping (888):
   861   p02 (TPT1 wt Allele) [Gene or Genome]
   861   50% [Finding]
Meta Mapping (888):
   861   p02 (TPT1 wt Allele) [Gene or Genome]
   861   <50 [Finding]

Phrase: pCO2 43 ,
Meta Mapping (861):
   861   PCO2 (Carbon dioxide measurement, partial pressure) [Laboratory Procedure]
Meta Mapping (861):
   861   pco2 (Partial pressure CO2 result) [Laboratory or Test Result]

Phrase: 82% on 100% high flow face masks .
Meta Mapping (737):
   748   100% [Quantitative Concept]
   748   High [Qualitative Concept]
   748   Flow (flow) [Natural Phenomenon or Process]
   778   face masks (Masks) [Medical Device]
Meta Mapping (737):
   748   100% [Quantitative Concept]
   748   High (Abnormally high) [Qualitative Concept]
   748   Flow (flow) [Natural Phenomenon or Process]
   778   face masks (Masks) [Medical Device]
Meta Mapping (737):
   748   100% [Quantitative Concept]
   748   HIGH (Value Above Reference Range) [Intellectual Product]
   748   Flow (flow) [Natural Phenomenon or Process]
   778   face masks (Masks) [Medical Device]
Meta Mapping (737):
   748   100% [Quantitative Concept]
   748   high (high - ActExposureLevelCode) [Idea or Concept]
   748   Flow (flow) [Natural Phenomenon or Process]
   778   face masks (Masks) [Medical Device]
Meta Mapping (737):
   748   100% [Quantitative Concept]
   748   High (High Mitosis-Karyorrhexis Index) [Quantitative Concept]
   748   Flow (flow) [Natural Phenomenon or Process]
   778   face masks (Masks) [Medical Device]
Processing 00000000.tx.91: Eyes - Anicteric sclera with pupils 2 mm and reactive . 

Phrase: Eyes - Anicteric sclera with pupils 2 mm
Meta Mapping (701):
   607   eyes pupils (Pupil) [Body Part, Organ, or Organ Component]
   581   Anicteric [Finding]
   748   SCLERA (Sclera) [Body Part, Organ, or Organ Component]
Meta Mapping (701):
   607   eyes pupils (Pupil) [Body Part, Organ, or Organ Component]
   581   Anicteric [Finding]
   748   Sclera (Entire sclera) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: reactive .
Meta Mapping (1000):
  1000   Reactive [Qualitative Concept]
Processing 00000000.tx.92: The oropharynx was not well appreciated secondary to ET tube . 

Phrase: The oropharynx
Meta Mapping (1000):
  1000   OROPHARYNX (Oropharyngeal) [Body Location or Region]
Meta Mapping (1000):
  1000   Oropharynx (Entire oropharynx) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   OROPHARYNX (Oropharyngeal Tissue) [Tissue]

Phrase: was

Phrase: not well appreciated secondary to ET tube .
Meta Mapping (719):
   612   Not well [Finding]
   778   Secondary to [Temporal Concept]
   581   TUBE (biomedical tube device) [Medical Device]
Meta Mapping (719):
   612   Not well [Finding]
   778   Secondary to [Temporal Concept]
   581   Tube NOS (Specimen Source Codes - Tube) [Intellectual Product]
Meta Mapping (719):
   612   Not well [Finding]
   778   Secondary to [Temporal Concept]
   581   Tube (tube) [Conceptual Entity]
Meta Mapping (719):
   612   Not well [Finding]
   778   Secondary to [Temporal Concept]
   581   {Tube} (Tube - unit dose) [Quantitative Concept]
Meta Mapping (719):
   612   Not well [Finding]
   778   Secondary to [Temporal Concept]
   581   TUBE (Packaging Tube) [Medical Device]
Processing 00000000.tx.93: No splenomegaly or abdominal masses . 

Phrase: No splenomegaly
Meta Mapping (1000):
  1000 N SPLENOMEGALY (Splenomegaly) [Finding]

Phrase: or

Phrase: abdominal masses .
Meta Mapping (1000):
  1000 N abdominal masses (Abdominal mass) [Finding]
Processing 00000000.tx.94: No cervical , axillary , supraclavicular , or inguinal lymphadenopathy . 

Phrase: No cervical , axillary , supraclavicular ,
Meta Mapping (851):
   660   Cervical (Neck) [Body Location or Region]
   660   Axillary (Axilla) [Body Location or Region]
   827   Supraclavicular (Supraclavicular approach) [Spatial Concept]
Meta Mapping (851):
   660   Cervical [Spatial Concept]
   660   Axillary (Axilla) [Body Location or Region]
   827   Supraclavicular (Supraclavicular approach) [Spatial Concept]

Phrase: or

Phrase: inguinal lymphadenopathy .
Meta Mapping (1000):
  1000 N Inguinal lymphadenopathy [Disease or Syndrome]
Processing 00000000.tx.95: Extremities : HOSPITAL COURSE : On 12/10/91 , the patient was noted to have an acutely diminished white count at 2.0 with a hematocrit of 32.0 . 

Phrase: Extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: On 12/10/91 ,
Meta Mapping (827):
   827   10% [Finding]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: an

Phrase: acutely

Phrase: diminished
Meta Mapping (1000):
  1000   Diminished (Decreased) [Quantitative Concept]

Phrase: white count at 2.0 with a hematocrit of 32.0 .
Meta Mapping (621):
   738   WHITE (Caucasoid Race) [Population Group]
   738   Count [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (621):
   738   WHITE (Caucasoid Race) [Population Group]
   738   Count [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit level) [Finding]
Meta Mapping (621):
   738   WHITE (Caucasoid Race) [Population Group]
   738   COUNT (Count Dosing Unit) [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (621):
   738   WHITE (Caucasoid Race) [Population Group]
   738   COUNT (Count Dosing Unit) [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit level) [Finding]
Meta Mapping (621):
   738   WHITE (Caucasians) [Population Group]
   738   Count [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (621):
   738   WHITE (Caucasians) [Population Group]
   738   Count [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit level) [Finding]
Meta Mapping (621):
   738   WHITE (Caucasians) [Population Group]
   738   COUNT (Count Dosing Unit) [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (621):
   738   WHITE (Caucasians) [Population Group]
   738   COUNT (Count Dosing Unit) [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit level) [Finding]
Meta Mapping (621):
   738   WHITE (White color) [Qualitative Concept]
   738   Count [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (621):
   738   WHITE (White color) [Qualitative Concept]
   738   Count [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit level) [Finding]
Meta Mapping (621):
   738   WHITE (White color) [Qualitative Concept]
   738   COUNT (Count Dosing Unit) [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (621):
   738   WHITE (White color) [Qualitative Concept]
   738   COUNT (Count Dosing Unit) [Quantitative Concept]
   738   0% [Finding]
   738   Hematocrit (Hematocrit level) [Finding]
Processing 00000000.tx.96: Batch :

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :
Processing 00000000.tx.1: </RECORD> <RECORD ID="731"> 10/10/1991 Discharge Date : OPERATIONS AND PROCEDURES : She was staged as lB and pathology showed a small cell neuroendocrine tumor of the cervix . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: >

Phrase: <RECORD ID="731"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 10/10/1991 Discharge Date
Meta Mapping (812):
   637   10% [Finding]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (812):
   637   10% [Finding]
   840   Discharge date [Temporal Concept]

Phrase: :

Phrase: OPERATIONS
Meta Mapping (1000):
  1000   operations (Surgical aspects) [Functional Concept]
Meta Mapping (1000):
  1000   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (1000):
  1000   operations (HL7PublishingSubSection <operations>) [Intellectual Product]

Phrase: AND

Phrase: PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: She

Phrase: was

Phrase: staged as lB
Meta Mapping (790):
   790   Staged, NOS [Finding]

Phrase: and

Phrase: pathology
Meta Mapping (1000):
  1000   Pathology [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   pathology (Pathological aspects) [Functional Concept]
Meta Mapping (1000):
  1000   pathology (Pathology processes) [Pathologic Function]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a small cell neuroendocrine tumor of the cervix .
Meta Mapping (826):
   578   SMALL (Small) [Quantitative Concept]
   767   Neuroendocrine Cell (Neuroendocrine Cells) [Cell]
   833   Tumour of the Cervix (Uterine Cervical Neoplasm) [Neoplastic Process]
Processing 00000000.tx.2: A CT , however , confirmed a large pelvic mass with bilateral hydronephrosis . 

Phrase: A CT ,
Meta Mapping (1000):
  1000   CT (Central African Republic) [Geographic Area]
Meta Mapping (1000):
  1000   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (1000):
  1000   CT (Computed Tomography Study File) [Intellectual Product]

Phrase: however ,

Phrase: confirmed
Meta Mapping (1000):
  1000   confirmed (Confirmed by) [Qualitative Concept]
Meta Mapping (1000):
  1000   Confirmed (Confirmation) [Idea or Concept]

Phrase: a large pelvic mass with bilateral hydronephrosis .
Meta Mapping (728):
   774   Large Mass [Finding]
   581   Pelvic (Pelvis) [Body Part, Organ, or Organ Component]
   612   Bilateral hydronephrosis [Disease or Syndrome]
Meta Mapping (728):
   581   LARGE (Large) [Quantitative Concept]
   778   pelvic mass (Pelvic swelling) [Finding]
   612   Bilateral hydronephrosis [Disease or Syndrome]
Meta Mapping (728):
   581   LARGE (Large) [Quantitative Concept]
   778   PELVIC MASS (Pelvic mass) [Finding]
   612   Bilateral hydronephrosis [Disease or Syndrome]
Processing 00000000.tx.3: Also in July of l99l , she had right hip pain . 

Phrase: Also in July of l99l ,
Meta Mapping (760):
   760   July [Qualitative Concept]

Phrase: she

Phrase: had

Phrase: right hip pain .
Meta Mapping (1000):
  1000   Right hip pain (Pain in right hip joint) [Sign or Symptom]
Processing 00000000.tx.4: On September 6 , she began the next cycle of second line chemotherapy consisting of Carboplatin , Ifosfamide , and Mesna . 

Phrase: On September 6 ,
Meta Mapping (861):
   861   September [Temporal Concept]

Phrase: she

Phrase: began
Meta Mapping (966):
   966   Begin (Beginning) [Temporal Concept]

Phrase: the next cycle of second line chemotherapy
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   next (Adjacent) [Spatial Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Following) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (second (number)) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   SECOND (seconds) [Temporal Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   /second (per second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   second (Precision - second) [Idea or Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Linear) [Spatial Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Intravascular line) [Medical Device]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Line Specimen) [Substance]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   cycle chemotherapy (Chemotherapy cycle) [Therapeutic or Preventive Procedure]
   581   Second (Second Suffix) [Qualitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Linear) [Spatial Concept]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Intravascular line) [Medical Device]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Specimen) [Substance]
   581   Chemotherapy [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (710):
   581   Next (Then) [Temporal Concept]
   774   Cycle/Second (Cycle per Second) [Quantitative Concept]
   581   Line (Line Unit of Length) [Quantitative Concept]
   581   Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: consisting of Carboplatin ,
Meta Mapping (730):
   756   CONSIST (Consistency) [Qualitative Concept]
   790   CARBOPLATIN (Carboplatin) [Organic Chemical,Pharmacologic Substance]

Phrase: Ifosfamide ,
Meta Mapping (1000):
  1000   Iphosphamide (Ifosfamide) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: Mesna .
Meta Mapping (1000):
  1000   MESNA (Mesna) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.5: PHYSICAL EXAMINATION : Regular rate and rhythm . 

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: Regular rate
Meta Mapping (888):
   694   Regular [Qualitative Concept]
   861   Rate (Rating (action)) [Activity]
Meta Mapping (888):
   694   Regular [Qualitative Concept]
   861   Rate [Quantitative Concept]

Phrase: and

Phrase: rhythm .
Meta Mapping (1000):
  1000   Rhythm [Finding]
Meta Mapping (1000):
  1000   rhythm (rhythmic process (biological)) [Physiologic Function]
Meta Mapping (1000):
  1000   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
Processing 00000000.tx.6: The patient was admitted for bone scan and blood transfusion as well as consideration of further chemotherapy . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted for bone scan
Meta Mapping (783):
   770   admitted (Hospital admission) [Health Care Activity]
   833   Bone Scan (Radioisotope scan of bone) [Diagnostic Procedure]
Meta Mapping (783):
   770   admitted (Hospital admission) [Health Care Activity]
   833   Bone Scan (Views^W radionuclide Intravenous:Finding:Point in time:Bone:Narrative:Radnuc) [Clinical Attribute]
Meta Mapping (783):
   770   Admitted (Admission activity) [Health Care Activity]
   833   Bone Scan (Radioisotope scan of bone) [Diagnostic Procedure]
Meta Mapping (783):
   770   Admitted (Admission activity) [Health Care Activity]
   833   Bone Scan (Views^W radionuclide Intravenous:Finding:Point in time:Bone:Narrative:Radnuc) [Clinical Attribute]

Phrase: and

Phrase: blood transfusion
Meta Mapping (1000):
  1000   BLOOD TRANSFUSION (Blood Transfusion) [Therapeutic or Preventive Procedure]

Phrase: as well as

Phrase: consideration of further chemotherapy .
Meta Mapping (733):
   770   Consideration (consideration) [Finding]
   604   Further [Spatial Concept]
   604   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (733):
   770   Consideration (consideration) [Finding]
   604   Further [Spatial Concept]
   604   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (733):
   770   Consideration (consideration) [Finding]
   604   Further [Spatial Concept]
   604   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (733):
   770   Consideration (consideration) [Finding]
   604   Further [Spatial Concept]
   604   Chemotherapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: She was also seen by the Dermatology Service who examined the rash and felt it was most likely a contact dermatitis . 

Phrase: She

Phrase: was

Phrase: also

Phrase: seen by the Dermatology Service
Meta Mapping (891):
   891   Seen by dermatology service [Finding]

Phrase: who

Phrase: examined
Meta Mapping (1000):
  1000   Examined [Finding]

Phrase: the rash
Meta Mapping (1000):
  1000   RASH (Exanthema) [Sign or Symptom]

Phrase: and

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: it

Phrase: was

Phrase: most likely
Meta Mapping (1000):
  1000   most likely [Idea or Concept]

Phrase: a contact dermatitis .
Meta Mapping (1000):
  1000   CONTACT DERMATITIS (Contact Dermatitis) [Disease or Syndrome]
Processing 00000000.tx.8: However , they felt that at the Venbonlea Health , there were several possible options including a possible phase I trial regimen . 

Phrase: However ,

Phrase: they

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that at the Venbonlea Health ,
Meta Mapping (760):
   760   Health [Idea or Concept]

Phrase: there

Phrase: were

Phrase: several possible options
Meta Mapping (851):
   660   Several (Numerous) [Quantitative Concept]
   660   Possible [Qualitative Concept]
   827   Options [Functional Concept]
Meta Mapping (851):
   660   Several (Numerous) [Quantitative Concept]
   660   Possible (Possibly Related to Intervention) [Qualitative Concept]
   827   Options [Functional Concept]
Meta Mapping (851):
   660   Several (Numerous) [Quantitative Concept]
   660   Possible (Possible diagnosis) [Qualitative Concept]
   827   Options [Functional Concept]
Meta Mapping (851):
   660   Several [Quantitative Concept]
   660   Possible [Qualitative Concept]
   827   Options [Functional Concept]
Meta Mapping (851):
   660   Several [Quantitative Concept]
   660   Possible (Possibly Related to Intervention) [Qualitative Concept]
   827   Options [Functional Concept]
Meta Mapping (851):
   660   Several [Quantitative Concept]
   660   Possible (Possible diagnosis) [Qualitative Concept]
   827   Options [Functional Concept]

Phrase: including
Meta Mapping (1000):
  1000   Including (Including (qualifier)) [Functional Concept]

Phrase: a possible phase I trial regimen .
Meta Mapping (875):
   637   Possible [Qualitative Concept]
   717   PHASE I TRIAL (Phase I Clinical Trials) [Research Activity]
   804   Regimen (Treatment Protocols) [Therapeutic or Preventive Procedure]
Meta Mapping (875):
   637   Possible [Qualitative Concept]
   717   PHASE I TRIAL (Phase I Clinical Trials) [Research Activity]
   804   regimen (Regimen - CHV concept) [Intellectual Product]
Meta Mapping (875):
   637   Possible (Possibly Related to Intervention) [Qualitative Concept]
   717   PHASE I TRIAL (Phase I Clinical Trials) [Research Activity]
   804   Regimen (Treatment Protocols) [Therapeutic or Preventive Procedure]
Meta Mapping (875):
   637   Possible (Possibly Related to Intervention) [Qualitative Concept]
   717   PHASE I TRIAL (Phase I Clinical Trials) [Research Activity]
   804   regimen (Regimen - CHV concept) [Intellectual Product]
Meta Mapping (875):
   637   Possible (Possible diagnosis) [Qualitative Concept]
   717   PHASE I TRIAL (Phase I Clinical Trials) [Research Activity]
   804   Regimen (Treatment Protocols) [Therapeutic or Preventive Procedure]
Meta Mapping (875):
   637   Possible (Possible diagnosis) [Qualitative Concept]
   717   PHASE I TRIAL (Phase I Clinical Trials) [Research Activity]
   804   regimen (Regimen - CHV concept) [Intellectual Product]
Processing 00000000.tx.9: SB325/2198 LAKO C. 

Phrase: SB325/2198 LAKO C.
Processing 00000000.tx.10: SCARVTWI , M.D. 

Phrase: SCARVTWI ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.11: TH0 10/12/91

Phrase: TH0 10/12/91
Meta Mapping (824):
   812   Th0 (Naive T-Lymphocyte) [Cell]
   861   10 - 12 [Finding]
Processing 00000000.tx.1: SMALL CELL CANCER OF THE BRAIN . 

Phrase: SMALL CELL CANCER OF THE BRAIN .
Meta Mapping (888):
   586   SMALL (Small) [Quantitative Concept]
   586   Cell (Cells) [Cell]
   882   Cancer of the Brain (Malignant neoplasm of brain) [Neoplastic Process]
Meta Mapping (888):
   586   SMALL (Small) [Quantitative Concept]
   586   Cell (Entire cell) [Cell]
   882   Cancer of the Brain (Malignant neoplasm of brain) [Neoplastic Process]
Meta Mapping (888):
   586   SMALL (Small) [Quantitative Concept]
   586   CELL (CEL gene) [Gene or Genome]
   882   Cancer of the Brain (Malignant neoplasm of brain) [Neoplastic Process]
Meta Mapping (888):
   586   SMALL (Small) [Quantitative Concept]
   586   Cell (Cell Device Component) [Medical Device]
   882   Cancer of the Brain (Malignant neoplasm of brain) [Neoplastic Process]
Meta Mapping (888):
   586   SMALL (Small) [Quantitative Concept]
   586   Cell (Cell (compartment)) [Spatial Concept]
   882   Cancer of the Brain (Malignant neoplasm of brain) [Neoplastic Process]
Processing 00000000.tx.2: The patient was a 66 year old right-handed female with a history of small cell carcinoma , who comes in for placement of an Omaya reservoir . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: a 66 year old right-handed female with a history of small cell carcinoma ,
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   FEMALE (Female) [Organism Attribute]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Woman) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   female (Females) [Population Group]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cells) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Entire cell) [Cell]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   CELL (CEL gene) [Gene or Genome]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell Device Component) [Medical Device]
Meta Mapping (687):
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   581   Right handed [Organism Attribute]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of - carcinoma (H/O: carcinoma) [Finding]
   568   SMALL (Small) [Quantitative Concept]
   568   Cell (Cell (compartment)) [Spatial Concept]

Phrase: who

Phrase: comes in

Phrase: for placement of an Omaya reservoir .
Meta Mapping (672):
   753   Placement (Clinical act of insertion) [Health Care Activity]
   586   Reservoir (Reservoir (environment)) [Geographic Area]
Meta Mapping (672):
   753   Placement (Clinical act of insertion) [Health Care Activity]
   586   Reservoir (Reservoir Device Component) [Manufactured Object]
Meta Mapping (672):
   753   Placement [Qualitative Concept]
   586   Reservoir (Reservoir (environment)) [Geographic Area]
Meta Mapping (672):
   753   Placement [Qualitative Concept]
   586   Reservoir (Reservoir Device Component) [Manufactured Object]
Meta Mapping (672):
   753   Placement (Placement action) [Health Care Activity]
   586   Reservoir (Reservoir (environment)) [Geographic Area]
Meta Mapping (672):
   753   Placement (Placement action) [Health Care Activity]
   586   Reservoir (Reservoir Device Component) [Manufactured Object]
Processing 00000000.tx.3: PHYSICAL EXAMINATION : Lungs were clear . 

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: Lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: clear .
Meta Mapping (1000):
  1000   Clear (Negative Surgical Margin) [Finding]
Meta Mapping (1000):
  1000   Clear [Qualitative Concept]
Processing 00000000.tx.4: 644490499 PUOMC Discharge Instruction Signed 11) HISTORY OF HYPERTENSION . 

Phrase: 644490499 PUOMC Discharge Instruction Signed 11
Meta Mapping (712):
   799   Discharge (Body Fluid Discharge) [Body Substance]
   799   Instruction (Educational process of instructing) [Educational Activity]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Body Fluid Discharge) [Body Substance]
   799   Instruction (Educational process of instructing) [Educational Activity]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Body Fluid Discharge) [Body Substance]
   799   Instruction (Instruction [Publication Type]) [Intellectual Product]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Body Fluid Discharge) [Body Substance]
   799   Instruction (Instruction [Publication Type]) [Intellectual Product]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Body Fluid Discharge) [Body Substance]
   799   instruction (Instructions) [Idea or Concept]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Body Fluid Discharge) [Body Substance]
   799   instruction (Instructions) [Idea or Concept]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Patient Discharge) [Health Care Activity]
   799   Instruction (Educational process of instructing) [Educational Activity]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Patient Discharge) [Health Care Activity]
   799   Instruction (Educational process of instructing) [Educational Activity]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Patient Discharge) [Health Care Activity]
   799   Instruction (Instruction [Publication Type]) [Intellectual Product]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Patient Discharge) [Health Care Activity]
   799   Instruction (Instruction [Publication Type]) [Intellectual Product]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Patient Discharge) [Health Care Activity]
   799   instruction (Instructions) [Idea or Concept]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Patient Discharge) [Health Care Activity]
   799   instruction (Instructions) [Idea or Concept]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Discharge, body substance) [Body Substance]
   799   Instruction (Educational process of instructing) [Educational Activity]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Discharge, body substance) [Body Substance]
   799   Instruction (Educational process of instructing) [Educational Activity]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Discharge, body substance) [Body Substance]
   799   Instruction (Instruction [Publication Type]) [Intellectual Product]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Discharge, body substance) [Body Substance]
   799   Instruction (Instruction [Publication Type]) [Intellectual Product]
   799   signed (signed - ParticipationSignature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Discharge, body substance) [Body Substance]
   799   instruction (Instructions) [Idea or Concept]
   799   Signed (Signature) [Intellectual Product]
Meta Mapping (712):
   799   Discharge (Discharge, body substance) [Body Substance]
   799   instruction (Instructions) [Idea or Concept]
   799   signed (signed - ParticipationSignature) [Intellectual Product]

Phrase: )

Phrase: HISTORY OF HYPERTENSION .
Meta Mapping (1000):
  1000   History of - hypertension (H/O: hypertension) [Finding]
Processing 00000000.tx.5: He was transferred to Stamgibonnole Hospital for further evaluation . 

Phrase: He

Phrase: was

Phrase: transferred to Stamgibonnole Hospital
Meta Mapping (708):
   770   transferred (Surgical transfer - action) [Functional Concept]
   770   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (708):
   770   transferred (Surgical transfer - action) [Functional Concept]
   770   Hospital (Hospital environment) [Qualitative Concept]
Meta Mapping (708):
   770   Transferred (Transfer Technique) [Functional Concept]
   770   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (708):
   770   Transferred (Transfer Technique) [Functional Concept]
   770   Hospital (Hospital environment) [Qualitative Concept]

Phrase: for further evaluation .
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Evaluation [Health Care Activity]
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Evaluation (Evaluation procedure) [Health Care Activity]
Processing 00000000.tx.6: Despite multiple attempts at extraction at that point they were unable to extract the foreign body and it was felt that the patient should be admitted and attempt extraction later in the afternoon . 

Phrase: Despite multiple attempts at extraction
Meta Mapping (685):
   593   MULTIPLE (Numerous) [Quantitative Concept]
   726   Attempt [Event]
   593   Extraction [Therapeutic or Preventive Procedure]
Meta Mapping (685):
   593   MULTIPLE (Numerous) [Quantitative Concept]
   726   Attempt [Event]
   593   extraction (Chemical extraction) [Laboratory Procedure]

Phrase: at that

Phrase: point
Meta Mapping (1000):
  1000   POINT (point - UnitsOfMeasure) [Quantitative Concept]
Meta Mapping (1000):
  1000   point (Point Name) [Quantitative Concept]
Meta Mapping (1000):
  1000   Point [Spatial Concept]

Phrase: they

Phrase: were

Phrase: unable
Meta Mapping (1000):
  1000   Unable [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: extract
Meta Mapping (1000):
  1000   Extract (Extract (substance)) [Substance]

Phrase: the foreign body
Meta Mapping (1000):
  1000   Foreign Body (Foreign Bodies) [Injury or Poisoning]

Phrase: and

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: should

Phrase: be

Phrase: admitted
Meta Mapping (1000):
  1000   admitted (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admitted (Admission activity) [Health Care Activity]

Phrase: and

Phrase: attempt extraction
Meta Mapping (888):
   694   Attempt [Event]
   861   Extraction [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Attempt [Event]
   861   extraction (Chemical extraction) [Laboratory Procedure]

Phrase: later in the afternoon .
Meta Mapping (708):
   770   Later (Late) [Temporal Concept]
   604   Afternoon [Temporal Concept]
Processing 00000000.tx.7: The patient was sent to the floor and GI wise was doing well until approximately 9/22/93 when he developed an ileus one day status post teeth extraction and general anesthesia . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: sent to the floor
Meta Mapping (708):
   770   Sent (Send (transmission)) [Functional Concept]
   770   Floor (floor (object)) [Manufactured Object]
Meta Mapping (708):
   770   Sent (Send (transmission)) [Functional Concept]
   770   Floor (Floor - story of building) [Geographic Area]
Meta Mapping (708):
   770   Sent (Send (transmission)) [Functional Concept]
   770   Floor (Floor (anatomic)) [Anatomical Structure]

Phrase: and

Phrase: GI
Meta Mapping (1000):
  1000   Gi (GNAI1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   GI (Digestive System Findings Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   GI (Gastrointestinal studies and measurements) [Intellectual Product]

Phrase: wise
Meta Mapping (1000):
  1000   WISE (SOSTDC1 gene) [Gene or Genome]

Phrase: was

Phrase: doing

Phrase: well
Meta Mapping (1000):
  1000   Well (Good) [Qualitative Concept]
Meta Mapping (1000):
  1000   Well [Manufactured Object]

Phrase: until

Phrase: approximately 9/22/93
Meta Mapping (812):
   812   Approximately (Approximate) [Qualitative Concept]

Phrase: when

Phrase: he

Phrase: developed

Phrase: an ileus one day status post teeth extraction
Meta Mapping (794):
   578   ILEUS (Ileus) [Disease or Syndrome]
   770   One day [Finding]
   578   Post [Temporal Concept]
   615   Tooth extraction status NOS [Disease or Syndrome]
Meta Mapping (794):
   578   ILEUS (Ileus) [Disease or Syndrome]
   770   One day [Finding]
   578   Post (Post Device Component) [Manufactured Object]
   615   Tooth extraction status NOS [Disease or Syndrome]
Meta Mapping (794):
   578   Ileus (Intestinal obstruction co-occurrent and due to decreased peristalsis) [Disease or Syndrome]
   770   One day [Finding]
   578   Post [Temporal Concept]
   615   Tooth extraction status NOS [Disease or Syndrome]
Meta Mapping (794):
   578   Ileus (Intestinal obstruction co-occurrent and due to decreased peristalsis) [Disease or Syndrome]
   770   One day [Finding]
   578   Post (Post Device Component) [Manufactured Object]
   615   Tooth extraction status NOS [Disease or Syndrome]

Phrase: and

Phrase: general anesthesia .
Meta Mapping (1000):
  1000   General anaesthesia (General Anesthesia) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   General Anesthesia (General Anesthesia [PE]) [Physiologic Function]
Processing 00000000.tx.8: The patient was saturating well throughout the initial part of the stay until he had the upper GI bleed on 9/22/93 at which time he also had significant aspiration of vomitus and was considered to have a probable aspiration pneumonia but with vague findings on chest x-ray . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: saturating
Meta Mapping (1000):
  1000   saturating (Saturated) [Phenomenon or Process]

Phrase: well throughout the initial part of the stay
Meta Mapping (684):
   744   Well (Good) [Qualitative Concept]
   744   Initial (Initially) [Temporal Concept]
   770   Part of [Spatial Concept]
Meta Mapping (684):
   744   Well (Good) [Qualitative Concept]
   744   Initial (Firstly) [Qualitative Concept]
   770   Part of [Spatial Concept]
Meta Mapping (684):
   744   Well (Good) [Qualitative Concept]
   744   Initial (Initial (abbreviation)) [Idea or Concept]
   770   Part of [Spatial Concept]
Meta Mapping (684):
   744   Well (Good) [Qualitative Concept]
   744   INITIAL (Initial Usage) [Functional Concept]
   770   Part of [Spatial Concept]
Meta Mapping (684):
   744   Well [Manufactured Object]
   744   Initial (Initially) [Temporal Concept]
   770   Part of [Spatial Concept]
Meta Mapping (684):
   744   Well [Manufactured Object]
   744   Initial (Firstly) [Qualitative Concept]
   770   Part of [Spatial Concept]
Meta Mapping (684):
   744   Well [Manufactured Object]
   744   Initial (Initial (abbreviation)) [Idea or Concept]
   770   Part of [Spatial Concept]
Meta Mapping (684):
   744   Well [Manufactured Object]
   744   INITIAL (Initial Usage) [Functional Concept]
   770   Part of [Spatial Concept]

Phrase: until

Phrase: he

Phrase: had

Phrase: the upper GI
Meta Mapping (1000):
  1000   Upper GI (Upper gastrointestinal tract series) [Diagnostic Procedure]

Phrase: bleed on 9/22/93
Meta Mapping (760):
   760   bleed (Hemorrhage) [Pathologic Function]

Phrase: at which time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: he

Phrase: also

Phrase: had

Phrase: significant aspiration of vomitus
Meta Mapping (916):
   604   significant (Statistical Significance) [Quantitative Concept]
   909   Aspiration of vomitus (Respiratory Aspiration of Gastric Contents) [Injury or Poisoning]
Meta Mapping (916):
   604   Significant [Idea or Concept]
   909   Aspiration of vomitus (Respiratory Aspiration of Gastric Contents) [Injury or Poisoning]
Meta Mapping (916):
   604   Significant (Event Seriousness - Significant) [Qualitative Concept]
   909   Aspiration of vomitus (Respiratory Aspiration of Gastric Contents) [Injury or Poisoning]

Phrase: and

Phrase: was

Phrase: considered
Meta Mapping (1000):
  1000   considered (consider) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: a probable aspiration pneumonia
Meta Mapping (901):
   660   Probable (Probability) [Quantitative Concept]
   901   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (901):
   660   Probable (Probability) [Quantitative Concept]
   901   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Meta Mapping (901):
   660   Probable (Probable diagnosis) [Qualitative Concept]
   901   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (901):
   660   Probable (Probable diagnosis) [Qualitative Concept]
   901   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]

Phrase: but with vague findings
Meta Mapping (722):
   770   Vague [Qualitative Concept]
   770   findings (findings aspects) [Functional Concept]
Meta Mapping (722):
   770   Vague [Qualitative Concept]
   770   Findings (Procedure findings:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (722):
   770   Vague [Qualitative Concept]
   770   FINDINGS (CDISC Findings Class) [Intellectual Product]

Phrase: on chest x-ray .
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
Processing 00000000.tx.9: 7) Social issues - The wife had obtained health proxy prior to this admission and it was felt that since the patient was not competent to make decisions on his own the wife would make decisions regarding the health status and treatment of the patient . 

Phrase: 7

Phrase: )

Phrase: Social issues -
Meta Mapping (1000):
  1000   Social issues [Social Behavior]

Phrase: The wife
Meta Mapping (1000):
  1000   Wife (wife) [Family Group]

Phrase: had

Phrase: obtained health proxy prior to this admission
Meta Mapping (751):
   581   Obtained (Obtain) [Functional Concept]
   581   Health [Idea or Concept]
   748   Proxy [Group]
   612   Prior to (Before) [Temporal Concept]
   581   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (751):
   581   Obtained (Obtain) [Functional Concept]
   581   Health [Idea or Concept]
   748   Proxy [Group]
   612   Prior to (Before) [Temporal Concept]
   581   Admission (Admission activity) [Health Care Activity]
Meta Mapping (751):
   581   Obtained (Obtain) [Functional Concept]
   581   Health [Idea or Concept]
   748   PROXY (Advance Directive - Proxy) [Intellectual Product]
   612   Prior to (Before) [Temporal Concept]
   581   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (751):
   581   Obtained (Obtain) [Functional Concept]
   581   Health [Idea or Concept]
   748   PROXY (Advance Directive - Proxy) [Intellectual Product]
   612   Prior to (Before) [Temporal Concept]
   581   Admission (Admission activity) [Health Care Activity]

Phrase: and

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: since

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: not competent
Meta Mapping (888):
   694   Not (Negation) [Functional Concept]
   861   Competent (Competence) [Qualitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: make
Meta Mapping (1000):
  1000   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: decisions on his
Meta Mapping (790):
   790 N decisions (Decision) [Mental Process]

Phrase: own

Phrase: the wife
Meta Mapping (1000):
  1000   Wife (wife) [Family Group]

Phrase: would

Phrase: make
Meta Mapping (1000):
  1000   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: decisions
Meta Mapping (1000):
  1000   decisions (Decision) [Mental Process]

Phrase: regarding

Phrase: the health status
Meta Mapping (1000):
  1000   Health Status [Qualitative Concept]

Phrase: and

Phrase: treatment of the patient .
Meta Mapping (819):
   819   Patient Treatment (HL7CommitteeIDInRIM <Patient Administration>) [Intellectual Product]
Meta Mapping (819):
   819   patient Treatment (healthcare operations <patient administration>) [Occupational Activity]
Meta Mapping (819):
   819   patient Treatment (HL7PublishingDomain <patient administration>) [Intellectual Product]
Processing 00000000.tx.10: He underwent extraction of all his teeth on 9/21/93 tolerating the procedure well initially but then developed the ileus as noted above and subsequently a GI bleed . 

Phrase: He

Phrase: underwent

Phrase: extraction of all
Meta Mapping (790):
   790   Extraction [Therapeutic or Preventive Procedure]
Meta Mapping (790):
   790   extraction (Chemical extraction) [Laboratory Procedure]

Phrase: his teeth on 9/21/93
Meta Mapping (767):
   767   Tooth 9 (Maxillary left central incisor) [Body Part, Organ, or Organ Component]
Meta Mapping (767):
   767   Tooth 21 (Mandibular left first premolar tooth) [Body Part, Organ, or Organ Component]

Phrase: tolerating

Phrase: the procedure well initially
Meta Mapping (851):
   827   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
   827   Well (Good) [Qualitative Concept]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
   827   Well [Manufactured Object]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
   827   Well (Good) [Qualitative Concept]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
   827   Well [Manufactured Object]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (Procedure (set of actions)) [Activity]
   827   Well (Good) [Qualitative Concept]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (Procedure (set of actions)) [Activity]
   827   Well [Manufactured Object]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
   827   Well (Good) [Qualitative Concept]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
   827   Well [Manufactured Object]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (Procedure Domain) [Intellectual Product]
   827   Well (Good) [Qualitative Concept]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (Procedure Domain) [Intellectual Product]
   827   Well [Manufactured Object]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
   827   Well (Good) [Qualitative Concept]
   827   Initially [Temporal Concept]
Meta Mapping (851):
   827   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
   827   Well [Manufactured Object]
   827   Initially [Temporal Concept]

Phrase: but

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: developed

Phrase: the ileus
Meta Mapping (1000):
  1000   ILEUS (Ileus) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Ileus (Intestinal obstruction co-occurrent and due to decreased peristalsis) [Disease or Syndrome]

Phrase: as

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: above
Meta Mapping (1000):
  1000   Above (Upper) [Spatial Concept]
Meta Mapping (1000):
  1000   above (Table Frame - above) [Idea or Concept]

Phrase: and

Phrase: subsequently

Phrase: a GI
Meta Mapping (1000):
  1000   Gi (GNAI1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   GI (Digestive System Findings Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   GI (Gastrointestinal studies and measurements) [Intellectual Product]

Phrase: bleed .
Meta Mapping (1000):
  1000   bleed (Hemorrhage) [Pathologic Function]
Processing 00000000.tx.11: The white count was 7.5 , platelets 196 . 

Phrase: The white count
Meta Mapping (888):
   694   WHITE (Caucasoid Race) [Population Group]
   861   Count [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (Caucasoid Race) [Population Group]
   861   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (Caucasians) [Population Group]
   861   Count [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (Caucasians) [Population Group]
   861   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (White color) [Qualitative Concept]
   861   Count [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (White color) [Qualitative Concept]
   861   COUNT (Count Dosing Unit) [Quantitative Concept]

Phrase: was

Phrase: 7.5 ,

Phrase: platelets 196 .
Meta Mapping (861):
   861   Platelets (Blood Platelets) [Cell]
Meta Mapping (861):
   861   Platelets (Platelets Adverse Event) [Finding]
Processing 00000000.tx.12: OPERATIVE PROCEDURES : The patient is to be transferred to Paw.ryfear Medical Center for further care including physical therapy , occupational therapy , and further nutritional support .

Phrase: OPERATIVE PROCEDURES
Meta Mapping (1000):
  1000   operative procedures (Surgical aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Operative procedures (Operative Surgical Procedures) [Health Care Activity]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: transferred to Paw.ryfear Medical Center
Meta Mapping (712):
   753   transferred (Surgical transfer - action) [Functional Concept]
   753   PAW (Paw) [Body Part, Organ, or Organ Component]
   790   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (712):
   753   transferred (Surgical transfer - action) [Functional Concept]
   753   PAW (Paw) [Body Part, Organ, or Organ Component]
   790   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (712):
   753   Transferred (Transfer Technique) [Functional Concept]
   753   PAW (Paw) [Body Part, Organ, or Organ Component]
   790   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (712):
   753   Transferred (Transfer Technique) [Functional Concept]
   753   PAW (Paw) [Body Part, Organ, or Organ Component]
   790   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: for further care
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Care (care activity) [Activity]

Phrase: including
Meta Mapping (1000):
  1000   Including (Including (qualifier)) [Functional Concept]

Phrase: physical therapy ,
Meta Mapping (1000):
  1000   physical therapy (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Physical Therapy (Physical therapy) [Therapeutic or Preventive Procedure]

Phrase: occupational therapy ,
Meta Mapping (1000):
  1000   Occupational Therapy (Occupational therapy regime) [Health Care Activity]

Phrase: and

Phrase: further nutritional support .
Meta Mapping (901):
   660   Further [Spatial Concept]
   901   Nutritional Support [Therapeutic or Preventive Procedure]
Processing 00000000.tx.1: 7271129 17744 <RECORD ID="736"> 219781 03/30/1993 12:00:00 AM 03/30/1993 Signed At that time , his shortness of breath worsened and his sputum became rusty-colored . 

Phrase: 7271129 17744

Phrase: <RECORD ID="736"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 219781 03/30/1993 12
Meta Mapping (804):
   804   30% [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: 03/30/1993 Signed At
Meta Mapping (686):
   593   30% [Finding]
   760   Signed (Signature) [Intellectual Product]
Meta Mapping (686):
   593   30% [Finding]
   760   signed (signed - ParticipationSignature) [Intellectual Product]

Phrase: that time ,
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: his shortness of breath
Meta Mapping (909):
   909   SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (909):
   909   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: worsened
Meta Mapping (1000):
  1000   Worsened (Worse) [Finding]

Phrase: and

Phrase: his sputum
Meta Mapping (1000):
  1000   SPUTUM (Sputum) [Body Substance]

Phrase: became

Phrase: rusty-
Meta Mapping (928):
   928   Rust (Uredinales) [Fungus]
Meta Mapping (928):
   928   Rust (Bacterial shell rot) [Disease or Syndrome]

Phrase: colored .
Meta Mapping (1000):
  1000   colored (With color) [Qualitative Concept]
Processing 00000000.tx.2: His last negative PPD was greater than one year ago . 

Phrase: His last negative PPD
Meta Mapping (901):
   660   Last [Qualitative Concept]
   901   Negative PPD (Mantoux: negative) [Laboratory or Test Result]

Phrase: was

Phrase: greater than one year ago .
Meta Mapping (926):
   926   Greater than one year [Temporal Concept]
Processing 00000000.tx.3: PAST MEDICAL HISTORY : Significant for rheumatic heart disease , prostate cancer , lung cancer . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: Significant for rheumatic heart disease ,
Meta Mapping (816):
   760   significant (Statistical Significance) [Quantitative Concept]
   695   RHEUMATIC HEART DISEASE (Rheumatic Heart Disease) [Disease or Syndrome]
Meta Mapping (816):
   760   Significant [Idea or Concept]
   695   RHEUMATIC HEART DISEASE (Rheumatic Heart Disease) [Disease or Syndrome]
Meta Mapping (816):
   760   Significant (Event Seriousness - Significant) [Qualitative Concept]
   695   RHEUMATIC HEART DISEASE (Rheumatic Heart Disease) [Disease or Syndrome]

Phrase: prostate cancer ,
Meta Mapping (1000):
  1000   Prostate Cancer (Malignant neoplasm of prostate) [Neoplastic Process]
Meta Mapping (1000):
  1000   Prostate Cancer (Prostate carcinoma) [Neoplastic Process]
Meta Mapping (1000):
  1000   Prostate cancer (Prostate Cancer Pathway) [Conceptual Entity]
Meta Mapping (1000):
  1000   Prostate Cancer (NCI CTEP SDC Prostate Cancer Sub-Category Terminology) [Intellectual Product]

Phrase: lung cancer .
Meta Mapping (1000):
  1000   Lung Cancer (Malignant neoplasm of lung) [Neoplastic Process]
Meta Mapping (1000):
  1000   -- Lung Cancer (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (1000):
  1000   Lung cancer (Primary malignant neoplasm of lung) [Neoplastic Process]
Processing 00000000.tx.4: Lungs revealed rales at the bases bilaterally with egophony at the left axilla . 

Phrase: Lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: rales at the bases bilaterally
Meta Mapping (756):
   756   basal Rales (Basilar Rales) [Finding]

Phrase: with egophony at the left axilla .
Meta Mapping (722):
   753   EGOPHONY (Egophony) [Finding]
   623   Left axilla (Structure of left axillary region) [Body Location or Region]
Processing 00000000.tx.5: There was no splenomegaly . 

Phrase: There

Phrase: was

Phrase: no splenomegaly .
Meta Mapping (1000):
  1000 N SPLENOMEGALY (Splenomegaly) [Finding]
Processing 00000000.tx.6: His respiratory status continued to deteriorate after his Solu-Medrol was discontinued and he was switched to Prednisone . 

Phrase: His respiratory status
Meta Mapping (1000):
  1000   Respiratory Status [Finding]
Meta Mapping (1000):
  1000   Respiratory status (Respiratory Status:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: deteriorate after his Solu-Medrol
Meta Mapping (745):
   760   deteriorate (Worse) [Finding]
   806   Solu-MEDROL (Solu-Medrol) [Organic Chemical,Pharmacologic Substance]

Phrase: was

Phrase: discontinued
Meta Mapping (1000):
  1000   Discontinued [Finding]

Phrase: and

Phrase: he

Phrase: was

Phrase: switched to Prednisone .
Meta Mapping (730):
   756   Switch (Switch Device Component) [Manufactured Object]
   790   PREDNISONE (Prednisone) [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.7: <RECORD ID="737"> 79633097 (7) Pernicious anemia . 

Phrase: <RECORD ID="737"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 79633097

Phrase: (7

Phrase: )

Phrase: Pernicious anemia .
Meta Mapping (1000):
  1000   Pernicious anaemia (Anemia, Pernicious) [Disease or Syndrome]
Processing 00000000.tx.8: (10) Hypothyroidism . 

Phrase: (10

Phrase: )

Phrase: Hypothyroidism .
Meta Mapping (1000):
  1000   HYPOTHYROIDISM (Hypothyroidism) [Disease or Syndrome]
Processing 00000000.tx.9: (2) Appendectomy . 

Phrase: (2
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]

Phrase: )

Phrase: Appendectomy .
Meta Mapping (1000):
  1000   APPENDECTOMY (Appendectomy) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.10: Her wounds remained dry without erythema . 

Phrase: Her wounds
Meta Mapping (1000):
  1000   wounds (Wounds - qualifier) [Finding]
Meta Mapping (1000):
  1000   WOUNDS (Injury wounds) [Injury or Poisoning]

Phrase: remained

Phrase: dry without erythema .
Meta Mapping (746):
   790   Dry (Desiccation) [Natural Phenomenon or Process]
   623 N ERYTHEMA (Erythema) [Disease or Syndrome]
Meta Mapping (746):
   790   Dry [Qualitative Concept]
   623 N ERYTHEMA (Erythema) [Disease or Syndrome]
Meta Mapping (746):
   790   Dry (Dryness (characteristic)) [Qualitative Concept]
   623 N ERYTHEMA (Erythema) [Disease or Syndrome]
Processing 00000000.tx.11: PHYSICAL THERAPY : Batch : 01/18/96 607079 NAME : 171-46-12 10/20/96 The patient had not had chest pain since the seventh and was transferred to the Ph University Of Medical Center in stable condition . 

Phrase: PHYSICAL THERAPY
Meta Mapping (1000):
  1000   physical therapy (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Physical Therapy (Physical therapy) [Therapeutic or Preventive Procedure]

Phrase: :

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: 01/18/96 607079 NAME
Meta Mapping (804):
   804   Name [Intellectual Product]
Meta Mapping (804):
   804   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: 171-46-12 10/20/96
Meta Mapping (716):
   799   10% [Finding]
   799   20% [Finding]

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: had

Phrase: chest pain
Meta Mapping (1000):
  1000 N CHEST PAIN (Chest Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]

Phrase: since

Phrase: the seventh
Meta Mapping (1000):
  1000   Seventh [Quantitative Concept]

Phrase: and

Phrase: was

Phrase: transferred to the Ph University Of Medical Center
Meta Mapping (717):
   744   transferred (Surgical transfer - action) [Functional Concept]
   744 N ph+ [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   transferred (Surgical transfer - action) [Functional Concept]
   744 N ph++ [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   transferred (Surgical transfer - action) [Functional Concept]
   744 N ph+++ [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   transferred (Surgical transfer - action) [Functional Concept]
   744   pH [Quantitative Concept]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   transferred (Surgical transfer - action) [Functional Concept]
   744 N PH (Infusion pump Alert priority PH) [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Transferred (Transfer Technique) [Functional Concept]
   744 N ph+ [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Transferred (Transfer Technique) [Functional Concept]
   744 N ph++ [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Transferred (Transfer Technique) [Functional Concept]
   744 N ph+++ [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Transferred (Transfer Technique) [Functional Concept]
   744   pH [Quantitative Concept]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Transferred (Transfer Technique) [Functional Concept]
   744 N PH (Infusion pump Alert priority PH) [Finding]
   793   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]

Phrase: in stable condition .
Meta Mapping (1000):
  1000 N Stable condition (Stable Disease) [Finding]
Meta Mapping (1000):
  1000 N Stable condition (Stable chronic Graft vs Host Disease) [Finding]
Processing 00000000.tx.12: Neurologically he is non-focal . 

Phrase: Neurologically

Phrase: he

Phrase: is

Phrase: non-focal .
Meta Mapping (888):
   861   Non (Negation) [Functional Concept]
   861   FOCAL (Focal) [Spatial Concept]
Processing 00000000.tx.13: However , there was no evidence of cholecystitis per laboratory work up of Mr. 

Phrase: However ,

Phrase: there

Phrase: was

Phrase: no evidence of cholecystitis
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604 N CHOLECYSTITIS (Cholecystitis) [Disease or Syndrome]
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604 N Cholecystitis (Cholecystitis Adverse Event) [Finding]

Phrase: per laboratory work up of Mr.
Meta Mapping (725):
   586   LABORATORY (Laboratory) [Manufactured Object,Organization]
   790   Work-up (work up) [Diagnostic Procedure]
   586   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (725):
   586   LABORATORY (Laboratory) [Manufactured Object,Organization]
   790   Work-up (work up) [Diagnostic Procedure]
   586   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (725):
   586   LABORATORY (Laboratory) [Manufactured Object,Organization]
   790   Work-up (work up) [Diagnostic Procedure]
   586 N MR (Minor Response) [Finding]
Meta Mapping (725):
   586   laboratory (Laboratory domain) [Functional Concept]
   790   Work-up (work up) [Diagnostic Procedure]
   586   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (725):
   586   laboratory (Laboratory domain) [Functional Concept]
   790   Work-up (work up) [Diagnostic Procedure]
   586   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (725):
   586   laboratory (Laboratory domain) [Functional Concept]
   790   Work-up (work up) [Diagnostic Procedure]
   586 N MR (Minor Response) [Finding]
Processing 00000000.tx.14: Forresneigh during this admission his liver function tests , bilirubins all remained within normal ranges . 

Phrase: Forresneigh during this admission
Meta Mapping (604):
   604   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (604):
   604   Admission (Admission activity) [Health Care Activity]

Phrase: his liver function tests ,
Meta Mapping (1000):
  1000   Liver Function Tests [Laboratory Procedure]

Phrase: bilirubins
Meta Mapping (966):
   966   BILIRUBIN (Bilirubin) [Biologically Active Substance,Organic Chemical]

Phrase: all

Phrase: remained within normal ranges .
Meta Mapping (833):
   833   Normal Ranges (Normal Range) [Quantitative Concept]
Processing 00000000.tx.15: 6) Glibornuride 5 mgs per day , 10/29/96 125721767 He continued to complain of shortness of breath with an episode of respiratory failure in the hospital requiring 100% nonrebreather . 

Phrase: 6

Phrase: )

Phrase: Glibornuride 5 mgs per day ,
Meta Mapping (761):
   593   GLIBORNURIDE (glibornuride) [Organic Chemical,Pharmacologic Substance]
   760   mgs (Magnesium) [Element, Ion, or Isotope]
   631   Day 5 [Finding]
Meta Mapping (761):
   593   GLIBORNURIDE (glibornuride) [Organic Chemical,Pharmacologic Substance]
   760   mgs (milligram) [Quantitative Concept]
   631   Day 5 [Finding]
Meta Mapping (761):
   593   GLIBORNURIDE (glibornuride) [Organic Chemical,Pharmacologic Substance]
   760   MGS (MUNGAN SYNDROME) [Disease or Syndrome]
   631   Day 5 [Finding]

Phrase: 10/29/96 125721767
Meta Mapping (861):
   861   10 - 29% [Finding]

Phrase: He

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: complain of shortness of breath
Meta Mapping (844):
   835   SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (844):
   835   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: with an episode of respiratory failure
Meta Mapping (771):
   790   Episode of [Temporal Concept]
   623   Failure, Respiratory (Respiratory Failure) [Disease or Syndrome]

Phrase: in the hospital
Meta Mapping (1000):
  1000   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (1000):
  1000   Hospital (Hospital environment) [Qualitative Concept]

Phrase: requiring

Phrase: 100% nonrebreather .
Meta Mapping (694):
   694   100% [Quantitative Concept]
Processing 00000000.tx.16: He was started on IV ig and IV Solu-Medrol for a diagnosis of myasthenia gravis given his past history of thymoma . 

Phrase: He

Phrase: was

Phrase: started on IV ig
Meta Mapping (733):
   770   Started [Qualitative Concept]
   770   IV (Ivory Coast) [Geographic Area]
   770   IG (Immunoglobulins) [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Meta Mapping (733):
   770   Started [Qualitative Concept]
   770   IV (Ivory Coast) [Geographic Area]
   770   IG (Gamma globulin serum) [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Meta Mapping (733):
   770   Started [Qualitative Concept]
   770   IV (Ivory Coast) [Geographic Area]
   770   IG (Intramuscular immunoglobulin) [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Meta Mapping (733):
   770   Started [Qualitative Concept]
   770   IV (Ivory Coast) [Geographic Area]
   770   IG (Integumentary System Findings Domain) [Idea or Concept]

Phrase: and

Phrase: IV Solu-Medrol for a diagnosis of myasthenia gravis
Meta Mapping (692):
   575   IV (Ivory Coast) [Geographic Area]
   764   Solu-MEDROL (Solu-Medrol) [Organic Chemical,Pharmacologic Substance]
   575   DIAGNOSIS (Diagnosis) [Finding]
   598   MYASTHENIA GRAVIS (Myasthenia Gravis) [Disease or Syndrome]
Meta Mapping (692):
   575   IV (Ivory Coast) [Geographic Area]
   764   Solu-MEDROL (Solu-Medrol) [Organic Chemical,Pharmacologic Substance]
   575   diagnosis (diagnosis aspect) [Qualitative Concept]
   598   MYASTHENIA GRAVIS (Myasthenia Gravis) [Disease or Syndrome]
Meta Mapping (692):
   575   IV (Ivory Coast) [Geographic Area]
   764   Solu-MEDROL (Solu-Medrol) [Organic Chemical,Pharmacologic Substance]
   575   DIAGNOSIS (Diagnosis Study) [Research Activity]
   598   MYASTHENIA GRAVIS (Myasthenia Gravis) [Disease or Syndrome]

Phrase: given
Meta Mapping (1000):
  1000   GIVEN [Conceptual Entity]
Meta Mapping (1000):
  1000   given (Entity Name Part Type - given) [Idea or Concept]
Meta Mapping (1000):
  1000   Given (Give - dosing instruction imperative) [Functional Concept]
Meta Mapping (1000):
  1000   given (Given name) [Intellectual Product]

Phrase: his past history of thymoma .
Meta Mapping (843):
   862   Past history of [Qualitative Concept]
   593   THYMOMA (Thymoma) [Neoplastic Process]
Meta Mapping (843):
   862   Past history of [Qualitative Concept]
   593   thymoma (THM gene) [Gene or Genome]
Meta Mapping (843):
   862   Past history of [Qualitative Concept]
   593   Thymoma (Thymus Neoplasms) [Neoplastic Process]
Processing 00000000.tx.17: Dictated By : Index No. 

Phrase: Dictated By
Meta Mapping (833):
   833   dictated (dictated - ParticipationMode) [Functional Concept]
Meta Mapping (833):
   833   Dictated (dictated - DocumentCompletion) [Idea or Concept]

Phrase: :

Phrase: Index
Meta Mapping (1000):
  1000   Index [Intellectual Product]
Meta Mapping (1000):
  1000   index (Html Link Type - index) [Idea or Concept]
Meta Mapping (1000):
  1000   % index [Quantitative Concept]

Phrase: No.
Processing 00000000.tx.18: EJDFG7458J </TEXT> <RECORD ID="740"> <TEXT> DISCHARGE SUMMARY ZETZFYFEDALEMNONJESC , RYSTA A 11/12/96 <RECORD ID="741"> RATHELIFE , TIEANAKI B 02/01/2000 Non-healing ulcer on the right leg . 

Phrase: EJDFG7458J

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: <RECORD ID="740"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: >

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > DISCHARGE SUMMARY ZETZFYFEDALEMNONJESC ,
Meta Mapping (734):
   734   Discharge summary [Intellectual Product]
Meta Mapping (734):
   734   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: RYSTA

Phrase: A 11/12/96
Meta Mapping (901):
   901   11-12 [Finding]

Phrase: <RECORD ID="741"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > RATHELIFE ,

Phrase: TIEANAKI B 02/01/2000 Non-healing ulcer on the right leg .
Meta Mapping (654):
   536   2000s [Temporal Concept]
   586   Non-healing (Non-healed) [Functional Concept]
   570   RIGHT (Right) [Spatial Concept]
   751 N Leg Ulcer [Acquired Abnormality,Disease or Syndrome]
Meta Mapping (654):
   536   2000s [Temporal Concept]
   586   Non-healing (Non-healed) [Functional Concept]
   570   Right (Right sided) [Spatial Concept]
   751 N Leg Ulcer [Acquired Abnormality,Disease or Syndrome]
Processing 00000000.tx.19: HISTORY OF PRESENT ILLNESS : The patient did well in the postoperative period . 

Phrase: HISTORY OF PRESENT ILLNESS
Meta Mapping (1000):
  1000   HISTORY OF PRESENT ILLNESS (History of present illness) [Organism Attribute]
Meta Mapping (1000):
  1000   History of present illness (History of present illness:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: did

Phrase: well in the postoperative period .
Meta Mapping (745):
   760   Well (Good) [Qualitative Concept]
   806   Postoperative Period [Temporal Concept]
Meta Mapping (745):
   760   Well [Manufactured Object]
   806   Postoperative Period [Temporal Concept]
Processing 00000000.tx.20: The patient while in bed had her legs elevated . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: while in bed
Meta Mapping (790):
   790   Bed (Beds) [Manufactured Object]

Phrase: had

Phrase: her legs
Meta Mapping (1000):
  1000   Legs (Leg) [Body Location or Region]

Phrase: elevated .
Meta Mapping (1000):
  1000   Elevated (High) [Qualitative Concept]
Meta Mapping (1000):
  1000   Elevated [Qualitative Concept]
Processing 00000000.tx.21: The patient is to follow up with Dr. 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: to follow up with Dr.
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-up (Follow-up status) [Finding]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow Up (follow-up) [Health Care Activity]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Togo) [Geographic Area]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-up (Follow-up status) [Finding]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow Up (follow-up) [Health Care Activity]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-up (Follow-up status) [Finding]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-up (Follow-up status) [Finding]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow Up (follow-up) [Health Care Activity]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow Up (follow-up) [Health Care Activity]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   Follow-Up (Follow-Up Report) [Intellectual Product]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (761):
   593   To [Qualitative Concept]
   806   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.22: Pop in one week and the patient was afebrile with stable vital signs at the time of discharge . 

Phrase: Pop in one week
Meta Mapping (861):
   861   One week [Temporal Concept]

Phrase: and

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: afebrile with stable vital signs
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   STABLE (Stable status) [Qualitative Concept]
   640   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   STABLE (Stable status) [Qualitative Concept]
   640   Signs, Vital (Vital signs) [Clinical Attribute]
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   Stable (Patient Condition Code - Stable) [Intellectual Product]
   640   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (761):
   760   Afebrile (Apyrexial) [Finding]
   593   Stable (Patient Condition Code - Stable) [Intellectual Product]
   640   Signs, Vital (Vital signs) [Clinical Attribute]

Phrase: at the time of discharge .
Meta Mapping (797):
   797   Discharge time [Temporal Concept]
Meta Mapping (797):
   797   Discharge time (Discharge time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]
Processing 00000000.tx.23: <RECORD ID="742"> Discharge Summary Unsigned DISCHARGE DATE : PRINCIPAL PROCEDURE : She had a witnessed seizure-like episode . 

Phrase: <RECORD ID="742"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > Discharge Summary Unsigned DISCHARGE DATE
Meta Mapping (812):
   897   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
   637   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (812):
   897   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
   637   Summary (Summary (document)) [Intellectual Product]
Meta Mapping (812):
   897   Discharge date [Temporal Concept]
   637   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (812):
   897   Discharge date [Temporal Concept]
   637   Summary (Summary (document)) [Intellectual Product]
Meta Mapping (812):
   673   Discharge summary [Intellectual Product]
   804   DATE (Date in time) [Temporal Concept]
Meta Mapping (812):
   673   Discharge summary [Intellectual Product]
   804   DATE (Date Fruit) [Food]
Meta Mapping (812):
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   804   DATE (Date in time) [Temporal Concept]
Meta Mapping (812):
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   804   DATE (Date Fruit) [Food]

Phrase: :

Phrase: PRINCIPAL PROCEDURE
Meta Mapping (1000):
  1000   Principal procedure (Primary procedure) [Functional Concept]

Phrase: :

Phrase: She

Phrase: had

Phrase: a witnessed seizure-like episode .
Meta Mapping (775):
   645   witnessed (Witnesses) [Population Group]
   645   SEIZURE (Seizures) [Sign or Symptom]
   812   Episode (Episode of) [Temporal Concept]
Meta Mapping (775):
   645   witnessed (Witnesses) [Population Group]
   645   Seizure (Seizure Adverse Event) [Finding]
   812   Episode (Episode of) [Temporal Concept]
Processing 00000000.tx.24: She had minimal crackles bilaterally and had an unremarkable electrocardiogram . 

Phrase: She

Phrase: had

Phrase: minimal
Meta Mapping (1000):
  1000   Minimal [Qualitative Concept]
Meta Mapping (1000):
  1000   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (1000):
  1000   Minimal (Mild (qualifier value)) [Qualitative Concept]

Phrase: crackles
Meta Mapping (1000):
  1000   Crackles (Rales) [Sign or Symptom]
Meta Mapping (1000):
  1000   Crackles (Basilar Rales) [Finding]

Phrase: bilaterally

Phrase: and

Phrase: had

Phrase: an unremarkable electrocardiogram .
Meta Mapping (888):
   694   Unremarkable (Normal) [Qualitative Concept]
   861   Electrocardiogram [Finding]
Meta Mapping (888):
   694   Unremarkable (Normal) [Qualitative Concept]
   861   Electro-Cardiogram [Spatial Concept]
Meta Mapping (888):
   694   Unremarkable (Normal) [Qualitative Concept]
   861   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (888):
   694   Unremarkable (Normal) [Qualitative Concept]
   861   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]
Processing 00000000.tx.25: She was admitted to the Medical Intensive Care Unit for further management . 

Phrase: She

Phrase: was

Phrase: admitted to the Medical Intensive Care Unit
Meta Mapping (840):
   859   Admit to intensive care unit NOS (Admission to intensive care unit) [Health Care Activity]
   748   Medical (Medical service) [Health Care Activity]
Meta Mapping (840):
   859   Admit to intensive care unit NOS (Admission to intensive care unit) [Health Care Activity]
   748   Medical [Functional Concept]

Phrase: for further management .
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Management (Administration occupational activities) [Occupational Activity]
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   management (Disease Management) [Health Care Activity]
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Management (Management procedure) [Occupational Activity]
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Management (Management Occupations) [Occupation or Discipline]
Processing 00000000.tx.26: Mild chronic dementia . 

Phrase: Mild chronic dementia .
Meta Mapping (901):
   913   Mild dementia [Mental or Behavioral Dysfunction]
   660   CHRONIC (chronic) [Temporal Concept]
Processing 00000000.tx.27: Depression . 

Phrase: Depression .
Meta Mapping (1000):
  1000   DEPRESSION (Mental Depression) [Mental or Behavioral Dysfunction]
Meta Mapping (1000):
  1000   -- Depression (Depressive disorder) [Mental or Behavioral Dysfunction]
Meta Mapping (1000):
  1000   depression (Depressed mood) [Finding]
Meta Mapping (1000):
  1000   Depression (Depression motion) [Functional Concept]
Meta Mapping (1000):
  1000   Depression (Depression Scale (BASC-2)) [Intellectual Product]
Processing 00000000.tx.28: Left breast mass with negative mammography . 

Phrase: Left breast mass with negative mammography .
Meta Mapping (776):
   833   left Breast mass (Lump in left breast) [Finding]
   586   Negative [Qualitative Concept]
   586   MAMMOGRAPHY (Mammography) [Diagnostic Procedure]
Meta Mapping (776):
   833   left Breast mass (Lump in left breast) [Finding]
   586   NEGATIVE (Negative Finding) [Finding]
   586   MAMMOGRAPHY (Mammography) [Diagnostic Procedure]
Meta Mapping (776):
   833   left Breast mass (Lump in left breast) [Finding]
   586   Negative (Negative Number) [Conceptual Entity]
   586   MAMMOGRAPHY (Mammography) [Diagnostic Procedure]
Meta Mapping (776):
   833   left Breast mass (Lump in left breast) [Finding]
   586   Negative (Negative Charge) [Qualitative Concept]
   586   MAMMOGRAPHY (Mammography) [Diagnostic Procedure]
Meta Mapping (776):
   833   left Breast mass (Lump in left breast) [Finding]
   586   Negative (Negative - answer) [Qualitative Concept]
   586   MAMMOGRAPHY (Mammography) [Diagnostic Procedure]
Processing 00000000.tx.29: Relafen which is contra-indicated because of ulcers . 

Phrase: Relafen
Meta Mapping (1000):
  1000   Relafen [Organic Chemical,Pharmacologic Substance]

Phrase: which

Phrase: is

Phrase: contra-indicated because of ulcers .
Meta Mapping (745):
   806   Contra-indicated (Contraindicated) [Finding]
   760   ULCERS (Ulcer) [Disease or Syndrome]
Processing 00000000.tx.30: Tetracycline . 

Phrase: Tetracycline .
Meta Mapping (1000):
  1000   TETRACYCLINE (Tetracycline) [Antibiotic,Organic Chemical]
Meta Mapping (1000):
  1000   tetracycline (Tetracycline Antibiotics) [Antibiotic,Organic Chemical]
Processing 00000000.tx.31: Bactrim . 

Phrase: Bactrim .
Meta Mapping (1000):
  1000   Bactrim [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.32: Rectal was guaiac positive . 

Phrase: Rectal
Meta Mapping (1000):
  1000   Rectal (rectal) [Spatial Concept]

Phrase: was

Phrase: guaiac positive .
Meta Mapping (1000):
  1000   guaiac positive [Laboratory or Test Result]
Processing 00000000.tx.33: Urine analysis showed no urinary tract infection . 

Phrase: Urine analysis
Meta Mapping (1000):
  1000   Urine--Analysis (Urinalysis) [Laboratory Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: no urinary tract infection .
Meta Mapping (1000):
  1000 N URINARY TRACT INFECTION (Urinary tract infection) [Disease or Syndrome]
Meta Mapping (1000):
  1000 N Urinary tract infection (Recurrent urinary tract infection) [Disease or Syndrome]
Processing 00000000.tx.34: 1. 

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.35: ENDOCRINE : She was aggressively diuresed for her minimal congestive heart failure . 

Phrase: ENDOCRINE
Meta Mapping (1000):
  1000   Endocrine (Endocrine system) [Body System]
Meta Mapping (1000):
  1000   Endocrine [Functional Concept]

Phrase: :

Phrase: She

Phrase: was

Phrase: aggressively

Phrase: diuresed for her minimal congestive heart failure .
Meta Mapping (744):
   714   Diurese [Organic Chemical,Pharmacologic Substance]
   748   Minimal [Qualitative Concept]
   814   CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (744):
   714   Diurese [Organic Chemical,Pharmacologic Substance]
   748   MINIMAL (Minimum) [Qualitative Concept]
   814   CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Meta Mapping (744):
   714   Diurese [Organic Chemical,Pharmacologic Substance]
   748   Minimal (Mild (qualifier value)) [Qualitative Concept]
   814   CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]
Processing 00000000.tx.36: MEDICATIONS ON DISCHARGE : 3. 

Phrase: MEDICATIONS ON DISCHARGE
Meta Mapping (858):
   858   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.37: Dulcolax 10 mg pr per day as needed . 

Phrase: Dulcolax 10 mg pr per day
Meta Mapping (753):
   586   Dulcolax [Organic Chemical,Pharmacologic Substance]
   586   10% [Finding]
   617   mg day (milligram/day) [Quantitative Concept]
   753   PR+ (progesterone receptor positive) [Laboratory or Test Result]
Meta Mapping (753):
   586   Dulcolax [Organic Chemical,Pharmacologic Substance]
   586   10% [Finding]
   617   mg day (milligram/day) [Quantitative Concept]
   753   PR- (progesterone receptor negative) [Laboratory or Test Result]
Meta Mapping (753):
   586   Dulcolax [Organic Chemical,Pharmacologic Substance]
   586   10% [Finding]
   617   mg day (milligram/day) [Quantitative Concept]
   753   PR@ (PR@ gene cluster) [Gene or Genome]
Meta Mapping (753):
   586   Dulcolax [Organic Chemical,Pharmacologic Substance]
   586   10% [Finding]
   617   mg day (milligram/day) [Quantitative Concept]
   753   PR (STANDARDS Pain Relief Questionnaire) [Intellectual Product]
Meta Mapping (753):
   586   Dulcolax [Organic Chemical,Pharmacologic Substance]
   586   10% [Finding]
   617   mg day (milligram/day) [Quantitative Concept]
   753   PR (Procedure Domain) [Intellectual Product]
Meta Mapping (753):
   586   Dulcolax [Organic Chemical,Pharmacologic Substance]
   586   10% [Finding]
   617   mg day (milligram/day) [Quantitative Concept]
   753   PR (Progesterone Receptor Measurement) [Laboratory Procedure]
Meta Mapping (753):
   586   Dulcolax [Organic Chemical,Pharmacologic Substance]
   586   10% [Finding]
   617   mg day (milligram/day) [Quantitative Concept]
   753   PR (Per rectum) [Functional Concept]

Phrase: as needed .
Meta Mapping (1000):
  1000   As needed (PRN (schedule frequency)) [Temporal Concept]
Meta Mapping (1000):
  1000   As Needed [Qualitative Concept]
Processing 00000000.tx.38: 12. 

Phrase: 12.
Processing 00000000.tx.39: Neurontin 200 mg po three times a day . 

Phrase: Neurontin 200 mg po three times
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   MG (Mongolia) [Geographic Area]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg% (mg/dL) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   mg % (Milligram percent) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Portugal) [Geographic Area]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   times (Time) [Temporal Concept]
Meta Mapping (763):
   632   Neurontin [Organic Chemical,Pharmacologic Substance]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   632   PO (Oral) [Spatial Concept]
   632   Three [Quantitative Concept]
   799   Times [Quantitative Concept]

Phrase: a day .
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]
Processing 00000000.tx.40: </TEXT> Report Status : </RECORD> PUOMC 9101799 ALLERGIES : No known drug allergies . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > Report Status
Meta Mapping (1000):
  1000   Report status [Finding]

Phrase: :

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > PUOMC 9101799 ALLERGIES
Meta Mapping (827):
   827   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: No known drug allergies .
Meta Mapping (901):
   660   Known [Qualitative Concept]
   901 N Drug Allergies (Drug Allergy) [Disease or Syndrome]
Processing 00000000.tx.41: Minipress . 

Phrase: Minipress .
Meta Mapping (1000):
  1000   Minipress [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.42: The head , eyes , ears , nose and throat examination was remarkable for poor dentition . 

Phrase: The head ,
Meta Mapping (1000):
  1000   HEAD (Head) [Body Location or Region]
Meta Mapping (1000):
  1000   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Head (Head - Component of Device) [Manufactured Object]

Phrase: eyes ,
Meta Mapping (1000):
  1000   Eyes (Eye) [Body Part, Organ, or Organ Component]

Phrase: ears ,
Meta Mapping (1000):
  1000   Ears (Ear structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   EARS (Entire ear) [Body Part, Organ, or Organ Component]

Phrase: nose
Meta Mapping (1000):
  1000   NOSE (Nose) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Nose (Entire nose) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: throat examination
Meta Mapping (694):
   694   Throat (Pharyngeal structure) [Body Part, Organ, or Organ Component]
Meta Mapping (694):
   694   Throat (Anterior portion of neck) [Body Location or Region]
Meta Mapping (694):
   694   Throat (Entire throat (surface region of neck)) [Body Part, Organ, or Organ Component]
Meta Mapping (694):
   694   THROAT (Throat) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: remarkable for poor dentition .
Meta Mapping (666):
   666   POOR DENTITION (poor dentition) [Sign or Symptom]
Processing 00000000.tx.43: The neck was supple without adenopathy . 

Phrase: The neck
Meta Mapping (1000):
  1000   NECK (Neck) [Body Location or Region]
Meta Mapping (1000):
  1000   Neck (Entire neck) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   neck (dendritic spine neck) [Cell Component]

Phrase: was

Phrase: supple without adenopathy .
Meta Mapping (746):
   790   Supple [Functional Concept]
   623 N ADENOPATHY (Lymphadenopathy) [Finding]
Processing 00000000.tx.44: The abdomen was soft and non-tender and obese . 

Phrase: The abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: soft
Meta Mapping (1000):
  1000   Soft [Qualitative Concept]
Meta Mapping (1000):
  1000   SOFT (SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME) [Disease or Syndrome]

Phrase: and

Phrase: non-tender
Meta Mapping (1000):
  1000   Non-tender [Qualitative Concept]

Phrase: and

Phrase: obese .
Meta Mapping (1000):
  1000 N OBESE (Obesity) [Disease or Syndrome]
Processing 00000000.tx.45: The genitourinary examination was notable for a suprapubic tube in place with normal male genitalia and guaiac negative stools on rectal examination . 

Phrase: The genitourinary examination
Meta Mapping (1000):
  1000   GENITOURINARY examination (Examination of urinary system) [Diagnostic Procedure]

Phrase: was

Phrase: notable for a suprapubic tube
Meta Mapping (528):
   593   Suprapubic (suprapubic approach) [Spatial Concept]
   593   TUBE (biomedical tube device) [Medical Device]
Meta Mapping (528):
   593   Suprapubic (suprapubic approach) [Spatial Concept]
   593   Tube NOS (Specimen Source Codes - Tube) [Intellectual Product]
Meta Mapping (528):
   593   Suprapubic (suprapubic approach) [Spatial Concept]
   593   Tube (tube) [Conceptual Entity]
Meta Mapping (528):
   593   Suprapubic (suprapubic approach) [Spatial Concept]
   593   {Tube} (Tube - unit dose) [Quantitative Concept]
Meta Mapping (528):
   593   Suprapubic (suprapubic approach) [Spatial Concept]
   593   TUBE (Packaging Tube) [Medical Device]
Meta Mapping (528):
   593   Suprapubic [Body Location or Region]
   593   TUBE (biomedical tube device) [Medical Device]
Meta Mapping (528):
   593   Suprapubic [Body Location or Region]
   593   Tube NOS (Specimen Source Codes - Tube) [Intellectual Product]
Meta Mapping (528):
   593   Suprapubic [Body Location or Region]
   593   Tube (tube) [Conceptual Entity]
Meta Mapping (528):
   593   Suprapubic [Body Location or Region]
   593   {Tube} (Tube - unit dose) [Quantitative Concept]
Meta Mapping (528):
   593   Suprapubic [Body Location or Region]
   593   TUBE (Packaging Tube) [Medical Device]

Phrase: in place with normal male genitalia
Meta Mapping (725):
   753   Place [Spatial Concept]
   586   NORMAL (Normal) [Qualitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place [Spatial Concept]
   586   Normal (Gait normal) [Finding]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place [Spatial Concept]
   586   % normal (Percent normal) [Quantitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place [Spatial Concept]
   586   % Normal (Mean Percent of Normal) [Quantitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (Place - dosing instruction imperative) [Functional Concept]
   586   NORMAL (Normal) [Qualitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (Place - dosing instruction imperative) [Functional Concept]
   586   Normal (Gait normal) [Finding]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (Place - dosing instruction imperative) [Functional Concept]
   586   % normal (Percent normal) [Quantitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (Place - dosing instruction imperative) [Functional Concept]
   586   % Normal (Mean Percent of Normal) [Quantitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (put - instruction imperative) [Activity]
   586   NORMAL (Normal) [Qualitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (put - instruction imperative) [Activity]
   586   Normal (Gait normal) [Finding]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (put - instruction imperative) [Activity]
   586   % normal (Percent normal) [Quantitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   753   Place (put - instruction imperative) [Activity]
   586   % Normal (Mean Percent of Normal) [Quantitative Concept]
   623   MALE GENITALIA (Male Genital Organs) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: guaiac negative stools on rectal examination .
Meta Mapping (759):
   783   guaiac stools (Fecal occult blood: positive) [Laboratory or Test Result]
   586   Negative [Qualitative Concept]
   623   Rectal examination [Diagnostic Procedure]
Meta Mapping (759):
   783   guaiac stools (Fecal occult blood: positive) [Laboratory or Test Result]
   586   NEGATIVE (Negative Finding) [Finding]
   623   Rectal examination [Diagnostic Procedure]
Meta Mapping (759):
   783   guaiac stools (Fecal occult blood: positive) [Laboratory or Test Result]
   586   Negative (Negative Number) [Conceptual Entity]
   623   Rectal examination [Diagnostic Procedure]
Meta Mapping (759):
   783   guaiac stools (Fecal occult blood: positive) [Laboratory or Test Result]
   586   Negative (Negative Charge) [Qualitative Concept]
   623   Rectal examination [Diagnostic Procedure]
Meta Mapping (759):
   783   guaiac stools (Fecal occult blood: positive) [Laboratory or Test Result]
   586   Negative (Negative - answer) [Qualitative Concept]
   623   Rectal examination [Diagnostic Procedure]
Processing 00000000.tx.46: There appeared to be a component of necrotizing fasciitis to this , and he was taken back to the operating room the next day for incision and drainage of a pelvic abscess and intraabdominal abscess . 

Phrase: There

Phrase: appeared
Meta Mapping (966):
   966   APPEAR (Appearance) [Qualitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: a component of necrotizing fasciitis
Meta Mapping (745):
   760   Component (Component object) [Manufactured Object]
   640   Necrotising fasciitis (Necrotizing fasciitis) [Disease or Syndrome]
Meta Mapping (745):
   760   Component (Component (part)) [Conceptual Entity]
   640   Necrotising fasciitis (Necrotizing fasciitis) [Disease or Syndrome]

Phrase: to this ,

Phrase: and

Phrase: he

Phrase: was

Phrase: taken
Meta Mapping (1000):
  1000   Taken [Conceptual Entity]

Phrase: back to the operating room
Meta Mapping (745):
   760   BACK (Back) [Body Location or Region]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   BACK (Back) [Body Location or Region]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]
Meta Mapping (745):
   760   BACK (Dorsal) [Spatial Concept]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   BACK (Dorsal) [Spatial Concept]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]
Meta Mapping (745):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   Back (Back structure, including back of neck) [Body Location or Region]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]
Meta Mapping (745):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   640   OPERATING ROOM (Operating Room) [Health Care Related Organization,Manufactured Object]
Meta Mapping (745):
   760   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   640   Operating Room (Patient location type - Operating Room) [Spatial Concept]

Phrase: the next day for incision
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   next (Adjacent) [Spatial Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   Next (Following) [Temporal Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   /day (Daily) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   DAY (day) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   593   Next (Then) [Temporal Concept]
   760   /day (per day) [Temporal Concept]
   593   Incision (Cranial incision point) [Body Location or Region]

Phrase: and

Phrase: drainage of a pelvic abscess
Meta Mapping (891):
   891   Drainage of pelvic abscess (Drainage of pelvic abscess (procedure)) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: intraabdominal abscess .
Meta Mapping (1000):
  1000   Intraabdominal abscess (Abdominal Abscess) [Disease or Syndrome]
Processing 00000000.tx.47: He continued to deteriorate until 12/3/96 , at which time he became bradycardic and asystolic . 

Phrase: He

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: deteriorate until 12/3/96 ,
Meta Mapping (760):
   760   deteriorate (Worse) [Finding]

Phrase: at which time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: he

Phrase: became

Phrase: bradycardic
Meta Mapping (928):
   928   Bradycardias (Bradycardia) [Pathologic Function]
Meta Mapping (928):
   928   BRADYCARDIA (Bradycardia by ECG Finding) [Finding]

Phrase: and

Phrase: asystolic .
Meta Mapping (928):
   928   asystolia (Cardiac Arrest) [Disease or Syndrome]
Meta Mapping (928):
   928   Asystole (Asystole Adverse Event) [Pathologic Function]
Meta Mapping (928):
   928   ASYSTOLE (Asystole by ECG Finding) [Finding]
Processing 00000000.tx.48: DD : 12/04/96 9:57 A HISTORY OF PRESENT ILLNESS : Her course has been complicated by atrial fibrillation first diagnosed in New Years Eve of l989 and she has been on Digoxin and Coumadin . 

Phrase: DD
Meta Mapping (1000):
  1000   DD (AKR1C2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   DD (ATP2A2 wt Allele) [Gene or Genome]

Phrase: :

Phrase: 12/04/96 9

Phrase: :

Phrase: 57

Phrase: A HISTORY OF PRESENT ILLNESS
Meta Mapping (926):
   926   HISTORY OF PRESENT ILLNESS (History of present illness) [Organism Attribute]
Meta Mapping (926):
   926   History of present illness (History of present illness:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]

Phrase: :

Phrase: Her course
Meta Mapping (1000):
  1000   Course [Temporal Concept]

Phrase: has

Phrase: been

Phrase: complicated by atrial fibrillation
Meta Mapping (783):
   770   Complicated [Functional Concept]
   833   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
Meta Mapping (783):
   770   Complicated [Functional Concept]
   833   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
Meta Mapping (783):
   770   Complicated [Functional Concept]
   833   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]

Phrase: first
Meta Mapping (1000):
  1000   First (First (number)) [Quantitative Concept]
Meta Mapping (1000):
  1000   First (Firstly) [Qualitative Concept]

Phrase: diagnosed in New Years Eve of l989
Meta Mapping (656):
   748   Diagnosed (Diagnosis) [Finding]
   748   NEW (New) [Qualitative Concept]
   748   YEARS (year) [Temporal Concept]

Phrase: and

Phrase: she

Phrase: has

Phrase: been on Digoxin
Meta Mapping (790):
   790   DIGOXIN (Digoxin) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: Coumadin .
Meta Mapping (1000):
  1000   Coumadin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.49: The patient &apos;s cardiac risk factors include a positive family history in that both parents died in their fifties of heart disease and two brothers had coronary artery bypass graft procedures in their thirties , hypercholesterolemia for several years , and hypertension . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s cardiac risk factors
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   861   Risk Factors (risk factors) [Quantitative Concept]
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   861   risk factors (risk factors - observation list) [Intellectual Product]
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   861   Risk Factors (risk factors) [Quantitative Concept]
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   861   risk factors (risk factors - observation list) [Intellectual Product]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   861   Risk Factors (risk factors) [Quantitative Concept]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Cardiac (Heart) [Body Part, Organ, or Organ Component]
   861   risk factors (risk factors - observation list) [Intellectual Product]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   861   Risk Factors (risk factors) [Quantitative Concept]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Cardiac (Cardiac - anatomy qualifier) [Spatial Concept]
   861   risk factors (risk factors - observation list) [Intellectual Product]

Phrase: include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: a positive family history in
Meta Mapping (763):
   593   % Positive (percent positive cells) [Quantitative Concept]
   806   FAMILY HISTORY (Family history) [Finding]
Meta Mapping (763):
   593   % Positive (percent positive cells) [Quantitative Concept]
   806   Family History (Family History Domain) [Idea or Concept]
Meta Mapping (763):
   593   Positive [Qualitative Concept]
   806   FAMILY HISTORY (Family history) [Finding]
Meta Mapping (763):
   593   Positive [Qualitative Concept]
   806   Family History (Family History Domain) [Idea or Concept]
Meta Mapping (763):
   593   POSITIVE (Positive Finding) [Finding]
   806   FAMILY HISTORY (Family history) [Finding]
Meta Mapping (763):
   593   POSITIVE (Positive Finding) [Finding]
   806   Family History (Family History Domain) [Idea or Concept]
Meta Mapping (763):
   593   Positive (Positive Charge) [Qualitative Concept]
   806   FAMILY HISTORY (Family history) [Finding]
Meta Mapping (763):
   593   Positive (Positive Charge) [Qualitative Concept]
   806   Family History (Family History Domain) [Idea or Concept]
Meta Mapping (763):
   593   Positive (Positive Number) [Conceptual Entity]
   806   FAMILY HISTORY (Family history) [Finding]
Meta Mapping (763):
   593   Positive (Positive Number) [Conceptual Entity]
   806   Family History (Family History Domain) [Idea or Concept]

Phrase: that

Phrase: both parents
Meta Mapping (1000):
  1000   Parents (parent) [Idea or Concept]

Phrase: died in their fifties of heart disease
Meta Mapping (681):
   748   Died (Cessation of life) [Organism Function]
   714   Fifty [Quantitative Concept]
   778   HEART DISEASE, NOS (Heart Diseases) [Disease or Syndrome]
Meta Mapping (681):
   748   Died (Death (finding)) [Finding]
   714   Fifty [Quantitative Concept]
   778   HEART DISEASE, NOS (Heart Diseases) [Disease or Syndrome]
Meta Mapping (681):
   748   Died (Patient Outcome - Died) [Finding]
   714   Fifty [Quantitative Concept]
   778   HEART DISEASE, NOS (Heart Diseases) [Disease or Syndrome]

Phrase: and

Phrase: two brothers
Meta Mapping (888):
   694   Two [Quantitative Concept]
   861   Brothers [Family Group]

Phrase: had

Phrase: coronary artery bypass graft procedures in their thirties ,
Meta Mapping (819):
   853   Coronary artery bypass graft procedure (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]
   578   Thirties [Finding]
Meta Mapping (819):
   853   coronary artery bypass graft procedure (coronary artery graft device) [Medical Device]
   578   Thirties [Finding]

Phrase: hypercholesterolemia for several years ,
Meta Mapping (708):
   770   HYPERCHOLESTEROLEMIA (Hypercholesterolemia) [Disease or Syndrome]
   604   YEARS (year) [Temporal Concept]
Meta Mapping (708):
   770   Hypercholesterolemia (Hypercholesterolemia result) [Finding]
   604   YEARS (year) [Temporal Concept]

Phrase: and

Phrase: hypertension .
Meta Mapping (1000):
  1000   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Hypertension (Hypertension Adverse Event) [Finding]
Processing 00000000.tx.50: HEENT : The patient &apos;s peripheral pulses were full . 

Phrase: HEENT
Meta Mapping (1000):
  1000   HEENT [Body Location or Region]

Phrase: :

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s peripheral pulses
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   peripheral pulses (Peripheral pulse) [Organ or Tissue Function]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   peripheral pulses (Peripheral pulse) [Organ or Tissue Function]

Phrase: were

Phrase: full .
Meta Mapping (1000):
  1000   Full [Qualitative Concept]
Processing 00000000.tx.51: She was having difficulty remembering certain events which had occurred that day .

Phrase: She

Phrase: was

Phrase: having

Phrase: difficulty remembering certain events
Meta Mapping (815):
   645   Difficulty (Has difficulty doing (qualifier value)) [Finding]
   645   remembering (Mental Recall) [Mental Process]
   574   Certainty (Certain (qualifier value)) [Qualitative Concept]
   812   Events (Event) [Event]
Meta Mapping (815):
   645   Difficulty (Has difficulty doing (qualifier value)) [Finding]
   645   remembering (Mental Recall) [Mental Process]
   574   Certainty (Certain (qualifier value)) [Qualitative Concept]
   812   EVENTS (CDISC Events Class) [Classification]
Meta Mapping (815):
   645   Difficulty (Has difficulty doing (qualifier value)) [Finding]
   645   remembering (Mental Recall) [Mental Process]
   574   Certainties [Qualitative Concept]
   812   Events (Event) [Event]
Meta Mapping (815):
   645   Difficulty (Has difficulty doing (qualifier value)) [Finding]
   645   remembering (Mental Recall) [Mental Process]
   574   Certainties [Qualitative Concept]
   812   EVENTS (CDISC Events Class) [Classification]

Phrase: which

Phrase: had

Phrase: occurred
Meta Mapping (1000):
  1000   Occurred (Occur (action)) [Activity]

Phrase: that day .
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]
Processing 00000000.tx.1: Ms. 

Phrase: Ms.
Meta Mapping (1000):
  1000   MS (5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   Ms. (Ms. - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   MS (MTR wt Allele) [Gene or Genome]
Processing 00000000.tx.2: Ere is a 60 year old lady with end-stage renal disease secondary to diabetes who was on hemodialysis since 1996 . 

Phrase: Ere

Phrase: is

Phrase: a 60 year old lady with end-stage renal disease
Meta Mapping (563):
   573   60% [Finding]
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   640   End Stage Renal Disease (Kidney Failure, Chronic) [Disease or Syndrome]
Meta Mapping (563):
   573   60% [Finding]
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   640   End Stage Renal Disease (Chronic kidney disease stage 5) [Disease or Syndrome]
Meta Mapping (563):
   573   60% [Finding]
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   640   End Stage Renal Disease (Kidney Failure, Chronic) [Disease or Syndrome]
Meta Mapping (563):
   573   60% [Finding]
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   640   End Stage Renal Disease (Chronic kidney disease stage 5) [Disease or Syndrome]

Phrase: secondary to diabetes
Meta Mapping (901):
   882   Secondary to [Temporal Concept]
   623   Diabetes [Disease or Syndrome]
Meta Mapping (901):
   882   Secondary to [Temporal Concept]
   623   Diabetes (Diabetes Mellitus) [Disease or Syndrome]

Phrase: who

Phrase: was on hemodialysis since 1996 .
Meta Mapping (760):
   760   Haemodialysis (Hemodialysis) [Therapeutic or Preventive Procedure]
Meta Mapping (760):
   760   Haemodialysis (Drug Administration via Hemodialysis) [Functional Concept]
Processing 00000000.tx.3: 7. 

Phrase: 7.
Processing 00000000.tx.4: Status post THA in 1987 . 

Phrase: Status post THA in 1987 .
Meta Mapping (640):
   640   Status post [Temporal Concept]
Meta Mapping (640):
   640   Status Post (Post) [Temporal Concept]
Processing 00000000.tx.5: Attending : Batch : 95601/1m70 Report Status : ADMISSION DATE : This is a 73-year-old man with squamous cell carcinoma of the lung , status post lobectomy and resection of left cervical recurrence , admitted here with fever and neutropenia . 

Phrase: Attending
Meta Mapping (1000):
  1000   Attending (Attending (provider role)) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   attending (Attending (action)) [Functional Concept]

Phrase: :

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: 95601/1m70 Report Status
Meta Mapping (861):
   861   Report status [Finding]

Phrase: :

Phrase: ADMISSION DATE
Meta Mapping (1000):
  1000   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (1000):
  1000   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: This

Phrase: is

Phrase: a 73-year-old man with squamous cell carcinoma of the lung ,
Meta Mapping (766):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Man (Male population group) [Population Group]
   666   Squamous Cell Carcinoma of the Lung (Squamous cell carcinoma of lung) [Neoplastic Process]
Meta Mapping (766):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   MAN (Homo sapiens) [Human]
   666   Squamous Cell Carcinoma of the Lung (Squamous cell carcinoma of lung) [Neoplastic Process]
Meta Mapping (766):
   570   YEAR (year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   MAN (Males) [Organism Attribute]
   666   Squamous Cell Carcinoma of the Lung (Squamous cell carcinoma of lung) [Neoplastic Process]
Meta Mapping (766):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   Man (Male population group) [Population Group]
   666   Squamous Cell Carcinoma of the Lung (Squamous cell carcinoma of lung) [Neoplastic Process]
Meta Mapping (766):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   MAN (Homo sapiens) [Human]
   666   Squamous Cell Carcinoma of the Lung (Squamous cell carcinoma of lung) [Neoplastic Process]
Meta Mapping (766):
   570   /Year (per year) [Temporal Concept]
   570   Old [Temporal Concept]
   736   MAN (Males) [Organism Attribute]
   666   Squamous Cell Carcinoma of the Lung (Squamous cell carcinoma of lung) [Neoplastic Process]

Phrase: status post lobectomy
Meta Mapping (1000):
  1000   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: resection of left cervical recurrence ,
Meta Mapping (761):
   760   resection (removal technique) [Therapeutic or Preventive Procedure]
   631   Cervical-left [Finding]
   593   Recurrence [Phenomenon or Process]
Meta Mapping (761):
   760   resection (removal technique) [Therapeutic or Preventive Procedure]
   631   Cervical-left [Finding]
   593   recurrence (Recurrent Malignant Neoplasm) [Neoplastic Process]
Meta Mapping (761):
   760   resection (removal technique) [Therapeutic or Preventive Procedure]
   631   Cervical-left [Finding]
   593   Recurrence (Recurrence (disease attribute)) [Pathologic Function]
Meta Mapping (761):
   760   Resection (Excision) [Therapeutic or Preventive Procedure]
   631   Cervical-left [Finding]
   593   Recurrence [Phenomenon or Process]
Meta Mapping (761):
   760   Resection (Excision) [Therapeutic or Preventive Procedure]
   631   Cervical-left [Finding]
   593   recurrence (Recurrent Malignant Neoplasm) [Neoplastic Process]
Meta Mapping (761):
   760   Resection (Excision) [Therapeutic or Preventive Procedure]
   631   Cervical-left [Finding]
   593   Recurrence (Recurrence (disease attribute)) [Pathologic Function]

Phrase: admitted
Meta Mapping (1000):
  1000   admitted (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admitted (Admission activity) [Health Care Activity]

Phrase: here with fever
Meta Mapping (790):
   790   FEVER (Fever) [Finding]
Meta Mapping (790):
   790   Fever (Fever symptoms (finding)) [Finding]

Phrase: and

Phrase: neutropenia .
Meta Mapping (1000):
  1000   NEUTROPENIA (Leukopenia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   NEUTROPENIA (Neutropenia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Neutropenia (Neutrophil count decreased) [Finding]
Processing 00000000.tx.6: LABORATORY DATA : The WBC was 0.9 , the ANC was 540 , platelets were 156,000 . 

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: The WBC
Meta Mapping (1000):
  1000   WBC (Leukocytes) [Cell]
Meta Mapping (1000):
  1000   % WBC (Percent in White Blood Count Differential) [Quantitative Concept]

Phrase: was

Phrase: 0.9 ,
Meta Mapping (861):
   861   0% [Finding]

Phrase: the ANC
Meta Mapping (1000):
  1000   ANC (Absolute neutrophil count) [Laboratory Procedure]

Phrase: was

Phrase: 540 ,

Phrase: platelets
Meta Mapping (1000):
  1000   Platelets (Blood Platelets) [Cell]
Meta Mapping (1000):
  1000   Platelets (Platelets Adverse Event) [Finding]

Phrase: were

Phrase: 156,000 .
Processing 00000000.tx.7: The neutropenia resolved and he was felt to be in satisfactory condition on discharge on 10/20/95 . 

Phrase: The neutropenia
Meta Mapping (1000):
  1000   NEUTROPENIA (Leukopenia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   NEUTROPENIA (Neutropenia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Neutropenia (Neutrophil count decreased) [Finding]

Phrase: resolved
Meta Mapping (1000):
  1000   Resolved (physiologic resolution) [Pathologic Function]
Meta Mapping (1000):
  1000   Resolved (Resolution) [Conceptual Entity]
Meta Mapping (1000):
  1000   Resolved [Finding]
Meta Mapping (1000):
  1000   Resolved (Resolved License) [Functional Concept]

Phrase: and

Phrase: he

Phrase: was

Phrase: felt
Meta Mapping (966):
   966 N feel (Emotions) [Mental Process]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be in satisfactory condition
Meta Mapping (722):
   770   Satisfactory (Sufficient) [Qualitative Concept]
   770 N condition (Disease) [Disease or Syndrome]
Meta Mapping (722):
   770   Satisfactory (Sufficient) [Qualitative Concept]
   770   Condition [Qualitative Concept]
Meta Mapping (722):
   770   Satisfactory (Sufficient) [Qualitative Concept]
   770   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (722):
   770   Satisfactory (Sufficient) [Qualitative Concept]
   770   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (722):
   770   Satisfactory (Satisfactory - Patient Condition Code) [Intellectual Product]
   770 N condition (Disease) [Disease or Syndrome]
Meta Mapping (722):
   770   Satisfactory (Satisfactory - Patient Condition Code) [Intellectual Product]
   770   Condition [Qualitative Concept]
Meta Mapping (722):
   770   Satisfactory (Satisfactory - Patient Condition Code) [Intellectual Product]
   770   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (722):
   770   Satisfactory (Satisfactory - Patient Condition Code) [Intellectual Product]
   770   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]

Phrase: on discharge on 10/20/95 .
Meta Mapping (722):
   753   Discharge (Body Fluid Discharge) [Body Substance]
   617 N 20/10 (6/3) [Finding]
Meta Mapping (722):
   753   Discharge (Patient Discharge) [Health Care Activity]
   617 N 20/10 (6/3) [Finding]
Meta Mapping (722):
   753   Discharge (Discharge, body substance) [Body Substance]
   617 N 20/10 (6/3) [Finding]
Processing 00000000.tx.8: 4/17/1995 12:00:00 AM 3. 

Phrase: 4/17/1995 12
Meta Mapping (812):
   812   4+ (4+ Answer to question) [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.9: Left ventricular aneurysm . 

Phrase: Left ventricular aneurysm .
Meta Mapping (1000):
  1000   Left Ventricular Aneurysm (Left ventricular aneurysm) [Disease or Syndrome]
Processing 00000000.tx.10: 4. 

Phrase: 4.
Meta Mapping (1000):
  1000   4+ (4+ Answer to question) [Finding]
Processing 00000000.tx.11: Imipenem , 500 mg. 

Phrase: Imipenem ,
Meta Mapping (1000):
  1000   IMIPENEM (Imipenem) [Antibiotic,Organic Chemical]

Phrase: 500 mg.
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.12: , intravenously , q6h. 

Phrase: , intravenously ,

Phrase: q6h.
Meta Mapping (1000):
  1000   Q6H (Every six hours) [Temporal Concept]
Processing 00000000.tx.13: Lungs : A perisplenic effusion was noted which appeared to communicate with the lesser sac collection . 

Phrase: Lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: A perisplenic effusion
Meta Mapping (888):
   694   Perisplenic [Spatial Concept]
   861   Effusion (effusion) [Pathologic Function]
Meta Mapping (888):
   694   Perisplenic [Spatial Concept]
   861   Effusion (Effusion (substance)) [Body Substance]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: which

Phrase: appeared
Meta Mapping (966):
   966   APPEAR (Appearance) [Qualitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: communicate with the lesser sac collection .
Meta Mapping (725):
   753   communicate (Does communicate) [Finding]
   790   Lesser sac (Omental Bursa) [Body Space or Junction]
   753   Collection (Collection (action)) [Functional Concept]
Meta Mapping (725):
   753   communicate (Does communicate) [Finding]
   790   Lesser sac (Omental Bursa) [Body Space or Junction]
   753   Collection (Item Collection) [Idea or Concept]
Processing 00000000.tx.14: The patient was admitted , placed on intravenous fluids . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted
Meta Mapping (1000):
  1000   admitted (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admitted (Admission activity) [Health Care Activity]

Phrase: ,

Phrase: placed on intravenous fluids .
Meta Mapping (749):
   737   Place [Spatial Concept]
   799   Intravenous Fluid (Intravenous fluid) [Substance]
Meta Mapping (749):
   737   Place (Place - dosing instruction imperative) [Functional Concept]
   799   Intravenous Fluid (Intravenous fluid) [Substance]
Meta Mapping (749):
   737   Place (put - instruction imperative) [Activity]
   799   Intravenous Fluid (Intravenous fluid) [Substance]
Processing 00000000.tx.15: He was continued on his imipenem , intravenously . 

Phrase: He

Phrase: was

Phrase: continued on his imipenem ,
Meta Mapping (708):
   770   Continued (Continuous) [Idea or Concept]
   770   IMIPENEM (Imipenem) [Antibiotic,Organic Chemical]

Phrase: intravenously .
Processing 00000000.tx.16: 5. 

Phrase: 5.
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]
Processing 00000000.tx.17: Carafate , one gram , po or per nasogastric tube , q.i.d. 

Phrase: Carafate ,
Meta Mapping (1000):
  1000   Carafate [Organic Chemical,Pharmacologic Substance]

Phrase: one gram ,
Meta Mapping (888):
   694   ONE (One) [Quantitative Concept]
   861   GRAM (gram) [Quantitative Concept]

Phrase: po
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: or per nasogastric tube ,
Meta Mapping (833):
   833   Nasogastric Tube (Nasogastric tube) [Medical Device]
Meta Mapping (833):
   833   Nasogastric tube (Nasogastric tube procedures) [Therapeutic or Preventive Procedure]

Phrase: q.i.d.
Meta Mapping (901):
   901   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: , Cardizem , 30 mg. 

Phrase: , Cardizem ,
Meta Mapping (1000):
  1000   Cardizem [Organic Chemical,Pharmacologic Substance]

Phrase: 30 mg.
Meta Mapping (888):
   694   30% [Finding]
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (888):
   694   30% [Finding]
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (888):
   694   30% [Finding]
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (888):
   694   30% [Finding]
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.19: , po , q6h , digoxin , 0.25 mg. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: q6h ,
Meta Mapping (1000):
  1000   Q6H (Every six hours) [Temporal Concept]

Phrase: digoxin ,
Meta Mapping (1000):
  1000   DIGOXIN (Digoxin) [Organic Chemical,Pharmacologic Substance]

Phrase: 0.25 mg.
Meta Mapping (802):
   660   0% [Finding]
   827   MG (Mongolia) [Geographic Area]
Meta Mapping (802):
   660   0% [Finding]
   827   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (802):
   660   0% [Finding]
   827   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (802):
   660   0% [Finding]
   827   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.20: , po or intravenously , qD , fluconazole , 200 mg. 

Phrase: , po
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: or

Phrase: intravenously ,

Phrase: qD ,
Meta Mapping (1000):
  1000   QD (Daily) [Temporal Concept]

Phrase: fluconazole ,
Meta Mapping (1000):
  1000   FLUCONAZOLE (Fluconazole) [Organic Chemical,Pharmacologic Substance]

Phrase: 200 mg.
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.21: , qD , for five more days , after transfer , for a total of a 14 day course , total parenteral nutrition to meet the patient &apos;s nutritional needs . 

Phrase: , qD ,
Meta Mapping (1000):
  1000   QD (Daily) [Temporal Concept]

Phrase: for five more days ,
Meta Mapping (896):
   896   FIVE-DAY (Five-Day Report) [Intellectual Product]

Phrase: after

Phrase: transfer ,
Meta Mapping (1000):
  1000   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (1000):
  1000   Transfer (Transfer Technique) [Functional Concept]

Phrase: for a total of a 14 day course ,
Meta Mapping (645):
   744   % total (% of total) [Quantitative Concept]
   578   /day (Daily) [Temporal Concept]
   578   Course [Temporal Concept]
Meta Mapping (645):
   744   % total (% of total) [Quantitative Concept]
   578   DAY (day) [Temporal Concept]
   578   Course [Temporal Concept]
Meta Mapping (645):
   744   % total (% of total) [Quantitative Concept]
   578   /day (per day) [Temporal Concept]
   578   Course [Temporal Concept]
Meta Mapping (645):
   744   Total [Qualitative Concept]
   578   /day (Daily) [Temporal Concept]
   578   Course [Temporal Concept]
Meta Mapping (645):
   744   Total [Qualitative Concept]
   578   DAY (day) [Temporal Concept]
   578   Course [Temporal Concept]
Meta Mapping (645):
   744   Total [Qualitative Concept]
   578   /day (per day) [Temporal Concept]
   578   Course [Temporal Concept]

Phrase: total parenteral nutrition
Meta Mapping (1000):
  1000   Parenteral Nutrition, Total [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Total Parenteral Nutrition (infusion of total parenteral nutrition) [Therapeutic or Preventive Procedure]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: meet
Meta Mapping (1000):
  1000   Meet (Fulfill) [Phenomenon or Process]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s nutritional needs .
Meta Mapping (851):
   660   /s (per second) [Quantitative Concept]
   660   Nutritional [Qualitative Concept]
   827   Needs [Qualitative Concept]
Meta Mapping (851):
   660   /s (per second) [Quantitative Concept]
   660   Nutritional [Qualitative Concept]
   827   needs (Patient need for (contextual qualifier)) [Functional Concept]
Meta Mapping (851):
   660   /s (per second) [Quantitative Concept]
   660   Nutritional (Nutritional:-:Point in time:^Patient:-) [Clinical Attribute]
   827   Needs [Qualitative Concept]
Meta Mapping (851):
   660   /s (per second) [Quantitative Concept]
   660   Nutritional (Nutritional:-:Point in time:^Patient:-) [Clinical Attribute]
   827   needs (Patient need for (contextual qualifier)) [Functional Concept]
Meta Mapping (851):
   660   S' (S prime) [Clinical Attribute]
   660   Nutritional [Qualitative Concept]
   827   Needs [Qualitative Concept]
Meta Mapping (851):
   660   S' (S prime) [Clinical Attribute]
   660   Nutritional [Qualitative Concept]
   827   needs (Patient need for (contextual qualifier)) [Functional Concept]
Meta Mapping (851):
   660   S' (S prime) [Clinical Attribute]
   660   Nutritional (Nutritional:-:Point in time:^Patient:-) [Clinical Attribute]
   827   Needs [Qualitative Concept]
Meta Mapping (851):
   660   S' (S prime) [Clinical Attribute]
   660   Nutritional (Nutritional:-:Point in time:^Patient:-) [Clinical Attribute]
   827   needs (Patient need for (contextual qualifier)) [Functional Concept]
Processing 00000000.tx.22: STAT discharge summary . 

Phrase: STAT discharge summary .
Meta Mapping (901):
   660   STAT (Stat (do immediately)) [Temporal Concept]
   901   Discharge summary [Intellectual Product]
Meta Mapping (901):
   660   STAT (Stat (do immediately)) [Temporal Concept]
   901   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Processing 00000000.tx.23: 908556207 RULE OUT MYOCARDIAL INFARCTION . 

Phrase: 908556207 RULE OUT MYOCARDIAL INFARCTION .
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Removed) [Qualitative Concept]
   840 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Removed) [Qualitative Concept]
   840 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Removed) [Qualitative Concept]
   840   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (798):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Removed) [Qualitative Concept]
   840   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Out (direction)) [Spatial Concept]
   840 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Out (direction)) [Spatial Concept]
   840 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Out (direction)) [Spatial Concept]
   840   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Out (direction)) [Spatial Concept]
   840   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Removed) [Qualitative Concept]
   840 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Removed) [Qualitative Concept]
   840 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Removed) [Qualitative Concept]
   840   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (798):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Removed) [Qualitative Concept]
   840   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Out (direction)) [Spatial Concept]
   840   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Removed) [Qualitative Concept]
   840 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Removed) [Qualitative Concept]
   840 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Removed) [Qualitative Concept]
   840   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (798):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Removed) [Qualitative Concept]
   840   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Processing 00000000.tx.24: 01/21/98 ASSOCIATED DIAGNOSIS : None . 

Phrase: 01/21/98 ASSOCIATED DIAGNOSIS
Meta Mapping (728):
   637   Associated (Associated with) [Qualitative Concept]
   804   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (728):
   637   Associated (Associated with) [Qualitative Concept]
   804   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (728):
   637   Associated (Associated with) [Qualitative Concept]
   804   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: :

Phrase: None .
Processing 00000000.tx.25: PAST MEDICAL HISTORY : 8. 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: 8.
Processing 00000000.tx.26: Status post excision of right thigh AV graft . 

Phrase: Status post excision of right thigh AV graft .
Meta Mapping (748):
   604   Status post [Temporal Concept]
   744   excision (removal technique) [Therapeutic or Preventive Procedure]
   604   Right Thigh (Structure of right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   604   Status post [Temporal Concept]
   744   excision (removal technique) [Therapeutic or Preventive Procedure]
   604   Right thigh (Entire right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   604   Status post [Temporal Concept]
   744   EXCISION (Excision) [Therapeutic or Preventive Procedure]
   604   Right Thigh (Structure of right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   604   Status post [Temporal Concept]
   744   EXCISION (Excision) [Therapeutic or Preventive Procedure]
   604   Right thigh (Entire right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   604   Status Post (Post) [Temporal Concept]
   744   excision (removal technique) [Therapeutic or Preventive Procedure]
   604   Right Thigh (Structure of right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   604   Status Post (Post) [Temporal Concept]
   744   excision (removal technique) [Therapeutic or Preventive Procedure]
   604   Right thigh (Entire right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   604   Status Post (Post) [Temporal Concept]
   744   EXCISION (Excision) [Therapeutic or Preventive Procedure]
   604   Right Thigh (Structure of right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   604   Status Post (Post) [Temporal Concept]
   744   EXCISION (Excision) [Therapeutic or Preventive Procedure]
   604   Right thigh (Entire right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   578   Status [Qualitative Concept]
   770   post excision [Temporal Concept]
   604   Right Thigh (Structure of right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Meta Mapping (748):
   578   Status [Qualitative Concept]
   770   post excision [Temporal Concept]
   604   Right thigh (Entire right thigh) [Body Part, Organ, or Organ Component]
   604   av graft (Arteriovenous graft) [Acquired Abnormality]
Processing 00000000.tx.27: 10. 

Phrase: 10.
Meta Mapping (1000):
  1000   10% [Finding]
Processing 00000000.tx.28: Status post carotid endarterectomy . 

Phrase: Status post carotid endarterectomy .
Meta Mapping (1000):
  1000   CAROTID ENDARTERECTOMY (Carotid Endarterectomy) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.29: 14. 

Phrase: 14.
Processing 00000000.tx.30: History of depression and anxiety . 

Phrase: History of depression
Meta Mapping (1000):
  1000   History of depression (H/O: depression) [Finding]

Phrase: and

Phrase: anxiety .
Meta Mapping (1000):
  1000   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (1000):
  1000   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (1000):
  1000   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Processing 00000000.tx.31: Skin : HEENT : Abdomen : The heparin was continued empirically for 48 hours . 

Phrase: Skin
Meta Mapping (1000):
  1000   Skin (Skin Specimen) [Body Substance]
Meta Mapping (1000):
  1000   SKIN (Skin) [Body System]
Meta Mapping (1000):
  1000   Skin (Entire skin) [Body System]

Phrase: :

Phrase: HEENT
Meta Mapping (1000):
  1000   HEENT [Body Location or Region]

Phrase: :

Phrase: Abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: The heparin
Meta Mapping (1000):
  1000   HEPARIN (Heparin) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   HEPARIN (heparin, porcine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: was

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: empirically for 48 hours .
Meta Mapping (833):
   833   48 hours (48 hour time frame) [Temporal Concept]
Meta Mapping (833):
   833   48 Hours [Temporal Concept]
Processing 00000000.tx.32: Based on this , she was managed conservatively . 

Phrase: Based on this ,
Meta Mapping (790):
   790   Based (Basis - conceptual entity) [Functional Concept]
Meta Mapping (790):
   790   Based (Base - General Qualifier) [Idea or Concept]

Phrase: she

Phrase: was

Phrase: managed
Meta Mapping (1000):
  1000   Managed (Management procedure) [Occupational Activity]

Phrase: conservatively .
Processing 00000000.tx.33: Isordil 30 mg. 

Phrase: Isordil 30 mg.
Meta Mapping (981):
   981   Isosorbide Dinitrate 30 MG [Clinical Drug]
Processing 00000000.tx.34: PO t.i.d. 

Phrase: PO t.i.d.
Meta Mapping (824):
   812   PO (Portugal) [Geographic Area]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (824):
   812   PO (Oral) [Spatial Concept]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.35: Captopril 12.5 mg. 

Phrase: Captopril 12.5 mg.
Meta Mapping (1000):
  1000   Captopril 12.5 MG [Clinical Drug]
Processing 00000000.tx.36: PO t.i.d. 

Phrase: PO t.i.d.
Meta Mapping (824):
   812   PO (Portugal) [Geographic Area]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (824):
   812   PO (Oral) [Spatial Concept]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.37: Ritalin 5 mg. 

Phrase: Ritalin 5 mg.
Meta Mapping (981):
   981   Methylphenidate Hydrochloride 5 MG [Clinical Drug]
Processing 00000000.tx.38: PO q a.m. 

Phrase: PO q a.m.
Meta Mapping (791):
   812   PO (Portugal) [Geographic Area]
   645   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (791):
   812   PO (Portugal) [Geographic Area]
   645   M+ (M+ (tumor staging)) [Intellectual Product]
Meta Mapping (791):
   812   PO (Oral) [Spatial Concept]
   645   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (791):
   812   PO (Oral) [Spatial Concept]
   645   M+ (M+ (tumor staging)) [Intellectual Product]
Processing 00000000.tx.39: TD :

Phrase: TD
Meta Mapping (1000):
  1000   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (1000):
  1000   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :
Processing 00000000.tx.1: 390115 ADMISSION DATE : Ms. 

Phrase: 390115 ADMISSION DATE
Meta Mapping (901):
   901   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (901):
   901   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: Ms.
Meta Mapping (1000):
  1000   MS (5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   Ms. (Ms. - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   MS (MTR wt Allele) [Gene or Genome]
Processing 00000000.tx.2: Lenkpruskihkooglekih is a 63-year-old lady with a history of frequent premature ventricular contractions and infrequent short runs of non-sustained ventricular tachycardia ( one four-beat run ) in 1991 , for which several antiarrhythmic agents including Propranolol , Quinidine , Procainamide , Tenormin , Norpace , Corgard , and Flecainide were used , but were stopped because of intolerance . 

Phrase: Lenkpruskihkooglekih

Phrase: is

Phrase: a 63-year-old lady with a history of frequent premature ventricular contractions
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History [Occupation or Discipline]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History [Occupation or Discipline]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   history (Historical aspects qualifier) [Functional Concept]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   history (Historical aspects qualifier) [Functional Concept]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History, NOS (History of present illness) [Organism Attribute]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History, NOS (History of present illness) [Organism Attribute]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Medical History) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Medical History) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Concept History) [Conceptual Entity]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Concept History) [Conceptual Entity]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (History of previous events) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (History of previous events) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History [Occupation or Discipline]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History [Occupation or Discipline]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   history (Historical aspects qualifier) [Functional Concept]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   history (Historical aspects qualifier) [Functional Concept]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History, NOS (History of present illness) [Organism Attribute]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History, NOS (History of present illness) [Organism Attribute]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Medical History) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Medical History) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Concept History) [Conceptual Entity]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (Concept History) [Conceptual Entity]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (History of previous events) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   PREMATURE VENTRICULAR CONTRACTIONS (Premature ventricular contractions) [Pathologic Function]
Meta Mapping (495):
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   569   History (History of previous events) [Finding]
   569   Frequent (Frequently) [Temporal Concept]
   599   Premature ventricular contractions (Premature ventricular contractions:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG) [Clinical Attribute]

Phrase: and

Phrase: infrequent short runs of non-sustained ventricular tachycardia
Meta Mapping (775):
   578   Infrequent [Temporal Concept]
   578   short (Shortened) [Qualitative Concept]
   744 N Runs (Does run (finding)) [Finding]
   666   NON-SUSTAINED VENTRICULAR TACHYCARDIA (Non-Sustained Ventricular Tachycardia by ECG Finding) [Disease or Syndrome]
Meta Mapping (775):
   578   Infrequent [Temporal Concept]
   578   Short [Quantitative Concept]
   744 N Runs (Does run (finding)) [Finding]
   666   NON-SUSTAINED VENTRICULAR TACHYCARDIA (Non-Sustained Ventricular Tachycardia by ECG Finding) [Disease or Syndrome]
Meta Mapping (775):
   578   Infrequent [Temporal Concept]
   578   Short (Short Value) [Quantitative Concept]
   744 N Runs (Does run (finding)) [Finding]
   666   NON-SUSTAINED VENTRICULAR TACHYCARDIA (Non-Sustained Ventricular Tachycardia by ECG Finding) [Disease or Syndrome]

Phrase: ( one four-beat run ) in 1991 ,
Meta Mapping (756):
   799   ONE (One) [Quantitative Concept]
   799   Four [Quantitative Concept]
   827   RUN-IN (Run-in Period) [Temporal Concept]

Phrase: for which several antiarrhythmic agents
Meta Mapping (890):
   660   Several (Numerous) [Quantitative Concept]
   884   Antiarrhythmic Agent (Anti-Arrhythmia Agents) [Pharmacologic Substance]
Meta Mapping (890):
   660   Several (Numerous) [Quantitative Concept]
   884   anti arrhythmic agent (Cardiac depressant drug, NOS) [Pharmacologic Substance]
Meta Mapping (890):
   660   Several [Quantitative Concept]
   884   Antiarrhythmic Agent (Anti-Arrhythmia Agents) [Pharmacologic Substance]
Meta Mapping (890):
   660   Several [Quantitative Concept]
   884   anti arrhythmic agent (Cardiac depressant drug, NOS) [Pharmacologic Substance]

Phrase: including
Meta Mapping (1000):
  1000   Including (Including (qualifier)) [Functional Concept]

Phrase: Propranolol ,
Meta Mapping (1000):
  1000   PROPRANOLOL (Propranolol) [Organic Chemical,Pharmacologic Substance]

Phrase: Quinidine ,
Meta Mapping (1000):
  1000   QUINIDINE (Quinidine) [Organic Chemical,Pharmacologic Substance]

Phrase: Procainamide ,
Meta Mapping (1000):
  1000   PROCAINAMIDE (Procainamide) [Organic Chemical,Pharmacologic Substance]

Phrase: Tenormin ,
Meta Mapping (1000):
  1000   Tenormin [Organic Chemical,Pharmacologic Substance]

Phrase: Norpace ,
Meta Mapping (1000):
  1000   Norpace [Organic Chemical,Pharmacologic Substance]

Phrase: Corgard ,
Meta Mapping (1000):
  1000   Corgard [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: Flecainide
Meta Mapping (1000):
  1000   FLECAINIDE (Flecainide) [Organic Chemical,Pharmacologic Substance]

Phrase: were

Phrase: used
Meta Mapping (1000):
  1000   used (Used by) [Finding]

Phrase: ,

Phrase: but

Phrase: were

Phrase: stopped because of intolerance .
Meta Mapping (708):
   770   stopped (To be stopped) [Qualitative Concept]
   770   Intolerance (intolerance function) [Organism Function]
Meta Mapping (708):
   770   stopped (To be stopped) [Qualitative Concept]
   770   intolerance (intolerance to substance) [Finding]
Meta Mapping (708):
   770   stopped (To be stopped) [Qualitative Concept]
   770   INTOLERANCE (Intolerance - biological effect of chemicals) [Organism Attribute]
Processing 00000000.tx.3: PAST MEDICAL HISTORY : PHYSICAL EXAMINATION : There was no evidence of left ventricular hypertrophy or asymmetric septal hypertrophy , which had been an issue that had been raised on an echocardiogram in Ownra Cin , New Mexico on 12/06/96 . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: There

Phrase: was

Phrase: no evidence of left ventricular hypertrophy
Meta Mapping (780):
   753   Evidence [Idea or Concept]
   666 N Hypertrophy, Left Ventricular (Left Ventricular Hypertrophy) [Disease or Syndrome]
Meta Mapping (780):
   753   Evidence [Idea or Concept]
   666   Left ventricular hypertrophy (Left ventricular hypertrophy:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]

Phrase: or

Phrase: asymmetric septal hypertrophy ,
Meta Mapping (1000):
  1000 N ASYMMETRIC SEPTAL HYPERTROPHY (Asymmetric Septal Hypertrophy) [Disease or Syndrome]

Phrase: which

Phrase: had

Phrase: been

Phrase: an issue
Meta Mapping (1000):
  1000   Issue (Problem) [Finding]
Meta Mapping (1000):
  1000   Issue (Issue (document)) [Intellectual Product]

Phrase: that

Phrase: had

Phrase: been

Phrase: raised on an echocardiogram
Meta Mapping (708):
   770   Raised [Qualitative Concept]
   770   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (708):
   770   Raised [Qualitative Concept]
   770   Echocardiogram (Echocardiogram (image)) [Intellectual Product]

Phrase: in Ownra Cin ,

Phrase: New Mexico on 12/06/96 .
Meta Mapping (790):
   790   New Mexico [Geographic Area]
Processing 00000000.tx.4: PAST SURGICAL HISTORY : The patient expired at 12:30 a.m. on the morning of 03/17/00 . 

Phrase: PAST SURGICAL HISTORY
Meta Mapping (1000):
  1000   Past surgical history (H/O: surgery) [Finding]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: expired at 12
Meta Mapping (790):
   790   EXPIRED (Cessation of life) [Organism Function]
Meta Mapping (790):
   790   Expired (Expiration, function) [Organ or Tissue Function]
Meta Mapping (790):
   790   Expired (Expiration) [Idea or Concept]

Phrase: :

Phrase: 30 a.m.
Meta Mapping (802):
   660   30% [Finding]
   827   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (802):
   660   30% [Finding]
   827   M+ (M+ (tumor staging)) [Intellectual Product]

Phrase: on the morning of 03/17/00 .
Meta Mapping (748):
   748   Morning [Temporal Concept]
Processing 00000000.tx.5: 03/16/00 Unsigned PRINCIPAL DIAGNOSIS : ASSOCIATED DIAGNOSIS : 1. 

Phrase: 03/16/00 Unsigned PRINCIPAL DIAGNOSIS
Meta Mapping (827):
   827   Principal Diagnosis (Principal diagnosis) [Qualitative Concept]
Meta Mapping (827):
   827   Principal Diagnosis (Principal Diagnosis:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: ASSOCIATED DIAGNOSIS
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: :

Phrase: 1.
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]
Processing 00000000.tx.6: Unstable angina pectoris . 

Phrase: Unstable angina pectoris .
Meta Mapping (1000):
  1000   Angina Pectoris, Unstable (Angina, Unstable) [Disease or Syndrome]
Processing 00000000.tx.7: In 05/96 , the patient had a cardiac catheterization that revealed a moderate right coronary artery ostial lesion , severe lesion at the ostial PLV , 50-60% circumflex lesion , 40% proximal left anterior descending , and severe proximal D1 . 

Phrase: In 05/96 ,

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: a cardiac catheterization
Meta Mapping (1000):
  1000   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]

Phrase: that

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a moderate right coronary artery ostial lesion ,
Meta Mapping (865):
   632   Moderate (Moderate (severity modifier)) [Qualitative Concept]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion [Finding]
Meta Mapping (865):
   632   Moderate (Moderate (severity modifier)) [Qualitative Concept]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]
Meta Mapping (865):
   632   MODERATE (Moderation) [Qualitative Concept]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion [Finding]
Meta Mapping (865):
   632   MODERATE (Moderation) [Qualitative Concept]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]
Meta Mapping (865):
   632   Moderate (Moderate Extremity Pain) [Intellectual Product]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion [Finding]
Meta Mapping (865):
   632   Moderate (Moderate Extremity Pain) [Intellectual Product]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]
Meta Mapping (865):
   632   Moderate (Borg Category-Ratio 10 Perceived Exertion Score 3) [Intellectual Product]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion [Finding]
Meta Mapping (865):
   632   Moderate (Borg Category-Ratio 10 Perceived Exertion Score 3) [Intellectual Product]
   698   Right coronary arterial ostium (Ostium of right coronary artery) [Body Space or Junction]
   799   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]

Phrase: severe lesion at the ostial PLV ,
Meta Mapping (698):
   790   Severe Lesion (High Grade Lesion) [Finding]
   514   Ostium [Body Space or Junction]

Phrase: 50-60% circumflex lesion ,
Meta Mapping (833):
   645   50% [Finding]
   645   60% [Finding]
   645   Circumflex [Spatial Concept]
   812   Lesion [Finding]
Meta Mapping (833):
   645   50% [Finding]
   645   60% [Finding]
   645   Circumflex [Spatial Concept]
   812   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]
Meta Mapping (833):
   645   <50 [Finding]
   645   60% [Finding]
   645   Circumflex [Spatial Concept]
   812   Lesion [Finding]
Meta Mapping (833):
   645   <50 [Finding]
   645   60% [Finding]
   645   Circumflex [Spatial Concept]
   812   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]

Phrase: 40% proximal left anterior descending ,
Meta Mapping (840):
   637   /40 [Temporal Concept]
   637   PROXIMAL (Proximal) [Spatial Concept]
   673   Left anterior [Spatial Concept]
   804   Descending [Qualitative Concept]
Meta Mapping (840):
   637   /40 [Temporal Concept]
   637   PROXIMAL (Proximal) [Spatial Concept]
   673   Left anterior [Spatial Concept]
   804   Descending (Sequencing - Descending) [Functional Concept]
Meta Mapping (840):
   637   40% [Quantitative Concept]
   637   PROXIMAL (Proximal) [Spatial Concept]
   673   Left anterior [Spatial Concept]
   804   Descending [Qualitative Concept]
Meta Mapping (840):
   637   40% [Quantitative Concept]
   637   PROXIMAL (Proximal) [Spatial Concept]
   673   Left anterior [Spatial Concept]
   804   Descending (Sequencing - Descending) [Functional Concept]

Phrase: and

Phrase: severe proximal D1 .
Meta Mapping (851):
   660   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   660   PROXIMAL (Proximal) [Spatial Concept]
   827   D1 (LMOD1 gene) [Gene or Genome]
Meta Mapping (851):
   660   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   660   PROXIMAL (Proximal) [Spatial Concept]
   827   D1 (BBS9 wt Allele) [Gene or Genome]
Meta Mapping (851):
   660   Severe (Severe Extremity Pain) [Intellectual Product]
   660   PROXIMAL (Proximal) [Spatial Concept]
   827   D1 (LMOD1 gene) [Gene or Genome]
Meta Mapping (851):
   660   Severe (Severe Extremity Pain) [Intellectual Product]
   660   PROXIMAL (Proximal) [Spatial Concept]
   827   D1 (BBS9 wt Allele) [Gene or Genome]
Meta Mapping (851):
   660   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   660   PROXIMAL (Proximal) [Spatial Concept]
   827   D1 (LMOD1 gene) [Gene or Genome]
Meta Mapping (851):
   660   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   660   PROXIMAL (Proximal) [Spatial Concept]
   827   D1 (BBS9 wt Allele) [Gene or Genome]
Processing 00000000.tx.8: HOSPITAL COURSE : The patient received 3 units of packed red blood cells . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: received
Meta Mapping (1000):
  1000   RECEIVED (Receive) [Qualitative Concept]

Phrase: 3 units of packed red blood cells .
Meta Mapping (848):
   581   <3 (<3 (qualifier value)) [Quantitative Concept]
   879   Packed red blood cells units (Packed erythrocytes units) [Quantitative Concept]
Meta Mapping (848):
   581   3+ (3+ Score) [Quantitative Concept]
   879   Packed red blood cells units (Packed erythrocytes units) [Quantitative Concept]
Meta Mapping (848):
   581   3+ (3+ Score, WHO) [Classification]
   879   Packed red blood cells units (Packed erythrocytes units) [Quantitative Concept]
Meta Mapping (848):
   581   3+ (3+ Answer to Question) [Finding]
   879   Packed red blood cells units (Packed erythrocytes units) [Quantitative Concept]
Processing 00000000.tx.9: She received 1 unit of normal saline . 

Phrase: She

Phrase: received
Meta Mapping (1000):
  1000   RECEIVED (Receive) [Qualitative Concept]

Phrase: 1 unit of normal saline .
Meta Mapping (752):
   593   1+ (1+ Score) [Quantitative Concept]
   760   Unit [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score) [Quantitative Concept]
   760   Unit (Unit of Measure) [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score) [Quantitative Concept]
   760   Unit (Storage Unit) [Manufactured Object]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score) [Quantitative Concept]
   760   Unit (Enzyme Unit) [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score) [Quantitative Concept]
   760   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score, WHO) [Classification]
   760   Unit [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score, WHO) [Classification]
   760   Unit (Unit of Measure) [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score, WHO) [Classification]
   760   Unit (Storage Unit) [Manufactured Object]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score, WHO) [Classification]
   760   Unit (Enzyme Unit) [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ (1+ Score, WHO) [Classification]
   760   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ [Finding]
   760   Unit [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ [Finding]
   760   Unit (Unit of Measure) [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ [Finding]
   760   Unit (Storage Unit) [Manufactured Object]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ [Finding]
   760   Unit (Enzyme Unit) [Quantitative Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (752):
   593   1+ [Finding]
   760   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
   640   Normal saline [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.10: Postoperatively , the patient was taken to the Surgical Intensive Care Unit . 

Phrase: Postoperatively ,

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: taken to the Surgical Intensive Care Unit .
Meta Mapping (808):
   748   Taken [Conceptual Entity]
   853   Surgical intensive care unit [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.11: Discharge follow up will be with Dr. 

Phrase: Discharge
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: follow up
Meta Mapping (1000):
  1000   Follow-up (Follow-up status) [Finding]
Meta Mapping (1000):
  1000   Follow Up (follow-up) [Health Care Activity]
Meta Mapping (1000):
  1000   Follow-Up (Follow-Up Report) [Intellectual Product]
Meta Mapping (1000):
  1000   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]

Phrase: will

Phrase: be with Dr.
Meta Mapping (790):
   790   DR (Dominican Republic) [Geographic Area]
Meta Mapping (790):
   790   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (790):
   790   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (790):
   790   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (790):
   790   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.12: Burgeshuff &apos;s service ( 438-9748 ) .

Phrase: Burgeshuff &apos

Phrase: ;s service
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Service (Services) [Occupational Activity]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Service (Software Service) [Manufactured Object]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Service (Services) [Occupational Activity]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Service (Software Service) [Manufactured Object]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   service (ActInformationPrivacyReason <service>) [Idea or Concept]

Phrase: ( 438-9748

Phrase: ) .
Processing 00000000.tx.1: 01/16/1991 12:00:00 AM The carotids were one plus with bruits bilaterally . 

Phrase: 01/16/1991 12

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: The carotids
Meta Mapping (1000):
  1000   carotids (carotid) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: one plus with bruits bilaterally .
Meta Mapping (696):
   593   ONE (One) [Quantitative Concept]
   760   Plus (In addition to) [Functional Concept]
   593   bruits (Bruit) [Finding]
Processing 00000000.tx.2: These changes in his medical regiment seemed to significantly improve his angina . 

Phrase: These changes in his medical regiment
Meta Mapping (672):
   753   changes (Changing) [Functional Concept]
   586   Medical (Medical service) [Health Care Activity]
Meta Mapping (672):
   753   changes (Changing) [Functional Concept]
   586   Medical [Functional Concept]
Meta Mapping (672):
   753   changes (Changed status) [Quantitative Concept]
   586   Medical (Medical service) [Health Care Activity]
Meta Mapping (672):
   753   changes (Changed status) [Quantitative Concept]
   586   Medical [Functional Concept]

Phrase: seemed

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: significantly

Phrase: improve

Phrase: his angina .
Meta Mapping (1000):
  1000   ANGINA (Angina Pectoris) [Finding]
Processing 00000000.tx.3: We were very reluctant to recommend further invasive interventions in view of his dissuse atherosclerosis and renal failure , which make him a very high risk candidate for further PTCAs . 

Phrase: We

Phrase: were

Phrase: very reluctant
Meta Mapping (888):
   694   Very [Qualitative Concept]
   861   Reluctant (Reluctance) [Mental Process]
Meta Mapping (888):
   694   Very (Very Much) [Qualitative Concept]
   861   Reluctant (Reluctance) [Mental Process]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: recommend
Meta Mapping (1000):
  1000   recommend (Recommendation) [Idea or Concept]

Phrase: further invasive interventions in view of his dissuse atherosclerosis
Meta Mapping (663):
   575   Further [Spatial Concept]
   748   Invasive Intervention (Open approach) [Spatial Concept]
   575   View [Spatial Concept]
   575   ATHEROSCLEROSIS (Arteriosclerosis) [Disease or Syndrome]
Meta Mapping (663):
   575   Further [Spatial Concept]
   748   Invasive Intervention (Open approach) [Spatial Concept]
   575   View [Spatial Concept]
   575   ATHEROSCLEROSIS (Atherosclerosis) [Disease or Syndrome]

Phrase: and

Phrase: renal failure ,
Meta Mapping (1000):
  1000   Failure, Renal (Kidney Failure) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Renal failure (Renal Failure Adverse Event) [Pathologic Function]

Phrase: which

Phrase: make
Meta Mapping (1000):
  1000   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: him a very high risk candidate for further PTCAs .
Meta Mapping (499):
   598   Very high [Finding]
   575   Risk [Idea or Concept]
   575   Further [Spatial Concept]
   542   PTCA (Percutaneous Transluminal Coronary Angioplasty) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: He was discharged in stable condition on the following medications : D : 86965002 Hypoglycemia leading to question seizure , non ST-elevation MI , GI bleed , anemia . 

Phrase: He

Phrase: was

Phrase: discharged in stable condition
Meta Mapping (783):
   770   Discharged (Patient Discharge) [Health Care Activity]
   833   Stable condition (Stable Disease) [Finding]
Meta Mapping (783):
   770   Discharged (Patient Discharge) [Health Care Activity]
   833   Stable condition (Stable chronic Graft vs Host Disease) [Finding]

Phrase: on the following medications
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: D
Meta Mapping (1000):
  1000   D NOS (Blood group antigen D) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (1000):
  1000   /d (Daily) [Temporal Concept]

Phrase: :

Phrase: 86965002 Hypoglycemia
Meta Mapping (861):
   861   HYPOGLYCEMIA (Hypoglycemia) [Disease or Syndrome]

Phrase: leading
Meta Mapping (1000):
  1000   Leading (Before) [Temporal Concept]
Meta Mapping (1000):
  1000   Leading [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: question
Meta Mapping (1000):
  1000   Question (Question (inquiry)) [Intellectual Product]

Phrase: seizure ,
Meta Mapping (1000):
  1000   SEIZURE (Seizures) [Sign or Symptom]
Meta Mapping (1000):
  1000   Seizure (Seizure Adverse Event) [Finding]

Phrase: non ST-elevation MI ,
Meta Mapping (861):
   645   Non (Negation) [Functional Concept]
   694 N ST ELEVATION (ST segment elevation (finding)) [Finding]
   812   MI (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]

Phrase: GI bleed ,
Meta Mapping (888):
   694   Gi (GNAI1 wt Allele) [Gene or Genome]
   861 N bleed (Hemorrhage) [Pathologic Function]
Meta Mapping (888):
   694   GI (Digestive System Findings Domain) [Intellectual Product]
   861 N bleed (Hemorrhage) [Pathologic Function]
Meta Mapping (888):
   694   GI (Gastrointestinal studies and measurements) [Intellectual Product]
   861 N bleed (Hemorrhage) [Pathologic Function]

Phrase: anemia .
Meta Mapping (1000):
  1000 N ANEMIA (Anemia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Anemia (Genus Anemia) [Plant]
Processing 00000000.tx.5: Question seizure / loss of consciousness with hypoglycemia , fingerstick blood sugar of 24 . 

Phrase: Question seizure / loss of consciousness
Meta Mapping (875):
   593   Question (Question (inquiry)) [Intellectual Product]
   593   SEIZURE (Seizures) [Sign or Symptom]
   862   LOSS OF CONSCIOUSNESS (Unconscious State) [Finding]
Meta Mapping (875):
   593   Question (Question (inquiry)) [Intellectual Product]
   593   Seizure (Seizure Adverse Event) [Finding]
   862   LOSS OF CONSCIOUSNESS (Unconscious State) [Finding]

Phrase: with hypoglycemia ,
Meta Mapping (1000):
  1000   HYPOGLYCEMIA (Hypoglycemia) [Disease or Syndrome]

Phrase: fingerstick blood sugar of 24 .
Meta Mapping (751):
   593   Finger Stick (Finger-prick sampling (procedure)) [Diagnostic Procedure]
   806   Blood Sugar (Blood Glucose) [Organic Chemical]
Meta Mapping (751):
   593   Finger Stick (Finger-prick sampling (procedure)) [Diagnostic Procedure]
   806   Blood Sugar (Blood glucose measurement) [Laboratory Procedure]
Processing 00000000.tx.6: An 82-year-old male with a history of CAD status post CABG , CVA status post CEA , diabetes mellitus , hypertension , GI bleeding , CHF with an EF of 35% , left lower lobe pneumonia on admission on 01/22/04 - 01/31/2004 , PVD and bladder cancer . 

Phrase: An 82-year-old male with a history of CAD
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   YEAR (year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   MALE (Males) [Organism Attribute]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Gender, Self Report) [Qualitative Concept]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male Phenotype) [Qualitative Concept]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History [Occupation or Discipline]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   history (Historical aspects qualifier) [Functional Concept]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History, NOS (History of present illness) [Organism Attribute]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History (Medical History) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History (Concept History) [Conceptual Entity]
   573   CAD (CALD1 wt Allele) [Gene or Genome]
Meta Mapping (640):
   573   /Year (per year) [Temporal Concept]
   573   Old [Temporal Concept]
   739   Male (Male, Self-Reported) [Organism Attribute]
   573   History (History of previous events) [Finding]
   573   CAD (CALD1 wt Allele) [Gene or Genome]

Phrase: status post CABG ,
Meta Mapping (1000):
  1000   CABG (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]

Phrase: CVA status post CEA ,
Meta Mapping (861):
   770   CVA, NOS (Cerebrovascular accident) [Disease or Syndrome]
   666   Status post [Temporal Concept]
   604   Cea (Cea (insect genus)) [Eukaryote]
Meta Mapping (861):
   770   CVA, NOS (Cerebrovascular accident) [Disease or Syndrome]
   666   Status Post (Post) [Temporal Concept]
   604   Cea (Cea (insect genus)) [Eukaryote]

Phrase: diabetes mellitus ,
Meta Mapping (1000):
  1000   DIABETES MELLITUS (Diabetes Mellitus) [Disease or Syndrome]

Phrase: hypertension ,
Meta Mapping (1000):
  1000   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Hypertension (Hypertension Adverse Event) [Finding]

Phrase: GI bleeding ,
Meta Mapping (1000):
  1000   GI Bleeding (Gastrointestinal Hemorrhage) [Pathologic Function]

Phrase: CHF with an EF of 35% ,
Meta Mapping (753):
   753   CHF (Congestive heart failure) [Disease or Syndrome]

Phrase: left lower lobe pneumonia
Meta Mapping (1000):
  1000   Left lower lobe pneumonia (Left lower zone pneumonia) [Disease or Syndrome]

Phrase: on admission on 01/22/04 - 01/31/2004 ,
Meta Mapping (650):
   742   Admission (Hospital admission) [Health Care Activity]
   575   31 [Intellectual Product]
Meta Mapping (650):
   742   Admission (Admission activity) [Health Care Activity]
   575   31 [Intellectual Product]

Phrase: PVD
Meta Mapping (1000):
  1000   pvd (Peripheral Vascular Diseases) [Disease or Syndrome]

Phrase: and

Phrase: bladder cancer .
Meta Mapping (1000):
  1000   BLADDER CANCER (Malignant neoplasm of urinary bladder) [Neoplastic Process]
Meta Mapping (1000):
  1000   Bladder Cancer (Carcinoma of bladder) [Neoplastic Process]
Meta Mapping (1000):
  1000   Bladder cancer (Bladder Cancer Pathway) [Conceptual Entity]
Processing 00000000.tx.7: The patient is status post a non ST elevation MI , a troponin peaked at 22 likely secondary to dehydration and presentation of acute renal failure . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is status post a non ST elevation MI ,
Meta Mapping (721):
   770   Status post [Temporal Concept]
   744   Non (Negation) [Functional Concept]
   770 N ST ELEVATION (ST segment elevation (finding)) [Finding]
   744   MI (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (721):
   770   Status Post (Post) [Temporal Concept]
   744   Non (Negation) [Functional Concept]
   770 N ST ELEVATION (ST segment elevation (finding)) [Finding]
   744   MI (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (721):
   744   Status [Qualitative Concept]
   767   post mi [Disease or Syndrome]
   744   Non (Negation) [Functional Concept]
   770 N ST ELEVATION (ST segment elevation (finding)) [Finding]

Phrase: a troponin
Meta Mapping (1000):
  1000   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: peaked at 22 likely secondary
Meta Mapping (696):
   760   peaked (Peak level) [Quantitative Concept]
   760   Likely (Probable diagnosis) [Qualitative Concept]
   760 N secondary (Neoplasm Metastasis) [Neoplastic Process]
Meta Mapping (696):
   760   peaked (Peak level) [Quantitative Concept]
   760   Likely (Probable diagnosis) [Qualitative Concept]
   760   Secondary (Secondary to) [Temporal Concept]
Meta Mapping (696):
   760   peaked (Peak level) [Quantitative Concept]
   760   Likely (Probable diagnosis) [Qualitative Concept]
   760   Secondary (second (number)) [Quantitative Concept]
Meta Mapping (696):
   760   peaked (Peak level) [Quantitative Concept]
   760   Likely (Probably) [Idea or Concept]
   760 N secondary (Neoplasm Metastasis) [Neoplastic Process]
Meta Mapping (696):
   760   peaked (Peak level) [Quantitative Concept]
   760   Likely (Probably) [Idea or Concept]
   760   Secondary (Secondary to) [Temporal Concept]
Meta Mapping (696):
   760   peaked (Peak level) [Quantitative Concept]
   760   Likely (Probably) [Idea or Concept]
   760   Secondary (second (number)) [Quantitative Concept]

Phrase: to dehydration
Meta Mapping (1000):
  1000   DEHYDRATION (Dehydration) [Disease or Syndrome]

Phrase: and

Phrase: presentation of acute renal failure .
Meta Mapping (816):
   760   Presentation [Idea or Concept]
   695   ACUTE RENAL FAILURE (Kidney Failure, Acute) [Disease or Syndrome]
Meta Mapping (816):
   760   Presentation [Idea or Concept]
   695   Acute renal failure (Pre-renal acute kidney injury) [Disease or Syndrome]
Processing 00000000.tx.8: Overall , the patient had preserved LV function despite a large troponin leak . 

Phrase: Overall ,
Meta Mapping (1000):
  1000   Overall (Overall Publication Type) [Intellectual Product]
Meta Mapping (1000):
  1000   Overall [Qualitative Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: preserved LV function despite a large troponin leak .
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Latvia) [Geographic Area]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Leucovorin Calcium) [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   function (physiological aspects) [Physiologic Function]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   FUNCTION (Function) [Functional Concept]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   FUNCTION (Function Axis) [Classification]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leaking) [Functional Concept]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak NOS (Gastrointestinal Leak Adverse Event NOS) [Finding]
Meta Mapping (693):
   578   Preserved (Biologic Preservation) [Laboratory Procedure]
   578   LV (Liposome Vesicle) [Chemical Viewed Structurally]
   744   Function (Mathematical Operator) [Intellectual Product]
   578   LARGE (Large) [Quantitative Concept]
   578   Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   578   Leak (Leakage Associated with Medical Device) [Phenomenon or Process]
Processing 00000000.tx.9: Hematocrit is stable . 

Phrase: Hematocrit
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit level) [Finding]

Phrase: is

Phrase: stable .
Meta Mapping (1000):
  1000   STABLE (Stable status) [Qualitative Concept]
Meta Mapping (1000):
  1000   Stable (Patient Condition Code - Stable) [Intellectual Product]
Processing 00000000.tx.10: Has remained stable above 30 without any need for further transfusions . 

Phrase: Has

Phrase: remained stable above 30
Meta Mapping (708):
   770   STABLE (Stable status) [Qualitative Concept]
   604   30% [Finding]
Meta Mapping (708):
   770   Stable (Patient Condition Code - Stable) [Intellectual Product]
   604   30% [Finding]

Phrase: without any need for further transfusions .
Meta Mapping (672):
   753   Need (Needs) [Qualitative Concept]
   586   Further [Spatial Concept]
   586   Transfusions (Blood Transfusion) [Therapeutic or Preventive Procedure]
Meta Mapping (672):
   753   Need (Needs) [Qualitative Concept]
   586   Further [Spatial Concept]
   586   transfusions (Transfusion - action) [Functional Concept]
Meta Mapping (672):
   753   Need (Needs) [Qualitative Concept]
   586   Further [Spatial Concept]
   586   Transfusions (Transfusion (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (672):
   753   need (Patient need for (contextual qualifier)) [Functional Concept]
   586   Further [Spatial Concept]
   586   Transfusions (Blood Transfusion) [Therapeutic or Preventive Procedure]
Meta Mapping (672):
   753   need (Patient need for (contextual qualifier)) [Functional Concept]
   586   Further [Spatial Concept]
   586   transfusions (Transfusion - action) [Functional Concept]
Meta Mapping (672):
   753   need (Patient need for (contextual qualifier)) [Functional Concept]
   586   Further [Spatial Concept]
   586   Transfusions (Transfusion (procedure)) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: The patient was initially started on Levo 250 mg q.d. for a UTI . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: initially
Meta Mapping (1000):
  1000   Initially [Temporal Concept]

Phrase: started on Levo 250 mg q.d.
Meta Mapping (687):
   748   Started [Qualitative Concept]
   748   Levo- (Left) [Spatial Concept]
   774   mg/d (milligram/day) [Quantitative Concept]

Phrase: for a UTI .
Meta Mapping (1000):
  1000   UTI (Urinary tract infection) [Disease or Syndrome]
Meta Mapping (1000):
  1000   UTI (urinastatin) [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Meta Mapping (1000):
  1000   UTI (AMBP gene) [Gene or Genome]
Processing 00000000.tx.12: However , his urine cultures were positive for MRSA and the patient completed a seven day course of Vancomycin IV . 

Phrase: However ,

Phrase: his urine cultures
Meta Mapping (966):
   966   Urine culture (Urine for culture) [Laboratory Procedure]

Phrase: were

Phrase: positive for MRSA
Meta Mapping (746):
   790   % Positive (percent positive cells) [Quantitative Concept]
   623   MRSA (Methicillin resistant Staphylococcus aureus (organism)) [Bacterium]
Meta Mapping (746):
   790   Positive [Qualitative Concept]
   623   MRSA (Methicillin resistant Staphylococcus aureus (organism)) [Bacterium]
Meta Mapping (746):
   790   POSITIVE (Positive Finding) [Finding]
   623   MRSA (Methicillin resistant Staphylococcus aureus (organism)) [Bacterium]
Meta Mapping (746):
   790   Positive (Positive Charge) [Qualitative Concept]
   623   MRSA (Methicillin resistant Staphylococcus aureus (organism)) [Bacterium]
Meta Mapping (746):
   790   Positive (Positive Number) [Conceptual Entity]
   623   MRSA (Methicillin resistant Staphylococcus aureus (organism)) [Bacterium]

Phrase: and

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: completed
Meta Mapping (1000):
  1000   COMPLETED (Complete) [Qualitative Concept]
Meta Mapping (1000):
  1000   completed (completed - RoleLinkStatus) [Idea or Concept]

Phrase: a seven day course of Vancomycin IV .
Meta Mapping (710):
   612   SEVEN-DAY (Seven-Day Report) [Intellectual Product]
   748   Course [Temporal Concept]
   581   VANCOMYCIN (Vancomycin) [Amino Acid, Peptide, or Protein,Antibiotic]
   581   IV (Ivory Coast) [Geographic Area]
Processing 00000000.tx.13: His baseline was 1.8-2.2 likely pre renal azotemia and subsequently his creatinine improved with hydration and the packed red blood cell transfusions , and his creatinine steadily decreased down to his baseline . 

Phrase: His baseline
Meta Mapping (1000):
  1000   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Baseline [Quantitative Concept]

Phrase: was

Phrase: 1.8-2.2 likely pre renal azotemia
Meta Mapping (793):
   626   1+ (1+ Score) [Quantitative Concept]
   626   Likely (Probable diagnosis) [Qualitative Concept]
   835   pre renal azotemia (azotemia pre renal) [Finding]
Meta Mapping (793):
   626   1+ (1+ Score) [Quantitative Concept]
   626   Likely (Probably) [Idea or Concept]
   835   pre renal azotemia (azotemia pre renal) [Finding]
Meta Mapping (793):
   626   1+ (1+ Score, WHO) [Classification]
   626   Likely (Probable diagnosis) [Qualitative Concept]
   835   pre renal azotemia (azotemia pre renal) [Finding]
Meta Mapping (793):
   626   1+ (1+ Score, WHO) [Classification]
   626   Likely (Probably) [Idea or Concept]
   835   pre renal azotemia (azotemia pre renal) [Finding]
Meta Mapping (793):
   626   1+ [Finding]
   626   Likely (Probable diagnosis) [Qualitative Concept]
   835   pre renal azotemia (azotemia pre renal) [Finding]
Meta Mapping (793):
   626   1+ [Finding]
   626   Likely (Probably) [Idea or Concept]
   835   pre renal azotemia (azotemia pre renal) [Finding]

Phrase: and

Phrase: subsequently

Phrase: his creatinine
Meta Mapping (1000):
  1000   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (1000):
  1000   Creatinine (Creatinine finding) [Finding]

Phrase: improved with hydration
Meta Mapping (746):
   790   Improved [Qualitative Concept]
   790   Hydration (Hydration status) [Finding]
Meta Mapping (746):
   790   Improved (Better) [Qualitative Concept]
   790   Hydration (Hydration status) [Finding]
Meta Mapping (746):
   790   Improved (Admission Level of Care Code - Improved) [Intellectual Product]
   790   Hydration (Hydration status) [Finding]

Phrase: and

Phrase: the packed red blood cell transfusions ,
Meta Mapping (966):
   966   Packed Red Blood Cell Transfusion (Transfusion of packed red blood cells) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: his creatinine
Meta Mapping (1000):
  1000   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (1000):
  1000   Creatinine (Creatinine finding) [Finding]

Phrase: steadily

Phrase: decreased down
Meta Mapping (833):
   833   Decreased [Quantitative Concept]
Meta Mapping (833):
   833   Decreased (Reduced) [Qualitative Concept]
Meta Mapping (833):
   833   decreased (Decreasing) [Qualitative Concept]

Phrase: to his baseline .
Meta Mapping (1000):
  1000   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Baseline [Quantitative Concept]
Processing 00000000.tx.14: Include Albuterol nebulizer 2.5 mg nebs q.4h , Colace 100 mg p.o. b.i.d. 

Phrase: Include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: Albuterol nebulizer 2.5 mg nebs q.4h ,
Meta Mapping (765):
   685   Albuterol 2 MG [Clinical Drug]
   626   Nebuliser (Nebulizers) [Medical Device]
   626   Nebs (Nebulizer solution) [Biomedical or Dental Material]
   793   4H (4 Hours) [Temporal Concept]
Meta Mapping (765):
   685   Albuterol 2 MG [Clinical Drug]
   626   Nebuliser (Nebulizers) [Medical Device]
   626   NEB (NEB gene) [Gene or Genome]
   793   4H (4 Hours) [Temporal Concept]
Meta Mapping (765):
   685   Albuterol 2 MG [Clinical Drug]
   626   Nebulizer (Nebulizer Device Component) [Manufactured Object]
   626   Nebs (Nebulizer solution) [Biomedical or Dental Material]
   793   4H (4 Hours) [Temporal Concept]
Meta Mapping (765):
   685   Albuterol 2 MG [Clinical Drug]
   626   Nebulizer (Nebulizer Device Component) [Manufactured Object]
   626   NEB (NEB gene) [Gene or Genome]
   793   4H (4 Hours) [Temporal Concept]

Phrase: Colace 100 mg p.o. b.i.d.
Meta Mapping (816):
   816   Docusate Sodium 100 MG [Clinical Drug]
Processing 00000000.tx.15: , Vitamin D 5000 units p.o. q.weekly , iron sulfate 325 mg p.o. t.i.d. 

Phrase: , Vitamin D 5000 units p.o. q.weekly ,
Meta Mapping (760):
   878   vitamin Q [Organic Chemical,Vitamin]
   793   UNITS (Unit) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   878   vitamin Q [Organic Chemical,Vitamin]
   793   Units (Unit of Measure) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   878   vitamin Q [Organic Chemical,Vitamin]
   793   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (Ergocalciferol) [Organic Chemical,Pharmacologic Substance,Vitamin]
   793   UNITS (Unit) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (Ergocalciferol) [Organic Chemical,Pharmacologic Substance,Vitamin]
   793   Units (Unit of Measure) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (Ergocalciferol) [Organic Chemical,Pharmacologic Substance,Vitamin]
   793   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   VITAMIN D (Vitamin D) [Organic Chemical,Pharmacologic Substance,Vitamin]
   793   UNITS (Unit) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   VITAMIN D (Vitamin D) [Organic Chemical,Pharmacologic Substance,Vitamin]
   793   Units (Unit of Measure) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   VITAMIN D (Vitamin D) [Organic Chemical,Pharmacologic Substance,Vitamin]
   793   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (Vitamin D [EPC]) [Vitamin]
   793   UNITS (Unit) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (Vitamin D [EPC]) [Vitamin]
   793   Units (Unit of Measure) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (Vitamin D [EPC]) [Vitamin]
   793   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (D Vitamin) [Pharmacologic Substance]
   793   UNITS (Unit) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (D Vitamin) [Pharmacologic Substance]
   793   Units (Unit of Measure) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   Vitamin D (D Vitamin) [Pharmacologic Substance]
   793   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   VITAMIN D (Vitamin D Drug Class) [Pharmacologic Substance,Vitamin]
   793   UNITS (Unit) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   VITAMIN D (Vitamin D Drug Class) [Pharmacologic Substance,Vitamin]
   793   Units (Unit of Measure) [Quantitative Concept]
   793   Weekly [Temporal Concept]
Meta Mapping (760):
   812   VITAMIN D (Vitamin D Drug Class) [Pharmacologic Substance,Vitamin]
   793   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   793   Weekly [Temporal Concept]

Phrase: iron sulfate 325 mg p.o. t.i.d.
Meta Mapping (759):
   807   Iron sulphate (ferrous sulfate) [Inorganic Chemical,Pharmacologic Substance]
   854   mg/d (milligram/day) [Quantitative Concept]
   791   I- (Iodides) [Inorganic Chemical]
Meta Mapping (759):
   807   Iron sulphate (ferrous sulfate) [Inorganic Chemical,Pharmacologic Substance]
   854   mg/d (milligram/day) [Quantitative Concept]
   791   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (759):
   807   Iron sulphate (ferrous sulfate) [Inorganic Chemical,Pharmacologic Substance]
   791   MG (Mongolia) [Geographic Area]
   807   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (759):
   807   Iron sulphate (ferrous sulfate) [Inorganic Chemical,Pharmacologic Substance]
   791   mg% (mg/dL) [Quantitative Concept]
   807   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (759):
   807   Iron sulphate (ferrous sulfate) [Inorganic Chemical,Pharmacologic Substance]
   791   mg % (Milligram percent) [Quantitative Concept]
   807   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (759):
   807   Iron sulphate (ferrous sulfate) [Inorganic Chemical,Pharmacologic Substance]
   791   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   807   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.16: , folate 1 mg p.o. q.d. 

Phrase: , folate 1 mg p.o. q.d.
Meta Mapping (796):
   629   Folate [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.17: , regular insulin sliding scale , Lopressor 25 mg p.o. t.i.d. 

Phrase: , regular insulin sliding scale ,
Meta Mapping (888):
   694   Insulin, Regular (Insulin) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   sliding scale [Therapeutic or Preventive Procedure]

Phrase: Lopressor 25 mg p.o. t.i.d.
Meta Mapping (795):
   793   Lopressor [Organic Chemical,Pharmacologic Substance]
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.18: , Neutrophos 250 mg p.o. t.i.d. 

Phrase: , Neutrophos 250 mg p.o. t.i.d.
Meta Mapping (864):
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.19: , Senna 2 tablets p.o. b.i.d. 

Phrase: , Senna 2 tablets p.o. b.i.d.
Meta Mapping (795):
   795   Senokot Tablets [Clinical Drug]
Processing 00000000.tx.20: , multivitamins with minerals one tab p.o. q.d. 

Phrase: , multivitamins with minerals one tab p.o. q.d.
Meta Mapping (724):
   790   MULTIVITAMINS WITH MINERALS (Multivitamins with minerals) [Pharmacologic Substance,Vitamin]
   575   ONE (One) [Quantitative Concept]
   575   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
Meta Mapping (724):
   790   MULTIVITAMINS WITH MINERALS (Multivitamins with minerals) [Pharmacologic Substance,Vitamin]
   575   ONE (One) [Quantitative Concept]
   575   Tab (Tablet Dosing Unit) [Quantitative Concept]
Processing 00000000.tx.21: , trazadone 50 mg p.o. q.h.s. p.r.n. insomnia , Zocor 40 mg p.o. q.h.s. 

Phrase: , trazadone 50 mg p.o. q.h.s. p.r.n. insomnia ,
Meta Mapping (745):
   621   50% [Finding]
   668   mg/s (Milligram per Second) [Quantitative Concept]
   787   INSOMNIA (Sleeplessness) [Sign or Symptom]
Meta Mapping (745):
   621   50% [Finding]
   668   mg/s (Milligram per Second) [Quantitative Concept]
   787   Insomnia (Insomnia Adverse Event) [Finding]
Meta Mapping (745):
   621   50% [Finding]
   658   mg/h [Quantitative Concept]
   787   INSOMNIA (Sleeplessness) [Sign or Symptom]
Meta Mapping (745):
   621   50% [Finding]
   658   mg/h [Quantitative Concept]
   787   Insomnia (Insomnia Adverse Event) [Finding]
Meta Mapping (745):
   621   <50 [Finding]
   668   mg/s (Milligram per Second) [Quantitative Concept]
   787   INSOMNIA (Sleeplessness) [Sign or Symptom]
Meta Mapping (745):
   621   <50 [Finding]
   668   mg/s (Milligram per Second) [Quantitative Concept]
   787   Insomnia (Insomnia Adverse Event) [Finding]
Meta Mapping (745):
   621   <50 [Finding]
   658   mg/h [Quantitative Concept]
   787   INSOMNIA (Sleeplessness) [Sign or Symptom]
Meta Mapping (745):
   621   <50 [Finding]
   658   mg/h [Quantitative Concept]
   787   Insomnia (Insomnia Adverse Event) [Finding]

Phrase: Zocor 40 mg p.o. q.h.s.
Meta Mapping (767):
   793   Zocor [Organic Chemical,Pharmacologic Substance]
   793   /40 [Temporal Concept]
   864   mg/s (Milligram per Second) [Quantitative Concept]
Meta Mapping (767):
   793   Zocor [Organic Chemical,Pharmacologic Substance]
   793   40% [Quantitative Concept]
   864   mg/s (Milligram per Second) [Quantitative Concept]
Processing 00000000.tx.22: , Atrovent nebulizers 0.5 mg nebs q.i.d. p.r.n. shortness of breath , Pulmicort two puffs inhaled b.i.d. and Nexium 40 mg p.o. b.i.d. 

Phrase: , Atrovent nebulizers 0.5 mg nebs q.i.d. p.r.n. shortness
Meta Mapping (710):
   620   Atrovent [Organic Chemical,Pharmacologic Substance]
   620   Nebulizers [Medical Device]
   655   mg/d (milligram/day) [Quantitative Concept]
   620   Nebs (Nebulizer solution) [Biomedical or Dental Material]
   715   short (Shortened) [Qualitative Concept]
Meta Mapping (710):
   620   Atrovent [Organic Chemical,Pharmacologic Substance]
   620   Nebulizers [Medical Device]
   655   mg/d (milligram/day) [Quantitative Concept]
   620   Nebs (Nebulizer solution) [Biomedical or Dental Material]
   715   Shortest (Short) [Quantitative Concept]
Meta Mapping (710):
   620   Atrovent [Organic Chemical,Pharmacologic Substance]
   620   Nebulizers [Medical Device]
   655   mg/d (milligram/day) [Quantitative Concept]
   620   Nebs (Nebulizer solution) [Biomedical or Dental Material]
   715   Short (Short Value) [Quantitative Concept]
Meta Mapping (710):
   620   Atrovent [Organic Chemical,Pharmacologic Substance]
   620   Nebulizers [Medical Device]
   655   mg/d (milligram/day) [Quantitative Concept]
   620   NEB (NEB gene) [Gene or Genome]
   715   short (Shortened) [Qualitative Concept]
Meta Mapping (710):
   620   Atrovent [Organic Chemical,Pharmacologic Substance]
   620   Nebulizers [Medical Device]
   655   mg/d (milligram/day) [Quantitative Concept]
   620   NEB (NEB gene) [Gene or Genome]
   715   Shortest (Short) [Quantitative Concept]
Meta Mapping (710):
   620   Atrovent [Organic Chemical,Pharmacologic Substance]
   620   Nebulizers [Medical Device]
   655   mg/d (milligram/day) [Quantitative Concept]
   620   NEB (NEB gene) [Gene or Genome]
   715   Short (Short Value) [Quantitative Concept]

Phrase: of breath ,
Meta Mapping (1000):
  1000   Breath [Body Substance]

Phrase: Pulmicort two puffs
Meta Mapping (851):
   660   Pulmicort [Organic Chemical,Pharmacologic Substance]
   660   Two [Quantitative Concept]
   827   Puffs (Puff unit dose) [Quantitative Concept]

Phrase: inhaled
Meta Mapping (1000):
  1000   Inhaled (Inspiration function) [Organism Function]

Phrase: b.i.d.
Meta Mapping (901):
   901   i d (Incision and drainage) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: Nexium 40 mg p.o. b.i.d.
Meta Mapping (767):
   793   Nexium [Organic Chemical,Pharmacologic Substance]
   793   /40 [Temporal Concept]
   864   mg/d (milligram/day) [Quantitative Concept]
Meta Mapping (767):
   793   Nexium [Organic Chemical,Pharmacologic Substance]
   793   40% [Quantitative Concept]
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.23: <TEXT> The patient was admitted to the hospital as a postoperative admit on December 7 for total hip replacement . 

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted to the hospital
Meta Mapping (819):
   819   admitted hospital (Hospital admission) [Health Care Activity]

Phrase: as a postoperative
Meta Mapping (1000):
  1000   Postoperative (Postoperative Period) [Temporal Concept]

Phrase: admit on December 7
Meta Mapping (708):
   770   Admit (Hospital admission) [Health Care Activity]
   770   December [Qualitative Concept]

Phrase: for total hip replacement .
Meta Mapping (1000):
  1000   Total Hip Replacement (Total Hip Replacement (procedure)) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.24: For further details of this procedure see operative note . 

Phrase: For further details of this procedure
Meta Mapping (672):
   586   Further [Spatial Concept]
   753   Details [Qualitative Concept]
   586   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (672):
   586   Further [Spatial Concept]
   753   Details [Qualitative Concept]
   586   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
Meta Mapping (672):
   586   Further [Spatial Concept]
   753   Details [Qualitative Concept]
   586   Procedure (Procedure (set of actions)) [Activity]
Meta Mapping (672):
   586   Further [Spatial Concept]
   753   Details [Qualitative Concept]
   586   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
Meta Mapping (672):
   586   Further [Spatial Concept]
   753   Details [Qualitative Concept]
   586   Procedure (Procedure Domain) [Intellectual Product]
Meta Mapping (672):
   586   Further [Spatial Concept]
   753   Details [Qualitative Concept]
   586   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]

Phrase: see
Meta Mapping (1000):
  1000   see (Vision) [Organism Function]
Meta Mapping (1000):
  1000   See [Activity]

Phrase: operative note .
Meta Mapping (1000):
  1000   Operative note (Surgical operation note:Find:Pt:{Setting}:Doc:{Role}) [Clinical Attribute]
Processing 00000000.tx.25: He was placed on Zantac 150 mg. 

Phrase: He

Phrase: was

Phrase: placed on Zantac 150 mg.
Meta Mapping (752):
   726   Place [Spatial Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   MG (Mongolia) [Geographic Area]
Meta Mapping (752):
   726   Place [Spatial Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (752):
   726   Place [Spatial Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (752):
   726   Place [Spatial Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (752):
   726   Place (Place - dosing instruction imperative) [Functional Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   MG (Mongolia) [Geographic Area]
Meta Mapping (752):
   726   Place (Place - dosing instruction imperative) [Functional Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (752):
   726   Place (Place - dosing instruction imperative) [Functional Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (752):
   726   Place (Place - dosing instruction imperative) [Functional Concept]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (752):
   726   Place (put - instruction imperative) [Activity]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   MG (Mongolia) [Geographic Area]
Meta Mapping (752):
   726   Place (put - instruction imperative) [Activity]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (752):
   726   Place (put - instruction imperative) [Activity]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (752):
   726   Place (put - instruction imperative) [Activity]
   806   Zantac 150 [Organic Chemical,Pharmacologic Substance]
   760   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.26: PO b.i.d. and H Pylori serology was sent . 

Phrase: PO b.i.d.
Meta Mapping (824):
   812   PO (Portugal) [Geographic Area]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (824):
   812   PO (Oral) [Spatial Concept]
   694   i d (Incision and drainage) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: H Pylori serology
Meta Mapping (901):
   734   H. pylori (Helicobacter pylori) [Bacterium]
   827   Serology (Study of serum) [Biomedical Occupation or Discipline]
Meta Mapping (901):
   734   H. pylori (Helicobacter pylori) [Bacterium]
   827   Serology (Serological aspects) [Functional Concept]
Meta Mapping (901):
   734   H. pylori (Helicobacter pylori) [Bacterium]
   827   Serology (Sample serology (procedure)) [Laboratory Procedure]

Phrase: was

Phrase: sent .
Meta Mapping (1000):
  1000   Sent (Send (transmission)) [Functional Concept]
Processing 00000000.tx.27: Distal neurovascular status was intact . 

Phrase: Distal neurovascular status
Meta Mapping (802):
   660   DISTAL (Distal) [Spatial Concept]
   827   Status [Qualitative Concept]

Phrase: was

Phrase: intact .
Meta Mapping (1000):
  1000   Intact [Qualitative Concept]
Meta Mapping (1000):
  1000   Intact (Gender Status - Intact) [Finding]
Processing 00000000.tx.28: </TEXT> PAST SURGICAL HISTORY : The chest tubes were maintained until 1/20/90 , at which time they were pulled sequentially . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > PAST SURGICAL HISTORY
Meta Mapping (1000):
  1000   Past surgical history (H/O: surgery) [Finding]

Phrase: :

Phrase: The chest tubes
Meta Mapping (1000):
  1000   Chest Tubes [Medical Device]

Phrase: were

Phrase: maintained until 1/20/90 ,
Meta Mapping (696):
   760   Maintained (Maintaining (action)) [Functional Concept]
   760   20% [Finding]
   760   >90 [Quantitative Concept]
Meta Mapping (696):
   760   Maintained (Maintaining (action)) [Functional Concept]
   760   20% [Finding]
   760   <90 [Quantitative Concept]
Meta Mapping (696):
   760   Maintained (Maintaining (action)) [Functional Concept]
   760   20% [Finding]
   760   90% [Finding]

Phrase: at which time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: they

Phrase: were

Phrase: pulled
Meta Mapping (1000):
  1000   pulled (Does pull) [Finding]

Phrase: sequentially .
Processing 00000000.tx.29: She may or may not be started again on a low daily Lasix dose of 20 mg q.d. 

Phrase: She

Phrase: may

Phrase: or

Phrase: may

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: be

Phrase: started
Meta Mapping (1000):
  1000   Started [Qualitative Concept]

Phrase: again on a low daily Lasix dose of 20 mg q.d.
Meta Mapping (708):
   736   Low (low) [Qualitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   DOSE (Dosage) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   Low (low) [Qualitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose (Unit dose) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   Low (low) [Qualitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose # (Dose number:Number:Point in time:^Patient:Quantitative) [Clinical Attribute]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   low (low confidentiality) [Intellectual Product]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   DOSE (Dosage) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   low (low confidentiality) [Intellectual Product]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose (Unit dose) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   low (low confidentiality) [Intellectual Product]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose # (Dose number:Number:Point in time:^Patient:Quantitative) [Clinical Attribute]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   Low (Low Mitosis-Karyorrhexis Index) [Quantitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   DOSE (Dosage) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   Low (Low Mitosis-Karyorrhexis Index) [Quantitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose (Unit dose) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   Low (Low Mitosis-Karyorrhexis Index) [Quantitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose # (Dose number:Number:Point in time:^Patient:Quantitative) [Clinical Attribute]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   low (low exposure) [Qualitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   DOSE (Dosage) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   low (low exposure) [Qualitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose (Unit dose) [Quantitative Concept]
   766   q.a.d. (Alternate days) [Temporal Concept]
Meta Mapping (708):
   736   low (low exposure) [Qualitative Concept]
   736   Daily [Temporal Concept]
   749   Furosemide 20 MG [Clinical Drug]
   736   Dose # (Dose number:Number:Point in time:^Patient:Quantitative) [Clinical Attribute]
   766   q.a.d. (Alternate days) [Temporal Concept]
Processing 00000000.tx.30: Batch : Dicatated By :

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: Dicatated By

Phrase: :
Processing 00000000.tx.1: Report Status : 08/29/2004 FONG , CONEY N. 

Phrase: Report Status
Meta Mapping (1000):
  1000   Report status [Finding]

Phrase: :

Phrase: 08/29/2004 FONG ,
Meta Mapping (763):
   645   29+ [Finding]
   812   FONG (FTCDNL1 gene) [Gene or Genome]

Phrase: CONEY N.
Meta Mapping (694):
   694   cony (Family Procaviidae) [Mammal]
Meta Mapping (694):
   694   Coney (Epinephelus fulvus) [Fish]
Processing 00000000.tx.2: , M.D. 

Phrase: , M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.3: Home w/ services Instructions : Override Notice : Number of Doses Required ( approximate ) : 1 SERIOUS INTERACTION : walking only with walker FOLLOW UP APPOINTMENT ( S ) : ADMIT DIAGNOSIS : Found by VNA , FS = 31 . 

Phrase: Home w/ services Instructions
Meta Mapping (824):
   708   home services (Home visit (procedure)) [Health Care Activity]
   812   instructions (Instruction [Publication Type]) [Intellectual Product]
Meta Mapping (824):
   708   home services (Home visit (procedure)) [Health Care Activity]
   812   Instructions [Idea or Concept]
Meta Mapping (824):
   708   home services (Home visit (procedure)) [Health Care Activity]
   812   Instructions (Instructions:Text:Point in time:^Patient:Narrative) [Clinical Attribute]

Phrase: :

Phrase: Override
Meta Mapping (1000):
  1000   Override [Activity]

Phrase: Notice

Phrase: :

Phrase: Number of Doses
Meta Mapping (841):
   841   Dose number (Dose number:Number:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (841):
   841   Dose number [Quantitative Concept]

Phrase: Required
Meta Mapping (1000):
  1000   Required (Requirement) [Functional Concept]

Phrase: ( approximate
Meta Mapping (1000):
  1000   Approximate [Qualitative Concept]

Phrase: )

Phrase: :

Phrase: 1 SERIOUS INTERACTION
Meta Mapping (851):
   660   1+ (1+ Score) [Quantitative Concept]
   660   Serious [Qualitative Concept]
   827   Interaction [Functional Concept]
Meta Mapping (851):
   660   1+ (1+ Score, WHO) [Classification]
   660   Serious [Qualitative Concept]
   827   Interaction [Functional Concept]
Meta Mapping (851):
   660   1+ [Finding]
   660   Serious [Qualitative Concept]
   827   Interaction [Functional Concept]

Phrase: :

Phrase: walking
Meta Mapping (1000):
  1000   Walking (Walking (activity)) [Daily or Recreational Activity]

Phrase: only with walker FOLLOW UP APPOINTMENT
Meta Mapping (753):
   753   Only (Singular) [Quantitative Concept]
   753   Walker (Walkers) [Medical Device]
   790   Follow-up (Follow-up status) [Finding]
   753   Appointment (Appointments) [Idea or Concept]
Meta Mapping (753):
   753   Only (Singular) [Quantitative Concept]
   753   Walker (Walkers) [Medical Device]
   790   Follow Up (follow-up) [Health Care Activity]
   753   Appointment (Appointments) [Idea or Concept]
Meta Mapping (753):
   753   Only (Singular) [Quantitative Concept]
   753   Walker (Walkers) [Medical Device]
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   753   Appointment (Appointments) [Idea or Concept]
Meta Mapping (753):
   753   Only (Singular) [Quantitative Concept]
   753   Walker (Walkers) [Medical Device]
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   753   Appointment (Appointments) [Idea or Concept]
Meta Mapping (753):
   753   Only (Only - dosing instruction fragment) [Intellectual Product]
   753   Walker (Walkers) [Medical Device]
   790   Follow-up (Follow-up status) [Finding]
   753   Appointment (Appointments) [Idea or Concept]
Meta Mapping (753):
   753   Only (Only - dosing instruction fragment) [Intellectual Product]
   753   Walker (Walkers) [Medical Device]
   790   Follow Up (follow-up) [Health Care Activity]
   753   Appointment (Appointments) [Idea or Concept]
Meta Mapping (753):
   753   Only (Only - dosing instruction fragment) [Intellectual Product]
   753   Walker (Walkers) [Medical Device]
   790   Follow-Up (Follow-Up Report) [Intellectual Product]
   753   Appointment (Appointments) [Idea or Concept]
Meta Mapping (753):
   753   Only (Only - dosing instruction fragment) [Intellectual Product]
   753   Walker (Walkers) [Medical Device]
   790   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   753   Appointment (Appointments) [Idea or Concept]

Phrase: ( S
Meta Mapping (1000):
  1000   /s (per second) [Quantitative Concept]
Meta Mapping (1000):
  1000   S' (S prime) [Clinical Attribute]

Phrase: )

Phrase: :

Phrase: ADMIT
Meta Mapping (1000):
  1000   Admit (Hospital admission) [Health Care Activity]

Phrase: DIAGNOSIS
Meta Mapping (1000):
  1000   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (1000):
  1000   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (1000):
  1000   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: :

Phrase: Found by VNA ,
Meta Mapping (790):
   790   Found (Present) [Quantitative Concept]

Phrase: FS
Meta Mapping (1000):
  1000   FS (French Southern Territories) [Geographic Area]
Meta Mapping (1000):
  1000   FS (FST wt Allele) [Gene or Genome]

Phrase: = 31 .
Meta Mapping (1000):
  1000   31 [Intellectual Product]
Processing 00000000.tx.4: V / S : V / Q ( prelim ) : indeterminate . 

Phrase: V / S
Meta Mapping (1000):
  1000   V/s (Volt Per Second) [Quantitative Concept]

Phrase: :

Phrase: V / Q
Meta Mapping (1000):
  1000   V/Q (Ventilation to Perfusion Ratio) [Quantitative Concept]

Phrase: ( prelim

Phrase: )

Phrase: :

Phrase: indeterminate .
Meta Mapping (1000):
  1000   INDETERMINATE (Indeterminate) [Idea or Concept]
Processing 00000000.tx.5: RLL rhonchi , start Levo for ? 

Phrase: RLL rhonchi ,
Meta Mapping (888):
   694   RLL (Structure of right lower lobe of lung) [Body Part, Organ, or Organ Component]
   861   RHONCHI (Rhonchi) [Finding]

Phrase: start
Meta Mapping (1000):
  1000   Start (Beginning) [Temporal Concept]

Phrase: Levo for ?
Meta Mapping (833):
   833   Levo- (Left) [Spatial Concept]
Processing 00000000.tx.6: CAP . 

Phrase: CAP .
Meta Mapping (1000):
  1000   Cap (Caps) [Manufactured Object]
Meta Mapping (1000):
  1000   CAP (Syringe Caps) [Medical Device]
Meta Mapping (1000):
  1000   Cap (Cap Device Component) [Manufactured Object]
Processing 00000000.tx.7: 4) Renal . 

Phrase: 4

Phrase: )

Phrase: Renal .
Meta Mapping (1000):
  1000   Renal (Kidney) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.8: Hold Lasix and can restart as outpatient if desired by pcp . 

Phrase: Hold
Meta Mapping (1000):
  1000   Hold (Hold - dosing instruction fragment) [Idea or Concept]
Meta Mapping (1000):
  1000   Hold (Hold (action)) [Activity]
Meta Mapping (1000):
  1000   hold (hold - Data Operation) [Functional Concept]

Phrase: Lasix
Meta Mapping (1000):
  1000   Lasix [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: can

Phrase: restart as outpatient
Meta Mapping (746):
   790   Restart [Qualitative Concept]
   790   Outpatient (Outpatients) [Patient or Disabled Group]
Meta Mapping (746):
   790   Restart [Qualitative Concept]
   790   Outpatient (Referral category - Outpatient) [Idea or Concept]
Meta Mapping (746):
   790   Restart [Qualitative Concept]
   790   Outpatient (Patient Class - Outpatient) [Classification]

Phrase: if

Phrase: desired by pcp .
Meta Mapping (730):
   756   desire [Mental Process]
   790   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]
Processing 00000000.tx.9: Continue ASA , B-B , ACE-I , statin . 

Phrase: Continue
Meta Mapping (1000):
  1000   Continue (Continuous) [Idea or Concept]

Phrase: ASA ,
Meta Mapping (1000):
  1000   ASA (Aspirin) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   ASA (Cerebroside-Sulfatase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   ASA (Arylsulfatase A, human) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: B-B ,

Phrase: ACE-I ,
Meta Mapping (888):
   861   ACE (ACE protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   I- (Iodides) [Inorganic Chemical]
Meta Mapping (888):
   861   ACE (ACE protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: statin .
Meta Mapping (1000):
  1000   Statin (Hydroxymethylglutaryl-CoA Reductase Inhibitors) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.10: If unable , then he will agree to placement . 

Phrase: If

Phrase: unable , then
Meta Mapping (888):
   861   Unable [Finding]
   861   Then [Temporal Concept]

Phrase: he

Phrase: will

Phrase: agree to placement .
Meta Mapping (746):
   790   Agree [Intellectual Product]
   790   Placement (Clinical act of insertion) [Health Care Activity]
Meta Mapping (746):
   790   Agree [Intellectual Product]
   790   Placement [Qualitative Concept]
Meta Mapping (746):
   790   Agree [Intellectual Product]
   790   Placement (Placement action) [Health Care Activity]
Processing 00000000.tx.11: Anemia likely secondary to chronic disease , and pt will have Hct checked on Tuesday , August 31st with result faxed to pcp . 

Phrase: Anemia
Meta Mapping (1000):
  1000   ANEMIA (Anemia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Anemia (Genus Anemia) [Plant]

Phrase: likely secondary to chronic disease ,
Meta Mapping (857):
   593   Likely (Probable diagnosis) [Qualitative Concept]
   806   Secondary to [Temporal Concept]
   640   Chronic Disease (Chronic disease) [Disease or Syndrome]
Meta Mapping (857):
   593   Likely (Probably) [Idea or Concept]
   806   Secondary to [Temporal Concept]
   640   Chronic Disease (Chronic disease) [Disease or Syndrome]

Phrase: and

Phrase: pt
Meta Mapping (1000):
  1000   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]

Phrase: will

Phrase: have

Phrase: Hct
Meta Mapping (1000):
  1000   HCT (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (1000):
  1000   HCT (Hemopoietic stem cell transplant) [Therapeutic or Preventive Procedure]

Phrase: checked on Tuesday ,
Meta Mapping (746):
   790   Checked (Checking (action)) [Activity]
   790   Tuesday [Temporal Concept]

Phrase: August 31st with result
Meta Mapping (708):
   770   August [Qualitative Concept]
   770   Result [Functional Concept]
Meta Mapping (708):
   770   August [Qualitative Concept]
   770   Result (What subject filter - Result) [Idea or Concept]
Meta Mapping (708):
   770   August [Qualitative Concept]
   770   Result (Experimental Result) [Finding]

Phrase: faxed to pcp .
Meta Mapping (730):
   756   Fax (Telefacsimile) [Manufactured Object]
   790   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]
Meta Mapping (730):
   756   FAX (Fax Number) [Conceptual Entity]
   790   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]
Meta Mapping (730):
   756   Fax (Facsimile Machine) [Manufactured Object]
   790   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]
Processing 00000000.tx.12: 9) DNR / DNI . 

Phrase: 9

Phrase: )

Phrase: DNR / DNI .
Meta Mapping (694):
   694   DNR (Daunorubicin) [Antibiotic,Organic Chemical]
Meta Mapping (694):
   694   DNR (DNR - Do not resuscitate) [Finding]
Processing 00000000.tx.13: If problem , need to call FLFDMC at 795-648-9919 . 

Phrase: If

Phrase: problem ,
Meta Mapping (1000):
  1000   Problem [Finding]
Meta Mapping (1000):
  1000   Problem (Problem:Find:Pt:^Patient:Nom) [Clinical Attribute]

Phrase: need
Meta Mapping (1000):
  1000   Need (Needs) [Qualitative Concept]
Meta Mapping (1000):
  1000   need (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: call
Meta Mapping (1000):
  1000   Call (Decision) [Mental Process]
Meta Mapping (1000):
  1000   Call (Call (Instruction)) [Functional Concept]

Phrase: FLFDMC at 795-648-9919 .
Processing 00000000.tx.14: Also pt needs to have fbs checked by AH with results called to PCP if &gt; 250 . 

Phrase: Also pt
Meta Mapping (861):
   861   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (861):
   861   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]

Phrase: needs
Meta Mapping (1000):
  1000   Needs [Qualitative Concept]
Meta Mapping (1000):
  1000   needs (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: fbs
Meta Mapping (1000):
  1000   FBS (Fetal Bovine Serum) [Indicator, Reagent, or Diagnostic Aid]

Phrase: checked by AH
Meta Mapping (746):
   790   Checked (Checking (action)) [Activity]
   790   AH (Total Hypotrichosis, Mari type) [Disease or Syndrome]

Phrase: with results
Meta Mapping (966):
   966   Result [Functional Concept]
Meta Mapping (966):
   966   Result (What subject filter - Result) [Idea or Concept]
Meta Mapping (966):
   966   Result (Experimental Result) [Finding]

Phrase: called to PCP
Meta Mapping (730):
   756   Call (Decision) [Mental Process]
   790   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]
Meta Mapping (730):
   756   Call (Call (Instruction)) [Functional Concept]
   790   PCP (Pneumocystis jiroveci pneumonia) [Disease or Syndrome]

Phrase: if

Phrase: &gt
Meta Mapping (1000):
  1000   GT (FABP6 protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ; 250 .
Processing 00000000.tx.15: 763248279 CTMC Report Status : DISCHARGE DIAGNOSIS : In July of l989 , she was walking with a four-prong cane and using a wheelchair for teaching ( she is an eighth grade school teacher ) . 

Phrase: 763248279 CTMC Report Status
Meta Mapping (861):
   861   Report status [Finding]

Phrase: :

Phrase: DISCHARGE DIAGNOSIS
Meta Mapping (1000):
  1000   Discharge diagnosis (discharge diagnosis) [Finding]

Phrase: :

Phrase: In July of l989 ,
Meta Mapping (770):
   770   July [Qualitative Concept]

Phrase: she

Phrase: was

Phrase: walking with a four-prong cane
Meta Mapping (725):
   586   Four [Quantitative Concept]
   586   Prong (Prong Device Component) [Medical Device]
   783   cane walking (Walks with cane (finding)) [Finding]

Phrase: and

Phrase: using
Meta Mapping (1000):
  1000   Using (Use of) [Functional Concept]

Phrase: a wheelchair for teaching
Meta Mapping (708):
   770   Wheelchair (wheelchair) [Medical Device]
   604   Teaching (Educational process of instructing) [Educational Activity]
Meta Mapping (708):
   770   Wheelchair (wheelchair) [Medical Device]
   604   teaching (Teaching aspects) [Educational Activity]
Meta Mapping (708):
   770   Wheelchair (wheelchair) [Medical Device]
   604   Teaching (Visit User Code - Teaching) [Intellectual Product]

Phrase: (

Phrase: she

Phrase: is

Phrase: an eighth grade school teacher
Meta Mapping (861):
   645   Eighth [Quantitative Concept]
   694   Grade School (Elementary School) [Intellectual Product]
   812   Teacher [Professional or Occupational Group]
Meta Mapping (861):
   645   Eighth [Quantitative Concept]
   694   Grade School (Elementary School) [Intellectual Product]
   812   teacher (Patient's teacher when immunized) [Finding]
Meta Mapping (861):
   645   Eighth [Quantitative Concept]
   645   Grade [Classification]
   861   School teacher (School Teachers) [Professional or Occupational Group]
Meta Mapping (861):
   645   Eighth [Quantitative Concept]
   645   Grade (Histopathologic Grade) [Classification]
   861   School teacher (School Teachers) [Professional or Occupational Group]
Meta Mapping (861):
   645   Eighth [Quantitative Concept]
   645   grade (School Grade) [Finding]
   861   School teacher (School Teachers) [Professional or Occupational Group]

Phrase: ) .
Processing 00000000.tx.16: 4) History of mitral valve prolapse diagnosed in l983 . 

Phrase: 4

Phrase: )

Phrase: History of mitral valve prolapse
Meta Mapping (816):
   760   History [Occupation or Discipline]
   695   MITRAL VALVE PROLAPSE (Mitral Valve Prolapse Syndrome) [Disease or Syndrome]
Meta Mapping (816):
   760   history (Historical aspects qualifier) [Functional Concept]
   695   MITRAL VALVE PROLAPSE (Mitral Valve Prolapse Syndrome) [Disease or Syndrome]
Meta Mapping (816):
   760   History, NOS (History of present illness) [Organism Attribute]
   695   MITRAL VALVE PROLAPSE (Mitral Valve Prolapse Syndrome) [Disease or Syndrome]
Meta Mapping (816):
   760   History (Medical History) [Finding]
   695   MITRAL VALVE PROLAPSE (Mitral Valve Prolapse Syndrome) [Disease or Syndrome]
Meta Mapping (816):
   760   History (Concept History) [Conceptual Entity]
   695   MITRAL VALVE PROLAPSE (Mitral Valve Prolapse Syndrome) [Disease or Syndrome]
Meta Mapping (816):
   760   History (History of previous events) [Finding]
   695   MITRAL VALVE PROLAPSE (Mitral Valve Prolapse Syndrome) [Disease or Syndrome]

Phrase: diagnosed in l983 .
Meta Mapping (790):
   790   Diagnosed (Diagnosis) [Finding]
Processing 00000000.tx.17: She has no known drug allergies . 

Phrase: She

Phrase: has

Phrase: no known drug allergies .
Meta Mapping (901):
   660   Known [Qualitative Concept]
   901 N Drug Allergies (Drug Allergy) [Disease or Syndrome]
Processing 00000000.tx.18: REVIEW OF SYSTEMS : Negative for bruises or other lesions . 

Phrase: REVIEW OF SYSTEMS
Meta Mapping (1000):
  1000   Review of systems (Review of systems:Finding:Point in time:^Patient:Narrative:Reported) [Clinical Attribute]
Meta Mapping (1000):
  1000   Review of systems (Review of systems:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]
Meta Mapping (1000):
  1000   Review of Systems (Review of systems (procedure)) [Health Care Activity]

Phrase: :

Phrase: Negative for bruises
Meta Mapping (746):
   790   Negative [Qualitative Concept]
   623 N Bruises (Contusions) [Injury or Poisoning]
Meta Mapping (746):
   790   NEGATIVE (Negative Finding) [Finding]
   623 N Bruises (Contusions) [Injury or Poisoning]
Meta Mapping (746):
   790   Negative (Negative Number) [Conceptual Entity]
   623 N Bruises (Contusions) [Injury or Poisoning]
Meta Mapping (746):
   790   Negative (Negative Charge) [Qualitative Concept]
   623 N Bruises (Contusions) [Injury or Poisoning]
Meta Mapping (746):
   790   Negative (Negative - answer) [Qualitative Concept]
   623 N Bruises (Contusions) [Injury or Poisoning]

Phrase: or

Phrase: other lesions .
Meta Mapping (1000):
  1000 N lesions (Lesion) [Finding]
Processing 00000000.tx.19: Knee flexors were 4+ bilaterally . 

Phrase: Knee flexors
Meta Mapping (872):
   694   Knee [Body Part, Organ, or Organ Component]
   827   Flexor (Flexor (Anatomical coordinate)) [Body Location or Region]
Meta Mapping (872):
   694   Knee (Knee joint) [Body Space or Junction]
   827   Flexor (Flexor (Anatomical coordinate)) [Body Location or Region]
Meta Mapping (872):
   694   Knee (Entire knee region) [Body Location or Region]
   827   Flexor (Flexor (Anatomical coordinate)) [Body Location or Region]
Meta Mapping (872):
   694   Knee, NOS (Knee region structure) [Body Location or Region]
   827   Flexor (Flexor (Anatomical coordinate)) [Body Location or Region]

Phrase: were

Phrase: 4+ bilaterally .
Meta Mapping (861):
   861   4+ (4+ Answer to question) [Finding]
Processing 00000000.tx.20: PT was l3.l and PTT was 30.9 . 

Phrase: PT
Meta Mapping (1000):
  1000   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]

Phrase: was

Phrase: l3.l
Meta Mapping (694):
   694   L3 (L3 innervation) [Body Location or Region]
Meta Mapping (694):
   694   L3 (RPL3 gene) [Gene or Genome]

Phrase: and

Phrase: PTT
Meta Mapping (1000):
  1000   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]

Phrase: was

Phrase: 30.9 .
Meta Mapping (861):
   861   30% [Finding]
Processing 00000000.tx.21: No old EKG was available for comparison . 

Phrase: No old EKG
Meta Mapping (888):
   694   Old [Temporal Concept]
   861 N EKG (Electrocardiogram) [Finding]
Meta Mapping (888):
   694   Old [Temporal Concept]
   861   EKG (Electrocardiography) [Diagnostic Procedure]

Phrase: was

Phrase: available for comparison .
Meta Mapping (746):
   790   Available (Availability of) [Functional Concept]
   623   Comparison [Activity]
Processing 00000000.tx.22: Serum IgG was elevated at l,520 . 

Phrase: Serum IgG
Meta Mapping (694):
   694   SERUM (Serum) [Body Substance]
Meta Mapping (694):
   694   Serum (Specimen Source Codes - Serum) [Intellectual Product]
Meta Mapping (694):
   694   Serum (Specimen Type - Serum) [Body Substance]

Phrase: was

Phrase: elevated at l,
Meta Mapping (790):
   790   Elevated (High) [Qualitative Concept]
Meta Mapping (790):
   790   Elevated [Qualitative Concept]

Phrase: 520 .
Processing 00000000.tx.23: ________________________________ 08/21/90 08/25/90 TRANGCA F. 

Phrase: ________________________________ 08/21/90 08/25/90 TRANGCA F.
Meta Mapping (576):
   670   21/25 [Quantitative Concept]
   626   >90 [Quantitative Concept]
Meta Mapping (576):
   670   21/25 [Quantitative Concept]
   626   <90 [Quantitative Concept]
Meta Mapping (576):
   670   21/25 [Quantitative Concept]
   626   90% [Finding]
Processing 00000000.tx.24: OR , M.D. 

Phrase: OR

Phrase: ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.25: OU12

Phrase: OU12
Processing 00000000.tx.1: The patient is a 28-year-old woman who is HIV positive for two years . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: a 28-year-old woman
Meta Mapping (775):
   645   YEAR (year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   WOMAN (Woman) [Population Group]
Meta Mapping (775):
   645   /Year (per year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   WOMAN (Woman) [Population Group]

Phrase: who

Phrase: is

Phrase: HIV positive for two years .
Meta Mapping (752):
   806   HIV POSITIVE (HIV Seropositivity) [Laboratory or Test Result]
   593   Two [Quantitative Concept]
   593   YEARS (year) [Temporal Concept]
Processing 00000000.tx.2: She has complaints of nausea and vomiting as well as left upper quadrant pain on and off getting progressively worse over the past month . 

Phrase: She

Phrase: has

Phrase: complaints of nausea
Meta Mapping (746):
   790   complaints (Chief complaint (finding)) [Finding]
   623   NAUSEA (Nausea) [Sign or Symptom]
Meta Mapping (746):
   790   complaints (Chief complaint (finding)) [Finding]
   623   Nausea (Nausea Adverse Event) [Pathologic Function]

Phrase: and

Phrase: vomiting
Meta Mapping (1000):
  1000   VOMITING (Vomiting) [Sign or Symptom]
Meta Mapping (1000):
  1000   Vomiting (Vomiting Adverse Event) [Pathologic Function]

Phrase: as well as

Phrase: left upper quadrant pain on and off getting
Meta Mapping (694):
   694   Left upper quadrant pain [Sign or Symptom]

Phrase: progressively worse over the past month .
Meta Mapping (672):
   753   worse (Worsening pattern) [Qualitative Concept]
   586   Past [Temporal Concept]
   586   /month (Monthly (qualifier value)) [Temporal Concept]
Meta Mapping (672):
   753   worse (Worsening pattern) [Qualitative Concept]
   586   Past [Temporal Concept]
   586   MONTH (month) [Temporal Concept]
Meta Mapping (672):
   753   worse (Worsening pattern) [Qualitative Concept]
   586   Past [Temporal Concept]
   586   /month (per month (qualifier value)) [Temporal Concept]
Meta Mapping (672):
   753   Worse (Deterioration of status) [Finding]
   586   Past [Temporal Concept]
   586   /month (Monthly (qualifier value)) [Temporal Concept]
Meta Mapping (672):
   753   Worse (Deterioration of status) [Finding]
   586   Past [Temporal Concept]
   586   MONTH (month) [Temporal Concept]
Meta Mapping (672):
   753   Worse (Deterioration of status) [Finding]
   586   Past [Temporal Concept]
   586   /month (per month (qualifier value)) [Temporal Concept]
Meta Mapping (672):
   753   Worse [Finding]
   586   Past [Temporal Concept]
   586   /month (Monthly (qualifier value)) [Temporal Concept]
Meta Mapping (672):
   753   Worse [Finding]
   586   Past [Temporal Concept]
   586   MONTH (month) [Temporal Concept]
Meta Mapping (672):
   753   Worse [Finding]
   586   Past [Temporal Concept]
   586   /month (per month (qualifier value)) [Temporal Concept]
Processing 00000000.tx.3: Extremities revealed a 2 x 3 cm tender mass in the lateral left calf , medial 1 cm mass above her knee . 

Phrase: Extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a 2 x 3 cm tender mass in the lateral left calf ,
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MASS (Mass of body structure) [Finding]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   CALF (Structure of calf of leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MASS (Mass of body structure) [Finding]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Entire calf of leg (body structure)) [Body Part, Organ, or Organ Component]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MASS (Mass of body structure) [Finding]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Cattle calf (organism)) [Mammal]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MASS (Mass of body structure) [Finding]
   570   LATERAL (Lateral) [Spatial Concept]
   586   Left calf (Posterior part of left leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Mass of body region) [Sign or Symptom]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   CALF (Structure of calf of leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Mass of body region) [Sign or Symptom]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Entire calf of leg (body structure)) [Body Part, Organ, or Organ Component]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Mass of body region) [Sign or Symptom]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Cattle calf (organism)) [Mammal]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Mass of body region) [Sign or Symptom]
   570   LATERAL (Lateral) [Spatial Concept]
   586   Left calf (Posterior part of left leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   CALF (Structure of calf of leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Entire calf of leg (body structure)) [Body Part, Organ, or Organ Component]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Cattle calf (organism)) [Mammal]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
   570   LATERAL (Lateral) [Spatial Concept]
   586   Left calf (Posterior part of left leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   CALF (Structure of calf of leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Entire calf of leg (body structure)) [Body Part, Organ, or Organ Component]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Cattle calf (organism)) [Mammal]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
   570   LATERAL (Lateral) [Spatial Concept]
   586   Left calf (Posterior part of left leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Molecular Mass) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   CALF (Structure of calf of leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Molecular Mass) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Entire calf of leg (body structure)) [Body Part, Organ, or Organ Component]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Molecular Mass) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Cattle calf (organism)) [Mammal]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   Mass (Molecular Mass) [Quantitative Concept]
   570   LATERAL (Lateral) [Spatial Concept]
   586   Left calf (Posterior part of left leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   mAs (Milliampere second) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   CALF (Structure of calf of leg) [Body Location or Region]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   mAs (Milliampere second) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Entire calf of leg (body structure)) [Body Part, Organ, or Organ Component]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   mAs (Milliampere second) [Quantitative Concept]
   586   lateral left (Lateral to the left) [Spatial Concept]
   570   Calf (Cattle calf (organism)) [Mammal]
Meta Mapping (686):
   599   CM 2-3 [Amino Acid, Peptide, or Protein]
   570   Tender [Qualitative Concept]
   736   mAs (Milliampere second) [Quantitative Concept]
   570   LATERAL (Lateral) [Spatial Concept]
   586   Left calf (Posterior part of left leg) [Body Location or Region]

Phrase: medial 1 cm mass above her knee .
Meta Mapping (701):
   581   MEDIAL (Medial) [Spatial Concept]
   774   KNEE MASS (Mass of knee) [Finding]
Processing 00000000.tx.4: Alkaline phosphatase 190 . 

Phrase: Alkaline phosphatase 190 .
Meta Mapping (901):
   901   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (901):
   901   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.5: A follow-up CT scan was done which did not show any evidence for splenomegaly or hepatomegaly . 

Phrase: A follow-up CT scan
Meta Mapping (888):
   694   Follow-up (Follow-up status) [Finding]
   861   CT SCAN (X-Ray Computed Tomography) [Diagnostic Procedure]
Meta Mapping (888):
   694   Follow Up (follow-up) [Health Care Activity]
   861   CT SCAN (X-Ray Computed Tomography) [Diagnostic Procedure]
Meta Mapping (888):
   694   Follow-Up (Follow-Up Report) [Intellectual Product]
   861   CT SCAN (X-Ray Computed Tomography) [Diagnostic Procedure]
Meta Mapping (888):
   694   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   861   CT SCAN (X-Ray Computed Tomography) [Diagnostic Procedure]

Phrase: was

Phrase: done

Phrase: which

Phrase: did

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: show
Meta Mapping (1000):
  1000   Show [Animal]

Phrase: any evidence for splenomegaly
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604 N SPLENOMEGALY (Splenomegaly) [Finding]

Phrase: or

Phrase: hepatomegaly .
Meta Mapping (1000):
  1000 N HEPATOMEGALY (Hepatomegaly) [Sign or Symptom]
Processing 00000000.tx.6: The 1 cm cyst which was seen in 10/92 was still present . 

Phrase: The 1 cm cyst
Meta Mapping (802):
   660   1+ (1+ Score) [Quantitative Concept]
   827   CYST (Cyst) [Disease or Syndrome]
Meta Mapping (802):
   660   1+ (1+ Score) [Quantitative Concept]
   827   Cyst (Cyst form of protozoa) [Eukaryote]
Meta Mapping (802):
   660   1+ (1+ Score, WHO) [Classification]
   827   CYST (Cyst) [Disease or Syndrome]
Meta Mapping (802):
   660   1+ (1+ Score, WHO) [Classification]
   827   Cyst (Cyst form of protozoa) [Eukaryote]
Meta Mapping (802):
   660   1+ [Finding]
   827   CYST (Cyst) [Disease or Syndrome]
Meta Mapping (802):
   660   1+ [Finding]
   827   Cyst (Cyst form of protozoa) [Eukaryote]

Phrase: which

Phrase: was

Phrase: seen in 10/92
Meta Mapping (708):
   770   Seen (seen) [Qualitative Concept]
   770   10% [Finding]

Phrase: was

Phrase: still

Phrase: present .
Meta Mapping (1000):
  1000   Present [Quantitative Concept]
Meta Mapping (1000):
  1000   Present (Presentation) [Idea or Concept]
Processing 00000000.tx.7: The patient was discharged to home in stable condition . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: discharged to home
Meta Mapping (988):
   988   Discharge to home [Therapeutic or Preventive Procedure]

Phrase: in stable condition .
Meta Mapping (1000):
  1000   Stable condition (Stable Disease) [Finding]
Meta Mapping (1000):
  1000   Stable condition (Stable chronic Graft vs Host Disease) [Finding]
Processing 00000000.tx.8: Batch : 977159532 Supple . 

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: 977159532 Supple .
Meta Mapping (861):
   861   Supple [Functional Concept]
Processing 00000000.tx.9: Regular rate and rhythm with a II / VI systolic ejection murmur heard best at the right second intercostal space . 

Phrase: Regular rate
Meta Mapping (888):
   694   Regular [Qualitative Concept]
   861   Rate (Rating (action)) [Activity]
Meta Mapping (888):
   694   Regular [Qualitative Concept]
   861   Rate [Quantitative Concept]

Phrase: and

Phrase: rhythm with a II / VI systolic ejection murmur heard
Meta Mapping (712):
   742   Rhythm [Finding]
   575   VI (British Virgin Islands) [Geographic Area]
   623   SYSTOLIC EJECTION MURMUR [Finding]
   542   hear (Hearing) [Physiologic Function]
Meta Mapping (712):
   742   Rhythm [Finding]
   575   VI (British Virgin Islands) [Geographic Area]
   623   SYSTOLIC EJECTION MURMUR [Finding]
   542   HEAR (HEAR - answer to question) [Finding]
Meta Mapping (712):
   742   rhythm (rhythmic process (biological)) [Physiologic Function]
   575   VI (British Virgin Islands) [Geographic Area]
   623   SYSTOLIC EJECTION MURMUR [Finding]
   542   hear (Hearing) [Physiologic Function]
Meta Mapping (712):
   742   rhythm (rhythmic process (biological)) [Physiologic Function]
   575   VI (British Virgin Islands) [Geographic Area]
   623   SYSTOLIC EJECTION MURMUR [Finding]
   542   HEAR (HEAR - answer to question) [Finding]
Meta Mapping (712):
   742   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
   575   VI (British Virgin Islands) [Geographic Area]
   623   SYSTOLIC EJECTION MURMUR [Finding]
   542   hear (Hearing) [Physiologic Function]
Meta Mapping (712):
   742   Rhythm Not Otherwise Specified (Rhythm Not Otherwise Specified ECG Assessment) [Intellectual Product]
   575   VI (British Virgin Islands) [Geographic Area]
   623   SYSTOLIC EJECTION MURMUR [Finding]
   542   HEAR (HEAR - answer to question) [Finding]

Phrase: best at the right second intercostal space .
Meta Mapping (755):
   748   Best (best (quality)) [Qualitative Concept]
   581   RIGHT (Right) [Spatial Concept]
   647   Second intercostal space (Structure of second intercostal space) [Body Space or Junction]
Meta Mapping (755):
   748   Best (best (quality)) [Qualitative Concept]
   581   RIGHT (Right) [Spatial Concept]
   647   Second intercostal space (Entire second intercostal space) [Body Space or Junction]
Meta Mapping (755):
   748   Best (best (quality)) [Qualitative Concept]
   581   Right (Right sided) [Spatial Concept]
   647   Second intercostal space (Structure of second intercostal space) [Body Space or Junction]
Meta Mapping (755):
   748   Best (best (quality)) [Qualitative Concept]
   581   Right (Right sided) [Spatial Concept]
   647   Second intercostal space (Entire second intercostal space) [Body Space or Junction]
Processing 00000000.tx.10: RECTAL : Her chest X-Ray was within normal limits with a calcified aortic knob . 

Phrase: RECTAL
Meta Mapping (1000):
  1000   Rectal (rectal) [Spatial Concept]

Phrase: :

Phrase: Her chest X-Ray
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: was within normal limits
Meta Mapping (833):
   833   Normal limits [Quantitative Concept]

Phrase: with a calcified aortic knob .
Meta Mapping (851):
   660   Calcified (Calcified (qualifier)) [Qualitative Concept]
   660   Aortic (Aorta) [Body Part, Organ, or Organ Component]
   827   Knob (Knob Device Component) [Manufactured Object]
Meta Mapping (851):
   660   Calcified (Calcified Medical Device Material) [Phenomenon or Process]
   660   Aortic (Aorta) [Body Part, Organ, or Organ Component]
   827   Knob (Knob Device Component) [Manufactured Object]
Meta Mapping (851):
   660   CALCIFIED (Calcified Specimen) [Qualitative Concept]
   660   Aortic (Aorta) [Body Part, Organ, or Organ Component]
   827   Knob (Knob Device Component) [Manufactured Object]
Processing 00000000.tx.11: DX608/0614 TOMEDANKELL D. 

Phrase: DX608/0614 TOMEDANKELL D.
Processing 00000000.tx.12: FLOWAYLES , JR , M.D. 

Phrase: FLOWAYLES ,

Phrase: JR ,
Meta Mapping (1000):
  1000   Jr (Junior) [Idea or Concept]
Meta Mapping (1000):
  1000   JR (BLOOD GROUP, JUNIOR SYSTEM) [Body System]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.13: CD0 9134959 (5) peptic ulcer disease . 

Phrase: CD0 9134959

Phrase: (5
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]

Phrase: )

Phrase: peptic ulcer disease .
Meta Mapping (1000):
  1000   PEPTIC ULCER DISEASE (Peptic Ulcer) [Disease or Syndrome]
Processing 00000000.tx.14: The chest tube was removed , but then replaced on the 14th of February , and maintained a continuous and large volume output . 

Phrase: The chest tube
Meta Mapping (1000):
  1000   Chest Tube (Chest Tubes) [Medical Device]

Phrase: was

Phrase: removed
Meta Mapping (1000):
  1000   Removed [Qualitative Concept]

Phrase: ,

Phrase: but

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: replaced on the 14th of February ,
Meta Mapping (672):
   753   Replaced (Replacement) [Functional Concept]
   753   February [Qualitative Concept]
Meta Mapping (672):
   753   replaced (Replaced by) [Functional Concept]
   753   February [Qualitative Concept]

Phrase: and

Phrase: maintained
Meta Mapping (1000):
  1000   Maintained (Maintaining (action)) [Functional Concept]

Phrase: a continuous
Meta Mapping (1000):
  1000   CONTINUOUS (Continuous) [Idea or Concept]

Phrase: and

Phrase: large volume output .
Meta Mapping (851):
   660   LARGE (Large) [Quantitative Concept]
   660   *Volume (Volume) [Quantitative Concept]
   827   Output (system output) [Conceptual Entity]
Meta Mapping (851):
   660   LARGE (Large) [Quantitative Concept]
   660   % volume (% volume (qualifier value)) [Qualitative Concept]
   827   Output (system output) [Conceptual Entity]
Meta Mapping (851):
   660   LARGE (Large) [Quantitative Concept]
   660   Volume (Volume (publication)) [Intellectual Product]
   827   Output (system output) [Conceptual Entity]
Meta Mapping (851):
   660   LARGE (Large) [Quantitative Concept]
   660   Volume (Volume Measurement) [Laboratory Procedure]
   827   Output (system output) [Conceptual Entity]
Processing 00000000.tx.15: Blood cultures in this setting grew out Staphylococcus aureus and antibiotic coverage was altered to cover this organism appropriately . 

Phrase: Blood cultures in this setting
Meta Mapping (734):
   781   Culture-blood (Blood culture) [Laboratory Procedure]
   593   Setting (contextual factors) [Functional Concept]
Meta Mapping (734):
   781   Culture-blood (Blood culture) [Laboratory Procedure]
   593   {Setting} [Quantitative Concept]
Meta Mapping (734):
   781   Culture - blood (Blood for culture) [Finding]
   593   Setting (contextual factors) [Functional Concept]
Meta Mapping (734):
   781   Culture - blood (Blood for culture) [Finding]
   593   {Setting} [Quantitative Concept]

Phrase: grew

Phrase: out Staphylococcus aureus
Meta Mapping (901):
   660   Out (Out (direction)) [Spatial Concept]
   901   STAPHYLOCOCCUS AUREUS (Staphylococcus aureus) [Bacterium]
Meta Mapping (901):
   660   Out (Out (direction)) [Spatial Concept]
   901   Staphylococcus aureus NOS (Staphylococcus aureus infection) [Disease or Syndrome]
Meta Mapping (901):
   660   Out (Removed) [Qualitative Concept]
   901   STAPHYLOCOCCUS AUREUS (Staphylococcus aureus) [Bacterium]
Meta Mapping (901):
   660   Out (Removed) [Qualitative Concept]
   901   Staphylococcus aureus NOS (Staphylococcus aureus infection) [Disease or Syndrome]

Phrase: and

Phrase: antibiotic coverage
Meta Mapping (1000):
  1000   Antibiotic coverage (Antibiotic Prophylaxis) [Therapeutic or Preventive Procedure]

Phrase: was

Phrase: altered
Meta Mapping (1000):
  1000   Altered (Changing) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: cover
Meta Mapping (1000):
  1000   cover (Covers (device)) [Medical Device]
Meta Mapping (1000):
  1000   Cover (Cover Device Component) [Medical Device]
Meta Mapping (1000):
  1000   Cover (Cover - action) [Functional Concept]
Meta Mapping (1000):
  1000   Cover (Cover (physical object)) [Manufactured Object]

Phrase: this organism appropriately .
Meta Mapping (861):
   861   Organism [Organism]
Processing 00000000.tx.16: 09/01/97 11:44 P 6/22/1993 12:00:00 AM DIS Mrs. 

Phrase: 09/01/97 11
Meta Mapping (812):
   812   97 [Intellectual Product]
Meta Mapping (812):
   812   >97 [Quantitative Concept]

Phrase: :

Phrase: 44 P 6/22/1993 12

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: DIS Mrs.
Meta Mapping (888):
   694   DIS (Diagnostic interview schedule) [Intellectual Product]
   861   MRS (magnetic resonance spectroscopic imaging) [Diagnostic Procedure]
Meta Mapping (888):
   694   DIS (Diagnostic interview schedule) [Intellectual Product]
   861   Mrs. (Mrs - title) [Conceptual Entity]
Meta Mapping (888):
   694   DIS (Diagnostic interview schedule) [Intellectual Product]
   861   MRS (Modified Rankin Scale Questionnaire) [Intellectual Product]
Meta Mapping (888):
   694   DIS (Diagnostic interview schedule) [Intellectual Product]
   861   mRS (Modified rankin scale:Score:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (888):
   694   DIS (Discontinued) [Finding]
   861   MRS (magnetic resonance spectroscopic imaging) [Diagnostic Procedure]
Meta Mapping (888):
   694   DIS (Discontinued) [Finding]
   861   Mrs. (Mrs - title) [Conceptual Entity]
Meta Mapping (888):
   694   DIS (Discontinued) [Finding]
   861   MRS (Modified Rankin Scale Questionnaire) [Intellectual Product]
Meta Mapping (888):
   694   DIS (Discontinued) [Finding]
   861   mRS (Modified rankin scale:Score:Point in time:^Patient:Ordinal) [Clinical Attribute]
Processing 00000000.tx.17: Cast is a 50 year old white female with a history of chronic obstructive pulmonary disease and evidence of severe lobular emphysema , who has progressive shortness of breath and inability to carry on with activities of daily living without assistance . 

Phrase: Cast
Meta Mapping (1000):
  1000   Cast (Orthopedic Cast) [Medical Device]
Meta Mapping (1000):
  1000   Cast (Casts body substance) [Body Substance]
Meta Mapping (1000):
  1000   CAST (CD3EAP protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Meta Mapping (1000):
  1000   CAST (Urine Casts) [Body Substance]

Phrase: is

Phrase: a 50 year old white female with a history of chronic obstructive pulmonary disease
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   50% [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   YEAR (year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasoid Race) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (Caucasians) [Population Group]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   FEMALE (Female) [Organism Attribute]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Woman) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   female (Females) [Population Group]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female, Self-Report) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease (disease history) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (H/O: Disorder) [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of disease [Finding]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (696):
   568   <50 [Finding]
   568   /Year (per year) [Temporal Concept]
   568   Old [Temporal Concept]
   734   WHITE (White color) [Qualitative Concept]
   734   Female (Female Phenotype) [Qualitative Concept]
   594   History of Disease (History of symptoms & diseases:Finding:Point in time:^Patient:Nominal:Observed) [Clinical Attribute]
   568   CHRONIC (chronic) [Temporal Concept]
   568   Obstructive (Obstructed) [Functional Concept]
   568   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]

Phrase: and

Phrase: evidence of severe lobular emphysema ,
Meta Mapping (733):
   760   Evidence [Idea or Concept]
   593   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   593   Lobular [Qualitative Concept]
   593   -- Emphysema (Pathological accumulation of air in tissues) [Pathologic Function]
Meta Mapping (733):
   760   Evidence [Idea or Concept]
   593   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   593   Lobular [Qualitative Concept]
   593   EMPHYSEMA (Pulmonary Emphysema) [Disease or Syndrome]
Meta Mapping (733):
   760   Evidence [Idea or Concept]
   593   Severe (Severe Extremity Pain) [Intellectual Product]
   593   Lobular [Qualitative Concept]
   593   -- Emphysema (Pathological accumulation of air in tissues) [Pathologic Function]
Meta Mapping (733):
   760   Evidence [Idea or Concept]
   593   Severe (Severe Extremity Pain) [Intellectual Product]
   593   Lobular [Qualitative Concept]
   593   EMPHYSEMA (Pulmonary Emphysema) [Disease or Syndrome]
Meta Mapping (733):
   760   Evidence [Idea or Concept]
   593   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   593   Lobular [Qualitative Concept]
   593   -- Emphysema (Pathological accumulation of air in tissues) [Pathologic Function]
Meta Mapping (733):
   760   Evidence [Idea or Concept]
   593   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   593   Lobular [Qualitative Concept]
   593   EMPHYSEMA (Pulmonary Emphysema) [Disease or Syndrome]

Phrase: who

Phrase: has

Phrase: progressive shortness of breath
Meta Mapping (916):
   604   Progressive [Functional Concept]
   909   SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (916):
   604   Progressive [Functional Concept]
   909   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: and

Phrase: inability

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: carry on
Meta Mapping (833):
   833   Carry (Carrying) [Activity]
Meta Mapping (833):
   833   carry (Does carry) [Finding]

Phrase: with activities of daily living
Meta Mapping (926):
   926   Activities of Daily Living (Activities of Daily Living (activity)) [Daily or Recreational Activity]
Meta Mapping (926):
   926   Activities of Daily Living (Activities of Daily Living Scale (BASC-2)) [Intellectual Product]

Phrase: without assistance .
Meta Mapping (1000):
  1000   Assistance (Helping Behavior) [Social Behavior]
Meta Mapping (1000):
  1000   Assistance (Assisted (qualifier value)) [Qualitative Concept]
Processing 00000000.tx.18: SOCIAL HISTORY : Serum sodium 141 , potassium 4.0 , chloride 106 , C02 29.6 , calcium 9.2 , phosphorus 3.6 . 

Phrase: SOCIAL HISTORY
Meta Mapping (1000):
  1000   Social history (Social and personal history) [Finding]
Meta Mapping (1000):
  1000   Social History [Finding]

Phrase: :

Phrase: Serum sodium 141 ,
Meta Mapping (901):
   901   Serum sodium (Serum sodium measurement) [Laboratory Procedure]

Phrase: potassium 4.0 ,
Meta Mapping (802):
   827   POTASSIUM (Potassium) [Element, Ion, or Isotope]
   827   0% [Finding]
Meta Mapping (802):
   827   Potassium+ (Potassium measurement) [Laboratory Procedure]
   827   0% [Finding]
Meta Mapping (802):
   827   POTASSIUM (Potassium supplement) [Inorganic Chemical,Pharmacologic Substance]
   827   0% [Finding]
Meta Mapping (802):
   827   Potassium (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
   827   0% [Finding]
Meta Mapping (802):
   827   POTASSIUM (Potassium Drug Class) [Pharmacologic Substance]
   827   0% [Finding]

Phrase: chloride 106 ,
Meta Mapping (861):
   861   Chloride, NOS (Chlorides) [Inorganic Chemical]
Meta Mapping (861):
   861   CHLORIDE (Chloride Ion) [Element, Ion, or Isotope]

Phrase: C02 29.6 ,
Meta Mapping (827):
   827   29+ [Finding]

Phrase: calcium 9.2 ,
Meta Mapping (913):
   913   Calcium 2+ (Calcium ion) [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: phosphorus 3.6 .
Meta Mapping (827):
   827   PHOSPHORUS (Phosphorus) [Element, Ion, or Isotope]
Meta Mapping (827):
   827   PHOSPHORUS (Dietary Phosphorus) [Element, Ion, or Isotope]
Meta Mapping (827):
   827   PHOSPHORUS (Phosphorus Drug Class) [Pharmacologic Substance]
Processing 00000000.tx.19: Estradialol pending . 

Phrase: Estradialol pending .
Processing 00000000.tx.20: Varicella antibody positive , CMV antibody positive , toxo negative , RPR non reactive . 

Phrase: Varicella antibody positive , CMV antibody positive , toxo negative ,
Meta Mapping (769):
   892   VARICELLA negative (Human herpesvirus 3 negative) [Laboratory or Test Result]
   645   antibody positive [Laboratory or Test Result]
   626   TOXO [Finding]

Phrase: RPR
Meta Mapping (1000):
  1000   RPR (EXTL3 wt Allele) [Gene or Genome]

Phrase: non reactive .
Meta Mapping (1000):
  1000   Non-Reactive [Qualitative Concept]
Processing 00000000.tx.21: A left and right heart catheterization and coronary angiogram revealed aortic 120/70 , mean 95 , PA 26/10 , mean 17 , PC 7 , RV 26/6 , RA 4 , cardiac output 5.7 , index 3.8 . 

Phrase: A left
Meta Mapping (1000):
  1000   LEFT (Left) [Spatial Concept]
Meta Mapping (1000):
  1000   Left (Left sided) [Spatial Concept]
Meta Mapping (1000):
  1000   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: and

Phrase: right heart catheterization
Meta Mapping (1000):
  1000   Right heart catheterisation (Catheterization of right heart) [Diagnostic Procedure]

Phrase: and

Phrase: coronary angiogram
Meta Mapping (1000):
  1000   Coronary angiogram, NOS (Coronary angiography) [Diagnostic Procedure]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: aortic 120/70 ,
Meta Mapping (802):
   827   Aortic (Aorta) [Body Part, Organ, or Organ Component]
   827   70% [Finding]

Phrase: mean 95 ,
Meta Mapping (861):
   861   Mean (Statistical mean) [Quantitative Concept]
Meta Mapping (861):
   861   Mean (Population Mean) [Quantitative Concept]
Meta Mapping (861):
   861   Mean (Sample Mean) [Quantitative Concept]

Phrase: PA 26/10 ,
Meta Mapping (802):
   827   PA (Paraguay) [Geographic Area]
   827   10% [Finding]
Meta Mapping (802):
   827   PA (Pairing Events Domain) [Intellectual Product]
   827   10% [Finding]

Phrase: mean 17 ,
Meta Mapping (861):
   861   Mean (Statistical mean) [Quantitative Concept]
Meta Mapping (861):
   861   Mean (Population Mean) [Quantitative Concept]
Meta Mapping (861):
   861   Mean (Sample Mean) [Quantitative Concept]

Phrase: PC 7 ,
Meta Mapping (861):
   861   PC (Pitcairn Island) [Geographic Area]
Meta Mapping (861):
   861   PC (Pyruvate Carboxylase Deficiency Disease) [Disease or Syndrome]
Meta Mapping (861):
   861   PC (PODXL protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Meta Mapping (861):
   861   PC (PROC wt Allele) [Gene or Genome]
Meta Mapping (861):
   861   PC (KRT17 wt Allele) [Gene or Genome]
Meta Mapping (861):
   861   PC (PODXL wt Allele) [Gene or Genome]

Phrase: RV 26/6 ,
Meta Mapping (827):
   827   RV (Residual volume) [Clinical Attribute]
Meta Mapping (827):
   827   RV (Randomization Validation) [Research Activity]

Phrase: RA 4 ,
Meta Mapping (861):
   861   Ra (Axial R) [Spatial Concept]
Meta Mapping (861):
   861   RA (Right arm) [Body Part, Organ, or Organ Component]

Phrase: cardiac output 5.7 ,
Meta Mapping (861):
   861   Cardiac Output [Clinical Attribute]

Phrase: index 3.8 .
Meta Mapping (827):
   827   Index [Intellectual Product]
Meta Mapping (827):
   827   index (Html Link Type - index) [Idea or Concept]
Meta Mapping (827):
   827   % index [Quantitative Concept]
Processing 00000000.tx.22: A quantitative VQ scan of the lung showed 42% ventilation to the left , 57% ventilation to the right , 42% perfusion to the left , 57% perfusion to the right . 

Phrase: A quantitative VQ scan of the lung
Meta Mapping (701):
   581   Quantitative [Quantitative Concept]
   778   vq scan (VQ - Ventilation perfusion scan) [Diagnostic Procedure]
   581   LUNG (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (701):
   581   Quantitative [Quantitative Concept]
   778   vq scan (VQ - Ventilation perfusion scan) [Diagnostic Procedure]
   581   LUNG (Structure of parenchyma of lung) [Tissue]
Meta Mapping (701):
   581   Quantitative [Quantitative Concept]
   778   vq scan (VQ - Ventilation perfusion scan) [Diagnostic Procedure]
   581   Lung (Entire lung) [Body Part, Organ, or Organ Component]
Meta Mapping (701):
   581   Quantitative [Quantitative Concept]
   748   VQ (United States Virgin Islands) [Geographic Area]
   774   scan lung (Radioisotope scan of lung) [Diagnostic Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: 42% ventilation to the left ,
Meta Mapping (686):
   760   ventilation (Respiration) [Physiologic Function]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (686):
   760   ventilation (Respiration) [Physiologic Function]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (686):
   760   ventilation (Respiration) [Physiologic Function]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (686):
   760   Ventilation (Environmental air flow) [Phenomenon or Process]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Environmental air flow) [Phenomenon or Process]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Environmental air flow) [Phenomenon or Process]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]
Meta Mapping (686):
   760   Ventilation (Ventilation, function (observable entity)) [Physiologic Function]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Ventilation, function (observable entity)) [Physiologic Function]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Ventilation, function (observable entity)) [Physiologic Function]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: 57% ventilation to the right ,
Meta Mapping (686):
   760   ventilation (Respiration) [Physiologic Function]
   593   RIGHT (Right) [Spatial Concept]
Meta Mapping (686):
   760   ventilation (Respiration) [Physiologic Function]
   593   Right (Right sided) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Environmental air flow) [Phenomenon or Process]
   593   RIGHT (Right) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Environmental air flow) [Phenomenon or Process]
   593   Right (Right sided) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Ventilation, function (observable entity)) [Physiologic Function]
   593   RIGHT (Right) [Spatial Concept]
Meta Mapping (686):
   760   Ventilation (Ventilation, function (observable entity)) [Physiologic Function]
   593   Right (Right sided) [Spatial Concept]

Phrase: 42% perfusion to the left ,
Meta Mapping (686):
   760   Perfusion (Perfusion (procedure)) [Therapeutic or Preventive Procedure]
   593   LEFT (Left) [Spatial Concept]
Meta Mapping (686):
   760   Perfusion (Perfusion (procedure)) [Therapeutic or Preventive Procedure]
   593   Left (Left sided) [Spatial Concept]
Meta Mapping (686):
   760   Perfusion (Perfusion (procedure)) [Therapeutic or Preventive Procedure]
   593   left (Table Cell Horizontal Align - left) [Functional Concept]

Phrase: 57% perfusion to the right .
Meta Mapping (686):
   760   Perfusion (Perfusion (procedure)) [Therapeutic or Preventive Procedure]
   593   RIGHT (Right) [Spatial Concept]
Meta Mapping (686):
   760   Perfusion (Perfusion (procedure)) [Therapeutic or Preventive Procedure]
   593   Right (Right sided) [Spatial Concept]
Processing 00000000.tx.23: </TEXT> COLON CARCINOMA DIS Sclerae were non-icteric . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > COLON CARCINOMA DIS Sclerae
Meta Mapping (852):
   694   COLON CARCINOMA (Colon Carcinoma) [Neoplastic Process]
   645   DIS (Diagnostic interview schedule) [Intellectual Product]
   779   SCLERA (Sclera) [Body Part, Organ, or Organ Component]
Meta Mapping (852):
   694   COLON CARCINOMA (Colon Carcinoma) [Neoplastic Process]
   645   DIS (Diagnostic interview schedule) [Intellectual Product]
   779   Sclera (Entire sclera) [Body Part, Organ, or Organ Component]
Meta Mapping (852):
   694   COLON CARCINOMA (Colon Carcinoma) [Neoplastic Process]
   645   DIS (Discontinued) [Finding]
   779   SCLERA (Sclera) [Body Part, Organ, or Organ Component]
Meta Mapping (852):
   694   COLON CARCINOMA (Colon Carcinoma) [Neoplastic Process]
   645   DIS (Discontinued) [Finding]
   779   Sclera (Entire sclera) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: non-icteric .
Meta Mapping (888):
   861   Non (Negation) [Functional Concept]
   861 N Icteric (Icterus) [Pathologic Function]
Meta Mapping (888):
   861   Non (Negation) [Functional Concept]
   861 N ICTERIC (Icteric Specimen) [Finding]
Processing 00000000.tx.24: No costovertebral angle tenderness was noted . 

Phrase: No costovertebral angle tenderness
Meta Mapping (1000):
  1000 N COSTOVERTEBRAL ANGLE TENDERNESS (Renal angle tenderness) [Sign or Symptom]

Phrase: was

Phrase: noted .
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]
Processing 00000000.tx.25: Neurological examination revealed that the patient was alert and oriented times three . 

Phrase: Neurological examination
Meta Mapping (1000):
  1000   Neurological Examination (Neurologic Examination) [Diagnostic Procedure]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: that

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: alert
Meta Mapping (1000):
  1000   ALERT (Consciousness clear) [Finding]
Meta Mapping (1000):
  1000   Alert [Functional Concept]
Meta Mapping (1000):
  1000   Alert (Alert:Type:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: and

Phrase: oriented
Meta Mapping (1000):
  1000   Oriented (Orientation (spatial)) [Spatial Concept]
Meta Mapping (1000):
  1000   Oriented (Oriented to place) [Finding]

Phrase: times three .
Meta Mapping (888):
   861   times (Time) [Temporal Concept]
   861   Three [Quantitative Concept]
Meta Mapping (888):
   861   Times [Quantitative Concept]
   861   Three [Quantitative Concept]
Processing 00000000.tx.26: The patient tolerated the procedure well . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: tolerated

Phrase: the procedure well .
Meta Mapping (888):
   861   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (Procedure (set of actions)) [Activity]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Procedure (set of actions)) [Activity]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (Procedure Domain) [Intellectual Product]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (Procedure Domain) [Intellectual Product]
   694   Well [Manufactured Object]
Meta Mapping (888):
   861   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
   694   Well (Good) [Qualitative Concept]
Meta Mapping (888):
   861   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
   694   Well [Manufactured Object]
Processing 00000000.tx.27: She was tolerating a house diet and was tolerating her pain with the aid of Percocet to be taken orally . 

Phrase: She

Phrase: was

Phrase: tolerating

Phrase: a house diet
Meta Mapping (888):
   694   house (Home environment) [Conceptual Entity]
   861   Diet [Food]
Meta Mapping (888):
   694   house (Home environment) [Conceptual Entity]
   861   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (888):
   694   house (Home environment) [Conceptual Entity]
   861   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   house (Home environment) [Conceptual Entity]
   861   DIET (Basal Diet) [Food]
Meta Mapping (888):
   694   house (Home environment) [Conceptual Entity]
   861   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (888):
   694   House (House (environment)) [Manufactured Object]
   861   Diet [Food]
Meta Mapping (888):
   694   House (House (environment)) [Manufactured Object]
   861   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (888):
   694   House (House (environment)) [Manufactured Object]
   861   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   House (House (environment)) [Manufactured Object]
   861   DIET (Basal Diet) [Food]
Meta Mapping (888):
   694   House (House (environment)) [Manufactured Object]
   861   Diet (Diet (animal life circumstance)) [Food]

Phrase: and

Phrase: was

Phrase: tolerating

Phrase: her pain with the aid of Percocet
Meta Mapping (652):
   748   PAIN (Pain) [Sign or Symptom]
   581   Aid (Manufactured aid) [Manufactured Object]
   581   Percocet [Organic Chemical,Pharmacologic Substance]
Meta Mapping (652):
   748   PAIN (Pain) [Sign or Symptom]
   581   Aid (Assisted (qualifier value)) [Qualitative Concept]
   581   Percocet [Organic Chemical,Pharmacologic Substance]
Meta Mapping (652):
   748   PAIN (Pain) [Sign or Symptom]
   581   AID (AICDA wt Allele) [Gene or Genome]
   581   Percocet [Organic Chemical,Pharmacologic Substance]
Meta Mapping (652):
   748   Pain NOS (Pain NOS Adverse Event) [Finding]
   581   Aid (Manufactured aid) [Manufactured Object]
   581   Percocet [Organic Chemical,Pharmacologic Substance]
Meta Mapping (652):
   748   Pain NOS (Pain NOS Adverse Event) [Finding]
   581   Aid (Assisted (qualifier value)) [Qualitative Concept]
   581   Percocet [Organic Chemical,Pharmacologic Substance]
Meta Mapping (652):
   748   Pain NOS (Pain NOS Adverse Event) [Finding]
   581   AID (AICDA wt Allele) [Gene or Genome]
   581   Percocet [Organic Chemical,Pharmacologic Substance]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: taken
Meta Mapping (1000):
  1000   Taken [Conceptual Entity]

Phrase: orally .
Meta Mapping (1000):
  1000   Orally (Oral) [Spatial Concept]
Processing 00000000.tx.28: Discharge Date : There were no arrhythmias , no ST changes to suggest ischemia . 

Phrase: Discharge Date
Meta Mapping (1000):
  1000   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Discharge date [Temporal Concept]

Phrase: :

Phrase: There

Phrase: were

Phrase: no arrhythmias ,
Meta Mapping (1000):
  1000 N Arrhythmias (Cardiac Arrhythmia) [Finding]

Phrase: no ST
Meta Mapping (1000):
  1000   ST (Saint Lucia) [Geographic Area]
Meta Mapping (1000):
  1000   ST (Character String Data Type) [Intellectual Product]

Phrase: changes
Meta Mapping (1000):
  1000   changes (Changing) [Functional Concept]
Meta Mapping (1000):
  1000   changes (Changed status) [Quantitative Concept]
Meta Mapping (1000):
  1000   Change (Delta (difference)) [Quantitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: suggest
Meta Mapping (1000):
  1000   Suggest (suggestion) [Idea or Concept]

Phrase: ischemia .
Meta Mapping (1000):
  1000 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Processing 00000000.tx.29: His extremities revealed no cyanosis , clubbing or edema . 

Phrase: His extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: no cyanosis ,
Meta Mapping (1000):
  1000 N CYANOSIS (Cyanosis) [Sign or Symptom]

Phrase: clubbing
Meta Mapping (1000):
  1000 N Clubbing (Clubbed Fingers) [Anatomical Abnormality]
Meta Mapping (1000):
  1000 N CLUBBING (Clubbing) [Sign or Symptom]

Phrase: or

Phrase: edema .
Meta Mapping (1000):
  1000 N OEDEMA (Edema) [Finding]
Meta Mapping (1000):
  1000   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Processing 00000000.tx.30: Hematocrit was 39.7 , white blood cell count 9.1 , platelets 202,000 , prothrombin time 12.4 , partial thromboplastin time 26.9 . 

Phrase: Hematocrit
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit level) [Finding]

Phrase: was

Phrase: 39.7 ,

Phrase: white blood cell count 9.1 ,
Meta Mapping (901):
   901   Blood Cell Count, White (White Blood Cell Count procedure) [Laboratory Procedure]
Meta Mapping (901):
   901   white blood cell count (White blood cell count laboratory result) [Laboratory or Test Result]

Phrase: platelets 202,000 ,
Meta Mapping (827):
   827   Platelets (Blood Platelets) [Cell]
Meta Mapping (827):
   827   Platelets (Platelets Adverse Event) [Finding]

Phrase: prothrombin time 12.4 ,
Meta Mapping (861):
   861   Time, Prothrombin (Prothrombin time assay) [Laboratory Procedure]
Meta Mapping (861):
   861   Prothrombin time (Coagulation tissue factor induced:Time:Pt:PPP:Qn:Coag) [Clinical Attribute]

Phrase: partial thromboplastin time 26.9 .
Meta Mapping (884):
   884   Partial Thromboplastin Time (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
Processing 00000000.tx.31: There was a question of a depressive component to his fatigue . 

Phrase: There

Phrase: was

Phrase: a question of a depressive component
Meta Mapping (672):
   753   Question (Question (inquiry)) [Intellectual Product]
   586   Component (Component object) [Manufactured Object]
Meta Mapping (672):
   753   Question (Question (inquiry)) [Intellectual Product]
   586   Component (Component (part)) [Conceptual Entity]

Phrase: to his fatigue .
Meta Mapping (1000):
  1000   FATIGUE (Fatigue) [Sign or Symptom]
Meta Mapping (1000):
  1000   Fatigue (Fatigue Subordinate Domain) [Intellectual Product]
Processing 00000000.tx.32: The patient was discharged on 2-6-90 . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: discharged on 2-6-90 .
Meta Mapping (686):
   760   Discharged (Patient Discharge) [Health Care Activity]
   760   >90 [Quantitative Concept]
Meta Mapping (686):
   760   Discharged (Patient Discharge) [Health Care Activity]
   760   <90 [Quantitative Concept]
Meta Mapping (686):
   760   Discharged (Patient Discharge) [Health Care Activity]
   760   90% [Finding]
Processing 00000000.tx.33: T : Admission Date : She drinks one to two glasses of scotch per day . 

Phrase: T
Meta Mapping (1000):
  1000   T' (T prime) [Clinical Attribute]

Phrase: :

Phrase: Admission Date
Meta Mapping (1000):
  1000   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (1000):
  1000   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: She

Phrase: drinks
Meta Mapping (1000):
  1000   Drinks (Drink (dietary substance)) [Food]

Phrase: one to two glasses of scotch
Meta Mapping (685):
   753   ONE (One) [Quantitative Concept]
   586   Two [Quantitative Concept]
   586   Glasses (Eyeglasses) [Medical Device]
   586   scotch [Food]

Phrase: per day .
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]
Processing 00000000.tx.34: Potassium 4.4 . 

Phrase: Potassium 4.4 .
Meta Mapping (827):
   827   POTASSIUM (Potassium) [Element, Ion, or Isotope]
Meta Mapping (827):
   827   Potassium+ (Potassium measurement) [Laboratory Procedure]
Meta Mapping (827):
   827   POTASSIUM (Potassium supplement) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (827):
   827   Potassium (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (827):
   827   POTASSIUM (Potassium Drug Class) [Pharmacologic Substance]
Processing 00000000.tx.35: HOSPITAL COURSE : She was slightly agitated on the first postoperative day but this resolved by the second postoperative day . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: She

Phrase: was

Phrase: slightly
Meta Mapping (1000):
  1000   Slightly (Slightly (qualifier value)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Slightly (Slight (qualifier value)) [Qualitative Concept]

Phrase: agitated on the first postoperative day
Meta Mapping (697):
   753   AGITATED (Agitation) [Sign or Symptom]
   753   First (First (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   AGITATED (Agitation) [Sign or Symptom]
   753   First (First (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   AGITATED (Agitation) [Sign or Symptom]
   753   First (First (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   AGITATED (Agitation) [Sign or Symptom]
   753   First (Firstly) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   AGITATED (Agitation) [Sign or Symptom]
   753   First (Firstly) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   AGITATED (Agitation) [Sign or Symptom]
   753   First (Firstly) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]

Phrase: but

Phrase: this

Phrase: resolved by the second postoperative day .
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (physiologic resolution) [Pathologic Function]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolution) [Conceptual Entity]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved [Finding]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   Second (second (number)) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   SECOND (seconds) [Temporal Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   /second (per second) [Quantitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   second (Precision - second) [Idea or Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   DAY (day) [Temporal Concept]
Meta Mapping (697):
   753   Resolved (Resolved License) [Functional Concept]
   753   Second (Second Suffix) [Qualitative Concept]
   753   Postoperative (Postoperative Period) [Temporal Concept]
   753   /day (per day) [Temporal Concept]
Processing 00000000.tx.36: Her PT drifted down to a level of 12.9 by 7/3 and therefore she will be discharged with 4 mg of Coumadin per day to be followed by the Coumadin Clinic at Cowerin Tonli Medical Center . 

Phrase: Her PT
Meta Mapping (1000):
  1000   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]

Phrase: drifted down

Phrase: to a level of 12.9
Meta Mapping (753):
   753   Level (Levels (qualifier value)) [Qualitative Concept]
Meta Mapping (753):
   753   Level (Disease classification level) [Classification]
Meta Mapping (753):
   753   Level (Floor - story of building) [Geographic Area]
Meta Mapping (753):
   753   Level [Pharmacologic Substance]

Phrase: by 7/3

Phrase: and

Phrase: therefore

Phrase: she

Phrase: will

Phrase: be

Phrase: discharged with 4 mg of Coumadin
Meta Mapping (666):
   753   Discharged (Patient Discharge) [Health Care Activity]
   753   MG (Mongolia) [Geographic Area]
   753   Coumadin [Organic Chemical,Pharmacologic Substance]
Meta Mapping (666):
   753   Discharged (Patient Discharge) [Health Care Activity]
   753   mg% (mg/dL) [Quantitative Concept]
   753   Coumadin [Organic Chemical,Pharmacologic Substance]
Meta Mapping (666):
   753   Discharged (Patient Discharge) [Health Care Activity]
   753   mg % (Milligram percent) [Quantitative Concept]
   753   Coumadin [Organic Chemical,Pharmacologic Substance]
Meta Mapping (666):
   753   Discharged (Patient Discharge) [Health Care Activity]
   753   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   753   Coumadin [Organic Chemical,Pharmacologic Substance]

Phrase: per day
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: followed by the Coumadin Clinic
Meta Mapping (752):
   806   Followed by [Temporal Concept]
   760   Coumadin [Organic Chemical,Pharmacologic Substance]
   760   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
Meta Mapping (752):
   806   Followed by [Temporal Concept]
   760   Coumadin [Organic Chemical,Pharmacologic Substance]
   760   Clinic [Health Care Related Organization,Manufactured Object]

Phrase: at Cowerin Tonli Medical Center .
Meta Mapping (861):
   861   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (861):
   861   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.37: 07/03/90 Report : </TEXT> <RECORD ID="767"> 11/24/1994 12:00:00 AM Signed 11/24/1994 He underwent an autologous bone marrow transplant in 10/92 at Petersly Hospital And Medical Center . 

Phrase: 07/03/90 Report
Meta Mapping (750):
   645   >90 [Quantitative Concept]
   812   Report (Report (document)) [Intellectual Product]
Meta Mapping (750):
   645   >90 [Quantitative Concept]
   812   Report (Reporting) [Health Care Activity]
Meta Mapping (750):
   645   >90 [Quantitative Concept]
   812   Report (Regulatory Report) [Intellectual Product]
Meta Mapping (750):
   645   <90 [Quantitative Concept]
   812   Report (Report (document)) [Intellectual Product]
Meta Mapping (750):
   645   <90 [Quantitative Concept]
   812   Report (Reporting) [Health Care Activity]
Meta Mapping (750):
   645   <90 [Quantitative Concept]
   812   Report (Regulatory Report) [Intellectual Product]
Meta Mapping (750):
   645   90% [Finding]
   812   Report (Report (document)) [Intellectual Product]
Meta Mapping (750):
   645   90% [Finding]
   812   Report (Reporting) [Health Care Activity]
Meta Mapping (750):
   645   90% [Finding]
   812   Report (Regulatory Report) [Intellectual Product]

Phrase: :

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: <RECORD ID="767"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 11/24/1994 12
Meta Mapping (902):
   902   11-12 [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: Signed
Meta Mapping (1000):
  1000   Signed (Signature) [Intellectual Product]
Meta Mapping (1000):
  1000   signed (signed - ParticipationSignature) [Intellectual Product]

Phrase: 11/24/1994

Phrase: He

Phrase: underwent

Phrase: an autologous bone marrow transplant in 10/92
Meta Mapping (784):
   833   Autologous Bone Marrow Transplant (Autologous bone marrow transplant) [Therapeutic or Preventive Procedure]
   578   10% [Finding]

Phrase: at Petersly Hospital
Meta Mapping (861):
   861   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (861):
   861   Hospital (Hospital environment) [Qualitative Concept]

Phrase: And

Phrase: Medical Center .
Meta Mapping (1000):
  1000   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (1000):
  1000   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.38: The patient &apos;s Decadron dose was increased to 12 mg q day and he was also started on MS Contin and radiation therapy was being planned and arranged at the Petersly Hospital And Medical Center . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s Decadron dose
Meta Mapping (882):
   660   /s (per second) [Quantitative Concept]
   873   Dexamethasone Dose (Dexamethasone:Mass:Pt:Dose:Qn) [Clinical Attribute]
Meta Mapping (882):
   660   S' (S prime) [Clinical Attribute]
   873   Dexamethasone Dose (Dexamethasone:Mass:Pt:Dose:Qn) [Clinical Attribute]

Phrase: was

Phrase: increased to 12 mg q day
Meta Mapping (716):
   783   mg++ increased [Finding]
   753   /day (Daily) [Temporal Concept]
Meta Mapping (716):
   783   mg++ increased [Finding]
   753   DAY (day) [Temporal Concept]
Meta Mapping (716):
   783   mg++ increased [Finding]
   753   /day (per day) [Temporal Concept]
Meta Mapping (716):
   753   Increased [Quantitative Concept]
   783   mg day (milligram/day) [Quantitative Concept]
Meta Mapping (716):
   753   Increased (Increase) [Functional Concept]
   783   mg day (milligram/day) [Quantitative Concept]

Phrase: and

Phrase: he

Phrase: was

Phrase: also

Phrase: started on MS Contin
Meta Mapping (783):
   770   Started [Qualitative Concept]
   833   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: radiation therapy
Meta Mapping (1000):
  1000   radiation therapy (radiotherapeutic) [Intellectual Product]
Meta Mapping (1000):
  1000   RADIATION THERAPY (Therapeutic radiology procedure) [Therapeutic or Preventive Procedure]

Phrase: was

Phrase: being

Phrase: planned
Meta Mapping (1000):
  1000   Planned [Functional Concept]

Phrase: and

Phrase: arranged at the Petersly Hospital
Meta Mapping (686):
   760   Arranged (Arranged (transportation)) [Idea or Concept]
   760   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (686):
   760   Arranged (Arranged (transportation)) [Idea or Concept]
   760   Hospital (Hospital environment) [Qualitative Concept]

Phrase: And

Phrase: Medical Center .
Meta Mapping (1000):
  1000   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (1000):
  1000   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.39: On transfer include Vancomycin , Ceftazidime , gentamicin , Solu Cortef 100 mg q8h , Lasix , Synthroid , insulin , MS Contin 60 mg b.i.d. 

Phrase: On transfer
Meta Mapping (1000):
  1000   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (1000):
  1000   Transfer (Transfer Technique) [Functional Concept]

Phrase: include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: Vancomycin ,
Meta Mapping (1000):
  1000   VANCOMYCIN (Vancomycin) [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: Ceftazidime ,
Meta Mapping (1000):
  1000   CEFTAZIDIME (Ceftazidime) [Antibiotic,Organic Chemical]

Phrase: gentamicin ,
Meta Mapping (1000):
  1000   Gentamycin (Gentamicin Sulfate (USP)) [Antibiotic,Organic Chemical]
Meta Mapping (1000):
  1000   Gentamycin (Gentamicin) [Antibiotic,Organic Chemical]

Phrase: Solu Cortef 100 mg q8h ,
Meta Mapping (857):
   604   Solus [Eukaryote]
   699   Hydrocortisone 100 MG [Clinical Drug]
   804   Q8H (Every eight hours) [Temporal Concept]

Phrase: Lasix ,
Meta Mapping (1000):
  1000   Lasix [Organic Chemical,Pharmacologic Substance]

Phrase: Synthroid ,
Meta Mapping (1000):
  1000   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: insulin ,
Meta Mapping (1000):
  1000   INSULIN (Insulin) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Meta Mapping (1000):
  1000   INSULIN (Recombinant Insulin) [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Insulin (Insulin [EPC]) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   INSULIN (Insulin Drug Class) [Hormone,Pharmacologic Substance]

Phrase: MS Contin 60 mg b.i.d.
Meta Mapping (773):
   651   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]
   629   60% [Finding]
   845   mg/d (milligram/day) [Quantitative Concept]
   629   I- (Iodides) [Inorganic Chemical]
Meta Mapping (773):
   651   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]
   629   60% [Finding]
   845   mg/d (milligram/day) [Quantitative Concept]
   629   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (773):
   651   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]
   629   60% [Finding]
   795   MG (Mongolia) [Geographic Area]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (773):
   651   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]
   629   60% [Finding]
   795   mg% (mg/dL) [Quantitative Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (773):
   651   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]
   629   60% [Finding]
   795   mg % (Milligram percent) [Quantitative Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (773):
   651   Contin, MS (MS Contin) [Organic Chemical,Pharmacologic Substance]
   629   60% [Finding]
   795   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.40: , MSO4 2 mg p.r.n. pain IV , Dopamine 12 mcg per minute . 

Phrase: , MSO4 2 mg p.r.n. pain IV ,
Meta Mapping (730):
   626   MG (Mongolia) [Geographic Area]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   PAIN (Pain) [Sign or Symptom]
   793   IV (Ivory Coast) [Geographic Area]
Meta Mapping (730):
   626   MG (Mongolia) [Geographic Area]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   Pain NOS (Pain NOS Adverse Event) [Finding]
   793   IV (Ivory Coast) [Geographic Area]
Meta Mapping (730):
   626   mg% (mg/dL) [Quantitative Concept]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   PAIN (Pain) [Sign or Symptom]
   793   IV (Ivory Coast) [Geographic Area]
Meta Mapping (730):
   626   mg% (mg/dL) [Quantitative Concept]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   Pain NOS (Pain NOS Adverse Event) [Finding]
   793   IV (Ivory Coast) [Geographic Area]
Meta Mapping (730):
   626   mg % (Milligram percent) [Quantitative Concept]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   PAIN (Pain) [Sign or Symptom]
   793   IV (Ivory Coast) [Geographic Area]
Meta Mapping (730):
   626   mg % (Milligram percent) [Quantitative Concept]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   Pain NOS (Pain NOS Adverse Event) [Finding]
   793   IV (Ivory Coast) [Geographic Area]
Meta Mapping (730):
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   PAIN (Pain) [Sign or Symptom]
   793   IV (Ivory Coast) [Geographic Area]
Meta Mapping (730):
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   R.N. (Registered nurse) [Professional or Occupational Group]
   626   Pain NOS (Pain NOS Adverse Event) [Finding]
   793   IV (Ivory Coast) [Geographic Area]

Phrase: Dopamine 12 mcg per minute .
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   mcg (microgram) [Quantitative Concept]
   593   MINUTE (Minute of time) [Temporal Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   mcg (microgram) [Quantitative Concept]
   593   minute (Small) [Quantitative Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   mcg (microgram) [Quantitative Concept]
   593   /minute (Per Minute) [Temporal Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   mcg (microgram) [Quantitative Concept]
   593   Minute (Minute (diminutive)) [Quantitative Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   mcg (microgram) [Quantitative Concept]
   593   Minute (Minute Unit of Plane Angle) [Quantitative Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   593   MINUTE (Minute of time) [Temporal Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   593   minute (Small) [Quantitative Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   593   /minute (Per Minute) [Temporal Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   593   Minute (Minute (diminutive)) [Quantitative Concept]
Meta Mapping (687):
   593   DOPAMINE (Dopamine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   MCG (miscellaneous Crenarchaeota group) [Archaeon]
   593   Minute (Minute Unit of Plane Angle) [Quantitative Concept]
Processing 00000000.tx.41: Neurological exam on admission revealed he was drowsy but easily arousable to voice , oriented to person , Retelk County Medical Center , and date , able to say no but mildly inattentive during examination . 

Phrase: Neurological exam
Meta Mapping (1000):
  1000   neurological exam (Neurologic Examination) [Diagnostic Procedure]

Phrase: on admission
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: he

Phrase: was

Phrase: drowsy
Meta Mapping (1000):
  1000   DROWSY (Drowsiness) [Finding]

Phrase: but

Phrase: easily arousable
Meta Mapping (694):
   694   Easily (Easy) [Qualitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: voice
Meta Mapping (1000):
  1000   VOICE (Voice) [Organism Function]
Meta Mapping (1000):
  1000   voice (TelecommunicationCapabilities <voice>) [Qualitative Concept]

Phrase: ,

Phrase: oriented to person ,
Meta Mapping (1000):
  1000   Oriented to person [Finding]

Phrase: Retelk County Medical Center ,
Meta Mapping (824):
   812   County (county) [Geographic Area]
   861   Medical centre (Medical center) [Health Care Related Organization,Manufactured Object]
Meta Mapping (824):
   812   County (county) [Geographic Area]
   861   Medical Center (Military Hospital - Medical Center) [Health Care Related Organization,Manufactured Object]

Phrase: and

Phrase: date ,
Meta Mapping (1000):
  1000   DATE (Date in time) [Temporal Concept]
Meta Mapping (1000):
  1000   DATE (Date Fruit) [Food]

Phrase: able
Meta Mapping (1000):
  1000   Able (Ability) [Organism Attribute]
Meta Mapping (1000):
  1000   Able (Able (finding)) [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: say

Phrase: no

Phrase: but

Phrase: mildly inattentive during examination .
Meta Mapping (686):
   604   MILDLY [Idea or Concept]
   699   Inattentiveness (Cognitive function: distractibility) [Finding]
Meta Mapping (686):
   604   MILDLY [Idea or Concept]
   699   Inattention [Mental or Behavioral Dysfunction]
Meta Mapping (686):
   604   Mildly (Mild (qualifier value)) [Qualitative Concept]
   699   Inattentiveness (Cognitive function: distractibility) [Finding]
Meta Mapping (686):
   604   Mildly (Mild (qualifier value)) [Qualitative Concept]
   699   Inattention [Mental or Behavioral Dysfunction]
Processing 00000000.tx.42: Cranial nerves intact . 

Phrase: Cranial nerves
Meta Mapping (1000):
  1000   CRANIAL NERVES (Cranial Nerves) [Body Part, Organ, or Organ Component]

Phrase: intact .
Meta Mapping (1000):
  1000   Intact [Qualitative Concept]
Meta Mapping (1000):
  1000   Intact (Gender Status - Intact) [Finding]
Processing 00000000.tx.43: Motor exam normal tone , positive asterixis , no drift . 

Phrase: Motor exam normal tone ,
Meta Mapping (815):
   645   Motor (motor movement) [Functional Concept]
   645   Exam (Medical Examination) [Health Care Activity]
   645   NORMAL (Normal) [Qualitative Concept]
   741   tonic (TONICS) [Pharmacologic Substance]
Meta Mapping (815):
   645   Motor (motor movement) [Functional Concept]
   645   Exam (Medical Examination) [Health Care Activity]
   645   Normal (Gait normal) [Finding]
   741   tonic (TONICS) [Pharmacologic Substance]
Meta Mapping (815):
   645   Motor (motor movement) [Functional Concept]
   645   Exam (Medical Examination) [Health Care Activity]
   645   % normal (Percent normal) [Quantitative Concept]
   741   tonic (TONICS) [Pharmacologic Substance]
Meta Mapping (815):
   645   Motor (motor movement) [Functional Concept]
   645   Exam (Medical Examination) [Health Care Activity]
   645   % Normal (Mean Percent of Normal) [Quantitative Concept]
   741   tonic (TONICS) [Pharmacologic Substance]
Meta Mapping (815):
   645   Motor (Device Motor) [Manufactured Object]
   645   Exam (Medical Examination) [Health Care Activity]
   645   NORMAL (Normal) [Qualitative Concept]
   741   tonic (TONICS) [Pharmacologic Substance]
Meta Mapping (815):
   645   Motor (Device Motor) [Manufactured Object]
   645   Exam (Medical Examination) [Health Care Activity]
   645   Normal (Gait normal) [Finding]
   741   tonic (TONICS) [Pharmacologic Substance]
Meta Mapping (815):
   645   Motor (Device Motor) [Manufactured Object]
   645   Exam (Medical Examination) [Health Care Activity]
   645   % normal (Percent normal) [Quantitative Concept]
   741   tonic (TONICS) [Pharmacologic Substance]
Meta Mapping (815):
   645   Motor (Device Motor) [Manufactured Object]
   645   Exam (Medical Examination) [Health Care Activity]
   645   % Normal (Mean Percent of Normal) [Quantitative Concept]
   741   tonic (TONICS) [Pharmacologic Substance]

Phrase: positive asterixis ,
Meta Mapping (888):
   694   % Positive (percent positive cells) [Quantitative Concept]
   861   ASTERIXIS (Asterixis) [Sign or Symptom]
Meta Mapping (888):
   694   Positive [Qualitative Concept]
   861   ASTERIXIS (Asterixis) [Sign or Symptom]
Meta Mapping (888):
   694   POSITIVE (Positive Finding) [Finding]
   861   ASTERIXIS (Asterixis) [Sign or Symptom]
Meta Mapping (888):
   694   Positive (Positive Charge) [Qualitative Concept]
   861   ASTERIXIS (Asterixis) [Sign or Symptom]
Meta Mapping (888):
   694   Positive (Positive Number) [Conceptual Entity]
   861   ASTERIXIS (Asterixis) [Sign or Symptom]

Phrase: no drift .
Processing 00000000.tx.44: Deep tendon reflexes were 2+ in the upper extremities , 1+ in the patella reflexes , no reflexes at the ankles , upgoing Babinski toes bilaterally . 

Phrase: Deep tendon reflexes
Meta Mapping (1000):
  1000   Deep tendon reflexes (Deep Tendon Reflex) [Clinical Attribute]

Phrase: were

Phrase: 2+
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]

Phrase: in the upper extremities ,
Meta Mapping (1000):
  1000   Extremities, Upper (Upper Extremity) [Body Part, Organ, or Organ Component]

Phrase: 1+
Meta Mapping (1000):
  1000   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   1+ (1+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   1+ [Finding]

Phrase: in the patella reflexes ,
Meta Mapping (947):
   947   Patellar reflex (Knee reflex) [Finding]

Phrase: no reflexes at the ankles ,
Meta Mapping (781):
   781 N Ankle Reflexes (Ankle reflex finding) [Finding]

Phrase: upgoing Babinski toes bilaterally .
Meta Mapping (812):
   812   Toes [Body Part, Organ, or Organ Component]
Processing 00000000.tx.45: Glucose 191 . 

Phrase: Glucose 191 .
Meta Mapping (861):
   861   GLUCOSE (Glucose) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.46: The patient &apos;s clinical situation was most consistent with a Pseudomonas cellulitis and subsequent sepsis . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s clinical situation
Meta Mapping (623):
   660   /s (per second) [Quantitative Concept]
   660   Clinical [Qualitative Concept]
Meta Mapping (623):
   660   /s (per second) [Quantitative Concept]
   660   Clinical (Psychologist - Clinical) [Professional or Occupational Group]
Meta Mapping (623):
   660   /s (per second) [Quantitative Concept]
   660   Clinical (Social Worker - Clinical) [Professional or Occupational Group]
Meta Mapping (623):
   660   /s (per second) [Quantitative Concept]
   660   Clinical (Neuropsychologist - Clinical) [Professional or Occupational Group]
Meta Mapping (623):
   660   S' (S prime) [Clinical Attribute]
   660   Clinical [Qualitative Concept]
Meta Mapping (623):
   660   S' (S prime) [Clinical Attribute]
   660   Clinical (Psychologist - Clinical) [Professional or Occupational Group]
Meta Mapping (623):
   660   S' (S prime) [Clinical Attribute]
   660   Clinical (Social Worker - Clinical) [Professional or Occupational Group]
Meta Mapping (623):
   660   S' (S prime) [Clinical Attribute]
   660   Clinical (Neuropsychologist - Clinical) [Professional or Occupational Group]

Phrase: was

Phrase: most consistent with a Pseudomonas cellulitis
Meta Mapping (741):
   586   Most [Quantitative Concept]
   790   Consistent with [Idea or Concept]
   586   PSEUDOMONAS (Pseudomonas) [Bacterium]
   586   CELLULITIS (Cellulitis) [Pathologic Function]

Phrase: and

Phrase: subsequent sepsis .
Meta Mapping (888):
   694   Subsequent (Following) [Temporal Concept]
   861   Sepsis (Septicemia) [Disease or Syndrome]
Meta Mapping (888):
   694   Subsequent (Following) [Temporal Concept]
   861   SEPSIS (Sepsis) [Disease or Syndrome]
Meta Mapping (888):
   694   Subsequent (Following) [Temporal Concept]
   861   Sepsis (Sepsis (Invertebrate)) [Eukaryote]
Processing 00000000.tx.47: He was subsequently switched to Imipenem and Tobramycin and was maintained on those medications throughout the hospital course . 

Phrase: He

Phrase: was

Phrase: subsequently

Phrase: switched to Imipenem
Meta Mapping (730):
   756   Switch (Switch Device Component) [Manufactured Object]
   790   IMIPENEM (Imipenem) [Antibiotic,Organic Chemical]

Phrase: and

Phrase: Tobramycin
Meta Mapping (1000):
  1000   TOBRAMYCIN (Tobramycin) [Antibiotic,Organic Chemical]

Phrase: and

Phrase: was

Phrase: maintained on those medications
Meta Mapping (708):
   770   Maintained (Maintaining (action)) [Functional Concept]
   770   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (708):
   770   Maintained (Maintaining (action)) [Functional Concept]
   770   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (708):
   770   Maintained (Maintaining (action)) [Functional Concept]
   770   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: throughout the hospital course .
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]
Processing 00000000.tx.48: In addition , the patient received a five day course of intravenous IgG to improve infection control . 

Phrase: In addition ,
Meta Mapping (861):
   861   Addition (In addition to) [Functional Concept]
Meta Mapping (861):
   861   Addition (Add - instruction imperative) [Functional Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: received
Meta Mapping (1000):
  1000   RECEIVED (Receive) [Qualitative Concept]

Phrase: a five day course of intravenous IgG
Meta Mapping (701):
   612   FIVE-DAY (Five-Day Report) [Intellectual Product]
   748   Course [Temporal Concept]
   581   Intravenous [Spatial Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: improve

Phrase: infection control .
Meta Mapping (1000):
  1000   Infection Control (Infectious disease prevention / control) [Health Care Activity]
Meta Mapping (1000):
  1000   Infection Control (Registered Nurse - Infection Control) [Professional or Occupational Group]
Processing 00000000.tx.49: The cause of this erythema is not know at this time but has not shown extensive progression . 

Phrase: The cause of this erythema
Meta Mapping (686):
   760   cause (Etiology aspects) [Functional Concept]
   593   ERYTHEMA (Erythema) [Disease or Syndrome]
Meta Mapping (686):
   760   Cause (Science of Etiology) [Conceptual Entity]
   593   ERYTHEMA (Erythema) [Disease or Syndrome]

Phrase: is

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: know at this time
Meta Mapping (770):
   770   TIME (Time) [Temporal Concept]
Meta Mapping (770):
   770   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: but

Phrase: has

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: shown
Meta Mapping (966):
   966   Show [Animal]

Phrase: extensive progression .
Meta Mapping (888):
   694   Extensive [Qualitative Concept]
   861 N Progression (Disease Progression) [Pathologic Function]
Meta Mapping (888):
   694   Extensive [Qualitative Concept]
   861   Progression [Functional Concept]
Processing 00000000.tx.50: An echocardiogram performed at the outside hospital while he was septic showed decreased global EF . 

Phrase: An echocardiogram
Meta Mapping (1000):
  1000   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Echocardiogram (Echocardiogram (image)) [Intellectual Product]

Phrase: performed at the outside hospital
Meta Mapping (696):
   760   Performed [Functional Concept]
   760   Outside (Extrinsic) [Spatial Concept]
   760   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (696):
   760   Performed [Functional Concept]
   760   Outside (Extrinsic) [Spatial Concept]
   760   Hospital (Hospital environment) [Qualitative Concept]

Phrase: while

Phrase: he

Phrase: was

Phrase: septic
Meta Mapping (1000):
  1000   Septic (septic) [Functional Concept]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: decreased global EF .
Meta Mapping (623):
   660   Decreased [Quantitative Concept]
   660   Global (Generalized) [Spatial Concept]
Meta Mapping (623):
   660   Decreased [Quantitative Concept]
   660   Global [Qualitative Concept]
Meta Mapping (623):
   660   Decreased (Reduced) [Qualitative Concept]
   660   Global (Generalized) [Spatial Concept]
Meta Mapping (623):
   660   Decreased (Reduced) [Qualitative Concept]
   660   Global [Qualitative Concept]
Meta Mapping (623):
   660   decreased (Decreasing) [Qualitative Concept]
   660   Global (Generalized) [Spatial Concept]
Meta Mapping (623):
   660   decreased (Decreasing) [Qualitative Concept]
   660   Global [Qualitative Concept]
Processing 00000000.tx.51: His neurological exam remained stable with no evidence of increasing lower extremity edema . 

Phrase: His neurological exam
Meta Mapping (1000):
  1000   neurological exam (Neurologic Examination) [Diagnostic Procedure]

Phrase: remained

Phrase: stable with no evidence of increasing lower extremity edema .
Meta Mapping (766):
   742   STABLE (Stable status) [Qualitative Concept]
   575   Evidence [Idea or Concept]
   575   Increasing [Functional Concept]
   637   Oedema of lower extremity (Edema of lower extremity) [Pathologic Function]
Meta Mapping (766):
   742   Stable (Patient Condition Code - Stable) [Intellectual Product]
   575   Evidence [Idea or Concept]
   575   Increasing [Functional Concept]
   637   Oedema of lower extremity (Edema of lower extremity) [Pathologic Function]
Processing 00000000.tx.52: 5) BLOOD SUGARS : He has been on increasing doses of insulin receiving NPH in the morning and night in addition to a CZI sliding scale on a q6h basis . 

Phrase: 5
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]

Phrase: )

Phrase: BLOOD SUGARS
Meta Mapping (1000):
  1000   blood sugars (Blood Glucose) [Organic Chemical]

Phrase: :

Phrase: He

Phrase: has

Phrase: been on increasing doses of insulin receiving NPH
Meta Mapping (711):
   744   Increasing [Functional Concept]
   711   Receive [Qualitative Concept]
   778   NPH Insulin Dose (Insulin NPH:Mass:Pt:Dose:Qn) [Clinical Attribute]

Phrase: in the morning
Meta Mapping (1000):
  1000   Morning [Temporal Concept]

Phrase: and

Phrase: night in addition to a CZI sliding scale
Meta Mapping (746):
   744   Night (Night time) [Temporal Concept]
   633   In addition to [Functional Concept]
   604   sliding scale [Therapeutic or Preventive Procedure]

Phrase: on a q6h basis .
Meta Mapping (888):
   694   Q6H (Every six hours) [Temporal Concept]
   861   Basis (Basis - conceptual entity) [Functional Concept]
Meta Mapping (888):
   694   Q6H (Every six hours) [Temporal Concept]
   861   BASIS (Basis) [Pharmacologic Substance]
Processing 00000000.tx.53: His PT and PTT are now normal , however , he continues to run a low platelet count . 

Phrase: His PT
Meta Mapping (1000):
  1000   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]

Phrase: and

Phrase: PTT
Meta Mapping (1000):
  1000   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]

Phrase: are

Phrase: now normal , however ,
Meta Mapping (790):
   827   Now (Now (temporal qualifier)) [Temporal Concept]
   827   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (790):
   827   Now (Now (temporal qualifier)) [Temporal Concept]
   827   Normal (Gait normal) [Finding]
Meta Mapping (790):
   827   Now (Now (temporal qualifier)) [Temporal Concept]
   827   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (790):
   827   Now (Now (temporal qualifier)) [Temporal Concept]
   827   % Normal (Mean Percent of Normal) [Quantitative Concept]

Phrase: he

Phrase: continues
Meta Mapping (1000):
  1000   Continue (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: run
Meta Mapping (1000):
  1000   run (Running (physical activity)) [Daily or Recreational Activity]
Meta Mapping (1000):
  1000   run (Does run (finding)) [Finding]
Meta Mapping (1000):
  1000   Run (Run action) [Functional Concept]
Meta Mapping (1000):
  1000   Run (History of recreational running) [Finding]

Phrase: a low platelet count .
Meta Mapping (1000):
  1000   Low platelet count (Decreased platelet count) [Finding]
Processing 00000000.tx.54: Index No. 

Phrase: Index
Meta Mapping (1000):
  1000   Index [Intellectual Product]
Meta Mapping (1000):
  1000   index (Html Link Type - index) [Idea or Concept]
Meta Mapping (1000):
  1000   % index [Quantitative Concept]

Phrase: No.
Processing 00000000.tx.55: FXZQ7B8JJX 583419 Admission Date : 07/02/2001 ****** DISCHARGE ORDERS ****** Previous override information : Override added on 07/02/01 by NOUNJOENSTIFCHAFF , SANTRACENIENI , MD on order for POTASSIUM CHLORIDE SR PO ( ref 19020836 ) POTENTIALLY SERIOUS INTERACTION : Food / Drug Interaction Instruction IMDUR ( ISOSORBIDE MONONIT. ( SR ) ) 60 MG PO QAM Starting IN AM ( 07/09 ) 25 MG PO QAM Starting IN AM ( 07/&apos;06 ) Take consistently with meals or on empty stomach . 

Phrase: FXZQ7B8JJX 583419 Admission Date
Meta Mapping (861):
   861   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (861):
   861   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: 07/02/2001

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: * DISCHARGE
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: ORDERS
Meta Mapping (1000):
  1000   Order (Order (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Order (Order (taxonomic)) [Classification]
Meta Mapping (1000):
  1000   Order (Order (action)) [Activity]
Meta Mapping (1000):
  1000   Order (Permutation) [Qualitative Concept]
Meta Mapping (1000):
  1000   orders (orders - HL7PublishingDomain) [Intellectual Product]
Meta Mapping (1000):
  1000   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: * Previous
Meta Mapping (1000):
  1000   Previous [Temporal Concept]
Meta Mapping (1000):
  1000   previous (Act Relationship Subset - previous) [Temporal Concept]

Phrase: override
Meta Mapping (1000):
  1000   Override [Activity]

Phrase: information
Meta Mapping (1000):
  1000   INFORMATION (Information) [Idea or Concept]

Phrase: :

Phrase: Override
Meta Mapping (1000):
  1000   Override [Activity]

Phrase: added on 07/02/01
Meta Mapping (760):
   760   Added (Additional) [Functional Concept]

Phrase: by NOUNJOENSTIFCHAFF ,

Phrase: SANTRACENIENI ,

Phrase: MD on order
Meta Mapping (623):
   623   Order (Order (document)) [Intellectual Product]
Meta Mapping (623):
   623   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (623):
   623   Order (Order (taxonomic)) [Classification]
Meta Mapping (623):
   623   Order (Order (action)) [Activity]
Meta Mapping (623):
   623   Order (Permutation) [Qualitative Concept]
Meta Mapping (623):
   623   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]

Phrase: for POTASSIUM CHLORIDE SR PO
Meta Mapping (916):
   756   potassium chloride sr [Inorganic Chemical,Pharmacologic Substance]
   812   PO (Portugal) [Geographic Area]
Meta Mapping (916):
   756   potassium chloride sr [Inorganic Chemical,Pharmacologic Substance]
   812   PO (Oral) [Spatial Concept]

Phrase: ( ref 19020836
Meta Mapping (861):
   861   REF (ALYREF gene) [Gene or Genome]

Phrase: )

Phrase: POTENTIALLY SERIOUS INTERACTION
Meta Mapping (790):
   660   Serious [Qualitative Concept]
   827   Interaction [Functional Concept]

Phrase: :

Phrase: Food / Drug Interaction Instruction IMDUR
Meta Mapping (875):
   717   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   637   Instruction (Educational process of instructing) [Educational Activity]
   804   Imdur [Organic Chemical,Pharmacologic Substance]
Meta Mapping (875):
   717   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   637   Instruction (Instruction [Publication Type]) [Intellectual Product]
   804   Imdur [Organic Chemical,Pharmacologic Substance]
Meta Mapping (875):
   717   Interaction, Food-Drug (Food-Drug Interactions) [Disease or Syndrome]
   637   instruction (Instructions) [Idea or Concept]
   804   Imdur [Organic Chemical,Pharmacologic Substance]

Phrase: ( ISOSORBIDE MONONIT.
Meta Mapping (888):
   694   ISOSORBIDE (Isosorbide) [Organic Chemical,Pharmacologic Substance]
   861   Mononit [Organic Chemical,Pharmacologic Substance]

Phrase: ( SR ) ) 60 MG PO QAM Starting IN AM
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Skin Response Domain) [Intellectual Product]
   626   60% [Finding]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (Final Statistical Report) [Intellectual Product]
   626   60% [Finding]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   MG (Mongolia) [Geographic Area]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   mg% (mg/dL) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   mg % (Milligram percent) [Quantitative Concept]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Portugal) [Geographic Area]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]
Meta Mapping (566):
   626   SR (SR cell line) [Experimental Model of Disease]
   626   60% [Finding]
   626   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   626   PO (Oral) [Spatial Concept]
   626   QAM (Every morning) [Temporal Concept]
   593   Start (Beginning) [Temporal Concept]

Phrase: ( 07/09

Phrase: )

Phrase: 25 MG PO QAM Starting IN AM
Meta Mapping (535):
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]
Meta Mapping (535):
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]
Meta Mapping (535):
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]
Meta Mapping (535):
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]
Meta Mapping (535):
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]
Meta Mapping (535):
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]
Meta Mapping (535):
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]
Meta Mapping (535):
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   QAM (Every morning) [Temporal Concept]
   595   Start (Beginning) [Temporal Concept]

Phrase: ( 07/&apos

Phrase: ;06

Phrase: )

Phrase: Take
Meta Mapping (1000):
  1000   Take [Health Care Activity]

Phrase: consistently with meals
Meta Mapping (790):
   790   Meals (Meal (occasion for eating)) [Daily or Recreational Activity]

Phrase: or on empty stomach .
Meta Mapping (722):
   770   Empty (Empty (qualifier)) [Qualitative Concept]
   770   STOMACH (Stomach) [Body Part, Organ, or Organ Component]
Meta Mapping (722):
   770   Empty (Empty (qualifier)) [Qualitative Concept]
   770   Stomach (Entire stomach) [Body Part, Organ, or Organ Component]
Meta Mapping (722):
   770   Empty (Empty (qualifier)) [Qualitative Concept]
   770   STOMACH (Gastric Tissue) [Tissue]
Meta Mapping (722):
   770   Empty (Empty (qualifier)) [Qualitative Concept]
   770   Stomach (Stomach structure) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.56: FOLLOW UP APPOINTMENT ( S ) : CHF OPERATIONS AND PROCEDURES : Control of hypertension and pulse rate , along with salt-restricted diet , will be important in preventing further episodes of CHF . 

Phrase: FOLLOW UP APPOINTMENT
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   Appointment (Appointments) [Idea or Concept]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   Appointment (Appointments) [Idea or Concept]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   Appointment (Appointments) [Idea or Concept]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   Appointment (Appointments) [Idea or Concept]

Phrase: ( S
Meta Mapping (1000):
  1000   /s (per second) [Quantitative Concept]
Meta Mapping (1000):
  1000   S' (S prime) [Clinical Attribute]

Phrase: )

Phrase: :

Phrase: CHF OPERATIONS
Meta Mapping (888):
   694   CHF (Congestive heart failure) [Disease or Syndrome]
   861   operations (Surgical aspects) [Functional Concept]
Meta Mapping (888):
   694   CHF (Congestive heart failure) [Disease or Syndrome]
   861   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (888):
   694   CHF (Congestive heart failure) [Disease or Syndrome]
   861   operations (HL7PublishingSubSection <operations>) [Intellectual Product]

Phrase: AND

Phrase: PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: Control of hypertension
Meta Mapping (746):
   790   control (control aspects) [Qualitative Concept]
   623   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (746):
   790   control (control aspects) [Qualitative Concept]
   623   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (746):
   790   Control (control substance) [Substance]
   623   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (746):
   790   Control (control substance) [Substance]
   623   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (746):
   790   Control (Scientific Control) [Conceptual Entity]
   623   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (746):
   790   Control (Scientific Control) [Conceptual Entity]
   623   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (746):
   790   Control (Control function) [Functional Concept]
   623   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (746):
   790   Control (Control function) [Functional Concept]
   623   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (746):
   790   Control (True Control Status) [Qualitative Concept]
   623   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (746):
   790   Control (True Control Status) [Qualitative Concept]
   623   Hypertension (Hypertension Adverse Event) [Finding]

Phrase: and

Phrase: pulse rate ,
Meta Mapping (1000):
  1000   Pulse Rate [Clinical Attribute]
Meta Mapping (1000):
  1000   Pulse Rate (Physiologic pulse) [Physiologic Function]

Phrase: along with salt-restricted diet ,
Meta Mapping (901):
   660   Salt (Salts) [Chemical Viewed Structurally]
   901   restricted diet [Finding]
Meta Mapping (901):
   660   Salt (Sodium Chloride) [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   901   restricted diet [Finding]
Meta Mapping (901):
   660   Salt (Sodium Chloride, Dietary) [Food]
   901   restricted diet [Finding]

Phrase: will

Phrase: be

Phrase: important in preventing further episodes of CHF .
Meta Mapping (740):
   748   Important [Qualitative Concept]
   548   PREVENT (PREVENT (product)) [Pharmacologic Substance]
   581   Further [Spatial Concept]
   595   Episode of [Temporal Concept]
   581   CHF (Congestive heart failure) [Disease or Syndrome]
Processing 00000000.tx.57: Renal function and electrolytes should be checked next week and results forwarded to MD . 

Phrase: Renal function
Meta Mapping (1000):
  1000   Renal function [Organ or Tissue Function]

Phrase: and

Phrase: electrolytes
Meta Mapping (1000):
  1000   ELECTROLYTES (Electrolytes) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Electrolytes (Electrolyte [EPC]) [Pharmacologic Substance]

Phrase: should

Phrase: be

Phrase: checked
Meta Mapping (1000):
  1000   Checked (Checking (action)) [Activity]

Phrase: next week
Meta Mapping (888):
   694   next (Adjacent) [Spatial Concept]
   861   /week (Weekly) [Temporal Concept]
Meta Mapping (888):
   694   next (Adjacent) [Spatial Concept]
   861   WEEK (week) [Temporal Concept]
Meta Mapping (888):
   694   Next (Following) [Temporal Concept]
   861   /week (Weekly) [Temporal Concept]
Meta Mapping (888):
   694   Next (Following) [Temporal Concept]
   861   WEEK (week) [Temporal Concept]
Meta Mapping (888):
   694   Next (Then) [Temporal Concept]
   861   /week (Weekly) [Temporal Concept]
Meta Mapping (888):
   694   Next (Then) [Temporal Concept]
   861   WEEK (week) [Temporal Concept]

Phrase: and

Phrase: results
Meta Mapping (966):
   966   Result [Functional Concept]
Meta Mapping (966):
   966   Result (What subject filter - Result) [Idea or Concept]
Meta Mapping (966):
   966   Result (Experimental Result) [Finding]

Phrase: forwarded to MD .
Meta Mapping (790):
   790   forwarded (Forward) [Spatial Concept]
Processing 00000000.tx.58: DISCHARGE CONDITION : TO DO / PLAN : </TEXT> 32395/a42u DIS Report Status : 12/8/95 PRINCIPAL DIAGNOSIS : malignant fibrous histiocytoma of duodenum , metastases to liver , anemia . 

Phrase: DISCHARGE CONDITION
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Body Fluid Discharge) [Body Substance]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Patient Discharge) [Health Care Activity]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   condition (Disease) [Disease or Syndrome]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition [Qualitative Concept]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition (Logical Condition) [Conceptual Entity]
Meta Mapping (888):
   694   Discharge (Discharge, body substance) [Body Substance]
   861   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]

Phrase: :

Phrase: TO DO / PLAN
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Planned) [Functional Concept]

Phrase: :

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 32395/a42u DIS Report Status
Meta Mapping (785):
   637   DIS (Diagnostic interview schedule) [Intellectual Product]
   840   Report status [Finding]
Meta Mapping (785):
   637   DIS (Discontinued) [Finding]
   840   Report status [Finding]

Phrase: :

Phrase: 12/8/95 PRINCIPAL DIAGNOSIS
Meta Mapping (840):
   840   Principal Diagnosis (Principal diagnosis) [Qualitative Concept]
Meta Mapping (840):
   840   Principal Diagnosis (Principal Diagnosis:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: malignant fibrous histiocytoma of duodenum ,
Meta Mapping (816):
   862   Fibrous Histiocytoma, Malignant (Malignant Fibrous Histiocytoma) [Neoplastic Process]
   593   DUODENUM (Duodenum) [Body Part, Organ, or Organ Component]
Meta Mapping (816):
   862   Fibrous Histiocytoma, Malignant (Malignant Fibrous Histiocytoma) [Neoplastic Process]
   593   Duodenum (Entire duodenum) [Body Part, Organ, or Organ Component]

Phrase: metastases to liver ,
Meta Mapping (1000):
  1000   Metastases to liver, NOS (Secondary malignant neoplasm of liver) [Neoplastic Process]

Phrase: anemia .
Meta Mapping (1000):
  1000   ANEMIA (Anemia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Anemia (Genus Anemia) [Plant]
Processing 00000000.tx.59: Vital signs are normal . 

Phrase: Vital signs
Meta Mapping (1000):
  1000   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (1000):
  1000   Signs, Vital (Vital signs) [Clinical Attribute]

Phrase: are

Phrase: normal .
Meta Mapping (1000):
  1000   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (1000):
  1000   Normal (Gait normal) [Finding]
Meta Mapping (1000):
  1000   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (1000):
  1000   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.60: The neck is without adenopathy . 

Phrase: The neck
Meta Mapping (1000):
  1000   NECK (Neck) [Body Location or Region]
Meta Mapping (1000):
  1000   Neck (Entire neck) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   neck (dendritic spine neck) [Cell Component]

Phrase: is without adenopathy .
Meta Mapping (790):
   790 N ADENOPATHY (Lymphadenopathy) [Finding]
Processing 00000000.tx.61: Extremities without edema . by / bmot Unsigned 08/19/97 The patient is a 79-year-old male with a history of Parkinson &apos;s disease x &apos;s 18 years , prostate cancer , urinary incontinence and recent subdurals after fall . 

Phrase: Extremities without edema .
Meta Mapping (858):
   858   Extremities Edema (Peripheral edema) [Finding]
Meta Mapping (858):
   858   extremities Edema (Swelling of limb) [Sign or Symptom]

Phrase: by / bmot Unsigned 08/19/97
Meta Mapping (804):
   804   97 [Intellectual Product]
Meta Mapping (804):
   804   >97 [Quantitative Concept]

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: a 79-year-old male with a history of Parkinson &apos
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   YEAR (year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   MALE (Males) [Organism Attribute]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Gender, Self Report) [Qualitative Concept]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male Phenotype) [Qualitative Concept]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History [Occupation or Discipline]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   history (Historical aspects qualifier) [Functional Concept]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History, NOS (History of present illness) [Organism Attribute]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History (Medical History) [Finding]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History (Concept History) [Conceptual Entity]
   471   Parkinsonia [Plant]
Meta Mapping (610):
   571   /Year (per year) [Temporal Concept]
   571   Old [Temporal Concept]
   738   Male (Male, Self-Reported) [Organism Attribute]
   571   History (History of previous events) [Finding]
   471   Parkinsonia [Plant]

Phrase: ;s disease x &apos
Meta Mapping (583):
   645   /s (per second) [Quantitative Concept]
   645   Disease [Disease or Syndrome]
Meta Mapping (583):
   645   S' (S prime) [Clinical Attribute]
   645   Disease [Disease or Syndrome]

Phrase: ;s 18 years ,
Meta Mapping (802):
   660   /s (per second) [Quantitative Concept]
   827   YEARS (year) [Temporal Concept]
Meta Mapping (802):
   660   S' (S prime) [Clinical Attribute]
   827   YEARS (year) [Temporal Concept]

Phrase: prostate cancer ,
Meta Mapping (1000):
  1000   Prostate Cancer (Malignant neoplasm of prostate) [Neoplastic Process]
Meta Mapping (1000):
  1000   Prostate Cancer (Prostate carcinoma) [Neoplastic Process]
Meta Mapping (1000):
  1000   Prostate cancer (Prostate Cancer Pathway) [Conceptual Entity]
Meta Mapping (1000):
  1000   Prostate Cancer (NCI CTEP SDC Prostate Cancer Sub-Category Terminology) [Intellectual Product]

Phrase: urinary incontinence
Meta Mapping (1000):
  1000   URINARY INCONTINENCE (Urinary Incontinence) [Pathologic Function]
Meta Mapping (1000):
  1000   Incontinence, urinary (Urinary Incontinence Adverse Event) [Finding]

Phrase: and

Phrase: recent subdurals after fall .
Meta Mapping (541):
   604   Recent [Temporal Concept]
   604   FALL (Falls) [Finding]
Meta Mapping (541):
   604   Recent [Temporal Concept]
   604   Fall (Autumn) [Temporal Concept]
Processing 00000000.tx.62: There was a question of aspiration pneumonia so he was switched from Ampicillin pen-g to aspiration pneumonia . 

Phrase: There

Phrase: was

Phrase: a question of aspiration pneumonia
Meta Mapping (745):
   760   Question (Question (inquiry)) [Intellectual Product]
   640   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (745):
   760   Question (Question (inquiry)) [Intellectual Product]
   640   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]

Phrase: so

Phrase: he

Phrase: was

Phrase: switched from Ampicillin pen-g
Meta Mapping (725):
   726   Switch (Switch Device Component) [Manufactured Object]
   760   AMPICILLIN (Ampicillin) [Antibiotic,Organic Chemical]
   760   Pen (Pre-filled Pen Syringe) [Manufactured Object]
   760   g% (Gram per Deciliter) [Quantitative Concept]

Phrase: to aspiration pneumonia .
Meta Mapping (1000):
  1000   ASPIRATION PNEUMONIA (Aspiration Pneumonia) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Aspiration Pneumonia (Aspiration pneumonitis) [Disease or Syndrome]
Processing 00000000.tx.63: Brachial consult was obtained and the patient was intubated and transferred to the Intensive Care Unit . 

Phrase: Brachial
Meta Mapping (1000):
  1000   Brachial [Spatial Concept]

Phrase: consult
Meta Mapping (1000):
  1000   Consult (Consultation) [Health Care Activity]

Phrase: was

Phrase: obtained
Meta Mapping (1000):
  1000   Obtained (Obtain) [Functional Concept]

Phrase: and

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: intubated

Phrase: and

Phrase: transferred to the Intensive Care Unit .
Meta Mapping (780):
   753   transferred (Surgical transfer - action) [Functional Concept]
   833   INTENSIVE CARE UNIT (intensive care unit) [Health Care Related Organization,Manufactured Object]
Meta Mapping (780):
   753   transferred (Surgical transfer - action) [Functional Concept]
   833   Intensive care unit (Room type - Intensive care unit) [Idea or Concept]
Meta Mapping (780):
   753   Transferred (Transfer Technique) [Functional Concept]
   833   INTENSIVE CARE UNIT (intensive care unit) [Health Care Related Organization,Manufactured Object]
Meta Mapping (780):
   753   Transferred (Transfer Technique) [Functional Concept]
   833   Intensive care unit (Room type - Intensive care unit) [Idea or Concept]
Processing 00000000.tx.64: He surprisingly made it through the next 24 hours . 

Phrase: He

Phrase: surprisingly

Phrase: made
Meta Mapping (966):
   966   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: it through the next 24 hours .
Meta Mapping (734):
   753   next (Adjacent) [Spatial Concept]
   790   24 hours (24 hour time frame) [Temporal Concept]
Meta Mapping (734):
   753   next (Adjacent) [Spatial Concept]
   790   /24 hours (per 24 hours) [Temporal Concept]
Meta Mapping (734):
   753   next (Adjacent) [Spatial Concept]
   790   24 Hours [Temporal Concept]
Meta Mapping (734):
   753   Next (Following) [Temporal Concept]
   790   24 hours (24 hour time frame) [Temporal Concept]
Meta Mapping (734):
   753   Next (Following) [Temporal Concept]
   790   /24 hours (per 24 hours) [Temporal Concept]
Meta Mapping (734):
   753   Next (Following) [Temporal Concept]
   790   24 Hours [Temporal Concept]
Meta Mapping (734):
   753   Next (Then) [Temporal Concept]
   790   24 hours (24 hour time frame) [Temporal Concept]
Meta Mapping (734):
   753   Next (Then) [Temporal Concept]
   790   /24 hours (per 24 hours) [Temporal Concept]
Meta Mapping (734):
   753   Next (Then) [Temporal Concept]
   790   24 Hours [Temporal Concept]
Processing 00000000.tx.65: They did at that time decide to make him do not resuscitate , but were interested in continuing supportive care to see how much he would bounce back . 

Phrase: They

Phrase: did at

Phrase: that time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: decide

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: make
Meta Mapping (1000):
  1000   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: him do not resuscitate ,
Meta Mapping (1000):
  1000   Do not resuscitate (DNR - Do not resuscitate) [Finding]

Phrase: but

Phrase: were

Phrase: interested in continuing supportive care
Meta Mapping (761):
   760   Interested [Mental Process]
   760   Continuing (Continuous) [Idea or Concept]
   806   Supportive Care (Supportive care) [Therapeutic or Preventive Procedure]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: see
Meta Mapping (1000):
  1000   see (Vision) [Organism Function]
Meta Mapping (1000):
  1000   See [Activity]

Phrase: how much

Phrase: he

Phrase: would

Phrase: bounce

Phrase: back .
Meta Mapping (1000):
  1000   BACK (Back) [Body Location or Region]
Meta Mapping (1000):
  1000   BACK (Dorsal) [Spatial Concept]
Meta Mapping (1000):
  1000   Back (Back structure, including back of neck) [Body Location or Region]
Meta Mapping (1000):
  1000   Back, NOS (Back structure, excluding neck) [Body Location or Region]
Processing 00000000.tx.66: The repeat echo showed no improvement in left ventricle or right ventricle function with marked akinesis of many walls . 

Phrase: The repeat echo
Meta Mapping (888):
   694   Repeat [Functional Concept]
   861   ECHO (ECHO protocol) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Repeat [Functional Concept]
   861   Echo (Echo (insect)) [Eukaryote]
Meta Mapping (888):
   694   Repeat (Repeat Pattern) [Temporal Concept]
   861   ECHO (ECHO protocol) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Repeat (Repeat Pattern) [Temporal Concept]
   861   Echo (Echo (insect)) [Eukaryote]
Meta Mapping (888):
   694   Repeat (Repeat Object) [Conceptual Entity]
   861   ECHO (ECHO protocol) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Repeat (Repeat Object) [Conceptual Entity]
   861   Echo (Echo (insect)) [Eukaryote]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: no improvement in left ventricle
Meta Mapping (745):
   760   Improvement [Conceptual Entity]
   640   LEFT VENTRICLE (Left ventricular structure) [Body Part, Organ, or Organ Component]
Meta Mapping (745):
   760   Improvement [Conceptual Entity]
   640   Left ventricle (Entire left ventricle) [Body Part, Organ, or Organ Component]

Phrase: or

Phrase: right ventricle function with marked akinesis of many walls .
Meta Mapping (724):
   742 N function (physiological aspects) [Physiologic Function]
   575   Marked (Massive) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Meta Mapping (724):
   742 N function (physiological aspects) [Physiologic Function]
   575   MARKED (Marked) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Meta Mapping (724):
   742   FUNCTION (Function) [Functional Concept]
   575   Marked (Massive) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Meta Mapping (724):
   742   FUNCTION (Function) [Functional Concept]
   575   MARKED (Marked) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Meta Mapping (724):
   742   FUNCTION (Function Axis) [Classification]
   575   Marked (Massive) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Meta Mapping (724):
   742   FUNCTION (Function Axis) [Classification]
   575   MARKED (Marked) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Meta Mapping (724):
   742   Function (Mathematical Operator) [Intellectual Product]
   575   Marked (Massive) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Meta Mapping (724):
   742   Function (Mathematical Operator) [Intellectual Product]
   575   MARKED (Marked) [Qualitative Concept]
   504   Akinetic [Functional Concept]
   626   Wall of right ventricle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.67: 92026282 10/29/1990 Denies orthopnea , PND . 

Phrase: 92026282 10/29/1990
Meta Mapping (813):
   861   10 - 29% [Finding]
   779   1990s [Temporal Concept]

Phrase: Denies
Meta Mapping (1000):
  1000   Deny (Deny (action)) [Activity]

Phrase: orthopnea ,
Meta Mapping (1000):
  1000 N Orthopnoea (Orthopnea) [Sign or Symptom]

Phrase: PND .
Meta Mapping (1000):
  1000   PND (NPPA gene) [Gene or Genome]
Meta Mapping (1000):
  1000 N PND (Paroxysmal nocturnal dyspnea) [Disease or Syndrome]
Processing 00000000.tx.68: The patient was electively intubated and treated with morphine , Lasix , nitroglycerin , Nitro Paste , and sublingual Nifedipine . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: electively

Phrase: intubated

Phrase: and

Phrase: treated with morphine ,
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   MORPHINE (Morphine) [Organic Chemical,Pharmacologic Substance]

Phrase: Lasix ,
Meta Mapping (1000):
  1000   Lasix [Organic Chemical,Pharmacologic Substance]

Phrase: nitroglycerin ,
Meta Mapping (1000):
  1000   nitroglycerine (Nitroglycerin) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   nitroglycerine (Glonoine, nitroglycerine, Homeopathic preparation) [Organic Chemical,Pharmacologic Substance]

Phrase: Nitro Paste ,
Meta Mapping (861):
   861   paste (Paste substance) [Substance]
Meta Mapping (861):
   861   PASTE (Paste) [Biomedical or Dental Material]

Phrase: and

Phrase: sublingual Nifedipine .
Meta Mapping (888):
   694   SUBLINGUAL (Sublingual Route of Drug Administration) [Functional Concept]
   861   NIFEDIPINE (Nifedipine) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   Sublingual (Sublingual location) [Body Location or Region]
   861   NIFEDIPINE (Nifedipine) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.69: PAST MEDICAL HISTORY : Nicotine abuse , quit in the 80s , and rare alcohol . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: Nicotine abuse ,
Meta Mapping (888):
   694   NICOTINE (Nicotine) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   ABUSE (Drug abuse) [Mental or Behavioral Dysfunction]
Meta Mapping (888):
   694   NICOTINE (Nicotine) [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   Abuse (Victim of abuse finding) [Finding]

Phrase: quit in the 80s ,
Meta Mapping (691):
   770   QUIT [Idea or Concept]
   570   80% [Finding]
Meta Mapping (691):
   770   Quit (Stop (Instruction Imperative)) [Activity]
   570   80% [Finding]

Phrase: and

Phrase: rare alcohol .
Meta Mapping (888):
   694   Rare (Infrequent) [Temporal Concept]
   861   ALCOHOL (Ethanol) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   Rare (Infrequent) [Temporal Concept]
   861   Alcohol (Alcohols) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   Rare [Qualitative Concept]
   861   ALCOHOL (Ethanol) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   Rare [Qualitative Concept]
   861   Alcohol (Alcohols) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   RARE (Retinoic Acid Response Element) [Gene or Genome]
   861   ALCOHOL (Ethanol) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   RARE (Retinoic Acid Response Element) [Gene or Genome]
   861   Alcohol (Alcohols) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.70: Chest with bibasilar crackles , otherwise clear to auscultation . 

Phrase: Chest with bibasilar
Meta Mapping (790):
   790   CHEST (Chest) [Body Location or Region]
Meta Mapping (790):
   790   Chest (Anterior thoracic region) [Body Location or Region]

Phrase: crackles
Meta Mapping (1000):
  1000   Crackles (Rales) [Sign or Symptom]
Meta Mapping (1000):
  1000   Crackles (Basilar Rales) [Finding]

Phrase: ,

Phrase: otherwise

Phrase: clear to auscultation .
Meta Mapping (746):
   790   Clear (Negative Surgical Margin) [Finding]
   790   AUSCULTATION (Auscultation) [Diagnostic Procedure]
Meta Mapping (746):
   790   Clear [Qualitative Concept]
   790   AUSCULTATION (Auscultation) [Diagnostic Procedure]
Processing 00000000.tx.71: Heart exam S4 , S1 , S2 . 

Phrase: Heart exam S4 ,
Meta Mapping (901):
   734   heart exam (Examination of heart) [Health Care Activity]
   827   S4+ [Element, Ion, or Isotope]
Meta Mapping (901):
   734   heart exam (Examination of heart) [Health Care Activity]
   827   S4 (S4 heart sound) [Finding]

Phrase: S1 ,
Meta Mapping (1000):
  1000   S1 [Finding]
Meta Mapping (1000):
  1000   S1 (Testicular Cancer Serum Markers Test Result S1) [Laboratory or Test Result]

Phrase: S2 .
Meta Mapping (1000):
  1000   S2 (S2 innervation) [Body Location or Region]
Meta Mapping (1000):
  1000   S2 (PSMD2 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   S2 (RPS2 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   S2 (Testicular Cancer Serum Markers Test Result S2) [Laboratory or Test Result]
Meta Mapping (1000):
  1000   S2 [Finding]
Processing 00000000.tx.72: The patient was put on Captopril 12.5 mg po tid . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: put on Captopril 12.5 mg po tid .
Meta Mapping (796):
   744   Put (put - instruction imperative) [Activity]
   833   Captopril 12.5 MG [Clinical Drug]
   744   PO (Portugal) [Geographic Area]
   744   TID (Three times daily) [Temporal Concept]
Meta Mapping (796):
   744   Put (put - instruction imperative) [Activity]
   833   Captopril 12.5 MG [Clinical Drug]
   744   PO (Portugal) [Geographic Area]
   744   TID (three times a day at institution-specified times) [Temporal Concept]
Meta Mapping (796):
   744   Put (put - instruction imperative) [Activity]
   833   Captopril 12.5 MG [Clinical Drug]
   744   PO (Oral) [Spatial Concept]
   744   TID (Three times daily) [Temporal Concept]
Meta Mapping (796):
   744   Put (put - instruction imperative) [Activity]
   833   Captopril 12.5 MG [Clinical Drug]
   744   PO (Oral) [Spatial Concept]
   744   TID (three times a day at institution-specified times) [Temporal Concept]
Processing 00000000.tx.73: Impression was non-diagnostic for ischemia in predischarge protocol . 

Phrase: Impression
Meta Mapping (1000):
  1000   impression (impression (attitude)) [Individual Behavior]
Meta Mapping (1000):
  1000   Impression [Qualitative Concept]
Meta Mapping (1000):
  1000   Impression (Radiologic Impression) [Finding]

Phrase: was

Phrase: non-diagnostic for ischemia
Meta Mapping (733):
   770   Non (Negation) [Functional Concept]
   770 N Diagnostic (Diagnosis) [Finding]
   604 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   770   Non (Negation) [Functional Concept]
   770   Diagnostic [Functional Concept]
   604 N Ischaemia, NOS (Ischemia) [Pathologic Function]
Meta Mapping (733):
   770   Non (Negation) [Functional Concept]
   770   Diagnostic (diagnostic procedure) [Diagnostic Procedure]
   604 N Ischaemia, NOS (Ischemia) [Pathologic Function]

Phrase: in predischarge protocol .
Meta Mapping (861):
   861   Protocol (Protocols documentation) [Intellectual Product]
Meta Mapping (861):
   861   Protocol (Clinical trial protocol document) [Intellectual Product]
Meta Mapping (861):
   861   Protocol (Library Protocol) [Intellectual Product]
Meta Mapping (861):
   861   Protocol (Study Protocol) [Intellectual Product]
Meta Mapping (861):
   861 N Protocol (Protocol - answer to question) [Finding]
Processing 00000000.tx.74: I received Lidocaine IV bolus , then Lidocaine constant effusion , and was transferred to the Intensive Care Unit . 

Phrase: I received Lidocaine IV bolus ,
Meta Mapping (840):
   637   I- (Iodides) [Inorganic Chemical]
   637   RECEIVED (Receive) [Qualitative Concept]
   673   lidocaine iv (IV Lidocaine) [Organic Chemical,Pharmacologic Substance]
   804   Bolus (bolus infusion) [Therapeutic or Preventive Procedure]
Meta Mapping (840):
   637   I- (Iodides) [Inorganic Chemical]
   637   RECEIVED (Receive) [Qualitative Concept]
   673   lidocaine iv (IV Lidocaine) [Organic Chemical,Pharmacologic Substance]
   804   {Bolus} (Bolus Dosing Unit) [Quantitative Concept]
Meta Mapping (840):
   637   I- (Iodides) [Inorganic Chemical]
   637   RECEIVED (Receive) [Qualitative Concept]
   673   lidocaine iv (IV Lidocaine) [Organic Chemical,Pharmacologic Substance]
   804   Bolus (Radiotherapy Bolus) [Medical Device]
Meta Mapping (840):
   637   I- (Iodides) [Inorganic Chemical]
   637   RECEIVED (Receive) [Qualitative Concept]
   637   LIDOCAINE (Lidocaine) [Organic Chemical,Pharmacologic Substance]
   840   IV BOLUS (Intravenous Bolus) [Functional Concept]
Meta Mapping (840):
   637   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   637   RECEIVED (Receive) [Qualitative Concept]
   673   lidocaine iv (IV Lidocaine) [Organic Chemical,Pharmacologic Substance]
   804   Bolus (bolus infusion) [Therapeutic or Preventive Procedure]
Meta Mapping (840):
   637   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   637   RECEIVED (Receive) [Qualitative Concept]
   673   lidocaine iv (IV Lidocaine) [Organic Chemical,Pharmacologic Substance]
   804   {Bolus} (Bolus Dosing Unit) [Quantitative Concept]
Meta Mapping (840):
   637   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   637   RECEIVED (Receive) [Qualitative Concept]
   673   lidocaine iv (IV Lidocaine) [Organic Chemical,Pharmacologic Substance]
   804   Bolus (Radiotherapy Bolus) [Medical Device]
Meta Mapping (840):
   637   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   637   RECEIVED (Receive) [Qualitative Concept]
   637   LIDOCAINE (Lidocaine) [Organic Chemical,Pharmacologic Substance]
   840   IV BOLUS (Intravenous Bolus) [Functional Concept]

Phrase: then Lidocaine constant effusion ,
Meta Mapping (833):
   645   Then [Temporal Concept]
   645   LIDOCAINE (Lidocaine) [Organic Chemical,Pharmacologic Substance]
   645   *Constant [Quantitative Concept]
   812   Effusion (effusion) [Pathologic Function]
Meta Mapping (833):
   645   Then [Temporal Concept]
   645   LIDOCAINE (Lidocaine) [Organic Chemical,Pharmacologic Substance]
   645   *Constant [Quantitative Concept]
   812   Effusion (Effusion (substance)) [Body Substance]
Meta Mapping (833):
   645   Then [Temporal Concept]
   645   LIDOCAINE (Lidocaine) [Organic Chemical,Pharmacologic Substance]
   645   Constant (Constant (qualifier)) [Qualitative Concept]
   812   Effusion (effusion) [Pathologic Function]
Meta Mapping (833):
   645   Then [Temporal Concept]
   645   LIDOCAINE (Lidocaine) [Organic Chemical,Pharmacologic Substance]
   645   Constant (Constant (qualifier)) [Qualitative Concept]
   812   Effusion (Effusion (substance)) [Body Substance]

Phrase: and

Phrase: was

Phrase: transferred to the Intensive Care Unit .
Meta Mapping (780):
   753   transferred (Surgical transfer - action) [Functional Concept]
   833   INTENSIVE CARE UNIT (intensive care unit) [Health Care Related Organization,Manufactured Object]
Meta Mapping (780):
   753   transferred (Surgical transfer - action) [Functional Concept]
   833   Intensive care unit (Room type - Intensive care unit) [Idea or Concept]
Meta Mapping (780):
   753   Transferred (Transfer Technique) [Functional Concept]
   833   INTENSIVE CARE UNIT (intensive care unit) [Health Care Related Organization,Manufactured Object]
Meta Mapping (780):
   753   Transferred (Transfer Technique) [Functional Concept]
   833   Intensive care unit (Room type - Intensive care unit) [Idea or Concept]
Processing 00000000.tx.75: SF640/2034 KAMA SCPRA , M.D. 

Phrase: SF640/2034 KAMA SCPRA ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.76: EN5 Batch : </TEXT> 425615 Discharge Summary SECONDARY DIAGNOSES : Blood pressure was 152/88 . 

Phrase: EN5 Batch
Meta Mapping (861):
   861   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (861):
   861   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (861):
   861   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 425615 Discharge Summary SECONDARY DIAGNOSES
Meta Mapping (818):
   673   Discharge summary [Intellectual Product]
   823   Secondary diagnosis [Qualitative Concept]
Meta Mapping (818):
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   823   Secondary diagnosis [Qualitative Concept]

Phrase: :

Phrase: Blood pressure
Meta Mapping (1000):
  1000   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (1000):
  1000   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (1000):
  1000   Blood pressure (Systemic arterial pressure) [Finding]

Phrase: was

Phrase: 152/88 .
Processing 00000000.tx.77: Neck was without bruits . 

Phrase: Neck
Meta Mapping (1000):
  1000   NECK (Neck) [Body Location or Region]
Meta Mapping (1000):
  1000   Neck (Entire neck) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   neck (dendritic spine neck) [Cell Component]

Phrase: was without bruits .
Meta Mapping (790):
   790 N bruits (Bruit) [Finding]
Processing 00000000.tx.78: There was an S4 . 

Phrase: There

Phrase: was

Phrase: an S4 .
Meta Mapping (1000):
  1000   S4+ [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   S4 (S4 heart sound) [Finding]
Processing 00000000.tx.79: Extremities were 2+ pedal edema to the knees . 

Phrase: Extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: 2+ pedal edema to the knees .
Meta Mapping (725):
   586   +2 [Quantitative Concept]
   790   Pedal oedema (Edema of foot (finding)) [Sign or Symptom]
   586   knees (Knee) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   586   +2 [Quantitative Concept]
   586   Pedal (Foot) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Meta Mapping (725):
   586   +2 [Quantitative Concept]
   586   Pedal (Paw) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Meta Mapping (725):
   586   2+ (2+ Score) [Quantitative Concept]
   790   Pedal oedema (Edema of foot (finding)) [Sign or Symptom]
   586   knees (Knee) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   586   2+ (2+ Score) [Quantitative Concept]
   586   Pedal (Foot) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Meta Mapping (725):
   586   2+ (2+ Score) [Quantitative Concept]
   586   Pedal (Paw) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Meta Mapping (725):
   586   2+ (2+ Score, WHO) [Classification]
   790   Pedal oedema (Edema of foot (finding)) [Sign or Symptom]
   586   knees (Knee) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   586   2+ (2+ Score, WHO) [Classification]
   586   Pedal (Foot) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Meta Mapping (725):
   586   2+ (2+ Score, WHO) [Classification]
   586   Pedal (Paw) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Meta Mapping (725):
   586   2+ [Finding]
   790   Pedal oedema (Edema of foot (finding)) [Sign or Symptom]
   586   knees (Knee) [Body Part, Organ, or Organ Component]
Meta Mapping (725):
   586   2+ [Finding]
   586   Pedal (Foot) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Meta Mapping (725):
   586   2+ [Finding]
   586   Pedal (Paw) [Body Part, Organ, or Organ Component]
   783   edema knees (Edema of knee) [Sign or Symptom]
Processing 00000000.tx.80: Examination of the sternal wound showed an opened area in the mid region of the wound with serosanguineous drainage and a scant amount of thick , yellow pus . 

Phrase: Examination of the sternal wound
Meta Mapping (640):
   640   Sternal Wound (sternal injury) [Injury or Poisoning]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: an opened area in the mid region of the wound
Meta Mapping (658):
   574   Open wound [Injury or Poisoning]
   722   regional area [Spatial Concept]

Phrase: with serosanguineous drainage
Meta Mapping (888):
   694   Serosanguinous (Serosanguineous) [Qualitative Concept]
   861   Drainage, NOS (Body Fluid Discharge) [Body Substance]
Meta Mapping (888):
   694   Serosanguinous (Serosanguineous) [Qualitative Concept]
   861   Drainage (Drainage procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Serosanguinous (Serosanguineous) [Qualitative Concept]
   861   Drainage (Discharge, body substance) [Body Substance]

Phrase: and

Phrase: a scant amount of thick , yellow pus .
Meta Mapping (692):
   581   Scant (Smallest) [Quantitative Concept]
   748   Amount (Quantity) [Quantitative Concept]
   581   THICK (Thick) [Qualitative Concept]
   581   YELLOW (Yellow color) [Qualitative Concept]
   581   PUS (Pus) [Body Substance]
Meta Mapping (692):
   581   Scant (Smallest) [Quantitative Concept]
   748   Amount (Quantity) [Quantitative Concept]
   581   THICK (Thick) [Qualitative Concept]
   581   YELLOW (Yellow color) [Qualitative Concept]
   581   Pus (Pus specimen) [Substance]
Meta Mapping (692):
   581   Scant [Finding]
   748   Amount (Quantity) [Quantitative Concept]
   581   THICK (Thick) [Qualitative Concept]
   581   YELLOW (Yellow color) [Qualitative Concept]
   581   PUS (Pus) [Body Substance]
Meta Mapping (692):
   581   Scant [Finding]
   748   Amount (Quantity) [Quantitative Concept]
   581   THICK (Thick) [Qualitative Concept]
   581   YELLOW (Yellow color) [Qualitative Concept]
   581   Pus (Pus specimen) [Substance]
Processing 00000000.tx.81: There was no induration . 

Phrase: There

Phrase: was

Phrase: no induration .
Meta Mapping (1000):
  1000 N Induration [Pathologic Function]
Processing 00000000.tx.82: During the first two days , he required 14 and 22 units of additional coverage . 

Phrase: During the first two days ,
Meta Mapping (851):
   660   First (First (number)) [Quantitative Concept]
   660   Two [Quantitative Concept]
   827   DAYS (day) [Temporal Concept]
Meta Mapping (851):
   660   First (Firstly) [Qualitative Concept]
   660   Two [Quantitative Concept]
   827   DAYS (day) [Temporal Concept]

Phrase: he

Phrase: required
Meta Mapping (1000):
  1000   Required (Requirement) [Functional Concept]

Phrase: 14

Phrase: and

Phrase: 22 units of additional coverage .
Meta Mapping (696):
   760   UNITS (Unit) [Quantitative Concept]
   593   Additional [Functional Concept]
   593   coverage (coverage - financial contract) [Idea or Concept]
Meta Mapping (696):
   760   UNITS (Unit) [Quantitative Concept]
   593   Additional [Functional Concept]
   593   Coverage (Cover - action) [Functional Concept]
Meta Mapping (696):
   760   UNITS (Unit) [Quantitative Concept]
   593   Additional [Functional Concept]
   593   coverage (coverage - HL7PublishingDomain) [Intellectual Product]
Meta Mapping (696):
   760   Units (Unit of Measure) [Quantitative Concept]
   593   Additional [Functional Concept]
   593   coverage (coverage - financial contract) [Idea or Concept]
Meta Mapping (696):
   760   Units (Unit of Measure) [Quantitative Concept]
   593   Additional [Functional Concept]
   593   Coverage (Cover - action) [Functional Concept]
Meta Mapping (696):
   760   Units (Unit of Measure) [Quantitative Concept]
   593   Additional [Functional Concept]
   593   coverage (coverage - HL7PublishingDomain) [Intellectual Product]
Meta Mapping (696):
   760   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   593   Additional [Functional Concept]
   593   coverage (coverage - financial contract) [Idea or Concept]
Meta Mapping (696):
   760   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   593   Additional [Functional Concept]
   593   Coverage (Cover - action) [Functional Concept]
Meta Mapping (696):
   760   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   593   Additional [Functional Concept]
   593   coverage (coverage - HL7PublishingDomain) [Intellectual Product]
Processing 00000000.tx.83: 02/26/92 status post aortic valve replacement , status post coronary artery bypass grafting . 

Phrase: 02/26/92 status post aortic valve replacement ,
Meta Mapping (763):
   770   Status post [Temporal Concept]
   800   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (763):
   770   Status Post (Post) [Temporal Concept]
   800   AORTIC VALVE REPLACEMENT (Replacement of aortic valve (procedure)) [Therapeutic or Preventive Procedure]

Phrase: status post coronary artery bypass grafting .
Meta Mapping (1000):
  1000   Coronary Artery Bypass Grafting (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.84: OTHER PROCEDURES : DOCTORS DISCHARGE ORDERS : A relook several days later led to a repeat percutaneous transluminal coronary angioplasty . 

Phrase: OTHER PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: DOCTORS
Meta Mapping (1000):
  1000   doctors (Physicians) [Professional or Occupational Group]

Phrase: DISCHARGE
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: ORDERS
Meta Mapping (1000):
  1000   orders (orders - HL7PublishingDomain) [Intellectual Product]

Phrase: :

Phrase: A relook several days
Meta Mapping (827):
   827   DAYS (day) [Temporal Concept]

Phrase: later
Meta Mapping (1000):
  1000   Later (Late) [Temporal Concept]

Phrase: led to a repeat percutaneous transluminal coronary angioplasty .
Meta Mapping (781):
   744   LED (Light Emitting Diode Device Component) [Manufactured Object]
   744   Repeat [Functional Concept]
   833   Percutaneous Transluminal Coronary Angioplasty [Therapeutic or Preventive Procedure]
Meta Mapping (781):
   744   LED (Light Emitting Diode Device Component) [Manufactured Object]
   744   Repeat (Repeat Pattern) [Temporal Concept]
   833   Percutaneous Transluminal Coronary Angioplasty [Therapeutic or Preventive Procedure]
Meta Mapping (781):
   744   LED (Light Emitting Diode Device Component) [Manufactured Object]
   744   Repeat (Repeat Object) [Conceptual Entity]
   833   Percutaneous Transluminal Coronary Angioplasty [Therapeutic or Preventive Procedure]
Processing 00000000.tx.85: He has has stable , mild angina , subsequently , mostly in the setting of stress . 

Phrase: He

Phrase: has

Phrase: has

Phrase: stable , mild angina ,
Meta Mapping (901):
   913   Angina, Stable (Stable angina) [Disease or Syndrome]
   660   MILD (Mild (qualifier value)) [Qualitative Concept]

Phrase: subsequently ,

Phrase: mostly in the setting of stress .
Meta Mapping (666):
   753   Mostly (Most) [Quantitative Concept]
   753   Setting (contextual factors) [Functional Concept]
   753   Stress [Finding]
Meta Mapping (666):
   753   Mostly (Most) [Quantitative Concept]
   753   {Setting} [Quantitative Concept]
   753   Stress [Finding]
Meta Mapping (666):
   753   MOSTLY [Idea or Concept]
   753   Setting (contextual factors) [Functional Concept]
   753   Stress [Finding]
Meta Mapping (666):
   753   MOSTLY [Idea or Concept]
   753   {Setting} [Quantitative Concept]
   753   Stress [Finding]
Processing 00000000.tx.86: The patient was admitted to the Surgical Service under the care of Dr. 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted to the Surgical Service
Meta Mapping (745):
   760   admitted (Hospital admission) [Health Care Activity]
   806   Surgical Service (Surgical service) [Health Care Activity]
Meta Mapping (745):
   760   Admitted (Admission activity) [Health Care Activity]
   806   Surgical Service (Surgical service) [Health Care Activity]

Phrase: under the care of Dr.
Meta Mapping (686):
   760   Care (care activity) [Activity]
   593   DR (Dominican Republic) [Geographic Area]
Meta Mapping (686):
   760   Care (care activity) [Activity]
   593   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (686):
   760   Care (care activity) [Activity]
   593   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (686):
   760   Care (care activity) [Activity]
   593   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (686):
   760   Care (care activity) [Activity]
   593   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.87: Lenni Pain . 

Phrase: Lenni Pain .
Meta Mapping (861):
   861   PAIN (Pain) [Sign or Symptom]
Meta Mapping (861):
   861   Pain NOS (Pain NOS Adverse Event) [Finding]
Processing 00000000.tx.88: Her abdominal exam revealed a diffusely tender abdomen which was greater in the lower quadrant without guarding , but with early peritoneal signs . 

Phrase: Her abdominal exam
Meta Mapping (888):
   694   Abdominal (Abdomen) [Body Location or Region]
   861   Exam (Medical Examination) [Health Care Activity]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a diffusely tender abdomen
Meta Mapping (901):
   901   tender abdomen (Abdominal tenderness absent) [Finding]

Phrase: which

Phrase: was

Phrase: greater in the lower quadrant
Meta Mapping (696):
   760   Greater [Quantitative Concept]
   593   LOWER (Lower - spatial qualifier) [Spatial Concept]
   593   Quadrant [Spatial Concept]
Meta Mapping (696):
   760   Greater [Quantitative Concept]
   593   Lower (Body Site Modifier - Lower) [Body Location or Region]
   593   Quadrant [Spatial Concept]
Meta Mapping (696):
   760   Greater [Quantitative Concept]
   593   Lower (Lower (action)) [Activity]
   593   Quadrant [Spatial Concept]

Phrase: without guarding ,
Meta Mapping (1000):
  1000 N Guarding (Protective muscle spasm) [Finding]

Phrase: but with early peritoneal signs .
Meta Mapping (714):
   760   Early [Temporal Concept]
   760   Peritoneal (Peritoneum) [Body Part, Organ, or Organ Component]
   760   signs (Aspects of signs) [Functional Concept]
Meta Mapping (714):
   760   Early [Temporal Concept]
   760   Peritoneal (Peritoneum) [Body Part, Organ, or Organ Component]
   760   signs (Manufactured sign) [Manufactured Object]
Meta Mapping (714):
   760   Early [Temporal Concept]
   760   Peritoneal (Peritoneum) [Body Part, Organ, or Organ Component]
   760   SIGNS (Physical findings) [Finding]
Meta Mapping (714):
   760   Early [Temporal Concept]
   760   Peritoneal (peritoneal) [Body Location or Region]
   760   signs (Aspects of signs) [Functional Concept]
Meta Mapping (714):
   760   Early [Temporal Concept]
   760   Peritoneal (peritoneal) [Body Location or Region]
   760   signs (Manufactured sign) [Manufactured Object]
Meta Mapping (714):
   760   Early [Temporal Concept]
   760   Peritoneal (peritoneal) [Body Location or Region]
   760   SIGNS (Physical findings) [Finding]
Processing 00000000.tx.89: An abdominal CT scan with oral contrast did not show any evidence for fluid collection or abscess . 

Phrase: An abdominal CT scan with oral contrast
Meta Mapping (798):
   748   Abdominal (Abdomen) [Body Location or Region]
   748   CT (Central African Republic) [Geographic Area]
   804   scan with contrast [Diagnostic Procedure]
   581   Oral [Spatial Concept]
Meta Mapping (798):
   748   Abdominal (Abdomen) [Body Location or Region]
   748   CT (PCYT1A wt Allele) [Gene or Genome]
   804   scan with contrast [Diagnostic Procedure]
   581   Oral [Spatial Concept]
Meta Mapping (798):
   748   Abdominal (Abdomen) [Body Location or Region]
   748   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
   804   scan with contrast [Diagnostic Procedure]
   581   Oral [Spatial Concept]
Meta Mapping (798):
   748   Abdominal (Abdomen) [Body Location or Region]
   748   CT (Computed Tomography Study File) [Intellectual Product]
   804   scan with contrast [Diagnostic Procedure]
   581   Oral [Spatial Concept]

Phrase: did

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: show
Meta Mapping (1000):
  1000   Show [Animal]

Phrase: any evidence for fluid collection
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   FLUID (Body Fluids) [Body Substance]
   593   Collection (Collection (action)) [Functional Concept]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   FLUID (Body Fluids) [Body Substance]
   593   Collection (Item Collection) [Idea or Concept]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   fluid (Liquid substance) [Substance]
   593   Collection (Collection (action)) [Functional Concept]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   fluid (Liquid substance) [Substance]
   593   Collection (Item Collection) [Idea or Concept]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Fluid (Fluid behavior) [Qualitative Concept]
   593   Collection (Collection (action)) [Functional Concept]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Fluid (Fluid behavior) [Qualitative Concept]
   593   Collection (Item Collection) [Idea or Concept]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Fluid (fluid - substance) [Substance]
   593   Collection (Collection (action)) [Functional Concept]
Meta Mapping (696):
   760   Evidence [Idea or Concept]
   593   Fluid (fluid - substance) [Substance]
   593   Collection (Item Collection) [Idea or Concept]

Phrase: or

Phrase: abscess .
Meta Mapping (1000):
  1000 N ABSCESS (Abscess) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Abcess (Specimen Type - Abscess) [Body Substance]
Processing 00000000.tx.90: However , repeated abdominal x-rays and CT scans continued to show no signs of obstruction or perforation . 

Phrase: However ,

Phrase: repeated
Meta Mapping (1000):
  1000   Repeated (Repeat) [Functional Concept]

Phrase: abdominal x-rays
Meta Mapping (1000):
  1000   abdominal x rays (Radiography, Abdominal) [Diagnostic Procedure]

Phrase: and

Phrase: CT scans
Meta Mapping (1000):
  1000   CT Scans (X-Ray Computed Tomography) [Diagnostic Procedure]

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: show
Meta Mapping (1000):
  1000   Show [Animal]

Phrase: no signs of obstruction
Meta Mapping (708):
   770   signs (Aspects of signs) [Functional Concept]
   604 N OBSTRUCTION (Obstruction) [Pathologic Function]
Meta Mapping (708):
   770   signs (Aspects of signs) [Functional Concept]
   604   Obstruction (Obstruction within Medical Device) [Phenomenon or Process]
Meta Mapping (708):
   770   signs (Manufactured sign) [Manufactured Object]
   604 N OBSTRUCTION (Obstruction) [Pathologic Function]
Meta Mapping (708):
   770   signs (Manufactured sign) [Manufactured Object]
   604   Obstruction (Obstruction within Medical Device) [Phenomenon or Process]
Meta Mapping (708):
   770   SIGNS (Physical findings) [Finding]
   604 N OBSTRUCTION (Obstruction) [Pathologic Function]
Meta Mapping (708):
   770   SIGNS (Physical findings) [Finding]
   604   Obstruction (Obstruction within Medical Device) [Phenomenon or Process]

Phrase: or

Phrase: perforation .
Meta Mapping (1000):
  1000 N PERFORATION (Perforation (observation)) [Finding]
Meta Mapping (1000):
  1000 N Perforation (Medical Device Material Perforation) [Pathologic Function]
Processing 00000000.tx.91: Dictated By : 07/26/96 T : CC : <RECORD ID="776"> 0079427 ASSOCIATED PROCEDURES : Head computerized tomography scan , echocardiogram , transcranial Dopplers , carotid noninvasives , Holter electrocardiogram , electroencephalogram , and visual field testing . 

Phrase: Dictated By
Meta Mapping (833):
   833   dictated (dictated - ParticipationMode) [Functional Concept]
Meta Mapping (833):
   833   Dictated (dictated - DocumentCompletion) [Idea or Concept]

Phrase: :

Phrase: 07/26/96 T

Phrase: :

Phrase: CC
Meta Mapping (1000):
  1000   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: <RECORD ID="776"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 0079427 ASSOCIATED PROCEDURES
Meta Mapping (884):
   884   Associated procedure [Classification]

Phrase: :

Phrase: Head computerized tomography scan ,
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   Scan (Radionuclide Imaging) [Diagnostic Procedure]
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   Scan (Scanning) [Diagnostic Procedure]
Meta Mapping (916):
   923   Computerized tomography, head (CAT scan of head) [Diagnostic Procedure]
   812   SCAN (Related to Cancer) [Finding]

Phrase: echocardiogram ,
Meta Mapping (1000):
  1000   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Echocardiogram (Echocardiogram (image)) [Intellectual Product]

Phrase: transcranial Dopplers ,
Meta Mapping (872):
   861   Transcranial (Transcranial approach) [Spatial Concept]
   827   Doppler (Doppler studies) [Diagnostic Procedure]

Phrase: carotid noninvasives ,
Meta Mapping (694):
   694   Carotid (carotid) [Body Part, Organ, or Organ Component]

Phrase: Holter electrocardiogram ,
Meta Mapping (861):
   861   Electrocardiogram [Finding]
Meta Mapping (861):
   861   Electro-Cardiogram [Spatial Concept]
Meta Mapping (861):
   861   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (861):
   861   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]

Phrase: electroencephalogram ,
Meta Mapping (1000):
  1000   Electroencephalogram (Electroencephalography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Electroencephalogram [Laboratory or Test Result]
Meta Mapping (1000):
  1000   Electro-Encephalogram [Spatial Concept]

Phrase: and

Phrase: visual field testing .
Meta Mapping (1000):
  1000   Visual field testing (Visual field study) [Diagnostic Procedure]
Processing 00000000.tx.92: The patient was referred to Ph University Of Medical Center for rule out transient ischemic attack and rule out stroke . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: referred to Ph University Of Medical Center
Meta Mapping (737):
   748   referred (Referring) [Functional Concept]
   748   ph+ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   referred (Referring) [Functional Concept]
   748   ph++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   referred (Referring) [Functional Concept]
   748   ph+++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   referred (Referring) [Functional Concept]
   748   pH [Quantitative Concept]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   referred (Referring) [Functional Concept]
   748   PH (Infusion pump Alert priority PH) [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Referred (Referral placed) [Functional Concept]
   748   ph+ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Referred (Referral placed) [Functional Concept]
   748   ph++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Referred (Referral placed) [Functional Concept]
   748   ph+++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Referred (Referral placed) [Functional Concept]
   748   pH [Quantitative Concept]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Referred (Referral placed) [Functional Concept]
   748   PH (Infusion pump Alert priority PH) [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]

Phrase: for rule out transient ischemic attack
Meta Mapping (875):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Out (direction)) [Spatial Concept]
   884 N Transient ischaemic attack (Transient Ischemic Attack) [Disease or Syndrome]
Meta Mapping (875):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Out (direction)) [Spatial Concept]
   884 N Transient ischemic attack (Transient Cerebral Ischemia) [Disease or Syndrome]
Meta Mapping (875):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Removed) [Qualitative Concept]
   884 N Transient ischaemic attack (Transient Ischemic Attack) [Disease or Syndrome]
Meta Mapping (875):
   637   Rule (derivation calculation) [Idea or Concept]
   637   Out (Removed) [Qualitative Concept]
   884 N Transient ischemic attack (Transient Cerebral Ischemia) [Disease or Syndrome]
Meta Mapping (875):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Out (direction)) [Spatial Concept]
   884 N Transient ischaemic attack (Transient Ischemic Attack) [Disease or Syndrome]
Meta Mapping (875):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Out (direction)) [Spatial Concept]
   884 N Transient ischemic attack (Transient Cerebral Ischemia) [Disease or Syndrome]
Meta Mapping (875):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Removed) [Qualitative Concept]
   884 N Transient ischaemic attack (Transient Ischemic Attack) [Disease or Syndrome]
Meta Mapping (875):
   637   Rule (Rule (guideline)) [Intellectual Product]
   637   Out (Removed) [Qualitative Concept]
   884 N Transient ischemic attack (Transient Cerebral Ischemia) [Disease or Syndrome]
Meta Mapping (875):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Out (direction)) [Spatial Concept]
   884 N Transient ischaemic attack (Transient Ischemic Attack) [Disease or Syndrome]
Meta Mapping (875):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Out (direction)) [Spatial Concept]
   884 N Transient ischemic attack (Transient Cerebral Ischemia) [Disease or Syndrome]
Meta Mapping (875):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Removed) [Qualitative Concept]
   884 N Transient ischaemic attack (Transient Ischemic Attack) [Disease or Syndrome]
Meta Mapping (875):
   637   rule (Positive) [Qualitative Concept]
   637   Out (Removed) [Qualitative Concept]
   884 N Transient ischemic attack (Transient Cerebral Ischemia) [Disease or Syndrome]

Phrase: and

Phrase: rule
Meta Mapping (1000):
  1000   Rule (derivation calculation) [Idea or Concept]
Meta Mapping (1000):
  1000   Rule (Rule (guideline)) [Intellectual Product]
Meta Mapping (1000):
  1000   rule (Positive) [Qualitative Concept]

Phrase: out
Meta Mapping (1000):
  1000   Out (Out (direction)) [Spatial Concept]
Meta Mapping (1000):
  1000   Out (Removed) [Qualitative Concept]

Phrase: stroke .
Meta Mapping (1000):
  1000 N STROKE (Cerebrovascular accident) [Disease or Syndrome]
Processing 00000000.tx.93: On neurological examination , the patient was alert , oriented to time , place and person . 

Phrase: On neurological examination ,
Meta Mapping (1000):
  1000   Neurological Examination (Neurologic Examination) [Diagnostic Procedure]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: alert ,
Meta Mapping (1000):
  1000   ALERT (Consciousness clear) [Finding]
Meta Mapping (1000):
  1000   Alert [Functional Concept]
Meta Mapping (1000):
  1000   Alert (Alert:Type:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: oriented to time ,
Meta Mapping (1000):
  1000   Oriented to time [Finding]

Phrase: place
Meta Mapping (1000):
  1000   Place [Spatial Concept]
Meta Mapping (1000):
  1000   Place (Place - dosing instruction imperative) [Functional Concept]
Meta Mapping (1000):
  1000   Place (put - instruction imperative) [Activity]

Phrase: and

Phrase: person .
Meta Mapping (1000):
  1000   Person (Persons) [Population Group]
Meta Mapping (1000):
  1000   Person (Person Observer) [Group]
Processing 00000000.tx.94: Insight , abstract thinking and ______________ test were all intact . 

Phrase: Insight ,
Meta Mapping (1000):
  1000   Insight [Mental Process]

Phrase: abstract thinking
Meta Mapping (1000):
  1000   Abstract thinking (Abstract thought disorder) [Mental or Behavioral Dysfunction]
Meta Mapping (1000):
  1000   Abstract thinking (Abstract thinking ability) [Mental Process]

Phrase: and _____________

Phrase: _ test
Meta Mapping (1000):
  1000   Test (Laboratory Procedures) [Laboratory Procedure]
Meta Mapping (1000):
  1000   Test (Testing) [Functional Concept]
Meta Mapping (1000):
  1000   test (Tests (qualifier value)) [Intellectual Product]
Meta Mapping (1000):
  1000   Test (Test Result) [Finding]

Phrase: were

Phrase: all intact .
Meta Mapping (1000):
  1000   Intact [Qualitative Concept]
Meta Mapping (1000):
  1000   Intact (Gender Status - Intact) [Finding]
Processing 00000000.tx.95: The pupils were bilaterally 4.5 mm and had been dilated at the Purckecation Balpoingdelt Pabarnes- Campa Memorial Hospital . 

Phrase: The pupils
Meta Mapping (1000):
  1000   Pupils (Pupil) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: bilaterally 4.5 mm

Phrase: and

Phrase: had

Phrase: been

Phrase: dilated at the Purckecation Balpoingdelt Pabarnes- Campa Memorial Hospital .
Meta Mapping (650):
   742   Dilated [Finding]
   742   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (650):
   742   Dilated [Finding]
   742   Hospital (Hospital environment) [Qualitative Concept]
Processing 00000000.tx.96: The gag reflex was intact . 

Phrase: The gag reflex
Meta Mapping (1000):
  1000   Gag reflex (Gagging) [Finding]

Phrase: was

Phrase: intact .
Meta Mapping (1000):
  1000   Intact [Qualitative Concept]
Meta Mapping (1000):
  1000   Intact (Gender Status - Intact) [Finding]
Processing 00000000.tx.97: The heel-shin-test was slightly clumsy bilaterally but the knee tapping was normal bilaterally . 

Phrase: The heel-shin-test
Meta Mapping (1000):
  1000   Heel-shin test (Heel-shin test response) [Finding]

Phrase: was

Phrase: slightly clumsy bilaterally
Meta Mapping (754):
   827   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   755   CLUMSINESS (Clumsiness) [Sign or Symptom]
Meta Mapping (754):
   827   Slightly (Slight (qualifier value)) [Qualitative Concept]
   755   CLUMSINESS (Clumsiness) [Sign or Symptom]

Phrase: but

Phrase: the knee tapping
Meta Mapping (694):
   694   Knee [Body Part, Organ, or Organ Component]
Meta Mapping (694):
   694   Knee (Knee joint) [Body Space or Junction]
Meta Mapping (694):
   694   Knee (Entire knee region) [Body Location or Region]
Meta Mapping (694):
   694   Knee, NOS (Knee region structure) [Body Location or Region]

Phrase: was

Phrase: normal bilaterally .
Meta Mapping (861):
   861   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (861):
   861   Normal (Gait normal) [Finding]
Meta Mapping (861):
   861   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (861):
   861   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.98: The patient had reflexes of two-plus bilaterally in the radials , the biceps , the triceps and the knee jerk . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: reflexes of two-plus bilaterally
Meta Mapping (696):
   760   Reflexes (Reflex action) [Organ or Tissue Function]
   593   Two [Quantitative Concept]
   593   Plus (In addition to) [Functional Concept]
Meta Mapping (696):
   760   Reflexes (Observation of reflex) [Finding]
   593   Two [Quantitative Concept]
   593   Plus (In addition to) [Functional Concept]

Phrase: in the radials ,
Meta Mapping (966):
   966   Radial [Conceptual Entity]
Meta Mapping (966):
   966   Radial (Circumpennate) [Conceptual Entity]

Phrase: the biceps ,
Meta Mapping (1000):
  1000   Biceps (Biceps brachii muscle structure) [Body Part, Organ, or Organ Component]

Phrase: the triceps
Meta Mapping (1000):
  1000   Triceps (Triceps brachii muscle structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Triceps [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: the knee jerk .
Meta Mapping (1000):
  1000   Knee jerk (Knee reflex) [Finding]
Processing 00000000.tx.99: The gait was intact and the tandem gait was intact as well . 

Phrase: The gait
Meta Mapping (1000):
  1000   Gait [Finding]

Phrase: was

Phrase: intact
Meta Mapping (1000):
  1000   Intact [Qualitative Concept]
Meta Mapping (1000):
  1000   Intact (Gender Status - Intact) [Finding]

Phrase: and

Phrase: the tandem gait
Meta Mapping (1000):
  1000   Tandem gait (Heel toe gait) [Sign or Symptom]

Phrase: was

Phrase: intact as well .
Meta Mapping (746):
   790   Intact [Qualitative Concept]
   623   Well (Good) [Qualitative Concept]
Meta Mapping (746):
   790   Intact [Qualitative Concept]
   623   Well [Manufactured Object]
Meta Mapping (746):
   790   Intact (Gender Status - Intact) [Finding]
   623   Well (Good) [Qualitative Concept]
Meta Mapping (746):
   790   Intact (Gender Status - Intact) [Finding]
   623   Well [Manufactured Object]
Processing 00000000.tx.100: Complete blood count : Prothrombin time 11.7 , partial thromboplastin time 30.4 . 

Phrase: Complete blood count
Meta Mapping (1000):
  1000   Complete Blood Count [Laboratory Procedure]

Phrase: :

Phrase: Prothrombin time 11.7 ,
Meta Mapping (861):
   861   Time, Prothrombin (Prothrombin time assay) [Laboratory Procedure]
Meta Mapping (861):
   861   Prothrombin time (Coagulation tissue factor induced:Time:Pt:PPP:Qn:Coag) [Clinical Attribute]

Phrase: partial thromboplastin time 30.4 .
Meta Mapping (854):
   884   Partial Thromboplastin Time (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
   804   30% [Finding]
Processing 00000000.tx.101: The right suggested decreased flow . 

Phrase: The right
Meta Mapping (1000):
  1000   RIGHT (Right) [Spatial Concept]
Meta Mapping (1000):
  1000   Right (Right sided) [Spatial Concept]

Phrase: suggested
Meta Mapping (966):
   966   Suggest (suggestion) [Idea or Concept]

Phrase: decreased flow .
Meta Mapping (888):
   694   Decreased [Quantitative Concept]
   861   Flow (flow) [Natural Phenomenon or Process]
Meta Mapping (888):
   694   Decreased (Reduced) [Qualitative Concept]
   861   Flow (flow) [Natural Phenomenon or Process]
Meta Mapping (888):
   694   decreased (Decreasing) [Qualitative Concept]
   861   Flow (flow) [Natural Phenomenon or Process]
Processing 00000000.tx.102: Overall left ventricle systolic function moderately impaired with and estimated ejection fraction of 35% . 

Phrase: Overall left ventricle systolic function
Meta Mapping (861):
   637   Overall (Overall Publication Type) [Intellectual Product]
   865   Left Ventricular Function [Organ or Tissue Function]
   637   Systolic (Systole) [Temporal Concept]
Meta Mapping (861):
   637   Overall [Qualitative Concept]
   865   Left Ventricular Function [Organ or Tissue Function]
   637   Systolic (Systole) [Temporal Concept]

Phrase: moderately
Meta Mapping (1000):
  1000   Moderately (Moderate (severity modifier)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Moderately (Moderation) [Qualitative Concept]

Phrase: impaired with
Meta Mapping (833):
   833   Impaired [Functional Concept]

Phrase: and

Phrase: estimated ejection fraction of 35% .
Meta Mapping (787):
   593   Estimated [Quantitative Concept]
   760   Ejection (Ejection as a Circumstance of Injury) [Phenomenon or Process]
   806   Fraction of [Quantitative Concept]
Meta Mapping (787):
   593   Estimated [Quantitative Concept]
   760   Ejection (Ejection as a Sports activity) [Daily or Recreational Activity]
   806   Fraction of [Quantitative Concept]
Meta Mapping (787):
   593   Estimated [Quantitative Concept]
   760   ejection (Ejection time) [Organism Attribute]
   806   Fraction of [Quantitative Concept]
Processing 00000000.tx.103: 3/10/1992 12:00:00 AM 03/22/1992 The patient is now admitted for fluid rehydration therapy and observation . 

Phrase: 3/10/1992 12
Meta Mapping (824):
   902   3/12 [Finding]
   812   10% [Finding]
Meta Mapping (824):
   812   <3 (<3 (qualifier value)) [Quantitative Concept]
   875   10 - 12 [Finding]
Meta Mapping (824):
   812   3+ (3+ Score) [Quantitative Concept]
   875   10 - 12 [Finding]
Meta Mapping (824):
   812   3+ (3+ Score, WHO) [Classification]
   875   10 - 12 [Finding]
Meta Mapping (824):
   812   3+ (3+ Answer to Question) [Finding]
   875   10 - 12 [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: 03/22/1992

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: now
Meta Mapping (1000):
  1000   Now (Now (temporal qualifier)) [Temporal Concept]

Phrase: admitted for fluid rehydration therapy
Meta Mapping (761):
   760   admitted (Hospital admission) [Health Care Activity]
   797   Fluid Therapy [Therapeutic or Preventive Procedure]
   760   Rehydration [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   admitted (Hospital admission) [Health Care Activity]
   760   FLUID (Body Fluids) [Body Substance]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   admitted (Hospital admission) [Health Care Activity]
   760   fluid (Liquid substance) [Substance]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   admitted (Hospital admission) [Health Care Activity]
   760   Fluid (Fluid behavior) [Qualitative Concept]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   admitted (Hospital admission) [Health Care Activity]
   760   Fluid (fluid - substance) [Substance]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   Admitted (Admission activity) [Health Care Activity]
   797   Fluid Therapy [Therapeutic or Preventive Procedure]
   760   Rehydration [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   Admitted (Admission activity) [Health Care Activity]
   760   FLUID (Body Fluids) [Body Substance]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   Admitted (Admission activity) [Health Care Activity]
   760   fluid (Liquid substance) [Substance]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   Admitted (Admission activity) [Health Care Activity]
   760   Fluid (Fluid behavior) [Qualitative Concept]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]
Meta Mapping (761):
   760   Admitted (Admission activity) [Health Care Activity]
   760   Fluid (fluid - substance) [Substance]
   806   Rehydration therapy (Rehydration) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: observation .
Meta Mapping (1000):
  1000   Observation (Observation in research) [Research Activity]
Meta Mapping (1000):
  1000   Observation (Patient observation) [Health Care Activity]
Meta Mapping (1000):
  1000   OBSERVATION (Observation - diagnostic procedure) [Diagnostic Procedure]
Processing 00000000.tx.104: PAST MEDICAL HISTORY : ALLERGIES : PHYSICAL EXAMINATION : <TEXT> Admission Date : 3) STATUS POST FALL . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > Admission Date
Meta Mapping (1000):
  1000   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (1000):
  1000   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: 3
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]

Phrase: )

Phrase: STATUS POST FALL .
Meta Mapping (1000):
  1000   FALL (Falls) [Finding]
Meta Mapping (1000):
  1000   Fall (Autumn) [Temporal Concept]
Processing 00000000.tx.105: 3) History of atrial fibrillation . 

Phrase: 3
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]

Phrase: )

Phrase: History of atrial fibrillation .
Meta Mapping (1000):
  1000   History of - atrial fibrillation (H/O: atrial fibrillation) [Finding]
Processing 00000000.tx.106: 5) Hypertension . 

Phrase: 5
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]

Phrase: )

Phrase: Hypertension .
Meta Mapping (1000):
  1000   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Hypertension (Hypertension Adverse Event) [Finding]
Processing 00000000.tx.107: The patient had no known drug allergies . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: no known drug allergies .
Meta Mapping (901):
   660   Known [Qualitative Concept]
   901 N Drug Allergies (Drug Allergy) [Disease or Syndrome]
Processing 00000000.tx.108: She has a son who is actively involved in her care . 

Phrase: She

Phrase: has

Phrase: a son
Meta Mapping (1000):
  1000   Son (Son (person)) [Family Group]

Phrase: who

Phrase: is

Phrase: actively

Phrase: involved in her care .
Meta Mapping (708):
   770   Involved (Involvement with) [Functional Concept]
   770   Care (care activity) [Activity]
Processing 00000000.tx.109: Vascular examination was notable for 1+ carotid impulses which were diminished and delayed and the above mentioned transmitted cardiac murmurs . 

Phrase: Vascular examination
Meta Mapping (950):
   950   Blood--Examination [Laboratory Procedure]

Phrase: was

Phrase: notable for 1+ carotid impulses
Meta Mapping (512):
   593   Carotid (carotid) [Body Part, Organ, or Organ Component]
   560   Impulse (Impulse technique) [Therapeutic or Preventive Procedure]

Phrase: which

Phrase: were

Phrase: diminished
Meta Mapping (1000):
  1000   Diminished (Decreased) [Quantitative Concept]

Phrase: and

Phrase: delayed
Meta Mapping (1000):
  1000   Delayed (Deferred) [Temporal Concept]
Meta Mapping (1000):
  1000   Delayed (Delayed Testing) [Qualitative Concept]

Phrase: and

Phrase: the above mentioned transmitted cardiac murmurs .
Meta Mapping (785):
   637   Transmitted (disease transmission) [Pathologic Function]
   840   Cardiac Murmurs (Heart murmur) [Finding]
Meta Mapping (785):
   637   transmitted (Transmitted by) [Functional Concept]
   840   Cardiac Murmurs (Heart murmur) [Finding]
Meta Mapping (785):
   637   Transmitted (transmission process) [Natural Phenomenon or Process]
   840   Cardiac Murmurs (Heart murmur) [Finding]
Processing 00000000.tx.110: At the time of discharge , the patient &apos;s mental status is back to its baseline . 

Phrase: At the time of discharge ,
Meta Mapping (797):
   797   Discharge time [Temporal Concept]
Meta Mapping (797):
   797   Discharge time (Discharge time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s mental status
Meta Mapping (901):
   913   S status (Scleral tumor invasion status) [Classification]
   660   mental (Psyche structure) [Mental Process]
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   Mental status (Mental state (observable entity)) [Finding]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   Mental status (Mental state (observable entity)) [Finding]

Phrase: is

Phrase: back to its baseline .
Meta Mapping (708):
   770   BACK (Back) [Body Location or Region]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   BACK (Back) [Body Location or Region]
   604   Baseline [Quantitative Concept]
Meta Mapping (708):
   770   BACK (Dorsal) [Spatial Concept]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   BACK (Dorsal) [Spatial Concept]
   604   Baseline [Quantitative Concept]
Meta Mapping (708):
   770   Back (Back structure, including back of neck) [Body Location or Region]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   Back (Back structure, including back of neck) [Body Location or Region]
   604   Baseline [Quantitative Concept]
Meta Mapping (708):
   770   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   604   baseline (BaseLine dental cement) [Biomedical or Dental Material]
Meta Mapping (708):
   770   Back, NOS (Back structure, excluding neck) [Body Location or Region]
   604   Baseline [Quantitative Concept]
Processing 00000000.tx.111: Fortunately , these issues were not active during the present admission . 

Phrase: Fortunately ,

Phrase: these issues
Meta Mapping (966):
   966   Issue (Problem) [Finding]
Meta Mapping (966):
   966   Issue (Issue (document)) [Intellectual Product]

Phrase: were

Phrase: not active during the present admission .
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active [Functional Concept]
   586   Present [Quantitative Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active [Functional Concept]
   586   Present [Quantitative Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active [Functional Concept]
   586   Present (Presentation) [Idea or Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active [Functional Concept]
   586   Present (Presentation) [Idea or Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   active (active (HL7 RoleLink)) [Idea or Concept]
   586   Present [Quantitative Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   active (active (HL7 RoleLink)) [Idea or Concept]
   586   Present [Quantitative Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   active (active (HL7 RoleLink)) [Idea or Concept]
   586   Present (Presentation) [Idea or Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   active (active (HL7 RoleLink)) [Idea or Concept]
   586   Present (Presentation) [Idea or Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active (Active License) [Qualitative Concept]
   586   Present [Quantitative Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active (Active License) [Qualitative Concept]
   586   Present [Quantitative Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active (Active License) [Qualitative Concept]
   586   Present (Presentation) [Idea or Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (691):
   586   Not (Negation) [Functional Concept]
   753   Active (Active License) [Qualitative Concept]
   586   Present (Presentation) [Idea or Concept]
   586   Admission (Admission activity) [Health Care Activity]
Processing 00000000.tx.112: 5) Atrial fibrillation : The patient &apos;s Coumadin was continued . 

Phrase: 5
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]

Phrase: )

Phrase: Atrial fibrillation
Meta Mapping (1000):
  1000   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
Meta Mapping (1000):
  1000   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]

Phrase: :

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s Coumadin
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Coumadin [Organic Chemical,Pharmacologic Substance]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Coumadin [Organic Chemical,Pharmacologic Substance]

Phrase: was

Phrase: continued .
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]
Processing 00000000.tx.113: On admission , the patient was noted to have elevated bilirubins in the 3 range and mildly elevated alkaline phosphatase consistent with a cholestatic picture . 

Phrase: On admission ,
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: elevated bilirubins in the 3 range
Meta Mapping (711):
   773   elevated bilirubin (Increased bilirubin level (finding)) [Finding]
   586   Range [Quantitative Concept]
Meta Mapping (711):
   773   elevated bilirubin (Increased bilirubin level (finding)) [Finding]
   586   Range (Sample Range) [Quantitative Concept]
Meta Mapping (711):
   773   elevated bilirubin (Increased bilirubin level (finding)) [Finding]
   586   Range (Concept model range (foundation metadata concept)) [Intellectual Product]

Phrase: and

Phrase: mildly
Meta Mapping (1000):
  1000   MILDLY [Idea or Concept]
Meta Mapping (1000):
  1000   Mildly (Mild (qualifier value)) [Qualitative Concept]

Phrase: elevated
Meta Mapping (1000):
  1000   Elevated (High) [Qualitative Concept]
Meta Mapping (1000):
  1000   Elevated [Qualitative Concept]

Phrase: alkaline phosphatase
Meta Mapping (1000):
  1000   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: consistent with a cholestatic picture .
Meta Mapping (734):
   806   Consistent with [Idea or Concept]
   521   Cholestasis [Disease or Syndrome]
   593   picture (photograph) [Manufactured Object]
Meta Mapping (734):
   806   Consistent with [Idea or Concept]
   521   Cholestasis [Disease or Syndrome]
   593   Picture [Manufactured Object]
Processing 00000000.tx.114: 10) Buspar 5 mg p.o. t.i.d. 

Phrase: 10

Phrase: )

Phrase: Buspar 5 mg p.o. t.i.d.
Meta Mapping (795):
   793   BuSpar (Buspar) [Organic Chemical,Pharmacologic Substance]
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.115: T : 08/18/98 73434966 DIS ****** DISCHARGE ORDERS ****** DISPOSITION : COLACE ( DOCUSATE SODIUM ) 100 MG PO TID DILAUDID ( HYDROMORPHONE HCL ) 2-4 MG PO Q4H PRN Pain LEVOFLOXACIN 500 MG PO QD DIET : ALLERGY : AMOXICILLIN 462491 Unsigned DISCHARGE DATE : The review of systems was negative . 

Phrase: T
Meta Mapping (1000):
  1000   T' (T prime) [Clinical Attribute]

Phrase: :

Phrase: 08/18/98 73434966 DIS *****
Meta Mapping (804):
   804   DIS (Diagnostic interview schedule) [Intellectual Product]
Meta Mapping (804):
   804 N DIS (Discontinued) [Finding]

Phrase: * DISCHARGE
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: ORDERS
Meta Mapping (1000):
  1000   Order (Order (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Order (Order (arrangement)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Order (Order (taxonomic)) [Classification]
Meta Mapping (1000):
  1000   Order (Order (action)) [Activity]
Meta Mapping (1000):
  1000   Order (Permutation) [Qualitative Concept]
Meta Mapping (1000):
  1000   orders (orders - HL7PublishingDomain) [Intellectual Product]
Meta Mapping (1000):
  1000   ORDER (Sequence of Planned Assessment Schedule) [Intellectual Product]

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: *

Phrase: * DISPOSITION
Meta Mapping (1000):
  1000   Disposition [Idea or Concept]
Meta Mapping (1000):
  1000   Disposition (Disposition Domain) [Intellectual Product]

Phrase: :

Phrase: COLACE
Meta Mapping (1000):
  1000   Colace [Organic Chemical,Pharmacologic Substance]

Phrase: ( DOCUSATE SODIUM
Meta Mapping (1000):
  1000   DOCUSATE SODIUM (Docusate Sodium) [Organic Chemical,Pharmacologic Substance]

Phrase: )

Phrase: 100 MG PO TID DILAUDID
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   MG (Mongolia) [Geographic Area]
   637   PO (Portugal) [Geographic Area]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   MG (Mongolia) [Geographic Area]
   637   PO (Portugal) [Geographic Area]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   MG (Mongolia) [Geographic Area]
   637   PO (Oral) [Spatial Concept]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   MG (Mongolia) [Geographic Area]
   637   PO (Oral) [Spatial Concept]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg% (mg/dL) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg% (mg/dL) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg% (mg/dL) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg% (mg/dL) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg % (Milligram percent) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg % (Milligram percent) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg % (Milligram percent) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   mg % (Milligram percent) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   637   PO (Portugal) [Geographic Area]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   637   PO (Portugal) [Geographic Area]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   637   PO (Oral) [Spatial Concept]
   637   TID (Three times daily) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]
Meta Mapping (822):
   637   100% [Quantitative Concept]
   637   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   637   PO (Oral) [Spatial Concept]
   637   TID (three times a day at institution-specified times) [Temporal Concept]
   804   Dilaudid [Organic Chemical,Pharmacologic Substance]

Phrase: ( HYDROMORPHONE HCL
Meta Mapping (1000):
  1000   hydromorphone hcl (Hydromorphone Hydrochloride) [Organic Chemical,Pharmacologic Substance]

Phrase: )

Phrase: 2-4 MG PO Q4H PRN Pain LEVOFLOXACIN 500 MG PO QD DIET
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   +2 [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score) [Quantitative Concept]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620   2+ (2+ Score, WHO) [Classification]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Portugal) [Geographic Area]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N PAIN (Pain) [Sign or Symptom]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet therapy) [Health Care Activity]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Special Diet Therapy) [Therapeutic or Preventive Procedure]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   DIET (Basal Diet) [Food]
Meta Mapping (709):
   620 N 2+ [Finding]
   680   mg/mg [Quantitative Concept]
   620   PO (Oral) [Spatial Concept]
   620   Q4H (Every four hours) [Temporal Concept]
   620 N Pain NOS (Pain NOS Adverse Event) [Finding]
   620   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
   620   QD (Daily) [Temporal Concept]
   786   Diet (Diet (animal life circumstance)) [Food]

Phrase: :

Phrase: ALLERGY
Meta Mapping (1000):
  1000   Allergy (Allergy Specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000 N ALLERGY (Hypersensitivity) [Pathologic Function]
Meta Mapping (1000):
  1000 N ALLERGY (Response to antigens) [Physiologic Function]
Meta Mapping (1000):
  1000 N Allergy (Allergic Reaction) [Pathologic Function]
Meta Mapping (1000):
  1000   Allergy (Allergy - Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000 N Allergy (Allergic disposition) [Disease or Syndrome]

Phrase: :

Phrase: AMOXICILLIN 462491 Unsigned DISCHARGE DATE
Meta Mapping (812):
   637   Amoxycillin (Amoxicillin) [Antibiotic,Organic Chemical]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (812):
   637   Amoxycillin (Amoxicillin) [Antibiotic,Organic Chemical]
   840   Discharge date [Temporal Concept]
Meta Mapping (812):
   637   Amoxicilline [Antibiotic,Organic Chemical]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (812):
   637   Amoxicilline [Antibiotic,Organic Chemical]
   840   Discharge date [Temporal Concept]

Phrase: :

Phrase: The review of systems
Meta Mapping (909):
   909   Review of systems (Review of systems:Finding:Point in time:^Patient:Narrative:Reported) [Clinical Attribute]
Meta Mapping (909):
   909   Review of systems (Review of systems:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]
Meta Mapping (909):
   909   Review of Systems (Review of systems (procedure)) [Health Care Activity]

Phrase: was

Phrase: negative .
Meta Mapping (1000):
  1000   Negative [Qualitative Concept]
Meta Mapping (1000):
  1000   NEGATIVE (Negative Finding) [Finding]
Meta Mapping (1000):
  1000   Negative (Negative Number) [Conceptual Entity]
Meta Mapping (1000):
  1000   Negative (Negative Charge) [Qualitative Concept]
Meta Mapping (1000):
  1000   Negative (Negative - answer) [Qualitative Concept]
Processing 00000000.tx.116: Despite these efforts and despite the lack of physical signs , on the day of the operation , he experienced a popping sensation in his abdomen while he was walking and then the onset of mild diffuse abdominal pain . 

Phrase: Despite these efforts
Meta Mapping (966):
   966   Effort (Exertion) [Organism Function]

Phrase: and despite the lack of physical signs ,
Meta Mapping (706):
   748   lack (Lacking) [Qualitative Concept]
   778   Physical signs (Physical findings) [Finding]

Phrase: on the day of the operation ,
Meta Mapping (783):
   783   Day Operation (Surgery, Day) [Therapeutic or Preventive Procedure]

Phrase: he

Phrase: experienced
Meta Mapping (966):
   966   experience (Practice Experience) [Mental Process]
Meta Mapping (966):
   966   Experience [Mental Process]

Phrase: a popping sensation in his abdomen
Meta Mapping (722):
   790   Popping Sensation (Popping sensation quality) [Qualitative Concept]
   586   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (722):
   790   Popping Sensation (Popping sensation quality) [Qualitative Concept]
   586   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (722):
   790   Popping Sensation (Popping sensation quality) [Qualitative Concept]
   586   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]
Meta Mapping (722):
   586   Popping (Popping sensation quality) [Qualitative Concept]
   783   sensation abdomen (Sensation of abdomen) [Finding]

Phrase: while

Phrase: he

Phrase: was

Phrase: walking
Meta Mapping (1000):
  1000   Walking (Walking (activity)) [Daily or Recreational Activity]

Phrase: and

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: the onset of mild diffuse abdominal pain .
Meta Mapping (719):
   748   Onset (Age of Onset) [Quantitative Concept]
   607   Mild pain [Finding]
   581   DIFFUSE (Diffuse) [Qualitative Concept]
   581   Abdominal (Abdomen) [Body Location or Region]
Meta Mapping (719):
   748   Onset (Age of Onset) [Quantitative Concept]
   581   MILD (Mild (qualifier value)) [Qualitative Concept]
   607   Diffuse pain [Sign or Symptom]
   581   Abdominal (Abdomen) [Body Location or Region]
Meta Mapping (719):
   748   Onset (Age of Onset) [Quantitative Concept]
   581   MILD (Mild (qualifier value)) [Qualitative Concept]
   581   DIFFUSE (Diffuse) [Qualitative Concept]
   612   ABDOMINAL PAIN (Abdominal Pain) [Sign or Symptom]
Meta Mapping (719):
   748   Onset (Onset of (contextual qualifier)) [Qualitative Concept]
   607   Mild pain [Finding]
   581   DIFFUSE (Diffuse) [Qualitative Concept]
   581   Abdominal (Abdomen) [Body Location or Region]
Meta Mapping (719):
   748   Onset (Onset of (contextual qualifier)) [Qualitative Concept]
   581   MILD (Mild (qualifier value)) [Qualitative Concept]
   607   Diffuse pain [Sign or Symptom]
   581   Abdominal (Abdomen) [Body Location or Region]
Meta Mapping (719):
   748   Onset (Onset of (contextual qualifier)) [Qualitative Concept]
   581   MILD (Mild (qualifier value)) [Qualitative Concept]
   581   DIFFUSE (Diffuse) [Qualitative Concept]
   612   ABDOMINAL PAIN (Abdominal Pain) [Sign or Symptom]
Meta Mapping (719):
   581   MILD (Mild (qualifier value)) [Qualitative Concept]
   581   DIFFUSE (Diffuse) [Qualitative Concept]
   581   Abdominal (Abdomen) [Body Location or Region]
   774   Pain onset [Finding]
Processing 00000000.tx.117: The patient continued to improve postoperatively and had essentially an unremarkable course with the exception that his creatinine became elevated . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: improve

Phrase: postoperatively

Phrase: and

Phrase: had

Phrase: essentially

Phrase: an unremarkable course with the exception
Meta Mapping (672):
   586   Unremarkable (Normal) [Qualitative Concept]
   753   Course [Temporal Concept]
   586   exception (exception - ResponseLevel) [Idea or Concept]
Meta Mapping (672):
   586   Unremarkable (Normal) [Qualitative Concept]
   753   Course [Temporal Concept]
   586   Exception (Exception - Property or Attribute) [Conceptual Entity]

Phrase: that

Phrase: his creatinine
Meta Mapping (1000):
  1000   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (1000):
  1000   Creatinine (Creatinine finding) [Finding]

Phrase: became

Phrase: elevated .
Meta Mapping (1000):
  1000   Elevated (High) [Qualitative Concept]
Meta Mapping (1000):
  1000   Elevated [Qualitative Concept]
Processing 00000000.tx.118: It was therefore felt that his elevation in creatinine was multifactorial related to the events surrounding surgery and the surgery itself . 

Phrase: It

Phrase: was

Phrase: therefore

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: his elevation in creatinine
Meta Mapping (708):
   770   Elevation (Elevation procedure) [Therapeutic or Preventive Procedure]
   604   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (708):
   770   Elevation (Elevation procedure) [Therapeutic or Preventive Procedure]
   604   Creatinine (Creatinine finding) [Finding]
Meta Mapping (708):
   770   Elevation [Spatial Concept]
   604   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (708):
   770   Elevation [Spatial Concept]
   604   Creatinine (Creatinine finding) [Finding]

Phrase: was

Phrase: multifactorial
Meta Mapping (1000):
  1000   Multifactorial [Finding]

Phrase: related to the events
Meta Mapping (708):
   770   Related (Relationships) [Qualitative Concept]
   770   Events (Event) [Event]
Meta Mapping (708):
   770   Related (Relationships) [Qualitative Concept]
   770   EVENTS (CDISC Events Class) [Classification]
Meta Mapping (708):
   770   Related (Related personal status) [Finding]
   770   Events (Event) [Event]
Meta Mapping (708):
   770   Related (Related personal status) [Finding]
   770   EVENTS (CDISC Events Class) [Classification]

Phrase: surrounding
Meta Mapping (1000):
  1000   Surrounding (Surrounding (qualifier value)) [Spatial Concept]

Phrase: surgery
Meta Mapping (1000):
  1000   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (1000):
  1000   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]

Phrase: and

Phrase: the surgery
Meta Mapping (1000):
  1000   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (1000):
  1000   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]

Phrase: itself .
Processing 00000000.tx.119: 98431395 Report Status : The patient on 2/8/90 underwent a right radical vulvectomy with excellent results and negative margins on frozen section . 

Phrase: 98431395 Report Status
Meta Mapping (901):
   901   Report status [Finding]

Phrase: :

Phrase: The patient on 2/8/90
Meta Mapping (672):
   753   *^patient (Patients) [Patient or Disabled Group]
   586   >90 [Quantitative Concept]
Meta Mapping (672):
   753   *^patient (Patients) [Patient or Disabled Group]
   586   <90 [Quantitative Concept]
Meta Mapping (672):
   753   *^patient (Patients) [Patient or Disabled Group]
   586   90% [Finding]
Meta Mapping (672):
   753   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   >90 [Quantitative Concept]
Meta Mapping (672):
   753   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   <90 [Quantitative Concept]
Meta Mapping (672):
   753   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   90% [Finding]
Meta Mapping (672):
   753   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   >90 [Quantitative Concept]
Meta Mapping (672):
   753   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   <90 [Quantitative Concept]
Meta Mapping (672):
   753   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   90% [Finding]
Meta Mapping (672):
   753   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   >90 [Quantitative Concept]
Meta Mapping (672):
   753   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   <90 [Quantitative Concept]
Meta Mapping (672):
   753   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   586   90% [Finding]

Phrase: underwent

Phrase: a right radical vulvectomy with excellent results
Meta Mapping (704):
   581   RIGHT (Right) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent - Specimen Quality) [Qualitative Concept]
   548   Result [Functional Concept]
Meta Mapping (704):
   581   RIGHT (Right) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent - Specimen Quality) [Qualitative Concept]
   548   Result (What subject filter - Result) [Idea or Concept]
Meta Mapping (704):
   581   RIGHT (Right) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent - Specimen Quality) [Qualitative Concept]
   548   Result (Experimental Result) [Finding]
Meta Mapping (704):
   581   RIGHT (Right) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent (qualifier value)) [Qualitative Concept]
   548   Result [Functional Concept]
Meta Mapping (704):
   581   RIGHT (Right) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent (qualifier value)) [Qualitative Concept]
   548   Result (What subject filter - Result) [Idea or Concept]
Meta Mapping (704):
   581   RIGHT (Right) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent (qualifier value)) [Qualitative Concept]
   548   Result (Experimental Result) [Finding]
Meta Mapping (704):
   581   Right (Right sided) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent - Specimen Quality) [Qualitative Concept]
   548   Result [Functional Concept]
Meta Mapping (704):
   581   Right (Right sided) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent - Specimen Quality) [Qualitative Concept]
   548   Result (What subject filter - Result) [Idea or Concept]
Meta Mapping (704):
   581   Right (Right sided) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent - Specimen Quality) [Qualitative Concept]
   548   Result (Experimental Result) [Finding]
Meta Mapping (704):
   581   Right (Right sided) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent (qualifier value)) [Qualitative Concept]
   548   Result [Functional Concept]
Meta Mapping (704):
   581   Right (Right sided) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent (qualifier value)) [Qualitative Concept]
   548   Result (What subject filter - Result) [Idea or Concept]
Meta Mapping (704):
   581   Right (Right sided) [Spatial Concept]
   778   Radical Vulvectomy (Radical vulvectomy) [Therapeutic or Preventive Procedure]
   581   Excellent (Excellent (qualifier value)) [Qualitative Concept]
   548   Result (Experimental Result) [Finding]

Phrase: and

Phrase: negative margins on frozen section .
Meta Mapping (768):
   790   Negative margin (Negative Surgical Margin) [Finding]
   640   Frozen Section (Frozen Sections) [Tissue]
Meta Mapping (768):
   790   Negative margin (Negative Surgical Margin) [Finding]
   640   Frozen Section (Cryoultramicrotomy) [Laboratory Procedure]
Processing 00000000.tx.120: <RECORD ID="782"> Ciprofloxacin 500 mg. po. 

Phrase: <RECORD ID="782"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > Ciprofloxacin 500 mg. po.
Meta Mapping (916):
   756   Ciprofloxacin 500 MG [Clinical Drug]
   812   PO (Portugal) [Geographic Area]
Meta Mapping (916):
   756   Ciprofloxacin 500 MG [Clinical Drug]
   812   PO (Oral) [Spatial Concept]
Processing 00000000.tx.121: q12 . 

Phrase: q12 .
Processing 00000000.tx.122: Benadryl 50 mg. intravenous tid prn . 

Phrase: Benadryl 50 mg. intravenous tid prn .
Meta Mapping (658):
   675   Diphenhydramine Hydrochloride 50 MG [Clinical Drug]
   632   Intravenous [Spatial Concept]
   632   TID (Three times daily) [Temporal Concept]
Meta Mapping (658):
   675   Diphenhydramine Hydrochloride 50 MG [Clinical Drug]
   632   Intravenous [Spatial Concept]
   632   TID (three times a day at institution-specified times) [Temporal Concept]
Processing 00000000.tx.123: Lasix prn . 

Phrase: Lasix prn .
Meta Mapping (694):
   694   Lasix [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.124: Otherwise he is awake , alert and appropriate and can respond to questions and can move his upper extremities . 

Phrase: Otherwise

Phrase: he

Phrase: is

Phrase: awake , alert
Meta Mapping (888):
   694   Awake [Finding]
   861   ALERT (Consciousness clear) [Finding]
Meta Mapping (888):
   694   Awake [Finding]
   861   Alert [Functional Concept]
Meta Mapping (888):
   694   Awake [Finding]
   861   Alert (Alert:Type:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: and

Phrase: appropriate
Meta Mapping (1000):
  1000   Appropriate [Qualitative Concept]

Phrase: and

Phrase: can

Phrase: respond to questions
Meta Mapping (756):
   756   Question (Question (inquiry)) [Intellectual Product]

Phrase: and

Phrase: can

Phrase: move
Meta Mapping (1000):
  1000   move (Moving) [Organism Function]
Meta Mapping (1000):
  1000   move (Does move) [Finding]
Meta Mapping (1000):
  1000   move (Moved from) [Functional Concept]
Meta Mapping (1000):
  1000   move (Moved to) [Functional Concept]
Meta Mapping (1000):
  1000   Move (Relocation of home or business) [Activity]

Phrase: his upper extremities .
Meta Mapping (1000):
  1000   Extremities, Upper (Upper Extremity) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.125: A copy of this ultrasound is also found in his records . 

Phrase: A copy of this ultrasound
Meta Mapping (686):
   760   Copy (Copy (object)) [Manufactured Object]
   593   ULTRASOUND (Ultrasonography) [Diagnostic Procedure]
Meta Mapping (686):
   760   Copy (Copy (object)) [Manufactured Object]
   593   ultrasound (Ultrasonic Shockwave) [Natural Phenomenon or Process]
Meta Mapping (686):
   760   Copy (Copy (object)) [Manufactured Object]
   593   ultrasound (Ultrasonic) [Functional Concept]
Meta Mapping (686):
   760   Copy (Copy (object)) [Manufactured Object]
   593   Ultrasound (Ultrasonics (sound)) [Natural Phenomenon or Process]
Meta Mapping (686):
   760   Copy (Copy (object)) [Manufactured Object]
   593   ULTRASOUND (ultrasound device) [Medical Device]

Phrase: is

Phrase: also

Phrase: found in his records .
Meta Mapping (708):
   770   Found (Present) [Quantitative Concept]
   770   Records [Intellectual Product]
Meta Mapping (708):
   770   Found (Present) [Quantitative Concept]
   770   Records (Quantity limited request - Records) [Idea or Concept]
Meta Mapping (708):
   770   Found (Present) [Quantitative Concept]
   770   Records (Query Quantity Unit - Records) [Qualitative Concept]
Processing 00000000.tx.126: These may be removed when the incisions are noted to be well healed . 

Phrase: These

Phrase: may

Phrase: be

Phrase: removed
Meta Mapping (1000):
  1000   Removed [Qualitative Concept]

Phrase: when

Phrase: the incisions
Meta Mapping (1000):
  1000   INCISIONS (Surgical incisions) [Therapeutic or Preventive Procedure]

Phrase: are

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: well
Meta Mapping (1000):
  1000   Well (Good) [Qualitative Concept]
Meta Mapping (1000):
  1000   Well [Manufactured Object]

Phrase: healed .
Meta Mapping (1000):
  1000   Healed [Functional Concept]
Processing 00000000.tx.127: The patient remains on Fluconazole . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: remains on Fluconazole .
Meta Mapping (790):
   790   FLUCONAZOLE (Fluconazole) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.128: Consulting Plastic Surgeon : Cealme Maressythe , M.D.

Phrase: Consulting
Meta Mapping (1000):
  1000   consulting (Consultation) [Health Care Activity]

Phrase: Plastic Surgeon
Meta Mapping (1000):
  1000   Plastic Surgeon (Plastic surgeon) [Professional or Occupational Group]

Phrase: :

Phrase: Cealme Maressythe ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.1: Admission Date : Signed Atrial fibrillation since 1990 . 

Phrase: Admission Date
Meta Mapping (1000):
  1000   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (1000):
  1000   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: Signed Atrial fibrillation since 1990 .
Meta Mapping (783):
   804   Signed (Signature) [Intellectual Product]
   840   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   771   1990s [Temporal Concept]
Meta Mapping (783):
   804   Signed (Signature) [Intellectual Product]
   840   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   771   1990s [Temporal Concept]
Meta Mapping (783):
   804   Signed (Signature) [Intellectual Product]
   840   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   771   1990s [Temporal Concept]
Meta Mapping (783):
   804   signed (signed - ParticipationSignature) [Intellectual Product]
   840   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   771   1990s [Temporal Concept]
Meta Mapping (783):
   804   signed (signed - ParticipationSignature) [Intellectual Product]
   840   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   771   1990s [Temporal Concept]
Meta Mapping (783):
   804   signed (signed - ParticipationSignature) [Intellectual Product]
   840   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   771   1990s [Temporal Concept]
Processing 00000000.tx.2: Tricuspid regurgitation . 

Phrase: Tricuspid regurgitation .
Meta Mapping (1000):
  1000   Regurgitation, Tricuspid (Tricuspid Valve Insufficiency) [Disease or Syndrome]
Processing 00000000.tx.3: Cipro 250 mg. b.i.d. 

Phrase: Cipro 250 mg. b.i.d.
Meta Mapping (768):
   799   Cipro [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   799   I- (Iodides) [Inorganic Chemical]
Meta Mapping (768):
   799   Cipro [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   799   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (768):
   799   Cipro [Organic Chemical,Pharmacologic Substance]
   799   MG (Mongolia) [Geographic Area]
   827   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   799   Cipro [Organic Chemical,Pharmacologic Substance]
   799   mg% (mg/dL) [Quantitative Concept]
   827   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   799   Cipro [Organic Chemical,Pharmacologic Substance]
   799   mg % (Milligram percent) [Quantitative Concept]
   827   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   799   Cipro [Organic Chemical,Pharmacologic Substance]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   827   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: Blood pressure was 104/66 . 

Phrase: Blood pressure
Meta Mapping (1000):
  1000   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (1000):
  1000   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (1000):
  1000   Blood pressure (Systemic arterial pressure) [Finding]

Phrase: was

Phrase: 104/66 .
Processing 00000000.tx.5: His abdomen was soft and nontender with a positive fluid wave and a liver edge 3 cm. below the costal margin . 

Phrase: His abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: soft
Meta Mapping (1000):
  1000   Soft [Qualitative Concept]
Meta Mapping (1000):
  1000   SOFT (SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME) [Disease or Syndrome]

Phrase: and

Phrase: nontender with a positive fluid wave
Meta Mapping (725):
   753   Nontender (Non-tender) [Qualitative Concept]
   586   % Positive (percent positive cells) [Quantitative Concept]
   623   Fluid wave (Fluid thrill in abdomen) [Finding]
Meta Mapping (725):
   753   Nontender (Non-tender) [Qualitative Concept]
   586   Positive [Qualitative Concept]
   623   Fluid wave (Fluid thrill in abdomen) [Finding]
Meta Mapping (725):
   753   Nontender (Non-tender) [Qualitative Concept]
   586   POSITIVE (Positive Finding) [Finding]
   623   Fluid wave (Fluid thrill in abdomen) [Finding]
Meta Mapping (725):
   753   Nontender (Non-tender) [Qualitative Concept]
   586   Positive (Positive Charge) [Qualitative Concept]
   623   Fluid wave (Fluid thrill in abdomen) [Finding]
Meta Mapping (725):
   753   Nontender (Non-tender) [Qualitative Concept]
   586   Positive (Positive Number) [Conceptual Entity]
   623   Fluid wave (Fluid thrill in abdomen) [Finding]

Phrase: and

Phrase: a liver edge 3 cm.
Meta Mapping (694):
   694   Liver edge [Finding]

Phrase: below the costal margin .
Meta Mapping (1000):
  1000   Costal margin (Border of rib) [Body Location or Region]
Processing 00000000.tx.6: After aggressive diuresis on the Medical Service , he was deemed stable for surgery . 

Phrase: After aggressive diuresis on the Medical Service ,
Meta Mapping (696):
   581   aggressive (Aggressive behavior) [Mental or Behavioral Dysfunction]
   748   Diuresis [Organ or Tissue Function]
   612   Medical service [Health Care Activity]
Meta Mapping (696):
   581   aggressive (Aggressive behavior) [Mental or Behavioral Dysfunction]
   748   Diuresis [Organ or Tissue Function]
   612   medical service (Physician service) [Health Care Activity]
Meta Mapping (696):
   581   aggressive (Aggressive behavior) [Mental or Behavioral Dysfunction]
   748   Diuresis [Organ or Tissue Function]
   612   Medical Service (Hospital Service - Medical Service) [Health Care Related Organization]
Meta Mapping (696):
   581   Aggressive (Aggressive course) [Temporal Concept]
   748   Diuresis [Organ or Tissue Function]
   612   Medical service [Health Care Activity]
Meta Mapping (696):
   581   Aggressive (Aggressive course) [Temporal Concept]
   748   Diuresis [Organ or Tissue Function]
   612   medical service (Physician service) [Health Care Activity]
Meta Mapping (696):
   581   Aggressive (Aggressive course) [Temporal Concept]
   748   Diuresis [Organ or Tissue Function]
   612   Medical Service (Hospital Service - Medical Service) [Health Care Related Organization]

Phrase: he

Phrase: was

Phrase: deemed

Phrase: stable for surgery .
Meta Mapping (746):
   790   STABLE (Stable status) [Qualitative Concept]
   623   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (746):
   790   STABLE (Stable status) [Qualitative Concept]
   623   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (746):
   790   STABLE (Stable status) [Qualitative Concept]
   623   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (746):
   790   STABLE (Stable status) [Qualitative Concept]
   623   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (746):
   790   STABLE (Stable status) [Qualitative Concept]
   623   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Meta Mapping (746):
   790   Stable (Patient Condition Code - Stable) [Intellectual Product]
   623   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (746):
   790   Stable (Patient Condition Code - Stable) [Intellectual Product]
   623   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (746):
   790   Stable (Patient Condition Code - Stable) [Intellectual Product]
   623   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (746):
   790   Stable (Patient Condition Code - Stable) [Intellectual Product]
   623   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (746):
   790   Stable (Patient Condition Code - Stable) [Intellectual Product]
   623   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Processing 00000000.tx.7: NILA S. 

Phrase: NILA S.
Processing 00000000.tx.8: KAYSCHIRD , M.D. 

Phrase: KAYSCHIRD ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.9: EW96 195773 Signed NAME : 7. 

Phrase: EW96 195773 Signed NAME
Meta Mapping (750):
   645   Signed (Signature) [Intellectual Product]
   812   Name [Intellectual Product]
Meta Mapping (750):
   645   Signed (Signature) [Intellectual Product]
   812   Name (Person Name) [Intellectual Product]
Meta Mapping (750):
   645   signed (signed - ParticipationSignature) [Intellectual Product]
   812   Name [Intellectual Product]
Meta Mapping (750):
   645   signed (signed - ParticipationSignature) [Intellectual Product]
   812   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: 7.
Processing 00000000.tx.10: Hypercalcemia . 

Phrase: Hypercalcemia .
Meta Mapping (1000):
  1000   HYPERCALCEMIA (Hypercalcemia) [Disease or Syndrome]
Processing 00000000.tx.11: She ultimately was admitted to the hospital because of delirium and difficulty controlling the pain . 

Phrase: She

Phrase: ultimately

Phrase: was

Phrase: admitted to the hospital
Meta Mapping (819):
   819   admitted hospital (Hospital admission) [Health Care Activity]

Phrase: because of delirium
Meta Mapping (1000):
  1000   DELIRIUM (Delirium) [Mental or Behavioral Dysfunction]

Phrase: and

Phrase: difficulty
Meta Mapping (1000):
  1000   Difficulty (Has difficulty doing (qualifier value)) [Finding]

Phrase: controlling
Meta Mapping (1000):
  1000   controlling (Controlling (action)) [Phenomenon or Process]
Meta Mapping (1000):
  1000   Controlling (Control function) [Functional Concept]

Phrase: the pain .
Meta Mapping (1000):
  1000   PAIN (Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Pain NOS (Pain NOS Adverse Event) [Finding]
Processing 00000000.tx.12: Her ALT 11 , her AST slightly up at 59 . 

Phrase: Her ALT 11 ,
Meta Mapping (861):
   861   ALT (Atypical Lipoma) [Neoplastic Process]

Phrase: her AST slightly up
Meta Mapping (722):
   770   AST (Atlantic Standard Time) [Temporal Concept]
   604   Slightly (Slightly (qualifier value)) [Qualitative Concept]
Meta Mapping (722):
   770   AST (Atlantic Standard Time) [Temporal Concept]
   604   Slightly (Slight (qualifier value)) [Qualitative Concept]

Phrase: at 59 .
Processing 00000000.tx.13: Tylenol 1-2 tabs q.4 p.r.n. pain . 

Phrase: Tylenol 1-2 tabs q.4 p.r.n. pain .
Meta Mapping (744):
   623   Tylenol [Organic Chemical,Pharmacologic Substance]
   623   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   790   PAIN (Pain) [Sign or Symptom]
Meta Mapping (744):
   623   Tylenol [Organic Chemical,Pharmacologic Substance]
   623   TAB (Tablet Dosage Form) [Biomedical or Dental Material]
   790   Pain NOS (Pain NOS Adverse Event) [Finding]
Meta Mapping (744):
   623   Tylenol [Organic Chemical,Pharmacologic Substance]
   623   Tab (Tablet Dosing Unit) [Quantitative Concept]
   790   PAIN (Pain) [Sign or Symptom]
Meta Mapping (744):
   623   Tylenol [Organic Chemical,Pharmacologic Substance]
   623   Tab (Tablet Dosing Unit) [Quantitative Concept]
   790   Pain NOS (Pain NOS Adverse Event) [Finding]
Processing 00000000.tx.14: TR : oi DD : Chronic venous insufficiency . 

Phrase: TR
Meta Mapping (1000):
  1000   TR (TXNRD1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (TXNRD2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (Tumor Results Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   TR (Thioredoxin Reductase 1, Cytoplasmic) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :

Phrase: oi DD
Meta Mapping (888):
   694   OI (Osteogenesis Imperfecta) [Congenital Abnormality,Disease or Syndrome]
   861   DD (AKR1C2 wt Allele) [Gene or Genome]
Meta Mapping (888):
   694   OI (Osteogenesis Imperfecta) [Congenital Abnormality,Disease or Syndrome]
   861   DD (ATP2A2 wt Allele) [Gene or Genome]

Phrase: :

Phrase: Chronic venous insufficiency .
Meta Mapping (1000):
  1000   Chronic venous insufficiency [Disease or Syndrome]
Processing 00000000.tx.15: Myocardial infarction . 

Phrase: Myocardial infarction .
Meta Mapping (1000):
  1000   Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (1000):
  1000   MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (1000):
  1000   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Processing 00000000.tx.16: On admission included Dilantin , 100 mg po t.i.d. 

Phrase: On admission
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: included
Meta Mapping (1000):
  1000   included (Including (qualifier)) [Functional Concept]

Phrase: Dilantin ,
Meta Mapping (1000):
  1000   Dilantin [Organic Chemical,Pharmacologic Substance]

Phrase: 100 mg po t.i.d.
Meta Mapping (769):
   632   100% [Quantitative Concept]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   MG (Mongolia) [Geographic Area]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   mg% (mg/dL) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   mg % (Milligram percent) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   100% [Quantitative Concept]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.17: ; Cardizem , 120 mg po t.i.d. 

Phrase: ; Cardizem ,
Meta Mapping (1000):
  1000   Cardizem [Organic Chemical,Pharmacologic Substance]

Phrase: 120 mg po t.i.d.
Meta Mapping (756):
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (756):
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (756):
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (756):
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (756):
   632   MG (Mongolia) [Geographic Area]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (756):
   632   MG (Mongolia) [Geographic Area]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (756):
   632   mg% (mg/dL) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (756):
   632   mg% (mg/dL) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (756):
   632   mg % (Milligram percent) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (756):
   632   mg % (Milligram percent) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (756):
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (756):
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: ; Procardia , 20 mg po t.i.d. 

Phrase: ; Procardia ,
Meta Mapping (1000):
  1000   Procardia [Organic Chemical,Pharmacologic Substance]

Phrase: 20 mg po t.i.d.
Meta Mapping (769):
   632   20% [Finding]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (769):
   632   20% [Finding]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (769):
   632   20% [Finding]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (769):
   632   20% [Finding]
   709   mg/d (milligram/day) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (769):
   632   20% [Finding]
   632   MG (Mongolia) [Geographic Area]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   20% [Finding]
   632   MG (Mongolia) [Geographic Area]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   20% [Finding]
   632   mg% (mg/dL) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   20% [Finding]
   632   mg% (mg/dL) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   20% [Finding]
   632   mg % (Milligram percent) [Quantitative Concept]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   20% [Finding]
   632   mg % (Milligram percent) [Quantitative Concept]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   20% [Finding]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   799   PO (Portugal) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (769):
   632   20% [Finding]
   632   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   799   PO (Oral) [Spatial Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.19: ; Beclomethasone , two puffs po q day ; aspirin , 325 mg po q day ; nitropaste , 1.5 inches q six hours . 

Phrase: ; Beclomethasone ,
Meta Mapping (1000):
  1000   BECLOMETHASONE (Beclomethasone) [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: two puffs po q day
Meta Mapping (766):
   637   Two [Quantitative Concept]
   637   Puffs (Puff unit dose) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   804   /day (Daily) [Temporal Concept]
Meta Mapping (766):
   637   Two [Quantitative Concept]
   637   Puffs (Puff unit dose) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   804   DAY (day) [Temporal Concept]
Meta Mapping (766):
   637   Two [Quantitative Concept]
   637   Puffs (Puff unit dose) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
   804   /day (per day) [Temporal Concept]
Meta Mapping (766):
   637   Two [Quantitative Concept]
   637   Puffs (Puff unit dose) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   804   /day (Daily) [Temporal Concept]
Meta Mapping (766):
   637   Two [Quantitative Concept]
   637   Puffs (Puff unit dose) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   804   DAY (day) [Temporal Concept]
Meta Mapping (766):
   637   Two [Quantitative Concept]
   637   Puffs (Puff unit dose) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]
   804   /day (per day) [Temporal Concept]

Phrase: ; aspirin ,
Meta Mapping (1000):
  1000   ASPIRIN (Aspirin) [Organic Chemical,Pharmacologic Substance]

Phrase: 325 mg po q day
Meta Mapping (790):
   875   mg day (milligram/day) [Quantitative Concept]
   637   PO (Portugal) [Geographic Area]
Meta Mapping (790):
   875   mg day (milligram/day) [Quantitative Concept]
   637   PO (Oral) [Spatial Concept]

Phrase: ; nitropaste ,

Phrase: 1.5 inches q six hours .
Meta Mapping (769):
   660   1/5 [Quantitative Concept]
   632   inches (Inch Unit of Length) [Quantitative Concept]
   632   Six [Quantitative Concept]
   799   HOURS (Hour) [Temporal Concept]
Processing 00000000.tx.20: LABORATORY DATA : Chest x-ray was clear . 

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: Chest x-ray
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: was

Phrase: clear .
Meta Mapping (1000):
  1000   Clear (Negative Surgical Margin) [Finding]
Meta Mapping (1000):
  1000   Clear [Qualitative Concept]
Processing 00000000.tx.21: He underwent coronary artery bypass graft times three . 

Phrase: He

Phrase: underwent

Phrase: coronary artery bypass graft times three .
Meta Mapping (888):
   901   Coronary Artery Bypass Graft (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]
   799   times (Time) [Temporal Concept]
   799   Three [Quantitative Concept]
Meta Mapping (888):
   901   Coronary Artery Bypass Graft (Coronary Artery Bypass Surgery) [Therapeutic or Preventive Procedure]
   799   Times [Quantitative Concept]
   799   Three [Quantitative Concept]
Meta Mapping (888):
   901   coronary artery bypass graft (coronary artery graft device) [Medical Device]
   799   times (Time) [Temporal Concept]
   799   Three [Quantitative Concept]
Meta Mapping (888):
   901   coronary artery bypass graft (coronary artery graft device) [Medical Device]
   799   Times [Quantitative Concept]
   799   Three [Quantitative Concept]
Processing 00000000.tx.22: He was returned to the Cardiac Surgery Intensive Care Unit at that time and he ruled out for a myocardial infarction . 

Phrase: He

Phrase: was

Phrase: returned to the Cardiac Surgery Intensive Care Unit
Meta Mapping (781):
   744   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (781):
   744   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (781):
   744   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (781):
   744   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (781):
   744   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]
Meta Mapping (781):
   744   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (781):
   744   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (781):
   744   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (781):
   744   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (781):
   744   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   822   Cardiac intensive care unit [Health Care Related Organization,Manufactured Object]
   744   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]

Phrase: at

Phrase: that time
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: and

Phrase: he

Phrase: ruled
Meta Mapping (1000):
  1000   ruled (Positive) [Qualitative Concept]

Phrase: out for a myocardial infarction .
Meta Mapping (745):
   760   Out (Out (direction)) [Spatial Concept]
   806 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (745):
   760   Out (Out (direction)) [Spatial Concept]
   806 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (745):
   760   Out (Out (direction)) [Spatial Concept]
   806   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (745):
   760   Out (Out (direction)) [Spatial Concept]
   806   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Meta Mapping (745):
   760   Out (Removed) [Qualitative Concept]
   806 N Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (745):
   760   Out (Removed) [Qualitative Concept]
   806 N MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (745):
   760   Out (Removed) [Qualitative Concept]
   806   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (745):
   760   Out (Removed) [Qualitative Concept]
   806   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]
Processing 00000000.tx.23: Leg wounds were also healing well . 

Phrase: Leg wounds
Meta Mapping (983):
   983   Leg Wound (Leg Injuries) [Injury or Poisoning]
Meta Mapping (983):
   983   leg Wound (Injury of lower leg) [Injury or Poisoning]

Phrase: were

Phrase: also

Phrase: healing
Meta Mapping (1000):
  1000   Healing (Wound Healing) [Organism Function]
Meta Mapping (1000):
  1000   Healing (Healed) [Functional Concept]

Phrase: well .
Meta Mapping (1000):
  1000   Well (Good) [Qualitative Concept]
Meta Mapping (1000):
  1000   Well [Manufactured Object]
Processing 00000000.tx.24: D : 02/28/90 Discharge Date : The patient has recently undergone repeat carotid studies at the Umsishipcilard Memorial Hospital which revealed no changes since the one performed in November of 1989 . 

Phrase: D
Meta Mapping (1000):
  1000   D NOS (Blood group antigen D) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (1000):
  1000   /d (Daily) [Temporal Concept]

Phrase: :

Phrase: 02/28/90 Discharge Date
Meta Mapping (785):
   637   >90 [Quantitative Concept]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (785):
   637   >90 [Quantitative Concept]
   840   Discharge date [Temporal Concept]
Meta Mapping (785):
   637   <90 [Quantitative Concept]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (785):
   637   <90 [Quantitative Concept]
   840   Discharge date [Temporal Concept]
Meta Mapping (785):
   637   90% [Finding]
   840   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (785):
   637   90% [Finding]
   840   Discharge date [Temporal Concept]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: has

Phrase: recently
Meta Mapping (1000):
  1000   Recently (Recent) [Temporal Concept]

Phrase: undergone

Phrase: repeat
Meta Mapping (1000):
  1000   Repeat [Functional Concept]
Meta Mapping (1000):
  1000   Repeat (Repeat Pattern) [Temporal Concept]
Meta Mapping (1000):
  1000   Repeat (Repeat Object) [Conceptual Entity]

Phrase: carotid studies at the Umsishipcilard Memorial Hospital
Meta Mapping (656):
   581   Carotid (carotid) [Body Part, Organ, or Organ Component]
   748   studies (Scientific Study) [Laboratory Procedure]
   581   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (656):
   581   Carotid (carotid) [Body Part, Organ, or Organ Component]
   748   studies (Scientific Study) [Laboratory Procedure]
   581   Hospital (Hospital environment) [Qualitative Concept]

Phrase: which

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: no changes
Meta Mapping (1000):
  1000   changes (Changing) [Functional Concept]
Meta Mapping (1000):
  1000   changes (Changed status) [Quantitative Concept]

Phrase: since

Phrase: the one
Meta Mapping (1000):
  1000   ONE (One) [Quantitative Concept]

Phrase: performed in November of 1989 .
Meta Mapping (686):
   760   Performed [Functional Concept]
   760   November [Temporal Concept]
Processing 00000000.tx.25: SOCIAL HISTORY : The pupils were equal , round , and reactive to light . 

Phrase: SOCIAL HISTORY
Meta Mapping (1000):
  1000   Social history (Social and personal history) [Finding]
Meta Mapping (1000):
  1000   Social History [Finding]

Phrase: :

Phrase: The pupils
Meta Mapping (1000):
  1000   Pupils (Pupil) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: equal , round ,
Meta Mapping (888):
   694   Equal [Qualitative Concept]
   861   ROUND (Round shape) [Spatial Concept]
Meta Mapping (888):
   694   Equal (Relational Operator - Equal) [Intellectual Product]
   861   ROUND (Round shape) [Spatial Concept]

Phrase: and

Phrase: reactive to light .
Meta Mapping (1000):
  1000   Reactive to light [Finding]
Processing 00000000.tx.26: On postoperative day two , the dressing was changed , and the wound was noted to be clean and dry . 

Phrase: On postoperative day two ,
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   /day (Daily) [Temporal Concept]
   827   Two [Quantitative Concept]
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   DAY (day) [Temporal Concept]
   827   Two [Quantitative Concept]
Meta Mapping (851):
   660   Postoperative (Postoperative Period) [Temporal Concept]
   660   /day (per day) [Temporal Concept]
   827   Two [Quantitative Concept]

Phrase: the dressing
Meta Mapping (1000):
  1000   DRESSING (Sterile coverings) [Medical Device]
Meta Mapping (1000):
  1000   Dressing (Dressing of skin or wound) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   dressing (Dressing self-care) [Finding]
Meta Mapping (1000):
  1000   Dressing (Dressing- activity of daily living) [Daily or Recreational Activity]

Phrase: was

Phrase: changed
Meta Mapping (1000):
  1000   Changed (Changing) [Functional Concept]
Meta Mapping (1000):
  1000   Changed (Changed status) [Quantitative Concept]

Phrase: ,

Phrase: and

Phrase: the wound
Meta Mapping (1000):
  1000   WOUND (Injury wounds) [Injury or Poisoning]
Meta Mapping (1000):
  1000   Wound (Traumatic injury) [Injury or Poisoning]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: clean
Meta Mapping (1000):
  1000   Clean (Cleaning (activity)) [Activity]

Phrase: and

Phrase: dry .
Meta Mapping (1000):
  1000   Dry (Desiccation) [Natural Phenomenon or Process]
Meta Mapping (1000):
  1000   Dry [Qualitative Concept]
Meta Mapping (1000):
  1000   Dry (Dryness (characteristic)) [Qualitative Concept]
Processing 00000000.tx.27: On postoperative day six , the patient complained of thigh spasms for which he was given Flexeril 10 mg p.o. t.i.d. with some relief . 

Phrase: On postoperative day six ,
Meta Mapping (851):
   827   Postoperative (Postoperative Period) [Temporal Concept]
   827   /day (Daily) [Temporal Concept]
   827   Six [Quantitative Concept]
Meta Mapping (851):
   827   Postoperative (Postoperative Period) [Temporal Concept]
   827   DAY (day) [Temporal Concept]
   827   Six [Quantitative Concept]
Meta Mapping (851):
   827   Postoperative (Postoperative Period) [Temporal Concept]
   827   /day (per day) [Temporal Concept]
   827   Six [Quantitative Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: complained of thigh spasms
Meta Mapping (722):
   770   THIGH (Thigh structure) [Body Location or Region]
   770   SPASMS (Spasm) [Sign or Symptom]
Meta Mapping (722):
   770   Thigh (Entire thigh) [Body Part, Organ, or Organ Component]
   770   SPASMS (Spasm) [Sign or Symptom]

Phrase: for which

Phrase: he

Phrase: was

Phrase: given
Meta Mapping (1000):
  1000   GIVEN [Conceptual Entity]
Meta Mapping (1000):
  1000   given (Entity Name Part Type - given) [Idea or Concept]
Meta Mapping (1000):
  1000   Given (Give - dosing instruction imperative) [Functional Concept]
Meta Mapping (1000):
  1000   given (Given name) [Intellectual Product]

Phrase: Flexeril 10 mg p.o. t.i.d.
Meta Mapping (767):
   793   Flexeril [Organic Chemical,Pharmacologic Substance]
   793   10% [Finding]
   864   mg/d (milligram/day) [Quantitative Concept]

Phrase: with some relief .
Meta Mapping (1000):
  1000   Relief (Feeling relief) [Finding]
Processing 00000000.tx.28: DISPOSITION : DISCHARGE MEDICATIONS : Include those from admission plus Demerol 100 mg p.o. 

Phrase: DISPOSITION
Meta Mapping (1000):
  1000   Disposition [Idea or Concept]
Meta Mapping (1000):
  1000   Disposition (Disposition Domain) [Intellectual Product]

Phrase: :

Phrase: DISCHARGE MEDICATIONS
Meta Mapping (1000):
  1000   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: Include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: those from admission plus Demerol 100 mg p.o.
Meta Mapping (746):
   762   Admission from [Health Care Activity]
   742   Plus (In addition to) [Functional Concept]
   771   Meperidine Hydrochloride 100 MG [Clinical Drug]
Processing 00000000.tx.29: q4 hours p.r.n. pain and Flexeril 10 mg p.o. t.i.d. p.r.n. spasm . 

Phrase: q4 hours p.r.n. pain
Meta Mapping (762):
   632   HOURS (Hour) [Temporal Concept]
   660   R.N. (Registered nurse) [Professional or Occupational Group]
   799   PAIN (Pain) [Sign or Symptom]
Meta Mapping (762):
   632   HOURS (Hour) [Temporal Concept]
   660   R.N. (Registered nurse) [Professional or Occupational Group]
   799   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: and

Phrase: Flexeril 10 mg p.o. t.i.d. p.r.n. spasm .
Meta Mapping (737):
   621   Flexeril [Organic Chemical,Pharmacologic Substance]
   621   10% [Finding]
   668   mg/d (milligram/day) [Quantitative Concept]
   787   Spasm (Muscle Cramp) [Sign or Symptom]
Meta Mapping (737):
   621   Flexeril [Organic Chemical,Pharmacologic Substance]
   621   10% [Finding]
   668   mg/d (milligram/day) [Quantitative Concept]
   787   Spasm [Sign or Symptom]
Meta Mapping (737):
   621   Flexeril [Organic Chemical,Pharmacologic Substance]
   621   10% [Finding]
   668   mg/d (milligram/day) [Quantitative Concept]
   787   Spasm (KANTR gene) [Gene or Genome]
Processing 00000000.tx.30: <RECORD ID="787"> Developmental Delay . 

Phrase: <RECORD ID="787"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > Developmental Delay .
Meta Mapping (1000):
  1000   Developmental Delay (Developmental delay (disorder)) [Mental or Behavioral Dysfunction]
Meta Mapping (1000):
  1000   Developmental delay (Global developmental delay) [Finding]
Processing 00000000.tx.31: The patient is presently being weaned off Phenobarbital and advanced onto Tegretol . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: presently
Meta Mapping (1000):
  1000   presently [Idea or Concept]

Phrase: being

Phrase: weaned off Phenobarbital
Meta Mapping (746):
   790   Weaned (Weaning) [Finding]
   790   PHENOBARBITAL (Phenobarbital) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: advanced onto Tegretol .
Meta Mapping (746):
   790   Advanced (Advanced phase) [Qualitative Concept]
   790   TEGretol (Tegretol) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.32: The patient &apos;s weight is 15 kilos On 08/10/90 the patient had surgery to remove granulomas in the trachea after traumatic intubation for seizures . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s weight
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Weight (Body Weight) [Organism Attribute]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   WEIGHT (Weight) [Quantitative Concept]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   weight (Weighing patient) [Diagnostic Procedure]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Weight (Importance Weight) [Idea or Concept]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Weight (Body Weight) [Organism Attribute]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   WEIGHT (Weight) [Quantitative Concept]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   weight (Weighing patient) [Diagnostic Procedure]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Weight (Importance Weight) [Idea or Concept]

Phrase: is

Phrase: 15 kilos On 08/10/90
Meta Mapping (661):
   719   Kilo [Quantitative Concept]
   586   10% [Finding]
   586   >90 [Quantitative Concept]
Meta Mapping (661):
   719   Kilo [Quantitative Concept]
   586   10% [Finding]
   586   <90 [Quantitative Concept]
Meta Mapping (661):
   719   Kilo [Quantitative Concept]
   586   10% [Finding]
   586   90% [Finding]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: surgery
Meta Mapping (1000):
  1000   Surgery (Surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   surgery (Surgical aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Surgery (Operative Surgical Procedures) [Health Care Activity]
Meta Mapping (1000):
  1000   Surgery (General surgery specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Surgery (Allopathic & Osteopathic Physicians - Surgery) [Professional or Occupational Group]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: remove
Meta Mapping (1000):
  1000   remove (Removed) [Qualitative Concept]
Meta Mapping (1000):
  1000   Remove (Removing (action)) [Activity]
Meta Mapping (1000):
  1000   remove (operate <remove>) [Functional Concept]

Phrase: granulomas in the trachea
Meta Mapping (767):
   767   Tracheal granuloma (Granuloma of trachea) [Finding]

Phrase: after traumatic intubation for seizures .
Meta Mapping (696):
   593   Traumatic [Functional Concept]
   760   INTUBATION (Intubation) [Therapeutic or Preventive Procedure]
   593   Seizures [Sign or Symptom]
Processing 00000000.tx.33: On 07/19/92 the patient awoke with significant stridor , respiratory distress and the use of accessory muscles . 

Phrase: On 07/19/92

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: awoke with significant stridor ,
Meta Mapping (722):
   737   Awake [Finding]
   770   significant (Statistical Significance) [Quantitative Concept]
   770   STRIDOR (Stridor) [Sign or Symptom]
Meta Mapping (722):
   737   Awake [Finding]
   770   Significant [Idea or Concept]
   770   STRIDOR (Stridor) [Sign or Symptom]
Meta Mapping (722):
   737   Awake [Finding]
   770   Significant (Event Seriousness - Significant) [Qualitative Concept]
   770   STRIDOR (Stridor) [Sign or Symptom]

Phrase: respiratory distress
Meta Mapping (1000):
  1000   Distress, Respiratory (Respiratory distress) [Sign or Symptom]

Phrase: and

Phrase: the use of accessory muscles .
Meta Mapping (815):
   806   Use of [Functional Concept]
   640   accessory muscles (Accessory skeletal muscle) [Congenital Abnormality]
Processing 00000000.tx.34: On 07/19/92 direct laryngoscopy showed an 80% tracheal stenosis beginning just below the sternal notch involving the proximal 50th percent of the trachea . 

Phrase: On 07/19/92 direct laryngoscopy
Meta Mapping (840):
   840   Direct laryngoscopy (Direct examination of larynx) [Diagnostic Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: an 80% tracheal stenosis
Meta Mapping (901):
   660   80% [Finding]
   901   Tracheal Stenosis [Disease or Syndrome]

Phrase: beginning
Meta Mapping (1000):
  1000   Beginning [Temporal Concept]

Phrase: just below the sternal notch
Meta Mapping (695):
   760   Sternal (Sternum) [Body Part, Organ, or Organ Component]
   760   Notch [Body Space or Junction]

Phrase: involving
Meta Mapping (1000):
  1000   Involving (Involvement with) [Functional Concept]

Phrase: the proximal 50th percent of the trachea .
Meta Mapping (652):
   581   PROXIMAL (Proximal) [Spatial Concept]
   748   PERCENT (Percent (qualifier value)) [Quantitative Concept]
   581   TRACHEA (Trachea) [Body Part, Organ, or Organ Component]
Meta Mapping (652):
   581   PROXIMAL (Proximal) [Spatial Concept]
   748   PERCENT (Percent (qualifier value)) [Quantitative Concept]
   581   Trachea (Entire trachea) [Body Part, Organ, or Organ Component]
Meta Mapping (652):
   581   PROXIMAL (Proximal) [Spatial Concept]
   748   PERCENT (Percent (qualifier value)) [Quantitative Concept]
   581   Trachea (Trachea (moth)) [Eukaryote]
Processing 00000000.tx.35: The patient was noted to have a stenosis of the proximal trachea approximately 3 cm long just below the vocal cords . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: a stenosis of the proximal trachea approximately 3 cm long just
Meta Mapping (677):
   772   Stenosis of trachea (Tracheal Stenosis) [Disease or Syndrome]
   571   PROXIMAL (Proximal) [Spatial Concept]
   571   Approximately (Approximate) [Qualitative Concept]
   571   Long [Qualitative Concept]
Meta Mapping (677):
   772   Stenosis of trachea (Tracheal Stenosis) [Disease or Syndrome]
   571   PROXIMAL (Proximal) [Spatial Concept]
   571   Approximately (Approximate) [Qualitative Concept]
   571   Long (Long Variable) [Qualitative Concept]

Phrase: below the vocal cords .
Meta Mapping (1000):
  1000   Vocal Cords (Vocal cord structure) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.36: The patient received oxygen for approximately 24 hours after the tracheostomy and is presently being maintained on room air with a humidified mask . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: received
Meta Mapping (1000):
  1000   RECEIVED (Receive) [Qualitative Concept]

Phrase: oxygen for approximately 24 hours
Meta Mapping (761):
   760   OXYGEN (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]
   593   Approximately (Approximate) [Qualitative Concept]
   640   24 hours (24 hour time frame) [Temporal Concept]
Meta Mapping (761):
   760   OXYGEN (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]
   593   Approximately (Approximate) [Qualitative Concept]
   640   /24 hours (per 24 hours) [Temporal Concept]
Meta Mapping (761):
   760   OXYGEN (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]
   593   Approximately (Approximate) [Qualitative Concept]
   640   24 Hours [Temporal Concept]

Phrase: after the tracheostomy
Meta Mapping (1000):
  1000   TRACHEOSTOMY (Tracheostomy procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   tracheostomy (Tracheostomy Route of Drug Administration) [Functional Concept]
Meta Mapping (1000):
  1000   TRACHEOSTOMY (Tracheostomy device) [Medical Device]

Phrase: and

Phrase: is

Phrase: presently
Meta Mapping (1000):
  1000   presently [Idea or Concept]

Phrase: being

Phrase: maintained on room air
Meta Mapping (783):
   770   Maintained (Maintaining (action)) [Functional Concept]
   833   Room air [Finding]

Phrase: with a humidified mask .
Meta Mapping (861):
   861   MASK (Masks) [Medical Device]
Meta Mapping (861):
   861   MASK (ANKHD1 gene) [Gene or Genome]
Meta Mapping (861):
   861   mask (masked - No information) [Idea or Concept]
Meta Mapping (861):
   861   MASK (STK26 gene) [Gene or Genome]
Processing 00000000.tx.37: The patient generally breaths between 20 and 30 breaths per minute and is otherwise stable . 

Phrase: The patient generally breaths between 20
Meta Mapping (666):
   586   *^patient (Patients) [Patient or Disabled Group]
   753   Breaths (Breath) [Body Substance]
   586   20% [Finding]
Meta Mapping (666):
   586   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   753   Breaths (Breath) [Body Substance]
   586   20% [Finding]
Meta Mapping (666):
   586   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   753   Breaths (Breath) [Body Substance]
   586   20% [Finding]
Meta Mapping (666):
   586   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   753   Breaths (Breath) [Body Substance]
   586   20% [Finding]

Phrase: and

Phrase: 30 breaths per minute
Meta Mapping (916):
   604   30% [Finding]
   909   Breaths per Minute (breaths per minute) [Quantitative Concept]

Phrase: and

Phrase: is

Phrase: otherwise stable .
Meta Mapping (861):
   861   STABLE (Stable status) [Qualitative Concept]
Meta Mapping (861):
   861   Stable (Patient Condition Code - Stable) [Intellectual Product]
Processing 00000000.tx.38: The patient was initially NPO and then begun on Pediasure feeds the first two days of hospitalization . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: initially NPO
Meta Mapping (888):
   694   Initially [Temporal Concept]
   861   NPO (Nonprofit Organizations) [Organization]
Meta Mapping (888):
   694   Initially [Temporal Concept]
   861   NPO (NPO - Nothing by mouth) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: begun on Pediasure
Meta Mapping (730):
   756   Begin (Beginning) [Temporal Concept]
   790   PEDIASURE [Food]

Phrase: feeds
Meta Mapping (1000):
  1000   Feed (Feeding patient) [Health Care Activity]
Meta Mapping (1000):
  1000   Feeds [Functional Concept]
Meta Mapping (1000):
  1000   Feed (Feeding Activity) [Activity]
Meta Mapping (1000):
  1000   Feed (Feed (action)) [Activity]

Phrase: the first two days of hospitalization .
Meta Mapping (697):
   586   First (First (number)) [Quantitative Concept]
   586   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
   586   hospitalisation (Hospitalization) [Health Care Activity]
Meta Mapping (697):
   586   First (Firstly) [Qualitative Concept]
   586   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
   586   hospitalisation (Hospitalization) [Health Care Activity]
Processing 00000000.tx.39: The patient generally does not drink much fluid . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: generally

Phrase: does

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: drink
Meta Mapping (1000):
  1000   Drink (Drink (dietary substance)) [Food]

Phrase: much fluid .
Meta Mapping (1000):
  1000   FLUID (Body Fluids) [Body Substance]
Meta Mapping (1000):
  1000   fluid (Liquid substance) [Substance]
Meta Mapping (1000):
  1000   Fluid (Fluid behavior) [Qualitative Concept]
Meta Mapping (1000):
  1000   Fluid (fluid - substance) [Substance]
Processing 00000000.tx.40: From a gastrointestinal point of view please note on ______________ at 5 a.m. the patient was noted to be aspirating bits of cereal and juices via his trach tube . 

Phrase: From a gastrointestinal point of view
Meta Mapping (725):
   586   Gastrointestinal (gastrointestinal) [Spatial Concept]
   783   Point A [Body Location or Region]
   586   View [Spatial Concept]

Phrase: please

Phrase: note
Meta Mapping (1000):
  1000   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (1000):
  1000   Note (Note (document)) [Intellectual Product]

Phrase: on ______________
Meta Mapping (1000):
  1000   On (Upon - dosing instruction fragment) [Functional Concept]
Meta Mapping (1000):
  1000   On (On (qualifier value)) [Intellectual Product]

Phrase: at 5 a.m.
Meta Mapping (802):
   660   >5 [Quantitative Concept]
   827   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (802):
   660   >5 [Quantitative Concept]
   827   M+ (M+ (tumor staging)) [Intellectual Product]
Meta Mapping (802):
   660   +5 [Quantitative Concept]
   827   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (802):
   660   +5 [Quantitative Concept]
   827   M+ (M+ (tumor staging)) [Intellectual Product]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: aspirating bits of cereal
Meta Mapping (722):
   604   aspirating (Aspirate substance) [Body Substance]
   737   Bit (bit - unit of measure) [Quantitative Concept]
   604   Cereal (Cereals) [Food]

Phrase: and

Phrase: juices via his trach tube .
Meta Mapping (745):
   760   juices (Juice) [Food]
   640   trach tube (Tracheostomy tube) [Medical Device]
Processing 00000000.tx.41: KUB on 7/23 showed hugely dilated loops of colon and small bowel which only briefly respond to an enema . 

Phrase: KUB on 7/23
Meta Mapping (708):
   770   KUB (Kidney-Ureter-Bladder) [Spatial Concept]
   604   23 [Quantitative Concept]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: hugely dilated loops of colon
Meta Mapping (710):
   593   Dilated [Finding]
   745   Colonic loop [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: small bowel
Meta Mapping (1000):
  1000   Bowel, Small (Intestines, Small) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Small Bowel (Small Intestinal Wall Tissue) [Tissue]

Phrase: which only
Meta Mapping (1000):
  1000   Only (Singular) [Quantitative Concept]
Meta Mapping (1000):
  1000   Only (Only - dosing instruction fragment) [Intellectual Product]

Phrase: briefly

Phrase: respond to an enema .
Meta Mapping (770):
   770   Enema (Administration of enema) [Therapeutic or Preventive Procedure]
Meta Mapping (770):
   770   ENEMA (Enema) [Biomedical or Dental Material]
Meta Mapping (770):
   770   Enema (Enema (eukaryote)) [Eukaryote]
Processing 00000000.tx.42: The patient has generally been stable . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: has

Phrase: generally

Phrase: been

Phrase: stable .
Meta Mapping (1000):
  1000   STABLE (Stable status) [Qualitative Concept]
Meta Mapping (1000):
  1000   Stable (Patient Condition Code - Stable) [Intellectual Product]
Processing 00000000.tx.43: The platelet count was 351,000 . 

Phrase: The platelet count
Meta Mapping (1000):
  1000   Platelet Count (Platelet Count measurement) [Laboratory Procedure]
Meta Mapping (1000):
  1000   Platelet count (Finding of platelet count) [Laboratory or Test Result]

Phrase: was

Phrase: 351,000 .
Processing 00000000.tx.44: The patient has always had good urine output with normal BUN and creatinine . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: has

Phrase: always
Meta Mapping (1000):
  1000   Always (Always (frequency)) [Temporal Concept]
Meta Mapping (1000):
  1000   Always (All of the Time) [Intellectual Product]

Phrase: had

Phrase: good urine output with normal BUN
Meta Mapping (759):
   586   Good [Qualitative Concept]
   790   urine output (Urine volume function) [Clinical Attribute]
   623   normal bun (Blood urea normal) [Finding]
Meta Mapping (759):
   586   Good [Qualitative Concept]
   790   Urine output (Urine volume finding) [Finding]
   623   normal bun (Blood urea normal) [Finding]

Phrase: and

Phrase: creatinine .
Meta Mapping (1000):
  1000   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (1000):
  1000   Creatinine (Creatinine finding) [Finding]
Processing 00000000.tx.45: Neurological : The patient has a history of of seizure disorder . 

Phrase: Neurological
Meta Mapping (1000):
  1000   NEUROLOGICAL (Neurologic (qualifier value)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Neurological (Neurological:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: has

Phrase: a history of of seizure disorder .
Meta Mapping (774):
   820   History of - disorder (H/O: Disorder) [Finding]
   586   SEIZURE (Seizures) [Sign or Symptom]
Meta Mapping (774):
   820   History of - disorder (H/O: Disorder) [Finding]
   586   Seizure (Seizure Adverse Event) [Finding]
Processing 00000000.tx.46: DOCTORS DISCHARGE ORDERS : The parents are being transferred back to Newstonpend to learn trach care and to set up homecare . 

Phrase: DOCTORS
Meta Mapping (1000):
  1000   doctors (Physicians) [Professional or Occupational Group]

Phrase: DISCHARGE
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: ORDERS
Meta Mapping (1000):
  1000   orders (orders - HL7PublishingDomain) [Intellectual Product]

Phrase: :

Phrase: The parents
Meta Mapping (1000):
  1000   Parents (parent) [Idea or Concept]

Phrase: are

Phrase: being

Phrase: transferred
Meta Mapping (1000):
  1000   transferred (Surgical transfer - action) [Functional Concept]
Meta Mapping (1000):
  1000   Transferred (Transfer Technique) [Functional Concept]

Phrase: back to Newstonpend
Meta Mapping (790):
   790   BACK (Back) [Body Location or Region]
Meta Mapping (790):
   790   BACK (Dorsal) [Spatial Concept]
Meta Mapping (790):
   790   Back (Back structure, including back of neck) [Body Location or Region]
Meta Mapping (790):
   790   Back, NOS (Back structure, excluding neck) [Body Location or Region]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: learn
Meta Mapping (1000):
  1000   learn (Learning) [Mental Process]

Phrase: trach care
Meta Mapping (888):
   694   trach [Therapeutic or Preventive Procedure]
   861   Care (care activity) [Activity]

Phrase: and

Phrase: to set up homecare .
Meta Mapping (857):
   645   TO (Togo) [Geographic Area]
   694   Set Up (Preparation) [Activity]
   812   Home Care (Home care of patient) [Health Care Activity]
Meta Mapping (857):
   645   TO (Togo) [Geographic Area]
   694   Set Up (Preparation) [Activity]
   812   home care (Home care aspects) [Health Care Activity]
Meta Mapping (857):
   645   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   694   Set Up (Preparation) [Activity]
   812   Home Care (Home care of patient) [Health Care Activity]
Meta Mapping (857):
   645   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   694   Set Up (Preparation) [Activity]
   812   home care (Home care aspects) [Health Care Activity]
Meta Mapping (857):
   645   To [Qualitative Concept]
   694   Set Up (Preparation) [Activity]
   812   Home Care (Home care of patient) [Health Care Activity]
Meta Mapping (857):
   645   To [Qualitative Concept]
   694   Set Up (Preparation) [Activity]
   812   home care (Home care aspects) [Health Care Activity]
Processing 00000000.tx.47: Additional laboratory data of note is a last white blood count on 7/24 was 9,000 with a differential of 70 polys , 25% lymphs , hemoglobin 10.1 , platelet count 351,000 . 

Phrase: Additional laboratory data of note
Meta Mapping (788):
   631   Additional note [Intellectual Product]
   806   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: is

Phrase: a last white blood count on 7/24
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasoid Race) [Population Group]
   744   Blood [Tissue]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasoid Race) [Population Group]
   744   Blood [Tissue]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasoid Race) [Population Group]
   744   BLOOD (In Blood) [Body Substance]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasoid Race) [Population Group]
   744   BLOOD (In Blood) [Body Substance]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasoid Race) [Population Group]
   744   BLOOD (peripheral blood) [Body Substance]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasoid Race) [Population Group]
   744   BLOOD (peripheral blood) [Body Substance]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasians) [Population Group]
   744   Blood [Tissue]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasians) [Population Group]
   744   Blood [Tissue]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasians) [Population Group]
   744   BLOOD (In Blood) [Body Substance]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasians) [Population Group]
   744   BLOOD (In Blood) [Body Substance]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasians) [Population Group]
   744   BLOOD (peripheral blood) [Body Substance]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (Caucasians) [Population Group]
   744   BLOOD (peripheral blood) [Body Substance]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (White color) [Qualitative Concept]
   744   Blood [Tissue]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (White color) [Qualitative Concept]
   744   Blood [Tissue]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (White color) [Qualitative Concept]
   744   BLOOD (In Blood) [Body Substance]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (White color) [Qualitative Concept]
   744   BLOOD (In Blood) [Body Substance]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (White color) [Qualitative Concept]
   744   BLOOD (peripheral blood) [Body Substance]
   744   Count [Quantitative Concept]
Meta Mapping (666):
   578   Last [Qualitative Concept]
   744   WHITE (White color) [Qualitative Concept]
   744   BLOOD (peripheral blood) [Body Substance]
   744   COUNT (Count Dosing Unit) [Quantitative Concept]

Phrase: was

Phrase: 9,000 with a differential of 70 polys ,
Meta Mapping (672):
   744   Differential (Differential quality) [Qualitative Concept]
   744   70% [Finding]
   750   Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
Meta Mapping (672):
   744   Differential (Different) [Qualitative Concept]
   744   70% [Finding]
   750   Poly A [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: 25% lymphs ,
Meta Mapping (861):
   861   Lymphs (Lymph) [Body Substance]
Meta Mapping (861):
   861   % Lymphs (Percent of Lymphocytes) [Quantitative Concept]

Phrase: hemoglobin 10.1 ,
Meta Mapping (790):
   827   Hemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   10% [Finding]

Phrase: platelet count 351,000 .
Meta Mapping (861):
   861   Platelet Count (Platelet Count measurement) [Laboratory Procedure]
Meta Mapping (861):
   861   Platelet count (Finding of platelet count) [Laboratory or Test Result]
Processing 00000000.tx.48: CTMC SECONDARY DIAGNOSES INCLUDE PERICARDIAL EFFUSION , PULMONARY LYMPHANGITIC SPREAD , AND LIVER AND SPLEEN METASTASES . 

Phrase: CTMC SECONDARY DIAGNOSES
Meta Mapping (884):
   884   Secondary diagnosis [Qualitative Concept]

Phrase: INCLUDE
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: PERICARDIAL EFFUSION ,
Meta Mapping (1000):
  1000   Effusion, Pericardial (Pericardial effusion) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Pericardial effusion (Pericardial effusion body substance) [Body Substance]

Phrase: PULMONARY LYMPHANGITIC
Meta Mapping (853):
   694   pulmonary (Lung) [Body Part, Organ, or Organ Component]
   789   Lymphangitides (Lymphangitis) [Disease or Syndrome]
Meta Mapping (853):
   694   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
   789   Lymphangitides (Lymphangitis) [Disease or Syndrome]
Meta Mapping (853):
   694   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]
   789   Lymphangitides (Lymphangitis) [Disease or Syndrome]

Phrase: SPREAD
Meta Mapping (1000):
  1000   Spread (Spreading (qualifier value)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Spread (Smear - instruction imperative) [Activity]

Phrase: ,

Phrase: AND

Phrase: LIVER
Meta Mapping (1000):
  1000   LIVER (Liver) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   LIVER (Liver parenchyma) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Liver (Entire liver) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   LIVER (Liver Flavor) [Food]

Phrase: AND

Phrase: SPLEEN METASTASES .
Meta Mapping (1000):
  1000   spleen metastases (Secondary malignant neoplasm of spleen) [Neoplastic Process]
Processing 00000000.tx.49: She was evaluated by Dr. 

Phrase: She

Phrase: was

Phrase: evaluated by Dr.
Meta Mapping (746):
   790   Evaluated (Evaluation) [Health Care Activity]
   790   DR (Dominican Republic) [Geographic Area]
Meta Mapping (746):
   790   Evaluated (Evaluation) [Health Care Activity]
   790   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (746):
   790   Evaluated (Evaluation) [Health Care Activity]
   790   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (746):
   790   Evaluated (Evaluation) [Health Care Activity]
   790   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (746):
   790   Evaluated (Evaluation) [Health Care Activity]
   790   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.50: Mielke , a Pulmonologist , who found her to be wheezing and performed pulmonary function tests which showed an FEV1 of 1.1 and an FVC of 1.8 . 

Phrase: Mielke ,

Phrase: a Pulmonologist ,
Meta Mapping (1000):
  1000   Pulmonologist [Professional or Occupational Group]

Phrase: who

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: her

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: wheezing
Meta Mapping (1000):
  1000   WHEEZING (Wheezing) [Sign or Symptom]

Phrase: and

Phrase: performed pulmonary function tests
Meta Mapping (916):
   645   Performed [Functional Concept]
   923   Pulmonary Function Tests (Pulmonary function tests) [Diagnostic Procedure]
Meta Mapping (916):
   645   Performed [Functional Concept]
   923   Pulmonary Function Tests (Pulmonary Function Tests:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: which

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: an FEV1 of 1.1
Meta Mapping (760):
   760   FEV 1.0 (Forced expiratory volume in 1 second finding) [Finding]
Meta Mapping (760):
   760   fev 1 (Pulmonary Function Test/Forced Expiratory Volume 1) [Diagnostic Procedure]
Meta Mapping (760):
   760   FEV(1) (FEV1 Adverse Event) [Finding]

Phrase: and

Phrase: an FVC of 1.8 .
Meta Mapping (760):
   760   FVC (Forced Vital Capacity) [Laboratory or Test Result]
Processing 00000000.tx.51: Room air arterial blood gas showed a pO2 of 56 , a pCO2 of 35 , and a pH of 7.52 . 

Phrase: Room air arterial blood gas
Meta Mapping (893):
   673   Room air [Finding]
   884   arterial blood gas (Analysis of arterial blood gases and pH) [Laboratory Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a pO2 of 56 ,
Meta Mapping (770):
   770   PO2 (Oxygen measurement, partial pressure, arterial) [Laboratory Procedure]
Meta Mapping (770):
   770   PO2 (PO2 measurement) [Laboratory Procedure]

Phrase: a pCO2 of 35 ,
Meta Mapping (770):
   770   PCO2 (Carbon dioxide measurement, partial pressure) [Laboratory Procedure]
Meta Mapping (770):
   770   pco2 (Partial pressure CO2 result) [Laboratory or Test Result]

Phrase: and

Phrase: a pH of 7.52 .
Meta Mapping (797):
   797   pH 7 (Neutral pH) [Qualitative Concept]
Processing 00000000.tx.52: CURRENT MEDICATIONS : Dry mucous membranes and myotic pupils . 

Phrase: CURRENT MEDICATIONS
Meta Mapping (983):
   983   current medication (medication current) [Finding]

Phrase: :

Phrase: Dry mucous membranes
Meta Mapping (901):
   660   Dry (Desiccation) [Natural Phenomenon or Process]
   901   Mucous Membranes (Mucous Membrane) [Tissue]
Meta Mapping (901):
   660   Dry [Qualitative Concept]
   901   Mucous Membranes (Mucous Membrane) [Tissue]
Meta Mapping (901):
   660   Dry (Dryness (characteristic)) [Qualitative Concept]
   901   Mucous Membranes (Mucous Membrane) [Tissue]

Phrase: and

Phrase: myotic pupils .
Meta Mapping (983):
   983   Miotic pupil (Pupil constriction observed) [Finding]
Processing 00000000.tx.53: ABDOMEN : Her steroids were tapered and Pulmonary was consulted who recommended a CT scan of the chest to evaluate the lung parenchyma , induce sputum for CBC , arterial blood gas , continuing of the beta agonist inhalers , and trial of steroid inhalers . 

Phrase: ABDOMEN
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: Her steroids
Meta Mapping (1000):
  1000   Steroids [Organic Chemical]

Phrase: were

Phrase: tapered
Meta Mapping (1000):
  1000   tapered (Tapering - action) [Health Care Activity]

Phrase: and

Phrase: Pulmonary
Meta Mapping (1000):
  1000   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (1000):
  1000   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]

Phrase: was

Phrase: consulted
Meta Mapping (1000):
  1000   consulted (Consultation) [Health Care Activity]

Phrase: who

Phrase: recommended
Meta Mapping (1000):
  1000   Recommended (Recommendation) [Idea or Concept]

Phrase: a CT scan of the chest
Meta Mapping (864):
   864   CT scan of chest (Chest CT) [Diagnostic Procedure]
Meta Mapping (864):
   864   CT scan of chest [Diagnostic Procedure]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: evaluate
Meta Mapping (1000):
  1000   Evaluate (Evaluation) [Health Care Activity]

Phrase: the lung parenchyma ,
Meta Mapping (1000):
  1000   Lung Parenchyma (Structure of parenchyma of lung) [Tissue]
Meta Mapping (1000):
  1000   Lung parenchyma (Entire lung parenchyma) [Body Location or Region]

Phrase: induce
Meta Mapping (1000):
  1000   Induce (Induce (action)) [Functional Concept]

Phrase: sputum for CBC ,
Meta Mapping (746):
   790   SPUTUM (Sputum) [Body Substance]
   623   CBC (Complete Blood Count) [Laboratory Procedure]
Meta Mapping (746):
   790   SPUTUM (Sputum) [Body Substance]
   623   CBC (Nuclear cap binding complex location) [Cell Component]

Phrase: arterial blood gas ,
Meta Mapping (1000):
  1000   arterial blood gas (Analysis of arterial blood gases and pH) [Laboratory Procedure]

Phrase: continuing of the beta agonist inhalers ,
Meta Mapping (697):
   753   Continuing (Continuous) [Idea or Concept]
   753   Beta (Beta plant) [Plant]
   753   Agonist [Pharmacologic Substance]
   753   Inhalers (Inhaler) [Medical Device]
Meta Mapping (697):
   753   Continuing (Continuous) [Idea or Concept]
   753   Beta (Beta greek letter) [Intellectual Product]
   753   Agonist [Pharmacologic Substance]
   753   Inhalers (Inhaler) [Medical Device]
Meta Mapping (697):
   753   Continuing (Continuous) [Idea or Concept]
   753   Beta (Beta (qualifier)) [Qualitative Concept]
   753   Agonist [Pharmacologic Substance]
   753   Inhalers (Inhaler) [Medical Device]

Phrase: and

Phrase: trial of steroid inhalers .
Meta Mapping (733):
   770   Trial (Clinical Trials) [Research Activity]
   604   Steroid (Steroids) [Organic Chemical]
   604   Inhalers (Inhaler) [Medical Device]
Processing 00000000.tx.54: She should have a follow-up echocardiogram . 

Phrase: She

Phrase: should

Phrase: have

Phrase: a follow-up echocardiogram .
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   Echocardiogram (Echocardiogram (image)) [Intellectual Product]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   Echocardiogram (Echocardiogram (image)) [Intellectual Product]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   Echocardiogram (Echocardiogram (image)) [Intellectual Product]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   Echocardiogram (Echocardiogram (image)) [Intellectual Product]
Processing 00000000.tx.55: Pulmonary felt this was consistent also with lymphangitic spread and they did not feel that a bronchoscopy would be of any assistance at this time . 

Phrase: Pulmonary
Meta Mapping (1000):
  1000   pulmonary (Lung) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Pulmonary (Pulmonary:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (1000):
  1000   Pulmonary (Pulmonary (qualifier value)) [Qualitative Concept]

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: this

Phrase: was

Phrase: consistent also with lymphangitic spread
Meta Mapping (788):
   797   Consistent with [Idea or Concept]
   806   Lymphangitic spread [Functional Concept]

Phrase: and

Phrase: they

Phrase: did

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: feel
Meta Mapping (1000):
  1000   feel (Emotions) [Mental Process]

Phrase: that

Phrase: a bronchoscopy
Meta Mapping (1000):
  1000   Bronchoscopy [Diagnostic Procedure]

Phrase: would

Phrase: be of any assistance
Meta Mapping (770):
   770   Assistance (Helping Behavior) [Social Behavior]
Meta Mapping (770):
   770   Assistance (Assisted (qualifier value)) [Qualitative Concept]

Phrase: at this time .
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]
Processing 00000000.tx.56: Her cardiac examination remained the same and there continued to be no evidence of tamponade . 

Phrase: Her cardiac examination
Meta Mapping (1000):
  1000   Cardiac examination (Examination of heart) [Health Care Activity]

Phrase: remained

Phrase: the same
Meta Mapping (1000):
  1000   SAME (Same) [Qualitative Concept]

Phrase: and

Phrase: there

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: no evidence of tamponade .
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604   Tamponade (Compressed structure) [Functional Concept]
Meta Mapping (708):
   770   Evidence [Idea or Concept]
   604   Tamponade (Tamponade - action) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.57: The Ifex was held as it was felt that it could have precipitated the mental status changes and that she was to receive no further Ifex . 

Phrase: The Ifex
Meta Mapping (1000):
  1000   Ifex [Organic Chemical,Pharmacologic Substance]

Phrase: was

Phrase: held
Meta Mapping (1000):
  1000   hELD (ARID1A protein, human) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Meta Mapping (1000):
  1000   held (Held - activity status) [Idea or Concept]
Meta Mapping (1000):
  1000   hELD (ARID1A wt Allele) [Gene or Genome]

Phrase: as

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: it

Phrase: could

Phrase: have

Phrase: precipitated
Meta Mapping (966):
   966   Precipitate (Precipitate in Medical Device) [Phenomenon or Process]

Phrase: the mental status changes
Meta Mapping (1000):
  1000   mental status changes [Mental or Behavioral Dysfunction]

Phrase: and

Phrase: that

Phrase: she

Phrase: was

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: receive
Meta Mapping (1000):
  1000   Receive [Qualitative Concept]

Phrase: no further Ifex .
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Ifex [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.58: Psychiatry was also consulted to help her with the changes she was feeling since her new diagnosis . 

Phrase: Psychiatry
Meta Mapping (1000):
  1000   Psychiatry (Psychiatry Specialty) [Biomedical Occupation or Discipline]

Phrase: was

Phrase: also

Phrase: consulted
Meta Mapping (1000):
  1000   consulted (Consultation) [Health Care Activity]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: help
Meta Mapping (1000):
  1000   Help (Assisted (qualifier value)) [Qualitative Concept]
Meta Mapping (1000):
  1000   help (Help document) [Intellectual Product]

Phrase: her with the changes
Meta Mapping (770):
   770   changes (Changing) [Functional Concept]
Meta Mapping (770):
   770   changes (Changed status) [Quantitative Concept]

Phrase: she

Phrase: was

Phrase: feeling
Meta Mapping (1000):
  1000   feeling (Emotions) [Mental Process]
Meta Mapping (1000):
  1000   Feeling (Feelings) [Mental Process]

Phrase: since

Phrase: her new diagnosis .
Meta Mapping (1000):
  1000   New Diagnosis (New Diagnosis Procedure) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   New diagnosis (New diagnosis (finding)) [Finding]
Processing 00000000.tx.59: </TEXT> 718483 ESOPHAGEAL CARCINOMA-METASTATIC . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 718483 ESOPHAGEAL CARCINOMA-METASTATIC .
Meta Mapping (824):
   694   OESOPHAGEAL CARCINOMA (Esophageal carcinoma) [Neoplastic Process]
   812   Metastatic (Metastatic to) [Functional Concept]
Meta Mapping (824):
   694   OESOPHAGEAL CARCINOMA (Esophageal carcinoma) [Neoplastic Process]
   812   metastatic (metastatic qualifier) [Quantitative Concept]
Processing 00000000.tx.60: He began Ifosfamide chemotherapy but in the last few cycles has had progressive disease . 

Phrase: He

Phrase: began
Meta Mapping (966):
   966   Begin (Beginning) [Temporal Concept]

Phrase: Ifosfamide chemotherapy
Meta Mapping (888):
   694   Iphosphamide (Ifosfamide) [Organic Chemical,Pharmacologic Substance]
   861   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Iphosphamide (Ifosfamide) [Organic Chemical,Pharmacologic Substance]
   861   chemotherapy (pharmacotherapeutic) [Functional Concept]
Meta Mapping (888):
   694   Iphosphamide (Ifosfamide) [Organic Chemical,Pharmacologic Substance]
   861   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Iphosphamide (Ifosfamide) [Organic Chemical,Pharmacologic Substance]
   861   Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: but in the last few cycles
Meta Mapping (672):
   753   Last [Qualitative Concept]
   753   Cycles (event cycle) [Temporal Concept]

Phrase: has

Phrase: had

Phrase: progressive disease .
Meta Mapping (1000):
  1000   progressive disease (Progressive Neoplastic Disease) [Neoplastic Process]
Meta Mapping (1000):
  1000   PROGRESSIVE DISEASE (Progressive Disease) [Finding]
Meta Mapping (1000):
  1000   Progressive Disease (Progressive cGVHD) [Disease or Syndrome]
Processing 00000000.tx.61: He has seen two local physicians , who have tried him first on Bactrim and subsequently Clarithromycin without improvement . 

Phrase: He

Phrase: has

Phrase: seen
Meta Mapping (1000):
  1000   Seen (seen) [Qualitative Concept]

Phrase: two local physicians ,
Meta Mapping (851):
   660   Two [Quantitative Concept]
   660   LOCAL (Local) [Spatial Concept]
   827   Physicians [Professional or Occupational Group]

Phrase: who

Phrase: have

Phrase: tried

Phrase: him first on Bactrim
Meta Mapping (708):
   770   First (First (number)) [Quantitative Concept]
   770   Bactrim [Organic Chemical,Pharmacologic Substance]
Meta Mapping (708):
   770   First (Firstly) [Qualitative Concept]
   770   Bactrim [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: subsequently Clarithromycin without improvement .
Meta Mapping (708):
   770   CLARITHROMYCIN (Clarithromycin) [Antibiotic,Organic Chemical]
   604   Improvement [Conceptual Entity]
Processing 00000000.tx.62: The head , eyes , ears , nose , throat exam reveals mild proptosis . 

Phrase: The head ,
Meta Mapping (1000):
  1000   HEAD (Head) [Body Location or Region]
Meta Mapping (1000):
  1000   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Head (Head - Component of Device) [Manufactured Object]

Phrase: eyes ,
Meta Mapping (1000):
  1000   Eyes (Eye) [Body Part, Organ, or Organ Component]

Phrase: ears ,
Meta Mapping (1000):
  1000   Ears (Ear structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   EARS (Entire ear) [Body Part, Organ, or Organ Component]

Phrase: nose ,
Meta Mapping (1000):
  1000   NOSE (Nose) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Nose (Entire nose) [Body Part, Organ, or Organ Component]

Phrase: throat exam
Meta Mapping (888):
   694   Throat (Pharyngeal structure) [Body Part, Organ, or Organ Component]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   Throat (Anterior portion of neck) [Body Location or Region]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   Throat (Entire throat (surface region of neck)) [Body Part, Organ, or Organ Component]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   THROAT (Throat) [Body Part, Organ, or Organ Component]
   861   Exam (Medical Examination) [Health Care Activity]

Phrase: reveals
Meta Mapping (1000):
  1000   reveals (Revealed) [Qualitative Concept]

Phrase: mild proptosis .
Meta Mapping (1000):
  1000   Mild proptosis [Finding]
Processing 00000000.tx.63: There is no thyroid , cervical , or supraclavicular adenopathy . 

Phrase: There

Phrase: is

Phrase: no thyroid ,
Meta Mapping (1000):
  1000   Thyroid, NOS (Thyroid Gland) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   THYROID (THYROID DIAGNOSTIC RADIOPHARMACEUTICALS) [Indicator, Reagent, or Diagnostic Aid]

Phrase: cervical ,
Meta Mapping (1000):
  1000   Cervical (Neck) [Body Location or Region]
Meta Mapping (1000):
  1000   Cervical [Spatial Concept]

Phrase: or

Phrase: supraclavicular adenopathy .
Meta Mapping (1000):
  1000 N SUPRACLAVICULAR Adenopathy (SUPRACLAVICULAR LYMPH NODE ENLARGEMENT) [Finding]
Meta Mapping (1000):
  1000 N supraclavicular Adenopathy (Supraclavicular lymphadenopathy) [Pathologic Function]
Processing 00000000.tx.64: There is minimal air movement on the left lower lobe . 

Phrase: There

Phrase: is

Phrase: minimal air movement on the left lower lobe .
Meta Mapping (742):
   578   Minimal [Qualitative Concept]
   770   Movement, Air (Air Movements) [Natural Phenomenon or Process]
   633   Left lower lobe (Structure of left lower lobe of lung) [Body Part, Organ, or Organ Component]
Meta Mapping (742):
   578   MINIMAL (Minimum) [Qualitative Concept]
   770   Movement, Air (Air Movements) [Natural Phenomenon or Process]
   633   Left lower lobe (Structure of left lower lobe of lung) [Body Part, Organ, or Organ Component]
Meta Mapping (742):
   578   Minimal (Mild (qualifier value)) [Qualitative Concept]
   770   Movement, Air (Air Movements) [Natural Phenomenon or Process]
   633   Left lower lobe (Structure of left lower lobe of lung) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.65: BAL was sent for culture and was negative for pathogenic organisms . 

Phrase: BAL
Meta Mapping (1000):
  1000 N BAL (Blood alcohol level result) [Laboratory or Test Result]

Phrase: was

Phrase: sent for culture
Meta Mapping (746):
   790   Sent (Send (transmission)) [Functional Concept]
   790   Culture (Anthropological Culture) [Idea or Concept]
Meta Mapping (746):
   790   Sent (Send (transmission)) [Functional Concept]
   790   culture (Cultural aspects) [Functional Concept]
Meta Mapping (746):
   790   Sent (Send (transmission)) [Functional Concept]
   790   Culture (Laboratory culture) [Laboratory Procedure]
Meta Mapping (746):
   790   Sent (Send (transmission)) [Functional Concept]
   790   Culture (Microbial culture (procedure)) [Laboratory Procedure]

Phrase: and

Phrase: was

Phrase: negative for pathogenic organisms .
Meta Mapping (772):
   770   Negative [Qualitative Concept]
   650   Pathogenic organism [Organism]
Meta Mapping (772):
   770   NEGATIVE (Negative Finding) [Finding]
   650   Pathogenic organism [Organism]
Meta Mapping (772):
   770   Negative (Negative Number) [Conceptual Entity]
   650   Pathogenic organism [Organism]
Meta Mapping (772):
   770   Negative (Negative Charge) [Qualitative Concept]
   650   Pathogenic organism [Organism]
Meta Mapping (772):
   770   Negative (Negative - answer) [Qualitative Concept]
   650   Pathogenic organism [Organism]
Processing 00000000.tx.66: His Coumadin was discontinued . 

Phrase: His Coumadin
Meta Mapping (1000):
  1000   Coumadin [Organic Chemical,Pharmacologic Substance]

Phrase: was

Phrase: discontinued .
Meta Mapping (1000):
  1000   Discontinued [Finding]
Processing 00000000.tx.67: In addition , he was sent home on Prednisone , 40 mg. q.day . 

Phrase: In addition ,
Meta Mapping (861):
   861   Addition (In addition to) [Functional Concept]
Meta Mapping (861):
   861   Addition (Add - instruction imperative) [Functional Concept]

Phrase: he

Phrase: was

Phrase: sent
Meta Mapping (1000):
  1000   Sent (Send (transmission)) [Functional Concept]

Phrase: home on Prednisone ,
Meta Mapping (746):
   790   HOME (Home environment) [Conceptual Entity]
   623   PREDNISONE (Prednisone) [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: 40 mg. q.day .
Meta Mapping (824):
   645   /40 [Temporal Concept]
   875   mg day (milligram/day) [Quantitative Concept]
Meta Mapping (824):
   645   40% [Quantitative Concept]
   875   mg day (milligram/day) [Quantitative Concept]
Processing 00000000.tx.68: TD : </TEXT>

Phrase: TD
Meta Mapping (1000):
  1000   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (1000):
  1000   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >
Processing 00000000.tx.1: PUOMC Discharge Summary Unsigned DISCHARGE DATE : CHIEF COMPLAINT : left axillary node dissection , status post breast carcinoma . 

Phrase: PUOMC Discharge Summary Unsigned DISCHARGE DATE
Meta Mapping (787):
   876   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
   632   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (787):
   876   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
   632   Summary (Summary (document)) [Intellectual Product]
Meta Mapping (787):
   876   Discharge date [Temporal Concept]
   632   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (787):
   876   Discharge date [Temporal Concept]
   632   Summary (Summary (document)) [Intellectual Product]
Meta Mapping (787):
   660   Discharge summary [Intellectual Product]
   799   DATE (Date in time) [Temporal Concept]
Meta Mapping (787):
   660   Discharge summary [Intellectual Product]
   799   DATE (Date Fruit) [Food]
Meta Mapping (787):
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   799   DATE (Date in time) [Temporal Concept]
Meta Mapping (787):
   660   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   799   DATE (Date Fruit) [Food]

Phrase: :

Phrase: CHIEF COMPLAINT
Meta Mapping (1000):
  1000   Chief Complaint (Chief complaint (finding)) [Finding]

Phrase: :

Phrase: left axillary node dissection ,
Meta Mapping (916):
   645   LEFT (Left) [Spatial Concept]
   923   Axillary Node Dissection (Excision of axillary lymph nodes) [Therapeutic or Preventive Procedure]
Meta Mapping (916):
   645   Left (Left sided) [Spatial Concept]
   923   Axillary Node Dissection (Excision of axillary lymph nodes) [Therapeutic or Preventive Procedure]
Meta Mapping (916):
   645   left (Table Cell Horizontal Align - left) [Functional Concept]
   923   Axillary Node Dissection (Excision of axillary lymph nodes) [Therapeutic or Preventive Procedure]

Phrase: status post breast carcinoma .
Meta Mapping (1000):
  1000   Breast Carcinoma (Malignant neoplasm of breast) [Neoplastic Process]
Meta Mapping (1000):
  1000   BREAST CARCINOMA (Breast Carcinoma) [Neoplastic Process]
Processing 00000000.tx.2: Pathology of this resection revealed a Grade III / III infiltrating ductal carcinoma . 

Phrase: Pathology of this resection
Meta Mapping (708):
   770   Pathology [Biomedical Occupation or Discipline]
   604   resection (removal technique) [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   Pathology [Biomedical Occupation or Discipline]
   604   Resection (Excision) [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   pathology (Pathological aspects) [Functional Concept]
   604   resection (removal technique) [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   pathology (Pathological aspects) [Functional Concept]
   604   Resection (Excision) [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   pathology (Pathology processes) [Pathologic Function]
   604   resection (removal technique) [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   pathology (Pathology processes) [Pathologic Function]
   604   Resection (Excision) [Therapeutic or Preventive Procedure]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a Grade III / III infiltrating ductal carcinoma .
Meta Mapping (822):
   660   Grade III (Poorly differentiated) [Qualitative Concept]
   861   Infiltrating Ductal Carcinoma (Invasive Ductal Breast Carcinoma) [Neoplastic Process]
Meta Mapping (822):
   660   Grade III (Grade three rank) [Qualitative Concept]
   861   Infiltrating Ductal Carcinoma (Invasive Ductal Breast Carcinoma) [Neoplastic Process]
Meta Mapping (822):
   660   grade 3 (Third grade in elementary school) [Intellectual Product]
   861   Infiltrating Ductal Carcinoma (Invasive Ductal Breast Carcinoma) [Neoplastic Process]
Meta Mapping (822):
   660   GRADE 3 (West Haven Hepatic Encephalopathy Grade 3) [Finding]
   861   Infiltrating Ductal Carcinoma (Invasive Ductal Breast Carcinoma) [Neoplastic Process]
Meta Mapping (822):
   660   Grade III (Clavien-Dindo Grade III) [Classification]
   861   Infiltrating Ductal Carcinoma (Invasive Ductal Breast Carcinoma) [Neoplastic Process]
Processing 00000000.tx.3: REVIEW OF SYSTEMS : :w The lungs were clear to auscultation and percussion . 

Phrase: REVIEW OF SYSTEMS
Meta Mapping (1000):
  1000   Review of systems (Review of systems:Finding:Point in time:^Patient:Narrative:Reported) [Clinical Attribute]
Meta Mapping (1000):
  1000   Review of systems (Review of systems:Finding:Point in time:^Patient:Nominal:Reported) [Clinical Attribute]
Meta Mapping (1000):
  1000   Review of Systems (Review of systems (procedure)) [Health Care Activity]

Phrase: :

Phrase: :

Phrase: w

Phrase: The lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: clear to auscultation
Meta Mapping (746):
   790   Clear (Negative Surgical Margin) [Finding]
   623   AUSCULTATION (Auscultation) [Diagnostic Procedure]
Meta Mapping (746):
   790   Clear [Qualitative Concept]
   623   AUSCULTATION (Auscultation) [Diagnostic Procedure]

Phrase: and

Phrase: percussion .
Meta Mapping (1000):
  1000   Percussion [Diagnostic Procedure]
Meta Mapping (1000):
  1000   PERCUSSION (Dental Percussion Procedure) [Diagnostic Procedure]
Processing 00000000.tx.4: The patient was discharged home on 9/15/93 . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: discharged
Meta Mapping (1000):
  1000   Discharged (Patient Discharge) [Health Care Activity]

Phrase: home on 9/15/93 .
Meta Mapping (760):
   760   HOME (Home environment) [Conceptual Entity]
Processing 00000000.tx.5: </RECORD> <TEXT> DISCHARGE SUMMARY SHUFF , RONHUM MEDICATIONS ON ADMISSION : DD : </TEXT> 10/14/1996 12:00:00 AM Left anterior temporal intraparenchymal hemorrhage . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: >

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > DISCHARGE SUMMARY SHUFF ,
Meta Mapping (734):
   734   Discharge summary [Intellectual Product]
Meta Mapping (734):
   734   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: RONHUM MEDICATIONS
Meta Mapping (861):
   861   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (861):
   861   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (861):
   861   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: ON ADMISSION
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: :

Phrase: DD
Meta Mapping (1000):
  1000   DD (AKR1C2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   DD (ATP2A2 wt Allele) [Gene or Genome]

Phrase: :

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 10/14/1996 12
Meta Mapping (902):
   902   10 - 12 [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: Left anterior temporal intraparenchymal hemorrhage .
Meta Mapping (840):
   673   Left anterior [Spatial Concept]
   637   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   804   INTRAPARENCHYMAL (Intraparenchymal Route of Administration) [Functional Concept]
   804   HEMORRHAGE (Hemorrhage) [Pathologic Function]
Meta Mapping (840):
   673   Left anterior [Spatial Concept]
   637   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   804   INTRAPARENCHYMAL (Intraparenchymal Route of Administration) [Functional Concept]
   804   HEMORRHAGE (Hemorrhage) [Pathologic Function]
Processing 00000000.tx.6: ASSOCIATED DIAGNOSIS : atrial fibrillation , deep venous thrombosis , pulmonary embolus , right frontal infarct , hypertension , and question progressive supranuclear palsy . 

Phrase: ASSOCIATED DIAGNOSIS
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: :

Phrase: atrial fibrillation ,
Meta Mapping (1000):
  1000   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
Meta Mapping (1000):
  1000   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]

Phrase: deep venous thrombosis ,
Meta Mapping (1000):
  1000   Deep Venous Thrombosis (Deep Vein Thrombosis) [Disease or Syndrome]

Phrase: pulmonary embolus ,
Meta Mapping (1000):
  1000   PULMONARY EMBOLUS (Pulmonary Embolism) [Disease or Syndrome]

Phrase: right frontal infarct ,
Meta Mapping (851):
   660   RIGHT (Right) [Spatial Concept]
   660   Frontal (Coronal) [Spatial Concept]
   827   INFARCT (Infarction) [Pathologic Function]
Meta Mapping (851):
   660   Right (Right sided) [Spatial Concept]
   660   Frontal (Coronal) [Spatial Concept]
   827   INFARCT (Infarction) [Pathologic Function]

Phrase: hypertension ,
Meta Mapping (1000):
  1000   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Hypertension (Hypertension Adverse Event) [Finding]

Phrase: and

Phrase: question
Meta Mapping (1000):
  1000   Question (Question (inquiry)) [Intellectual Product]

Phrase: progressive supranuclear palsy .
Meta Mapping (1000):
  1000   Progressive Supranuclear Palsy (Progressive supranuclear palsy) [Disease or Syndrome]
Processing 00000000.tx.7: He was later seen by Dr. 

Phrase: He

Phrase: was

Phrase: later
Meta Mapping (1000):
  1000   Later (Late) [Temporal Concept]

Phrase: seen by Dr.
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   DR (Dominican Republic) [Geographic Area]
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.8: Flo Cuchkote at the Ph University Of Medical Center and diagnosed with progressive supranuclear palsy . 

Phrase: Flo Cuchkote at the Ph University Of Medical Center
Meta Mapping (527):
   542   Flos (Flowers) [Plant]
   575   ph+ [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flowers) [Plant]
   575   ph++ [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flowers) [Plant]
   575   ph+++ [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flowers) [Plant]
   575   pH [Quantitative Concept]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flowers) [Plant]
   575   PH (Infusion pump Alert priority PH) [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flos <butterflies>) [Eukaryote]
   575   ph+ [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flos <butterflies>) [Eukaryote]
   575   ph++ [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flos <butterflies>) [Eukaryote]
   575   ph+++ [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flos <butterflies>) [Eukaryote]
   575   pH [Quantitative Concept]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (527):
   542   Flos (Flos <butterflies>) [Eukaryote]
   575   PH (Infusion pump Alert priority PH) [Finding]
   617   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]

Phrase: and

Phrase: diagnosed with progressive supranuclear palsy .
Meta Mapping (816):
   760   Diagnosed (Diagnosis) [Finding]
   862   Progressive Supranuclear Palsy (Progressive supranuclear palsy) [Disease or Syndrome]
Processing 00000000.tx.9: Over the five to six weeks prior to admission he had a drop off in his mental functioning with more frequent episodes of confusion and disorientation and requiring more assistance with his activities of daily living . 

Phrase: Over the five to six weeks
Meta Mapping (672):
   753   Five [Quantitative Concept]
   753   Six [Quantitative Concept]
   753   WEEKS (week) [Temporal Concept]

Phrase: prior to admission
Meta Mapping (1000):
  1000   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admission (Admission activity) [Health Care Activity]

Phrase: he

Phrase: had

Phrase: a drop off in his mental functioning
Meta Mapping (695):
   748   Drop (Drop measurement) [Quantitative Concept]
   595   Mental function [Mental Process]
Meta Mapping (695):
   748   Drop (Drop measurement) [Quantitative Concept]
   595   Mental function (Mental function:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (695):
   748   Drop (Dropping) [Activity]
   595   Mental function [Mental Process]
Meta Mapping (695):
   748   Drop (Dropping) [Activity]
   595   Mental function (Mental function:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (695):
   748   Drop (Medical Drop) [Quantitative Concept]
   595   Mental function [Mental Process]
Meta Mapping (695):
   748   Drop (Medical Drop) [Quantitative Concept]
   595   Mental function (Mental function:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (695):
   748   Drop (Drop British) [Quantitative Concept]
   595   Mental function [Mental Process]
Meta Mapping (695):
   748   Drop (Drop British) [Quantitative Concept]
   595   Mental function (Mental function:Find:Pt:^Patient:Nom) [Clinical Attribute]
Meta Mapping (695):
   748   Drop (Drop - Unit of Volume) [Quantitative Concept]
   595   Mental function [Mental Process]
Meta Mapping (695):
   748   Drop (Drop - Unit of Volume) [Quantitative Concept]
   595   Mental function (Mental function:Find:Pt:^Patient:Nom) [Clinical Attribute]

Phrase: with more frequent episodes of confusion
Meta Mapping (771):
   586   More [Functional Concept]
   586   Frequent (Frequently) [Temporal Concept]
   773   Episode of [Temporal Concept]
   586   CONFUSION (Confusion) [Mental or Behavioral Dysfunction]
Meta Mapping (771):
   586   More [Functional Concept]
   586   Frequent (Frequently) [Temporal Concept]
   773   Episode of [Temporal Concept]
   586   Confusion (Clouded consciousness) [Sign or Symptom]
Meta Mapping (771):
   586   More [Functional Concept]
   586   Frequent (Frequently) [Temporal Concept]
   773   Episode of [Temporal Concept]
   586   Confusion (Confusion Adverse Event) [Finding]

Phrase: and

Phrase: disorientation
Meta Mapping (1000):
  1000   Disorientation (Confusion) [Mental or Behavioral Dysfunction]
Meta Mapping (1000):
  1000   DISORIENTATION (Disorientation) [Mental or Behavioral Dysfunction]

Phrase: and

Phrase: requiring more assistance with his activities of daily living .
Meta Mapping (767):
   742   Assistance (Helping Behavior) [Social Behavior]
   651   Activities of Daily Living (Activities of Daily Living (activity)) [Daily or Recreational Activity]
Meta Mapping (767):
   742   Assistance (Helping Behavior) [Social Behavior]
   651   Activities of Daily Living (Activities of Daily Living Scale (BASC-2)) [Intellectual Product]
Meta Mapping (767):
   742   Assistance (Assisted (qualifier value)) [Qualitative Concept]
   651   Activities of Daily Living (Activities of Daily Living (activity)) [Daily or Recreational Activity]
Meta Mapping (767):
   742   Assistance (Assisted (qualifier value)) [Qualitative Concept]
   651   Activities of Daily Living (Activities of Daily Living Scale (BASC-2)) [Intellectual Product]
Processing 00000000.tx.10: ALLERGIES : chest x-ray clear . 

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: chest x-ray
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: clear .
Meta Mapping (1000):
  1000   Clear (Negative Surgical Margin) [Finding]
Meta Mapping (1000):
  1000   Clear [Qualitative Concept]
Processing 00000000.tx.11: Head CT scan showed a 2 x 2 x 2 left anterior temporal hemorrhage with minimal surrounding edema . 

Phrase: Head CT scan
Meta Mapping (1000):
  1000   head ct scan (CAT scan of head) [Diagnostic Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a 2 x 2 x 2 left anterior temporal hemorrhage with minimal surrounding edema .
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   +2 [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score) [Quantitative Concept]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ (2+ Score, WHO) [Classification]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   TEMPORAL (Temporal - Regional site descriptor) [Spatial Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   MINIMAL (Minimum) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   OEDEMA (Edema) [Finding]
Meta Mapping (644):
   568   2+ [Finding]
   581   Left anterior [Spatial Concept]
   568   Temporal (Temporal -Temporal Qualifier) [Temporal Concept]
   734   HEMORRHAGE (Hemorrhage) [Pathologic Function]
   568   Minimal (Mild (qualifier value)) [Qualitative Concept]
   568   Surrounding (Surrounding (qualifier value)) [Spatial Concept]
   568   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Processing 00000000.tx.12: There was also evidence of an old right frontal infarction . 

Phrase: There

Phrase: was

Phrase: also evidence of an old right frontal infarction .
Meta Mapping (678):
   744   Evidence [Idea or Concept]
   578   Old [Temporal Concept]
   578   RIGHT (Right) [Spatial Concept]
   578   Frontal (Coronal) [Spatial Concept]
   578   Infarction [Pathologic Function]
Meta Mapping (678):
   744   Evidence [Idea or Concept]
   578   Old [Temporal Concept]
   578   Right (Right sided) [Spatial Concept]
   578   Frontal (Coronal) [Spatial Concept]
   578   Infarction [Pathologic Function]
Processing 00000000.tx.13: His diagnosis of progressive supranuclear palsy was placed under question on further examination of his eye movement since he was able to have excellent superior gaze especially with the bells phenomenon which would not be seen with progressive supranuclear palsy . 

Phrase: His diagnosis of progressive supranuclear palsy
Meta Mapping (780):
   753   DIAGNOSIS (Diagnosis) [Finding]
   666   Progressive Supranuclear Palsy (Progressive supranuclear palsy) [Disease or Syndrome]
Meta Mapping (780):
   753   diagnosis (diagnosis aspect) [Qualitative Concept]
   666   Progressive Supranuclear Palsy (Progressive supranuclear palsy) [Disease or Syndrome]
Meta Mapping (780):
   753   DIAGNOSIS (Diagnosis Study) [Research Activity]
   666   Progressive Supranuclear Palsy (Progressive supranuclear palsy) [Disease or Syndrome]

Phrase: was

Phrase: placed under question
Meta Mapping (730):
   756   Place [Spatial Concept]
   790   Question (Question (inquiry)) [Intellectual Product]
Meta Mapping (730):
   756   Place (Place - dosing instruction imperative) [Functional Concept]
   790   Question (Question (inquiry)) [Intellectual Product]
Meta Mapping (730):
   756   Place (put - instruction imperative) [Activity]
   790   Question (Question (inquiry)) [Intellectual Product]

Phrase: on further examination of his eye movement
Meta Mapping (746):
   581   Further [Spatial Concept]
   804   Examination of eye (Ophthalmic examination and evaluation) [Therapeutic or Preventive Procedure]
   581   Movement [Organism Function]

Phrase: since

Phrase: he

Phrase: was

Phrase: able
Meta Mapping (1000):
  1000   Able (Ability) [Organism Attribute]
Meta Mapping (1000):
  1000   Able (Able (finding)) [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: excellent superior gaze especially with the bells phenomenon
Meta Mapping (682):
   578   Excellent (Excellent - Specimen Quality) [Qualitative Concept]
   578   SUPERIOR (Upper) [Spatial Concept]
   744   Gaze [Finding]
   587   Bell phenomenon (Bell's phenomenon) [Finding]
Meta Mapping (682):
   578   Excellent (Excellent (qualifier value)) [Qualitative Concept]
   578   SUPERIOR (Upper) [Spatial Concept]
   744   Gaze [Finding]
   587   Bell phenomenon (Bell's phenomenon) [Finding]

Phrase: which

Phrase: would

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: be

Phrase: seen with progressive supranuclear palsy .
Meta Mapping (816):
   760   Seen (seen) [Qualitative Concept]
   862 N Progressive Supranuclear Palsy (Progressive supranuclear palsy) [Disease or Syndrome]
Processing 00000000.tx.14: That was at the highest percentage that he had and after this his percentage came down to 1.6 , 1.0 on subsequent CKMBs and was felt that he had a very small &quot; leaflet &quot; . 

Phrase: That

Phrase: was at the highest percentage
Meta Mapping (695):
   760   Highest [Qualitative Concept]
   760   Percentage (Percent (qualifier value)) [Quantitative Concept]
Meta Mapping (695):
   760   Highest [Qualitative Concept]
   760   Percentage (Amount type - Percentage) [Idea or Concept]
Meta Mapping (695):
   760   Highest [Qualitative Concept]
   760   Percentage (Money or percentage indicator - Percentage) [Idea or Concept]

Phrase: that

Phrase: he

Phrase: had

Phrase: and after this

Phrase: his percentage
Meta Mapping (1000):
  1000   Percentage (Percent (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   Percentage (Amount type - Percentage) [Idea or Concept]
Meta Mapping (1000):
  1000   Percentage (Money or percentage indicator - Percentage) [Idea or Concept]

Phrase: came down

Phrase: to 1.6 ,
Meta Mapping (861):
   861   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (861):
   861   1+ (1+ Score, WHO) [Classification]
Meta Mapping (861):
   861   1+ [Finding]

Phrase: 1.0 on subsequent CKMBs
Meta Mapping (696):
   760   1+ (1+ Score) [Quantitative Concept]
   760   0% [Finding]
   760   Subsequent (Following) [Temporal Concept]
Meta Mapping (696):
   760   1+ (1+ Score, WHO) [Classification]
   760   0% [Finding]
   760   Subsequent (Following) [Temporal Concept]
Meta Mapping (696):
   760   1+ [Finding]
   760   0% [Finding]
   760   Subsequent (Following) [Temporal Concept]

Phrase: and

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: he

Phrase: had

Phrase: a very small &quot
Meta Mapping (734):
   734   Very Small (Can Do Very Little) [Intellectual Product]

Phrase: ; leaflet &quot
Meta Mapping (694):
   694   Leaflet (Leaflet Device Component) [Manufactured Object]
Meta Mapping (694):
   694   Leaflet [Intellectual Product]

Phrase: ; .
Processing 00000000.tx.15: He remained chest pain free throughout his admission . 

Phrase: He

Phrase: remained

Phrase: chest pain free throughout his admission .
Meta Mapping (725):
   790   CHEST PAIN (Chest Pain) [Sign or Symptom]
   753   free (Free of (attribute)) [Functional Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   790   CHEST PAIN (Chest Pain) [Sign or Symptom]
   753   free (Free of (attribute)) [Functional Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (725):
   790   CHEST PAIN (Chest Pain) [Sign or Symptom]
   753   Free (Empty (qualifier)) [Qualitative Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   790   CHEST PAIN (Chest Pain) [Sign or Symptom]
   753   Free (Empty (qualifier)) [Qualitative Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (725):
   790   CHEST PAIN (Chest Pain) [Sign or Symptom]
   753   Free (Free (available (qualifier))) [Qualitative Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   790   CHEST PAIN (Chest Pain) [Sign or Symptom]
   753   Free (Free (available (qualifier))) [Qualitative Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (725):
   790   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   753   free (Free of (attribute)) [Functional Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   790   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   753   free (Free of (attribute)) [Functional Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (725):
   790   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   753   Free (Empty (qualifier)) [Qualitative Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   790   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   753   Free (Empty (qualifier)) [Qualitative Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (725):
   790   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   753   Free (Free (available (qualifier))) [Qualitative Concept]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   790   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   753   Free (Free (available (qualifier))) [Qualitative Concept]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (725):
   753   CHEST (Chest) [Body Location or Region]
   790   Pain-Free [Organic Chemical]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   753   CHEST (Chest) [Body Location or Region]
   790   Pain-Free [Organic Chemical]
   586   Admission (Admission activity) [Health Care Activity]
Meta Mapping (725):
   753   Chest (Anterior thoracic region) [Body Location or Region]
   790   Pain-Free [Organic Chemical]
   586   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (725):
   753   Chest (Anterior thoracic region) [Body Location or Region]
   790   Pain-Free [Organic Chemical]
   586   Admission (Admission activity) [Health Care Activity]
Processing 00000000.tx.16: Stable . 

Phrase: Stable .
Meta Mapping (1000):
  1000   STABLE (Stable status) [Qualitative Concept]
Meta Mapping (1000):
  1000   Stable (Patient Condition Code - Stable) [Intellectual Product]
Processing 00000000.tx.17: </RECORD> OPERATIONS AND PROCEDURES : There were no signs of infection or septic arthritis at the time of discharge . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > OPERATIONS
Meta Mapping (1000):
  1000   operations (Surgical aspects) [Functional Concept]
Meta Mapping (1000):
  1000   operations (ActInformationPrivacyReason <operations>) [Functional Concept]
Meta Mapping (1000):
  1000   operations (HL7PublishingSubSection <operations>) [Intellectual Product]

Phrase: AND

Phrase: PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: There

Phrase: were

Phrase: no signs of infection
Meta Mapping (708):
   770   signs (Aspects of signs) [Functional Concept]
   604 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (708):
   770   signs (Aspects of signs) [Functional Concept]
   604 N INFECTION (Infection) [Pathologic Function]
Meta Mapping (708):
   770   signs (Manufactured sign) [Manufactured Object]
   604 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (708):
   770   signs (Manufactured sign) [Manufactured Object]
   604 N INFECTION (Infection) [Pathologic Function]
Meta Mapping (708):
   770   SIGNS (Physical findings) [Finding]
   604 N Infection, NOS (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (708):
   770   SIGNS (Physical findings) [Finding]
   604 N INFECTION (Infection) [Pathologic Function]

Phrase: or

Phrase: septic arthritis at the time of discharge .
Meta Mapping (719):
   778 N ARTHRITIS, SEPTIC (Arthritis, Infectious) [Disease or Syndrome]
   607   Discharge time [Temporal Concept]
Meta Mapping (719):
   778 N ARTHRITIS, SEPTIC (Arthritis, Infectious) [Disease or Syndrome]
   607   Discharge time (Discharge time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]
Meta Mapping (719):
   778 N Septic Arthritis (Arthritis, Bacterial) [Disease or Syndrome]
   607   Discharge time [Temporal Concept]
Meta Mapping (719):
   778 N Septic Arthritis (Arthritis, Bacterial) [Disease or Syndrome]
   607   Discharge time (Discharge time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]
Processing 00000000.tx.18: 07/20/90 385056 November 19 , 1997 , he underwent a resection of a skull base chordoma and a lateral mandibulotomy with tracheostomy . 

Phrase: 07/20/90 385056 November 19 ,
Meta Mapping (719):
   799   20% [Finding]
   799   >90 [Quantitative Concept]
   799   November [Temporal Concept]
Meta Mapping (719):
   799   20% [Finding]
   799   <90 [Quantitative Concept]
   799   November [Temporal Concept]
Meta Mapping (719):
   799   20% [Finding]
   799   90% [Finding]
   799   November [Temporal Concept]

Phrase: 1997 ,

Phrase: he

Phrase: underwent

Phrase: a resection of a skull base chordoma
Meta Mapping (799):
   748   resection (removal technique) [Therapeutic or Preventive Procedure]
   664   Chordoma of Skull Base (Skull Base Chordoma) [Neoplastic Process]
Meta Mapping (799):
   748   Resection (Excision) [Therapeutic or Preventive Procedure]
   664   Chordoma of Skull Base (Skull Base Chordoma) [Neoplastic Process]

Phrase: and

Phrase: a lateral mandibulotomy with tracheostomy .
Meta Mapping (745):
   631   Lateral tracheostomy [Therapeutic or Preventive Procedure]
   760   Mandibulotomy (Osteotomy of mandible) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.19: He was discharged home with at follow-up MRI and on December 25 , 1997 again revealed a large ill defined lobulated skull based mass with a mass effect on the medulla . 

Phrase: He

Phrase: was

Phrase: discharged
Meta Mapping (1000):
  1000   Discharged (Patient Discharge) [Health Care Activity]

Phrase: home with
Meta Mapping (833):
   833   HOME (Home environment) [Conceptual Entity]

Phrase: at follow-up MRI
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   MRI (C7orf49 gene) [Gene or Genome]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]

Phrase: and on December 25 ,
Meta Mapping (770):
   770   December [Qualitative Concept]

Phrase: 1997

Phrase: again

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: a large ill defined lobulated skull
Meta Mapping (794):
   897   Large skull (Large head (disorder)) [Finding]
   637   Ill (Malaise) [Sign or Symptom]
   637   Defined (Definition) [Intellectual Product]
Meta Mapping (794):
   897   Large skull (Large head (disorder)) [Finding]
   637   Ill (Malaise) [Sign or Symptom]
   637   Defined (Sufficiently defined concept definition status (core metadata concept)) [Intellectual Product]

Phrase: based
Meta Mapping (1000):
  1000   Based (Basis - conceptual entity) [Functional Concept]
Meta Mapping (1000):
  1000   Based (Base - General Qualifier) [Idea or Concept]

Phrase: mass with a mass effect
Meta Mapping (520):
   593   MASS (Mass of body structure) [Finding]
   593   Effect [Qualitative Concept]
Meta Mapping (520):
   593   MASS (Mass of body structure) [Finding]
   593   Effect (Effect, Appearance) [Qualitative Concept]
Meta Mapping (520):
   593   Mass (Mass of body region) [Sign or Symptom]
   593   Effect [Qualitative Concept]
Meta Mapping (520):
   593   Mass (Mass of body region) [Sign or Symptom]
   593   Effect (Effect, Appearance) [Qualitative Concept]
Meta Mapping (520):
   593   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
   593   Effect [Qualitative Concept]
Meta Mapping (520):
   593   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
   593   Effect (Effect, Appearance) [Qualitative Concept]
Meta Mapping (520):
   593   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
   593   Effect [Qualitative Concept]
Meta Mapping (520):
   593   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
   593   Effect (Effect, Appearance) [Qualitative Concept]
Meta Mapping (520):
   593   Mass (Molecular Mass) [Quantitative Concept]
   593   Effect [Qualitative Concept]
Meta Mapping (520):
   593   Mass (Molecular Mass) [Quantitative Concept]
   593   Effect (Effect, Appearance) [Qualitative Concept]
Meta Mapping (520):
   593   mAs (Milliampere second) [Quantitative Concept]
   593   Effect [Qualitative Concept]
Meta Mapping (520):
   593   mAs (Milliampere second) [Quantitative Concept]
   593   Effect (Effect, Appearance) [Qualitative Concept]

Phrase: on the medulla .
Meta Mapping (1000):
  1000   medulla (Medulla Oblongata) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Medulla (Entire medulla oblongata) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Medulla [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Medulla (Pith - plant part) [Plant]
Processing 00000000.tx.20: The patient is allergic to Codeine which causes nausea and Morphine which causes swelling . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: allergic to Codeine
Meta Mapping (746):
   790   Allergic (allergic) [Functional Concept]
   623   CODEINE (Codeine) [Organic Chemical,Pharmacologic Substance]

Phrase: which

Phrase: causes
Meta Mapping (1000):
  1000   causes (Etiology aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Causes (Etiology) [Functional Concept]
Meta Mapping (1000):
  1000   Cause (Science of Etiology) [Conceptual Entity]

Phrase: nausea
Meta Mapping (1000):
  1000   NAUSEA (Nausea) [Sign or Symptom]
Meta Mapping (1000):
  1000   Nausea (Nausea Adverse Event) [Pathologic Function]

Phrase: and

Phrase: Morphine
Meta Mapping (1000):
  1000   MORPHINE (Morphine) [Organic Chemical,Pharmacologic Substance]

Phrase: which

Phrase: causes
Meta Mapping (1000):
  1000   causes (Etiology aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Causes (Etiology) [Functional Concept]
Meta Mapping (1000):
  1000   Cause (Science of Etiology) [Conceptual Entity]

Phrase: swelling .
Meta Mapping (1000):
  1000   SWELLING (Edema) [Finding]
Meta Mapping (1000):
  1000   SWELLING (Swelling) [Finding]
Processing 00000000.tx.21: A lumbar drain was placed and for the next five days 50 cc was drained every eight hours . 

Phrase: A lumbar drain
Meta Mapping (888):
   694   Lumbar (Lumbar Region) [Body Location or Region]
   861   drain (Drainage procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Lumbar (Lumbar Region) [Body Location or Region]
   861   DRAIN (Drain device) [Medical Device]

Phrase: was

Phrase: placed
Meta Mapping (966):
   966   Place [Spatial Concept]
Meta Mapping (966):
   966   Place (Place - dosing instruction imperative) [Functional Concept]
Meta Mapping (966):
   966   Place (put - instruction imperative) [Activity]

Phrase: and for the next five days 50 cc
Meta Mapping (703):
   744   next (Adjacent) [Spatial Concept]
   754   FIVE-DAY (Five-Day Report) [Intellectual Product]
   744   50% [Finding]
   744   CC (C-Circle) [Cell Component]
Meta Mapping (703):
   744   next (Adjacent) [Spatial Concept]
   754   FIVE-DAY (Five-Day Report) [Intellectual Product]
   744   <50 [Finding]
   744   CC (C-Circle) [Cell Component]
Meta Mapping (703):
   744   Next (Following) [Temporal Concept]
   754   FIVE-DAY (Five-Day Report) [Intellectual Product]
   744   50% [Finding]
   744   CC (C-Circle) [Cell Component]
Meta Mapping (703):
   744   Next (Following) [Temporal Concept]
   754   FIVE-DAY (Five-Day Report) [Intellectual Product]
   744   <50 [Finding]
   744   CC (C-Circle) [Cell Component]
Meta Mapping (703):
   744   Next (Then) [Temporal Concept]
   754   FIVE-DAY (Five-Day Report) [Intellectual Product]
   744   50% [Finding]
   744   CC (C-Circle) [Cell Component]
Meta Mapping (703):
   744   Next (Then) [Temporal Concept]
   754   FIVE-DAY (Five-Day Report) [Intellectual Product]
   744   <50 [Finding]
   744   CC (C-Circle) [Cell Component]

Phrase: was

Phrase: drained
Meta Mapping (966):
   966   drain (Drainage procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (966):
   966   DRAIN (Drain device) [Medical Device]

Phrase: every eight hours .
Meta Mapping (888):
   694   Eight [Quantitative Concept]
   861   HOURS (Hour) [Temporal Concept]
Processing 00000000.tx.22: He was followed by the Speech Pathology Team who noted that he still had evidence of aspiration . 

Phrase: He

Phrase: was

Phrase: followed by the Speech Pathology Team
Meta Mapping (759):
   790   Followed by [Temporal Concept]
   790   Pathology, Speech [Biomedical Occupation or Discipline]
   753   Team (teams) [Group]

Phrase: who

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: that

Phrase: he

Phrase: still

Phrase: had

Phrase: evidence of aspiration .
Meta Mapping (746):
   790   Evidence [Idea or Concept]
   623   Aspiration (Endotracheal aspiration) [Health Care Activity]
Meta Mapping (746):
   790   Evidence [Idea or Concept]
   623   Aspiration (Aspiration-action) [Therapeutic or Preventive Procedure]
Meta Mapping (746):
   790   Evidence [Idea or Concept]
   623   ASPIRATION (Pulmonary aspiration) [Pathologic Function]
Meta Mapping (746):
   790   Evidence [Idea or Concept]
   623   Aspiration (Actual Aspiration) [Finding]
Meta Mapping (746):
   790   Evidence [Idea or Concept]
   623   Aspiration (Unintentional Material Aspiration) [Finding]
Processing 00000000.tx.23: Prior to admission Mr. 

Phrase: Prior to admission Mr.
Meta Mapping (888):
   694   Admission (Hospital admission) [Health Care Activity]
   861   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (888):
   694   Admission (Hospital admission) [Health Care Activity]
   861   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (888):
   694   Admission (Hospital admission) [Health Care Activity]
   861   MR (Minor Response) [Finding]
Meta Mapping (888):
   694   Admission (Admission activity) [Health Care Activity]
   861   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (888):
   694   Admission (Admission activity) [Health Care Activity]
   861   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (888):
   694   Admission (Admission activity) [Health Care Activity]
   861   MR (Minor Response) [Finding]
Processing 00000000.tx.24: Marker had been taking one can of Jevity every two hours as a bolus . 

Phrase: Marker
Meta Mapping (1000):
  1000   Marker (Biological Markers) [Clinical Attribute]

Phrase: had

Phrase: been

Phrase: taking
Meta Mapping (966):
   966   Take [Health Care Activity]

Phrase: one
Meta Mapping (1000):
  1000   ONE (One) [Quantitative Concept]

Phrase: can of Jevity
Meta Mapping (790):
   790   JEVITY [Food]

Phrase: every two hours as a bolus .
Meta Mapping (672):
   586   Two [Quantitative Concept]
   753   HOURS (Hour) [Temporal Concept]
   586   Bolus (bolus infusion) [Therapeutic or Preventive Procedure]
Meta Mapping (672):
   586   Two [Quantitative Concept]
   753   HOURS (Hour) [Temporal Concept]
   586   {Bolus} (Bolus Dosing Unit) [Quantitative Concept]
Meta Mapping (672):
   586   Two [Quantitative Concept]
   753   HOURS (Hour) [Temporal Concept]
   586   Bolus (Radiotherapy Bolus) [Medical Device]
Processing 00000000.tx.25: He will needed a follow-up CT or MRI for the pseudomeningocele . 

Phrase: He

Phrase: will

Phrase: needed
Meta Mapping (1000):
  1000   Needed (Needs) [Qualitative Concept]
Meta Mapping (1000):
  1000   needed (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: a follow-up CT
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   CT (Central African Republic) [Geographic Area]
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (901):
   734   Follow-up (Follow-up status) [Finding]
   827   CT (Computed Tomography Study File) [Intellectual Product]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   CT (Central African Republic) [Geographic Area]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (901):
   734   Follow Up (follow-up) [Health Care Activity]
   827   CT (Computed Tomography Study File) [Intellectual Product]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   CT (Central African Republic) [Geographic Area]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (901):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
   827   CT (Computed Tomography Study File) [Intellectual Product]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   CT (Central African Republic) [Geographic Area]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (901):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   827   CT (Computed Tomography Study File) [Intellectual Product]

Phrase: or

Phrase: MRI for the pseudomeningocele .
Meta Mapping (708):
   770   MRI (Magnetic Resonance Imaging) [Diagnostic Procedure]
   604   Pseudomeningocoele (Pseudomeningocele) [Disease or Syndrome]
Meta Mapping (708):
   770   MRI (C7orf49 gene) [Gene or Genome]
   604   Pseudomeningocoele (Pseudomeningocele) [Disease or Syndrome]
Meta Mapping (708):
   770   MRI (Magnetic Resonance Imaging Study File) [Intellectual Product]
   604   Pseudomeningocoele (Pseudomeningocele) [Disease or Syndrome]
Processing 00000000.tx.26: 9/20/1990 12:00:00 AM The patient was diagnosed with lymphoma in January of 1988 when a biopsy of her left cervical node revealed T cell versus Hodgkin &apos;s lymphoma . 

Phrase: 9/20/1990 12
Meta Mapping (733):
   812   20% [Finding]
   779   1990s [Temporal Concept]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: diagnosed with lymphoma
Meta Mapping (746):
   790   Diagnosed (Diagnosis) [Finding]
   790   LYMPHOMA (Lymphoma) [Neoplastic Process]

Phrase: in January of 1988
Meta Mapping (770):
   770   January [Qualitative Concept]

Phrase: when

Phrase: a biopsy of her left cervical node
Meta Mapping (704):
   607   Cervical-left [Finding]
   724   nodule biopsy (biopsy nodule) [Diagnostic Procedure]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: T cell
Meta Mapping (1000):
  1000   T Cell (T-Lymphocyte) [Cell]

Phrase: versus

Phrase: Hodgkin &apos

Phrase: ;s lymphoma .
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   LYMPHOMA (Lymphoma) [Neoplastic Process]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   LYMPHOMA (Lymphoma) [Neoplastic Process]
Processing 00000000.tx.27: He was then admitted on 9/20/90 for autologous bone marrow transplantation . 

Phrase: He

Phrase: was

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: admitted on 9/20/90
Meta Mapping (696):
   760   admitted (Hospital admission) [Health Care Activity]
   760   20% [Finding]
   760   >90 [Quantitative Concept]
Meta Mapping (696):
   760   admitted (Hospital admission) [Health Care Activity]
   760   20% [Finding]
   760   <90 [Quantitative Concept]
Meta Mapping (696):
   760   admitted (Hospital admission) [Health Care Activity]
   760   20% [Finding]
   760   90% [Finding]
Meta Mapping (696):
   760   Admitted (Admission activity) [Health Care Activity]
   760   20% [Finding]
   760   >90 [Quantitative Concept]
Meta Mapping (696):
   760   Admitted (Admission activity) [Health Care Activity]
   760   20% [Finding]
   760   <90 [Quantitative Concept]
Meta Mapping (696):
   760   Admitted (Admission activity) [Health Care Activity]
   760   20% [Finding]
   760   90% [Finding]

Phrase: for autologous bone marrow transplantation .
Meta Mapping (1000):
  1000   Autologous Bone Marrow Transplantation (Autologous bone marrow transplant) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.28: The patient underwent conditioning with Cytoxan , VP-16 , and VCNU . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: underwent

Phrase: conditioning with Cytoxan ,
Meta Mapping (746):
   790   CONDITIONING (Conditioning (Psychology)) [Mental Process]
   623   Cytoxan [Organic Chemical,Pharmacologic Substance]

Phrase: VP-16 ,
Meta Mapping (1000):
  1000   VP16 (VP-16) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: VCNU .
Processing 00000000.tx.29: He was treated with multiple antibiotics including ceftazidime , gentamicin , vancomycin and ampho . 

Phrase: He

Phrase: was

Phrase: treated with multiple antibiotics
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (Antibiotics, Antitubercular) [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (Antibiotics for systemic use) [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (Antifungal Antibiotics, Topical) [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (Antibiotic throat preparations) [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE) [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (Antibiotics, Gynecological) [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (antibiotics, intestinal) [Antibiotic]
Meta Mapping (861):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   MULTIPLE (Numerous) [Quantitative Concept]
   770   Antibiotics (Antibiotics, ophthalmologic) [Antibiotic]

Phrase: including
Meta Mapping (1000):
  1000   Including (Including (qualifier)) [Functional Concept]

Phrase: ceftazidime ,
Meta Mapping (1000):
  1000   CEFTAZIDIME (Ceftazidime) [Antibiotic,Organic Chemical]

Phrase: gentamicin ,
Meta Mapping (1000):
  1000   Gentamycin (Gentamicin Sulfate (USP)) [Antibiotic,Organic Chemical]
Meta Mapping (1000):
  1000   Gentamycin (Gentamicin) [Antibiotic,Organic Chemical]

Phrase: vancomycin
Meta Mapping (1000):
  1000   VANCOMYCIN (Vancomycin) [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: and

Phrase: ampho .
Processing 00000000.tx.30: This progressed inexorably until he developed massive ascites and marked hyperbilirubinemia . 

Phrase: This progressed inexorably
Meta Mapping (861):
   861   progressed (status - In progress) [Functional Concept]

Phrase: until

Phrase: he

Phrase: developed

Phrase: massive ascites
Meta Mapping (888):
   694   Massive [Qualitative Concept]
   861   ASCITES (Ascites) [Finding]

Phrase: and

Phrase: marked hyperbilirubinemia .
Meta Mapping (888):
   694   Marked (Massive) [Qualitative Concept]
   861   Hyperbilirubinaemia (Hyperbilirubinemia) [Disease or Syndrome]
Meta Mapping (888):
   694   Marked (Massive) [Qualitative Concept]
   861   Hyperbilirubinemia (Increased bilirubin level (finding)) [Finding]
Meta Mapping (888):
   694   MARKED (Marked) [Qualitative Concept]
   861   Hyperbilirubinaemia (Hyperbilirubinemia) [Disease or Syndrome]
Meta Mapping (888):
   694   MARKED (Marked) [Qualitative Concept]
   861   Hyperbilirubinemia (Increased bilirubin level (finding)) [Finding]
Processing 00000000.tx.31: Because of mechanical limitations imposed by his ascites , the patient had severe tachypnea and required supplemental oxygen to maintain his oxygenation . 

Phrase: Because of mechanical limitations
Meta Mapping (888):
   694   Mechanical (Mechanical Methods) [Functional Concept]
   861   limitations (Limitation) [Functional Concept]

Phrase: imposed by his ascites ,
Meta Mapping (770):
   770   ASCITES (Ascites) [Finding]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: severe tachypnea
Meta Mapping (888):
   694   SEVERE (Severe (severity modifier)) [Qualitative Concept]
   861   Tachypnoea (Tachypnea) [Finding]
Meta Mapping (888):
   694   Severe (Severe Extremity Pain) [Intellectual Product]
   861   Tachypnoea (Tachypnea) [Finding]
Meta Mapping (888):
   694   Severe (Borg Category-Ratio 10 Perceived Exertion Score 5) [Intellectual Product]
   861   Tachypnoea (Tachypnea) [Finding]

Phrase: and

Phrase: required supplemental oxygen
Meta Mapping (851):
   660   Required (Requirement) [Functional Concept]
   660   Supplemental (Supplement) [Functional Concept]
   827   OXYGEN (Oxygen) [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: maintain
Meta Mapping (1000):
  1000   Maintain (Maintenance) [Activity]

Phrase: his oxygenation .
Meta Mapping (1000):
  1000   oxygenation (Alveolar ventilation function) [Organ or Tissue Function]
Meta Mapping (1000):
  1000   oxygenation (Cell Respiration) [Cell Function]
Processing 00000000.tx.32: D : Batch : Report : G4950K98 693519617 2328487 END-STAGE RENAL DISEASE . 

Phrase: D
Meta Mapping (1000):
  1000   D NOS (Blood group antigen D) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (1000):
  1000   /d (Daily) [Temporal Concept]

Phrase: :

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: Report
Meta Mapping (1000):
  1000   Report (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Report (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]

Phrase: :

Phrase: G4950K98 693519617 2328487 END-STAGE RENAL DISEASE .
Meta Mapping (877):
   877   End Stage Renal Disease (Kidney Failure, Chronic) [Disease or Syndrome]
Meta Mapping (877):
   877   End Stage Renal Disease (Chronic kidney disease stage 5) [Disease or Syndrome]
Processing 00000000.tx.33: End-stage renal disease . 

Phrase: End-stage renal disease .
Meta Mapping (1000):
  1000   End Stage Renal Disease (Kidney Failure, Chronic) [Disease or Syndrome]
Meta Mapping (1000):
  1000   End Stage Renal Disease (Chronic kidney disease stage 5) [Disease or Syndrome]
Processing 00000000.tx.34: 5. 

Phrase: 5.
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]
Processing 00000000.tx.35: Pulmonary emboli . 

Phrase: Pulmonary emboli .
Meta Mapping (966):
   966   PULMONARY EMBOLUS (Pulmonary Embolism) [Disease or Syndrome]
Processing 00000000.tx.36: 7. 

Phrase: 7.
Processing 00000000.tx.37: Coronary artery disease . 

Phrase: Coronary artery disease .
Meta Mapping (1000):
  1000   coronary artery disease (Coronary Arteriosclerosis) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Coronary (artery) disease (Coronary heart disease) [Disease or Syndrome]
Meta Mapping (1000):
  1000   CORONARY ARTERY DISEASE (Coronary Artery Disease) [Disease or Syndrome]
Processing 00000000.tx.38: On transfer , the patient was not sedated , but was unresponsive and extremely dyssynchronous with the ventilator . 

Phrase: On transfer ,
Meta Mapping (1000):
  1000   TRANSFER (Psychological Transfer) [Mental Process]
Meta Mapping (1000):
  1000   Transfer (Transfer Technique) [Functional Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: sedated
Meta Mapping (1000):
  1000 N Sedated (Sedated state) [Finding]

Phrase: ,

Phrase: but

Phrase: was

Phrase: unresponsive
Meta Mapping (1000):
  1000   Unresponsive (Unresponsive to Treatment) [Functional Concept]
Meta Mapping (1000):
  1000   UNRESPONSIVE (unresponsive behavior) [Finding]

Phrase: and

Phrase: extremely dyssynchronous with the ventilator .
Meta Mapping (520):
   593   Extremely (Extreme) [Qualitative Concept]
   593   Ventilator (Ventilator - respiratory equipment) [Medical Device]
Meta Mapping (520):
   593   Extremely (Extreme) [Qualitative Concept]
   593   Ventilator (Location Equipment - Ventilator) [Spatial Concept]
Meta Mapping (520):
   593   Extremely (Extreme) [Qualitative Concept]
   593   Ventilator (Household ventilator) [Medical Device]
Processing 00000000.tx.39: The patient was found to have substantial auto PEEP with an elevated dead space . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: substantial auto PEEP with an elevated dead space .
Meta Mapping (682):
   770   AutoPEEP (Positive-Pressure Respiration, Intrinsic) [Disease or Syndrome]
   578   Elevated (High) [Qualitative Concept]
   578   Dead (Cessation of life) [Organism Function]
   578   Space (Space - property) [Spatial Concept]
Meta Mapping (682):
   770   AutoPEEP (Positive-Pressure Respiration, Intrinsic) [Disease or Syndrome]
   578   Elevated [Qualitative Concept]
   578   Dead (Cessation of life) [Organism Function]
   578   Space (Space - property) [Spatial Concept]
Processing 00000000.tx.40: A pulmonary arteriogram on 01/03/98 demonstrated multiple pulmonary emboli , likely less than one week old , possibly introduced at the time of the renal vein thrombosis of 12/19/97 . 

Phrase: A pulmonary arteriogram on 01/03/98 demonstrated multiple pulmonary emboli ,
Meta Mapping (677):
   756   Pulmonary Arteriogram [Diagnostic Procedure]
   587   Multiple emboli [Pathologic Function]

Phrase: likely less than one week old ,
Meta Mapping (725):
   753   Likely (Probable diagnosis) [Qualitative Concept]
   790   One week [Temporal Concept]
   753   Old [Temporal Concept]
Meta Mapping (725):
   753   Likely (Probably) [Idea or Concept]
   790   One week [Temporal Concept]
   753   Old [Temporal Concept]

Phrase: possibly
Meta Mapping (1000):
  1000   Possibly (Possible diagnosis) [Qualitative Concept]

Phrase: introduced at the time of the renal vein thrombosis of 12/19/97 .
Meta Mapping (680):
   702   introduce (Introduces) [Functional Concept]
   735   TIME (Time) [Temporal Concept]
   777   Thrombosis of renal vein [Disease or Syndrome]
   735   97 [Intellectual Product]
Meta Mapping (680):
   702   introduce (Introduces) [Functional Concept]
   735   TIME (Time) [Temporal Concept]
   777   Thrombosis of renal vein [Disease or Syndrome]
   735   >97 [Quantitative Concept]
Meta Mapping (680):
   702   introduce (Introduces) [Functional Concept]
   735   Time (Time (foundation metadata concept)) [Temporal Concept]
   777   Thrombosis of renal vein [Disease or Syndrome]
   735   97 [Intellectual Product]
Meta Mapping (680):
   702   introduce (Introduces) [Functional Concept]
   735   Time (Time (foundation metadata concept)) [Temporal Concept]
   777   Thrombosis of renal vein [Disease or Syndrome]
   735   >97 [Quantitative Concept]
Processing 00000000.tx.41: The patient required high pressures to ventilate adequately , possibly related to an abdominal compartment syndrome . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: required
Meta Mapping (1000):
  1000   Required (Requirement) [Functional Concept]

Phrase: high pressures
Meta Mapping (888):
   694   High [Qualitative Concept]
   861   Pressures (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (888):
   694   High [Qualitative Concept]
   861   pressures (Pressure (finding)) [Finding]
Meta Mapping (888):
   694   High (Abnormally high) [Qualitative Concept]
   861   Pressures (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (888):
   694   High (Abnormally high) [Qualitative Concept]
   861   pressures (Pressure (finding)) [Finding]
Meta Mapping (888):
   694   HIGH (Value Above Reference Range) [Intellectual Product]
   861   Pressures (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (888):
   694   HIGH (Value Above Reference Range) [Intellectual Product]
   861   pressures (Pressure (finding)) [Finding]
Meta Mapping (888):
   694   high (high - ActExposureLevelCode) [Idea or Concept]
   861   Pressures (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (888):
   694   high (high - ActExposureLevelCode) [Idea or Concept]
   861   pressures (Pressure (finding)) [Finding]
Meta Mapping (888):
   694   High (High Mitosis-Karyorrhexis Index) [Quantitative Concept]
   861   Pressures (Pressure- physical agent) [Phenomenon or Process]
Meta Mapping (888):
   694   High (High Mitosis-Karyorrhexis Index) [Quantitative Concept]
   861   pressures (Pressure (finding)) [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: ventilate
Meta Mapping (1000):
  1000   Ventilate (Environmental air flow) [Phenomenon or Process]
Meta Mapping (1000):
  1000   ventilate (Ventilated) [Functional Concept]

Phrase: adequately ,

Phrase: possibly
Meta Mapping (1000):
  1000   Possibly (Possible diagnosis) [Qualitative Concept]

Phrase: related to an abdominal compartment syndrome .
Meta Mapping (780):
   753   Related (Relationships) [Qualitative Concept]
   833   Abdominal Compartment Syndrome [Disease or Syndrome]
Meta Mapping (780):
   753   Related (Related personal status) [Finding]
   833   Abdominal Compartment Syndrome [Disease or Syndrome]
Processing 00000000.tx.42: He was taken to fluoroscopy , where oral contrast was demonstrated to be extravasating through a posterior duodenum . 

Phrase: He

Phrase: was

Phrase: taken to fluoroscopy ,
Meta Mapping (746):
   790   Taken [Conceptual Entity]
   790   FLUOROSCOPY (Fluoroscopy) [Diagnostic Procedure]

Phrase: where oral contrast
Meta Mapping (790):
   660   Oral [Spatial Concept]
   827   Contrast (Contrast Media) [Indicator, Reagent, or Diagnostic Aid]
Meta Mapping (790):
   660   Oral [Spatial Concept]
   827   Contrast [Qualitative Concept]

Phrase: was

Phrase: demonstrated

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: extravasating through a posterior duodenum .
Meta Mapping (528):
   593   POSTERIOR (Dorsal) [Spatial Concept]
   593   DUODENUM (Duodenum) [Body Part, Organ, or Organ Component]
Meta Mapping (528):
   593   POSTERIOR (Dorsal) [Spatial Concept]
   593   Duodenum (Entire duodenum) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.43: There was no evidence of cardiac tamponade or specific underlying coronary dysfunction . 

Phrase: There

Phrase: was

Phrase: no evidence of cardiac tamponade
Meta Mapping (745):
   760   Evidence [Idea or Concept]
   640 N CARDIAC TAMPONADE (Cardiac Tamponade) [Disease or Syndrome]

Phrase: or

Phrase: specific underlying coronary dysfunction .
Meta Mapping (824):
   645   Specific (Specific qualifier value) [Qualitative Concept]
   861 N coronary dysfunction (Myocardial dysfunction) [Pathologic Function]
Meta Mapping (824):
   645   Specific (Specific qualifier value) [Qualitative Concept]
   861 N coronary dysfunction (Cardiac dysfunction) [Finding]
Meta Mapping (824):
   645   specific (Entity Determiner - specific) [Intellectual Product]
   861 N coronary dysfunction (Myocardial dysfunction) [Pathologic Function]
Meta Mapping (824):
   645   specific (Entity Determiner - specific) [Intellectual Product]
   861 N coronary dysfunction (Cardiac dysfunction) [Finding]
Processing 00000000.tx.44: His course was complicated by atrial fibrillation requiring cardioversion . 

Phrase: His course
Meta Mapping (1000):
  1000   Course [Temporal Concept]

Phrase: was

Phrase: complicated by atrial fibrillation requiring cardioversion .
Meta Mapping (712):
   753   Complicated [Functional Concept]
   790   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   753   Cardioversion (Electric Countershock) [Therapeutic or Preventive Procedure]
Meta Mapping (712):
   753   Complicated [Functional Concept]
   790   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   753   Cardioversion (Electric Countershock) [Therapeutic or Preventive Procedure]
Meta Mapping (712):
   753   Complicated [Functional Concept]
   790   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   753   Cardioversion (Electric Countershock) [Therapeutic or Preventive Procedure]
Meta Mapping (712):
   753   Complicated [Functional Concept]
   783   Atrial cardioversion [Therapeutic or Preventive Procedure]
   753   FIBRILLATION (Fibrillation) [Disease or Syndrome]
Processing 00000000.tx.45: All physicians and the family were in agreement that the most appropriate approach was to institute comfort measures . cc : Signed Chemotherapy of IFEX , MESNA and VP-16 . 

Phrase: All physicians
Meta Mapping (1000):
  1000   Physicians [Professional or Occupational Group]

Phrase: and

Phrase: the family
Meta Mapping (1000):
  1000   Family [Family Group]
Meta Mapping (1000):
  1000   Family (Family (taxonomic)) [Conceptual Entity]

Phrase: were in agreement
Meta Mapping (790):
   790   Agreement (agreement) [Social Behavior]

Phrase: that

Phrase: the most appropriate approach
Meta Mapping (851):
   660   Most [Quantitative Concept]
   660   Appropriate [Qualitative Concept]
   827   Approach [Spatial Concept]

Phrase: was

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: institute
Meta Mapping (1000):
  1000   institute (Institutes) [Organization]
Meta Mapping (1000):
  1000   Institute (Institution (social concept)) [Idea or Concept]

Phrase: comfort measures . cc
Meta Mapping (901):
   734   Comfort Measures (Palliative Care) [Biomedical Occupation or Discipline]
   827   CC (C-Circle) [Cell Component]
Meta Mapping (901):
   734   Comfort measures [Health Care Activity]
   827   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: Signed Chemotherapy of IFEX ,
Meta Mapping (733):
   604   Signed (Signature) [Intellectual Product]
   770   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
   604   Ifex [Organic Chemical,Pharmacologic Substance]
Meta Mapping (733):
   604   Signed (Signature) [Intellectual Product]
   770   chemotherapy (pharmacotherapeutic) [Functional Concept]
   604   Ifex [Organic Chemical,Pharmacologic Substance]
Meta Mapping (733):
   604   Signed (Signature) [Intellectual Product]
   770   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
   604   Ifex [Organic Chemical,Pharmacologic Substance]
Meta Mapping (733):
   604   Signed (Signature) [Intellectual Product]
   770   Chemotherapy [Therapeutic or Preventive Procedure]
   604   Ifex [Organic Chemical,Pharmacologic Substance]
Meta Mapping (733):
   604   signed (signed - ParticipationSignature) [Intellectual Product]
   770   Chemotherapy (Pharmacotherapy) [Therapeutic or Preventive Procedure]
   604   Ifex [Organic Chemical,Pharmacologic Substance]
Meta Mapping (733):
   604   signed (signed - ParticipationSignature) [Intellectual Product]
   770   chemotherapy (pharmacotherapeutic) [Functional Concept]
   604   Ifex [Organic Chemical,Pharmacologic Substance]
Meta Mapping (733):
   604   signed (signed - ParticipationSignature) [Intellectual Product]
   770   Chemotherapy, NOS (Chemotherapy Regimen) [Therapeutic or Preventive Procedure]
   604   Ifex [Organic Chemical,Pharmacologic Substance]
Meta Mapping (733):
   604   signed (signed - ParticipationSignature) [Intellectual Product]
   770   Chemotherapy [Therapeutic or Preventive Procedure]
   604   Ifex [Organic Chemical,Pharmacologic Substance]

Phrase: MESNA
Meta Mapping (1000):
  1000   MESNA (Mesna) [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: VP-16 .
Meta Mapping (1000):
  1000   VP16 (VP-16) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.46: Coumadin 5 mg po q d , Tagamet 400 mg po q d , Amoxicillin which was started on Labor Day , for a sore throat and Ativan 1 mg po prn nausea / anxiety . 

Phrase: Coumadin 5 mg po q d ,
Meta Mapping (768):
   632   Coumadin [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (768):
   632   Coumadin [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]

Phrase: Tagamet 400 mg po q d ,
Meta Mapping (768):
   632   Tagamet [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (768):
   632   Tagamet [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]

Phrase: Amoxicillin
Meta Mapping (1000):
  1000   Amoxycillin (Amoxicillin) [Antibiotic,Organic Chemical]
Meta Mapping (1000):
  1000   Amoxicilline [Antibiotic,Organic Chemical]

Phrase: which

Phrase: was

Phrase: started on Labor Day ,
Meta Mapping (772):
   802   start labor (Onset of labor first stage) [Finding]
   770   /day (Daily) [Temporal Concept]
Meta Mapping (772):
   802   start labor (Onset of labor first stage) [Finding]
   770   DAY (day) [Temporal Concept]
Meta Mapping (772):
   802   start labor (Onset of labor first stage) [Finding]
   770   /day (per day) [Temporal Concept]

Phrase: for a sore throat
Meta Mapping (1000):
  1000   Sore Throat (Pharyngitis) [Disease or Syndrome]
Meta Mapping (1000):
  1000   SORETHROAT (Sore Throat) [Sign or Symptom]

Phrase: and

Phrase: Ativan 1 mg po prn nausea / anxiety .
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Portugal) [Geographic Area]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   NAUSEA (Nausea) [Sign or Symptom]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   -- Anxiety (Anxiety) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Disorders) [Mental or Behavioral Dysfunction]
Meta Mapping (731):
   629   Ativan [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   629   PO (Oral) [Spatial Concept]
   629   Nausea (Nausea Adverse Event) [Pathologic Function]
   795   Anxiety (Anxiety Scale (BASC-2)) [Intellectual Product]
Processing 00000000.tx.47: ALLERGIES : The lungs were clear to auscultation . 

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: The lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: clear to auscultation .
Meta Mapping (746):
   790   Clear (Negative Surgical Margin) [Finding]
   623   AUSCULTATION (Auscultation) [Diagnostic Procedure]
Meta Mapping (746):
   790   Clear [Qualitative Concept]
   623   AUSCULTATION (Auscultation) [Diagnostic Procedure]
Processing 00000000.tx.48: The patient &apos;s hematocrit on the day of discharge was 35.6 showing significant bump in her count after her second two units of packed RBC&apos;s . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s hematocrit on the day of discharge
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   /s (per second) [Quantitative Concept]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (Daily) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   DAY (day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (664):
   581   S' (S prime) [Clinical Attribute]
   748   Hematocrit (Hematocrit level) [Finding]
   581   /day (per day) [Temporal Concept]
   581   Discharge (Discharge, body substance) [Body Substance]

Phrase: was

Phrase: 35.6

Phrase: showing
Meta Mapping (966):
   966   Show [Animal]

Phrase: significant bump in her count
Meta Mapping (520):
   593   significant (Statistical Significance) [Quantitative Concept]
   593   Count [Quantitative Concept]
Meta Mapping (520):
   593   significant (Statistical Significance) [Quantitative Concept]
   593   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (520):
   593   Significant [Idea or Concept]
   593   Count [Quantitative Concept]
Meta Mapping (520):
   593   Significant [Idea or Concept]
   593   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (520):
   593   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   Count [Quantitative Concept]
Meta Mapping (520):
   593   Significant (Event Seriousness - Significant) [Qualitative Concept]
   593   COUNT (Count Dosing Unit) [Quantitative Concept]

Phrase: after her second two units of packed RBC&apos
Meta Mapping (665):
   745   second - unit (seconds) [Temporal Concept]
   575   Two [Quantitative Concept]
   575   Packed (Insertion of pack (procedure)) [Therapeutic or Preventive Procedure]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   745   second - unit (seconds) [Temporal Concept]
   575   Two [Quantitative Concept]
   575   Packed (Pack unit) [Drug Delivery Device]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   Second (second (number)) [Quantitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   UNITS (Unit) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   Second (second (number)) [Quantitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit of Measure) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   Second (second (number)) [Quantitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   SECOND (seconds) [Temporal Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   UNITS (Unit) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   SECOND (seconds) [Temporal Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit of Measure) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   SECOND (seconds) [Temporal Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   /second (per second) [Quantitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   UNITS (Unit) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   /second (per second) [Quantitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit of Measure) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   /second (per second) [Quantitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   second (Precision - second) [Idea or Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   UNITS (Unit) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   second (Precision - second) [Idea or Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit of Measure) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   second (Precision - second) [Idea or Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   Second (Second Suffix) [Qualitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   UNITS (Unit) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   Second (Second Suffix) [Qualitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit of Measure) [Quantitative Concept]
   575   RBC (Erythrocytes) [Cell]
Meta Mapping (665):
   575   Second (Second Suffix) [Qualitative Concept]
   578   Two Pack (Dual Pack Dosing Unit) [Quantitative Concept]
   742   Units (Unit - NCI Thesaurus Property) [Functional Concept]
   575   RBC (Erythrocytes) [Cell]

Phrase: ;s .
Meta Mapping (1000):
  1000   /s (per second) [Quantitative Concept]
Meta Mapping (1000):
  1000   S' (S prime) [Clinical Attribute]
Processing 00000000.tx.49: 09/14/92 366812021 29532565 Admission Date : Discharge Date : T : RZ878Y3 </TEXT> New Years Day 12:00:00 AM Report Status : He was monitored closely and started on folic acid . 

Phrase: 09/14/92 366812021 29532565 Admission Date
Meta Mapping (818):
   818   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (818):
   818   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: Discharge Date
Meta Mapping (1000):
  1000   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Discharge date [Temporal Concept]

Phrase: :

Phrase: T
Meta Mapping (1000):
  1000   T' (T prime) [Clinical Attribute]

Phrase: :

Phrase: RZ878Y3

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > New Years Day 12
Meta Mapping (775):
   812   NEW (New) [Qualitative Concept]
   812   YEARS (year) [Temporal Concept]
   812   /day (Daily) [Temporal Concept]
Meta Mapping (775):
   812   NEW (New) [Qualitative Concept]
   812   YEARS (year) [Temporal Concept]
   812   DAY (day) [Temporal Concept]
Meta Mapping (775):
   812   NEW (New) [Qualitative Concept]
   812   YEARS (year) [Temporal Concept]
   812   /day (per day) [Temporal Concept]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: Report
Meta Mapping (1000):
  1000   Report (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Report (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]

Phrase: Status
Meta Mapping (1000):
  1000   Status [Qualitative Concept]

Phrase: :

Phrase: He

Phrase: was

Phrase: monitored
Meta Mapping (966):
   966   monitor (Patient Monitoring) [Health Care Activity]
Meta Mapping (966):
   966   monitor (Preventive monitoring) [Health Care Activity]
Meta Mapping (966):
   966   Monitor (Biomedical Monitors) [Medical Device]
Meta Mapping (966):
   966   Monitor (Monitoring Device) [Medical Device]
Meta Mapping (966):
   966   Monitor (Monitor, occupation) [Professional or Occupational Group]
Meta Mapping (966):
   966   Monitor (Monitor Device Component) [Manufactured Object]

Phrase: closely

Phrase: and

Phrase: started on folic acid .
Meta Mapping (783):
   770   Started [Qualitative Concept]
   833   FOLIC ACID (Folic Acid) [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.50: He was treated with 5-azacytidine due to increasing number of blasts . 

Phrase: He

Phrase: was

Phrase: treated with 5-azacytidine
Meta Mapping (783):
   833   Treated with [Therapeutic or Preventive Procedure]
   770   Azacytidine (Azacitidine) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: due to increasing number of blasts .
Meta Mapping (753):
   623   Due To (Due to) [Functional Concept]
   586   Increasing [Functional Concept]
   753   *Number (Numbers) [Quantitative Concept]
   586   blasts (Blast (physical force)) [Natural Phenomenon or Process]
Meta Mapping (753):
   623   Due To (Due to) [Functional Concept]
   586   Increasing [Functional Concept]
   753   *Number (Numbers) [Quantitative Concept]
   586   Blasts (Blast Cell) [Cell]
Meta Mapping (753):
   623   Due To (Due to) [Functional Concept]
   586   Increasing [Functional Concept]
   753   *Number (Numbers) [Quantitative Concept]
   586   Blasts (Blast count procedure) [Laboratory Procedure]
Meta Mapping (753):
   623   Due To (Due to) [Functional Concept]
   586   Increasing [Functional Concept]
   753   Number (Count of entities) [Quantitative Concept]
   586   blasts (Blast (physical force)) [Natural Phenomenon or Process]
Meta Mapping (753):
   623   Due To (Due to) [Functional Concept]
   586   Increasing [Functional Concept]
   753   Number (Count of entities) [Quantitative Concept]
   586   Blasts (Blast Cell) [Cell]
Meta Mapping (753):
   623   Due To (Due to) [Functional Concept]
   586   Increasing [Functional Concept]
   753   Number (Count of entities) [Quantitative Concept]
   586   Blasts (Blast count procedure) [Laboratory Procedure]
Processing 00000000.tx.51: He has had only a few polys on his white blood cell differential . 

Phrase: He

Phrase: has

Phrase: had

Phrase: only
Meta Mapping (1000):
  1000   Only (Singular) [Quantitative Concept]
Meta Mapping (1000):
  1000   Only (Only - dosing instruction fragment) [Intellectual Product]

Phrase: a few polys on his white blood cell
Meta Mapping (734):
   578   Few [Quantitative Concept]
   750   Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
   633   White Blood Cell (Leukocytes) [Cell]

Phrase: differential .
Meta Mapping (1000):
  1000   Differential (Differential quality) [Qualitative Concept]
Meta Mapping (1000):
  1000   Differential (Different) [Qualitative Concept]
Processing 00000000.tx.52: For the past three days , he has been complaining of pain in his shoulder with motion and also a little bit of pain in his left lower quadrant . 

Phrase: For the past three days ,
Meta Mapping (851):
   660   Past [Temporal Concept]
   660   Three [Quantitative Concept]
   827   DAYS (day) [Temporal Concept]

Phrase: he

Phrase: has

Phrase: been

Phrase: complaining of pain
Meta Mapping (623):
   623   PAIN (Pain) [Sign or Symptom]
Meta Mapping (623):
   623   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: in his shoulder with motion
Meta Mapping (686):
   760   SHOULDER (Shoulder) [Body Location or Region]
   593   Motion [Natural Phenomenon or Process]
Meta Mapping (686):
   760   Shoulder (Entire shoulder region) [Body Location or Region]
   593   Motion [Natural Phenomenon or Process]

Phrase: and

Phrase: also

Phrase: a little bit of pain
Meta Mapping (696):
   593   Little (Small) [Quantitative Concept]
   760   Bit (bit - unit of measure) [Quantitative Concept]
   593   PAIN (Pain) [Sign or Symptom]
Meta Mapping (696):
   593   Little (Small) [Quantitative Concept]
   760   Bit (bit - unit of measure) [Quantitative Concept]
   593   Pain NOS (Pain NOS Adverse Event) [Finding]
Meta Mapping (696):
   593   Little (Smallest) [Quantitative Concept]
   760   Bit (bit - unit of measure) [Quantitative Concept]
   593   PAIN (Pain) [Sign or Symptom]
Meta Mapping (696):
   593   Little (Smallest) [Quantitative Concept]
   760   Bit (bit - unit of measure) [Quantitative Concept]
   593   Pain NOS (Pain NOS Adverse Event) [Finding]
Meta Mapping (696):
   593   Little NOS [Finding]
   760   Bit (bit - unit of measure) [Quantitative Concept]
   593   PAIN (Pain) [Sign or Symptom]
Meta Mapping (696):
   593   Little NOS [Finding]
   760   Bit (bit - unit of measure) [Quantitative Concept]
   593   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: in his left lower quadrant .
Meta Mapping (1000):
  1000   Left lower quadrant [Spatial Concept]
Processing 00000000.tx.53: PAST MEDICAL HISTORY : The patient reports five days of right upper extremity / axillary and posterior shoulder pain , which he describes as shooting in nature . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: reports
Meta Mapping (1000):
  1000   Reports (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   reports (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]
Meta Mapping (1000):
  1000   Reports (Clinical Trial Final Report) [Intellectual Product]

Phrase: five days of right upper extremity / axillary
Meta Mapping (766):
   762   FIVE-DAY (Five-Day Report) [Intellectual Product]
   647   Right upper extremity [Body Part, Organ, or Organ Component]
   581   Axillary (Axilla) [Body Location or Region]

Phrase: and

Phrase: posterior shoulder pain ,
Meta Mapping (901):
   913   Posterior pain (Back Pain) [Sign or Symptom]
   827   SHOULDER (Shoulder) [Body Location or Region]
Meta Mapping (901):
   913   Posterior pain (Back Pain) [Sign or Symptom]
   827   Shoulder (Entire shoulder region) [Body Location or Region]
Meta Mapping (901):
   660   POSTERIOR (Dorsal) [Spatial Concept]
   901   SHOULDER PAIN (Shoulder Pain) [Sign or Symptom]

Phrase: which

Phrase: he

Phrase: describes as shooting
Meta Mapping (790):
   790   Shooting (Shooting sensation quality) [Finding]

Phrase: in nature .
Meta Mapping (1000):
  1000   Nature [Idea or Concept]
Meta Mapping (1000):
  1000   Nature (Natures) [Functional Concept]
Processing 00000000.tx.54: He also reports rhinorrhea with clear discharge . 

Phrase: He

Phrase: also

Phrase: reports
Meta Mapping (1000):
  1000   Reports (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   reports (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]
Meta Mapping (1000):
  1000   Reports (Clinical Trial Final Report) [Intellectual Product]

Phrase: rhinorrhea with clear discharge .
Meta Mapping (733):
   770   Rhinorrhoea (Rhinorrhea) [Sign or Symptom]
   604   Clear (Negative Surgical Margin) [Finding]
   604   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (733):
   770   Rhinorrhoea (Rhinorrhea) [Sign or Symptom]
   604   Clear (Negative Surgical Margin) [Finding]
   604   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (733):
   770   Rhinorrhoea (Rhinorrhea) [Sign or Symptom]
   604   Clear (Negative Surgical Margin) [Finding]
   604   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (733):
   770   Rhinorrhoea (Rhinorrhea) [Sign or Symptom]
   604   Clear [Qualitative Concept]
   604   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (733):
   770   Rhinorrhoea (Rhinorrhea) [Sign or Symptom]
   604   Clear [Qualitative Concept]
   604   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (733):
   770   Rhinorrhoea (Rhinorrhea) [Sign or Symptom]
   604   Clear [Qualitative Concept]
   604   Discharge (Discharge, body substance) [Body Substance]
Processing 00000000.tx.55: HEENT : HOSPITALIZATION COURSE : 3. 

Phrase: HEENT
Meta Mapping (1000):
  1000   HEENT [Body Location or Region]

Phrase: :

Phrase: HOSPITALIZATION COURSE
Meta Mapping (888):
   694   hospitalisation (Hospitalization) [Health Care Activity]
   861   Course [Temporal Concept]

Phrase: :

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.56: Hematology : FINAL DIAGNOSES : Acyclovir 400 mg t.i.d. 

Phrase: Hematology
Meta Mapping (1000):
  1000   Haematology NOS (Hematology (discipline)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Hematology (Hematology procedure) [Laboratory Procedure]

Phrase: :

Phrase: FINAL DIAGNOSES
Meta Mapping (983):
   983   final diagnosis (Final diagnosis (discharge)) [Qualitative Concept]

Phrase: :

Phrase: Acyclovir 400 mg t.i.d.
Meta Mapping (822):
   861   Acyclovir 400 MG [Clinical Drug]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.57: , atenolol 25 mg daily , Peridex 15 mL b.i.d. 

Phrase: , atenolol 25 mg daily ,
Meta Mapping (916):
   923   Atenolol 25 MG [Clinical Drug]
   645   Daily [Temporal Concept]

Phrase: Peridex 15 mL b.i.d.
Meta Mapping (780):
   632   Peridex [Organic Chemical,Pharmacologic Substance]
   839   ML I (Lipomucopolysaccharidosis) [Disease or Syndrome]
Processing 00000000.tx.58: , Colace 100 mg b.i.d. 

Phrase: , Colace 100 mg b.i.d.
Meta Mapping (819):
   842   Docusate Sodium 100 MG [Clinical Drug]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.59: , folic acid 1 mg daily , nystatin suspension 5 cc q.i.d. 

Phrase: , folic acid 1 mg daily ,
Meta Mapping (928):
   937   Folic Acid 1 MG [Clinical Drug]
   637   Daily [Temporal Concept]

Phrase: nystatin suspension 5 cc q.i.d.
Meta Mapping (749):
   629   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   629   SUSPENSION (Suspensions) [Biomedical or Dental Material]
   795   CC (C-Circle) [Cell Component]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   629   Suspension (Suspension substance) [Substance]
   795   CC (C-Circle) [Cell Component]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   NYSTATIN (Nystatin) [Antibiotic,Organic Chemical]
   629   Suspension (Suspension (action)) [Functional Concept]
   795   CC (C-Circle) [Cell Component]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.60: , oxycodone 5 to 10 mg q.4h. 

Phrase: , oxycodone 5 to 10 mg q.4h.
Meta Mapping (747):
   804   Oxycodone 10 MG [Clinical Drug]
   748   4H (4 Hours) [Temporal Concept]
Processing 00000000.tx.61: p.r.n. for pain , Eucerin lotion apply topically q.8h. 

Phrase: p.r.n.
Meta Mapping (901):
   827   P NOS (P Blood group antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Meta Mapping (901):
   827   P' (P prime) [Clinical Attribute]
   901   R.N. (Registered nurse) [Professional or Occupational Group]

Phrase: for pain ,
Meta Mapping (1000):
  1000   PAIN (Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: Eucerin lotion
Meta Mapping (888):
   694   EUCERIN (eucerin) [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   LOTION (Lotion) [Biomedical or Dental Material]

Phrase: apply
Meta Mapping (1000):
  1000   Apply (apply - action) [Functional Concept]
Meta Mapping (1000):
  1000   Apply (Apply (instruction)) [Functional Concept]
Meta Mapping (1000):
  1000   Apply [Functional Concept]

Phrase: topically q.8h.
Meta Mapping (827):
   827   8H (8 Hours) [Temporal Concept]
Processing 00000000.tx.62: to dry skin , senna two tablets q.12h. 

Phrase: to dry skin ,
Meta Mapping (901):
   660   TO (Togo) [Geographic Area]
   901   DRY SKIN (Dry skin) [Sign or Symptom]
Meta Mapping (901):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   901   DRY SKIN (Dry skin) [Sign or Symptom]
Meta Mapping (901):
   660   To [Qualitative Concept]
   901   DRY SKIN (Dry skin) [Sign or Symptom]

Phrase: senna two tablets q.12h.
Meta Mapping (780):
   658   Senokot Tablets [Clinical Drug]
   637   Two [Quantitative Concept]
   804   /12h [Temporal Concept]
Processing 00000000.tx.63: p.r.n. for constipation , multivitamin 1 tablet daily , doxazosin 1 mg daily , tacrolimus 0.5 mg daily , Mepron 750 mg b.i.d. 

Phrase: p.r.n.
Meta Mapping (901):
   827   P NOS (P Blood group antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Meta Mapping (901):
   827   P' (P prime) [Clinical Attribute]
   901   R.N. (Registered nurse) [Professional or Occupational Group]

Phrase: for constipation ,
Meta Mapping (1000):
  1000   CONSTIPATION (Constipation) [Sign or Symptom]
Meta Mapping (1000):
  1000   Constipation (Constipation Adverse Event) [Finding]

Phrase: multivitamin 1 tablet daily ,
Meta Mapping (824):
   875   Multivitamin tablet [Pharmacologic Substance]
   645   Daily [Temporal Concept]

Phrase: doxazosin 1 mg daily ,
Meta Mapping (916):
   923   Doxazosin 1 MG [Clinical Drug]
   645   Daily [Temporal Concept]

Phrase: tacrolimus 0.5 mg daily ,
Meta Mapping (928):
   937   Tacrolimus 0.5 MG [Clinical Drug]
   637   Daily [Temporal Concept]

Phrase: Mepron 750 mg b.i.d.
Meta Mapping (768):
   632   Mepron [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I- (Iodides) [Inorganic Chemical]
Meta Mapping (768):
   632   Mepron [Organic Chemical,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (768):
   632   Mepron [Organic Chemical,Pharmacologic Substance]
   799   MG (Mongolia) [Geographic Area]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   632   Mepron [Organic Chemical,Pharmacologic Substance]
   799   mg% (mg/dL) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   632   Mepron [Organic Chemical,Pharmacologic Substance]
   799   mg % (Milligram percent) [Quantitative Concept]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (768):
   632   Mepron [Organic Chemical,Pharmacologic Substance]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   660   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.64: , levofloxacin 500 mg daily , Celexa 20 mg daily , voriconazole 300 mg q.12h. 

Phrase: , levofloxacin 500 mg daily ,
Meta Mapping (916):
   923   Levofloxacin 500 MG [Clinical Drug]
   645   Daily [Temporal Concept]

Phrase: Celexa 20 mg daily ,
Meta Mapping (833):
   645   Celexa [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   812   MG (Mongolia) [Geographic Area]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   Celexa [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   812   mg% (mg/dL) [Quantitative Concept]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   Celexa [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   812   mg % (Milligram percent) [Quantitative Concept]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   Celexa [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   812   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   Daily [Temporal Concept]

Phrase: voriconazole 300 mg q.12h.
Meta Mapping (754):
   637   VORICONAZOLE (voriconazole) [Organic Chemical,Pharmacologic Substance]
   637   MG (Mongolia) [Geographic Area]
   804   /12h [Temporal Concept]
Meta Mapping (754):
   637   VORICONAZOLE (voriconazole) [Organic Chemical,Pharmacologic Substance]
   637   mg% (mg/dL) [Quantitative Concept]
   804   /12h [Temporal Concept]
Meta Mapping (754):
   637   VORICONAZOLE (voriconazole) [Organic Chemical,Pharmacologic Substance]
   637   mg % (Milligram percent) [Quantitative Concept]
   804   /12h [Temporal Concept]
Meta Mapping (754):
   637   VORICONAZOLE (voriconazole) [Organic Chemical,Pharmacologic Substance]
   637   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   804   /12h [Temporal Concept]
Processing 00000000.tx.65: , Prilosec 40 mg daily , and magnesium oxide 400 mg t.i.d. 

Phrase: , Prilosec 40 mg daily ,
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   /40 [Temporal Concept]
   812   MG (Mongolia) [Geographic Area]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   /40 [Temporal Concept]
   812   mg% (mg/dL) [Quantitative Concept]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   /40 [Temporal Concept]
   812   mg % (Milligram percent) [Quantitative Concept]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   /40 [Temporal Concept]
   812   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   40% [Quantitative Concept]
   812   MG (Mongolia) [Geographic Area]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   40% [Quantitative Concept]
   812   mg% (mg/dL) [Quantitative Concept]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   40% [Quantitative Concept]
   812   mg % (Milligram percent) [Quantitative Concept]
   645   Daily [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   40% [Quantitative Concept]
   812   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   645   Daily [Temporal Concept]

Phrase: and

Phrase: magnesium oxide 400 mg t.i.d.
Meta Mapping (840):
   877   Magnesium Oxide 400 MG [Clinical Drug]
   629   I- (Iodides) [Inorganic Chemical]
Meta Mapping (840):
   877   Magnesium Oxide 400 MG [Clinical Drug]
   629   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.66: </TEXT> Report Status : ASSOCIATED DIAGNOSIS : 3. 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > Report Status
Meta Mapping (1000):
  1000   Report status [Finding]

Phrase: :

Phrase: ASSOCIATED DIAGNOSIS
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (888):
   694   Associated (Associated with) [Qualitative Concept]
   861   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: :

Phrase: 3.
Meta Mapping (1000):
  1000   <3 (<3 (qualifier value)) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   3+ (3+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   3+ (3+ Answer to Question) [Finding]
Processing 00000000.tx.67: Pulmonary hypertension . 

Phrase: Pulmonary hypertension .
Meta Mapping (1000):
  1000   Hypertension, pulmonary (Pulmonary Hypertension) [Pathologic Function]
Meta Mapping (1000):
  1000   Pulmonary hypertension (Pulmonary Hypertension Adverse Event) [Finding]
Processing 00000000.tx.68: 8. 

Phrase: 8.
Processing 00000000.tx.69: Right bundle branch block . 

Phrase: Right bundle branch block .
Meta Mapping (1000):
  1000   BUNDLE BRANCH BLOCK, RIGHT (Right bundle branch block) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Right Bundle Branch Block (Electrocardiogram: right bundle branch block) [Finding]
Processing 00000000.tx.70: 9. 

Phrase: 9.
Processing 00000000.tx.71: Pericarditis . 

Phrase: Pericarditis .
Meta Mapping (1000):
  1000   PERICARDITIS (Pericarditis) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Pericarditis (Pericarditis Adverse Event) [Finding]
Processing 00000000.tx.72: He has a family history of hypertension as well . 

Phrase: He

Phrase: has

Phrase: a family history of hypertension
Meta Mapping (926):
   926   Family history of hypertension (FH: Hypertension) [Finding]

Phrase: as well .
Meta Mapping (1000):
  1000   Well (Good) [Qualitative Concept]
Meta Mapping (1000):
  1000   Well [Manufactured Object]
Processing 00000000.tx.73: Blood pressure 140/100 , phosphorus 94 , weight 181 lb . 

Phrase: Blood pressure 140/100 ,
Meta Mapping (824):
   861   BLOOD PRESSURE (Blood Pressure) [Organism Function]
   812   100% [Quantitative Concept]
Meta Mapping (824):
   861   Blood Pressure (Blood pressure finding) [Finding]
   812   100% [Quantitative Concept]
Meta Mapping (824):
   861   Blood pressure (Systemic arterial pressure) [Finding]
   812   100% [Quantitative Concept]

Phrase: phosphorus 94 ,
Meta Mapping (861):
   861   PHOSPHORUS (Phosphorus) [Element, Ion, or Isotope]
Meta Mapping (861):
   861   PHOSPHORUS (Dietary Phosphorus) [Element, Ion, or Isotope]
Meta Mapping (861):
   861   PHOSPHORUS (Phosphorus Drug Class) [Pharmacologic Substance]

Phrase: weight 181 lb .
Meta Mapping (660):
   660   Weight (Body Weight) [Organism Attribute]
Meta Mapping (660):
   660   WEIGHT (Weight) [Quantitative Concept]
Meta Mapping (660):
   660   weight (Weighing patient) [Diagnostic Procedure]
Meta Mapping (660):
   660   Weight (Importance Weight) [Idea or Concept]
Processing 00000000.tx.74: Neurological : LABORATORY DATA : Selective coronary angiography showed an occluded right coronary artery in its midportion . 

Phrase: Neurological
Meta Mapping (1000):
  1000   NEUROLOGICAL (Neurologic (qualifier value)) [Qualitative Concept]
Meta Mapping (1000):
  1000   Neurological (Neurological:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: Selective coronary angiography
Meta Mapping (901):
   913   Selective angiography (Non-coronary arterial angiography, NOS) [Diagnostic Procedure]
   827   coronary (Heart) [Body Part, Organ, or Organ Component]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: an occluded right coronary artery in its midportion .
Meta Mapping (750):
   578   occluded (Obstruction) [Pathologic Function]
   800   Right Coronary Artery (Right coronary artery structure) [Body Part, Organ, or Organ Component]
Meta Mapping (750):
   578   Occluded [Functional Concept]
   800   Right Coronary Artery (Right coronary artery structure) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.75: A paraphimosis was noted and treated by Dr. 

Phrase: A paraphimosis
Meta Mapping (1000):
  1000   PARAPHIMOSIS (Paraphimosis) [Disease or Syndrome]

Phrase: was

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: and

Phrase: treated by Dr.
Meta Mapping (746):
   790   Treated (Treating) [Functional Concept]
   790   DR (Dominican Republic) [Geographic Area]
Meta Mapping (746):
   790   Treated (Treating) [Functional Concept]
   790   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (746):
   790   Treated (Treating) [Functional Concept]
   790   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (746):
   790   Treated (Treating) [Functional Concept]
   790   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (746):
   790   Treated (Treating) [Functional Concept]
   790   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.76: Ryna Jescdrig . 

Phrase: Ryna Jescdrig .
Processing 00000000.tx.77: He was able to be rapidly weaned and extubated .

Phrase: He

Phrase: was

Phrase: able
Meta Mapping (1000):
  1000   Able (Ability) [Organism Attribute]
Meta Mapping (1000):
  1000   Able (Able (finding)) [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: rapidly
Meta Mapping (1000):
  1000   Rapidly (Rapid) [Qualitative Concept]

Phrase: weaned
Meta Mapping (1000):
  1000   Weaned (Weaning) [Finding]

Phrase: and

Phrase: extubated .
Meta Mapping (966):
   966   Extubate (Tracheal Extubation) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.1: </RECORD> Report Status : 12/28/02 AT 11:00 AM YES Avoid grapefruit unless MD instructs otherwise . renal artery stenosis Chronic renal failure Rising creatinine and suboptimal control of hypertension . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > Report Status
Meta Mapping (1000):
  1000   Report status [Finding]

Phrase: :

Phrase: 12/28/02 AT 11
Meta Mapping (797):
   797   11-12 [Finding]

Phrase: :

Phrase: 00

Phrase: AM

Phrase: YES
Meta Mapping (1000):
  1000   Yes (Yes - Yes/no indicator) [Idea or Concept]
Meta Mapping (1000):
  1000   YES (Yes (indicator)) [Conceptual Entity]

Phrase: Avoid

Phrase: grapefruit
Meta Mapping (1000):
  1000   GRAPEFRUIT (GRAPEFRUIT EXTRACT) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   grapefruit (Citrus paradisi) [Plant]
Meta Mapping (1000):
  1000   GRAPEFRUIT (Grapefruit (food)) [Food]
Meta Mapping (1000):
  1000   GRAPEFRUIT (Grapefruit Flavor) [Food]

Phrase: unless

Phrase: MD

Phrase: instructs

Phrase: otherwise . renal artery stenosis Chronic renal failure Rising creatinine
Meta Mapping (791):
   660   RENAL ARTERY STENOSIS (Renal Artery Stenosis) [Disease or Syndrome]
   660   CHRONIC RENAL FAILURE (Kidney Failure, Chronic) [Disease or Syndrome]
   791   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (791):
   660   RENAL ARTERY STENOSIS (Renal Artery Stenosis) [Disease or Syndrome]
   660   CHRONIC RENAL FAILURE (Kidney Failure, Chronic) [Disease or Syndrome]
   791   Creatinine (Creatinine finding) [Finding]
Meta Mapping (791):
   660   RENAL ARTERY STENOSIS (Renal Artery Stenosis) [Disease or Syndrome]
   660   Chronic Renal Failure (Chronic Kidney Diseases) [Disease or Syndrome]
   791   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (791):
   660   RENAL ARTERY STENOSIS (Renal Artery Stenosis) [Disease or Syndrome]
   660   Chronic Renal Failure (Chronic Kidney Diseases) [Disease or Syndrome]
   791   Creatinine (Creatinine finding) [Finding]
Meta Mapping (791):
   660   RENAL ARTERY STENOSIS (Renal Artery Stenosis) [Disease or Syndrome]
   660   Chronic renal failure (Chronic kidney disease stage 5) [Disease or Syndrome]
   791   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (791):
   660   RENAL ARTERY STENOSIS (Renal Artery Stenosis) [Disease or Syndrome]
   660   Chronic renal failure (Chronic kidney disease stage 5) [Disease or Syndrome]
   791   Creatinine (Creatinine finding) [Finding]

Phrase: and

Phrase: suboptimal control of hypertension .
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   control (control aspects) [Qualitative Concept]
   604   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   control (control aspects) [Qualitative Concept]
   604   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (control substance) [Substance]
   604   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (control substance) [Substance]
   604   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (Scientific Control) [Conceptual Entity]
   604   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (Scientific Control) [Conceptual Entity]
   604   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (Control function) [Functional Concept]
   604   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (Control function) [Functional Concept]
   604   Hypertension (Hypertension Adverse Event) [Finding]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (True Control Status) [Qualitative Concept]
   604   HYPERTENSION (Hypertensive disease) [Disease or Syndrome]
Meta Mapping (733):
   604   Suboptimal [Qualitative Concept]
   770   Control (True Control Status) [Qualitative Concept]
   604   Hypertension (Hypertension Adverse Event) [Finding]
Processing 00000000.tx.2: November 7 , 2002 , BUN of 50 and creatinine of 3.1 . 

Phrase: November 7 ,
Meta Mapping (861):
   861   November [Temporal Concept]

Phrase: 2002 ,

Phrase: BUN of 50
Meta Mapping (623):
   623   50% [Finding]
Meta Mapping (623):
   623   <50 [Finding]

Phrase: and

Phrase: creatinine of 3.1 .
Meta Mapping (770):
   770   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (770):
   770   Creatinine (Creatinine finding) [Finding]
Processing 00000000.tx.3: The right femoral arteriotomy site was closed with a 6Fr Angioseal . 

Phrase: The right femoral arteriotomy site
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   645   Arteriotomy (Incision of artery) [Therapeutic or Preventive Procedure]
   812   Site [Spatial Concept]
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   645   Arteriotomy (Incision of artery) [Therapeutic or Preventive Procedure]
   812   Site (Anatomic Site) [Body Location or Region]
Meta Mapping (833):
   645   RIGHT (Right) [Spatial Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   645   Arteriotomy (Incision of artery) [Therapeutic or Preventive Procedure]
   812   Site (Study Site) [Spatial Concept]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   645   Arteriotomy (Incision of artery) [Therapeutic or Preventive Procedure]
   812   Site [Spatial Concept]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   645   Arteriotomy (Incision of artery) [Therapeutic or Preventive Procedure]
   812   Site (Anatomic Site) [Body Location or Region]
Meta Mapping (833):
   645   Right (Right sided) [Spatial Concept]
   645   Femoral (Femur) [Body Part, Organ, or Organ Component]
   645   Arteriotomy (Incision of artery) [Therapeutic or Preventive Procedure]
   812   Site (Study Site) [Spatial Concept]

Phrase: was

Phrase: closed with a 6Fr Angioseal .
Meta Mapping (686):
   760   Closed [Functional Concept]
   760   6Fr (6 French gauge) [Quantitative Concept]
Processing 00000000.tx.4: When he was dressed and walking around he became unsteady , lightheaded , and diaphoretic . 

Phrase: When

Phrase: he

Phrase: was

Phrase: dressed
Meta Mapping (966):
   966   Dress (dress garment) [Manufactured Object]
Meta Mapping (966):
   966   DRESS (Drug Hypersensitivity Syndrome) [Disease or Syndrome]

Phrase: and

Phrase: walking around he
Meta Mapping (790):
   790   Walking (Walking (activity)) [Daily or Recreational Activity]

Phrase: became

Phrase: unsteady , lightheaded ,
Meta Mapping (888):
   694   Unsteady [Qualitative Concept]
   861   Lightheaded (Lightheadedness) [Sign or Symptom]

Phrase: and

Phrase: diaphoretic .
Meta Mapping (1000):
  1000   Diaphoretic [Qualitative Concept]
Processing 00000000.tx.5: TO DO / PLAN : ENTERED BY : </RECORD> 4107358 OTHER PROCEDURES : None . 

Phrase: TO DO / PLAN
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Togo) [Geographic Area]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
   827   Plan (Planned) [Functional Concept]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   PLAN (Infantile Neuroaxonal Dystrophy) [Disease or Syndrome]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Treatment Plan) [Intellectual Product]
Meta Mapping (802):
   660   To [Qualitative Concept]
   827   Plan (Planned) [Functional Concept]

Phrase: :

Phrase: ENTERED BY
Meta Mapping (833):
   833   Entered [Qualitative Concept]

Phrase: :

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 4107358

Phrase: OTHER PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: None .
Processing 00000000.tx.6: A repeat angiogram performed a year later showed marked progression of coronary allograft disease . 

Phrase: A repeat angiogram
Meta Mapping (888):
   694   Repeat [Functional Concept]
   861   Angiogram (angiogram) [Diagnostic Procedure]
Meta Mapping (888):
   694   Repeat [Functional Concept]
   861   Angiogram (Angiogram - Consent Type) [Health Care Activity]
Meta Mapping (888):
   694   Repeat [Functional Concept]
   861   Angiogram (X-ray-Based Angiogram) [Laboratory or Test Result]
Meta Mapping (888):
   694   Repeat (Repeat Pattern) [Temporal Concept]
   861   Angiogram (angiogram) [Diagnostic Procedure]
Meta Mapping (888):
   694   Repeat (Repeat Pattern) [Temporal Concept]
   861   Angiogram (Angiogram - Consent Type) [Health Care Activity]
Meta Mapping (888):
   694   Repeat (Repeat Pattern) [Temporal Concept]
   861   Angiogram (X-ray-Based Angiogram) [Laboratory or Test Result]
Meta Mapping (888):
   694   Repeat (Repeat Object) [Conceptual Entity]
   861   Angiogram (angiogram) [Diagnostic Procedure]
Meta Mapping (888):
   694   Repeat (Repeat Object) [Conceptual Entity]
   861   Angiogram (Angiogram - Consent Type) [Health Care Activity]
Meta Mapping (888):
   694   Repeat (Repeat Object) [Conceptual Entity]
   861   Angiogram (X-ray-Based Angiogram) [Laboratory or Test Result]

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: a year
Meta Mapping (1000):
  1000   YEAR (year) [Temporal Concept]
Meta Mapping (1000):
  1000   /Year (per year) [Temporal Concept]

Phrase: later
Meta Mapping (1000):
  1000   Later (Late) [Temporal Concept]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: marked progression of coronary allograft disease .
Meta Mapping (776):
   586   Marked (Massive) [Qualitative Concept]
   814   Coronary Disease progression (Coronary artery atherosclerosis progression) [Disease or Syndrome]
   586   allograft (Transplantation, Homologous) [Therapeutic or Preventive Procedure]
Meta Mapping (776):
   586   Marked (Massive) [Qualitative Concept]
   814   Coronary Disease progression (Coronary artery atherosclerosis progression) [Disease or Syndrome]
   586   Allograft (Allograft surgical material) [Biomedical or Dental Material]
Meta Mapping (776):
   586   MARKED (Marked) [Qualitative Concept]
   814   Coronary Disease progression (Coronary artery atherosclerosis progression) [Disease or Syndrome]
   586   allograft (Transplantation, Homologous) [Therapeutic or Preventive Procedure]
Meta Mapping (776):
   586   MARKED (Marked) [Qualitative Concept]
   814   Coronary Disease progression (Coronary artery atherosclerosis progression) [Disease or Syndrome]
   586   Allograft (Allograft surgical material) [Biomedical or Dental Material]
Processing 00000000.tx.7: PAST MEDICAL HISTORY : Crackles were increased 1/4 of the way up . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: Crackles
Meta Mapping (1000):
  1000   Crackles (Rales) [Sign or Symptom]
Meta Mapping (1000):
  1000   Crackles (Basilar Rales) [Finding]

Phrase: were

Phrase: increased
Meta Mapping (1000):
  1000   Increased [Quantitative Concept]
Meta Mapping (1000):
  1000   Increased (Increase) [Functional Concept]

Phrase: 1/4 of the way
Meta Mapping (760):
   760   1+ (1+ Score) [Quantitative Concept]
Meta Mapping (760):
   760   1+ (1+ Score, WHO) [Classification]
Meta Mapping (760):
   760   1+ [Finding]

Phrase: up .
Processing 00000000.tx.8: The patient diuresed and responded to Lasix 100 mg administered in the emergency room and was admitted to a monitored bed . 

Phrase: The patient diuresed
Meta Mapping (872):
   694   *^patient (Patients) [Patient or Disabled Group]
   827   Diurese [Organic Chemical,Pharmacologic Substance]
Meta Mapping (872):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   827   Diurese [Organic Chemical,Pharmacologic Substance]
Meta Mapping (872):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   827   Diurese [Organic Chemical,Pharmacologic Substance]
Meta Mapping (872):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
   827   Diurese [Organic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: responded to Lasix 100 mg
Meta Mapping (714):
   760   Lasix [Organic Chemical,Pharmacologic Substance]
   760   100% [Quantitative Concept]
   760   MG (Mongolia) [Geographic Area]
Meta Mapping (714):
   760   Lasix [Organic Chemical,Pharmacologic Substance]
   760   100% [Quantitative Concept]
   760   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (714):
   760   Lasix [Organic Chemical,Pharmacologic Substance]
   760   100% [Quantitative Concept]
   760   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (714):
   760   Lasix [Organic Chemical,Pharmacologic Substance]
   760   100% [Quantitative Concept]
   760   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: administered in the emergency room
Meta Mapping (745):
   760   Administered (Having administered) [Functional Concept]
   806   EMERGENCY ROOM (Accident and Emergency department) [Health Care Related Organization]

Phrase: and

Phrase: was

Phrase: admitted to a monitored bed .
Meta Mapping (685):
   760   admitted (Hospital admission) [Health Care Activity]
   726   monitor (Patient Monitoring) [Health Care Activity]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   admitted (Hospital admission) [Health Care Activity]
   726   monitor (Preventive monitoring) [Health Care Activity]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   admitted (Hospital admission) [Health Care Activity]
   726   Monitor (Biomedical Monitors) [Medical Device]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   admitted (Hospital admission) [Health Care Activity]
   726   Monitor (Monitoring Device) [Medical Device]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   admitted (Hospital admission) [Health Care Activity]
   726   Monitor (Monitor, occupation) [Professional or Occupational Group]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   admitted (Hospital admission) [Health Care Activity]
   726   Monitor (Monitor Device Component) [Manufactured Object]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   Admitted (Admission activity) [Health Care Activity]
   726   monitor (Patient Monitoring) [Health Care Activity]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   Admitted (Admission activity) [Health Care Activity]
   726   monitor (Preventive monitoring) [Health Care Activity]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   Admitted (Admission activity) [Health Care Activity]
   726   Monitor (Biomedical Monitors) [Medical Device]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   Admitted (Admission activity) [Health Care Activity]
   726   Monitor (Monitoring Device) [Medical Device]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   Admitted (Admission activity) [Health Care Activity]
   726   Monitor (Monitor, occupation) [Professional or Occupational Group]
   760   Bed (Beds) [Manufactured Object]
Meta Mapping (685):
   760   Admitted (Admission activity) [Health Care Activity]
   726   Monitor (Monitor Device Component) [Manufactured Object]
   760   Bed (Beds) [Manufactured Object]
Processing 00000000.tx.9: Upon arrival of the covering access physician the patient was being ventilated mechanically and CPR was being performed . 

Phrase: Upon arrival of the covering access physician
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covers (device)) [Medical Device]
   581   Access [Spatial Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covers (device)) [Medical Device]
   581   Access [Spatial Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covers (device)) [Medical Device]
   581   access (Role Class - access) [Functional Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covers (device)) [Medical Device]
   581   access (Role Class - access) [Functional Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   Access [Spatial Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   Access [Spatial Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   access (Role Class - access) [Functional Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   arrival (arrival - ActRelationshipType) [Functional Concept]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   access (Role Class - access) [Functional Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covers (device)) [Medical Device]
   581   Access [Spatial Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covers (device)) [Medical Device]
   581   Access [Spatial Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covers (device)) [Medical Device]
   581   access (Role Class - access) [Functional Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covers (device)) [Medical Device]
   581   access (Role Class - access) [Functional Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   Access [Spatial Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   Access [Spatial Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   access (Role Class - access) [Functional Concept]
   581   PHYSICIAN (Physicians) [Professional or Occupational Group]
Meta Mapping (673):
   748   Arrival (Arrival - action) [Activity]
   581   covering (Covered (qualifier value)) [Functional Concept]
   581   access (Role Class - access) [Functional Concept]
   581   Physician (Physician:Identifier:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: being

Phrase: ventilated
Meta Mapping (1000):
  1000   Ventilated [Functional Concept]

Phrase: mechanically

Phrase: and

Phrase: CPR
Meta Mapping (1000):
  1000   CPR (Cardiopulmonary Resuscitation) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   CPR (NADPH--Cytochrome P450 Reductase, Human) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   cPR (Clinical Partial Response) [Finding]

Phrase: was

Phrase: being

Phrase: performed .
Meta Mapping (1000):
  1000   Performed [Functional Concept]
Processing 00000000.tx.10: A pericardiocentesis was attempted with no yield of pericardial fluid . 

Phrase: A pericardiocentesis
Meta Mapping (1000):
  1000   PERICARDIOCENTESIS (Pericardiocentesis) [Therapeutic or Preventive Procedure]

Phrase: was

Phrase: attempted with no yield of pericardial fluid .
Meta Mapping (706):
   748   Attempted (Attempt) [Event]
   778 N FLUID, PERICARDIAL (Pericardial effusion) [Disease or Syndrome]
Meta Mapping (706):
   748   Attempted (Attempt) [Event]
   778   Pericardial Fluid (Pericardial fluid (substance)) [Body Substance]
Meta Mapping (706):
   748   Attempted (Attempt) [Event]
   778   Fluid, Pericardial (Fluid, Pericardial - Specimen Source Code) [Substance]
Processing 00000000.tx.11: Patient &apos;s mother was informed by Dr. 

Phrase: Patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s mother
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Mother (Mother (person)) [Family Group]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Mother (Mother (person)) [Family Group]

Phrase: was

Phrase: informed by Dr.
Meta Mapping (746):
   790   Informed [Qualitative Concept]
   790   DR (Dominican Republic) [Geographic Area]
Meta Mapping (746):
   790   Informed [Qualitative Concept]
   790   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (746):
   790   Informed [Qualitative Concept]
   790   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (746):
   790   Informed [Qualitative Concept]
   790   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (746):
   790   Informed [Qualitative Concept]
   790   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.12: Vessels . 

Phrase: Vessels .
Meta Mapping (1000):
  1000   Vessels (Blood Vessel) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.13: </TEXT> STATUS POST MULTIPLE EMBOLISMS AND LEFT VENTRICULAR THROMBUS PROCEDURES : LEFT VENTRICULAR THROMBECTOMY . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: >

Phrase: STATUS POST MULTIPLE EMBOLISMS
Meta Mapping (966):
   966   Multiple Embolism (Multiple emboli) [Pathologic Function]
Meta Mapping (966):
   966   multiple Embolism (computed tomography of chest: multiple emboli) [Finding]

Phrase: AND

Phrase: LEFT VENTRICULAR THROMBUS PROCEDURES
Meta Mapping (916):
   756   Left ventricular thrombus [Disease or Syndrome]
   812   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (916):
   756   Left ventricular thrombus [Disease or Syndrome]
   812   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (916):
   756   Left ventricular thrombus [Disease or Syndrome]
   812   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: LEFT VENTRICULAR THROMBECTOMY .
Meta Mapping (1000):
  1000   Left ventricular thrombectomy (Removal of left ventricular thrombus) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.14: A recent echo showed 1+ MR , inferior apical and left ventricular akinesis and a 3 x 2.5 cm spherical mass in the inferior apical left ventricle . 

Phrase: A recent echo
Meta Mapping (888):
   694   Recent [Temporal Concept]
   861   ECHO (ECHO protocol) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Recent [Temporal Concept]
   861   Echo (Echo (insect)) [Eukaryote]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: 1+ MR ,
Meta Mapping (888):
   694   1+ (1+ Score) [Quantitative Concept]
   861   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (888):
   694   1+ (1+ Score) [Quantitative Concept]
   861   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (888):
   694   1+ (1+ Score) [Quantitative Concept]
   861   MR (Minor Response) [Finding]
Meta Mapping (888):
   694   1+ (1+ Score, WHO) [Classification]
   861   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (888):
   694   1+ (1+ Score, WHO) [Classification]
   861   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (888):
   694   1+ (1+ Score, WHO) [Classification]
   861   MR (Minor Response) [Finding]
Meta Mapping (888):
   694   1+ [Finding]
   861   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (888):
   694   1+ [Finding]
   861   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (888):
   694   1+ [Finding]
   861   MR (Minor Response) [Finding]

Phrase: inferior apical
Meta Mapping (888):
   694   INFERIOR (Inferior) [Spatial Concept]
   861   APICAL (Apical) [Spatial Concept]
Meta Mapping (888):
   694   inferior (inferiority) [Social Behavior]
   861   APICAL (Apical) [Spatial Concept]

Phrase: and

Phrase: left ventricular akinesis
Meta Mapping (865):
   734   Left Ventricular (Left ventricular structure) [Body Part, Organ, or Organ Component]
   755   Akinetic [Functional Concept]

Phrase: and

Phrase: a 3 x 2.5 cm spherical mass in the inferior apical left ventricle .
Meta Mapping (672):
   592   CM 2-3 [Amino Acid, Peptide, or Protein]
   568   Spherical (Spherical shape) [Spatial Concept]
   568   INFERIOR (Inferior) [Spatial Concept]
   568   APICAL (Apical) [Spatial Concept]
   736   Left Ventricular Mass (Left ventricular mass) [Finding]
Meta Mapping (672):
   592   CM 2-3 [Amino Acid, Peptide, or Protein]
   568   Spherical (Spherical shape) [Spatial Concept]
   568   inferior (inferiority) [Social Behavior]
   568   APICAL (Apical) [Spatial Concept]
   736   Left Ventricular Mass (Left ventricular mass) [Finding]
Processing 00000000.tx.15: Synthroid .1 mg po q d , Metamucil one pack po q d , Persantine 50 mg po t.i.d. 

Phrase: Synthroid .1 mg po q d ,
Meta Mapping (768):
   632   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (768):
   632   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   858   mg/d (milligram/day) [Quantitative Concept]
   632   PO (Oral) [Spatial Concept]

Phrase: Metamucil one pack po q d ,
Meta Mapping (567):
   632   Metamucil [Organic Chemical,Pharmacologic Substance]
   632   ONE (One) [Quantitative Concept]
   632   Pack (Pack (physical object)) [Medical Device]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (567):
   632   Metamucil [Organic Chemical,Pharmacologic Substance]
   632   ONE (One) [Quantitative Concept]
   632   Pack (Pack (physical object)) [Medical Device]
   632   PO (Oral) [Spatial Concept]
Meta Mapping (567):
   632   Metamucil [Organic Chemical,Pharmacologic Substance]
   632   ONE (One) [Quantitative Concept]
   632   PACK (Pack unit) [Drug Delivery Device]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (567):
   632   Metamucil [Organic Chemical,Pharmacologic Substance]
   632   ONE (One) [Quantitative Concept]
   632   PACK (Pack unit) [Drug Delivery Device]
   632   PO (Oral) [Spatial Concept]
Meta Mapping (567):
   632   Metamucil [Organic Chemical,Pharmacologic Substance]
   632   ONE (One) [Quantitative Concept]
   632   PACK (Packing (action)) [Activity]
   632   PO (Portugal) [Geographic Area]
Meta Mapping (567):
   632   Metamucil [Organic Chemical,Pharmacologic Substance]
   632   ONE (One) [Quantitative Concept]
   632   PACK (Packing (action)) [Activity]
   632   PO (Oral) [Spatial Concept]

Phrase: Persantine 50 mg po t.i.d.
Meta Mapping (789):
   660   Dipyridamole 50 MG [Clinical Drug]
   795   PO (Portugal) [Geographic Area]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (789):
   660   Dipyridamole 50 MG [Clinical Drug]
   795   PO (Oral) [Spatial Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.16: , Lopressor 25 mg po b.i.d. 

Phrase: , Lopressor 25 mg po b.i.d.
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   695   mg/d (milligram/day) [Quantitative Concept]
   795   PO (Portugal) [Geographic Area]
   629   I- (Iodides) [Inorganic Chemical]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   695   mg/d (milligram/day) [Quantitative Concept]
   795   PO (Portugal) [Geographic Area]
   629   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   695   mg/d (milligram/day) [Quantitative Concept]
   795   PO (Oral) [Spatial Concept]
   629   I- (Iodides) [Inorganic Chemical]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   695   mg/d (milligram/day) [Quantitative Concept]
   795   PO (Oral) [Spatial Concept]
   629   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   795   PO (Portugal) [Geographic Area]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   MG (Mongolia) [Geographic Area]
   795   PO (Oral) [Spatial Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   795   PO (Portugal) [Geographic Area]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   mg% (mg/dL) [Quantitative Concept]
   795   PO (Oral) [Spatial Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   795   PO (Portugal) [Geographic Area]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   mg % (Milligram percent) [Quantitative Concept]
   795   PO (Oral) [Spatial Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   795   PO (Portugal) [Geographic Area]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (749):
   629   Lopressor [Organic Chemical,Pharmacologic Substance]
   629   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   795   PO (Oral) [Spatial Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.17: , Anusol cream at anal t.i.d. 

Phrase: , Anusol cream at anal t.i.d.
Meta Mapping (701):
   581   ANUSOL (Anusol) [Organic Chemical,Pharmacologic Substance]
   748   Cream (Dairy Cream) [Food]
   581   Anal (Anus) [Body Part, Organ, or Organ Component]
   612   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (701):
   581   ANUSOL (Anusol) [Organic Chemical,Pharmacologic Substance]
   748   Cream (Dairy Cream) [Food]
   581   Anal (Anal (qualifier value)) [Spatial Concept]
   612   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (701):
   581   ANUSOL (Anusol) [Organic Chemical,Pharmacologic Substance]
   748   Cream [Biomedical or Dental Material]
   581   Anal (Anus) [Body Part, Organ, or Organ Component]
   612   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (701):
   581   ANUSOL (Anusol) [Organic Chemical,Pharmacologic Substance]
   748   Cream [Biomedical or Dental Material]
   581   Anal (Anal (qualifier value)) [Spatial Concept]
   612   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: , Coumadin for PTT equal 20 seconds as directed , Albuterol inhaler two puffs q 6 h prn . 

Phrase: , Coumadin for PTT equal 20 seconds
Meta Mapping (735):
   753   Coumadin [Organic Chemical,Pharmacologic Substance]
   586   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
   586   Equal [Qualitative Concept]
   586   20% [Finding]
   586   seconds [Temporal Concept]
Meta Mapping (735):
   753   Coumadin [Organic Chemical,Pharmacologic Substance]
   586   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
   586   Equal (Relational Operator - Equal) [Intellectual Product]
   586   20% [Finding]
   586   seconds [Temporal Concept]

Phrase: as

Phrase: directed
Meta Mapping (966):
   966   Direct (Direct type of relationship) [Qualitative Concept]
Meta Mapping (966):
   966   Direct (Direct (qualifier)) [Qualitative Concept]

Phrase: ,

Phrase: Albuterol inhaler two puffs q 6 h prn .
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler) [Medical Device]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler) [Medical Device]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler) [Medical Device]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   H+ (Hepatic Involvement) [Classification]
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler) [Medical Device]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   /h (/hour) [Quantitative Concept]
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler Dosing Unit) [Quantitative Concept]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler Dosing Unit) [Quantitative Concept]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler Dosing Unit) [Quantitative Concept]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   H+ (Hepatic Involvement) [Classification]
Meta Mapping (560):
   626   ALBUTEROL (Albuterol) [Organic Chemical,Pharmacologic Substance]
   626   INHALER (Inhaler Dosing Unit) [Quantitative Concept]
   626   Two [Quantitative Concept]
   626   Puffs (Puff unit dose) [Quantitative Concept]
   626   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.19: WIN AGNE , M.D. 

Phrase: WIN AGNE ,
Meta Mapping (694):
   694   WIN (FOXM1 wt Allele) [Gene or Genome]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.20: 203669293 35955/he64 Unsigned Unsigned DISCHARGE DATE : 8/24/95 ASSOCIATED DIAGNOSIS : The arterial blood gases on room air sitting upright PO2 67 mm. 

Phrase: 203669293 35955/he64 Unsigned Unsigned DISCHARGE DATE
Meta Mapping (818):
   818   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (818):
   818   Discharge date [Temporal Concept]

Phrase: :

Phrase: 8/24/95 ASSOCIATED DIAGNOSIS
Meta Mapping (728):
   637   Associated (Associated with) [Qualitative Concept]
   804   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (728):
   637   Associated (Associated with) [Qualitative Concept]
   804   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (728):
   637   Associated (Associated with) [Qualitative Concept]
   804   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: :

Phrase: The arterial blood gases on room air
Meta Mapping (764):
   814   Arterial blood gases (Analysis of arterial blood gases and pH) [Laboratory Procedure]
   612   Room air [Finding]

Phrase: sitting
Meta Mapping (1000):
  1000   SITTING (Sitting position) [Finding]
Meta Mapping (1000):
  1000   Sitting (Sitting Function) [Physiologic Function]
Meta Mapping (1000):
  1000   Sitting (Ability to Sit question) [Intellectual Product]

Phrase: upright PO2 67 mm.
Meta Mapping (583):
   645   Upright [Spatial Concept]
   645   PO2 (Oxygen measurement, partial pressure, arterial) [Laboratory Procedure]
Meta Mapping (583):
   645   Upright [Spatial Concept]
   645   PO2 (PO2 measurement) [Laboratory Procedure]
Meta Mapping (583):
   645   Upright (Special Handling Code - Upright) [Intellectual Product]
   645   PO2 (Oxygen measurement, partial pressure, arterial) [Laboratory Procedure]
Meta Mapping (583):
   645   Upright (Special Handling Code - Upright) [Intellectual Product]
   645   PO2 (PO2 measurement) [Laboratory Procedure]
Meta Mapping (583):
   645   upright (Entity Handling - upright) [Human-caused Phenomenon or Process]
   645   PO2 (Oxygen measurement, partial pressure, arterial) [Laboratory Procedure]
Meta Mapping (583):
   645   upright (Entity Handling - upright) [Human-caused Phenomenon or Process]
   645   PO2 (PO2 measurement) [Laboratory Procedure]
Processing 00000000.tx.21: Mercury , PCO2 42 mm. 

Phrase: Mercury ,
Meta Mapping (1000):
  1000   MERCURY (Mercury) [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
Meta Mapping (1000):
  1000   Mercury+ (Mercury(1+)) [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   Mercury (Dietary Mercury) [Element, Ion, or Isotope]

Phrase: PCO2 42 mm.
Meta Mapping (660):
   660   PCO2 (Carbon dioxide measurement, partial pressure) [Laboratory Procedure]
Meta Mapping (660):
   660   pco2 (Partial pressure CO2 result) [Laboratory or Test Result]
Processing 00000000.tx.22: Mercury , pH 7.47. 

Phrase: Mercury ,
Meta Mapping (1000):
  1000   MERCURY (Mercury) [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
Meta Mapping (1000):
  1000   Mercury+ (Mercury(1+)) [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   Mercury (Dietary Mercury) [Element, Ion, or Isotope]

Phrase: pH 7.47.
Meta Mapping (901):
   901   pH 7 (Neutral pH) [Qualitative Concept]
Processing 00000000.tx.23: hematocrit 41.4 , sodium 123 , potassium 3.5 , chloride 88 , BUN 12 , creatinine .6 mg. 

Phrase: hematocrit 41.4 ,
Meta Mapping (827):
   827   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (827):
   827   Hematocrit (Hematocrit level) [Finding]

Phrase: sodium 123 ,
Meta Mapping (861):
   861   SODIUM (Sodium) [Biologically Active Substance,Element, Ion, or Isotope]
Meta Mapping (861):
   861   Sodium+ (Sodium Cation) [Element, Ion, or Isotope]
Meta Mapping (861):
   861   Sodium (Sodium supplements) [Pharmacologic Substance]
Meta Mapping (861):
   861   SODIUM (Sodium Drug Class) [Pharmacologic Substance]

Phrase: potassium 3.5 ,
Meta Mapping (827):
   827   POTASSIUM (Potassium) [Element, Ion, or Isotope]
Meta Mapping (827):
   827   Potassium+ (Potassium measurement) [Laboratory Procedure]
Meta Mapping (827):
   827   POTASSIUM (Potassium supplement) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (827):
   827   Potassium (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (827):
   827   POTASSIUM (Potassium Drug Class) [Pharmacologic Substance]

Phrase: chloride 88 ,
Meta Mapping (861):
   861   Chloride, NOS (Chlorides) [Inorganic Chemical]
Meta Mapping (861):
   861   CHLORIDE (Chloride Ion) [Element, Ion, or Isotope]

Phrase: BUN 12 ,

Phrase: creatinine .6 mg.
Meta Mapping (802):
   660   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
   827   MG (Mongolia) [Geographic Area]
Meta Mapping (802):
   660   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
   827   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (802):
   660   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
   827   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (802):
   660   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
   827   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (802):
   660   Creatinine (Creatinine finding) [Finding]
   827   MG (Mongolia) [Geographic Area]
Meta Mapping (802):
   660   Creatinine (Creatinine finding) [Finding]
   827   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (802):
   660   Creatinine (Creatinine finding) [Finding]
   827   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (802):
   660   Creatinine (Creatinine finding) [Finding]
   827   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.24: % , LDH 692 , units , alkaline phosphatase 234 units , her chest X-ray showed consolidation of the right upper lobe and a markedly elevated right hemidiaphragm . 

Phrase: % ,

Phrase: LDH 692 ,
Meta Mapping (861):
   861   LDH (Lactate Dehydrogenase) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: units ,
Meta Mapping (1000):
  1000   UNITS (Unit) [Quantitative Concept]
Meta Mapping (1000):
  1000   Units (Unit of Measure) [Quantitative Concept]
Meta Mapping (1000):
  1000   Units (Unit - NCI Thesaurus Property) [Functional Concept]

Phrase: alkaline phosphatase 234 units ,
Meta Mapping (824):
   694   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
   812   UNITS (Unit) [Quantitative Concept]
Meta Mapping (824):
   694   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
   812   Units (Unit of Measure) [Quantitative Concept]
Meta Mapping (824):
   694   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
   812   Units (Unit - NCI Thesaurus Property) [Functional Concept]
Meta Mapping (824):
   694   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   UNITS (Unit) [Quantitative Concept]
Meta Mapping (824):
   694   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   Units (Unit of Measure) [Quantitative Concept]
Meta Mapping (824):
   694   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   Units (Unit - NCI Thesaurus Property) [Functional Concept]

Phrase: her chest X-ray
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: consolidation of the right upper lobe
Meta Mapping (780):
   753   Consolidation [Qualitative Concept]
   666   Right upper lobe (Structure of right upper lobe of lung) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: a

Phrase: markedly
Meta Mapping (1000):
  1000   Markedly (Massive) [Qualitative Concept]

Phrase: elevated
Meta Mapping (1000):
  1000   Elevated (High) [Qualitative Concept]
Meta Mapping (1000):
  1000   Elevated [Qualitative Concept]

Phrase: right hemidiaphragm .
Meta Mapping (1000):
  1000   Right hemidiaphragm [Body Part, Organ, or Organ Component]
Processing 00000000.tx.25: She had a bronchoscopy by Dr. 

Phrase: She

Phrase: had

Phrase: a bronchoscopy by Dr.
Meta Mapping (708):
   770   Bronchoscopy [Diagnostic Procedure]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (708):
   770   Bronchoscopy [Diagnostic Procedure]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (708):
   770   Bronchoscopy [Diagnostic Procedure]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (708):
   770   Bronchoscopy [Diagnostic Procedure]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (708):
   770   Bronchoscopy [Diagnostic Procedure]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.26: Cranka , which showed diffuse involvement and narrowing of the bronchi to the right lung by extrinsic compression . 

Phrase: Cranka ,

Phrase: which

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: diffuse involvement
Meta Mapping (888):
   694   DIFFUSE (Diffuse) [Qualitative Concept]
   861   Involvement (Involvement with) [Functional Concept]

Phrase: and

Phrase: narrowing of the bronchi
Meta Mapping (708):
   770   Narrowing (Narrowed structure) [Spatial Concept]
   604   BRONCHI (Bronchi) [Body Part, Organ, or Organ Component]
Meta Mapping (708):
   770   narrowing (Narrow) [Quantitative Concept]
   604   BRONCHI (Bronchi) [Body Part, Organ, or Organ Component]
Meta Mapping (708):
   770   Narrowing [Anatomical Abnormality]
   604   BRONCHI (Bronchi) [Body Part, Organ, or Organ Component]

Phrase: to the right lung by extrinsic compression .
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic [Spatial Concept]
   581   Compression (Compressed structure) [Functional Concept]
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic [Spatial Concept]
   581   Compression NOS (Compression procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic [Spatial Concept]
   581   Compression [Natural Phenomenon or Process]
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic [Spatial Concept]
   581   Compression (Data Compression) [Machine Activity,Occupational Activity]
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic (Extrinsic origin) [Functional Concept]
   581   Compression (Compressed structure) [Functional Concept]
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic (Extrinsic origin) [Functional Concept]
   581   Compression NOS (Compression procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic (Extrinsic origin) [Functional Concept]
   581   Compression [Natural Phenomenon or Process]
Meta Mapping (696):
   778   Right Lung (Right lung) [Body Part, Organ, or Organ Component]
   581   Extrinsic (Extrinsic origin) [Functional Concept]
   581   Compression (Data Compression) [Machine Activity,Occupational Activity]
Processing 00000000.tx.27: LENNI BREUTZOLN , M.D. 

Phrase: LENNI BREUTZOLN ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.28: 9/14/&apos;06

Phrase: 9/14/&apos

Phrase: ;06
Processing 00000000.tx.1: 10/11/1991 Paralyzed right arm since birth . 

Phrase: 10/11/1991 Paralyzed right arm
Meta Mapping (805):
   632   10% [Finding]
   827   Right arm (Right upper arm structure) [Body Part, Organ, or Organ Component]
Meta Mapping (805):
   632   10% [Finding]
   827   Right arm (Entire right upper arm) [Body Part, Organ, or Organ Component]
Meta Mapping (805):
   632   10% [Finding]
   827   Right Arm (Right arm) [Body Part, Organ, or Organ Component]

Phrase: since

Phrase: birth .
Meta Mapping (1000):
  1000   Birth [Organism Function]
Meta Mapping (1000):
  1000   birth (Entity Name Part Qualifier - birth) [Intellectual Product]
Meta Mapping (1000):
  1000   birth (Name Given at Birth) [Intellectual Product]
Processing 00000000.tx.2: ASPIRIN CAUSES HAND SWELLING AND A RASH . 

Phrase: ASPIRIN
Meta Mapping (1000):
  1000   ASPIRIN (Aspirin) [Organic Chemical,Pharmacologic Substance]

Phrase: CAUSES
Meta Mapping (1000):
  1000   causes (Etiology aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Causes (Etiology) [Functional Concept]
Meta Mapping (1000):
  1000   Cause (Science of Etiology) [Conceptual Entity]

Phrase: HAND SWELLING
Meta Mapping (1000):
  1000   hand swelling (swelling of hands (finding)) [Finding]

Phrase: AND

Phrase: A RASH .
Meta Mapping (1000):
  1000   RASH (Exanthema) [Sign or Symptom]
Processing 00000000.tx.3: The patient was discharged home in stable condition . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: discharged
Meta Mapping (1000):
  1000   Discharged (Patient Discharge) [Health Care Activity]

Phrase: home in stable condition .
Meta Mapping (783):
   770   HOME (Home environment) [Conceptual Entity]
   666   Stable condition (Stable Disease) [Finding]
Meta Mapping (783):
   770   HOME (Home environment) [Conceptual Entity]
   666   Stable condition (Stable chronic Graft vs Host Disease) [Finding]
Processing 00000000.tx.4: Dicatated By :

Phrase: Dicatated By

Phrase: :
Processing 00000000.tx.1: The patient is a 71-year-old right-handed white female with a history of confusion and difficulty with speech for about one year . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: a 71-year-old right-handed white female with a history of confusion
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   YEAR (year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   right handed (Structure of right hand) [Body Part, Organ, or Organ Component]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasoid Race) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (Caucasians) [Population Group]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   FEMALE (Female) [Organism Attribute]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Woman) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   female (Females) [Population Group]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female, Self-Report) [Qualitative Concept]
   599   History of confusion [Finding]
Meta Mapping (706):
   569   71 [Intellectual Product]
   569   /Year (per year) [Temporal Concept]
   569   Old [Temporal Concept]
   583   Right handed [Organism Attribute]
   735   WHITE (White color) [Qualitative Concept]
   735   Female (Female Phenotype) [Qualitative Concept]
   599   History of confusion [Finding]

Phrase: and

Phrase: difficulty with speech
Meta Mapping (858):
   858   speech difficulty (Speech impairment) [Finding]

Phrase: for about one year .
Meta Mapping (901):
   660   About (Approximate) [Qualitative Concept]
   901   One year [Temporal Concept]
Processing 00000000.tx.2: A CAT scan done at that time , of the head , showed tumor in the left frontal region . 

Phrase: A CAT scan
Meta Mapping (1000):
  1000   CAT Scan (X-Ray Computed Tomography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   CAT Scan (CAT Scan Section ID) [Intellectual Product]

Phrase: done at
Meta Mapping (833):
   833   Done (Done (qualifier value)) [Qualitative Concept]

Phrase: that time ,
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]

Phrase: of the head ,
Meta Mapping (1000):
  1000   HEAD (Head) [Body Location or Region]
Meta Mapping (1000):
  1000   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Head (Head - Component of Device) [Manufactured Object]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: tumor in the left frontal region .
Meta Mapping (780):
   753   Tumour NOS (Neoplasms) [Neoplastic Process]
   666   Left Frontal region (Left frontal lobe structure) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumour NOS (Neoplasms) [Neoplastic Process]
   666   Left Frontal region (Entire left frontal lobe) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumour NOS (Neoplasms) [Neoplastic Process]
   666   Left frontal region (Left prefrontal cortex) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
   666   Left Frontal region (Left frontal lobe structure) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
   666   Left Frontal region (Entire left frontal lobe) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
   666   Left frontal region (Left prefrontal cortex) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumor (Tumor Mass) [Finding]
   666   Left Frontal region (Left frontal lobe structure) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumor (Tumor Mass) [Finding]
   666   Left Frontal region (Entire left frontal lobe) [Body Part, Organ, or Organ Component]
Meta Mapping (780):
   753   Tumor (Tumor Mass) [Finding]
   666   Left frontal region (Left prefrontal cortex) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.3: Ph University Of Medical Center , Doctor Lou , 02-15-90 , operated and removed the tumor via craniotomy incision . 

Phrase: Ph University Of Medical Center ,
Meta Mapping (807):
   593   ph+ [Finding]
   844   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (807):
   593   ph++ [Finding]
   844   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (807):
   593   ph+++ [Finding]
   844   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (807):
   593   pH [Quantitative Concept]
   844   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (807):
   593   PH (Infusion pump Alert priority PH) [Finding]
   844   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]

Phrase: Doctor Lou ,
Meta Mapping (694):
   694   Doctor (Physicians) [Professional or Occupational Group]
Meta Mapping (694):
   694   Doctor (Doctor - Title) [Conceptual Entity]

Phrase: 02-15-90 ,
Meta Mapping (827):
   827   >90 [Quantitative Concept]
Meta Mapping (827):
   827   <90 [Quantitative Concept]
Meta Mapping (827):
   827   90% [Finding]

Phrase: operated
Meta Mapping (966):
   966   operate [Functional Concept]

Phrase: and

Phrase: removed
Meta Mapping (1000):
  1000   Removed [Qualitative Concept]

Phrase: the tumor via craniotomy incision .
Meta Mapping (696):
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Cranial incision point) [Body Location or Region]
Meta Mapping (696):
   760   Tumor (Tumor Mass) [Finding]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Surgical incisions) [Therapeutic or Preventive Procedure]
Meta Mapping (696):
   760   Tumor (Tumor Mass) [Finding]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Surgical wound) [Injury or Poisoning]
Meta Mapping (696):
   760   Tumor (Tumor Mass) [Finding]
   593   CRANIOTOMY (Craniotomy) [Therapeutic or Preventive Procedure]
   593   Incision (Cranial incision point) [Body Location or Region]
Processing 00000000.tx.4: She recurred with some seizures , and underwent admission this time for evaluation for a ventriculo-peritoneal VP shunt placement for the hydrocephalus . 

Phrase: She

Phrase: recurred with some seizures ,
Meta Mapping (708):
   770   recurred (Recurrence) [Phenomenon or Process]
   770   Seizures [Sign or Symptom]

Phrase: and

Phrase: underwent

Phrase: admission
Meta Mapping (1000):
  1000   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (1000):
  1000   Admission (Admission activity) [Health Care Activity]

Phrase: this time for evaluation
Meta Mapping (708):
   770   TIME (Time) [Temporal Concept]
   604   Evaluation [Health Care Activity]
Meta Mapping (708):
   770   TIME (Time) [Temporal Concept]
   604   Evaluation (Evaluation procedure) [Health Care Activity]
Meta Mapping (708):
   770   Time (Time (foundation metadata concept)) [Temporal Concept]
   604   Evaluation [Health Care Activity]
Meta Mapping (708):
   770   Time (Time (foundation metadata concept)) [Temporal Concept]
   604   Evaluation (Evaluation procedure) [Health Care Activity]

Phrase: for a ventriculo-peritoneal VP shunt placement for the hydrocephalus .
Meta Mapping (726):
   628   VP - Ventriculoperitoneal shunt (Ventriculoperitoneal catheter) [Medical Device]
   739   Placement (Clinical act of insertion) [Health Care Activity]
   573   HYDROCEPHALUS (Hydrocephalus) [Disease or Syndrome]
Meta Mapping (726):
   628   VP - Ventriculoperitoneal shunt (Ventriculoperitoneal catheter) [Medical Device]
   739   Placement (Clinical act of insertion) [Health Care Activity]
   573   Hydrocephalus (Hydrocephalus Adverse Event) [Pathologic Function]
Meta Mapping (726):
   628   VP - Ventriculoperitoneal shunt (Ventriculoperitoneal catheter) [Medical Device]
   739   Placement [Qualitative Concept]
   573   HYDROCEPHALUS (Hydrocephalus) [Disease or Syndrome]
Meta Mapping (726):
   628   VP - Ventriculoperitoneal shunt (Ventriculoperitoneal catheter) [Medical Device]
   739   Placement [Qualitative Concept]
   573   Hydrocephalus (Hydrocephalus Adverse Event) [Pathologic Function]
Meta Mapping (726):
   628   VP - Ventriculoperitoneal shunt (Ventriculoperitoneal catheter) [Medical Device]
   739   Placement (Placement action) [Health Care Activity]
   573   HYDROCEPHALUS (Hydrocephalus) [Disease or Syndrome]
Meta Mapping (726):
   628   VP - Ventriculoperitoneal shunt (Ventriculoperitoneal catheter) [Medical Device]
   739   Placement (Placement action) [Health Care Activity]
   573   Hydrocephalus (Hydrocephalus Adverse Event) [Pathologic Function]
Processing 00000000.tx.5: Brother died of lung cancer . 

Phrase: Brother
Meta Mapping (1000):
  1000   Brother (Brothers) [Family Group]

Phrase: died of lung cancer .
Meta Mapping (916):
   770   Died (Cessation of life) [Organism Function]
   881   Cancer of Lung (Malignant neoplasm of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Cessation of life) [Organism Function]
   881   Cancer of Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Death (finding)) [Finding]
   881   Cancer of Lung (Malignant neoplasm of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Death (finding)) [Finding]
   881   Cancer of Lung (Carcinoma of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Patient Outcome - Died) [Finding]
   881   Cancer of Lung (Malignant neoplasm of lung) [Neoplastic Process]
Meta Mapping (916):
   770   Died (Patient Outcome - Died) [Finding]
   881   Cancer of Lung (Carcinoma of lung) [Neoplastic Process]
Processing 00000000.tx.6: Tongue was midline . 

Phrase: Tongue
Meta Mapping (1000):
  1000   TONGUE (Tongue) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Tongue (Entire tongue) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: midline .
Meta Mapping (1000):
  1000   MIDLINE (Midline (qualifier value)) [Spatial Concept]
Meta Mapping (1000):
  1000   midline (midline cell component) [Cell Component]
Meta Mapping (1000):
  1000   Midline (Median (qualifier value)) [Spatial Concept]
Processing 00000000.tx.7: Anterior tibialis and extensor hallucis longus were 5 bilaterally , as well as the gastrocnemii . 

Phrase: Anterior tibialis
Meta Mapping (1000):
  1000   anterior tibialis (Tibialis anterior muscle structure) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: extensor hallucis longus
Meta Mapping (1000):
  1000   Extensor hallucis longus (Extensor hallucis longus muscle structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Extensor hallucis longus (Entire extensor hallucis longus muscle) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: 5 bilaterally ,
Meta Mapping (861):
   861   >5 [Quantitative Concept]
Meta Mapping (861):
   861   +5 [Quantitative Concept]

Phrase: as well as

Phrase: the gastrocnemii .
Meta Mapping (966):
   966   Gastrocnemius (Gastrocnemius muscle structure) [Body Part, Organ, or Organ Component]
Meta Mapping (966):
   966   Gastrocnemius (Entire gastrocnemius) [Body Part, Organ, or Organ Component]
Processing 00000000.tx.8: Gait was decreased arm swing , slightly wide-based , negative Romberg , mildly unsteady . 

Phrase: Gait
Meta Mapping (1000):
  1000   Gait [Finding]

Phrase: was

Phrase: decreased
Meta Mapping (1000):
  1000   Decreased [Quantitative Concept]
Meta Mapping (1000):
  1000   Decreased (Reduced) [Qualitative Concept]
Meta Mapping (1000):
  1000   decreased (Decreasing) [Qualitative Concept]

Phrase: arm swing ,
Meta Mapping (694):
   694   ARM (Upper arm) [Body Location or Region]
Meta Mapping (694):
   694   Arm (Entire upper limb) [Body Part, Organ, or Organ Component]
Meta Mapping (694):
   694   Arm (Entire upper arm) [Body Part, Organ, or Organ Component]
Meta Mapping (694):
   694   ARM (AKR1A1 wt Allele) [Gene or Genome]

Phrase: slightly wide-based , negative Romberg ,
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   NEGATIVE (Negative Finding) [Finding]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative (Negative Number) [Conceptual Entity]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative (Negative Charge) [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative (Negative - answer) [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   NEGATIVE (Negative Finding) [Finding]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative (Negative Number) [Conceptual Entity]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative (Negative Charge) [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slightly (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative (Negative - answer) [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   NEGATIVE (Negative Finding) [Finding]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative (Negative Number) [Conceptual Entity]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative (Negative Charge) [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Basis - conceptual entity) [Functional Concept]
   637   Negative (Negative - answer) [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   NEGATIVE (Negative Finding) [Finding]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative (Negative Number) [Conceptual Entity]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative (Negative Charge) [Qualitative Concept]
Meta Mapping (604):
   637   Slightly (Slight (qualifier value)) [Qualitative Concept]
   637   Wide (Widening) [Spatial Concept]
   637   Based (Base - General Qualifier) [Idea or Concept]
   637   Negative (Negative - answer) [Qualitative Concept]

Phrase: mildly unsteady .
Meta Mapping (888):
   694   MILDLY [Idea or Concept]
   861   Unsteady [Qualitative Concept]
Meta Mapping (888):
   694   Mildly (Mild (qualifier value)) [Qualitative Concept]
   861   Unsteady [Qualitative Concept]
Processing 00000000.tx.9: Dictated By : Batch : 710832021 PULMONARY HYPERTENSION . 

Phrase: Dictated By
Meta Mapping (833):
   833   dictated (dictated - ParticipationMode) [Functional Concept]
Meta Mapping (833):
   833   Dictated (dictated - DocumentCompletion) [Idea or Concept]

Phrase: :

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :

Phrase: 710832021 PULMONARY HYPERTENSION .
Meta Mapping (901):
   901   Hypertension, pulmonary (Pulmonary Hypertension) [Pathologic Function]
Meta Mapping (901):
   901   Pulmonary hypertension (Pulmonary Hypertension Adverse Event) [Finding]
Processing 00000000.tx.10: Staphylococcus aureus . 

Phrase: Staphylococcus aureus .
Meta Mapping (1000):
  1000   STAPHYLOCOCCUS AUREUS (Staphylococcus aureus) [Bacterium]
Meta Mapping (1000):
  1000   Staphylococcus aureus NOS (Staphylococcus aureus infection) [Disease or Syndrome]
Processing 00000000.tx.11: Bacteremia . 

Phrase: Bacteremia .
Meta Mapping (1000):
  1000   Bacteraemia NOS (Bacteremia) [Disease or Syndrome]
Processing 00000000.tx.12: Hematology was consult and the thrombocytopenia was likely due to Heparin . 

Phrase: Hematology
Meta Mapping (1000):
  1000   Haematology NOS (Hematology (discipline)) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Hematology (Hematology procedure) [Laboratory Procedure]

Phrase: was

Phrase: consult
Meta Mapping (1000):
  1000   Consult (Consultation) [Health Care Activity]

Phrase: and

Phrase: the thrombocytopenia
Meta Mapping (1000):
  1000   thrombocytopaenia (Thrombocytopenia) [Finding]

Phrase: was

Phrase: likely due to Heparin .
Meta Mapping (861):
   770   Likely (Probable diagnosis) [Qualitative Concept]
   833   Due To (Due to) [Functional Concept]
   770   HEPARIN (Heparin) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (861):
   770   Likely (Probable diagnosis) [Qualitative Concept]
   833   Due To (Due to) [Functional Concept]
   770   HEPARIN (heparin, porcine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (861):
   770   Likely (Probably) [Idea or Concept]
   833   Due To (Due to) [Functional Concept]
   770   HEPARIN (Heparin) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Meta Mapping (861):
   770   Likely (Probably) [Idea or Concept]
   833   Due To (Due to) [Functional Concept]
   770   HEPARIN (heparin, porcine) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.13: LABORATORY DATA : DUMP , M.D. 

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: DUMP ,
Meta Mapping (1000):
  1000   dUMP (2'-deoxyuridylic acid) [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.14: DICTATING FOR RENLAN FYFEZEIS , M.D. 

Phrase: DICTATING FOR RENLAN FYFEZEIS ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.15: TR : Signed Significant for malignant for fibrohistiocytoma . 

Phrase: TR
Meta Mapping (1000):
  1000   TR (TXNRD1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (TXNRD2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (Tumor Results Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   TR (Thioredoxin Reductase 1, Cytoplasmic) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :

Phrase: Signed Significant for malignant
Meta Mapping (733):
   604   Signed (Signature) [Intellectual Product]
   770   significant (Statistical Significance) [Quantitative Concept]
   604   MALIGNANT (Malignant - descriptor) [Qualitative Concept]
Meta Mapping (733):
   604   Signed (Signature) [Intellectual Product]
   770   Significant [Idea or Concept]
   604   MALIGNANT (Malignant - descriptor) [Qualitative Concept]
Meta Mapping (733):
   604   Signed (Signature) [Intellectual Product]
   770   Significant (Event Seriousness - Significant) [Qualitative Concept]
   604   MALIGNANT (Malignant - descriptor) [Qualitative Concept]
Meta Mapping (733):
   604   signed (signed - ParticipationSignature) [Intellectual Product]
   770   significant (Statistical Significance) [Quantitative Concept]
   604   MALIGNANT (Malignant - descriptor) [Qualitative Concept]
Meta Mapping (733):
   604   signed (signed - ParticipationSignature) [Intellectual Product]
   770   Significant [Idea or Concept]
   604   MALIGNANT (Malignant - descriptor) [Qualitative Concept]
Meta Mapping (733):
   604   signed (signed - ParticipationSignature) [Intellectual Product]
   770   Significant (Event Seriousness - Significant) [Qualitative Concept]
   604   MALIGNANT (Malignant - descriptor) [Qualitative Concept]

Phrase: for fibrohistiocytoma .
Processing 00000000.tx.16: His head is atraumatic , neck was supple with no lymphadenopathy , lungs are clear . 

Phrase: His head
Meta Mapping (1000):
  1000   HEAD (Head) [Body Location or Region]
Meta Mapping (1000):
  1000   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Head (Head - Component of Device) [Manufactured Object]

Phrase: is

Phrase: atraumatic , neck
Meta Mapping (861):
   861   NECK (Neck) [Body Location or Region]
Meta Mapping (861):
   861   Neck (Entire neck) [Body Part, Organ, or Organ Component]
Meta Mapping (861):
   861   neck (dendritic spine neck) [Cell Component]

Phrase: was

Phrase: supple with no lymphadenopathy ,
Meta Mapping (708):
   770   Supple [Functional Concept]
   604 N LYMPHADENOPATHY (Lymphadenopathy) [Finding]

Phrase: lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: are

Phrase: clear .
Meta Mapping (1000):
  1000 N Clear (Negative Surgical Margin) [Finding]
Meta Mapping (1000):
  1000   Clear [Qualitative Concept]
Processing 00000000.tx.17: The patient had an abdominal CT scan done on Memorial Day , 2000 for a question of an abdominal wall infection or abscess . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: an abdominal CT scan
Meta Mapping (901):
   913   abdominal scan (abdomen scan) [Diagnostic Procedure]
   827   CT (Central African Republic) [Geographic Area]
Meta Mapping (901):
   913   abdominal scan (abdomen scan) [Diagnostic Procedure]
   827   CT (PCYT1A wt Allele) [Gene or Genome]
Meta Mapping (901):
   913   abdominal scan (abdomen scan) [Diagnostic Procedure]
   827   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
Meta Mapping (901):
   913   abdominal scan (abdomen scan) [Diagnostic Procedure]
   827   CT (Computed Tomography Study File) [Intellectual Product]
Meta Mapping (901):
   827   Abdominal (Abdomen) [Body Location or Region]
   901   CT SCAN (X-Ray Computed Tomography) [Diagnostic Procedure]

Phrase: done on Memorial Day ,
Meta Mapping (708):
   770   Done (Done (qualifier value)) [Qualitative Concept]
   770   /day (Daily) [Temporal Concept]
Meta Mapping (708):
   770   Done (Done (qualifier value)) [Qualitative Concept]
   770   DAY (day) [Temporal Concept]
Meta Mapping (708):
   770   Done (Done (qualifier value)) [Qualitative Concept]
   770   /day (per day) [Temporal Concept]

Phrase: 2000 for a question of an abdominal wall infection
Meta Mapping (663):
   708   2000s [Temporal Concept]
   742   Question (Question (inquiry)) [Intellectual Product]
   762   Abdominal Infection (Intraabdominal Infections) [Disease or Syndrome]
   742   Wall (Walls of a building) [Manufactured Object]

Phrase: or

Phrase: abscess .
Meta Mapping (1000):
  1000   ABSCESS (Abscess) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Abcess (Specimen Type - Abscess) [Body Substance]
Processing 00000000.tx.18: He began having intractable hiccups which was his main complaint by the first few days of June and we gave his some Thorazine which seemed to work fairly well . 

Phrase: He

Phrase: began
Meta Mapping (966):
   966   Begin (Beginning) [Temporal Concept]

Phrase: having

Phrase: intractable hiccups
Meta Mapping (888):
   694   Intractable (Unresponsive to Treatment) [Functional Concept]
   861   HICCUPS (Hiccup) [Finding]

Phrase: which

Phrase: was

Phrase: his main complaint by the first few days of June
Meta Mapping (635):
   573   Main (Primary) [Qualitative Concept]
   739   Complaint (Chief complaint (finding)) [Finding]
   573   First (First (number)) [Quantitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]
Meta Mapping (635):
   573   Main (Primary) [Qualitative Concept]
   739   Complaint (Chief complaint (finding)) [Finding]
   573   First (Firstly) [Qualitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]
Meta Mapping (635):
   573   Main (Primary) [Qualitative Concept]
   739   Complaint (Complaint:Find:Pt:^Patient:Nom) [Clinical Attribute]
   573   First (First (number)) [Quantitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]
Meta Mapping (635):
   573   Main (Primary) [Qualitative Concept]
   739   Complaint (Complaint:Find:Pt:^Patient:Nom) [Clinical Attribute]
   573   First (Firstly) [Qualitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]
Meta Mapping (635):
   573   Main [Qualitative Concept]
   739   Complaint (Chief complaint (finding)) [Finding]
   573   First (First (number)) [Quantitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]
Meta Mapping (635):
   573   Main [Qualitative Concept]
   739   Complaint (Chief complaint (finding)) [Finding]
   573   First (Firstly) [Qualitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]
Meta Mapping (635):
   573   Main [Qualitative Concept]
   739   Complaint (Complaint:Find:Pt:^Patient:Nom) [Clinical Attribute]
   573   First (First (number)) [Quantitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]
Meta Mapping (635):
   573   Main [Qualitative Concept]
   739   Complaint (Complaint:Find:Pt:^Patient:Nom) [Clinical Attribute]
   573   First (Firstly) [Qualitative Concept]
   573   DAYS (day) [Temporal Concept]
   573   June [Temporal Concept]

Phrase: and

Phrase: we

Phrase: gave
Meta Mapping (966):
   966   Give (Give - dosing instruction imperative) [Functional Concept]

Phrase: his some Thorazine
Meta Mapping (1000):
  1000   Thorazine [Organic Chemical,Pharmacologic Substance]

Phrase: which

Phrase: seemed

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: work
Meta Mapping (1000):
  1000   Work [Occupational Activity]

Phrase: fairly well .
Meta Mapping (861):
   861   Well (Good) [Qualitative Concept]
Meta Mapping (861):
   861   Well [Manufactured Object]
Processing 00000000.tx.19: Casodex 50 Meigs po q day , Tylenol PRN , Benzocaine oral spray PRN , Artificial tears PRN , Halcion 0.125 to 0.25 Meigs po q.h.s. 

Phrase: Casodex 50 Meigs po q day ,
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   50% [Finding]
   632   PO (Portugal) [Geographic Area]
   799   /day (Daily) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   50% [Finding]
   632   PO (Portugal) [Geographic Area]
   799   DAY (day) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   50% [Finding]
   632   PO (Portugal) [Geographic Area]
   799   /day (per day) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   50% [Finding]
   632   PO (Oral) [Spatial Concept]
   799   /day (Daily) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   50% [Finding]
   632   PO (Oral) [Spatial Concept]
   799   DAY (day) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   50% [Finding]
   632   PO (Oral) [Spatial Concept]
   799   /day (per day) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   <50 [Finding]
   632   PO (Portugal) [Geographic Area]
   799   /day (Daily) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   <50 [Finding]
   632   PO (Portugal) [Geographic Area]
   799   DAY (day) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   <50 [Finding]
   632   PO (Portugal) [Geographic Area]
   799   /day (per day) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   <50 [Finding]
   632   PO (Oral) [Spatial Concept]
   799   /day (Daily) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   <50 [Finding]
   632   PO (Oral) [Spatial Concept]
   799   DAY (day) [Temporal Concept]
Meta Mapping (740):
   632   Casodex [Organic Chemical,Pharmacologic Substance]
   632   <50 [Finding]
   632   PO (Oral) [Spatial Concept]
   799   /day (per day) [Temporal Concept]

Phrase: Tylenol PRN ,
Meta Mapping (694):
   694   Tylenol [Organic Chemical,Pharmacologic Substance]

Phrase: Benzocaine oral spray PRN ,
Meta Mapping (756):
   756   Benzocaine Oral Spray [Clinical Drug]

Phrase: Artificial tears PRN ,
Meta Mapping (734):
   734   artificial tears (artificial tears (medication)) [Pharmacologic Substance]
Meta Mapping (734):
   734   Tears, Artificial (Lubricant Eye Drops) [Pharmacologic Substance]
Meta Mapping (734):
   734   Artificial Tears [Pharmacologic Substance]

Phrase: Halcion 0.125 to 0.25 Meigs po q.h.s.
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Portugal) [Geographic Area]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Portugal) [Geographic Area]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Portugal) [Geographic Area]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   H+ (Hepatic Involvement) [Classification]
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Portugal) [Geographic Area]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   /h (/hour) [Quantitative Concept]
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Oral) [Spatial Concept]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Oral) [Spatial Concept]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Oral) [Spatial Concept]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   H+ (Hepatic Involvement) [Classification]
Meta Mapping (658):
   738   Halcion [Organic Chemical,Pharmacologic Substance]
   738   0% [Finding]
   738   PO (Oral) [Spatial Concept]
   754   q.s. (QS -Quantity Sufficient (potency unit)) [Quantitative Concept]
   738   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.20: PRN . 

Phrase: PRN .
Processing 00000000.tx.21: DD : PUOMC The patient underwent a right upper lobectomy on February 11 , 1997 and returned for a left lower lobectomy . 

Phrase: DD
Meta Mapping (1000):
  1000   DD (AKR1C2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   DD (ATP2A2 wt Allele) [Gene or Genome]

Phrase: :

Phrase: PUOMC

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: underwent

Phrase: a right upper lobectomy on February 11 ,
Meta Mapping (701):
   778   Right Upper (Right superior) [Spatial Concept]
   748   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
   581   February [Qualitative Concept]

Phrase: 1997

Phrase: and

Phrase: returned for a left lower lobectomy .
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   LEFT (Left) [Spatial Concept]
   753   LOWER (Lower - spatial qualifier) [Spatial Concept]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   LEFT (Left) [Spatial Concept]
   753   Lower (Body Site Modifier - Lower) [Body Location or Region]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   LEFT (Left) [Spatial Concept]
   753   Lower (Lower (action)) [Activity]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   Left (Left sided) [Spatial Concept]
   753   LOWER (Lower - spatial qualifier) [Spatial Concept]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   Left (Left sided) [Spatial Concept]
   753   Lower (Body Site Modifier - Lower) [Body Location or Region]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   Left (Left sided) [Spatial Concept]
   753   Lower (Lower (action)) [Activity]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   left (Table Cell Horizontal Align - left) [Functional Concept]
   753   LOWER (Lower - spatial qualifier) [Spatial Concept]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   left (Table Cell Horizontal Align - left) [Functional Concept]
   753   Lower (Body Site Modifier - Lower) [Body Location or Region]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   753   left (Table Cell Horizontal Align - left) [Functional Concept]
   753   Lower (Lower (action)) [Activity]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   LEFT (Left) [Spatial Concept]
   753   LOWER (Lower - spatial qualifier) [Spatial Concept]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   LEFT (Left) [Spatial Concept]
   753   Lower (Body Site Modifier - Lower) [Body Location or Region]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   LEFT (Left) [Spatial Concept]
   753   Lower (Lower (action)) [Activity]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   Left (Left sided) [Spatial Concept]
   753   LOWER (Lower - spatial qualifier) [Spatial Concept]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   Left (Left sided) [Spatial Concept]
   753   Lower (Body Site Modifier - Lower) [Body Location or Region]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   Left (Left sided) [Spatial Concept]
   753   Lower (Lower (action)) [Activity]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   left (Table Cell Horizontal Align - left) [Functional Concept]
   753   LOWER (Lower - spatial qualifier) [Spatial Concept]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   left (Table Cell Horizontal Align - left) [Functional Concept]
   753   Lower (Body Site Modifier - Lower) [Body Location or Region]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Meta Mapping (697):
   753   Returned (Quantity Final Containers Returned) [Quantitative Concept]
   753   left (Table Cell Horizontal Align - left) [Functional Concept]
   753   Lower (Lower (action)) [Activity]
   753   LOBECTOMY (Lobectomy) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.22: Father and grandfather with coronary artery disease . 

Phrase: Father
Meta Mapping (1000):
  1000   Father (Father (person)) [Family Group]

Phrase: and

Phrase: grandfather with coronary artery disease .
Meta Mapping (816):
   760   Grandfather [Family Group]
   695   coronary artery disease (Coronary Arteriosclerosis) [Disease or Syndrome]
Meta Mapping (816):
   760   Grandfather [Family Group]
   695   Coronary (artery) disease (Coronary heart disease) [Disease or Syndrome]
Meta Mapping (816):
   760   Grandfather [Family Group]
   695   CORONARY ARTERY DISEASE (Coronary Artery Disease) [Disease or Syndrome]
Processing 00000000.tx.23: He did require Albumin and continued with intravenous fluids . 

Phrase: He

Phrase: did

Phrase: require

Phrase: Albumin
Meta Mapping (1000):
  1000   ALBUMIN (Albumins) [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: and

Phrase: continued with intravenous fluids .
Meta Mapping (766):
   770   Continued (Continuous) [Idea or Concept]
   799   Intravenous Fluid (Intravenous fluid) [Substance]
Processing 00000000.tx.24: He was followed closely by infectious disease . 

Phrase: He

Phrase: was

Phrase: followed
Meta Mapping (1000):
  1000   followed (Followed by) [Temporal Concept]

Phrase: closely by infectious disease .
Meta Mapping (833):
   833   Infectious Disease (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (833):
   833   Infectious Disease (Infectious Disease Pathway) [Functional Concept]
Processing 00000000.tx.25: Mr. 

Phrase: Mr.
Meta Mapping (1000):
  1000   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   MR (Minor Response) [Finding]
Processing 00000000.tx.26: Stire then became lethargic and decompensated neurologically . 

Phrase: Stire

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: became

Phrase: lethargic
Meta Mapping (1000):
  1000   Lethargic (Lethargy) [Sign or Symptom]

Phrase: and

Phrase: decompensated
Meta Mapping (1000):
  1000   Decompensated [Qualitative Concept]

Phrase: neurologically .
Processing 00000000.tx.27: He was also seen by radiation oncology and started radiation treatment . 

Phrase: He

Phrase: was

Phrase: also

Phrase: seen by radiation oncology
Meta Mapping (783):
   770   Seen (seen) [Qualitative Concept]
   833   Radiation Oncology (Radiation Oncology specialty) [Biomedical Occupation or Discipline]
Meta Mapping (783):
   770   Seen (seen) [Qualitative Concept]
   833   Oncology, Radiation (Clinic/Center - Oncology, Radiation) [Health Care Related Organization,Manufactured Object]

Phrase: and

Phrase: started radiation treatment .
Meta Mapping (901):
   660   Started [Qualitative Concept]
   901   Radiation treatment [Therapeutic or Preventive Procedure]
Processing 00000000.tx.28: Lotrimin cream to effected area b.i.d. 

Phrase: Lotrimin cream to effected area b.i.d.
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream (Dairy Cream) [Food]
   544   Effect [Qualitative Concept]
   578   Area (Geographic Locations) [Geographic Area]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream (Dairy Cream) [Food]
   544   Effect [Qualitative Concept]
   578   AREA (Area) [Spatial Concept]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream (Dairy Cream) [Food]
   544   Effect (Effect, Appearance) [Qualitative Concept]
   578   Area (Geographic Locations) [Geographic Area]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream (Dairy Cream) [Food]
   544   Effect (Effect, Appearance) [Qualitative Concept]
   578   AREA (Area) [Spatial Concept]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream [Biomedical or Dental Material]
   544   Effect [Qualitative Concept]
   578   Area (Geographic Locations) [Geographic Area]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream [Biomedical or Dental Material]
   544   Effect [Qualitative Concept]
   578   AREA (Area) [Spatial Concept]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream [Biomedical or Dental Material]
   544   Effect (Effect, Appearance) [Qualitative Concept]
   578   Area (Geographic Locations) [Geographic Area]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Meta Mapping (689):
   578   Lotrimin [Organic Chemical,Pharmacologic Substance]
   744   Cream [Biomedical or Dental Material]
   544   Effect (Effect, Appearance) [Qualitative Concept]
   578   AREA (Area) [Spatial Concept]
   604   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.29: Cisapride 10 milligrams per NG tube t.i.d. 

Phrase: Cisapride 10 milligrams per NG tube t.i.d.
Meta Mapping (702):
   575   CISAPRIDE (Cisapride) [Organic Chemical,Pharmacologic Substance]
   575   10% [Finding]
   742   milligrams (milligram) [Quantitative Concept]
   598   NG tube (Nasogastric tube) [Medical Device]
   598   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.30: Decadron 4 milligrams intravenous q.i.d. 

Phrase: Decadron 4 milligrams intravenous q.i.d.
Meta Mapping (749):
   629   Decadron [Organic Chemical,Pharmacologic Substance]
   795   milligrams (milligram) [Quantitative Concept]
   629   Intravenous [Spatial Concept]
   651   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.31: RORI CORE , R.N. 

Phrase: RORI CORE ,
Meta Mapping (861):
   861   Core [Spatial Concept]
Meta Mapping (861):
   861   core (viral nucleocapsid location) [Cell Component]
Meta Mapping (861):
   861   Core (Core Device Component) [Medical Device]
Meta Mapping (861):
   861   Core (Processor Core) [Manufactured Object]
Meta Mapping (861):
   861   Core (Core Specimen) [Body Substance]

Phrase: R.N.
Meta Mapping (1000):
  1000   R.N. (Registered nurse) [Professional or Occupational Group]
Processing 00000000.tx.32: TR :

Phrase: TR
Meta Mapping (1000):
  1000   TR (TXNRD1 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (TXNRD2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   TR (Tumor Results Domain) [Intellectual Product]
Meta Mapping (1000):
  1000   TR (Thioredoxin Reductase 1, Cytoplasmic) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: :
Processing 00000000.tx.1: 02/12/1991 MEDICATIONS ON DISCHARGE were Synthroid .2 milligrams by mouth per day , Colace 100 milligrams by mouth 3 times a day . 

Phrase: 02/12/1991 MEDICATIONS ON DISCHARGE
Meta Mapping (783):
   783   Discharge medications (Medication.discharge) [Finding]

Phrase: were

Phrase: Synthroid .2 milligrams by mouth
Meta Mapping (687):
   593   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   milligrams (milligram) [Quantitative Concept]
   593   MOUTH (Oral cavity) [Body Space or Junction]
Meta Mapping (687):
   593   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   milligrams (milligram) [Quantitative Concept]
   593   Mouth (Oral region) [Body Location or Region]
Meta Mapping (687):
   593   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   milligrams (milligram) [Quantitative Concept]
   593   Mouth, NOS (Entire mouth region) [Body Location or Region]
Meta Mapping (687):
   593   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   milligrams (milligram) [Quantitative Concept]
   593   Mouth (Entire oral cavity) [Body Location or Region]

Phrase: per day ,
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]

Phrase: Colace 100 milligrams by mouth 3 times
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   MOUTH (Oral cavity) [Body Space or Junction]
   581   times (Time) [Temporal Concept]
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   MOUTH (Oral cavity) [Body Space or Junction]
   581   Times [Quantitative Concept]
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   Mouth (Oral region) [Body Location or Region]
   581   times (Time) [Temporal Concept]
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   Mouth (Oral region) [Body Location or Region]
   581   Times [Quantitative Concept]
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   Mouth, NOS (Entire mouth region) [Body Location or Region]
   581   times (Time) [Temporal Concept]
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   Mouth, NOS (Entire mouth region) [Body Location or Region]
   581   Times [Quantitative Concept]
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   Mouth (Entire oral cavity) [Body Location or Region]
   581   times (Time) [Temporal Concept]
Meta Mapping (688):
   581   Colace [Organic Chemical,Pharmacologic Substance]
   581   100% [Quantitative Concept]
   748   milligrams (milligram) [Quantitative Concept]
   581   Mouth (Entire oral cavity) [Body Location or Region]
   581   Times [Quantitative Concept]

Phrase: a day .
Meta Mapping (1000):
  1000   /day (Daily) [Temporal Concept]
Meta Mapping (1000):
  1000   DAY (day) [Temporal Concept]
Meta Mapping (1000):
  1000   /day (per day) [Temporal Concept]
Processing 00000000.tx.2: </RECORD> 753143 Report Status : In 1990 the patient was diagnosed with dilated cardiomyopathy in Hispit , Delaware . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 753143 Report Status
Meta Mapping (901):
   901   Report status [Finding]

Phrase: :

Phrase: In 1990
Meta Mapping (966):
   966   1990s [Temporal Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: diagnosed with dilated cardiomyopathy
Meta Mapping (783):
   770   Diagnosed (Diagnosis) [Finding]
   833   Cardiomyopathy, Dilated [Disease or Syndrome]
Meta Mapping (783):
   770   Diagnosed (Diagnosis) [Finding]
   833   Dilated cardiomyopathy (Dilated Cardiomyopathy Pathway) [Functional Concept]

Phrase: in Hispit ,

Phrase: Delaware .
Meta Mapping (1000):
  1000   Delaware [Geographic Area]
Meta Mapping (1000):
  1000   Delaware (Delaware Language) [Language]
Meta Mapping (1000):
  1000   Delaware (Delaware Indian) [Population Group]
Processing 00000000.tx.3: Coronaries were completely normal . 

Phrase: Coronaries
Meta Mapping (966):
   966   coronary (Heart) [Body Part, Organ, or Organ Component]

Phrase: were

Phrase: completely normal .
Meta Mapping (888):
   694   Completely (Complete) [Qualitative Concept]
   861   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (888):
   694   Completely (Complete) [Qualitative Concept]
   861   Normal (Gait normal) [Finding]
Meta Mapping (888):
   694   Completely (Complete) [Qualitative Concept]
   861   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (888):
   694   Completely (Complete) [Qualitative Concept]
   861   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.4: In the CCU the patient was initially treated with nitroprusside and eventually switched to Captopril and Isordil . 

Phrase: In the CCU

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: initially
Meta Mapping (1000):
  1000   Initially [Temporal Concept]

Phrase: treated with nitroprusside
Meta Mapping (901):
   882   Treated with [Therapeutic or Preventive Procedure]
   790   NITROPRUSSIDE (Nitroprusside) [Inorganic Chemical,Pharmacologic Substance]

Phrase: and

Phrase: eventually

Phrase: switched to Captopril
Meta Mapping (730):
   756   Switch (Switch Device Component) [Manufactured Object]
   790   CAPTOPRIL (Captopril) [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: and

Phrase: Isordil .
Meta Mapping (1000):
  1000   Isordil [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.5: Hemodynamics were optimized resulting in a cardiac output of 4.4 with a SVR of 1300 and a wedge of 16 . 

Phrase: Hemodynamics
Meta Mapping (1000):
  1000   Hemodynamics [Organ or Tissue Function]

Phrase: were

Phrase: optimized

Phrase: resulting in a cardiac output of 4.4
Meta Mapping (708):
   770   Resulting in [Functional Concept]
   770   Cardiac Output [Clinical Attribute]

Phrase: with a SVR of 1300
Meta Mapping (760):
   760   SVR (Total Peripheral Resistance) [Physiologic Function]
Meta Mapping (760):
   760   SVR (Sustained Virologic Response) [Finding]

Phrase: and

Phrase: a wedge of 16 .
Meta Mapping (770):
   770   Wedge [Spatial Concept]
Processing 00000000.tx.6: On 02/22/94 an EPS study was performed . 

Phrase: On 02/22/94

Phrase: an EPS study
Meta Mapping (861):
   861   Study (Room of building - Study) [Manufactured Object]
Meta Mapping (861):
   861   Study [Research Activity]

Phrase: was

Phrase: performed .
Meta Mapping (1000):
  1000   Performed [Functional Concept]
Processing 00000000.tx.7: At this point it was felt the patient would go home on 03/13/94 . 

Phrase: At this point
Meta Mapping (1000):
  1000   POINT (point - UnitsOfMeasure) [Quantitative Concept]
Meta Mapping (1000):
  1000   point (Point Name) [Quantitative Concept]
Meta Mapping (1000):
  1000   Point [Spatial Concept]

Phrase: it

Phrase: was

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: would

Phrase: go
Meta Mapping (1000):
  1000   GO (GORAB gene) [Gene or Genome]

Phrase: home on 03/13/94 .
Meta Mapping (760):
   760   HOME (Home environment) [Conceptual Entity]
Processing 00000000.tx.8: Within normal limits . 

Phrase: Within normal limits .
Meta Mapping (1000):
  1000   Normal limits [Quantitative Concept]
Processing 00000000.tx.9: CONDITION ON DISCHARGE : WOLFE-PARKINSON WHITE SYNDROME . 

Phrase: CONDITION ON DISCHARGE
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Discharge, body substance) [Body Substance]

Phrase: :

Phrase: WOLFE-PARKINSON WHITE SYNDROME .
Meta Mapping (824):
   875   PARKINSON'S SYNDROME (Parkinson Disease) [Disease or Syndrome]
   812   WHITE (Caucasoid Race) [Population Group]
Meta Mapping (824):
   875   PARKINSON'S SYNDROME (Parkinson Disease) [Disease or Syndrome]
   812   WHITE (Caucasians) [Population Group]
Meta Mapping (824):
   875   PARKINSON'S SYNDROME (Parkinson Disease) [Disease or Syndrome]
   812   WHITE (White color) [Qualitative Concept]
Processing 00000000.tx.10: Report Status : He subsequently had an echocardiogram in December 1994 which showed normal left ventricular size and systolic function . 

Phrase: Report Status
Meta Mapping (1000):
  1000   Report status [Finding]

Phrase: :

Phrase: He

Phrase: subsequently

Phrase: had

Phrase: an echocardiogram in December 1994
Meta Mapping (686):
   760   ECHOCARDIOGRAM (Echocardiography) [Diagnostic Procedure]
   593   December [Qualitative Concept]
Meta Mapping (686):
   760   Echocardiogram (Echocardiogram (image)) [Intellectual Product]
   593   December [Qualitative Concept]

Phrase: which

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: normal left ventricular size
Meta Mapping (916):
   645   NORMAL (Normal) [Qualitative Concept]
   923   Left ventricular size [Clinical Attribute]
Meta Mapping (916):
   645   Normal (Gait normal) [Finding]
   923   Left ventricular size [Clinical Attribute]
Meta Mapping (916):
   645   % normal (Percent normal) [Quantitative Concept]
   923   Left ventricular size [Clinical Attribute]
Meta Mapping (916):
   645   % Normal (Mean Percent of Normal) [Quantitative Concept]
   923   Left ventricular size [Clinical Attribute]

Phrase: and

Phrase: systolic function .
Meta Mapping (888):
   694   Systolic (Systole) [Temporal Concept]
   861   function (physiological aspects) [Physiologic Function]
Meta Mapping (888):
   694   Systolic (Systole) [Temporal Concept]
   861   FUNCTION (Function) [Functional Concept]
Meta Mapping (888):
   694   Systolic (Systole) [Temporal Concept]
   861   FUNCTION (Function Axis) [Classification]
Meta Mapping (888):
   694   Systolic (Systole) [Temporal Concept]
   861   Function (Mathematical Operator) [Intellectual Product]
Processing 00000000.tx.11: He continued to have intermittent runs of the wide complex tachycardia and was therefore transferred to Ph University Of Medical Center for further evaluation and management . 

Phrase: He

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: intermittent runs of the wide complex tachycardia
Meta Mapping (692):
   581   INTERMITTENT (Intermittent) [Temporal Concept]
   748   Runs (Does run (finding)) [Finding]
   581   Wide (Widening) [Spatial Concept]
   581   Complex [Qualitative Concept]
   581   TACHYCARDIA (Tachycardia) [Pathologic Function]
Meta Mapping (692):
   581   INTERMITTENT (Intermittent) [Temporal Concept]
   748   Runs (Does run (finding)) [Finding]
   581   Wide (Widening) [Spatial Concept]
   581   Complex [Qualitative Concept]
   581   TACHYCARDIA (Tachycardia by ECG Finding) [Finding]
Meta Mapping (692):
   581   INTERMITTENT (Intermittent) [Temporal Concept]
   748   Runs (Does run (finding)) [Finding]
   581   Wide (Widening) [Spatial Concept]
   581   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   581   TACHYCARDIA (Tachycardia) [Pathologic Function]
Meta Mapping (692):
   581   INTERMITTENT (Intermittent) [Temporal Concept]
   748   Runs (Does run (finding)) [Finding]
   581   Wide (Widening) [Spatial Concept]
   581   Complex (complex (molecular entity)) [Chemical Viewed Structurally]
   581   TACHYCARDIA (Tachycardia by ECG Finding) [Finding]

Phrase: and

Phrase: was

Phrase: therefore

Phrase: transferred to Ph University Of Medical Center
Meta Mapping (737):
   748   transferred (Surgical transfer - action) [Functional Concept]
   748   ph+ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   transferred (Surgical transfer - action) [Functional Concept]
   748   ph++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   transferred (Surgical transfer - action) [Functional Concept]
   748   ph+++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   transferred (Surgical transfer - action) [Functional Concept]
   748   pH [Quantitative Concept]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   transferred (Surgical transfer - action) [Functional Concept]
   748   PH (Infusion pump Alert priority PH) [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Transferred (Transfer Technique) [Functional Concept]
   748   ph+ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Transferred (Transfer Technique) [Functional Concept]
   748   ph++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Transferred (Transfer Technique) [Functional Concept]
   748   ph+++ [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Transferred (Transfer Technique) [Functional Concept]
   748   pH [Quantitative Concept]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (737):
   748   Transferred (Transfer Technique) [Functional Concept]
   748   PH (Infusion pump Alert priority PH) [Finding]
   804   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]

Phrase: for further evaluation
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Evaluation [Health Care Activity]
Meta Mapping (888):
   694   Further [Spatial Concept]
   861   Evaluation (Evaluation procedure) [Health Care Activity]

Phrase: and

Phrase: management .
Meta Mapping (1000):
  1000   Management (Administration occupational activities) [Occupational Activity]
Meta Mapping (1000):
  1000   management (Disease Management) [Health Care Activity]
Meta Mapping (1000):
  1000   Management (Management procedure) [Occupational Activity]
Meta Mapping (1000):
  1000   Management (Management Occupations) [Occupation or Discipline]
Processing 00000000.tx.12: MEDICATIONS ON ADMISSION : He was comfortable with a blood pressure of 156/78 , pulse 56 and respirations of 16 . 

Phrase: MEDICATIONS
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: ON ADMISSION
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: :

Phrase: He

Phrase: was

Phrase: comfortable with a blood pressure of 156/78 ,
Meta Mapping (604):
   604   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (604):
   604   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (604):
   604   Blood pressure (Systemic arterial pressure) [Finding]

Phrase: pulse 56
Meta Mapping (861):
   861   PULSE (Pulse Rate) [Clinical Attribute]
Meta Mapping (861):
   861   Pulse (Physiologic pulse) [Physiologic Function]
Meta Mapping (861):
   861   Pulse (Pulse phenomenon) [Phenomenon or Process]

Phrase: and

Phrase: respirations of 16 .
Meta Mapping (790):
   790   respirations (Respiration) [Physiologic Function]
Processing 00000000.tx.13: There was a grade 1/6 holosystolic murmur at the lower left sternal border radiating to the apex . 

Phrase: There

Phrase: was

Phrase: a grade 1/6 holosystolic murmur at the lower left sternal border radiating
Meta Mapping (690):
   582   grade 6 [Intellectual Product]
   750   Holosystolic murmur (Pansystolic murmur) [Disease or Syndrome]
   569   LOWER (Lower - spatial qualifier) [Spatial Concept]
   599   Left sternal border [Body Space or Junction]
   569   radiating (Radiating to) [Functional Concept]
Meta Mapping (690):
   582   grade 6 [Intellectual Product]
   750   Holosystolic murmur (Pansystolic murmur) [Disease or Syndrome]
   569   Lower (Body Site Modifier - Lower) [Body Location or Region]
   599   Left sternal border [Body Space or Junction]
   569   radiating (Radiating to) [Functional Concept]
Meta Mapping (690):
   582   grade 6 [Intellectual Product]
   750   Holosystolic murmur (Pansystolic murmur) [Disease or Syndrome]
   569   Lower (Lower (action)) [Activity]
   599   Left sternal border [Body Space or Junction]
   569   radiating (Radiating to) [Functional Concept]

Phrase: to the apex .
Meta Mapping (1000):
  1000   Apex (Highest) [Qualitative Concept]
Meta Mapping (1000):
  1000   apex (dinoflagellate apex) [Cell Component]
Processing 00000000.tx.14: Carotid pulses were 2+ bilaterally and there was no jugular venous distention . 

Phrase: Carotid pulses
Meta Mapping (1000):
  1000   carotid PULSES [Finding]

Phrase: were

Phrase: 2+ bilaterally
Meta Mapping (861):
   861   +2 [Quantitative Concept]
Meta Mapping (861):
   861   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (861):
   861   2+ (2+ Score, WHO) [Classification]
Meta Mapping (861):
   861   2+ [Finding]

Phrase: and

Phrase: there

Phrase: was

Phrase: no jugular venous distention .
Meta Mapping (1000):
  1000 N Jugular venous distension (Jugular venous engorgement) [Finding]
Processing 00000000.tx.15: His initial cardiac catheterization had to be postponed given the possibility of an allergy to Prednisone . 

Phrase: His initial cardiac catheterization
Meta Mapping (901):
   660   Initial (Initially) [Temporal Concept]
   901   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
Meta Mapping (901):
   660   Initial (Firstly) [Qualitative Concept]
   901   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
Meta Mapping (901):
   660   Initial (Initial (abbreviation)) [Idea or Concept]
   901   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]
Meta Mapping (901):
   660   INITIAL (Initial Usage) [Functional Concept]
   901   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]

Phrase: had

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: postponed

Phrase: given
Meta Mapping (1000):
  1000   GIVEN [Conceptual Entity]
Meta Mapping (1000):
  1000   given (Entity Name Part Type - given) [Idea or Concept]
Meta Mapping (1000):
  1000   Given (Give - dosing instruction imperative) [Functional Concept]
Meta Mapping (1000):
  1000   given (Given name) [Intellectual Product]

Phrase: the possibility of an allergy
Meta Mapping (650):
   688   Possible [Qualitative Concept]
   593   Allergy (Allergy Specialty) [Biomedical Occupation or Discipline]
Meta Mapping (650):
   688   Possible [Qualitative Concept]
   593   ALLERGY (Hypersensitivity) [Pathologic Function]
Meta Mapping (650):
   688   Possible [Qualitative Concept]
   593   ALLERGY (Response to antigens) [Physiologic Function]
Meta Mapping (650):
   688   Possible [Qualitative Concept]
   593   Allergy (Allergic Reaction) [Pathologic Function]
Meta Mapping (650):
   688   Possible [Qualitative Concept]
   593   Allergy (Allergy - Physicians) [Professional or Occupational Group]
Meta Mapping (650):
   688   Possible [Qualitative Concept]
   593   Allergy (Allergic disposition) [Disease or Syndrome]
Meta Mapping (650):
   688   Possible (Possibly Related to Intervention) [Qualitative Concept]
   593   Allergy (Allergy Specialty) [Biomedical Occupation or Discipline]
Meta Mapping (650):
   688   Possible (Possibly Related to Intervention) [Qualitative Concept]
   593   ALLERGY (Hypersensitivity) [Pathologic Function]
Meta Mapping (650):
   688   Possible (Possibly Related to Intervention) [Qualitative Concept]
   593   ALLERGY (Response to antigens) [Physiologic Function]
Meta Mapping (650):
   688   Possible (Possibly Related to Intervention) [Qualitative Concept]
   593   Allergy (Allergic Reaction) [Pathologic Function]
Meta Mapping (650):
   688   Possible (Possibly Related to Intervention) [Qualitative Concept]
   593   Allergy (Allergy - Physicians) [Professional or Occupational Group]
Meta Mapping (650):
   688   Possible (Possibly Related to Intervention) [Qualitative Concept]
   593   Allergy (Allergic disposition) [Disease or Syndrome]
Meta Mapping (650):
   688   Possible (Possible diagnosis) [Qualitative Concept]
   593   Allergy (Allergy Specialty) [Biomedical Occupation or Discipline]
Meta Mapping (650):
   688   Possible (Possible diagnosis) [Qualitative Concept]
   593   ALLERGY (Hypersensitivity) [Pathologic Function]
Meta Mapping (650):
   688   Possible (Possible diagnosis) [Qualitative Concept]
   593   ALLERGY (Response to antigens) [Physiologic Function]
Meta Mapping (650):
   688   Possible (Possible diagnosis) [Qualitative Concept]
   593   Allergy (Allergic Reaction) [Pathologic Function]
Meta Mapping (650):
   688   Possible (Possible diagnosis) [Qualitative Concept]
   593   Allergy (Allergy - Physicians) [Professional or Occupational Group]
Meta Mapping (650):
   688   Possible (Possible diagnosis) [Qualitative Concept]
   593   Allergy (Allergic disposition) [Disease or Syndrome]

Phrase: to Prednisone .
Meta Mapping (1000):
  1000   PREDNISONE (Prednisone) [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.16: He will have a visiting nurse to see him on Iat . 

Phrase: He

Phrase: will

Phrase: have

Phrase: a visiting nurse
Meta Mapping (1000):
  1000   Visiting Nurse (Visiting Nurses) [Professional or Occupational Group]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: see
Meta Mapping (1000):
  1000   see (Vision) [Organism Function]
Meta Mapping (1000):
  1000   See [Activity]

Phrase: him on Iat .
Processing 00000000.tx.17: FOLLOW-UP : He will follow-up with Dr. 

Phrase: FOLLOW-UP
Meta Mapping (1000):
  1000   Follow-up (Follow-up status) [Finding]
Meta Mapping (1000):
  1000   Follow Up (follow-up) [Health Care Activity]
Meta Mapping (1000):
  1000   Follow-Up (Follow-Up Report) [Intellectual Product]
Meta Mapping (1000):
  1000   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]

Phrase: :

Phrase: He

Phrase: will

Phrase: follow-up with Dr.
Meta Mapping (783):
   833   Follow-up (Follow-up status) [Finding]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833   Follow-up (Follow-up status) [Finding]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833   Follow-up (Follow-up status) [Finding]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833   Follow-up (Follow-up status) [Finding]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833   Follow-up (Follow-up status) [Finding]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833   Follow Up (follow-up) [Health Care Activity]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833   Follow-Up (Follow-Up Report) [Intellectual Product]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (783):
   833   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.18: Taarnna Service at Ph University Of Medical Center as well as Dr. 

Phrase: Taarnna Service at Ph University Of Medical Center
Meta Mapping (717):
   744   Service (Services) [Occupational Activity]
   578   ph+ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Services) [Occupational Activity]
   578   ph++ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Services) [Occupational Activity]
   578   ph+++ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Services) [Occupational Activity]
   578   pH [Quantitative Concept]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Services) [Occupational Activity]
   578   PH (Infusion pump Alert priority PH) [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Software Service) [Manufactured Object]
   578   ph+ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Software Service) [Manufactured Object]
   578   ph++ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Software Service) [Manufactured Object]
   578   ph+++ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Software Service) [Manufactured Object]
   578   pH [Quantitative Concept]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   Service (Software Service) [Manufactured Object]
   578   PH (Infusion pump Alert priority PH) [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   service (ActInformationPrivacyReason <service>) [Idea or Concept]
   578   ph+ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   service (ActInformationPrivacyReason <service>) [Idea or Concept]
   578   ph++ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   service (ActInformationPrivacyReason <service>) [Idea or Concept]
   578   ph+++ [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   service (ActInformationPrivacyReason <service>) [Idea or Concept]
   578   pH [Quantitative Concept]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (717):
   744   service (ActInformationPrivacyReason <service>) [Idea or Concept]
   578   PH (Infusion pump Alert priority PH) [Finding]
   626   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]

Phrase: as well as

Phrase: Dr.
Meta Mapping (1000):
  1000   DR (Dominican Republic) [Geographic Area]
Meta Mapping (1000):
  1000   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.19: Lupevickette Folk and Dr. 

Phrase: Lupevickette Folk

Phrase: and

Phrase: Dr.
Meta Mapping (1000):
  1000   DR (Dominican Republic) [Geographic Area]
Meta Mapping (1000):
  1000   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.20: Dwainco Rallsversgach on Villean Garl . 

Phrase: Dwainco Rallsversgach on Villean Garl .
Processing 00000000.tx.21: Prilosec 20 mg qd . 

Phrase: Prilosec 20 mg qd .
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   MG (Mongolia) [Geographic Area]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   mg% (mg/dL) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   mg % (Milligram percent) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (833):
   645   PriLOSEC (Prilosec) [Organic Chemical,Pharmacologic Substance]
   645   20% [Finding]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   812   QD (Daily) [Temporal Concept]
Processing 00000000.tx.22: Oxybutynin 5 mg qd . 

Phrase: Oxybutynin 5 mg qd .
Meta Mapping (775):
   645   OXYBUTYNIN (oxybutynin) [Organic Chemical,Pharmacologic Substance]
   645   MG (Mongolia) [Geographic Area]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (775):
   645   OXYBUTYNIN (oxybutynin) [Organic Chemical,Pharmacologic Substance]
   645   mg% (mg/dL) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (775):
   645   OXYBUTYNIN (oxybutynin) [Organic Chemical,Pharmacologic Substance]
   645   mg % (Milligram percent) [Quantitative Concept]
   812   QD (Daily) [Temporal Concept]
Meta Mapping (775):
   645   OXYBUTYNIN (oxybutynin) [Organic Chemical,Pharmacologic Substance]
   645   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   812   QD (Daily) [Temporal Concept]
Processing 00000000.tx.23: 09/23/1998 Unsigned OTHER PROCEDURES : His hematocrit was 37.4 and urinalysis was normal . 

Phrase: 09/23/1998 Unsigned
Meta Mapping (645):
   645   23 [Quantitative Concept]

Phrase: OTHER PROCEDURES
Meta Mapping (1000):
  1000   procedures (Methods aspects) [Intellectual Product]
Meta Mapping (1000):
  1000   PROCEDURES (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Procedures (Procedure (set of actions)) [Activity]

Phrase: :

Phrase: His hematocrit
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (1000):
  1000   Hematocrit (Hematocrit level) [Finding]

Phrase: was

Phrase: 37.4

Phrase: and

Phrase: urinalysis
Meta Mapping (1000):
  1000   Urinalysis [Laboratory Procedure]

Phrase: was

Phrase: normal .
Meta Mapping (1000):
  1000   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (1000):
  1000   Normal (Gait normal) [Finding]
Meta Mapping (1000):
  1000   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (1000):
  1000   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.24: Coagulation factors were normal . 

Phrase: Coagulation factors
Meta Mapping (1000):
  1000   COAGULATION FACTORS (Blood Coagulation Factor) [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: were

Phrase: normal .
Meta Mapping (1000):
  1000   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (1000):
  1000   Normal (Gait normal) [Finding]
Meta Mapping (1000):
  1000   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (1000):
  1000   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.25: 05-17-94 TD : CTMC Patient reports no significant changes in how he feels over the past week . 

Phrase: 05-17-94 TD
Meta Mapping (812):
   812   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (812):
   812   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :

Phrase: CTMC Patient
Meta Mapping (861):
   861   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (861):
   861   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (861):
   861   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (861):
   861   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: reports
Meta Mapping (1000):
  1000   Reports (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   reports (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]
Meta Mapping (1000):
  1000   Reports (Clinical Trial Final Report) [Intellectual Product]

Phrase: no significant changes in how
Meta Mapping (695):
   593   significant (Statistical Significance) [Quantitative Concept]
   760   changes (Changing) [Functional Concept]
Meta Mapping (695):
   593   significant (Statistical Significance) [Quantitative Concept]
   760   changes (Changed status) [Quantitative Concept]
Meta Mapping (695):
   593   Significant [Idea or Concept]
   760   changes (Changing) [Functional Concept]
Meta Mapping (695):
   593   Significant [Idea or Concept]
   760   changes (Changed status) [Quantitative Concept]
Meta Mapping (695):
   593   Significant (Event Seriousness - Significant) [Qualitative Concept]
   760   changes (Changing) [Functional Concept]
Meta Mapping (695):
   593   Significant (Event Seriousness - Significant) [Qualitative Concept]
   760   changes (Changed status) [Quantitative Concept]

Phrase: he

Phrase: feels over the past week .
Meta Mapping (745):
   760 N feels (Emotions) [Mental Process]
   806   Past Week [Temporal Concept]
Processing 00000000.tx.26: Denies cough , shortness of breath , chest pain , nausea , vomiting , diarrhea , dysuria , neck stiffness , new skin lesions , worsening red petechiae , or increasing sinus symptoms . 

Phrase: Denies
Meta Mapping (1000):
  1000   Deny (Deny (action)) [Activity]

Phrase: cough
Meta Mapping (1000):
  1000 N COUGH (Coughing) [Sign or Symptom]
Meta Mapping (1000):
  1000 N Cough (Cough Adverse Event) [Finding]

Phrase: ,

Phrase: shortness of breath ,
Meta Mapping (1000):
  1000 N SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (1000):
  1000   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: chest pain ,
Meta Mapping (1000):
  1000 N CHEST PAIN (Chest Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Chest pain (Chest pain:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]

Phrase: nausea ,
Meta Mapping (1000):
  1000 N NAUSEA (Nausea) [Sign or Symptom]
Meta Mapping (1000):
  1000 N Nausea (Nausea Adverse Event) [Pathologic Function]

Phrase: vomiting
Meta Mapping (1000):
  1000 N VOMITING (Vomiting) [Sign or Symptom]
Meta Mapping (1000):
  1000 N Vomiting (Vomiting Adverse Event) [Pathologic Function]

Phrase: ,

Phrase: diarrhea ,
Meta Mapping (1000):
  1000 N DIARRHOEA (Diarrhea) [Sign or Symptom]
Meta Mapping (1000):
  1000 N Diarrhea (Diarrhea Adverse Event) [Finding]

Phrase: dysuria ,
Meta Mapping (1000):
  1000 N DYSURIA (Dysuria) [Sign or Symptom]

Phrase: neck stiffness ,
Meta Mapping (1000):
  1000   NECK STIFFNESS (Neck stiffness) [Sign or Symptom]

Phrase: new skin lesions ,
Meta Mapping (884):
   660   NEW (New) [Qualitative Concept]
   867   SKIN LESION (Skin lesion) [Disease or Syndrome]

Phrase: worsening
Meta Mapping (1000):
  1000   Worsening (Worsening pattern) [Qualitative Concept]
Meta Mapping (1000):
  1000   Worsening (Worse) [Finding]
Meta Mapping (1000):
  1000   Worsening (Patient Outcome - Worsening) [Idea or Concept]

Phrase: red petechiae ,
Meta Mapping (888):
   694   Red (Redness) [Finding]
   861   PETECHIAE (Petechiae) [Disease or Syndrome]
Meta Mapping (888):
   694   RED (Red color) [Qualitative Concept]
   861   PETECHIAE (Petechiae) [Disease or Syndrome]
Meta Mapping (888):
   694   RED (Radiological Exposure Device) [Manufactured Object]
   861   PETECHIAE (Petechiae) [Disease or Syndrome]

Phrase: or

Phrase: increasing sinus symptoms .
Meta Mapping (851):
   660   Increasing [Functional Concept]
   660   Sinus (pathologic fistula) [Anatomical Abnormality]
   827   symptoms (Symptoms aspect) [Functional Concept]
Meta Mapping (851):
   660   Increasing [Functional Concept]
   660   Sinus (pathologic fistula) [Anatomical Abnormality]
   827   SYMPTOMS (Symptoms) [Sign or Symptom]
Meta Mapping (851):
   660   Increasing [Functional Concept]
   660   Sinus (Nasal sinus) [Body Space or Junction]
   827   symptoms (Symptoms aspect) [Functional Concept]
Meta Mapping (851):
   660   Increasing [Functional Concept]
   660   Sinus (Nasal sinus) [Body Space or Junction]
   827   SYMPTOMS (Symptoms) [Sign or Symptom]
Meta Mapping (851):
   660   Increasing [Functional Concept]
   660   SINUS (Sinus - general anatomical term) [Body Space or Junction]
   827   symptoms (Symptoms aspect) [Functional Concept]
Meta Mapping (851):
   660   Increasing [Functional Concept]
   660   SINUS (Sinus - general anatomical term) [Body Space or Junction]
   827   SYMPTOMS (Symptoms) [Sign or Symptom]
Processing 00000000.tx.27: ALLERGIES : Erythematous nodules on arms at elbows and on right thigh , as previous . 

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: Erythematous nodules on arms
Meta Mapping (783):
   833   erythematous nodules (nodule erythematous) [Finding]
   604   ARMS (Alveolar rhabdomyosarcoma) [Neoplastic Process]
Meta Mapping (783):
   833   erythematous nodules (nodule erythematous) [Finding]
   604   Arms (Upper arm) [Body Location or Region]
Meta Mapping (783):
   833   erythematous nodules (nodule erythematous) [Finding]
   604   Arm (Entire upper limb) [Body Part, Organ, or Organ Component]
Meta Mapping (783):
   833   erythematous nodules (nodule erythematous) [Finding]
   604   Arm (Entire upper arm) [Body Part, Organ, or Organ Component]
Meta Mapping (783):
   833   erythematous nodules (nodule erythematous) [Finding]
   604   ARMS (KIDINS220 gene) [Gene or Genome]
Meta Mapping (783):
   833   erythematous nodules (nodule erythematous) [Finding]
   604   ARM (AKR1A1 wt Allele) [Gene or Genome]

Phrase: at elbows
Meta Mapping (966):
   966   Elbow [Body Location or Region]
Meta Mapping (966):
   966   Elbow (Elbow joint structure) [Body Space or Junction]
Meta Mapping (966):
   966   Elbow, NOS (Entire elbow region) [Body Part, Organ, or Organ Component]

Phrase: and on right thigh ,
Meta Mapping (833):
   833   Right Thigh (Structure of right thigh) [Body Part, Organ, or Organ Component]
Meta Mapping (833):
   833   Right thigh (Entire right thigh) [Body Part, Organ, or Organ Component]

Phrase: as

Phrase: previous .
Meta Mapping (1000):
  1000   Previous [Temporal Concept]
Meta Mapping (1000):
  1000   previous (Act Relationship Subset - previous) [Temporal Concept]
Processing 00000000.tx.28: A repeat CMV hypercapture , negative for presence of CMV . 

Phrase: A repeat CMV hypercapture ,
Meta Mapping (660):
   660   Repeat [Functional Concept]
Meta Mapping (660):
   660   Repeat (Repeat Pattern) [Temporal Concept]
Meta Mapping (660):
   660   Repeat (Repeat Object) [Conceptual Entity]

Phrase: negative for presence of CMV .
Meta Mapping (736):
   593   Presence (Present) [Quantitative Concept]
   797   CMV Negative [Idea or Concept]
Meta Mapping (736):
   593   Presence (Providing presence (regime/therapy)) [Therapeutic or Preventive Procedure]
   797   CMV Negative [Idea or Concept]
Meta Mapping (736):
   593   Presence (Presence (property)) [Qualitative Concept]
   797   CMV Negative [Idea or Concept]
Processing 00000000.tx.29: Infectious disease consult was obtained and recommendation was to switch from voriconazole to itraconazole , on which there was more existing data on treatment of Acanthamoeba infection . 

Phrase: Infectious disease
Meta Mapping (1000):
  1000   Infectious Disease (Communicable Diseases) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Infectious Disease (Infectious Disease Pathway) [Functional Concept]

Phrase: consult
Meta Mapping (1000):
  1000   Consult (Consultation) [Health Care Activity]

Phrase: was

Phrase: obtained
Meta Mapping (1000):
  1000   Obtained (Obtain) [Functional Concept]

Phrase: and

Phrase: recommendation
Meta Mapping (1000):
  1000   Recommendation [Idea or Concept]

Phrase: was

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: switch from voriconazole
Meta Mapping (746):
   790   Switch (Switch Device Component) [Manufactured Object]
   790   VORICONAZOLE (voriconazole) [Organic Chemical,Pharmacologic Substance]

Phrase: to itraconazole ,
Meta Mapping (1000):
  1000   ITRACONAZOLE (Itraconazole) [Organic Chemical,Pharmacologic Substance]

Phrase: on which

Phrase: there

Phrase: was

Phrase: more existing data
Meta Mapping (802):
   660   More [Functional Concept]
   827   Data [Idea or Concept]
Meta Mapping (802):
   660   More [Functional Concept]
   827   data (Data call receiving device) [Medical Device]
Meta Mapping (802):
   660   More [Functional Concept]
   827   Data (Data (eukaryote)) [Eukaryote]

Phrase: on treatment of Acanthamoeba infection .
Meta Mapping (752):
   760   On (Upon - dosing instruction fragment) [Functional Concept]
   760   treatment (therapeutic aspects) [Functional Concept]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (Upon - dosing instruction fragment) [Functional Concept]
   760   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (Upon - dosing instruction fragment) [Functional Concept]
   760   Treatment (Treating) [Functional Concept]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (Upon - dosing instruction fragment) [Functional Concept]
   760   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (Upon - dosing instruction fragment) [Functional Concept]
   760   Treatment (Biomaterial Treatment) [Conceptual Entity]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (Upon - dosing instruction fragment) [Functional Concept]
   760   TREATMENT (Treatment Epoch) [Research Activity]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (Upon - dosing instruction fragment) [Functional Concept]
   760   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (On (qualifier value)) [Intellectual Product]
   760   treatment (therapeutic aspects) [Functional Concept]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (On (qualifier value)) [Intellectual Product]
   760   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (On (qualifier value)) [Intellectual Product]
   760   Treatment (Treating) [Functional Concept]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (On (qualifier value)) [Intellectual Product]
   760   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (On (qualifier value)) [Intellectual Product]
   760   Treatment (Biomaterial Treatment) [Conceptual Entity]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (On (qualifier value)) [Intellectual Product]
   760   TREATMENT (Treatment Epoch) [Research Activity]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Meta Mapping (752):
   760   On (On (qualifier value)) [Intellectual Product]
   760   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
   640   Acanthamoeba infection (Infection by Acanthamoeba) [Disease or Syndrome]
Processing 00000000.tx.30: A single blood culture positive for coagulase negative Staphylococcus was treated with a course of vancomycin in the setting of a PICC line and a chest x-ray on November 20 indicating possible developing pneumonia , resulted in a course of levofloxacin , for both possible pneumonia , as well as treatment of any bacterial superinfection of Acanthamoeba sinusitis . 

Phrase: A single blood culture positive for coagulase negative Staphylococcus
Meta Mapping (805):
   575   Single (Unmarried person) [Population Group]
   615   Blood for culture [Finding]
   742   % Positive (percent positive cells) [Quantitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   Single (Unmarried person) [Population Group]
   615   Blood for culture [Finding]
   742   Positive [Qualitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   Single (Unmarried person) [Population Group]
   615   Blood for culture [Finding]
   742   POSITIVE (Positive Finding) [Finding]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   Single (Unmarried person) [Population Group]
   615   Blood for culture [Finding]
   742   Positive (Positive Charge) [Qualitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   Single (Unmarried person) [Population Group]
   615   Blood for culture [Finding]
   742   Positive (Positive Number) [Conceptual Entity]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   single (Unmarried) [Finding]
   615   Blood for culture [Finding]
   742   % Positive (percent positive cells) [Quantitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   single (Unmarried) [Finding]
   615   Blood for culture [Finding]
   742   Positive [Qualitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   single (Unmarried) [Finding]
   615   Blood for culture [Finding]
   742   POSITIVE (Positive Finding) [Finding]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   single (Unmarried) [Finding]
   615   Blood for culture [Finding]
   742   Positive (Positive Charge) [Qualitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   single (Unmarried) [Finding]
   615   Blood for culture [Finding]
   742   Positive (Positive Number) [Conceptual Entity]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   SINGLE (Singular) [Quantitative Concept]
   615   Blood for culture [Finding]
   742   % Positive (percent positive cells) [Quantitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   SINGLE (Singular) [Quantitative Concept]
   615   Blood for culture [Finding]
   742   Positive [Qualitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   SINGLE (Singular) [Quantitative Concept]
   615   Blood for culture [Finding]
   742   POSITIVE (Positive Finding) [Finding]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   SINGLE (Singular) [Quantitative Concept]
   615   Blood for culture [Finding]
   742   Positive (Positive Charge) [Qualitative Concept]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]
Meta Mapping (805):
   575   SINGLE (Singular) [Quantitative Concept]
   615   Blood for culture [Finding]
   742   Positive (Positive Number) [Conceptual Entity]
   623   COAGULASE NEGATIVE STAPHYLOCOCCUS (Staphylococcus, coagulase negative (organism)) [Bacterium]

Phrase: was

Phrase: treated with a course of vancomycin
Meta Mapping (712):
   790   Treated with [Therapeutic or Preventive Procedure]
   753   Course [Temporal Concept]
   753   VANCOMYCIN (Vancomycin) [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: in the setting of a PICC line
Meta Mapping (706):
   748   Setting (contextual factors) [Functional Concept]
   612   PICC line (Peripherally inserted central catheter (physical object)) [Medical Device]
Meta Mapping (706):
   748   {Setting} [Quantitative Concept]
   612   PICC line (Peripherally inserted central catheter (physical object)) [Medical Device]

Phrase: and

Phrase: a chest x-ray on November 20
Meta Mapping (746):
   814   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
   581   November [Temporal Concept]
   581   20% [Finding]
Meta Mapping (746):
   814   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]
   581   November [Temporal Concept]
   581   20% [Finding]

Phrase: indicating

Phrase: possible developing pneumonia ,
Meta Mapping (802):
   660   Possible [Qualitative Concept]
   827   PNEUMONIA (Pneumonia) [Disease or Syndrome]
Meta Mapping (802):
   660   Possible (Possibly Related to Intervention) [Qualitative Concept]
   827   PNEUMONIA (Pneumonia) [Disease or Syndrome]
Meta Mapping (802):
   660   Possible (Possible diagnosis) [Qualitative Concept]
   827   PNEUMONIA (Pneumonia) [Disease or Syndrome]

Phrase: resulted in a course of levofloxacin ,
Meta Mapping (655):
   719   Result [Functional Concept]
   753   Course [Temporal Concept]
   753   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
Meta Mapping (655):
   719   Result (What subject filter - Result) [Idea or Concept]
   753   Course [Temporal Concept]
   753   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]
Meta Mapping (655):
   719   Result (Experimental Result) [Finding]
   753   Course [Temporal Concept]
   753   LEVOFLOXACIN (Levofloxacin) [Antibiotic,Organic Chemical]

Phrase: for both possible pneumonia ,
Meta Mapping (888):
   694   Possible [Qualitative Concept]
   861   PNEUMONIA (Pneumonia) [Disease or Syndrome]
Meta Mapping (888):
   694   Possible (Possibly Related to Intervention) [Qualitative Concept]
   861   PNEUMONIA (Pneumonia) [Disease or Syndrome]
Meta Mapping (888):
   694   Possible (Possible diagnosis) [Qualitative Concept]
   861   PNEUMONIA (Pneumonia) [Disease or Syndrome]

Phrase: as well as

Phrase: treatment of any bacterial superinfection of Acanthamoeba sinusitis .
Meta Mapping (682):
   744   treatment (therapeutic aspects) [Functional Concept]
   600   Bacterial sinusitis [Disease or Syndrome]
   578   SUPERINFECTION (Superinfection) [Disease or Syndrome]
   578   Acanthameba (Acanthamoeba) [Eukaryote]
Meta Mapping (682):
   744   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   600   Bacterial sinusitis [Disease or Syndrome]
   578   SUPERINFECTION (Superinfection) [Disease or Syndrome]
   578   Acanthameba (Acanthamoeba) [Eukaryote]
Meta Mapping (682):
   744   Treatment (Treating) [Functional Concept]
   600   Bacterial sinusitis [Disease or Syndrome]
   578   SUPERINFECTION (Superinfection) [Disease or Syndrome]
   578   Acanthameba (Acanthamoeba) [Eukaryote]
Meta Mapping (682):
   744   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
   600   Bacterial sinusitis [Disease or Syndrome]
   578   SUPERINFECTION (Superinfection) [Disease or Syndrome]
   578   Acanthameba (Acanthamoeba) [Eukaryote]
Meta Mapping (682):
   744   Treatment (Biomaterial Treatment) [Conceptual Entity]
   600   Bacterial sinusitis [Disease or Syndrome]
   578   SUPERINFECTION (Superinfection) [Disease or Syndrome]
   578   Acanthameba (Acanthamoeba) [Eukaryote]
Meta Mapping (682):
   744   TREATMENT (Treatment Epoch) [Research Activity]
   600   Bacterial sinusitis [Disease or Syndrome]
   578   SUPERINFECTION (Superinfection) [Disease or Syndrome]
   578   Acanthameba (Acanthamoeba) [Eukaryote]
Meta Mapping (682):
   744   treatment (treatment - ActInformationManagementReason) [Health Care Activity]
   600   Bacterial sinusitis [Disease or Syndrome]
   578   SUPERINFECTION (Superinfection) [Disease or Syndrome]
   578   Acanthameba (Acanthamoeba) [Eukaryote]
Processing 00000000.tx.31: LA K. 

Phrase: LA K.
Meta Mapping (888):
   694   La (Lanthanum) [Element, Ion, or Isotope]
   861   K+ (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (888):
   694   La (Lanthanum) [Element, Ion, or Isotope]
   861   K' (K Prime) [Quantitative Concept]
Meta Mapping (888):
   694   LA (Left upper arm structure) [Body Part, Organ, or Organ Component]
   861   K+ (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (888):
   694   LA (Left upper arm structure) [Body Part, Organ, or Organ Component]
   861   K' (K Prime) [Quantitative Concept]
Meta Mapping (888):
   694   LA (Lupus Anticoagulant Antibody) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   K+ (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (888):
   694   LA (Lupus Anticoagulant Antibody) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   K' (K Prime) [Quantitative Concept]
Processing 00000000.tx.32: SKI , M.D. 

Phrase: SKI ,
Meta Mapping (1000):
  1000   Ski (Manufactured ski) [Manufactured Object]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.33: OF1 WS584/564649 D : <RECORD ID="815"> 237916498 PUOMC Unsigned DIS Report Status : NAME : ADMISSION DATE : 10/02/96 She was last admitted in 06/96 for pelvic fracture which was accompanied by bright red blood per rectum . 

Phrase: OF1 WS584/564649 D

Phrase: :

Phrase: <RECORD ID="815"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 237916498 PUOMC Unsigned DIS Report Status
Meta Mapping (762):
   632   DIS (Diagnostic interview schedule) [Intellectual Product]
   827   Report status [Finding]
Meta Mapping (762):
   632   DIS (Discontinued) [Finding]
   827   Report status [Finding]

Phrase: :

Phrase: NAME
Meta Mapping (1000):
  1000   Name [Intellectual Product]
Meta Mapping (1000):
  1000   Name (Person Name) [Intellectual Product]

Phrase: :

Phrase: ADMISSION DATE
Meta Mapping (1000):
  1000   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (1000):
  1000   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: 10/02/96
Meta Mapping (827):
   827   10% [Finding]

Phrase: She

Phrase: was

Phrase: last
Meta Mapping (1000):
  1000   Last [Qualitative Concept]

Phrase: admitted in 06/96
Meta Mapping (770):
   770   admitted (Hospital admission) [Health Care Activity]
Meta Mapping (770):
   770   Admitted (Admission activity) [Health Care Activity]

Phrase: for pelvic fracture
Meta Mapping (1000):
  1000   PELVIC FRACTURE (Fracture of pelvis) [Injury or Poisoning]

Phrase: which

Phrase: was

Phrase: accompanied by bright red blood per rectum .
Meta Mapping (897):
   897   BRIGHT RED BLOOD PER RECTUM (Hematochezia) [Finding]
Processing 00000000.tx.34: The head and neck exam was unremarkable . 

Phrase: The head
Meta Mapping (1000):
  1000   HEAD (Head) [Body Location or Region]
Meta Mapping (1000):
  1000   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Head (Head - Component of Device) [Manufactured Object]

Phrase: and

Phrase: neck exam
Meta Mapping (888):
   694   NECK (Neck) [Body Location or Region]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   Neck (Entire neck) [Body Part, Organ, or Organ Component]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   neck (dendritic spine neck) [Cell Component]
   861   Exam (Medical Examination) [Health Care Activity]

Phrase: was

Phrase: unremarkable .
Meta Mapping (1000):
  1000   Unremarkable (Normal) [Qualitative Concept]
Processing 00000000.tx.35: Her admission vital signs included a blood pressure of 99/54 , pulse 72 , respirations 20 , temperature 98.8 . 

Phrase: Her admission vital signs
Meta Mapping (901):
   660   Admission (Hospital admission) [Health Care Activity]
   901   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (901):
   660   Admission (Hospital admission) [Health Care Activity]
   901   Signs, Vital (Vital signs) [Clinical Attribute]
Meta Mapping (901):
   660   Admission (Admission activity) [Health Care Activity]
   901   Vital signs (Taking vital signs) [Health Care Activity]
Meta Mapping (901):
   660   Admission (Admission activity) [Health Care Activity]
   901   Signs, Vital (Vital signs) [Clinical Attribute]

Phrase: included
Meta Mapping (1000):
  1000   included (Including (qualifier)) [Functional Concept]

Phrase: a blood pressure of 99/54 ,
Meta Mapping (790):
   790   BLOOD PRESSURE (Blood Pressure) [Organism Function]
Meta Mapping (790):
   790   Blood Pressure (Blood pressure finding) [Finding]
Meta Mapping (790):
   790   Blood pressure (Systemic arterial pressure) [Finding]

Phrase: pulse 72 ,
Meta Mapping (861):
   861   PULSE (Pulse Rate) [Clinical Attribute]
Meta Mapping (861):
   861   Pulse (Physiologic pulse) [Physiologic Function]
Meta Mapping (861):
   861   Pulse (Pulse phenomenon) [Phenomenon or Process]

Phrase: respirations 20 ,
Meta Mapping (888):
   861   respirations (Respiration) [Physiologic Function]
   861   20% [Finding]

Phrase: temperature 98.8 .
Meta Mapping (827):
   827   temperature (Body Temperature) [Organism Attribute]
Meta Mapping (827):
   827   *Temperature (Temperature) [Quantitative Concept]
Processing 00000000.tx.36: The lungs had mild bibasilar rales , superimposed over baseline wheezes . 

Phrase: The lungs
Meta Mapping (1000):
  1000   LUNGS (Lung) [Body Part, Organ, or Organ Component]

Phrase: had

Phrase: mild bibasilar rales ,
Meta Mapping (802):
   660   MILD (Mild (qualifier value)) [Qualitative Concept]
   827   RALES (Rales) [Sign or Symptom]
Meta Mapping (802):
   660   MILD (Mild (qualifier value)) [Qualitative Concept]
   827   Rales (Basilar Rales) [Finding]

Phrase: superimposed over baseline wheezes .
Meta Mapping (722):
   770   baseline (BaseLine dental cement) [Biomedical or Dental Material]
   770   Wheezes (Wheezing) [Sign or Symptom]
Meta Mapping (722):
   770   Baseline [Quantitative Concept]
   770   Wheezes (Wheezing) [Sign or Symptom]
Processing 00000000.tx.37: The patient underwent colonoscopy on 10/4/96 and rectal carcinoma was observed and cauterized with a Yag laser . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: underwent

Phrase: colonoscopy on 10/4/96
Meta Mapping (686):
   760   Colonoscopy (colonoscopy) [Diagnostic Procedure]
   593   10% [Finding]
Meta Mapping (686):
   760   Colonoscopy (Consent Type - Colonoscopy) [Health Care Activity]
   593   10% [Finding]

Phrase: and

Phrase: rectal carcinoma
Meta Mapping (1000):
  1000   RECTAL CARCINOMA (Rectal Carcinoma) [Neoplastic Process]
Meta Mapping (1000):
  1000   rectal carcinoma (Adenocarcinoma of rectum) [Neoplastic Process]

Phrase: was

Phrase: observed
Meta Mapping (1000):
  1000   Observed [Functional Concept]

Phrase: and

Phrase: cauterized with a Yag laser .
Meta Mapping (745):
   760   cauterized (Cauterization - action) [Therapeutic or Preventive Procedure]
   806   YAG - laser (YAG Lasers) [Medical Device]
Processing 00000000.tx.38: TD : cc : CTMC Discharge Date : 01/20/1996 The course had multiple complications requiring pressors . 

Phrase: TD
Meta Mapping (1000):
  1000   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (1000):
  1000   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :

Phrase: cc
Meta Mapping (1000):
  1000   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: CTMC Discharge Date
Meta Mapping (901):
   901   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (901):
   901   Discharge date [Temporal Concept]

Phrase: :

Phrase: 01/20/1996
Meta Mapping (827):
   827   20% [Finding]

Phrase: The course
Meta Mapping (1000):
  1000   Course [Temporal Concept]

Phrase: had

Phrase: multiple complications
Meta Mapping (888):
   694   MULTIPLE (Numerous) [Quantitative Concept]
   861   Complications (Complication) [Pathologic Function]
Meta Mapping (888):
   694   MULTIPLE (Numerous) [Quantitative Concept]
   861   complications (Complication Aspects) [Pathologic Function]

Phrase: requiring

Phrase: pressors .
Meta Mapping (1000):
  1000   Pressors [Pharmacologic Substance]
Processing 00000000.tx.39: ALLERGIES : He does not drink alcohol . 

Phrase: ALLERGIES
Meta Mapping (1000):
  1000   Allergies (Hypersensitivity) [Pathologic Function]

Phrase: :

Phrase: He

Phrase: does

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: drink
Meta Mapping (1000):
  1000   Drink (Drink (dietary substance)) [Food]

Phrase: alcohol .
Meta Mapping (1000):
  1000   ALCOHOL (Ethanol) [Organic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Alcohol (Alcohols) [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.40: EXTREMITIES : No edema with 2+ pulses . 

Phrase: EXTREMITIES
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: No edema with 2+ pulses .
Meta Mapping (686):
   760 N OEDEMA (Edema) [Finding]
   593   Pulses (Pulse taking) [Health Care Activity]
Meta Mapping (686):
   760 N OEDEMA (Edema) [Finding]
   593 N PULSES (Physiologic pulse) [Physiologic Function]
Meta Mapping (686):
   760   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   593   Pulses (Pulse taking) [Health Care Activity]
Meta Mapping (686):
   760   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
   593 N PULSES (Physiologic pulse) [Physiologic Function]
Processing 00000000.tx.41: Chest x-ray showed no infiltrates and no pulmonary edema . 

Phrase: Chest x-ray
Meta Mapping (1000):
  1000   Chest X-ray (Plain chest X-ray) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Chest X-ray (Views:Finding:Point in time:Chest:Narrative:XR) [Clinical Attribute]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: no infiltrates
Meta Mapping (1000):
  1000 N Infiltrates (Infiltration) [Pathologic Function]

Phrase: and

Phrase: no pulmonary edema .
Meta Mapping (1000):
  1000 N PULMONARY OEDEMA (Pulmonary Edema) [Disease or Syndrome]
Processing 00000000.tx.42: At cardiac catheterization he had an RA pressure of 8 , an RV pressure of 52/10 , PA pressure of 60/25 , and wedge of 26 . 

Phrase: At cardiac catheterization
Meta Mapping (1000):
  1000   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]

Phrase: he

Phrase: had

Phrase: an RA pressure of 8 ,
Meta Mapping (806):
   806   RA pressure (Intrachamber:Pres:Pt:Heart.atrium.right:Qn) [Clinical Attribute]

Phrase: an RV pressure of 52/10 ,
Meta Mapping (672):
   586   RV (Residual volume) [Clinical Attribute]
   753   Pressure (Pressure- physical agent) [Phenomenon or Process]
   586   10% [Finding]
Meta Mapping (672):
   586   RV (Residual volume) [Clinical Attribute]
   753   Pressure (Pressure (finding)) [Finding]
   586   10% [Finding]
Meta Mapping (672):
   586   RV (Residual volume) [Clinical Attribute]
   753   Pressure (Pressure - action) [Functional Concept]
   586   10% [Finding]
Meta Mapping (672):
   586   RV (Randomization Validation) [Research Activity]
   753   Pressure (Pressure- physical agent) [Phenomenon or Process]
   586   10% [Finding]
Meta Mapping (672):
   586   RV (Randomization Validation) [Research Activity]
   753   Pressure (Pressure (finding)) [Finding]
   586   10% [Finding]
Meta Mapping (672):
   586   RV (Randomization Validation) [Research Activity]
   753   Pressure (Pressure - action) [Functional Concept]
   586   10% [Finding]

Phrase: PA pressure of 60/25 ,
Meta Mapping (696):
   593   PA (Paraguay) [Geographic Area]
   760   Pressure (Pressure- physical agent) [Phenomenon or Process]
   593   60% [Finding]
Meta Mapping (696):
   593   PA (Paraguay) [Geographic Area]
   760   Pressure (Pressure (finding)) [Finding]
   593   60% [Finding]
Meta Mapping (696):
   593   PA (Paraguay) [Geographic Area]
   760   Pressure (Pressure - action) [Functional Concept]
   593   60% [Finding]
Meta Mapping (696):
   593   PA (Pairing Events Domain) [Intellectual Product]
   760   Pressure (Pressure- physical agent) [Phenomenon or Process]
   593   60% [Finding]
Meta Mapping (696):
   593   PA (Pairing Events Domain) [Intellectual Product]
   760   Pressure (Pressure (finding)) [Finding]
   593   60% [Finding]
Meta Mapping (696):
   593   PA (Pairing Events Domain) [Intellectual Product]
   760   Pressure (Pressure - action) [Functional Concept]
   593   60% [Finding]

Phrase: and

Phrase: wedge of 26 .
Meta Mapping (790):
   790   Wedge [Spatial Concept]
Processing 00000000.tx.43: DISCHARGE MEDICATIONS : Index No. 

Phrase: DISCHARGE MEDICATIONS
Meta Mapping (1000):
  1000   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: Index
Meta Mapping (1000):
  1000   Index [Intellectual Product]
Meta Mapping (1000):
  1000   index (Html Link Type - index) [Idea or Concept]
Meta Mapping (1000):
  1000   % index [Quantitative Concept]

Phrase: No.
Processing 00000000.tx.44: WDXZUZ7Y9B DIS Unsigned ED DISCHARGE NOTIFICATION / SUMMARY Sent message via pager Discharge Status : Condition on Discharge : Stable 2. 

Phrase: WDXZUZ7Y9B DIS Unsigned ED DISCHARGE NOTIFICATION / SUMMARY
Meta Mapping (751):
   629   DIS (Diagnostic interview schedule) [Intellectual Product]
   629   ED (Endocrine System Findings Domain) [Idea or Concept]
   829   Discharge summary [Intellectual Product]
   629   NOTIFICATION (Notifications) [Health Care Activity]
Meta Mapping (751):
   629   DIS (Diagnostic interview schedule) [Intellectual Product]
   629   ED (Endocrine System Findings Domain) [Idea or Concept]
   829   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   629   NOTIFICATION (Notifications) [Health Care Activity]
Meta Mapping (751):
   629   DIS (Discontinued) [Finding]
   629   ED (Endocrine System Findings Domain) [Idea or Concept]
   829   Discharge summary [Intellectual Product]
   629   NOTIFICATION (Notifications) [Health Care Activity]
Meta Mapping (751):
   629   DIS (Discontinued) [Finding]
   629   ED (Endocrine System Findings Domain) [Idea or Concept]
   829   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
   629   NOTIFICATION (Notifications) [Health Care Activity]

Phrase: Sent
Meta Mapping (1000):
  1000   Sent (Send (transmission)) [Functional Concept]

Phrase: message via pager Discharge Status
Meta Mapping (761):
   760   Message (message) [Intellectual Product]
   593   pager (Hospital Communication Systems, Paging) [Intellectual Product]
   640   Discharge status [Finding]
Meta Mapping (761):
   760   Message (message) [Intellectual Product]
   593   pager (Hospital Communication Systems, Paging) [Intellectual Product]
   640   Discharge Status (Discharge Status:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (761):
   760   Message (message) [Intellectual Product]
   593   Pager (Pagers) [Manufactured Object]
   640   Discharge status [Finding]
Meta Mapping (761):
   760   Message (message) [Intellectual Product]
   593   Pager (Pagers) [Manufactured Object]
   640   Discharge Status (Discharge Status:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: Condition on Discharge
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Discharge, body substance) [Body Substance]

Phrase: :

Phrase: Stable 2.
Meta Mapping (861):
   861   STABLE (Stable status) [Qualitative Concept]
Meta Mapping (861):
   861   Stable (Patient Condition Code - Stable) [Intellectual Product]
Processing 00000000.tx.45: Have dressing changed at HD tomorrow This report was created by SAGEPL , SHASQUALENA 05/18/2003 09:06 PM <TEXT> Unsigned Accordingly she presents for operative therapy at this time . 

Phrase: Have

Phrase: dressing
Meta Mapping (1000):
  1000   DRESSING (Sterile coverings) [Medical Device]
Meta Mapping (1000):
  1000   Dressing (Dressing of skin or wound) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   dressing (Dressing self-care) [Finding]
Meta Mapping (1000):
  1000   Dressing (Dressing- activity of daily living) [Daily or Recreational Activity]

Phrase: changed at HD tomorrow
Meta Mapping (770):
   770   Changed (Changing) [Functional Concept]
Meta Mapping (770):
   770   Changed (Changed status) [Quantitative Concept]

Phrase: This report
Meta Mapping (1000):
  1000   Report (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Report (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]

Phrase: was

Phrase: created by SAGEPL ,
Meta Mapping (882):
   882   Created By [Qualitative Concept]

Phrase: SHASQUALENA 05/18/2003 09

Phrase: :

Phrase: 06 PM
Meta Mapping (861):
   861   PM (Panama) [Geographic Area]
Meta Mapping (861):
   861   PM (Infusion pump Alert priority PM) [Finding]

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > Unsigned Accordingly

Phrase: she

Phrase: presents for operative therapy
Meta Mapping (783):
   770   Present [Quantitative Concept]
   833   operative therapy (Surgical aspects) [Functional Concept]
Meta Mapping (783):
   770   Present (Presentation) [Idea or Concept]
   833   operative therapy (Surgical aspects) [Functional Concept]

Phrase: at this time .
Meta Mapping (1000):
  1000   TIME (Time) [Temporal Concept]
Meta Mapping (1000):
  1000   Time (Time (foundation metadata concept)) [Temporal Concept]
Processing 00000000.tx.46: MEDICATIONS : Pelvic exam showed a small mobile uterus . 

Phrase: MEDICATIONS
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: Pelvic exam
Meta Mapping (1000):
  1000   Pelvic Exam (Manual pelvic examination (procedure)) [Diagnostic Procedure]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a small mobile uterus .
Meta Mapping (901):
   913   Small uterus [Finding]
   660   Mobile [Functional Concept]
Meta Mapping (901):
   913   Small uterus [Finding]
   660   Mobile (Clinic / Center - Mobile) [Health Care Related Organization,Manufactured Object]
Meta Mapping (901):
   913   Small uterus [Finding]
   660   MOBILE (Lipid R1 MRI) [Diagnostic Procedure]
Processing 00000000.tx.47: Report : <RECORD ID="819"> PAST MEDICAL HISTORY : She failed to improve following placement of the ventriculostomy and her poor prognosis was discussed with the family . 

Phrase: Report
Meta Mapping (1000):
  1000   Report (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Report (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]

Phrase: :

Phrase: <RECORD ID="819"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: She

Phrase: failed
Meta Mapping (1000):
  1000   Failed (failed) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: improve

Phrase: following
Meta Mapping (1000):
  1000   Following (Status post) [Temporal Concept]
Meta Mapping (1000):
  1000   Following [Temporal Concept]

Phrase: placement of the ventriculostomy
Meta Mapping (708):
   770   Placement (Clinical act of insertion) [Health Care Activity]
   604   Ventriculostomy [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   Placement [Qualitative Concept]
   604   Ventriculostomy [Therapeutic or Preventive Procedure]
Meta Mapping (708):
   770   Placement (Placement action) [Health Care Activity]
   604   Ventriculostomy [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: her poor prognosis
Meta Mapping (1000):
  1000   Poor prognosis (Prognosis bad) [Finding]

Phrase: was

Phrase: discussed with the family .
Meta Mapping (691):
   737   Discuss (Discussion (communication)) [Social Behavior]
   770   Family [Family Group]
Meta Mapping (691):
   737   Discuss (Discussion (communication)) [Social Behavior]
   770   Family (Family (taxonomic)) [Conceptual Entity]
Processing 00000000.tx.48: The family was informed and all questions were answered . 

Phrase: The family
Meta Mapping (1000):
  1000   Family [Family Group]
Meta Mapping (1000):
  1000   Family (Family (taxonomic)) [Conceptual Entity]

Phrase: was

Phrase: informed
Meta Mapping (1000):
  1000   Informed [Qualitative Concept]

Phrase: and

Phrase: all questions
Meta Mapping (966):
   966   Question (Question (inquiry)) [Intellectual Product]

Phrase: were

Phrase: answered .
Meta Mapping (966):
   966   Answer (Response (statement)) [Intellectual Product]
Processing 00000000.tx.49: </TEXT> DISCHARGE DATE : Subarachnoid hemorrhage . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > DISCHARGE DATE
Meta Mapping (1000):
  1000   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Discharge date [Temporal Concept]

Phrase: :

Phrase: Subarachnoid hemorrhage .
Meta Mapping (1000):
  1000   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
Processing 00000000.tx.50: Coumadin 3 mg. per day prior to admission . 

Phrase: Coumadin 3 mg.
Meta Mapping (802):
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   MG (Mongolia) [Geographic Area]
Meta Mapping (802):
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (802):
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (802):
   660   Coumadin [Organic Chemical,Pharmacologic Substance]
   827   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: per day prior to admission .
Meta Mapping (787):
   760   /day (Daily) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (787):
   760   /day (Daily) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Admission activity) [Health Care Activity]
Meta Mapping (787):
   760   DAY (day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (787):
   760   DAY (day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Admission activity) [Health Care Activity]
Meta Mapping (787):
   760   /day (per day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (787):
   760   /day (per day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Admission (Admission activity) [Health Care Activity]
Processing 00000000.tx.51: He was found to be an obese male with eyes closed . 

Phrase: He

Phrase: was

Phrase: found
Meta Mapping (1000):
  1000   Found (Present) [Quantitative Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: an obese male with eyes
Meta Mapping (696):
   593   OBESE (Obesity) [Disease or Syndrome]
   760   MALE (Males) [Organism Attribute]
   593   Eyes (Eye) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   593   OBESE (Obesity) [Disease or Syndrome]
   760   Male (Male Gender, Self Report) [Qualitative Concept]
   593   Eyes (Eye) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   593   OBESE (Obesity) [Disease or Syndrome]
   760   Male (Male Phenotype) [Qualitative Concept]
   593   Eyes (Eye) [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   593   OBESE (Obesity) [Disease or Syndrome]
   760   Male (Male, Self-Reported) [Organism Attribute]
   593   Eyes (Eye) [Body Part, Organ, or Organ Component]

Phrase: closed .
Meta Mapping (1000):
  1000   Closed [Functional Concept]
Processing 00000000.tx.52: A CT scan on admission showed a pre-pontine subarachnoid hemorrhage with minimal spread to the sylvian fissure . 

Phrase: A CT scan
Meta Mapping (1000):
  1000   CT SCAN (X-Ray Computed Tomography) [Diagnostic Procedure]

Phrase: on admission
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a pre-pontine subarachnoid hemorrhage with minimal
Meta Mapping (719):
   581   Pre (Before) [Temporal Concept]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before) [Temporal Concept]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before) [Temporal Concept]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before) [Temporal Concept]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before) [Temporal Concept]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before) [Temporal Concept]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before values) [Qualitative Concept]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before values) [Qualitative Concept]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before values) [Qualitative Concept]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before values) [Qualitative Concept]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before values) [Qualitative Concept]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   Pre (Before values) [Qualitative Concept]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (photoreactivating enzyme activity) [Genetic Function]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   PRE (photoreactivating enzyme activity) [Genetic Function]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (photoreactivating enzyme activity) [Genetic Function]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (photoreactivating enzyme activity) [Genetic Function]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   PRE (photoreactivating enzyme activity) [Genetic Function]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (photoreactivating enzyme activity) [Genetic Function]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (Pure Spanish horse breed (organism)) [Mammal]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   PRE (Pure Spanish horse breed (organism)) [Mammal]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (Pure Spanish horse breed (organism)) [Mammal]
   774   Pontine haemorrhage (Intrapontine hemorrhage) [Pathologic Function]
   748   SUBARACHNOID (Subarachnoid Route of Drug Administration) [Functional Concept]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (Pure Spanish horse breed (organism)) [Mammal]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal [Qualitative Concept]
Meta Mapping (719):
   581   PRE (Pure Spanish horse breed (organism)) [Mammal]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   MINIMAL (Minimum) [Qualitative Concept]
Meta Mapping (719):
   581   PRE (Pure Spanish horse breed (organism)) [Mammal]
   581   Pontine (Pontine structure) [Body Part, Organ, or Organ Component]
   778   SUBARACHNOID HEMORRHAGE (Subarachnoid Hemorrhage) [Disease or Syndrome]
   581   Minimal (Mild (qualifier value)) [Qualitative Concept]

Phrase: spread to the sylvian fissure .
Meta Mapping (745):
   760   Spread (Spreading (qualifier value)) [Qualitative Concept]
   806   Sylvian Fissure (Structure of fissure of Sylvius) [Body Space or Junction]
Meta Mapping (745):
   760   Spread (Smear - instruction imperative) [Activity]
   806   Sylvian Fissure (Structure of fissure of Sylvius) [Body Space or Junction]
Processing 00000000.tx.53: His neurological exam deteriorated over the first week of admission to the extent that he was at times responsive to voice by opening his eyes , but was not able to follow commands . 

Phrase: His neurological exam
Meta Mapping (1000):
  1000   neurological exam (Neurologic Examination) [Diagnostic Procedure]

Phrase: deteriorated over the first week of admission
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (First (number)) [Quantitative Concept]
   748   /week (Weekly) [Temporal Concept]
   748   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (First (number)) [Quantitative Concept]
   748   /week (Weekly) [Temporal Concept]
   748   Admission (Admission activity) [Health Care Activity]
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (First (number)) [Quantitative Concept]
   748   WEEK (week) [Temporal Concept]
   748   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (First (number)) [Quantitative Concept]
   748   WEEK (week) [Temporal Concept]
   748   Admission (Admission activity) [Health Care Activity]
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (Firstly) [Qualitative Concept]
   748   /week (Weekly) [Temporal Concept]
   748   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (Firstly) [Qualitative Concept]
   748   /week (Weekly) [Temporal Concept]
   748   Admission (Admission activity) [Health Care Activity]
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (Firstly) [Qualitative Concept]
   748   WEEK (week) [Temporal Concept]
   748   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (664):
   748   Deteriorated (Worse) [Finding]
   748   First (Firstly) [Qualitative Concept]
   748   WEEK (week) [Temporal Concept]
   748   Admission (Admission activity) [Health Care Activity]

Phrase: to the extent
Meta Mapping (1000):
  1000   Extent [Spatial Concept]

Phrase: that

Phrase: he

Phrase: was at times
Meta Mapping (790):
   790   times (Time) [Temporal Concept]
Meta Mapping (790):
   790   Times [Quantitative Concept]

Phrase: responsive
Meta Mapping (1000):
  1000   Responsive [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: voice by opening
Meta Mapping (746):
   790   VOICE (Voice) [Organism Function]
   790   Opening (Open) [Spatial Concept]
Meta Mapping (746):
   790   VOICE (Voice) [Organism Function]
   790   Opening [Spatial Concept]
Meta Mapping (746):
   790   voice (TelecommunicationCapabilities <voice>) [Qualitative Concept]
   790   Opening (Open) [Spatial Concept]
Meta Mapping (746):
   790   voice (TelecommunicationCapabilities <voice>) [Qualitative Concept]
   790   Opening [Spatial Concept]

Phrase: his eyes ,
Meta Mapping (1000):
  1000   Eyes (Eye) [Body Part, Organ, or Organ Component]

Phrase: but

Phrase: was

Phrase: not able
Meta Mapping (888):
   694   Not (Negation) [Functional Concept]
   861   Able (Ability) [Organism Attribute]
Meta Mapping (888):
   694   Not (Negation) [Functional Concept]
   861 N Able (Able (finding)) [Finding]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: follow
Meta Mapping (1000):
  1000   follow (Followed by) [Temporal Concept]
Meta Mapping (1000):
  1000   Follow [Intellectual Product]

Phrase: commands .
Meta Mapping (1000):
  1000   Commands (CDISC ADAS-Cog - Commands Summary Score) [Intellectual Product]
Processing 00000000.tx.54: This meeting took place on July 30th from 10:00 AM until approximately noon . 

Phrase: This meeting
Meta Mapping (1000):
  1000   Meeting (Meetings) [Activity]

Phrase: took
Meta Mapping (966):
   966   Take [Health Care Activity]

Phrase: place on July 30th
Meta Mapping (708):
   770   Place [Spatial Concept]
   604   July [Qualitative Concept]
Meta Mapping (708):
   770   Place (Place - dosing instruction imperative) [Functional Concept]
   604   July [Qualitative Concept]
Meta Mapping (708):
   770   Place (put - instruction imperative) [Activity]
   604   July [Qualitative Concept]

Phrase: from 10
Meta Mapping (1000):
  1000   10% [Finding]

Phrase: :

Phrase: 00

Phrase: AM

Phrase: until

Phrase: approximately noon .
Meta Mapping (888):
   694   Approximately (Approximate) [Qualitative Concept]
   861   Noon [Temporal Concept]
Processing 00000000.tx.55: At approximately 1:45 PM on July 30th , his ventriculostomy tube was discontinued . 

Phrase: At approximately 1
Meta Mapping (861):
   861   Approximately (Approximate) [Qualitative Concept]

Phrase: :

Phrase: 45 PM on July 30th ,
Meta Mapping (686):
   760   PM (Panama) [Geographic Area]
   593   July [Qualitative Concept]
Meta Mapping (686):
   760   PM (Infusion pump Alert priority PM) [Finding]
   593   July [Qualitative Concept]

Phrase: his ventriculostomy tube
Meta Mapping (888):
   694   Ventriculostomy [Therapeutic or Preventive Procedure]
   861   TUBE (biomedical tube device) [Medical Device]
Meta Mapping (888):
   694   Ventriculostomy [Therapeutic or Preventive Procedure]
   861   Tube NOS (Specimen Source Codes - Tube) [Intellectual Product]
Meta Mapping (888):
   694   Ventriculostomy [Therapeutic or Preventive Procedure]
   861   Tube (tube) [Conceptual Entity]
Meta Mapping (888):
   694   Ventriculostomy [Therapeutic or Preventive Procedure]
   861   {Tube} (Tube - unit dose) [Quantitative Concept]
Meta Mapping (888):
   694   Ventriculostomy [Therapeutic or Preventive Procedure]
   861   TUBE (Packaging Tube) [Medical Device]

Phrase: was

Phrase: discontinued .
Meta Mapping (1000):
  1000   Discontinued [Finding]
Processing 00000000.tx.56: Shortly thereafter , his arterial line was removed . 

Phrase: Shortly thereafter ,

Phrase: his arterial line
Meta Mapping (1000):
  1000   Arterial line (Arterial Lines) [Medical Device]
Meta Mapping (1000):
  1000   Line, Arterial (Specimen Collection Method - Line, Arterial) [Diagnostic Procedure]

Phrase: was

Phrase: removed .
Meta Mapping (1000):
  1000   Removed [Qualitative Concept]
Processing 00000000.tx.57: </RECORD> He has been having difficult access problems and now has a left upper arm PTFE . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: >

Phrase: He

Phrase: has

Phrase: been

Phrase: having

Phrase: difficult access problems
Meta Mapping (851):
   660   Difficult (Difficult (qualifier value)) [Qualitative Concept]
   660   Access [Spatial Concept]
   827   Problems (Problems - What subject filter) [Idea or Concept]
Meta Mapping (851):
   660   Difficult (Difficult (qualifier value)) [Qualitative Concept]
   660   access (Role Class - access) [Functional Concept]
   827   Problems (Problems - What subject filter) [Idea or Concept]
Meta Mapping (851):
   660   Difficult (Has difficulty doing (qualifier value)) [Finding]
   660   Access [Spatial Concept]
   827   Problems (Problems - What subject filter) [Idea or Concept]
Meta Mapping (851):
   660   Difficult (Has difficulty doing (qualifier value)) [Finding]
   660   access (Role Class - access) [Functional Concept]
   827   Problems (Problems - What subject filter) [Idea or Concept]

Phrase: and

Phrase: now
Meta Mapping (1000):
  1000   Now (Now (temporal qualifier)) [Temporal Concept]

Phrase: has

Phrase: a left upper arm PTFE .
Meta Mapping (916):
   756   Left Upper Arm (Left upper arm structure) [Body Part, Organ, or Organ Component]
   812   PTFE (Polytetrafluoroethylene) [Biomedical or Dental Material,Organic Chemical]
Processing 00000000.tx.58: Otherwise , she has been healthy and her last hemodialysis was the day prior to transplant . 

Phrase: Otherwise ,

Phrase: she

Phrase: has

Phrase: been

Phrase: healthy
Meta Mapping (1000):
  1000   Healthy [Qualitative Concept]

Phrase: and

Phrase: her last hemodialysis
Meta Mapping (888):
   694   Last [Qualitative Concept]
   861   Haemodialysis (Hemodialysis) [Therapeutic or Preventive Procedure]
Meta Mapping (888):
   694   Last [Qualitative Concept]
   861   Haemodialysis (Drug Administration via Hemodialysis) [Functional Concept]

Phrase: was

Phrase: the day prior to transplant .
Meta Mapping (787):
   760   /day (Daily) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant (Transplantation) [Therapeutic or Preventive Procedure]
Meta Mapping (787):
   760   /day (Daily) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant (Transplanted tissue) [Tissue]
Meta Mapping (787):
   760   /day (Daily) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant [Finding]
Meta Mapping (787):
   760   DAY (day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant (Transplantation) [Therapeutic or Preventive Procedure]
Meta Mapping (787):
   760   DAY (day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant (Transplanted tissue) [Tissue]
Meta Mapping (787):
   760   DAY (day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant [Finding]
Meta Mapping (787):
   760   /day (per day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant (Transplantation) [Therapeutic or Preventive Procedure]
Meta Mapping (787):
   760   /day (per day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant (Transplanted tissue) [Tissue]
Meta Mapping (787):
   760   /day (per day) [Temporal Concept]
   640   Prior to (Before) [Temporal Concept]
   593   Transplant [Finding]
Processing 00000000.tx.59: Multiple angio accesses , TAH at age 18 , cadaveric renal allograft in 03/93 , reoperation for bleed followed by transplant nephrectomy . 

Phrase: Multiple angio accesses ,
Meta Mapping (851):
   660   MULTIPLE (Numerous) [Quantitative Concept]
   827   Angio [Body Part, Organ, or Organ Component]
   827   accesses (Access) [Spatial Concept]

Phrase: TAH at age 18 ,
Meta Mapping (708):
   770   tah (Total abdominal hysterectomy) [Therapeutic or Preventive Procedure]
   604   AGE (Age) [Organism Attribute]

Phrase: cadaveric renal allograft in 03/93 ,
Meta Mapping (679):
   586   Renal (Kidney) [Body Part, Organ, or Organ Component]
   753   allograft (Transplantation, Homologous) [Therapeutic or Preventive Procedure]
Meta Mapping (679):
   586   Renal (Kidney) [Body Part, Organ, or Organ Component]
   753   Allograft (Allograft surgical material) [Biomedical or Dental Material]

Phrase: reoperation for bleed
Meta Mapping (746):
   790   Reoperation (Repeat Surgery) [Therapeutic or Preventive Procedure]
   623   bleed (Hemorrhage) [Pathologic Function]
Meta Mapping (746):
   790   Reoperation (Second Look Surgery) [Therapeutic or Preventive Procedure]
   623   bleed (Hemorrhage) [Pathologic Function]

Phrase: followed by transplant nephrectomy .
Meta Mapping (888):
   833   Followed by [Temporal Concept]
   833   Transplant nephrectomy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.60: HOSPITAL COURSE : She was started on her immunosuppressive agents as per protocol . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: She

Phrase: was

Phrase: started on her immunosuppressive agents
Meta Mapping (745):
   760   Started [Qualitative Concept]
   806   Immunosuppressive Agents [Immunologic Factor,Pharmacologic Substance]

Phrase: as per protocol .
Meta Mapping (1000):
  1000   per protocol [Functional Concept]
Processing 00000000.tx.61: Her creatinine fell to the normal range early .

Phrase: Her creatinine
Meta Mapping (1000):
  1000   CREATININE (Creatinine) [Biologically Active Substance,Organic Chemical]
Meta Mapping (1000):
  1000   Creatinine (Creatinine finding) [Finding]

Phrase: fell to the normal range early .
Meta Mapping (714):
   719   FALL (Falls) [Finding]
   790   Normal Range [Quantitative Concept]
   753   Early [Temporal Concept]
Meta Mapping (714):
   719   Fall (Autumn) [Temporal Concept]
   790   Normal Range [Quantitative Concept]
   753   Early [Temporal Concept]
Processing 00000000.tx.1: </RECORD> <RECORD ID="822"> 5838116 12/11/2002 Biopsy confirmed foci of astrocytoma . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: >

Phrase: <RECORD ID="822"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: > 5838116 12/11/2002 Biopsy confirmed foci of astrocytoma .
Meta Mapping (679):
   595   11-12 [Finding]
   575   BIOPSY (Biopsy) [Diagnostic Procedure]
   575   confirmed (Confirmed by) [Qualitative Concept]
   742   Foci (Focal) [Spatial Concept]
   575   ASTROCYTOMA (Astrocytoma) [Neoplastic Process]
Meta Mapping (679):
   595   11-12 [Finding]
   575   BIOPSY (Biopsy) [Diagnostic Procedure]
   575   Confirmed (Confirmation) [Idea or Concept]
   742   Foci (Focal) [Spatial Concept]
   575   ASTROCYTOMA (Astrocytoma) [Neoplastic Process]
Meta Mapping (679):
   595   11-12 [Finding]
   575   biopsy (biopsy characteristics) [Functional Concept]
   575   confirmed (Confirmed by) [Qualitative Concept]
   742   Foci (Focal) [Spatial Concept]
   575   ASTROCYTOMA (Astrocytoma) [Neoplastic Process]
Meta Mapping (679):
   595   11-12 [Finding]
   575   biopsy (biopsy characteristics) [Functional Concept]
   575   Confirmed (Confirmation) [Idea or Concept]
   742   Foci (Focal) [Spatial Concept]
   575   ASTROCYTOMA (Astrocytoma) [Neoplastic Process]
Processing 00000000.tx.2: Patient is awake , alert , oriented x 3 . 

Phrase: Patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: awake , alert ,
Meta Mapping (888):
   694   Awake [Finding]
   861   ALERT (Consciousness clear) [Finding]
Meta Mapping (888):
   694   Awake [Finding]
   861   Alert [Functional Concept]
Meta Mapping (888):
   694   Awake [Finding]
   861   Alert (Alert:Type:Point in time:^Patient:Nominal) [Clinical Attribute]

Phrase: oriented
Meta Mapping (1000):
  1000   Oriented (Orientation (spatial)) [Spatial Concept]
Meta Mapping (1000):
  1000   Oriented (Oriented to place) [Finding]

Phrase: x 3 .
Processing 00000000.tx.3: Strength was 5/5 . 

Phrase: Strength
Meta Mapping (1000):
  1000   Strength (Physical Strength) [Quantitative Concept]
Meta Mapping (1000):
  1000   Strength (STRENGTH (attribute)) [Idea or Concept]
Meta Mapping (1000):
  1000   Strength (Pharmaceutical Strength) [Quantitative Concept]

Phrase: was

Phrase: 5/5 .
Meta Mapping (1000):
  1000   5/5 [Quantitative Concept]
Processing 00000000.tx.4: HOSPITAL COURSE : CTMC 04/09/1991 This is an 87 year old white female who is otherwise healthy by history and presented with a several day history of upper respiratory infection . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: CTMC 04/09/1991

Phrase: This

Phrase: is

Phrase: an 87 year old white female
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   FEMALE (Female) [Organism Attribute]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   female (Woman) [Population Group]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   female (Females) [Population Group]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   Female (Female, Self-Report) [Qualitative Concept]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   Female (Female Phenotype) [Qualitative Concept]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   FEMALE (Female) [Organism Attribute]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   female (Woman) [Population Group]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   female (Females) [Population Group]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   Female (Female, Self-Report) [Qualitative Concept]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   Female (Female Phenotype) [Qualitative Concept]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   FEMALE (Female) [Organism Attribute]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   female (Woman) [Population Group]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   female (Females) [Population Group]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   Female (Female, Self-Report) [Qualitative Concept]
Meta Mapping (771):
   637   YEAR (year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   Female (Female Phenotype) [Qualitative Concept]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   FEMALE (Female) [Organism Attribute]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   female (Woman) [Population Group]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   female (Females) [Population Group]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   Female (Female, Self-Report) [Qualitative Concept]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasoid Race) [Population Group]
   804   Female (Female Phenotype) [Qualitative Concept]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   FEMALE (Female) [Organism Attribute]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   female (Woman) [Population Group]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   female (Females) [Population Group]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   Female (Female, Self-Report) [Qualitative Concept]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (Caucasians) [Population Group]
   804   Female (Female Phenotype) [Qualitative Concept]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   FEMALE (Female) [Organism Attribute]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   female (Woman) [Population Group]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   female (Females) [Population Group]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   Female (Female, Self-Report) [Qualitative Concept]
Meta Mapping (771):
   637   /Year (per year) [Temporal Concept]
   637   Old [Temporal Concept]
   804   WHITE (White color) [Qualitative Concept]
   804   Female (Female Phenotype) [Qualitative Concept]

Phrase: who

Phrase: is

Phrase: otherwise healthy by history
Meta Mapping (783):
   783   health history (PMH - past medical history) [Finding]

Phrase: and

Phrase: presented with a several day history of upper respiratory infection .
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (Daily) [Temporal Concept]
   739   History [Occupation or Discipline]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (Daily) [Temporal Concept]
   739   history (Historical aspects qualifier) [Functional Concept]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (Daily) [Temporal Concept]
   739   History, NOS (History of present illness) [Organism Attribute]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (Daily) [Temporal Concept]
   739   History (Medical History) [Finding]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (Daily) [Temporal Concept]
   739   History (Concept History) [Conceptual Entity]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (Daily) [Temporal Concept]
   739   History (History of previous events) [Finding]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   DAY (day) [Temporal Concept]
   739   History [Occupation or Discipline]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   DAY (day) [Temporal Concept]
   739   history (Historical aspects qualifier) [Functional Concept]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   DAY (day) [Temporal Concept]
   739   History, NOS (History of present illness) [Organism Attribute]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   DAY (day) [Temporal Concept]
   739   History (Medical History) [Finding]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   DAY (day) [Temporal Concept]
   739   History (Concept History) [Conceptual Entity]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   DAY (day) [Temporal Concept]
   739   History (History of previous events) [Finding]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (per day) [Temporal Concept]
   739   History [Occupation or Discipline]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (per day) [Temporal Concept]
   739   history (Historical aspects qualifier) [Functional Concept]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (per day) [Temporal Concept]
   739   History, NOS (History of present illness) [Organism Attribute]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (per day) [Temporal Concept]
   739   History (Medical History) [Finding]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (per day) [Temporal Concept]
   739   History (Concept History) [Conceptual Entity]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Meta Mapping (689):
   739   Presented (Presentation) [Idea or Concept]
   739   /day (per day) [Temporal Concept]
   739   History (History of previous events) [Finding]
   782   Respiratory Infection, Upper (Upper Respiratory Infections) [Disease or Syndrome]
Processing 00000000.tx.5: She presented to the Emergency Room with some throat discomfort , some mild hoarseness , which she said had been progressing over the last few days . 

Phrase: She

Phrase: presented to the Emergency Room
Meta Mapping (745):
   760   Presented (Presentation) [Idea or Concept]
   806   EMERGENCY ROOM (Accident and Emergency department) [Health Care Related Organization]

Phrase: with some throat discomfort ,
Meta Mapping (1000):
  1000   Throat discomfort (Sore Throat) [Sign or Symptom]

Phrase: some mild hoarseness ,
Meta Mapping (888):
   694   MILD (Mild (qualifier value)) [Qualitative Concept]
   861   HOARSENESS (Hoarseness) [Sign or Symptom]

Phrase: which

Phrase: she

Phrase: said

Phrase: had

Phrase: been

Phrase: progressing over the last few days .
Meta Mapping (672):
   753   progressing (Progressive) [Functional Concept]
   753   DAYS (day) [Temporal Concept]
Processing 00000000.tx.6: PAST MEDICAL HISTORY : Otherwise normal and the trachea was midline . 

Phrase: PAST MEDICAL HISTORY
Meta Mapping (1000):
  1000   Past Medical History (Medical History) [Finding]
Meta Mapping (1000):
  1000   Past medical history (PMH - past medical history) [Finding]

Phrase: :

Phrase: Otherwise normal
Meta Mapping (861):
   861   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (861):
   861   Normal (Gait normal) [Finding]
Meta Mapping (861):
   861   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (861):
   861   % Normal (Mean Percent of Normal) [Quantitative Concept]

Phrase: and

Phrase: the trachea
Meta Mapping (1000):
  1000   TRACHEA (Trachea) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Trachea (Entire trachea) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Trachea (Trachea (moth)) [Eukaryote]

Phrase: was

Phrase: midline .
Meta Mapping (1000):
  1000   MIDLINE (Midline (qualifier value)) [Spatial Concept]
Meta Mapping (1000):
  1000   midline (midline cell component) [Cell Component]
Meta Mapping (1000):
  1000   Midline (Median (qualifier value)) [Spatial Concept]
Processing 00000000.tx.7: The right pyriform was narrowed by edema . 

Phrase: The right pyriform
Meta Mapping (694):
   694   RIGHT (Right) [Spatial Concept]
Meta Mapping (694):
   694   Right (Right sided) [Spatial Concept]

Phrase: was

Phrase: narrowed by edema .
Meta Mapping (746):
   790   Narrowed (Narrow) [Quantitative Concept]
   790   OEDEMA (Edema) [Finding]
Meta Mapping (746):
   790   Narrowed (Narrow) [Quantitative Concept]
   790   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Processing 00000000.tx.8: Extremities : Normal . 

Phrase: Extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: Normal .
Meta Mapping (1000):
  1000   NORMAL (Normal) [Qualitative Concept]
Meta Mapping (1000):
  1000   Normal (Gait normal) [Finding]
Meta Mapping (1000):
  1000   % normal (Percent normal) [Quantitative Concept]
Meta Mapping (1000):
  1000   % Normal (Mean Percent of Normal) [Quantitative Concept]
Processing 00000000.tx.9: The patient was sedated . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: sedated .
Meta Mapping (1000):
  1000   Sedated (Sedated state) [Finding]
Processing 00000000.tx.10: Her edema decreased over the next two days and repeat fiberoptic examination on both 4/3 and 4/4 revealed decreasing edema . 

Phrase: Her edema
Meta Mapping (1000):
  1000   OEDEMA (Edema) [Finding]
Meta Mapping (1000):
  1000   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]

Phrase: decreased over the next two days
Meta Mapping (697):
   753   Decreased [Quantitative Concept]
   753   next (Adjacent) [Spatial Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   Decreased [Quantitative Concept]
   753   Next (Following) [Temporal Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   Decreased [Quantitative Concept]
   753   Next (Then) [Temporal Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   Decreased (Reduced) [Qualitative Concept]
   753   next (Adjacent) [Spatial Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   Decreased (Reduced) [Qualitative Concept]
   753   Next (Following) [Temporal Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   Decreased (Reduced) [Qualitative Concept]
   753   Next (Then) [Temporal Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   decreased (Decreasing) [Qualitative Concept]
   753   next (Adjacent) [Spatial Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   decreased (Decreasing) [Qualitative Concept]
   753   Next (Following) [Temporal Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]
Meta Mapping (697):
   753   decreased (Decreasing) [Qualitative Concept]
   753   Next (Then) [Temporal Concept]
   753   Two [Quantitative Concept]
   753   DAYS (day) [Temporal Concept]

Phrase: and

Phrase: repeat
Meta Mapping (1000):
  1000   Repeat [Functional Concept]
Meta Mapping (1000):
  1000   Repeat (Repeat Pattern) [Temporal Concept]
Meta Mapping (1000):
  1000   Repeat (Repeat Object) [Conceptual Entity]

Phrase: fiberoptic examination on both 4/3
Meta Mapping (586):
   586   fiber optic (Fiber Optic Technology) [Occupation or Discipline]
Meta Mapping (586):
   586   Fiberoptic (Fiberoptic Device Component) [Manufactured Object]

Phrase: and

Phrase: 4/4 revealed decreasing edema .
Meta Mapping (766):
   637   4+ (4+ Answer to question) [Finding]
   637   Revealed [Qualitative Concept]
   637   Decreasing [Qualitative Concept]
   804   OEDEMA (Edema) [Finding]
Meta Mapping (766):
   637   4+ (4+ Answer to question) [Finding]
   637   Revealed [Qualitative Concept]
   637   Decreasing [Qualitative Concept]
   804   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Processing 00000000.tx.11: On 4/5/91 in the ICU under controlled conditions , she was electively extubated and had no problems . 

Phrase: On 4/5/91 in the ICU under controlled conditions ,
Meta Mapping (660):
   760   4 5 (4/5) [Quantitative Concept]
   739   ICU (intensive care unit) [Health Care Related Organization,Manufactured Object]
   726   control condition (disorder control (procedure)) [Therapeutic or Preventive Procedure]

Phrase: she

Phrase: was

Phrase: electively

Phrase: extubated
Meta Mapping (966):
   966   Extubate (Tracheal Extubation) [Therapeutic or Preventive Procedure]

Phrase: and

Phrase: had

Phrase: no problems .
Meta Mapping (1000):
  1000   Problems (Problems - What subject filter) [Idea or Concept]
Processing 00000000.tx.12: Tube feedings were started on 4/3/91 and the NG tube was discontinued on 4/5/91 prior to extubation to give a better look at the epiglottis prior to extubating her . 

Phrase: Tube feedings
Meta Mapping (966):
   966   tube feeding (Enteral Nutrition) [Therapeutic or Preventive Procedure]
Meta Mapping (966):
   966   Tube Feeding (Tube feeding of patient) [Therapeutic or Preventive Procedure]
Meta Mapping (966):
   966   tube feeding (Enteral Nutrition Preparation) [Food]

Phrase: were

Phrase: started on 4/3/91
Meta Mapping (760):
   760   Started [Qualitative Concept]

Phrase: and

Phrase: the NG tube
Meta Mapping (1000):
  1000   NG tube (Nasogastric tube) [Medical Device]

Phrase: was

Phrase: discontinued on 4/5/91
Meta Mapping (760):
   760   Discontinued [Finding]

Phrase: prior to extubation
Meta Mapping (1000):
  1000   Extubation (Tracheal Extubation) [Therapeutic or Preventive Procedure]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: give
Meta Mapping (1000):
  1000   Give (Give - dosing instruction imperative) [Functional Concept]

Phrase: a better
Meta Mapping (1000):
  1000   Better [Qualitative Concept]

Phrase: look at the epiglottis
Meta Mapping (708):
   770   look (Personal appearance) [Organism Attribute]
   770   EPIGLOTTIS (Epiglottis structure) [Body Part, Organ, or Organ Component]
Meta Mapping (708):
   770   look (Personal appearance) [Organism Attribute]
   770   Epiglottis (Entire epiglottis) [Body Part, Organ, or Organ Component]

Phrase: prior to extubating
Meta Mapping (966):
   966   Extubate (Tracheal Extubation) [Therapeutic or Preventive Procedure]

Phrase: her .
Processing 00000000.tx.13: Her mental status began to clear under the family &apos;s request . 

Phrase: Her mental status
Meta Mapping (1000):
  1000   Mental status (Mental state (observable entity)) [Finding]

Phrase: began
Meta Mapping (966):
   966   Begin (Beginning) [Temporal Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: clear under the family &apos
Meta Mapping (686):
   760   Clear (Negative Surgical Margin) [Finding]
   760   Family [Family Group]
Meta Mapping (686):
   760   Clear (Negative Surgical Margin) [Finding]
   760   Family (Family (taxonomic)) [Conceptual Entity]
Meta Mapping (686):
   760   Clear [Qualitative Concept]
   760   Family [Family Group]
Meta Mapping (686):
   760   Clear [Qualitative Concept]
   760   Family (Family (taxonomic)) [Conceptual Entity]

Phrase: ;s request .
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Request (Request - action) [Functional Concept]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Request (Question (inquiry)) [Intellectual Product]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Request (Request - action) [Functional Concept]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Request (Question (inquiry)) [Intellectual Product]
Processing 00000000.tx.14: If she does have a lesion , then we may entertain , given her age , the possibility of radiating this lesion as opposed to putting her through laryngectomy . 

Phrase: If

Phrase: she

Phrase: does

Phrase: have

Phrase: a lesion ,
Meta Mapping (1000):
  1000   Lesion [Finding]
Meta Mapping (1000):
  1000   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]

Phrase: then
Meta Mapping (1000):
  1000   Then [Temporal Concept]

Phrase: we

Phrase: may

Phrase: entertain

Phrase: ,

Phrase: given
Meta Mapping (1000):
  1000   GIVEN [Conceptual Entity]
Meta Mapping (1000):
  1000   given (Entity Name Part Type - given) [Idea or Concept]
Meta Mapping (1000):
  1000   Given (Give - dosing instruction imperative) [Functional Concept]
Meta Mapping (1000):
  1000   given (Given name) [Intellectual Product]

Phrase: her age ,
Meta Mapping (1000):
  1000   AGE (Age) [Organism Attribute]

Phrase: the possibility of radiating
Meta Mapping (672):
   699   Possible [Qualitative Concept]
   604   radiating (Radiating to) [Functional Concept]
Meta Mapping (672):
   699   Possible (Possibly Related to Intervention) [Qualitative Concept]
   604   radiating (Radiating to) [Functional Concept]
Meta Mapping (672):
   699   Possible (Possible diagnosis) [Qualitative Concept]
   604   radiating (Radiating to) [Functional Concept]

Phrase: this lesion
Meta Mapping (1000):
  1000   Lesion [Finding]
Meta Mapping (1000):
  1000   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]

Phrase: as

Phrase: opposed to putting
Meta Mapping (756):
   756   Put (put - instruction imperative) [Activity]

Phrase: her through laryngectomy .
Meta Mapping (790):
   790   LARYNGECTOMY (Laryngectomy) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.15: <TEXT> CHOLANGIOCARCINOMA , RECURRENT ; STATUS POST RADIATION The patient is a 55-year-old man who is status post resection of a Klatskin tumor , who returns with persistent jaundice and right upper quadrant pain . 

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > CHOLANGIOCARCINOMA ,
Meta Mapping (1000):
  1000   Cholangiocarcinoma [Neoplastic Process]

Phrase: RECURRENT
Meta Mapping (1000):
  1000   RECURRENT (Recurrent) [Temporal Concept]

Phrase: ;

Phrase: STATUS POST RADIATION
Meta Mapping (1000):
  1000   Radiation (Electromagnetic Radiation) [Natural Phenomenon or Process]
Meta Mapping (1000):
  1000   Radiation (Unit of radiation dose) [Quantitative Concept]
Meta Mapping (1000):
  1000   Radiation [Natural Phenomenon or Process]
Meta Mapping (1000):
  1000   RADIATION (Therapeutic radiology procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Radiation (Radiation Ionizing Radiotherapy) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Radiation (Radiotherapy Research) [Research Activity]

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: a 55-year-old man
Meta Mapping (833):
   645   55 [Intellectual Product]
   645   YEAR (year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   Man (Male population group) [Population Group]
Meta Mapping (833):
   645   55 [Intellectual Product]
   645   YEAR (year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   MAN (Homo sapiens) [Human]
Meta Mapping (833):
   645   55 [Intellectual Product]
   645   YEAR (year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   MAN (Males) [Organism Attribute]
Meta Mapping (833):
   645   55 [Intellectual Product]
   645   /Year (per year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   Man (Male population group) [Population Group]
Meta Mapping (833):
   645   55 [Intellectual Product]
   645   /Year (per year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   MAN (Homo sapiens) [Human]
Meta Mapping (833):
   645   55 [Intellectual Product]
   645   /Year (per year) [Temporal Concept]
   645   Old [Temporal Concept]
   812   MAN (Males) [Organism Attribute]

Phrase: who

Phrase: is status post resection of a Klatskin tumor ,
Meta Mapping (711):
   770   Status post [Temporal Concept]
   767   tumor resection (tumor removal) [Therapeutic or Preventive Procedure]
Meta Mapping (711):
   770   Status post [Temporal Concept]
   767   resection tumor (Excision of neoplasm) [Therapeutic or Preventive Procedure]
Meta Mapping (711):
   770   post resection (POST REMOVAL (NOT IN CONJUCTION WITH ENDODONTIC THERAPY)) [Therapeutic or Preventive Procedure]
   767   Tumour status (Tumor status) [Qualitative Concept]
Meta Mapping (711):
   770   Status Post (Post) [Temporal Concept]
   767   tumor resection (tumor removal) [Therapeutic or Preventive Procedure]
Meta Mapping (711):
   770   Status Post (Post) [Temporal Concept]
   767   resection tumor (Excision of neoplasm) [Therapeutic or Preventive Procedure]
Meta Mapping (711):
   770   post resection (post removal (dental restoration procedure)) [Therapeutic or Preventive Procedure]
   767   Tumour status (Tumor status) [Qualitative Concept]
Meta Mapping (711):
   770   post resection (post excision) [Temporal Concept]
   767   Tumour status (Tumor status) [Qualitative Concept]

Phrase: who

Phrase: returns with persistent jaundice
Meta Mapping (733):
   770   Return (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   770   Persistent (persistent) [Temporal Concept]
   770   JAUNDICE (Icterus) [Pathologic Function]
Meta Mapping (733):
   770   Return (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   770   Persistent (persistent) [Temporal Concept]
   770   jaundice [Finding]

Phrase: and

Phrase: right upper quadrant pain .
Meta Mapping (1000):
  1000   RIGHT UPPER QUADRANT PAIN (Right upper quadrant pain) [Sign or Symptom]
Processing 00000000.tx.16: The present illness is marked by presentation with jaundice and pain in August of 1994 , and a computerized tomography scan that showed bile duct dilatation . 

Phrase: The present illness
Meta Mapping (888):
   694   Present [Quantitative Concept]
   861   Illness (Illness (finding)) [Sign or Symptom]
Meta Mapping (888):
   694   Present (Presentation) [Idea or Concept]
   861   Illness (Illness (finding)) [Sign or Symptom]

Phrase: is

Phrase: marked by presentation
Meta Mapping (746):
   790   Marked (Massive) [Qualitative Concept]
   790   Presentation [Idea or Concept]
Meta Mapping (746):
   790   MARKED (Marked) [Qualitative Concept]
   790   Presentation [Idea or Concept]

Phrase: with jaundice
Meta Mapping (1000):
  1000   JAUNDICE (Icterus) [Pathologic Function]
Meta Mapping (1000):
  1000   jaundice [Finding]

Phrase: and

Phrase: pain in August of 1994 ,
Meta Mapping (686):
   760   PAIN (Pain) [Sign or Symptom]
   593   August [Qualitative Concept]
Meta Mapping (686):
   760   Pain NOS (Pain NOS Adverse Event) [Finding]
   593   August [Qualitative Concept]

Phrase: and

Phrase: a computerized tomography scan
Meta Mapping (950):
   950   Computerized tomograph scan (X-Ray Computed Tomography) [Diagnostic Procedure]

Phrase: that

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: bile duct dilatation .
Meta Mapping (1000):
  1000   bile duct dilatation (Dilatation of bile duct (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Bile duct dilatation (Bile duct dilatation (finding)) [Finding]
Processing 00000000.tx.17: LABORATORY DATA : His bilirubin was total 11.1 , with a direct bilirubin of 10.2 and his alkaline phosphatase was 2,188 . 

Phrase: LABORATORY DATA
Meta Mapping (1000):
  1000   Laboratory Data (Laboratory Data Domain) [Idea or Concept]

Phrase: :

Phrase: His bilirubin
Meta Mapping (1000):
  1000   BILIRUBIN (Bilirubin) [Biologically Active Substance,Organic Chemical]

Phrase: was

Phrase: total 11.1 ,
Meta Mapping (827):
   827   % total (% of total) [Quantitative Concept]
Meta Mapping (827):
   827   Total [Qualitative Concept]

Phrase: with a direct bilirubin of 10.2
Meta Mapping (706):
   778   Direct bilirubin (Direct reacting bilirubin) [Biologically Active Substance,Organic Chemical]
   581   10% [Finding]

Phrase: and

Phrase: his alkaline phosphatase
Meta Mapping (1000):
  1000   ALKALINE PHOSPHATASE (Alkaline Phosphatase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   Alkaline phosphatase (Alkaline phosphatase stain) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: was

Phrase: 2,188 .
Meta Mapping (861):
   861   +2 [Quantitative Concept]
Meta Mapping (861):
   861   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (861):
   861   2+ (2+ Score, WHO) [Classification]
Meta Mapping (861):
   861   2+ [Finding]
Processing 00000000.tx.18: ED DISCHARGE NOTIFICATION This is to notify you that your patient , BURCE , LLNO arrived in the Emergency Department at Ph University Of Medical Center on 09/24/2005 08:04 AM . 

Phrase: ED DISCHARGE NOTIFICATION
Meta Mapping (851):
   660   ED (Endocrine System Findings Domain) [Idea or Concept]
   660   Discharge (Body Fluid Discharge) [Body Substance]
   827   NOTIFICATION (Notifications) [Health Care Activity]
Meta Mapping (851):
   660   ED (Endocrine System Findings Domain) [Idea or Concept]
   660   Discharge (Patient Discharge) [Health Care Activity]
   827   NOTIFICATION (Notifications) [Health Care Activity]
Meta Mapping (851):
   660   ED (Endocrine System Findings Domain) [Idea or Concept]
   660   Discharge (Discharge, body substance) [Body Substance]
   827   NOTIFICATION (Notifications) [Health Care Activity]

Phrase: This

Phrase: is

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: notify
Meta Mapping (1000):
  1000   Notify (Notifications) [Health Care Activity]

Phrase: you

Phrase: that

Phrase: your patient ,
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: BURCE ,

Phrase: LLNO

Phrase: arrived in the Emergency Department
Meta Mapping (745):
   760   Arrived (Arrival - action) [Activity]
   806   Emergency Department (Accident and Emergency department) [Health Care Related Organization]

Phrase: at Ph University Of Medical Center
Meta Mapping (774):
   586   ph+ [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   ph++ [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   ph+++ [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   pH [Quantitative Concept]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   PH (Infusion pump Alert priority PH) [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]

Phrase: on 09/24/2005 08

Phrase: :

Phrase: 04

Phrase: AM .
Processing 00000000.tx.19: </RECORD> 4/27/1995 12:00:00 AM DIS The patient was recently discharged from the hospital after her second cycle of high-dose ARA-C chemotherapy . 

Phrase: </RECORD
Meta Mapping (1000):
  1000   Record (Records) [Intellectual Product]
Meta Mapping (1000):
  1000   record (Record - QueryRequestLimit) [Quantitative Concept]

Phrase: > 4/27/1995 12
Meta Mapping (812):
   812   4+ (4+ Answer to question) [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: DIS
Meta Mapping (1000):
  1000   DIS (Diagnostic interview schedule) [Intellectual Product]
Meta Mapping (1000):
  1000   DIS (Discontinued) [Finding]

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: recently
Meta Mapping (1000):
  1000   Recently (Recent) [Temporal Concept]

Phrase: discharged from the hospital
Meta Mapping (881):
   881   Discharged from hospital [Finding]

Phrase: after her second cycle of high-dose ARA-C chemotherapy .
Meta Mapping (725):
   757   Cycle/Second (Cycle per Second) [Quantitative Concept]
   611   High Dose Chemotherapy (high-dose chemotherapy) [Therapeutic or Preventive Procedure]
   593   ARA-C (Ara-C) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.20: After the transfusion the patient &apos;s platelet count improved to 101,000 on May 2 . 

Phrase: After the transfusion
Meta Mapping (1000):
  1000   Transfusion (Blood Transfusion) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Transfusion (Transfusion - action) [Functional Concept]
Meta Mapping (1000):
  1000   Transfusion (Transfusion (procedure)) [Therapeutic or Preventive Procedure]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s platelet count
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   Platelet Count (Platelet Count measurement) [Laboratory Procedure]
Meta Mapping (901):
   660   /s (per second) [Quantitative Concept]
   901   Platelet count (Finding of platelet count) [Laboratory or Test Result]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   Platelet Count (Platelet Count measurement) [Laboratory Procedure]
Meta Mapping (901):
   660   S' (S prime) [Clinical Attribute]
   901   Platelet count (Finding of platelet count) [Laboratory or Test Result]

Phrase: improved to 101,000
Meta Mapping (770):
   770   Improved [Qualitative Concept]
Meta Mapping (770):
   770   Improved (Better) [Qualitative Concept]
Meta Mapping (770):
   770   Improved (Admission Level of Care Code - Improved) [Intellectual Product]

Phrase: on May 2 .
Meta Mapping (861):
   861   May (Month of May) [Temporal Concept]
Processing 00000000.tx.21: MEDICATIONS ON DISCHARGE : Decadron 6 mg po tid ; and she should continue Inderal , Synthroid and Zoloft at the present dose and frequency . 

Phrase: MEDICATIONS ON DISCHARGE
Meta Mapping (858):
   858   Discharge medications (Medication.discharge) [Finding]

Phrase: :

Phrase: Decadron 6 mg po tid
Meta Mapping (864):
   699   Dexamethasone 6 MG [Clinical Drug]
   637   PO (Portugal) [Geographic Area]
   804   TID (Three times daily) [Temporal Concept]
Meta Mapping (864):
   699   Dexamethasone 6 MG [Clinical Drug]
   637   PO (Portugal) [Geographic Area]
   804   TID (three times a day at institution-specified times) [Temporal Concept]
Meta Mapping (864):
   699   Dexamethasone 6 MG [Clinical Drug]
   637   PO (Oral) [Spatial Concept]
   804   TID (Three times daily) [Temporal Concept]
Meta Mapping (864):
   699   Dexamethasone 6 MG [Clinical Drug]
   637   PO (Oral) [Spatial Concept]
   804   TID (three times a day at institution-specified times) [Temporal Concept]

Phrase: ;

Phrase: and

Phrase: she

Phrase: should

Phrase: continue
Meta Mapping (1000):
  1000   Continue (Continuous) [Idea or Concept]

Phrase: Inderal ,
Meta Mapping (1000):
  1000   Inderal [Organic Chemical,Pharmacologic Substance]

Phrase: Synthroid
Meta Mapping (1000):
  1000   Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: and

Phrase: Zoloft at the present dose
Meta Mapping (696):
   760   Zoloft [Organic Chemical,Pharmacologic Substance]
   593   Present [Quantitative Concept]
   593   DOSE (Dosage) [Quantitative Concept]
Meta Mapping (696):
   760   Zoloft [Organic Chemical,Pharmacologic Substance]
   593   Present [Quantitative Concept]
   593   Dose (Unit dose) [Quantitative Concept]
Meta Mapping (696):
   760   Zoloft [Organic Chemical,Pharmacologic Substance]
   593   Present [Quantitative Concept]
   593   Dose # (Dose number:Number:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (696):
   760   Zoloft [Organic Chemical,Pharmacologic Substance]
   593   Present (Presentation) [Idea or Concept]
   593   DOSE (Dosage) [Quantitative Concept]
Meta Mapping (696):
   760   Zoloft [Organic Chemical,Pharmacologic Substance]
   593   Present (Presentation) [Idea or Concept]
   593   Dose (Unit dose) [Quantitative Concept]
Meta Mapping (696):
   760   Zoloft [Organic Chemical,Pharmacologic Substance]
   593   Present (Presentation) [Idea or Concept]
   593   Dose # (Dose number:Number:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: and

Phrase: frequency .
Meta Mapping (1000):
  1000   Frequency (With frequency) [Quantitative Concept]
Meta Mapping (1000):
  1000   Frequency (Frequencies (time pattern)) [Temporal Concept]
Meta Mapping (1000):
  1000   Frequency (Spatial Frequency) [Quantitative Concept]
Meta Mapping (1000):
  1000   Frequency (Kind of quantity - Frequency) [Qualitative Concept]
Meta Mapping (1000):
  1000   Frequency (Statistical Frequency) [Quantitative Concept]
Meta Mapping (1000):
  1000   Frequency (How Often) [Intellectual Product]
Processing 00000000.tx.22: The patient was instructed to call us with any clinical or neurological symptoms . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: instructed

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: call
Meta Mapping (1000):
  1000   Call (Decision) [Mental Process]
Meta Mapping (1000):
  1000   Call (Call (Instruction)) [Functional Concept]

Phrase: us with any clinical
Meta Mapping (770):
   770   Clinical [Qualitative Concept]
Meta Mapping (770):
   770   Clinical (Psychologist - Clinical) [Professional or Occupational Group]
Meta Mapping (770):
   770   Clinical (Social Worker - Clinical) [Professional or Occupational Group]
Meta Mapping (770):
   770   Clinical (Neuropsychologist - Clinical) [Professional or Occupational Group]

Phrase: or

Phrase: neurological symptoms .
Meta Mapping (1000):
  1000   neurological symptoms (Neurologic Symptoms) [Sign or Symptom]
Processing 00000000.tx.23: Unsigned Following evaluation and treatment , the patient &apos;s disposition at the end of the visit was ADMITTED AS AN INPATIENT TO PH UNIVERSITY OF MEDICAL CENTER . 

Phrase: Unsigned

Phrase: Following
Meta Mapping (1000):
  1000   Following (Status post) [Temporal Concept]
Meta Mapping (1000):
  1000   Following [Temporal Concept]

Phrase: evaluation
Meta Mapping (1000):
  1000   Evaluation [Health Care Activity]
Meta Mapping (1000):
  1000   Evaluation (Evaluation procedure) [Health Care Activity]

Phrase: and

Phrase: treatment ,
Meta Mapping (1000):
  1000   treatment (therapeutic aspects) [Functional Concept]
Meta Mapping (1000):
  1000   Treatment (Therapeutic procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Treatment (Treating) [Functional Concept]
Meta Mapping (1000):
  1000   Treatment (Administration procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Treatment (Biomaterial Treatment) [Conceptual Entity]
Meta Mapping (1000):
  1000   TREATMENT (Treatment Epoch) [Research Activity]
Meta Mapping (1000):
  1000   treatment (treatment - ActInformationManagementReason) [Health Care Activity]

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s disposition at the end of the visit
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition [Idea or Concept]
   578   End [Spatial Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition [Idea or Concept]
   578   End [Spatial Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition [Idea or Concept]
   578   End [Spatial Concept]
   578   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition [Idea or Concept]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition [Idea or Concept]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition [Idea or Concept]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End [Spatial Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End [Spatial Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End [Spatial Concept]
   578   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   /s (per second) [Quantitative Concept]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition [Idea or Concept]
   578   End [Spatial Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition [Idea or Concept]
   578   End [Spatial Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition [Idea or Concept]
   578   End [Spatial Concept]
   578   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition [Idea or Concept]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition [Idea or Concept]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition [Idea or Concept]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End [Spatial Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End [Spatial Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End [Spatial Concept]
   578   VISIT (Visit Name) [Intellectual Product]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   Visit [Behavior]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   visit (Patient Visit) [Health Care Activity]
Meta Mapping (649):
   578   S' (S prime) [Clinical Attribute]
   744   Disposition (Disposition Domain) [Intellectual Product]
   578   End (Stop (qualifier value)) [Temporal Concept]
   578   VISIT (Visit Name) [Intellectual Product]

Phrase: was

Phrase: ADMITTED AS AN INPATIENT
Meta Mapping (708):
   770   admitted (Hospital admission) [Health Care Activity]
   770   Inpatient (inpatient) [Patient or Disabled Group]
Meta Mapping (708):
   770   admitted (Hospital admission) [Health Care Activity]
   770   Inpatient (Referral category - Inpatient) [Idea or Concept]
Meta Mapping (708):
   770   admitted (Hospital admission) [Health Care Activity]
   770   Inpatient (Patient Class - Inpatient) [Idea or Concept]
Meta Mapping (708):
   770   Admitted (Admission activity) [Health Care Activity]
   770   Inpatient (inpatient) [Patient or Disabled Group]
Meta Mapping (708):
   770   Admitted (Admission activity) [Health Care Activity]
   770   Inpatient (Referral category - Inpatient) [Idea or Concept]
Meta Mapping (708):
   770   Admitted (Admission activity) [Health Care Activity]
   770   Inpatient (Patient Class - Inpatient) [Idea or Concept]

Phrase: TO PH UNIVERSITY OF MEDICAL CENTER .
Meta Mapping (774):
   586   ph+ [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   ph++ [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   ph+++ [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   pH [Quantitative Concept]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Meta Mapping (774):
   586   PH (Infusion pump Alert priority PH) [Finding]
   820   University Medical Center (Academic Medical Centers) [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.24: 260740 Adenocarcinoma of the lung . 

Phrase: 260740 Adenocarcinoma of the lung .
Meta Mapping (926):
   926   Adenocarcinoma of the Lung (Adenocarcinoma of lung (disorder)) [Neoplastic Process]
Processing 00000000.tx.25: 5. 

Phrase: 5.
Meta Mapping (1000):
  1000   >5 [Quantitative Concept]
Meta Mapping (1000):
  1000   +5 [Quantitative Concept]
Processing 00000000.tx.26: atrial flutter . 

Phrase: atrial flutter .
Meta Mapping (1000):
  1000   ATRIAL FLUTTER (Atrial Flutter) [Pathologic Function]
Meta Mapping (1000):
  1000   Atrial Flutter (Atrial Flutter by ECG Finding) [Laboratory or Test Result]
Meta Mapping (1000):
  1000   Atrial flutter (Atrial Flutter Adverse Event) [Pathologic Function]
Processing 00000000.tx.27: 7. 

Phrase: 7.
Processing 00000000.tx.28: cerebrovascular accident . 

Phrase: cerebrovascular accident .
Meta Mapping (1000):
  1000   CEREBROVASCULAR ACCIDENT (Cerebrovascular accident) [Disease or Syndrome]
Processing 00000000.tx.29: Right therapeutic thoracentesis , 06/07/94 . 

Phrase: Right therapeutic thoracentesis ,
Meta Mapping (851):
   660   RIGHT (Right) [Spatial Concept]
   660   Therapeutic (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   827   Thoracentesis [Health Care Activity]
Meta Mapping (851):
   660   RIGHT (Right) [Spatial Concept]
   660   Therapeutic [Functional Concept]
   827   Thoracentesis [Health Care Activity]
Meta Mapping (851):
   660   Right (Right sided) [Spatial Concept]
   660   Therapeutic (Therapeutic procedure) [Therapeutic or Preventive Procedure]
   827   Thoracentesis [Health Care Activity]
Meta Mapping (851):
   660   Right (Right sided) [Spatial Concept]
   660   Therapeutic [Functional Concept]
   827   Thoracentesis [Health Care Activity]

Phrase: 06/07/94 .
Processing 00000000.tx.30: On admission , she was an elderly female in moderate respiratory distress , blood pressure 100/60 , respirations 26 , pulse 68 , temperature afebrile . 

Phrase: On admission ,
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: she

Phrase: was

Phrase: an elderly female in moderate respiratory distress ,
Meta Mapping (728):
   778   Elderly female (Elderly woman) [Age Group]
   581   Moderate (Moderate (severity modifier)) [Qualitative Concept]
   612   Distress, Respiratory (Respiratory distress) [Sign or Symptom]
Meta Mapping (728):
   778   Elderly female (Elderly woman) [Age Group]
   581   MODERATE (Moderation) [Qualitative Concept]
   612   Distress, Respiratory (Respiratory distress) [Sign or Symptom]
Meta Mapping (728):
   778   Elderly female (Elderly woman) [Age Group]
   581   Moderate (Moderate Extremity Pain) [Intellectual Product]
   612   Distress, Respiratory (Respiratory distress) [Sign or Symptom]
Meta Mapping (728):
   778   Elderly female (Elderly woman) [Age Group]
   581   Moderate (Borg Category-Ratio 10 Perceived Exertion Score 3) [Intellectual Product]
   612   Distress, Respiratory (Respiratory distress) [Sign or Symptom]

Phrase: blood pressure 100/60 ,
Meta Mapping (861):
   861   BLOOD PRESSURE (Blood Pressure) [Organism Function]
   812   100% [Quantitative Concept]
   812   60% [Finding]
Meta Mapping (861):
   861   Blood Pressure (Blood pressure finding) [Finding]
   812   100% [Quantitative Concept]
   812   60% [Finding]
Meta Mapping (861):
   861   Blood pressure (Systemic arterial pressure) [Finding]
   812   100% [Quantitative Concept]
   812   60% [Finding]

Phrase: respirations 26 ,
Meta Mapping (861):
   861   respirations (Respiration) [Physiologic Function]

Phrase: pulse 68 ,
Meta Mapping (888):
   861   PULSE (Pulse Rate) [Clinical Attribute]
   861   68 [Intellectual Product]
Meta Mapping (888):
   861   Pulse (Physiologic pulse) [Physiologic Function]
   861   68 [Intellectual Product]
Meta Mapping (888):
   861   Pulse (Pulse phenomenon) [Phenomenon or Process]
   861   68 [Intellectual Product]

Phrase: temperature
Meta Mapping (1000):
  1000   temperature (Body Temperature) [Organism Attribute]
Meta Mapping (1000):
  1000   *Temperature (Temperature) [Quantitative Concept]

Phrase: afebrile .
Meta Mapping (1000):
  1000   Afebrile (Apyrexial) [Finding]
Processing 00000000.tx.31: No S3 was present . 

Phrase: No S3
Meta Mapping (1000):
  1000   S3 (S3 (sacral segmental innervation)) [Body Location or Region]
Meta Mapping (1000):
  1000   S3 (RPS3 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   S3 (PSMD3 gene) [Gene or Genome]
Meta Mapping (1000):
  1000 N S3 (Testicular Cancer Serum Markers Test Result S3) [Laboratory or Test Result]

Phrase: was

Phrase: present .
Meta Mapping (1000):
  1000   Present [Quantitative Concept]
Meta Mapping (1000):
  1000   Present (Presentation) [Idea or Concept]
Processing 00000000.tx.32: 07-02-94 Specifically , his coronary flow maximally increased by a factor of 2-2.5 whereas a normal response is considered to a 3-4 fold increasing in coronary flow to maximal stimulus . 

Phrase: 07-02-94 Specifically ,

Phrase: his coronary flow
Meta Mapping (1000):
  1000   coronary flow (Cardiac flow) [Organ or Tissue Function]

Phrase: maximally

Phrase: increased by a factor of 2-2.5
Meta Mapping (694):
   744   Increased [Quantitative Concept]
   767   factor A [Organic Chemical]
Meta Mapping (694):
   744   Increased (Increase) [Functional Concept]
   767   factor A [Organic Chemical]

Phrase: whereas

Phrase: a normal response
Meta Mapping (888):
   694   NORMAL (Normal) [Qualitative Concept]
   861   Response (Response process) [Organism Attribute]
Meta Mapping (888):
   694   NORMAL (Normal) [Qualitative Concept]
   861   Response (Disease Response) [Finding]
Meta Mapping (888):
   694   NORMAL (Normal) [Qualitative Concept]
   861   Response (Response (statement)) [Intellectual Product]
Meta Mapping (888):
   694   NORMAL (Normal) [Qualitative Concept]
   861   Response (Response (communication)) [Mental Process]
Meta Mapping (888):
   694   Normal (Gait normal) [Finding]
   861   Response (Response process) [Organism Attribute]
Meta Mapping (888):
   694   Normal (Gait normal) [Finding]
   861   Response (Disease Response) [Finding]
Meta Mapping (888):
   694   Normal (Gait normal) [Finding]
   861   Response (Response (statement)) [Intellectual Product]
Meta Mapping (888):
   694   Normal (Gait normal) [Finding]
   861   Response (Response (communication)) [Mental Process]
Meta Mapping (888):
   694   % normal (Percent normal) [Quantitative Concept]
   861   Response (Response process) [Organism Attribute]
Meta Mapping (888):
   694   % normal (Percent normal) [Quantitative Concept]
   861   Response (Disease Response) [Finding]
Meta Mapping (888):
   694   % normal (Percent normal) [Quantitative Concept]
   861   Response (Response (statement)) [Intellectual Product]
Meta Mapping (888):
   694   % normal (Percent normal) [Quantitative Concept]
   861   Response (Response (communication)) [Mental Process]
Meta Mapping (888):
   694   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   Response (Response process) [Organism Attribute]
Meta Mapping (888):
   694   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   Response (Disease Response) [Finding]
Meta Mapping (888):
   694   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   Response (Response (statement)) [Intellectual Product]
Meta Mapping (888):
   694   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   Response (Response (communication)) [Mental Process]

Phrase: is

Phrase: considered to a 3-4 fold increasing
Meta Mapping (656):
   748   considered (consider) [Idea or Concept]
   748   Fold (Folded structure) [Spatial Concept]
   748   Increasing [Functional Concept]
Meta Mapping (656):
   748   considered (consider) [Idea or Concept]
   748   Fold (Fold in Medical Device Material) [Phenomenon or Process]
   748   Increasing [Functional Concept]

Phrase: in coronary flow to maximal stimulus .
Meta Mapping (719):
   790   coronary flow (Cardiac flow) [Organ or Tissue Function]
   586   Maximal (Maximal (qualifier value)) [Qualitative Concept]
   586   Stimulus [Phenomenon or Process]
Meta Mapping (719):
   790   coronary flow (Cardiac flow) [Organ or Tissue Function]
   586   Maximal (Maximum) [Quantitative Concept]
   586   Stimulus [Phenomenon or Process]
Meta Mapping (719):
   790   coronary flow (Cardiac flow) [Organ or Tissue Function]
   586   Maximal (Borg Category-Ratio 10 Perceived Exertion Score 10) [Intellectual Product]
   586   Stimulus [Phenomenon or Process]
Processing 00000000.tx.33: His medications were adjusted many times without adequate interruption of the pattern of increasingly frequent and increasingly severe episodes of pain . 

Phrase: His medications
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: were

Phrase: adjusted
Meta Mapping (1000):
  1000   Adjusted (Adjustment Action) [Functional Concept]

Phrase: many times without adequate interruption of the pattern of increasingly frequent
Meta Mapping (664):
   738   times (Time) [Temporal Concept]
   571   Adequate (Sufficient) [Qualitative Concept]
   571   interruption (Disruption) [Functional Concept]
   579   Pattern of frequency [Temporal Concept]
Meta Mapping (664):
   738   times (Time) [Temporal Concept]
   571   Adequate (Sufficient) [Qualitative Concept]
   571   Interruption [Temporal Concept]
   579   Pattern of frequency [Temporal Concept]
Meta Mapping (664):
   738   times (Time) [Temporal Concept]
   571   Adequate [Qualitative Concept]
   571   interruption (Disruption) [Functional Concept]
   579   Pattern of frequency [Temporal Concept]
Meta Mapping (664):
   738   times (Time) [Temporal Concept]
   571   Adequate [Qualitative Concept]
   571   Interruption [Temporal Concept]
   579   Pattern of frequency [Temporal Concept]
Meta Mapping (664):
   738   Times [Quantitative Concept]
   571   Adequate (Sufficient) [Qualitative Concept]
   571   interruption (Disruption) [Functional Concept]
   579   Pattern of frequency [Temporal Concept]
Meta Mapping (664):
   738   Times [Quantitative Concept]
   571   Adequate (Sufficient) [Qualitative Concept]
   571   Interruption [Temporal Concept]
   579   Pattern of frequency [Temporal Concept]
Meta Mapping (664):
   738   Times [Quantitative Concept]
   571   Adequate [Qualitative Concept]
   571   interruption (Disruption) [Functional Concept]
   579   Pattern of frequency [Temporal Concept]
Meta Mapping (664):
   738   Times [Quantitative Concept]
   571   Adequate [Qualitative Concept]
   571   Interruption [Temporal Concept]
   579   Pattern of frequency [Temporal Concept]

Phrase: and

Phrase: increasingly severe episodes of pain .
Meta Mapping (807):
   631 N Severe pain [Finding]
   790   Episode of [Temporal Concept]
Meta Mapping (807):
   631   Severe Pain (Severe Extremity Pain) [Intellectual Product]
   790   Episode of [Temporal Concept]
Processing 00000000.tx.34: His most recent admission to the Morehegron Valley Hospital is on April 5 , of 1994 . 

Phrase: His most recent admission to the Morehegron Valley Hospital
Meta Mapping (724):
   598   Most Recent [Temporal Concept]
   784   Admission to hospital (Hospital admission) [Health Care Activity]
   575   Valley [Spatial Concept]

Phrase: is on April 5 , of 1994 .
Meta Mapping (753):
   753   April [Temporal Concept]
Meta Mapping (753):
   753   APRIL (TNFSF13 wt Allele) [Gene or Genome]
Meta Mapping (753):
   753   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]
Processing 00000000.tx.35: His medications that had been used individually or in combination include beta blockers and Lodapine cardiazem , nifidepine and coumadin , aspirin , cyclopadine and seratonin antagonists . 

Phrase: His medications
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: that

Phrase: had

Phrase: been

Phrase: used
Meta Mapping (1000):
  1000   used (Used by) [Finding]

Phrase: individually

Phrase: or in combination
Meta Mapping (790):
   790   Combination (Combined) [Qualitative Concept]
Meta Mapping (790):
   790   Combination (combination of objects) [Physical Object]
Meta Mapping (790):
   790   Combination (combination - answer to question) [Finding]

Phrase: include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: beta blockers
Meta Mapping (1000):
  1000   Beta blockers (Adrenergic beta-Antagonists) [Pharmacologic Substance]

Phrase: and

Phrase: Lodapine cardiazem ,

Phrase: nifidepine

Phrase: and

Phrase: coumadin ,
Meta Mapping (1000):
  1000   Coumadin [Organic Chemical,Pharmacologic Substance]

Phrase: aspirin ,
Meta Mapping (1000):
  1000   ASPIRIN (Aspirin) [Organic Chemical,Pharmacologic Substance]

Phrase: cyclopadine

Phrase: and

Phrase: seratonin antagonists .
Meta Mapping (861):
   861   antagonists [Chemical Viewed Functionally]
Processing 00000000.tx.36: His abdomen was obese with no palpable organomegaly . 

Phrase: His abdomen
Meta Mapping (1000):
  1000   ABDOMEN (Abdomen) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Abdominal Cavity) [Body Location or Region]
Meta Mapping (1000):
  1000   Abdomen (Entire abdomen) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: obese with no palpable organomegaly .
Meta Mapping (696):
   760 N OBESE (Obesity) [Disease or Syndrome]
   593   Palpable [Qualitative Concept]
   593 N Organomegaly [Finding]
Processing 00000000.tx.37: Rheumatology felt that there was no good evidence of a primary vasculitic process as the source of his presumed small vessell coronary disease and no further rheumatologic work-up was undertaken . 

Phrase: Rheumatology
Meta Mapping (1000):
  1000   Rheumatology (Rheumatology specialty) [Biomedical Occupation or Discipline]
Meta Mapping (1000):
  1000   Rheumatology (Rheumatologist) [Professional or Occupational Group]

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: that

Phrase: there

Phrase: was

Phrase: no good evidence of a primary vasculitic process
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary [Qualitative Concept]
   506 N Vasculitides (Vasculitis) [Disease or Syndrome]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary [Qualitative Concept]
   506 N Vasculitides (Vasculitis) [Disease or Syndrome]
   578   Process [Phenomenon or Process]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary [Qualitative Concept]
   506 N Vasculitis (Vasculitis Adverse Event) [Finding]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary [Qualitative Concept]
   506 N Vasculitis (Vasculitis Adverse Event) [Finding]
   578   Process [Phenomenon or Process]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (True primary (qualifier value)) [Temporal Concept]
   506 N Vasculitides (Vasculitis) [Disease or Syndrome]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (True primary (qualifier value)) [Temporal Concept]
   506 N Vasculitides (Vasculitis) [Disease or Syndrome]
   578   Process [Phenomenon or Process]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (True primary (qualifier value)) [Temporal Concept]
   506 N Vasculitis (Vasculitis Adverse Event) [Finding]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (True primary (qualifier value)) [Temporal Concept]
   506 N Vasculitis (Vasculitis Adverse Event) [Finding]
   578   Process [Phenomenon or Process]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (Primary operation) [Therapeutic or Preventive Procedure]
   506 N Vasculitides (Vasculitis) [Disease or Syndrome]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (Primary operation) [Therapeutic or Preventive Procedure]
   506 N Vasculitides (Vasculitis) [Disease or Syndrome]
   578   Process [Phenomenon or Process]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (Primary operation) [Therapeutic or Preventive Procedure]
   506 N Vasculitis (Vasculitis Adverse Event) [Finding]
   578   Process (bony process) [Body Part, Organ, or Organ Component]
Meta Mapping (656):
   578   Good [Qualitative Concept]
   744   Evidence [Idea or Concept]
   578   Primary (Primary operation) [Therapeutic or Preventive Procedure]
   506 N Vasculitis (Vasculitis Adverse Event) [Finding]
   578   Process [Phenomenon or Process]

Phrase: as the source of his presumed small vessell coronary disease
Meta Mapping (691):
   777 N Source of disease [Finding]
   573   SMALL (Small) [Quantitative Concept]
   573   coronary (Heart) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: no further rheumatologic work-up
Meta Mapping (837):
   645   Further [Spatial Concept]
   574   Rheumatology (Rheumatology specialty) [Biomedical Occupation or Discipline]
   861   Work-up (work up) [Diagnostic Procedure]
Meta Mapping (837):
   645   Further [Spatial Concept]
   574   Rheumatology (Rheumatologist) [Professional or Occupational Group]
   861   Work-up (work up) [Diagnostic Procedure]

Phrase: was

Phrase: undertaken .
Processing 00000000.tx.38: To evaluate the efficacy of this prior to commiting him to a permanent blockade procedure , a temporary sympathetic blockade was performed using a local anesthetic and stellate ganglion injection . 

Phrase: To
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: evaluate
Meta Mapping (1000):
  1000   Evaluate (Evaluation) [Health Care Activity]

Phrase: the efficacy of this prior to commiting
Meta Mapping (706):
   748   Efficacy (Effectiveness) [Qualitative Concept]
   612   Prior to (Before) [Temporal Concept]
Meta Mapping (706):
   748   EFFICACY (Efficacy Study) [Research Activity]
   612   Prior to (Before) [Temporal Concept]

Phrase: him to a permanent blockade procedure ,
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade (Blocking) [Functional Concept]
   753   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade (Blocking) [Functional Concept]
   753   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade (Blocking) [Functional Concept]
   753   Procedure (Procedure (set of actions)) [Activity]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade (Blocking) [Functional Concept]
   753   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade (Blocking) [Functional Concept]
   753   Procedure (Procedure Domain) [Intellectual Product]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade (Blocking) [Functional Concept]
   753   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade [Pharmacologic Substance]
   753   Procedure (Interventional procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade [Pharmacologic Substance]
   753   Procedure (Surgical and medical procedures) [Therapeutic or Preventive Procedure]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade [Pharmacologic Substance]
   753   Procedure (Procedure (set of actions)) [Activity]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade [Pharmacologic Substance]
   753   PROCEDURE (Physical Medical Procedure) [Health Care Activity]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade [Pharmacologic Substance]
   753   Procedure (Procedure Domain) [Intellectual Product]
Meta Mapping (685):
   753   Permanent [Temporal Concept]
   753   Blockade [Pharmacologic Substance]
   753   Procedure (CDISC SDTM Procedure Terminology) [Intellectual Product]

Phrase: a temporary sympathetic blockade
Meta Mapping (901):
   660   Temporary (Transitory) [Temporal Concept]
   901   Sympathetic Blockade (Sympathetic Nerve Block) [Therapeutic or Preventive Procedure]
Meta Mapping (901):
   660   Temporary (Job Status - Temporary) [Idea or Concept]
   901   Sympathetic Blockade (Sympathetic Nerve Block) [Therapeutic or Preventive Procedure]
Meta Mapping (901):
   660   temporary (EntityNameUseR2 <temporary>) [Intellectual Product]
   901   Sympathetic Blockade (Sympathetic Nerve Block) [Therapeutic or Preventive Procedure]

Phrase: was

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: using
Meta Mapping (1000):
  1000   Using (Use of) [Functional Concept]

Phrase: a local anesthetic
Meta Mapping (1000):
  1000   Local anesthetic NOS (Local anesthesia) [Therapeutic or Preventive Procedure]
Meta Mapping (1000):
  1000   Local anesthetic (Local Anesthetics) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Local Anesthetic (Local Anesthetic [EPC]) [Pharmacologic Substance]

Phrase: and

Phrase: stellate ganglion injection .
Meta Mapping (901):
   734   Stellate Ganglion (Structure of stellate ganglion) [Body Part, Organ, or Organ Component]
   827   injection (Injection of therapeutic agent) [Therapeutic or Preventive Procedure]
Meta Mapping (901):
   734   Stellate Ganglion (Structure of stellate ganglion) [Body Part, Organ, or Organ Component]
   827   INJECTION (Injection product) [Biomedical or Dental Material]
Meta Mapping (901):
   734   Stellate Ganglion (Structure of stellate ganglion) [Body Part, Organ, or Organ Component]
   827   Injection (Injection procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (901):
   734   Stellate Ganglion (Structure of stellate ganglion) [Body Part, Organ, or Organ Component]
   827   Injection (Injection Route of Drug Administration) [Functional Concept]
Meta Mapping (901):
   734   Stellate Ganglion (Structure of stellate ganglion) [Body Part, Organ, or Organ Component]
   827   Injection (Injection Dosing Unit) [Quantitative Concept]
Meta Mapping (901):
   734   Stellate ganglion (Entire stellate ganglion) [Body Part, Organ, or Organ Component]
   827   injection (Injection of therapeutic agent) [Therapeutic or Preventive Procedure]
Meta Mapping (901):
   734   Stellate ganglion (Entire stellate ganglion) [Body Part, Organ, or Organ Component]
   827   INJECTION (Injection product) [Biomedical or Dental Material]
Meta Mapping (901):
   734   Stellate ganglion (Entire stellate ganglion) [Body Part, Organ, or Organ Component]
   827   Injection (Injection procedure) [Therapeutic or Preventive Procedure]
Meta Mapping (901):
   734   Stellate ganglion (Entire stellate ganglion) [Body Part, Organ, or Organ Component]
   827   Injection (Injection Route of Drug Administration) [Functional Concept]
Meta Mapping (901):
   734   Stellate ganglion (Entire stellate ganglion) [Body Part, Organ, or Organ Component]
   827   Injection (Injection Dosing Unit) [Quantitative Concept]
Processing 00000000.tx.39: Prior to performing that an exercise tolerance test was performed on May 13 . 

Phrase: Prior to performing
Meta Mapping (966):
   966   Perform (Performed) [Functional Concept]
Meta Mapping (966):
   966   Perform [Pharmacologic Substance]

Phrase: that

Phrase: an exercise tolerance test
Meta Mapping (1000):
  1000   Exercise tolerance test NOS (Exercise stress test) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Exercise tolerance test (Exercise stress ECG test) [Diagnostic Procedure]

Phrase: was

Phrase: performed on May 13 .
Meta Mapping (708):
   770   Performed [Functional Concept]
   770   May (Month of May) [Temporal Concept]
Processing 00000000.tx.40: After extended discussions with pain service , Mr. 

Phrase: After extended discussions with pain service ,
Meta Mapping (691):
   586   Extended (Extension) [Functional Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   Service (Services) [Occupational Activity]
Meta Mapping (691):
   586   Extended (Extension) [Functional Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   Service (Software Service) [Manufactured Object]
Meta Mapping (691):
   586   Extended (Extension) [Functional Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (691):
   586   Extended (Extension) [Functional Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   Service (Services) [Occupational Activity]
Meta Mapping (691):
   586   Extended (Extension) [Functional Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   Service (Software Service) [Manufactured Object]
Meta Mapping (691):
   586   Extended (Extension) [Functional Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (691):
   586   Extended [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   Service (Services) [Occupational Activity]
Meta Mapping (691):
   586   Extended [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   Service (Software Service) [Manufactured Object]
Meta Mapping (691):
   586   Extended [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (691):
   586   Extended [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   Service (Services) [Occupational Activity]
Meta Mapping (691):
   586   Extended [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   Service (Software Service) [Manufactured Object]
Meta Mapping (691):
   586   Extended [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (691):
   586   extended (Extent) [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   Service (Services) [Occupational Activity]
Meta Mapping (691):
   586   extended (Extent) [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   Service (Software Service) [Manufactured Object]
Meta Mapping (691):
   586   extended (Extent) [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   PAIN (Pain) [Sign or Symptom]
   586   service (ActInformationPrivacyReason <service>) [Idea or Concept]
Meta Mapping (691):
   586   extended (Extent) [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   Service (Services) [Occupational Activity]
Meta Mapping (691):
   586   extended (Extent) [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   Service (Software Service) [Manufactured Object]
Meta Mapping (691):
   586   extended (Extent) [Spatial Concept]
   753   discussions (Discussion (procedure)) [Therapeutic or Preventive Procedure]
   586   Pain NOS (Pain NOS Adverse Event) [Finding]
   586   service (ActInformationPrivacyReason <service>) [Idea or Concept]

Phrase: Mr.
Meta Mapping (1000):
  1000   MR (MRC1 gene) [Gene or Genome]
Meta Mapping (1000):
  1000   Mr. (Mr. - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   MR (Minor Response) [Finding]
Processing 00000000.tx.41: Leach was brought back down to the pain clinic on October 27 . 

Phrase: Leach

Phrase: was

Phrase: brought
Meta Mapping (1000):
  1000   brought (Brought on by) [Functional Concept]

Phrase: back down
Meta Mapping (833):
   833   BACK (Back) [Body Location or Region]
Meta Mapping (833):
   833   BACK (Dorsal) [Spatial Concept]
Meta Mapping (833):
   833   Back (Back structure, including back of neck) [Body Location or Region]
Meta Mapping (833):
   833   Back, NOS (Back structure, excluding neck) [Body Location or Region]

Phrase: to the pain clinic on October 27 .
Meta Mapping (706):
   778   Pain Clinic (Pain Clinics) [Health Care Related Organization,Manufactured Object]
   581   October [Qualitative Concept]
Processing 00000000.tx.42: Left thorascopic sympathectomy on May 21 and cardiac catheterization and coronary angiograph and left ventriculography on April 10 , 1994 . 

Phrase: Left thorascopic sympathectomy on May 21
Meta Mapping (666):
   586   LEFT (Left) [Spatial Concept]
   753   Sympathectomy [Therapeutic or Preventive Procedure]
   586   May (Month of May) [Temporal Concept]
Meta Mapping (666):
   586   Left (Left sided) [Spatial Concept]
   753   Sympathectomy [Therapeutic or Preventive Procedure]
   586   May (Month of May) [Temporal Concept]
Meta Mapping (666):
   586   left (Table Cell Horizontal Align - left) [Functional Concept]
   753   Sympathectomy [Therapeutic or Preventive Procedure]
   586   May (Month of May) [Temporal Concept]

Phrase: and

Phrase: cardiac catheterization
Meta Mapping (1000):
  1000   Cardiac catheterisation (Cardiac Catheterization Procedures) [Health Care Activity]

Phrase: and

Phrase: coronary angiograph
Meta Mapping (950):
   950   Coronary Angiographies (Coronary angiography) [Diagnostic Procedure]
Meta Mapping (950):
   950   Coronary Angiography (Consent Type - Coronary Angiography) [Health Care Activity]

Phrase: and

Phrase: left ventriculography on April 10 ,
Meta Mapping (752):
   806   left ventriculography (Left ventriculogram) [Diagnostic Procedure]
   593   April [Temporal Concept]
   593   10% [Finding]
Meta Mapping (752):
   806   left ventriculography (Left ventriculogram) [Diagnostic Procedure]
   593   APRIL (TNFSF13 wt Allele) [Gene or Genome]
   593   10% [Finding]
Meta Mapping (752):
   806   left ventriculography (Left ventriculogram) [Diagnostic Procedure]
   593   APRIL (A Proliferation-Inducing Ligand Measurement) [Laboratory Procedure]
   593   10% [Finding]

Phrase: 1994 .
Processing 00000000.tx.43: Treadmill exercise testing X2 on May 13 and May 14 . 

Phrase: Treadmill exercise testing X2 on May 13
Meta Mapping (590):
   647   treadmill exercise testing (Cardiovascular stress test using treadmill) [Diagnostic Procedure]
   581   May (Month of May) [Temporal Concept]

Phrase: and

Phrase: May 14 .
Meta Mapping (861):
   861   May (Month of May) [Temporal Concept]
Processing 00000000.tx.44: CTMC Admission Date : Signed A mass was palpable on vaginal exam and a biopsy was performed which revealed squamous cell carcinoma . 

Phrase: CTMC Admission Date
Meta Mapping (901):
   901   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (901):
   901   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: Signed
Meta Mapping (1000):
  1000   Signed (Signature) [Intellectual Product]
Meta Mapping (1000):
  1000   signed (signed - ParticipationSignature) [Intellectual Product]

Phrase: A mass
Meta Mapping (1000):
  1000   MASS (Mass of body structure) [Finding]
Meta Mapping (1000):
  1000   Mass (Mass of body region) [Sign or Symptom]
Meta Mapping (1000):
  1000   MAS (Macrophage Activation Syndrome) [Disease or Syndrome]
Meta Mapping (1000):
  1000   *Mass (Mass, a measure of quantity of matter) [Quantitative Concept]
Meta Mapping (1000):
  1000   Mass (Molecular Mass) [Quantitative Concept]
Meta Mapping (1000):
  1000   mAs (Milliampere second) [Quantitative Concept]

Phrase: was

Phrase: palpable on vaginal exam
Meta Mapping (783):
   770   Palpable [Qualitative Concept]
   666   Vaginal Exam (Vaginal Examination) [Diagnostic Procedure]

Phrase: and

Phrase: a biopsy
Meta Mapping (1000):
  1000   BIOPSY (Biopsy) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   biopsy (biopsy characteristics) [Functional Concept]

Phrase: was

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: which

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: squamous cell carcinoma .
Meta Mapping (1000):
  1000   Squamous Cell Carcinoma (Squamous cell carcinoma) [Neoplastic Process]
Meta Mapping (1000):
  1000   Squamous cell carcinoma (Squamous cell carcinoma - category) [Neoplastic Process]
Processing 00000000.tx.45: HOSPITAL COURSE : 10/09/91 95090749 Unsigned DIS Admission Date : Discharge Date : He had been on diuretic therapy for the past several months with worsening shortness of breath . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: 10/09/91 95090749 Unsigned DIS Admission Date
Meta Mapping (767):
   626   10% [Finding]
   626   DIS (Diagnostic interview schedule) [Intellectual Product]
   812   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (767):
   626   10% [Finding]
   626   DIS (Diagnostic interview schedule) [Intellectual Product]
   812   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (767):
   626   10% [Finding]
   626   DIS (Discontinued) [Finding]
   812   Admission date (Date of admission) [Temporal Concept]
Meta Mapping (767):
   626   10% [Finding]
   626   DIS (Discontinued) [Finding]
   812   Admission date (Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]

Phrase: :

Phrase: Discharge Date
Meta Mapping (1000):
  1000   Discharge date (Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Discharge date [Temporal Concept]

Phrase: :

Phrase: He

Phrase: had

Phrase: been on diuretic therapy
Meta Mapping (833):
   833   diuretic therapy [Therapeutic or Preventive Procedure]

Phrase: for the past several months with worsening shortness of breath .
Meta Mapping (694):
   573   Past [Temporal Concept]
   739   MONTHS (month) [Temporal Concept]
   573   Worsening (Worsening pattern) [Qualitative Concept]
   615   SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (694):
   573   Past [Temporal Concept]
   739   MONTHS (month) [Temporal Concept]
   573   Worsening (Worsening pattern) [Qualitative Concept]
   615   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (694):
   573   Past [Temporal Concept]
   739   MONTHS (month) [Temporal Concept]
   573   Worsening (Worse) [Finding]
   615   SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (694):
   573   Past [Temporal Concept]
   739   MONTHS (month) [Temporal Concept]
   573   Worsening (Worse) [Finding]
   615   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]
Meta Mapping (694):
   573   Past [Temporal Concept]
   739   MONTHS (month) [Temporal Concept]
   573   Worsening (Patient Outcome - Worsening) [Idea or Concept]
   615   SHORTNESS OF BREATH (Dyspnea) [Sign or Symptom]
Meta Mapping (694):
   573   Past [Temporal Concept]
   739   MONTHS (month) [Temporal Concept]
   573   Worsening (Patient Outcome - Worsening) [Idea or Concept]
   615   Shortness of breath (Shortness of breath:-:Point in time:^Patient:-) [Clinical Attribute]
Processing 00000000.tx.46: Coumadin 2 mg p.o. daily ; prednisone 10 mg p.o. q.o.d. alternating with 7.5 mg q.o.d. 

Phrase: Coumadin 2 mg p.o. daily
Meta Mapping (750):
   799   Coumadin [Organic Chemical,Pharmacologic Substance]
   799   MG (Mongolia) [Geographic Area]
   799   Daily [Temporal Concept]
Meta Mapping (750):
   799   Coumadin [Organic Chemical,Pharmacologic Substance]
   799   mg% (mg/dL) [Quantitative Concept]
   799   Daily [Temporal Concept]
Meta Mapping (750):
   799   Coumadin [Organic Chemical,Pharmacologic Substance]
   799   mg % (Milligram percent) [Quantitative Concept]
   799   Daily [Temporal Concept]
Meta Mapping (750):
   799   Coumadin [Organic Chemical,Pharmacologic Substance]
   799   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
   799   Daily [Temporal Concept]

Phrase: ; prednisone 10 mg p.o. q.o.d. alternating
Meta Mapping (819):
   660   Prednisone 10 MG [Clinical Drug]
   791   Alternating [Functional Concept]

Phrase: with 7.5 mg q.o.d.
Meta Mapping (858):
   858   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.47: ; Imuran 100 mg daily ; cyclosporine 70 mg p.o. b.i.d. 

Phrase: ; Imuran 100 mg daily
Meta Mapping (902):
   905   Azathioprine 100 MG [Clinical Drug]
   645   Daily [Temporal Concept]

Phrase: ; cyclosporine 70 mg p.o. b.i.d.
Meta Mapping (767):
   892   cyclosporin D [Amino Acid, Peptide, or Protein]
   793   70% [Finding]
   793   MG (Mongolia) [Geographic Area]
Meta Mapping (767):
   892   cyclosporin D [Amino Acid, Peptide, or Protein]
   793   70% [Finding]
   793   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (767):
   892   cyclosporin D [Amino Acid, Peptide, or Protein]
   793   70% [Finding]
   793   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (767):
   892   cyclosporin D [Amino Acid, Peptide, or Protein]
   793   70% [Finding]
   793   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (767):
   793   Cyclosporin (Cyclosporine) [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   70% [Finding]
   864   mg/d (milligram/day) [Quantitative Concept]
Meta Mapping (767):
   793   Cyclosporine (Cyclosporins) [Immunologic Factor,Pharmacologic Substance]
   793   70% [Finding]
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.48: ; Lopressor 25 mg p.o. b.i.d. 

Phrase: ; Lopressor 25 mg p.o. b.i.d.
Meta Mapping (795):
   793   Lopressor [Organic Chemical,Pharmacologic Substance]
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.49: ; Ventolin two puffs q6h p.r.n. 

Phrase: ; Ventolin two puffs q6h
Meta Mapping (833):
   645   Ventolin [Organic Chemical,Pharmacologic Substance]
   645   Two [Quantitative Concept]
   645   Puffs (Puff unit dose) [Quantitative Concept]
   812   Q6H (Every six hours) [Temporal Concept]

Phrase: p.r.n.
Meta Mapping (901):
   827   P NOS (P Blood group antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Meta Mapping (901):
   827   P' (P prime) [Clinical Attribute]
   901   R.N. (Registered nurse) [Professional or Occupational Group]
Processing 00000000.tx.50: 42516916 VENTRICULAR FIBRILLATION . 

Phrase: 42516916 VENTRICULAR FIBRILLATION .
Meta Mapping (901):
   901   Fibrillation, Ventricular (Ventricular Fibrillation) [Disease or Syndrome]
Meta Mapping (901):
   901   Ventricular Fibrillation (Ventricular Fibrillation by ECG Finding) [Laboratory or Test Result]
Meta Mapping (901):
   901   Ventricular fibrillation (Ventricular Fibrillation Adverse Event) [Pathologic Function]
Processing 00000000.tx.51: He was seen in clinic by Dr. 

Phrase: He

Phrase: was

Phrase: seen
Meta Mapping (1000):
  1000   Seen (seen) [Qualitative Concept]

Phrase: in clinic by Dr.
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (733):
   770   In (Present) [Quantitative Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (733):
   770   In (Within) [Spatial Concept]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic (Ambulatory Care Facilities) [Health Care Related Organization,Manufactured Object]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Dominican Republic) [Geographic Area]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (733):
   770   IN (CD44 wt Allele) [Gene or Genome]
   770   Clinic [Health Care Related Organization,Manufactured Object]
   604   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.52: Stisie H. 

Phrase: Stisie H.
Meta Mapping (861):
   861   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (861):
   861   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (861):
   861   H+ (Hepatic Involvement) [Classification]
Meta Mapping (861):
   861   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.53: Pain , who felt he had congestive heart failure exacerbation , although myocardial infarction , pulmonary embolism , inferior vena cava obstruction could not be totally ruled out . 

Phrase: Pain ,
Meta Mapping (1000):
  1000   PAIN (Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: who

Phrase: felt
Meta Mapping (966):
   966   feel (Emotions) [Mental Process]

Phrase: he

Phrase: had

Phrase: congestive heart failure exacerbation ,
Meta Mapping (756):
   756   CONGESTIVE HEART FAILURE (Congestive heart failure) [Disease or Syndrome]

Phrase: although

Phrase: myocardial infarction ,
Meta Mapping (1000):
  1000   Infarction, Myocardial (Myocardial Infarction) [Disease or Syndrome]
Meta Mapping (1000):
  1000   MYOCARDIAL INFARCTION (Electrocardiogram: myocardial infarction (finding)) [Laboratory or Test Result]
Meta Mapping (1000):
  1000   Myocardial infarction (Myocardial infarction:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Myocardial Infarction (Myocardial Infarction ECG Assessment) [Diagnostic Procedure]

Phrase: pulmonary embolism ,
Meta Mapping (1000):
  1000   PULMONARY EMBOLISM (Pulmonary Embolism) [Disease or Syndrome]

Phrase: inferior vena cava obstruction
Meta Mapping (1000):
  1000   Inferior vena cava obstruction (Inferior vena cava syndrome) [Disease or Syndrome]

Phrase: could

Phrase: not
Meta Mapping (1000):
  1000   Not (Negation) [Functional Concept]

Phrase: be

Phrase: totally

Phrase: ruled
Meta Mapping (1000):
  1000   ruled (Positive) [Qualitative Concept]

Phrase: out .
Meta Mapping (1000):
  1000   Out (Out (direction)) [Spatial Concept]
Meta Mapping (1000):
  1000   Out (Removed) [Qualitative Concept]
Processing 00000000.tx.54: Guaiac was negative . 

Phrase: Guaiac
Meta Mapping (1000):
  1000   GUAIAC (Guaiac) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: was

Phrase: negative .
Meta Mapping (1000):
  1000   Negative [Qualitative Concept]
Meta Mapping (1000):
  1000   NEGATIVE (Negative Finding) [Finding]
Meta Mapping (1000):
  1000   Negative (Negative Number) [Conceptual Entity]
Meta Mapping (1000):
  1000   Negative (Negative Charge) [Qualitative Concept]
Meta Mapping (1000):
  1000   Negative (Negative - answer) [Qualitative Concept]
Processing 00000000.tx.55: His white count was 7.83 thousand , hematocrit 39 , mean corpuscular volume 78.9 , platelet count 295,000 . 

Phrase: His white count
Meta Mapping (888):
   694   WHITE (Caucasoid Race) [Population Group]
   861   Count [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (Caucasoid Race) [Population Group]
   861   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (Caucasians) [Population Group]
   861   Count [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (Caucasians) [Population Group]
   861   COUNT (Count Dosing Unit) [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (White color) [Qualitative Concept]
   861   Count [Quantitative Concept]
Meta Mapping (888):
   694   WHITE (White color) [Qualitative Concept]
   861   COUNT (Count Dosing Unit) [Quantitative Concept]

Phrase: was

Phrase: 7.83 thousand ,
Meta Mapping (827):
   827   Thousand (One Thousand) [Quantitative Concept]

Phrase: hematocrit 39 ,
Meta Mapping (861):
   861   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (861):
   861   Hematocrit (Hematocrit level) [Finding]

Phrase: mean corpuscular volume 78.9 ,
Meta Mapping (884):
   884   Volume, Mean Corpuscular (Mean Corpuscular Volume (result)) [Laboratory or Test Result]
Meta Mapping (884):
   884   Mean corpuscular volume - NOS (Mean corpuscular volume analyses) [Laboratory Procedure]
Meta Mapping (884):
   884   mean corpuscular volume (Erythrocyte Mean Corpuscular Volume Measurement) [Laboratory Procedure]

Phrase: platelet count 295,000 .
Meta Mapping (861):
   861   Platelet Count (Platelet Count measurement) [Laboratory Procedure]
Meta Mapping (861):
   861   Platelet count (Finding of platelet count) [Laboratory or Test Result]
Processing 00000000.tx.56: The electrocardiogram showed atrial fibrillation at 100 beats per minute , QRS was 0.08 , QTC 0.30 , axis +60 degrees , there was T-wave inversion in V4 through V6 , flat T-waves in I , II , III and AVL , no changes compared to the previous electrocardiogram on 9-8-90 . 

Phrase: The electrocardiogram
Meta Mapping (1000):
  1000   Electrocardiogram [Finding]
Meta Mapping (1000):
  1000   Electro-Cardiogram [Spatial Concept]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: atrial fibrillation at 100 beats
Meta Mapping (745):
   806   ATRIAL FIBRILLATION (Atrial Fibrillation) [Disease or Syndrome]
   593   100% [Quantitative Concept]
Meta Mapping (745):
   806   Atrial Fibrillation (Atrial Fibrillation by ECG Finding) [Laboratory or Test Result]
   593   100% [Quantitative Concept]
Meta Mapping (745):
   806   Atrial fibrillation (Atrial Fibrillation Adverse Event) [Finding]
   593   100% [Quantitative Concept]

Phrase: per minute ,
Meta Mapping (1000):
  1000   MINUTE (Minute of time) [Temporal Concept]
Meta Mapping (1000):
  1000   minute (Small) [Quantitative Concept]
Meta Mapping (1000):
  1000   /minute (Per Minute) [Temporal Concept]
Meta Mapping (1000):
  1000   Minute (Minute (diminutive)) [Quantitative Concept]
Meta Mapping (1000):
  1000   Minute (Minute Unit of Plane Angle) [Quantitative Concept]

Phrase: QRS

Phrase: was

Phrase: 0.08 ,
Meta Mapping (861):
   861   0% [Finding]

Phrase: QTC 0.30 ,
Meta Mapping (790):
   827   0% [Finding]
   827   30% [Finding]

Phrase: axis +60 degrees ,
Meta Mapping (851):
   660   Axis (Axis vertebra) [Body Part, Organ, or Organ Component]
   660   60% [Finding]
   827   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (851):
   660   Axis (Axis vertebra) [Body Part, Organ, or Organ Component]
   660   60% [Finding]
   827   degrees (Academic degree) [Intellectual Product]
Meta Mapping (851):
   660   Axis (Genus Axis) [Mammal]
   660   60% [Finding]
   827   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (851):
   660   Axis (Genus Axis) [Mammal]
   660   60% [Finding]
   827   degrees (Academic degree) [Intellectual Product]
Meta Mapping (851):
   660   Axis [Spatial Concept]
   660   60% [Finding]
   827   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (851):
   660   Axis [Spatial Concept]
   660   60% [Finding]
   827   degrees (Academic degree) [Intellectual Product]

Phrase: there

Phrase: was

Phrase: T-wave inversion in V4
Meta Mapping (816):
   862   T Wave Inversion (Inverted T wave) [Finding]
   593   V4+ [Element, Ion, or Isotope]

Phrase: through V6 ,
Meta Mapping (1000):
  1000   V6 (Superior segmental vein) [Body Part, Organ, or Organ Component]

Phrase: flat T-waves in I ,
Meta Mapping (761):
   593   Flat (Flat shape) [Spatial Concept]
   806   t waves (T wave feature) [Finding]
   593   I- (Iodides) [Inorganic Chemical]
Meta Mapping (761):
   593   Flat (Flat shape) [Spatial Concept]
   806   t waves (T wave feature) [Finding]
   593   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (761):
   593   Flat (Residential flat) [Manufactured Object]
   806   t waves (T wave feature) [Finding]
   593   I- (Iodides) [Inorganic Chemical]
Meta Mapping (761):
   593   Flat (Residential flat) [Manufactured Object]
   806   t waves (T wave feature) [Finding]
   593   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: II ,

Phrase: III
Meta Mapping (1000):
  1000   III (Roman Numeral III) [Intellectual Product]
Meta Mapping (1000):
  1000   III (III (suffix)) [Qualitative Concept]

Phrase: and

Phrase: AVL ,
Meta Mapping (1000):
  1000   aVL (aVL - Lead site) [Spatial Concept]

Phrase: no changes
Meta Mapping (1000):
  1000   changes (Changing) [Functional Concept]
Meta Mapping (1000):
  1000   changes (Changed status) [Quantitative Concept]

Phrase: compared to the previous electrocardiogram
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   Previous [Temporal Concept]
   760 N Electrocardiogram [Finding]
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   Previous [Temporal Concept]
   760   Electro-Cardiogram [Spatial Concept]
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   Previous [Temporal Concept]
   760   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   Previous [Temporal Concept]
   760   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   previous (Act Relationship Subset - previous) [Temporal Concept]
   760 N Electrocardiogram [Finding]
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   previous (Act Relationship Subset - previous) [Temporal Concept]
   760   Electro-Cardiogram [Spatial Concept]
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   previous (Act Relationship Subset - previous) [Temporal Concept]
   760   Electrocardiogram (Electrocardiography) [Diagnostic Procedure]
Meta Mapping (696):
   760   Compared (Comparison) [Activity]
   760   previous (Act Relationship Subset - previous) [Temporal Concept]
   760   Electrocardiogram (Electrocardiogram Domain) [Intellectual Product]

Phrase: on 9-8-90 .
Meta Mapping (827):
   827   >90 [Quantitative Concept]
Meta Mapping (827):
   827   <90 [Quantitative Concept]
Meta Mapping (827):
   827   90% [Finding]
Processing 00000000.tx.57: His weight had decreased to 68.1 kilograms at the time of discharge , and edema was significantly reduced . 

Phrase: His weight
Meta Mapping (1000):
  1000   Weight (Body Weight) [Organism Attribute]
Meta Mapping (1000):
  1000   WEIGHT (Weight) [Quantitative Concept]
Meta Mapping (1000):
  1000   weight (Weighing patient) [Diagnostic Procedure]
Meta Mapping (1000):
  1000   Weight (Importance Weight) [Idea or Concept]

Phrase: had

Phrase: decreased to 68.1 kilograms
Meta Mapping (687):
   760   Decreased [Quantitative Concept]
   760   68 [Intellectual Product]
   760   kilograms (Kilogram) [Quantitative Concept]
Meta Mapping (687):
   760   Decreased (Reduced) [Qualitative Concept]
   760   68 [Intellectual Product]
   760   kilograms (Kilogram) [Quantitative Concept]
Meta Mapping (687):
   760   decreased (Decreasing) [Qualitative Concept]
   760   68 [Intellectual Product]
   760   kilograms (Kilogram) [Quantitative Concept]

Phrase: at the time of discharge ,
Meta Mapping (797):
   797   Discharge time [Temporal Concept]
Meta Mapping (797):
   797   Discharge time (Discharge time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]

Phrase: and

Phrase: edema
Meta Mapping (1000):
  1000   OEDEMA (Edema) [Finding]
Meta Mapping (1000):
  1000   Edema (Edema:Finding:Point in time:^Patient:Ordinal) [Clinical Attribute]

Phrase: was

Phrase: significantly

Phrase: reduced .
Meta Mapping (1000):
  1000   Reduced [Qualitative Concept]
Processing 00000000.tx.58: 03/15/91 T : SHONDMAGSHAO M. 

Phrase: 03/15/91 T

Phrase: :

Phrase: SHONDMAGSHAO M.
Meta Mapping (861):
   861   M NOS (M NOS ANTIBODY) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (861):
   861   M+ (M+ (tumor staging)) [Intellectual Product]
Processing 00000000.tx.59: H. 

Phrase: H.
Meta Mapping (1000):
  1000   H+ (Protons) [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   H NOS (H NOS Antibodies) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (1000):
  1000   H+ (Hepatic Involvement) [Classification]
Meta Mapping (1000):
  1000   /h (/hour) [Quantitative Concept]
Processing 00000000.tx.60: PAIN , M.D. 

Phrase: PAIN ,
Meta Mapping (1000):
  1000   PAIN (Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000   Pain NOS (Pain NOS Adverse Event) [Finding]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.61: </TEXT> 8/20/1991 12:00:00 AM Discharge Summary Signed The patient is a 67 year old white male with progressive debilitating bilateral knee pain times two years . 

Phrase: </TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 8/20/1991 12
Meta Mapping (812):
   812   20% [Finding]

Phrase: :

Phrase: 00

Phrase: :

Phrase: 00

Phrase: AM

Phrase: Discharge
Meta Mapping (1000):
  1000   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (1000):
  1000   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (1000):
  1000   Discharge (Discharge, body substance) [Body Substance]

Phrase: Summary
Meta Mapping (1000):
  1000   summary (summary - ActRelationshipSubset) [Intellectual Product]
Meta Mapping (1000):
  1000   Summary (Summary (document)) [Intellectual Product]

Phrase: Signed
Meta Mapping (1000):
  1000   Signed (Signature) [Intellectual Product]
Meta Mapping (1000):
  1000   signed (signed - ParticipationSignature) [Intellectual Product]

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: is

Phrase: a 67 year old white male with progressive debilitating bilateral knee pain times two years .
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   YEAR (year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   /Year (per year) [Temporal Concept]
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   Two Times (Twice (Numerical Qualifier)) [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasoid Race) [Population Group]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (Caucasians) [Population Group]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   MALE (Males) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male Gender, Self Report) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male Phenotype) [Qualitative Concept]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Meta Mapping (683):
   567   Old [Temporal Concept]
   567   WHITE (White color) [Qualitative Concept]
   733   Male (Male, Self-Reported) [Organism Attribute]
   567   Progressive [Functional Concept]
   593   Bilateral knee pain [Sign or Symptom]
   578   times year (times/year) [Quantitative Concept]
   567   Two [Quantitative Concept]
   567   YEARS (year) [Temporal Concept]
Processing 00000000.tx.62: Medications : On admission the patient had a hematocrit of 32.3 , white blood cell count of 3.52 , glucose 94 , PT 12.2 , PTT 33.9 . 

Phrase: Medications
Meta Mapping (1000):
  1000   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (1000):
  1000   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (1000):
  1000   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: :

Phrase: On admission
Meta Mapping (1000):
  1000   On admission [Temporal Concept]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: a hematocrit of 32.3 ,
Meta Mapping (760):
   760   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
Meta Mapping (760):
   760   Hematocrit (Hematocrit level) [Finding]

Phrase: white blood cell count of 3.52 ,
Meta Mapping (853):
   853   Blood Cell Count, White (White Blood Cell Count procedure) [Laboratory Procedure]
Meta Mapping (853):
   853   white blood cell count (White blood cell count laboratory result) [Laboratory or Test Result]

Phrase: glucose 94 ,
Meta Mapping (861):
   861   GLUCOSE (Glucose) [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: PT 12.2 ,
Meta Mapping (827):
   827   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (827):
   827   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]

Phrase: PTT 33.9 .
Meta Mapping (827):
   827   PTT (Activated Partial Thromboplastin Time measurement) [Laboratory Procedure]
Processing 00000000.tx.63: The patient had a white blood cell count of 7.1 and a hematocrit of 23.4 , PT 13.8 . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: had

Phrase: a white blood cell count of 7.1
Meta Mapping (833):
   833   Blood Cell Count, White (White Blood Cell Count procedure) [Laboratory Procedure]
Meta Mapping (833):
   833   white blood cell count (White blood cell count laboratory result) [Laboratory or Test Result]

Phrase: and

Phrase: a hematocrit of 23.4 ,
Meta Mapping (686):
   760   Hematocrit (Hematocrit procedure) [Laboratory Procedure]
   593   23 [Quantitative Concept]
Meta Mapping (686):
   760   Hematocrit (Hematocrit level) [Finding]
   593   23 [Quantitative Concept]

Phrase: PT 13.8 .
Meta Mapping (827):
   827   PT (Physical therapy (field)) [Biomedical Occupation or Discipline]
Meta Mapping (827):
   827   PT (Pharmacogenomics Trial Characteristics Domain) [Intellectual Product]
Processing 00000000.tx.64: NECK : HEAD : In terms of range of motion right head flexion to 120 degrees , extension 0 , left head flexion to 115 degrees , extension to 0 with positive crepitus bilaterally . 

Phrase: NECK
Meta Mapping (1000):
  1000   NECK (Neck) [Body Location or Region]
Meta Mapping (1000):
  1000   Neck (Entire neck) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   neck (dendritic spine neck) [Cell Component]

Phrase: :

Phrase: HEAD
Meta Mapping (1000):
  1000   HEAD (Head) [Body Location or Region]
Meta Mapping (1000):
  1000   Head (Entire head) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Head (Head - Component of Device) [Manufactured Object]

Phrase: :

Phrase: In terms of range of motion right head flexion to 120 degrees ,
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term Birth) [Organism Function]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term Birth) [Organism Function]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Present) [Quantitative Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term Birth) [Organism Function]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term Birth) [Organism Function]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term Birth) [Organism Function]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   In (Within) [Spatial Concept]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term Birth) [Organism Function]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term Birth) [Organism Function]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term Birth) [Organism Function]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term Birth) [Organism Function]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term Birth) [Organism Function]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term Birth) [Organism Function]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (temporal)) [Temporal Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (temporal)) [Temporal Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (temporal)) [Temporal Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (lexical)) [Idea or Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (lexical)) [Idea or Concept]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   Term (Term (lexical)) [Idea or Concept]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of Motion (Range of Motion, Articular) [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   TERM (Reported Term) [Intellectual Product]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   TERM (Reported Term) [Intellectual Product]
   599   range of motion (Range of motion exercise) [Therapeutic or Preventive Procedure]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (693):
   570   IN (CD44 wt Allele) [Gene or Genome]
   536   TERM (Reported Term) [Intellectual Product]
   599   Range of motion [Clinical Attribute]
   584   head Right (Structure of right half of head) [Body Location or Region]
   736   Flexion (Flexion, function) [Organ or Tissue Function]
   570   degrees (Academic degree) [Intellectual Product]

Phrase: extension 0 ,
Meta Mapping (888):
   861   Extension [Functional Concept]
   861   0% [Finding]
Meta Mapping (888):
   861   Extension (Telephone Extension Number) [Conceptual Entity]
   861   0% [Finding]

Phrase: left head flexion to 115 degrees ,
Meta Mapping (697):
   586   LEFT (Left) [Spatial Concept]
   586   HEAD (Head) [Body Location or Region]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   LEFT (Left) [Spatial Concept]
   586   HEAD (Head) [Body Location or Region]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   LEFT (Left) [Spatial Concept]
   586   Head (Entire head) [Body Part, Organ, or Organ Component]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   LEFT (Left) [Spatial Concept]
   586   Head (Entire head) [Body Part, Organ, or Organ Component]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   LEFT (Left) [Spatial Concept]
   586   Head (Head - Component of Device) [Manufactured Object]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   LEFT (Left) [Spatial Concept]
   586   Head (Head - Component of Device) [Manufactured Object]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   Left (Left sided) [Spatial Concept]
   586   HEAD (Head) [Body Location or Region]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   Left (Left sided) [Spatial Concept]
   586   HEAD (Head) [Body Location or Region]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   Left (Left sided) [Spatial Concept]
   586   Head (Entire head) [Body Part, Organ, or Organ Component]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   Left (Left sided) [Spatial Concept]
   586   Head (Entire head) [Body Part, Organ, or Organ Component]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   Left (Left sided) [Spatial Concept]
   586   Head (Head - Component of Device) [Manufactured Object]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   Left (Left sided) [Spatial Concept]
   586   Head (Head - Component of Device) [Manufactured Object]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   left (Table Cell Horizontal Align - left) [Functional Concept]
   586   HEAD (Head) [Body Location or Region]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   left (Table Cell Horizontal Align - left) [Functional Concept]
   586   HEAD (Head) [Body Location or Region]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   left (Table Cell Horizontal Align - left) [Functional Concept]
   586   Head (Entire head) [Body Part, Organ, or Organ Component]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   left (Table Cell Horizontal Align - left) [Functional Concept]
   586   Head (Entire head) [Body Part, Organ, or Organ Component]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]
Meta Mapping (697):
   586   left (Table Cell Horizontal Align - left) [Functional Concept]
   586   Head (Head - Component of Device) [Manufactured Object]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Degree or extent) [Quantitative Concept]
Meta Mapping (697):
   586   left (Table Cell Horizontal Align - left) [Functional Concept]
   586   Head (Head - Component of Device) [Manufactured Object]
   753   Flexion (Flexion, function) [Organ or Tissue Function]
   586   degrees (Academic degree) [Intellectual Product]

Phrase: extension to 0
Meta Mapping (746):
   790   Extension [Functional Concept]
   623   0% [Finding]
Meta Mapping (746):
   790   Extension (Telephone Extension Number) [Conceptual Entity]
   623   0% [Finding]

Phrase: with positive crepitus bilaterally .
Meta Mapping (790):
   660   % Positive (percent positive cells) [Quantitative Concept]
   827   Crepitus (Subcutaneous crepitus) [Pathologic Function]
Meta Mapping (790):
   660   Positive [Qualitative Concept]
   827   Crepitus (Subcutaneous crepitus) [Pathologic Function]
Meta Mapping (790):
   660   POSITIVE (Positive Finding) [Finding]
   827   Crepitus (Subcutaneous crepitus) [Pathologic Function]
Meta Mapping (790):
   660   Positive (Positive Charge) [Qualitative Concept]
   827   Crepitus (Subcutaneous crepitus) [Pathologic Function]
Meta Mapping (790):
   660   Positive (Positive Number) [Conceptual Entity]
   827   Crepitus (Subcutaneous crepitus) [Pathologic Function]
Processing 00000000.tx.65: TVI NORTSPALDFYFE , M.D. 

Phrase: TVI NORTSPALDFYFE ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.66: CH771/8971 NU JESCRALN , M.D. 

Phrase: CH771/8971 NU JESCRALN ,
Meta Mapping (645):
   645   NU (Mice, Nude) [Mammal]
Meta Mapping (645):
   645   NU (Nicaragua) [Geographic Area]
Meta Mapping (645):
   645   Nu (Greek letter nu) [Intellectual Product]
Meta Mapping (645):
   645   NU (PSMA1 gene) [Gene or Genome]

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.67: TK5

Phrase: TK5
Meta Mapping (1000):
  1000   TK5 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.1: PUOMC Thoracoabdominal aneurysm . 

Phrase: PUOMC Thoracoabdominal aneurysm .
Meta Mapping (790):
   827   Thoracoabdominal [Spatial Concept]
   827   ANEURYSM (Aneurysm) [Disease or Syndrome]
Processing 00000000.tx.2: HISTORY : Since the patient &apos;s last admission she gives no history of chest or back pain and continues to be quite active . 

Phrase: HISTORY
Meta Mapping (1000):
  1000   History [Occupation or Discipline]
Meta Mapping (1000):
  1000   history (Historical aspects qualifier) [Functional Concept]
Meta Mapping (1000):
  1000   History, NOS (History of present illness) [Organism Attribute]
Meta Mapping (1000):
  1000   History (Medical History) [Finding]
Meta Mapping (1000):
  1000   History (Concept History) [Conceptual Entity]
Meta Mapping (1000):
  1000   History (History of previous events) [Finding]

Phrase: :

Phrase: Since

Phrase: the patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s last admission
Meta Mapping (802):
   660   /s (per second) [Quantitative Concept]
   827   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (802):
   660   /s (per second) [Quantitative Concept]
   827   Admission (Admission activity) [Health Care Activity]
Meta Mapping (802):
   660   S' (S prime) [Clinical Attribute]
   827   Admission (Hospital admission) [Health Care Activity]
Meta Mapping (802):
   660   S' (S prime) [Clinical Attribute]
   827   Admission (Admission activity) [Health Care Activity]

Phrase: she

Phrase: gives
Meta Mapping (1000):
  1000   Give (Give - dosing instruction imperative) [Functional Concept]

Phrase: no history of chest
Meta Mapping (708):
   770   History [Occupation or Discipline]
   604   CHEST (Chest) [Body Location or Region]
Meta Mapping (708):
   770   History [Occupation or Discipline]
   604   Chest (Anterior thoracic region) [Body Location or Region]
Meta Mapping (708):
   770   history (Historical aspects qualifier) [Functional Concept]
   604   CHEST (Chest) [Body Location or Region]
Meta Mapping (708):
   770   history (Historical aspects qualifier) [Functional Concept]
   604   Chest (Anterior thoracic region) [Body Location or Region]
Meta Mapping (708):
   770   History, NOS (History of present illness) [Organism Attribute]
   604   CHEST (Chest) [Body Location or Region]
Meta Mapping (708):
   770   History, NOS (History of present illness) [Organism Attribute]
   604   Chest (Anterior thoracic region) [Body Location or Region]
Meta Mapping (708):
   770 N History (Medical History) [Finding]
   604   CHEST (Chest) [Body Location or Region]
Meta Mapping (708):
   770 N History (Medical History) [Finding]
   604   Chest (Anterior thoracic region) [Body Location or Region]
Meta Mapping (708):
   770   History (Concept History) [Conceptual Entity]
   604   CHEST (Chest) [Body Location or Region]
Meta Mapping (708):
   770   History (Concept History) [Conceptual Entity]
   604   Chest (Anterior thoracic region) [Body Location or Region]
Meta Mapping (708):
   770 N History (History of previous events) [Finding]
   604   CHEST (Chest) [Body Location or Region]
Meta Mapping (708):
   770 N History (History of previous events) [Finding]
   604   Chest (Anterior thoracic region) [Body Location or Region]

Phrase: or

Phrase: back pain
Meta Mapping (1000):
  1000 N BACKPAIN (Back Pain) [Sign or Symptom]
Meta Mapping (1000):
  1000 N Back pain (Back Pain Adverse Event) [Finding]

Phrase: and

Phrase: continues
Meta Mapping (1000):
  1000   Continue (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: be

Phrase: quite active .
Meta Mapping (861):
   861   Active [Functional Concept]
Meta Mapping (861):
   861   active (active (HL7 RoleLink)) [Idea or Concept]
Meta Mapping (861):
   861   Active (Active License) [Qualitative Concept]
Processing 00000000.tx.3: The patient continued to make slight gains in motor movement of the left lower extremity as manifested by digital function and some knee jerk return and by postoperative day eight she was manifesting some dorsiflexion in addition to urodynamics being performed revealed good detrusion contraction , normal sensation and a coordinated sphincter which suggested no disability to the sympathetic control of her bowel and bladder . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: continued
Meta Mapping (1000):
  1000   Continued (Continuous) [Idea or Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: make
Meta Mapping (1000):
  1000   Make (Make - Instruction Imperative) [Functional Concept]

Phrase: slight gains in motor movement of the left lower extremity
Meta Mapping (696):
   573   Slight (Slight (qualifier value)) [Qualitative Concept]
   706   Gain [Quantitative Concept]
   593   motor movement [Functional Concept]
   615   Left lower extremity [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   573   Slight (Mild (qualifier value)) [Qualitative Concept]
   706   Gain [Quantitative Concept]
   593   motor movement [Functional Concept]
   615   Left lower extremity [Body Part, Organ, or Organ Component]
Meta Mapping (696):
   573   Slight (Borg Category-Ratio 10 Perceived Exertion Score 2) [Intellectual Product]
   706   Gain [Quantitative Concept]
   593   motor movement [Functional Concept]
   615   Left lower extremity [Body Part, Organ, or Organ Component]

Phrase: as

Phrase: manifested by digital function
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital (Digital X-ray) [Intellectual Product]
   770   function (physiological aspects) [Physiologic Function]
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital (Digital X-ray) [Intellectual Product]
   770   FUNCTION (Function) [Functional Concept]
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital (Digital X-ray) [Intellectual Product]
   770   FUNCTION (Function Axis) [Classification]
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital (Digital X-ray) [Intellectual Product]
   770   Function (Mathematical Operator) [Intellectual Product]
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital [Qualitative Concept]
   770   function (physiological aspects) [Physiologic Function]
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital [Qualitative Concept]
   770   FUNCTION (Function) [Functional Concept]
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital [Qualitative Concept]
   770   FUNCTION (Function Axis) [Classification]
Meta Mapping (861):
   833   Manifested by [Qualitative Concept]
   770   Digital [Qualitative Concept]
   770   Function (Mathematical Operator) [Intellectual Product]

Phrase: and

Phrase: some knee jerk return
Meta Mapping (901):
   734   Knee jerk (Knee reflex) [Finding]
   827   Return (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]

Phrase: and by postoperative day eight
Meta Mapping (714):
   760   Postoperative (Postoperative Period) [Temporal Concept]
   760   /day (Daily) [Temporal Concept]
   760   Eight [Quantitative Concept]
Meta Mapping (714):
   760   Postoperative (Postoperative Period) [Temporal Concept]
   760   DAY (day) [Temporal Concept]
   760   Eight [Quantitative Concept]
Meta Mapping (714):
   760   Postoperative (Postoperative Period) [Temporal Concept]
   760   /day (per day) [Temporal Concept]
   760   Eight [Quantitative Concept]

Phrase: she

Phrase: was

Phrase: manifesting
Meta Mapping (1000):
  1000   manifesting (Manifest) [Functional Concept]

Phrase: some dorsiflexion in addition to urodynamics
Meta Mapping (632):
   666   In addition to [Functional Concept]
   586   Urodynamics [Organ or Tissue Function]
Meta Mapping (632):
   666   In addition to [Functional Concept]
   586   Urodynamics (Urodynamic studies (procedure)) [Diagnostic Procedure]

Phrase: being

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: good detrusion contraction ,
Meta Mapping (802):
   660   Good [Qualitative Concept]
   827   Contraction (Contraction (finding)) [Pathologic Function]

Phrase: normal sensation
Meta Mapping (1000):
  1000   Normal sensation [Finding]

Phrase: and

Phrase: a coordinated sphincter
Meta Mapping (888):
   694   Coordinated (No incoordination) [Finding]
   861   Sphincter [Body Part, Organ, or Organ Component]
Meta Mapping (888):
   694   Coordinated [Functional Concept]
   861   Sphincter [Body Part, Organ, or Organ Component]

Phrase: which

Phrase: suggested
Meta Mapping (966):
   966   Suggest (suggestion) [Idea or Concept]

Phrase: no disability to the sympathetic control of her bowel
Meta Mapping (683):
   742 N DISABILITY (Disability) [Finding]
   595   Bowel control (Bowel control, function) [Organism Function]

Phrase: and

Phrase: bladder .
Meta Mapping (1000):
  1000   BLADDER (Urinary Bladder) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Bladder (Entire bladder) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Bladder (Bladder Tissue) [Tissue]
Processing 00000000.tx.4: CONDITION ON DISCHARGE : COMPLICATIONS : Dr. 

Phrase: CONDITION ON DISCHARGE
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   condition (Disease) [Disease or Syndrome]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition [Qualitative Concept]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Logical Condition) [Conceptual Entity]
   623   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (746):
   790   Condition (Condition:Find:Pt:^Patient:Nom) [Clinical Attribute]
   623   Discharge (Discharge, body substance) [Body Substance]

Phrase: :

Phrase: COMPLICATIONS
Meta Mapping (1000):
  1000   Complications (Complication) [Pathologic Function]
Meta Mapping (1000):
  1000   complications (Complication Aspects) [Pathologic Function]

Phrase: :

Phrase: Dr.
Meta Mapping (1000):
  1000   DR (Dominican Republic) [Geographic Area]
Meta Mapping (1000):
  1000   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.5: Nabeth Glyncred , Dr. 

Phrase: Nabeth Glyncred ,

Phrase: Dr.
Meta Mapping (1000):
  1000   DR (Dominican Republic) [Geographic Area]
Meta Mapping (1000):
  1000   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.6: Riode Zetllille , Dr. 

Phrase: Riode Zetllille ,

Phrase: Dr.
Meta Mapping (1000):
  1000   DR (Dominican Republic) [Geographic Area]
Meta Mapping (1000):
  1000   DR (Physicians) [Professional or Occupational Group]
Meta Mapping (1000):
  1000   DR (Delayed Release Dosage Form) [Biomedical or Dental Material]
Meta Mapping (1000):
  1000   Dr. (Doctor - Title) [Conceptual Entity]
Meta Mapping (1000):
  1000   DR (Device to Subject Relationship Domain) [Intellectual Product]
Processing 00000000.tx.7: Stie Fyfe STAT DISCHARGE SUMMARY ( 02-28-94 Laelk Memorial Hospital ) 651486 ED Discharge Summary MRN : 65y REGISTRATION DATE : Documented . 

Phrase: Stie Fyfe STAT DISCHARGE SUMMARY
Meta Mapping (785):
   637   STAT (Stat (do immediately)) [Temporal Concept]
   840   Discharge summary [Intellectual Product]
Meta Mapping (785):
   637   STAT (Stat (do immediately)) [Temporal Concept]
   840   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: ( 02-28-94 Laelk Memorial Hospital
Meta Mapping (799):
   799   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (799):
   799   Hospital (Hospital environment) [Qualitative Concept]

Phrase: )

Phrase: 651486 ED Discharge Summary MRN
Meta Mapping (619):
   637   ED (Endocrine System Findings Domain) [Idea or Concept]
   673   Discharge summary [Intellectual Product]
Meta Mapping (619):
   637   ED (Endocrine System Findings Domain) [Idea or Concept]
   673   Discharge summary (Discharge summarization note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]

Phrase: :

Phrase: 65y REGISTRATION DATE
Meta Mapping (790):
   660   Registration [Health Care Activity]
   827   DATE (Date in time) [Temporal Concept]
Meta Mapping (790):
   660   Registration [Health Care Activity]
   827   DATE (Date Fruit) [Food]
Meta Mapping (790):
   660   registration (registration - ActClass) [Intellectual Product]
   827   DATE (Date in time) [Temporal Concept]
Meta Mapping (790):
   660   registration (registration - ActClass) [Intellectual Product]
   827   DATE (Date Fruit) [Food]
Meta Mapping (790):
   660   Registration (Image Registration) [Machine Activity]
   827   DATE (Date in time) [Temporal Concept]
Meta Mapping (790):
   660   Registration (Image Registration) [Machine Activity]
   827   DATE (Date Fruit) [Food]

Phrase: :

Phrase: Documented .
Meta Mapping (1000):
  1000   Documented [Health Care Activity]
Meta Mapping (1000):
  1000   Documented (Document completion status - Documented) [Intellectual Product]
Processing 00000000.tx.8: Diarrhea responded initially to Paromomicin , but subsequent medical compliance was poor . 

Phrase: Diarrhea
Meta Mapping (1000):
  1000   DIARRHOEA (Diarrhea) [Sign or Symptom]
Meta Mapping (1000):
  1000   Diarrhea (Diarrhea Adverse Event) [Finding]

Phrase: responded

Phrase: initially to Paromomicin ,
Meta Mapping (790):
   790   Initially [Temporal Concept]

Phrase: but

Phrase: subsequent medical compliance
Meta Mapping (901):
   660   Subsequent (Following) [Temporal Concept]
   901   medical compliance [Idea or Concept]

Phrase: was

Phrase: poor .
Meta Mapping (1000):
  1000   Poor (Poverty) [Group Attribute]
Meta Mapping (1000):
  1000   Poor (Poor - grade value) [Qualitative Concept]
Meta Mapping (1000):
  1000   Poor (Poor - qualifier) [Qualitative Concept]
Processing 00000000.tx.9: PHYSICAL EXAMINATION : Skin : Scattered Kaposi &apos;s sarcoma , several necrotic lesions , right lower extremity , consistent with chronic ulcers . 

Phrase: PHYSICAL EXAMINATION
Meta Mapping (1000):
  1000   PHYSICAL EXAMINATION (Physical Examination) [Health Care Activity]

Phrase: :

Phrase: Skin
Meta Mapping (1000):
  1000   Skin (Skin Specimen) [Body Substance]
Meta Mapping (1000):
  1000   SKIN (Skin) [Body System]
Meta Mapping (1000):
  1000   Skin (Entire skin) [Body System]

Phrase: :

Phrase: Scattered Kaposi &apos
Meta Mapping (660):
   660   Scattered [Spatial Concept]

Phrase: ;s sarcoma ,
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   SARCOMA (Sarcoma) [Neoplastic Process]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Sarcoma (Sarcoma - category (morphologic abnormality)) [Neoplastic Process]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   SARCOMA (Sarcoma) [Neoplastic Process]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Sarcoma (Sarcoma - category (morphologic abnormality)) [Neoplastic Process]

Phrase: several necrotic lesions ,
Meta Mapping (901):
   913   Several lesions (Multiple lesions) [Finding]
   660   Necrotic (Necrosis) [Organ or Tissue Function]

Phrase: right lower extremity ,
Meta Mapping (1000):
  1000   Right lower extremity [Body Part, Organ, or Organ Component]

Phrase: consistent with chronic ulcers .
Meta Mapping (888):
   833   Consistent with [Idea or Concept]
   666   chronic ulcers (Chronic ulcer) [Disease or Syndrome]
Processing 00000000.tx.10: Extremities : Question left facial weakness , otherwise nonfocal . 

Phrase: Extremities
Meta Mapping (1000):
  1000   Extremities (Limb structure) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   extremities (All extremities) [Body Part, Organ, or Organ Component]

Phrase: :

Phrase: Question left facial weakness ,
Meta Mapping (861):
   645   Question (Question (inquiry)) [Intellectual Product]
   645   LEFT (Left) [Spatial Concept]
   861   Facial weakness (Facial Paresis) [Sign or Symptom]
Meta Mapping (861):
   645   Question (Question (inquiry)) [Intellectual Product]
   645   Left (Left sided) [Spatial Concept]
   861   Facial weakness (Facial Paresis) [Sign or Symptom]
Meta Mapping (861):
   645   Question (Question (inquiry)) [Intellectual Product]
   645   left (Table Cell Horizontal Align - left) [Functional Concept]
   861   Facial weakness (Facial Paresis) [Sign or Symptom]

Phrase: otherwise nonfocal .
Processing 00000000.tx.11: 2. 

Phrase: 2.
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]
Processing 00000000.tx.12: Kaposi &apos;s sarcoma : He received one unit packed red blood cells . 

Phrase: Kaposi &apos

Phrase: ;s sarcoma
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   SARCOMA (Sarcoma) [Neoplastic Process]
Meta Mapping (888):
   694   /s (per second) [Quantitative Concept]
   861   Sarcoma (Sarcoma - category (morphologic abnormality)) [Neoplastic Process]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   SARCOMA (Sarcoma) [Neoplastic Process]
Meta Mapping (888):
   694   S' (S prime) [Clinical Attribute]
   861   Sarcoma (Sarcoma - category (morphologic abnormality)) [Neoplastic Process]

Phrase: :

Phrase: He

Phrase: received
Meta Mapping (1000):
  1000   RECEIVED (Receive) [Qualitative Concept]

Phrase: one unit packed red blood cells .
Meta Mapping (888):
   632   ONE (One) [Quantitative Concept]
   632   Unit [Quantitative Concept]
   901   Packed red blood cells [Pharmacologic Substance]
Meta Mapping (888):
   632   ONE (One) [Quantitative Concept]
   632   Unit (Unit of Measure) [Quantitative Concept]
   901   Packed red blood cells [Pharmacologic Substance]
Meta Mapping (888):
   632   ONE (One) [Quantitative Concept]
   632   Unit (Storage Unit) [Manufactured Object]
   901   Packed red blood cells [Pharmacologic Substance]
Meta Mapping (888):
   632   ONE (One) [Quantitative Concept]
   632   Unit (Enzyme Unit) [Quantitative Concept]
   901   Packed red blood cells [Pharmacologic Substance]
Meta Mapping (888):
   632   ONE (One) [Quantitative Concept]
   632   Unit (Unit - NCI Thesaurus Property) [Functional Concept]
   901   Packed red blood cells [Pharmacologic Substance]
Processing 00000000.tx.13: 10/6/92 , full panel pending . 

Phrase: 10/6/92 ,
Meta Mapping (901):
   901   10^6 (Million) [Quantitative Concept]

Phrase: full panel pending .
Meta Mapping (623):
   660   Full [Qualitative Concept]
   660   Panel (Groups) [Idea or Concept]
Meta Mapping (623):
   660   Full [Qualitative Concept]
   660   Panel (Laboratory Order Panels) [Intellectual Product]
Meta Mapping (623):
   660   Full [Qualitative Concept]
   660   Panel (Panel Device Component) [Manufactured Object]
Processing 00000000.tx.14: Clarithromycin , 250 mg. 

Phrase: Clarithromycin ,
Meta Mapping (1000):
  1000   CLARITHROMYCIN (Clarithromycin) [Antibiotic,Organic Chemical]

Phrase: 250 mg.
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.15: , po , b.i.d. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: b.i.d.
Meta Mapping (901):
   901   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.16: , multivitamins , one , po , qD , Diflucan , 100 mg. 

Phrase: , multivitamins ,
Meta Mapping (1000):
  1000   MULTIVITAMINS (Multivitamin preparation) [Organic Chemical,Pharmacologic Substance,Vitamin]
Meta Mapping (1000):
  1000   MULTIVITAMINS (Multivitamin Drug Class) [Pharmacologic Substance,Vitamin]

Phrase: one ,
Meta Mapping (1000):
  1000   ONE (One) [Quantitative Concept]

Phrase: po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: qD ,
Meta Mapping (1000):
  1000   QD (Daily) [Temporal Concept]

Phrase: Diflucan ,
Meta Mapping (1000):
  1000   Diflucan [Organic Chemical,Pharmacologic Substance]

Phrase: 100 mg.
Meta Mapping (888):
   694   100% [Quantitative Concept]
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (888):
   694   100% [Quantitative Concept]
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (888):
   694   100% [Quantitative Concept]
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (888):
   694   100% [Quantitative Concept]
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.17: , po , qD , pyrimethamine , 25 mg. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: qD ,
Meta Mapping (1000):
  1000   QD (Daily) [Temporal Concept]

Phrase: pyrimethamine ,
Meta Mapping (1000):
  1000   PYRIMETHAMINE (Pyrimethamine) [Organic Chemical,Pharmacologic Substance]

Phrase: 25 mg.
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.18: , po , qD , Sulfadiazene , 500 mg. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: qD ,
Meta Mapping (1000):
  1000   QD (Daily) [Temporal Concept]

Phrase: Sulfadiazene ,

Phrase: 500 mg.
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.19: , po , b.i.d. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: b.i.d.
Meta Mapping (901):
   901   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.20: , acyclovir , 400 mg. 

Phrase: , acyclovir ,
Meta Mapping (1000):
  1000   Aciclovir (Acyclovir) [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: 400 mg.
Meta Mapping (861):
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (861):
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (861):
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (861):
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.21: , po , t.i.d. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: t.i.d.
Meta Mapping (901):
   827   T' (T prime) [Clinical Attribute]
   901   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.22: , Pyridex swish and spit , t.i.d. 

Phrase: , Pyridex swish
Meta Mapping (861):
   861   Swish [Functional Concept]

Phrase: and

Phrase: spit ,
Meta Mapping (1000):
  1000   spit (Spitting) [Physiologic Function]

Phrase: t.i.d.
Meta Mapping (901):
   827   T' (T prime) [Clinical Attribute]
   901   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.23: , leucovorin , 5 mg. 

Phrase: , leucovorin ,
Meta Mapping (1000):
  1000   Leukovorin (Leucovorin) [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: 5 mg.
Meta Mapping (888):
   694   >5 [Quantitative Concept]
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (888):
   694   >5 [Quantitative Concept]
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (888):
   694   >5 [Quantitative Concept]
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (888):
   694   >5 [Quantitative Concept]
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (888):
   694   +5 [Quantitative Concept]
   861   MG (Mongolia) [Geographic Area]
Meta Mapping (888):
   694   +5 [Quantitative Concept]
   861   mg% (mg/dL) [Quantitative Concept]
Meta Mapping (888):
   694   +5 [Quantitative Concept]
   861   mg % (Milligram percent) [Quantitative Concept]
Meta Mapping (888):
   694   +5 [Quantitative Concept]
   861   Mg++ (Magnesium Cation) [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.24: , po , q.o.d. 

Phrase: , po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: q.o.d.
Processing 00000000.tx.25: , Neutro-Phos I , 2 , po , qD . 

Phrase: , Neutro-Phos I ,
Meta Mapping (790):
   660   PHOS (Phosphate measurement) [Laboratory Procedure]
   827   I- (Iodides) [Inorganic Chemical]
Meta Mapping (790):
   660   PHOS (Phosphate measurement) [Laboratory Procedure]
   827   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]
Meta Mapping (790):
   660   Phos (Phos <invertebrate>) [Eukaryote]
   827   I- (Iodides) [Inorganic Chemical]
Meta Mapping (790):
   660   Phos (Phos <invertebrate>) [Eukaryote]
   827   I NOS (Blood group antibody I) [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: 2 ,
Meta Mapping (1000):
  1000   +2 [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score) [Quantitative Concept]
Meta Mapping (1000):
  1000   2+ (2+ Score, WHO) [Classification]
Meta Mapping (1000):
  1000   2+ [Finding]

Phrase: po ,
Meta Mapping (1000):
  1000   PO (Portugal) [Geographic Area]
Meta Mapping (1000):
  1000   PO (Oral) [Spatial Concept]

Phrase: qD .
Meta Mapping (1000):
  1000   QD (Daily) [Temporal Concept]
Processing 00000000.tx.26: TD :

Phrase: TD
Meta Mapping (1000):
  1000   TD (Trinidad and Tobago) [Geographic Area]
Meta Mapping (1000):
  1000   TD (Trial Disease Assessments Domain) [Intellectual Product]

Phrase: :
Processing 00000000.tx.1: 366324 Report Status : MRN : PRELIMINARY REPORT Your patient was admitted under the care of ANER , AEA M with a preliminary diagnosis of LINE SEPSIS .

Phrase: 366324 Report Status
Meta Mapping (901):
   901   Report status [Finding]

Phrase: :

Phrase: MRN

Phrase: :

Phrase: PRELIMINARY
Meta Mapping (1000):
  1000   Preliminary [Temporal Concept]

Phrase: REPORT
Meta Mapping (1000):
  1000   Report (Report (document)) [Intellectual Product]
Meta Mapping (1000):
  1000   Report (Reporting) [Health Care Activity]
Meta Mapping (1000):
  1000   Report (Regulatory Report) [Intellectual Product]

Phrase: Your patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted under the care of ANER ,
Meta Mapping (672):
   753   admitted (Hospital admission) [Health Care Activity]
   753   Care (care activity) [Activity]
Meta Mapping (672):
   753   Admitted (Admission activity) [Health Care Activity]
   753   Care (care activity) [Activity]

Phrase: AEA M with a preliminary diagnosis of LINE SEPSIS .
Meta Mapping (684):
   762   M line [Cell Component]
   598   Preliminary diagnosis (Preliminary diagnosis qualifier value) [Qualitative Concept]
   575   Sepsis (Septicemia) [Disease or Syndrome]
Meta Mapping (684):
   762   M line [Cell Component]
   598   Preliminary diagnosis (Preliminary diagnosis qualifier value) [Qualitative Concept]
   575   SEPSIS (Sepsis) [Disease or Syndrome]
Meta Mapping (684):
   762   M line [Cell Component]
   598   Preliminary diagnosis (Preliminary diagnosis qualifier value) [Qualitative Concept]
   575   Sepsis (Sepsis (Invertebrate)) [Eukaryote]
Meta Mapping (684):
   762   M line [Cell Component]
   598   Preliminary diagnosis (Diagnosis.preliminary:Impression/interpretation of study:Point in time:^Patient:Nominal) [Clinical Attribute]
   575   Sepsis (Septicemia) [Disease or Syndrome]
Meta Mapping (684):
   762   M line [Cell Component]
   598   Preliminary diagnosis (Diagnosis.preliminary:Impression/interpretation of study:Point in time:^Patient:Nominal) [Clinical Attribute]
   575   SEPSIS (Sepsis) [Disease or Syndrome]
Meta Mapping (684):
   762   M line [Cell Component]
   598   Preliminary diagnosis (Diagnosis.preliminary:Impression/interpretation of study:Point in time:^Patient:Nominal) [Clinical Attribute]
   575   Sepsis (Sepsis (Invertebrate)) [Eukaryote]
Processing 00000000.tx.1: 163688755 06/21/1991 INDUCIBLE COMPLETE HEART BLOCK . 

Phrase: 163688755 06/21/1991 INDUCIBLE COMPLETE HEART BLOCK .
Meta Mapping (777):
   626   Inducible (Induce (action)) [Functional Concept]
   835   Complete Heart Block (Complete atrioventricular block) [Disease or Syndrome]
Meta Mapping (777):
   626   Inducible (Induce (action)) [Functional Concept]
   835   Complete Heart Block (Electrocardiogram atrioventricular block complete heart block) [Finding]
Meta Mapping (777):
   626   Inducible NOS (NOS2A protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
   835   Complete Heart Block (Complete atrioventricular block) [Disease or Syndrome]
Meta Mapping (777):
   626   Inducible NOS (NOS2A protein, human) [Amino Acid, Peptide, or Protein,Enzyme]
   835   Complete Heart Block (Electrocardiogram atrioventricular block complete heart block) [Finding]
Processing 00000000.tx.2: Following discontinuation of this drug the patient noted return of palpitations . 

Phrase: Following
Meta Mapping (1000):
  1000   Following (Status post) [Temporal Concept]
Meta Mapping (1000):
  1000   Following [Temporal Concept]

Phrase: discontinuation of this drug
Meta Mapping (708):
   770   Discontinuation (Discontinuation (procedure)) [Health Care Activity]
   604   Drug (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (708):
   770   Discontinuation (Discontinuation (procedure)) [Health Care Activity]
   604   DRUG (Pharmacologic Substance) [Pharmacologic Substance]
Meta Mapping (708):
   770   Discontinuation (Discontinued) [Finding]
   604   Drug (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (708):
   770   Discontinuation (Discontinued) [Finding]
   604   DRUG (Pharmacologic Substance) [Pharmacologic Substance]

Phrase: the patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: noted
Meta Mapping (966):
   966   Note (Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}) [Clinical Attribute]
Meta Mapping (966):
   966   Note (Note (document)) [Intellectual Product]

Phrase: return of palpitations .
Meta Mapping (746):
   790   Return (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   623   PALPITATIONS (Palpitations) [Finding]
Meta Mapping (746):
   790   Return (Return to (contextual qualifier) (qualifier value)) [Qualitative Concept]
   623   Palpitations (Palpitations Adverse Event) [Finding]
Processing 00000000.tx.3: History of upper GI bleeding in 1985 while on nonsteroidal anti-inflammatory medicines . 

Phrase: History of upper GI bleeding
Meta Mapping (816):
   760   History [Occupation or Discipline]
   695   Upper GI bleeding (Upper gastrointestinal hemorrhage) [Pathologic Function]
Meta Mapping (816):
   760   history (Historical aspects qualifier) [Functional Concept]
   695   Upper GI bleeding (Upper gastrointestinal hemorrhage) [Pathologic Function]
Meta Mapping (816):
   760   History, NOS (History of present illness) [Organism Attribute]
   695   Upper GI bleeding (Upper gastrointestinal hemorrhage) [Pathologic Function]
Meta Mapping (816):
   760   History (Medical History) [Finding]
   695   Upper GI bleeding (Upper gastrointestinal hemorrhage) [Pathologic Function]
Meta Mapping (816):
   760   History (Concept History) [Conceptual Entity]
   695   Upper GI bleeding (Upper gastrointestinal hemorrhage) [Pathologic Function]
Meta Mapping (816):
   760   History (History of previous events) [Finding]
   695   Upper GI bleeding (Upper gastrointestinal hemorrhage) [Pathologic Function]

Phrase: in 1985

Phrase: while on nonsteroidal anti-inflammatory medicines .
Meta Mapping (833):
   833   Anti Inflammatory Medicines (Anti-Inflammatory Agents) [Pharmacologic Substance]
Processing 00000000.tx.4: MEDICATIONS ON ADMIT : SOCIAL HISTORY : Skin : She was taken to the Cardiac Catheterization Laboratory where a catheterization revealed an 80% mid-RCA stenosis , 80% mid-LAD lesion and an LVEF of approximately 80% . 

Phrase: MEDICATIONS ON
Meta Mapping (833):
   833   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
Meta Mapping (833):
   833   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
Meta Mapping (833):
   833   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]

Phrase: ADMIT
Meta Mapping (1000):
  1000   Admit (Hospital admission) [Health Care Activity]

Phrase: :

Phrase: SOCIAL HISTORY
Meta Mapping (1000):
  1000   Social history (Social and personal history) [Finding]
Meta Mapping (1000):
  1000   Social History [Finding]

Phrase: :

Phrase: Skin
Meta Mapping (1000):
  1000   Skin (Skin Specimen) [Body Substance]
Meta Mapping (1000):
  1000   SKIN (Skin) [Body System]
Meta Mapping (1000):
  1000   Skin (Entire skin) [Body System]

Phrase: :

Phrase: She

Phrase: was

Phrase: taken to the Cardiac Catheterization Laboratory where
Meta Mapping (756):
   748   Taken [Conceptual Entity]
   814   Cardiac Catheterization Laboratory [Health Care Related Organization]

Phrase: a catheterization
Meta Mapping (1000):
  1000   Catheterization [Therapeutic or Preventive Procedure]

Phrase: revealed
Meta Mapping (1000):
  1000   Revealed [Qualitative Concept]

Phrase: an 80% mid-RCA stenosis ,
Meta Mapping (791):
   645   80% [Finding]
   812   Stenosis (Stenosis Morphology) [Qualitative Concept]
Meta Mapping (791):
   645   80% [Finding]
   812   Stenosis [Pathologic Function]
Meta Mapping (791):
   645   80% [Finding]
   812   Stenosis (Stenosis (invertebrate)) [Eukaryote]

Phrase: 80% mid-LAD lesion
Meta Mapping (791):
   645   80% [Finding]
   812   Lesion [Finding]
Meta Mapping (791):
   645   80% [Finding]
   812   Lesion (Specimen Source Codes - Lesion) [Intellectual Product]

Phrase: and

Phrase: an LVEF of approximately 80% .
Meta Mapping (696):
   760   LVEF (Left ventricular ejection fraction) [Clinical Attribute]
   593   Approximately (Approximate) [Qualitative Concept]
   593   80% [Finding]
Meta Mapping (696):
   760   LV EF (Ejection fraction:Volume Fraction:Point in time:Heart.ventricle.left:Quantitative) [Clinical Attribute]
   593   Approximately (Approximate) [Qualitative Concept]
   593   80% [Finding]
Processing 00000000.tx.5: On the following day , she was taken to electrophysiologic study . 

Phrase: On the following day ,
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   /day (Daily) [Temporal Concept]
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   DAY (day) [Temporal Concept]
Meta Mapping (888):
   694   Following (Status post) [Temporal Concept]
   861   /day (per day) [Temporal Concept]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   /day (Daily) [Temporal Concept]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   DAY (day) [Temporal Concept]
Meta Mapping (888):
   694   Following [Temporal Concept]
   861   /day (per day) [Temporal Concept]

Phrase: she

Phrase: was

Phrase: taken to electrophysiologic study .
Meta Mapping (783):
   770   Taken [Conceptual Entity]
   833   electrophysiologic study (Cardiac electrophysiologic stimulation and recording study) [Diagnostic Procedure]
Processing 00000000.tx.6: During the study , the right bundle branch was hit by the catheter , inducing a right bundle branch block . 

Phrase: During the study ,
Meta Mapping (1000):
  1000   Study (Room of building - Study) [Manufactured Object]
Meta Mapping (1000):
  1000   Study [Research Activity]

Phrase: the right bundle branch
Meta Mapping (1000):
  1000   Right bundle branch (Structure of right branch of atrioventricular bundle) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Right bundle branch (Entire right branch of atrioventricular bundle) [Body Part, Organ, or Organ Component]

Phrase: was

Phrase: hit by the catheter ,
Meta Mapping (708):
   770   HIT (Heparin-induced thrombocytopenia) [Disease or Syndrome]
   770   CATHETER (catheter device) [Medical Device]
Meta Mapping (708):
   770   HIT (Heparin-induced thrombocytopenia) [Disease or Syndrome]
   770   Catheter (Catheter Device Component) [Medical Device]
Meta Mapping (708):
   770   hit (Struck by) [Functional Concept]
   770   CATHETER (catheter device) [Medical Device]
Meta Mapping (708):
   770   hit (Struck by) [Functional Concept]
   770   Catheter (Catheter Device Component) [Medical Device]
Meta Mapping (708):
   770   HIT (Hit - database search return) [Functional Concept]
   770   CATHETER (catheter device) [Medical Device]
Meta Mapping (708):
   770   HIT (Hit - database search return) [Functional Concept]
   770   Catheter (Catheter Device Component) [Medical Device]

Phrase: inducing
Meta Mapping (1000):
  1000   Inducing (Induce (action)) [Functional Concept]

Phrase: a right bundle branch block .
Meta Mapping (1000):
  1000   BUNDLE BRANCH BLOCK, RIGHT (Right bundle branch block) [Disease or Syndrome]
Meta Mapping (1000):
  1000   Right Bundle Branch Block (Electrocardiogram: right bundle branch block) [Finding]
Processing 00000000.tx.7: TAMYRCLEO KOTE , M.D. 

Phrase: TAMYRCLEO KOTE ,

Phrase: M.D.
Meta Mapping (1000):
  1000   M.D. (Doctor of Medicine) [Intellectual Product]
Processing 00000000.tx.8: EV68 ASSOCIATED DIAGNOSIS : On 01/24 she was taken to the Rys Memorial Hospital hospital , where she was diagnosed with choledocholithiasis . 

Phrase: EV68

Phrase: ASSOCIATED
Meta Mapping (1000):
  1000   Associated (Associated with) [Qualitative Concept]

Phrase: DIAGNOSIS
Meta Mapping (1000):
  1000   DIAGNOSIS (Diagnosis) [Finding]
Meta Mapping (1000):
  1000   diagnosis (diagnosis aspect) [Qualitative Concept]
Meta Mapping (1000):
  1000   DIAGNOSIS (Diagnosis Study) [Research Activity]

Phrase: :

Phrase: On 01/24

Phrase: she

Phrase: was

Phrase: taken to the Rys Memorial Hospital hospital ,
Meta Mapping (663):
   748   Taken [Conceptual Entity]
   748   HOSPITAL (Hospitals) [Health Care Related Organization,Manufactured Object]
Meta Mapping (663):
   748   Taken [Conceptual Entity]
   748   Hospital (Hospital environment) [Qualitative Concept]

Phrase: where

Phrase: she

Phrase: was

Phrase: diagnosed with choledocholithiasis .
Meta Mapping (746):
   790   Diagnosed (Diagnosis) [Finding]
   790   CHOLEDOCHOLITHIASIS (Choledocholithiasis) [Disease or Syndrome]
Processing 00000000.tx.9: Her mother died of an unspecified tumor . 

Phrase: Her mother
Meta Mapping (1000):
  1000   Mother (Mother (person)) [Family Group]

Phrase: died of an unspecified tumor .
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Cessation of life) [Organism Function]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Death (finding)) [Finding]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   UNSPECIFIED (Unspecified) [Qualitative Concept]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   Unspecified (Unspecified - Name type) [Idea or Concept]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   UNSPECIFIED (Unspecified State of Consciousness) [Finding]
   760   Tumor (Tumor Mass) [Finding]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumour NOS (Neoplasms) [Neoplastic Process]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumor (Specimen Source Codes - tumor) [Intellectual Product]
Meta Mapping (696):
   760   Died (Patient Outcome - Died) [Finding]
   760   Unspecified (External cause codes: Unspecified) [Finding]
   760   Tumor (Tumor Mass) [Finding]
Processing 00000000.tx.10: Sed rate 100 . 

Phrase: Sed rate 100 .
Meta Mapping (901):
   901   Sed Rate (Erythrocyte sedimentation rate measurement) [Laboratory Procedure]
   827   100% [Quantitative Concept]
Processing 00000000.tx.11: HOSPITAL COURSE : The patient was seen in consultation by the Gastroenterology service and it was decided that an esophagogastroduodenoscopy would be performed . 

Phrase: HOSPITAL COURSE
Meta Mapping (1000):
  1000   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (1000):
  1000   Hospital course [Finding]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: seen in consultation
Meta Mapping (746):
   790   Seen (seen) [Qualitative Concept]
   790   Consultation [Health Care Activity]

Phrase: by the Gastroenterology service
Meta Mapping (1000):
  1000   Gastroenterology service [Health Care Related Organization]

Phrase: and

Phrase: it

Phrase: was

Phrase: decided

Phrase: that

Phrase: an esophagogastroduodenoscopy
Meta Mapping (1000):
  1000   Oesophagogastroduodenoscopy (Esophagogastroduodenoscopy) [Diagnostic Procedure]

Phrase: would

Phrase: be

Phrase: performed .
Meta Mapping (1000):
  1000   Performed [Functional Concept]
Processing 00000000.tx.12: Prior to this study , however , a CT examination of the abdomen was obtained which showed a mass in the porta causing biliary ductal dilatation proximally and gastric outlet obstruction . 

Phrase: Prior to this study ,
Meta Mapping (1000):
  1000   Study (Room of building - Study) [Manufactured Object]
Meta Mapping (1000):
  1000   Study [Research Activity]

Phrase: however ,

Phrase: a CT examination of the abdomen
Meta Mapping (780):
   586   CT (Central African Republic) [Geographic Area]
   820   Examination of abdomen [Diagnostic Procedure]
Meta Mapping (780):
   586   CT (PCYT1A wt Allele) [Gene or Genome]
   820   Examination of abdomen [Diagnostic Procedure]
Meta Mapping (780):
   586   CT (Cancer/Testis Antigen) [Amino Acid, Peptide, or Protein]
   820   Examination of abdomen [Diagnostic Procedure]
Meta Mapping (780):
   586   CT (Computed Tomography Study File) [Intellectual Product]
   820   Examination of abdomen [Diagnostic Procedure]

Phrase: was

Phrase: obtained
Meta Mapping (1000):
  1000   Obtained (Obtain) [Functional Concept]

Phrase: which

Phrase: showed
Meta Mapping (966):
   966   Show [Animal]

Phrase: a mass in the porta
Meta Mapping (762):
   762   Portal mass (Liver mass) [Disease or Syndrome]

Phrase: causing
Meta Mapping (1000):
  1000   Causing [Functional Concept]

Phrase: biliary ductal dilatation proximally
Meta Mapping (875):
   875   bile duct dilatation (Dilatation of bile duct (procedure)) [Therapeutic or Preventive Procedure]
Meta Mapping (875):
   875   Bile duct dilatation (Bile duct dilatation (finding)) [Finding]

Phrase: and

Phrase: gastric outlet obstruction .
Meta Mapping (1000):
  1000   Gastric Outlet Obstruction (Pyloric Stenosis) [Pathologic Function]
Meta Mapping (1000):
  1000   Gastric Outlet Obstruction (Gastric outlet obstruction) [Disease or Syndrome]
Processing 00000000.tx.13: It appeared that there was a large tumor mass obstructing the duodenum and pylorus area , and therefore it was decided that she would benefit from a gastrojejunostomy for drainage of her stomach . 

Phrase: It

Phrase: appeared
Meta Mapping (966):
   966   APPEAR (Appearance) [Qualitative Concept]

Phrase: that

Phrase: there

Phrase: was

Phrase: a large tumor mass
Meta Mapping (1000):
  1000   Large Tumor Mass (Large tumor) [Qualitative Concept]

Phrase: obstructing
Meta Mapping (907):
   907   Obstructed [Functional Concept]

Phrase: the duodenum
Meta Mapping (1000):
  1000   DUODENUM (Duodenum) [Body Part, Organ, or Organ Component]
Meta Mapping (1000):
  1000   Duodenum (Entire duodenum) [Body Part, Organ, or Organ Component]

Phrase: and

Phrase: pylorus area ,
Meta Mapping (888):
   694   Pylorus [Body Part, Organ, or Organ Component]
   861   Area (Geographic Locations) [Geographic Area]
Meta Mapping (888):
   694   Pylorus [Body Part, Organ, or Organ Component]
   861   AREA (Area) [Spatial Concept]

Phrase: and

Phrase: therefore

Phrase: it

Phrase: was

Phrase: decided

Phrase: that

Phrase: she

Phrase: would

Phrase: benefit from a gastrojejunostomy
Meta Mapping (720):
   770   Benefit (benefit) [Quantitative Concept]
   770   gastro-jejunostomy (Gastrojejunostomy) [Therapeutic or Preventive Procedure]

Phrase: for drainage of her stomach .
Meta Mapping (770):
   770   Drainage, Gastric (Drainage, Gastric (specimen source code)) [Intellectual Product]
Processing 00000000.tx.14: The General Surgery service was involved at this stage , and on 05/08 a posterior gastrojejunostomy with wedge liver biopsy was performed to facilitate gastric drainage . 

Phrase: The General Surgery service
Meta Mapping (976):
   976   General surgical service [Health Care Related Organization]

Phrase: was

Phrase: involved at this stage ,
Meta Mapping (708):
   770   Involved (Involvement with) [Functional Concept]
   770   Stage (Phase) [Temporal Concept]
Meta Mapping (708):
   770   Involved (Involvement with) [Functional Concept]
   770   Stage (Tumor stage) [Clinical Attribute]
Meta Mapping (708):
   770   Involved (Involvement with) [Functional Concept]
   770   Stage [Qualitative Concept]

Phrase: and on 05/08

Phrase: a posterior gastrojejunostomy with wedge liver biopsy
Meta Mapping (728):
   778   Posterior gastrojejunostomy [Therapeutic or Preventive Procedure]
   607   Wedge Biopsy [Diagnostic Procedure]
   581   LIVER (Liver) [Body Part, Organ, or Organ Component]
Meta Mapping (728):
   778   Posterior gastrojejunostomy [Therapeutic or Preventive Procedure]
   607   Wedge Biopsy [Diagnostic Procedure]
   581   LIVER (Liver parenchyma) [Body Part, Organ, or Organ Component]
Meta Mapping (728):
   778   Posterior gastrojejunostomy [Therapeutic or Preventive Procedure]
   607   Wedge Biopsy [Diagnostic Procedure]
   581   Liver (Entire liver) [Body Part, Organ, or Organ Component]
Meta Mapping (728):
   778   Posterior gastrojejunostomy [Therapeutic or Preventive Procedure]
   607   Wedge Biopsy [Diagnostic Procedure]
   581   LIVER (Liver Flavor) [Food]
Meta Mapping (728):
   778   Posterior gastrojejunostomy [Therapeutic or Preventive Procedure]
   581   Wedge [Spatial Concept]
   612   Liver Biopsy (Biopsy of liver (procedure)) [Diagnostic Procedure]

Phrase: was

Phrase: performed
Meta Mapping (1000):
  1000   Performed [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: facilitate

Phrase: gastric drainage .
Meta Mapping (1000):
  1000   Drainage, Gastric (Drainage, Gastric (specimen source code)) [Intellectual Product]
Processing 00000000.tx.15: The patient &apos;s subsequent hospital course was fairly uneventful . 

Phrase: The patient &apos
Meta Mapping (694):
   694   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (694):
   694   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (694):
   694   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: ;s subsequent hospital course
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Subsequent (Following) [Temporal Concept]
   861   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (861):
   645   /s (per second) [Quantitative Concept]
   645   Subsequent (Following) [Temporal Concept]
   861   Hospital course [Finding]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Subsequent (Following) [Temporal Concept]
   861   Hospital course (Hospital course:Finding:Point in time:^Patient:Narrative) [Clinical Attribute]
Meta Mapping (861):
   645   S' (S prime) [Clinical Attribute]
   645   Subsequent (Following) [Temporal Concept]
   861   Hospital course [Finding]

Phrase: was

Phrase: fairly uneventful .
Processing 00000000.tx.16: DD : CC : <RECORD ID="840"> <TEXT> 30735304 Medications at the time of admission include Dapsone 50 mg p.o. on Monday , Wednesday and Friday , Ceftazidime 1 gram IV q. 

Phrase: DD
Meta Mapping (1000):
  1000   DD (AKR1C2 wt Allele) [Gene or Genome]
Meta Mapping (1000):
  1000   DD (ATP2A2 wt Allele) [Gene or Genome]

Phrase: :

Phrase: CC
Meta Mapping (1000):
  1000   CC (C-Circle) [Cell Component]

Phrase: :

Phrase: <RECORD ID="840"
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   Record (Records) [Intellectual Product]
   827   ID (Immune diffusion) [Laboratory Procedure]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Identifier) [Intellectual Product]
Meta Mapping (790):
   827   record (Record - QueryRequestLimit) [Quantitative Concept]
   827   ID (Immune diffusion) [Laboratory Procedure]

Phrase: >

Phrase: <TEXT
Meta Mapping (1000):
  1000   Text [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text - MDFAttributeType) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text Line) [Intellectual Product]
Meta Mapping (1000):
  1000   Text (Text (foundation metadata concept)) [Intellectual Product]

Phrase: > 30735304 Medications at the time of admission
Meta Mapping (701):
   748   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
   607   Admission time (Admission time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]
Meta Mapping (701):
   748   Medications (Pharmaceutical Preparations) [Pharmacologic Substance]
   607   Admission time [Temporal Concept]
Meta Mapping (701):
   748   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
   607   Admission time (Admission time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]
Meta Mapping (701):
   748   Medications (Medications:Presence or Identity:Duration of the study:^Patient:Nominal) [Clinical Attribute]
   607   Admission time [Temporal Concept]
Meta Mapping (701):
   748   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]
   607   Admission time (Admission time:ClockTime:Pt:^Patient:Qn) [Clinical Attribute]
Meta Mapping (701):
   748   Medications (Medications:-:Point in time:^Patient:-) [Clinical Attribute]
   607   Admission time [Temporal Concept]

Phrase: include
Meta Mapping (1000):
  1000   include (Including (qualifier)) [Functional Concept]
Meta Mapping (1000):
  1000   include (include - SetOperator) [Idea or Concept]
Meta Mapping (1000):
  1000   Include (Include (action)) [Activity]

Phrase: Dapsone 50 mg p.o.
Meta Mapping (717):
   717   Dapsone 50 MG [Clinical Drug]

Phrase: on Monday ,
Meta Mapping (1000):
  1000   Monday [Temporal Concept]

Phrase: Wednesday
Meta Mapping (1000):
  1000   Wednesday [Temporal Concept]

Phrase: and

Phrase: Friday ,
Meta Mapping (1000):
  1000   Friday [Temporal Concept]

Phrase: Ceftazidime 1 gram IV q.
Meta Mapping (574):
   637   CEFTAZIDIME (Ceftazidime) [Antibiotic,Organic Chemical]
   637   GRAM (gram) [Quantitative Concept]
   637   IV (Ivory Coast) [Geographic Area]
Processing 00000000.tx.17: 8 hours , Cipro 750 mg p.o. b.i.d. 

Phrase: 8 hours ,
Meta Mapping (1000):
  1000   8 Hours [Temporal Concept]

Phrase: Cipro 750 mg p.o. b.i.d.
Meta Mapping (795):
   793   Cipro [Organic Chemical,Pharmacologic Substance]
   864   mg/d (milligram/day) [Quantitative Concept]
Processing 00000000.tx.18: , Acyclovir 400 mg p.o. q. day , Megastrol 80 mg p.o. t.i.d. and G-CSF 150 micrograms subcu b.i.d. 

Phrase: , Acyclovir 400 mg p.o. q. day ,
Meta Mapping (828):
   679   Acyclovir 400 MG [Clinical Drug]
   795   /day (Daily) [Temporal Concept]
Meta Mapping (828):
   679   Acyclovir 400 MG [Clinical Drug]
   795   DAY (day) [Temporal Concept]
Meta Mapping (828):
   679   Acyclovir 400 MG [Clinical Drug]
   795   /day (per day) [Temporal Concept]

Phrase: Megastrol 80 mg p.o. t.i.d.
Meta Mapping (784):
   793   80% [Finding]
   864   mg/d (milligram/day) [Quantitative Concept]

Phrase: and

Phrase: G-CSF 150 micrograms subcu b.i.d.
Meta Mapping (595):
   645   G CSF (Granulocyte Colony-Stimulating Factor) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   626   micrograms (microgram) [Quantitative Concept]
   645   i d (Incision and drainage) [Therapeutic or Preventive Procedure]
Processing 00000000.tx.19: Cardiovascular exam has a normal S1 and S2 without murmurs . 

Phrase: Cardiovascular exam
Meta Mapping (888):
   694   Cardiovascular (Cardiovascular system) [Body System]
   861   Exam (Medical Examination) [Health Care Activity]
Meta Mapping (888):
   694   CARDIOVASCULAR (Cardiovascular) [Body Location or Region]
   861   Exam (Medical Examination) [Health Care Activity]

Phrase: has

Phrase: a normal S1
Meta Mapping (888):
   694   NORMAL (Normal) [Qualitative Concept]
   861   S1 [Finding]
Meta Mapping (888):
   694   NORMAL (Normal) [Qualitative Concept]
   861   S1 (Testicular Cancer Serum Markers Test Result S1) [Laboratory or Test Result]
Meta Mapping (888):
   694   Normal (Gait normal) [Finding]
   861   S1 [Finding]
Meta Mapping (888):
   694   Normal (Gait normal) [Finding]
   861   S1 (Testicular Cancer Serum Markers Test Result S1) [Laboratory or Test Result]
Meta Mapping (888):
   694   % normal (Percent normal) [Quantitative Concept]
   861   S1 [Finding]
Meta Mapping (888):
   694   % normal (Percent normal) [Quantitative Concept]
   861   S1 (Testicular Cancer Serum Markers Test Result S1) [Laboratory or Test Result]
Meta Mapping (888):
   694   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   S1 [Finding]
Meta Mapping (888):
   694   % Normal (Mean Percent of Normal) [Quantitative Concept]
   861   S1 (Testicular Cancer Serum Markers Test Result S1) [Laboratory or Test Result]

Phrase: and

Phrase: S2 without murmurs .
Meta Mapping (746):
   790   S2 (S2 innervation) [Body Location or Region]
   623 N murmurs (Heart murmur) [Finding]
Meta Mapping (746):
   790   S2 (PSMD2 gene) [Gene or Genome]
   623 N murmurs (Heart murmur) [Finding]
Meta Mapping (746):
   790   S2 (RPS2 gene) [Gene or Genome]
   623 N murmurs (Heart murmur) [Finding]
Meta Mapping (746):
   790 N S2 (Testicular Cancer Serum Markers Test Result S2) [Laboratory or Test Result]
   623 N murmurs (Heart murmur) [Finding]
Meta Mapping (746):
   790 N S2 [Finding]
   623 N murmurs (Heart murmur) [Finding]
Processing 00000000.tx.20: The patient was started on Amphotericine at .6 mg / kg for a total of 250 mg for positive blood cultures for candida . 

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: started on Amphotericine
Meta Mapping (790):
   790   Started [Qualitative Concept]

Phrase: at .6 mg / kg for a total of 250 mg
Meta Mapping (679):
   760   mg kg (ug/g) [Quantitative Concept]
   573   % total (% of total) [Quantitative Concept]
Meta Mapping (679):
   760   mg kg (ug/g) [Quantitative Concept]
   573   Total [Qualitative Concept]

Phrase: for positive blood cultures for candida .
Meta Mapping (782):
   586   % Positive (percent positive cells) [Quantitative Concept]
   803   Blood for culture [Finding]
   586   CANDIDA (Candida (fungus)) [Fungus]
Meta Mapping (782):
   586   Positive [Qualitative Concept]
   803   Blood for culture [Finding]
   586   CANDIDA (Candida (fungus)) [Fungus]
Meta Mapping (782):
   586   POSITIVE (Positive Finding) [Finding]
   803   Blood for culture [Finding]
   586   CANDIDA (Candida (fungus)) [Fungus]
Meta Mapping (782):
   586   Positive (Positive Charge) [Qualitative Concept]
   803   Blood for culture [Finding]
   586   CANDIDA (Candida (fungus)) [Fungus]
Meta Mapping (782):
   586   Positive (Positive Number) [Conceptual Entity]
   803   Blood for culture [Finding]
   586   CANDIDA (Candida (fungus)) [Fungus]
Processing 00000000.tx.21: DISPOSITION : The patient needs to have his blood drawn the day after discharge to check a potassium and magnesium which he has been wasting secondary to Amphotericine . 

Phrase: DISPOSITION
Meta Mapping (1000):
  1000   Disposition [Idea or Concept]
Meta Mapping (1000):
  1000   Disposition (Disposition Domain) [Intellectual Product]

Phrase: :

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: needs
Meta Mapping (1000):
  1000   Needs [Qualitative Concept]
Meta Mapping (1000):
  1000   needs (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: have

Phrase: his blood
Meta Mapping (1000):
  1000   Blood [Tissue]
Meta Mapping (1000):
  1000   BLOOD (In Blood) [Body Substance]
Meta Mapping (1000):
  1000   BLOOD (peripheral blood) [Body Substance]

Phrase: drawn
Meta Mapping (966):
   966   Draw (Drawings (art)) [Intellectual Product]

Phrase: the day after discharge
Meta Mapping (802):
   660   /day (Daily) [Temporal Concept]
   827   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (802):
   660   /day (Daily) [Temporal Concept]
   827   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (802):
   660   /day (Daily) [Temporal Concept]
   827   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (802):
   660   DAY (day) [Temporal Concept]
   827   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (802):
   660   DAY (day) [Temporal Concept]
   827   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (802):
   660   DAY (day) [Temporal Concept]
   827   Discharge (Discharge, body substance) [Body Substance]
Meta Mapping (802):
   660   /day (per day) [Temporal Concept]
   827   Discharge (Body Fluid Discharge) [Body Substance]
Meta Mapping (802):
   660   /day (per day) [Temporal Concept]
   827   Discharge (Patient Discharge) [Health Care Activity]
Meta Mapping (802):
   660   /day (per day) [Temporal Concept]
   827   Discharge (Discharge, body substance) [Body Substance]

Phrase: to
Meta Mapping (1000):
  1000   TO (Togo) [Geographic Area]
Meta Mapping (1000):
  1000   TO (Tryptophanase) [Amino Acid, Peptide, or Protein,Enzyme]
Meta Mapping (1000):
  1000   To [Qualitative Concept]

Phrase: check
Meta Mapping (1000):
  1000   Check (Checking (action)) [Activity]

Phrase: a potassium
Meta Mapping (1000):
  1000   POTASSIUM (Potassium) [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   Potassium+ (Potassium measurement) [Laboratory Procedure]
Meta Mapping (1000):
  1000   POTASSIUM (Potassium supplement) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   Potassium (Potassium Ion) [Element, Ion, or Isotope,Pharmacologic Substance]
Meta Mapping (1000):
  1000   POTASSIUM (Potassium Drug Class) [Pharmacologic Substance]

Phrase: and

Phrase: magnesium
Meta Mapping (1000):
  1000   MAGNESIUM (Magnesium) [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   MAGNESIUM (Dietary Magnesium) [Element, Ion, or Isotope]
Meta Mapping (1000):
  1000   Magnesium (Magnesium supplements) [Inorganic Chemical,Pharmacologic Substance]
Meta Mapping (1000):
  1000   MAGNESIUM (Magnesium Drug Class) [Pharmacologic Substance]

Phrase: which he

Phrase: has

Phrase: been

Phrase: wasting
Meta Mapping (1000):
  1000   Wasting (Cachexia) [Sign or Symptom]
Meta Mapping (1000):
  1000   WASTING (Wasting) [Disease or Syndrome]

Phrase: secondary to Amphotericine .
Meta Mapping (882):
   882   Secondary to [Temporal Concept]
Processing 00000000.tx.22: He will need follow up lytes drawn throughout the week . 

Phrase: He

Phrase: will

Phrase: need
Meta Mapping (1000):
  1000   Need (Needs) [Qualitative Concept]
Meta Mapping (1000):
  1000   need (Patient need for (contextual qualifier)) [Functional Concept]

Phrase: follow up lytes
Meta Mapping (734):
   734   Follow-up (Follow-up status) [Finding]
Meta Mapping (734):
   734   Follow Up (follow-up) [Health Care Activity]
Meta Mapping (734):
   734   Follow-Up (Follow-Up Report) [Intellectual Product]
Meta Mapping (734):
   734   FOLLOW-UP (Clinical Study Follow-up) [Health Care Activity]

Phrase: drawn throughout the week .
Meta Mapping (691):
   737   Draw (Drawings (art)) [Intellectual Product]
   770   /week (Weekly) [Temporal Concept]
Meta Mapping (691):
   737   Draw (Drawings (art)) [Intellectual Product]
   770   WEEK (week) [Temporal Concept]
Processing 00000000.tx.23: Batch :

Phrase: Batch
Meta Mapping (1000):
  1000   Batch (Batch (Response Modality)) [Intellectual Product]
Meta Mapping (1000):
  1000   Batch (Batch (group)) [Quantitative Concept]
Meta Mapping (1000):
  1000   BATCH (Batch Number) [Intellectual Product]

Phrase: :
Processing 00000000.tx.1: 07/10/1998 The patient was admitted preoperatively for surgery on 7/4/98 .

Phrase: 07/10/1998
Meta Mapping (827):
   827   10% [Finding]

Phrase: The patient
Meta Mapping (1000):
  1000   *^patient (Patients) [Patient or Disabled Group]
Meta Mapping (1000):
  1000   Patient (Abortion consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Hysterectomy consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]
Meta Mapping (1000):
  1000   Patient (Sterilization consent:Finding:Point in time:^Patient:Document) [Clinical Attribute]

Phrase: was

Phrase: admitted
Meta Mapping (1000):
  1000   admitted (Hospital admission) [Health Care Activity]
